data_1zzv_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1zzv _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 11.7 pt20 . . . . . 0 C--O 1.233 0.207 0 N-CA-C 109.438 -0.579 . . . . 4.51 109.438 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.424 HG11 HG13 ' A' ' 5' ' ' ILE . 48.0 t -139.88 141.18 34.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.528 -0.305 . . . . 2.2 110.919 -174.879 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -129.35 110.49 11.97 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.313 0.578 . . . . 2.75 109.67 177.415 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.424 HG13 HG11 ' A' ' 3' ' ' VAL . 58.2 mt -137.33 156.79 33.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 N-CA-C 109.413 -0.588 . . . . 1.5 109.413 -178.129 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . 0.629 ' HB1' ' HD2' ' A' ' 7' ' ' PRO . . . -161.69 163.45 19.54 Favored Pre-proline 0 C--N 1.324 -0.507 0 N-CA-C 109.796 -0.446 . . . . 1.99 109.796 -174.578 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.629 ' HD2' ' HB1' ' A' ' 6' ' ' ALA . 6.1 Cg_exo -38.4 135.63 0.68 Allowed 'Trans proline' 0 C--N 1.352 0.735 0 C-N-CA 124.317 3.345 . . . . 1.73 114.151 -176.623 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.439 ' O ' ' HB2' ' A' ' 9' ' ' SER . . . -178.05 -75.71 0.06 OUTLIER Glycine 0 N--CA 1.443 -0.859 0 N-CA-C 110.31 -1.116 . . . . 1.84 110.31 -179.637 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.439 ' HB2' ' O ' ' A' ' 8' ' ' GLY . 8.5 t 174.04 148.25 0.07 Allowed 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 107.277 -1.379 . . . . 1.87 107.277 175.389 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.517 HD21 HG22 ' A' ' 32' ' ' THR . 56.1 tp -56.09 -42.59 76.98 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 119.348 0.976 . . . . 1.83 111.304 -173.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -50.75 -55.52 16.33 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 115.795 -0.638 . . . . 2.11 112.006 177.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 55.7 mtmt -65.13 -27.51 68.78 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 111.719 0.266 . . . . 3.11 111.719 179.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -65.23 -54.88 22.78 Favored 'General case' 0 C--O 1.233 0.237 0 CA-C-O 120.952 0.406 . . . . 1.17 110.114 179.602 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 94.9 mt -59.36 -38.34 80.16 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 115.836 -0.62 . . . . 1.31 111.129 176.614 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 50.8 t-20 -60.0 -47.05 87.41 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.659 -0.497 . . . . 1.98 109.659 178.641 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . 0.435 HE21 ' HB3' ' A' ' 16' ' ' GLN . 1.0 OUTLIER -61.74 -42.32 98.81 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.799 -0.637 . . . . 2.33 111.108 -179.982 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.462 ' HD1' ' HZ ' ' A' ' 23' ' ' PHE . 1.9 t80 -66.67 -39.55 88.22 Favored 'General case' 0 CA--C 1.53 0.187 0 N-CA-C 109.747 -0.464 . . . . 1.05 109.747 -177.837 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.75 ' HA ' ' CE2' ' A' ' 23' ' ' PHE . . . -52.71 -42.82 65.19 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.186 -0.461 . . . . 1.15 111.872 177.772 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.37 -22.88 67.15 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.221 -0.445 . . . . 1.26 111.851 -179.344 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . 0.429 ' HB3' ' O ' ' A' ' 17' ' ' TYR . 77.2 t60 -64.82 -62.9 1.28 Allowed 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.18 0.437 . . . . 2.52 112.18 -178.534 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.644 ' HB2' ' CD1' ' A' ' 23' ' ' PHE . 9.6 m -100.46 -4.65 28.43 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 112.543 0.572 . . . . 1.79 112.543 -172.676 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 67.27 47.49 63.65 Favored Glycine 0 CA--C 1.52 0.379 0 C-N-CA 121.099 -0.572 . . . . 0.68 113.419 177.642 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.75 ' CE2' ' HA ' ' A' ' 18' ' ' ALA . 3.7 p90 -104.61 171.4 7.35 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 110.152 -0.314 . . . . 0.68 110.152 178.285 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.405 ' O ' ' HB3' ' A' ' 68' ' ' SER . 24.0 m -97.06 122.69 40.34 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.255 0.55 . . . . 1.3 111.959 -175.237 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.651 HD21 ' CE3' ' A' ' 69' ' ' TRP . 1.5 mm? -96.27 143.35 27.43 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.56 -0.746 . . . . 2.3 111.07 178.148 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 8.0 t -123.03 91.37 3.47 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 108.943 -0.762 . . . . 1.67 108.943 172.43 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 6.0 p -148.76 138.26 15.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.929 -0.578 . . . . 1.52 110.581 -175.054 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -102.27 131.87 48.58 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.293 -0.412 . . . . 2.38 110.153 178.54 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.1 70.34 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.34 0 O-C-N 123.583 0.552 . . . . 2.45 112.215 178.338 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 50.0 p -163.98 -49.08 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.146 -0.479 . . . . 2.48 109.939 -177.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.417 ' O ' HD12 ' A' ' 59' ' ' LEU . 98.0 mt -63.63 -39.07 93.43 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.213 -0.449 . . . . 1.92 110.227 176.295 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.517 HG22 HD21 ' A' ' 10' ' ' LEU . 2.3 p -91.65 3.07 55.93 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.662 -0.699 . . . . 1.82 111.446 179.6 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 6.0 tpp180 -75.42 106.41 6.95 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.064 -0.516 . . . . 5.19 111.216 -174.189 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 119.27 -45.89 1.2 Allowed Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.346 -0.931 . . . . 1.62 113.808 172.33 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.782 ' HD2' ' H ' ' A' ' 35' ' ' LYS . 0.0 OUTLIER -67.94 137.08 54.9 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.545 0.688 . . . . 3.17 111.741 -174.355 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 5.3 tp-100 -102.73 152.84 20.76 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 114.921 -1.036 . . . . 2.52 110.073 -175.269 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 22.9 t -133.99 123.28 24.33 Favored 'General case' 0 N--CA 1.444 -0.743 0 N-CA-C 107.174 -1.417 . . . . 1.14 107.174 175.29 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 11.7 m120 -67.79 3.28 1.52 Allowed 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 112.907 0.706 . . . . 1.28 112.907 -173.591 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 107.35 -176.52 21.02 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.612 -0.804 . . . . 0.49 112.958 170.395 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.422 HD11 ' HB3' ' A' ' 52' ' ' GLN . 39.6 tp -160.3 122.89 3.33 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 108.778 -0.823 . . . . 1.36 108.778 -176.366 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 10.7 t-80 -144.48 98.59 3.22 Favored 'General case' 0 C--N 1.321 -0.664 0 C-N-CA 120.296 -0.561 . . . . 3.8 110.964 -179.202 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -168.91 -169.5 32.37 Favored Glycine 0 N--CA 1.446 -0.636 0 CA-C-N 115.264 -0.88 . . . . 0.55 111.627 177.04 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -81.99 76.75 8.87 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.242 -0.651 . . . . 2.18 109.242 175.305 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 78.8 m-85 -107.82 138.38 44.15 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.25 0.548 . . . . 1.5 111.707 -175.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -101.93 -170.35 1.81 Allowed 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 108.904 -0.776 . . . . 2.23 108.904 173.208 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 56.0 t -51.97 -71.31 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 112.739 0.644 . . . . 1.25 112.739 -173.321 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -64.4 -40.82 96.54 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 112.548 0.573 . . . . 2.39 112.548 -172.237 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 56.7 m -71.02 -25.9 62.88 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-O 120.919 0.39 . . . . 1.65 110.877 -174.518 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.47 ' O ' ' HG ' ' A' ' 53' ' ' LEU . . . -72.4 -37.71 58.61 Favored Glycine 0 N--CA 1.447 -0.621 0 C-N-CA 120.761 -0.733 . . . . 0.4 111.466 178.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.536 HD21 HG11 ' A' ' 61' ' ' VAL . 84.8 mt -67.53 -43.1 81.6 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.024 0.44 . . . . 1.63 110.86 -178.808 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 36.2 tt0 -56.99 -42.19 79.78 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.625 -0.716 . . . . 3.01 110.839 -179.39 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.422 ' HB3' HD11 ' A' ' 40' ' ' LEU . 25.6 mm-40 -70.0 -37.71 75.75 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 111.895 0.331 . . . . 2.18 111.895 176.205 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.47 ' HG ' ' O ' ' A' ' 49' ' ' GLY . 58.9 mt -58.47 -17.74 23.33 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 112.197 0.443 . . . . 1.4 112.197 178.852 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 79.6 mt -69.8 -12.31 61.53 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.443 -0.344 . . . . 2.78 111.007 177.517 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -67.4 109.55 3.22 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 121.041 0.448 . . . . 2.24 110.038 178.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 105.66 -6.65 41.51 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.925 -0.655 . . . . 1.96 112.109 -179.221 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 49.1 m -121.75 169.35 10.82 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.833 0.349 . . . . 2.28 110.845 -179.145 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -121.21 15.62 9.34 Favored Glycine 0 N--CA 1.444 -0.813 0 N-CA-C 110.58 -1.008 . . . . 1.79 110.58 172.317 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.515 HD13 HD21 ' A' ' 71' ' ' LEU . 90.8 mt -92.56 -179.4 5.17 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.697 -0.482 . . . . 1.82 109.697 -178.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . 0.403 ' OE1' ' HB1' ' A' ' 74' ' ' ALA . 49.7 mt-30 -139.72 117.85 11.9 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 108.772 -0.825 . . . . 3.26 108.772 177.837 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.536 HG11 HD21 ' A' ' 50' ' ' LEU . 18.4 t -86.99 113.6 24.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 N-CA-C 109.095 -0.706 . . . . 2.17 109.095 177.084 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -115.95 116.86 40.08 Favored Pre-proline 0 C--N 1.32 -0.702 0 CA-C-N 116.333 -0.394 . . . . 2.29 110.027 -171.112 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_exo -52.7 121.8 9.82 Favored 'Trans proline' 0 N--CA 1.463 -0.284 0 C-N-CA 122.646 2.231 . . . . 0.94 111.551 176.508 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.566 ' H ' ' HA ' ' A' ' 69' ' ' TRP . 3.3 tm? -68.53 -53.8 20.79 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.673 -0.694 . . . . 2.32 109.523 -177.696 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 176.78 149.33 7.62 Favored Glycine 0 N--CA 1.441 -0.986 0 N-CA-C 110.484 -1.046 . . . . 1.69 110.484 178.16 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 91.2 m-20 65.47 -82.07 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 122.606 0.362 . . . . 3.67 111.239 -179.612 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -147.16 13.18 1.1 Allowed 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.404 -0.591 . . . . 2.59 109.404 -178.713 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' SER . . . . . 0.405 ' HB3' ' O ' ' A' ' 24' ' ' THR . 42.9 m -103.56 174.32 5.92 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 108.691 -0.855 . . . . 1.54 108.691 -174.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' TRP . . . . . 0.651 ' CE3' HD21 ' A' ' 25' ' ' LEU . 34.1 m0 -139.64 161.92 36.36 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 118.136 0.426 . . . . 0.54 109.874 -173.671 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 13.9 t -142.72 149.3 38.6 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 108.071 -1.085 . . . . 1.49 108.071 169.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.515 HD21 HD13 ' A' ' 59' ' ' LEU . 37.9 tp -92.45 105.52 17.69 Favored 'General case' 0 C--N 1.32 -0.694 0 C-N-CA 120.048 -0.661 . . . . 2.24 110.186 -178.377 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -87.2 118.79 70.45 Favored Pre-proline 0 C--N 1.317 -0.808 0 CA-C-N 114.699 -1.137 . . . . 2.25 110.024 -179.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -83.17 115.01 2.26 Favored 'Trans proline' 0 N--CA 1.45 -1.087 0 C-N-CA 122.341 2.027 . . . . 1.45 112.409 -178.552 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.403 ' HB1' ' OE1' ' A' ' 60' ' ' GLN . . . . . . . . 0 C--N 1.32 -0.704 0 CA-C-N 115.474 -0.784 . . . . 2.07 110.137 174.316 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.454 -0.25 0 CA-C-O 121.697 0.76 . . . . 4.51 110.674 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 27.7 m -94.83 129.76 44.57 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-N 115.497 -0.774 . . . . 2.2 109.828 -177.474 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 40.1 m-80 -128.16 96.71 4.54 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.413 0.625 . . . . 2.75 109.329 -178.114 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.688 HD11 ' HB3' ' A' ' 40' ' ' LEU . 3.6 mp -105.0 112.39 38.43 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-N 115.279 -0.873 . . . . 1.5 109.563 -178.069 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -85.49 155.94 59.4 Favored Pre-proline 0 C--N 1.32 -0.705 0 CA-C-N 115.855 -0.611 . . . . 1.99 109.491 178.302 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.626 ' HA ' ' O ' ' A' ' 37' ' ' SER . 31.6 Cg_exo -58.88 136.07 71.08 Favored 'Trans proline' 0 C--O 1.234 0.323 0 C-N-CA 121.663 1.575 . . . . 1.73 109.858 169.779 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 149.2 49.9 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.011 -1.09 . . . . 1.84 111.893 -170.475 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.651 ' HA ' ' HA ' ' A' ' 36' ' ' GLN . 25.9 t 66.36 145.85 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 123.282 0.633 . . . . 1.87 112.1 -177.697 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.907 HD23 ' HB3' ' A' ' 37' ' ' SER . 3.0 mm? -57.52 -28.9 63.89 Favored 'General case' 0 N--CA 1.461 0.086 0 CA-C-N 115.784 -0.643 . . . . 1.83 109.987 172.547 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.632 ' HB2' ' HB ' ' A' ' 32' ' ' THR . 18.7 t70 -44.11 -62.48 1.13 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 114.549 -1.205 . . . . 2.11 111.796 178.563 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.427 ' HA ' ' HB3' ' A' ' 15' ' ' ASN . 36.5 ttpt -69.38 -19.93 63.83 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.423 -0.353 . . . . 3.11 111.535 -177.743 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -65.7 -56.45 12.0 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-O 121.134 0.493 . . . . 1.17 109.677 178.529 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 74.5 mt -57.86 -38.31 75.46 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.513 -0.767 . . . . 1.31 110.943 174.437 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . 0.427 ' HB3' ' HA ' ' A' ' 12' ' ' LYS . 21.4 t-20 -58.83 -42.02 88.25 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.124 -0.489 . . . . 1.98 110.655 177.106 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . 0.456 HE21 ' HB3' ' A' ' 16' ' ' GLN . 1.0 OUTLIER -60.63 -43.08 97.95 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.953 -0.567 . . . . 2.33 110.548 178.191 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.436 ' HD1' ' HZ ' ' A' ' 23' ' ' PHE . 0.3 OUTLIER -67.42 -51.14 55.31 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.767 0.317 . . . . 1.05 110.63 -179.094 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.74 ' HA ' ' CE2' ' A' ' 23' ' ' PHE . . . -52.26 -53.4 44.29 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 115.799 -0.637 . . . . 1.15 112.352 -177.598 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.77 -21.07 66.24 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.255 -0.429 . . . . 1.26 111.958 -177.245 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 32.0 t60 -65.26 -53.62 41.56 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 111.622 0.23 . . . . 2.52 111.622 -177.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.567 ' HB3' ' CD1' ' A' ' 23' ' ' PHE . 48.1 t -99.81 -7.63 25.18 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.064 0.459 . . . . 1.79 110.997 -178.109 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 76.3 44.27 17.96 Favored Glycine 0 N--CA 1.446 -0.687 0 CA-C-N 115.715 -0.675 . . . . 0.68 112.864 178.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.74 ' CE2' ' HA ' ' A' ' 18' ' ' ALA . 14.1 p90 -108.57 149.72 28.47 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.532 -0.544 . . . . 0.68 109.532 176.903 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 28.1 m -90.31 123.61 34.21 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.083 -0.508 . . . . 1.3 111.219 -174.392 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.599 HD11 ' HE3' ' A' ' 69' ' ' TRP . 0.9 OUTLIER -92.86 140.5 29.44 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.655 -0.702 . . . . 2.3 111.458 -179.914 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.514 ' HB3' ' HA ' ' A' ' 70' ' ' THR . 29.6 t -100.66 92.18 4.99 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.041 -0.725 . . . . 1.67 109.041 174.043 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.778 ' HB ' HD23 ' A' ' 71' ' ' LEU . 7.4 p -146.5 134.27 15.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.816 -0.629 . . . . 1.52 110.429 -178.729 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 -89.43 128.82 35.99 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.058 -0.519 . . . . 2.38 110.216 178.636 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.79 60.87 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.425 0 O-C-N 123.722 0.639 . . . . 2.45 111.667 173.36 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.768 ' HA ' ' HG3' ' A' ' 33' ' ' ARG . 68.7 m -165.28 -27.79 0.03 OUTLIER 'General case' 0 C--N 1.321 -0.642 0 C-N-CA 123.429 0.692 . . . . 2.48 109.406 -176.956 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 97.1 mt -73.29 -23.13 60.25 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.414 0.626 . . . . 1.92 109.585 173.513 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.632 ' HB ' ' HB2' ' A' ' 11' ' ' ASP . 17.5 p -98.45 13.0 33.27 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.167 -0.924 . . . . 1.82 111.212 179.527 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.768 ' HG3' ' HA ' ' A' ' 30' ' ' SER . 29.4 mtt180 -67.16 126.17 28.35 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.114 -0.494 . . . . 5.19 111.245 -179.429 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 67.58 17.27 68.68 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 121.038 -0.601 . . . . 1.62 112.275 178.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 5.8 mptp? -88.44 148.96 23.94 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.05 0.452 . . . . 3.17 110.572 178.606 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . 0.651 ' HA ' ' HA ' ' A' ' 9' ' ' SER . 15.0 pt20 -144.02 137.87 27.97 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.51 -0.768 . . . . 2.52 109.787 171.24 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.907 ' HB3' HD23 ' A' ' 10' ' ' LEU . 50.7 p -119.99 124.59 46.31 Favored 'General case' 0 N--CA 1.443 -0.784 0 N-CA-C 108.226 -1.027 . . . . 1.14 108.226 -177.066 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -57.26 -32.45 66.6 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 112.274 0.472 . . . . 1.28 112.274 -175.545 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 134.17 178.24 15.49 Favored Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 120.312 -0.947 . . . . 0.49 112.481 175.316 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.688 ' HB3' HD11 ' A' ' 5' ' ' ILE . 55.1 tp -160.14 126.12 4.15 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 107.603 -1.258 . . . . 1.36 107.603 -179.678 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 72.1 m80 -142.43 99.61 3.53 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.992 0.425 . . . . 3.8 111.439 -174.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -169.14 -170.13 33.35 Favored Glycine 0 N--CA 1.449 -0.459 0 N-CA-C 111.346 -0.702 . . . . 0.55 111.346 175.488 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -101.35 76.61 1.71 Allowed 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 108.353 -0.98 . . . . 2.18 108.353 171.543 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 26.6 m-85 -91.18 150.42 21.37 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.043 -0.98 . . . . 1.5 111.421 -173.735 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 50.4 m-20 -110.24 176.03 5.21 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 107.941 -1.133 . . . . 2.23 107.941 169.218 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 16.5 t -49.11 -62.49 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 N-CA-C 112.211 0.448 . . . . 1.25 112.211 -169.331 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 25.9 mm-40 -44.31 -60.44 1.92 Allowed 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 113.182 0.808 . . . . 2.39 113.182 179.667 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 10.2 m -69.04 -28.02 66.18 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.087 0.47 . . . . 1.65 110.904 -173.035 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.479 ' O ' ' HG ' ' A' ' 53' ' ' LEU . . . -74.4 -39.36 42.98 Favored Glycine 0 N--CA 1.444 -0.818 0 C-N-CA 120.765 -0.731 . . . . 0.4 111.853 -176.303 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.545 ' O ' ' HG ' ' A' ' 54' ' ' LEU . 84.0 mt -72.12 -41.38 67.29 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.563 0.221 . . . . 1.63 110.505 -178.187 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 -52.89 -51.16 62.17 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 116.254 -0.43 . . . . 3.01 111.7 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 25.8 mm-40 -64.42 -39.92 94.78 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.998 -0.281 . . . . 2.18 111.205 -179.13 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.479 ' HG ' ' O ' ' A' ' 49' ' ' GLY . 92.7 mt -59.32 -25.23 63.98 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.199 -0.455 . . . . 1.4 112.123 177.626 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.545 ' HG ' ' O ' ' A' ' 50' ' ' LEU . 96.7 mt -76.3 -14.06 60.12 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 111.922 0.341 . . . . 2.78 111.922 -176.394 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -82.88 103.9 12.7 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.989 0.423 . . . . 2.24 111.116 -177.263 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 78.9 20.71 69.94 Favored Glycine 0 N--CA 1.45 -0.379 0 CA-C-N 115.698 -0.683 . . . . 1.96 113.485 174.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.445 ' CB ' ' HG ' ' A' ' 10' ' ' LEU . 16.3 p -88.8 -32.49 17.83 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.934 0.397 . . . . 2.28 110.981 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 87.86 9.01 71.94 Favored Glycine 0 N--CA 1.444 -0.815 0 N-CA-C 111.3 -0.72 . . . . 1.79 111.3 -176.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.56 ' HB3' HD11 ' A' ' 71' ' ' LEU . 85.7 mt -129.71 171.55 12.54 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 120.854 0.359 . . . . 1.82 110.611 -176.275 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . 0.522 ' HB2' ' HB3' ' A' ' 74' ' ' ALA . 6.4 tt0 -136.16 118.84 16.04 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.177 -0.675 . . . . 3.26 109.177 176.192 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.417 ' H ' HD23 ' A' ' 54' ' ' LEU . 52.6 t -87.26 118.46 33.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-O 120.905 0.383 . . . . 2.17 110.69 -178.288 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.428 ' HE3' ' HB3' ' A' ' 62' ' ' LYS . 22.4 mmmt -125.69 117.92 24.45 Favored Pre-proline 0 C--N 1.325 -0.47 0 CA-C-N 115.944 -0.571 . . . . 2.29 110.172 177.663 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . 0.424 ' HA ' ' HA ' ' A' ' 69' ' ' TRP . 41.7 Cg_exo -57.94 121.0 9.27 Favored 'Trans proline' 0 C--O 1.233 0.234 0 C-N-CA 122.351 2.034 . . . . 0.94 110.762 174.763 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -75.61 -57.98 3.56 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.784 -0.643 . . . . 2.32 110.831 -171.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -127.04 -98.68 1.04 Allowed Glycine 0 N--CA 1.445 -0.73 0 C-N-CA 120.195 -1.002 . . . . 1.69 112.395 -178.228 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -91.87 -74.07 0.52 Allowed 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.741 0.305 . . . . 3.67 110.929 -177.633 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 27.2 p-10 -122.19 34.87 5.03 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.186 0.517 . . . . 2.59 110.877 -178.143 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 47.0 t -126.66 169.21 13.37 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 108.713 -0.847 . . . . 1.54 108.713 179.315 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' TRP . . . . . 0.599 ' HE3' HD11 ' A' ' 25' ' ' LEU . 6.8 m0 -142.31 162.32 35.76 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 107.824 -1.176 . . . . 0.54 107.824 -173.529 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.514 ' HA ' ' HB3' ' A' ' 26' ' ' SER . 12.4 t -140.32 146.52 38.6 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 109.517 -0.549 . . . . 1.49 109.517 174.19 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.778 HD23 ' HB ' ' A' ' 27' ' ' VAL . 4.2 mm? -93.63 102.93 15.12 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.613 0.72 . . . . 2.24 110.751 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.43 ' HA ' ' HD3' ' A' ' 73' ' ' PRO . 24.9 mt-10 -86.65 126.28 64.4 Favored Pre-proline 0 C--N 1.319 -0.733 0 CA-C-N 114.744 -1.116 . . . . 2.25 109.54 173.658 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 72' ' ' GLU . 38.9 Cg_exo -60.81 114.46 2.16 Favored 'Trans proline' 0 N--CA 1.462 -0.378 0 C-N-CA 122.746 2.297 . . . . 1.45 111.897 -176.494 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.522 ' HB3' ' HB2' ' A' ' 60' ' ' GLN . . . . . . . . 0 C--N 1.32 -0.686 0 CA-C-N 115.007 -0.997 . . . . 2.07 108.86 178.239 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . 1.008 ' H ' ' HA ' ' A' ' 43' ' ' ASP . 9.7 tt0 . . . . . 0 N--CA 1.452 -0.369 0 CA-C-O 121.814 0.816 . . . . 4.51 110.198 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 31.8 m -140.8 147.66 22.58 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 114.766 -1.106 . . . . 2.2 109.867 178.411 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 84.2 m-20 -129.2 102.56 6.51 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.465 -0.569 . . . . 2.75 109.465 179.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.41 HD11 ' HB3' ' A' ' 40' ' ' LEU . 56.6 mt -129.96 152.33 37.22 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 116.172 -0.467 . . . . 1.5 109.851 -174.774 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . 0.482 ' HB3' ' HD2' ' A' ' 7' ' ' PRO . . . -163.95 167.46 10.83 Favored Pre-proline 0 C--N 1.327 -0.39 0 N-CA-C 110.112 -0.329 . . . . 1.99 110.112 -174.551 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.55 ' HA ' ' O ' ' A' ' 37' ' ' SER . 71.2 Cg_exo -49.31 136.86 31.48 Favored 'Trans proline' 0 C--N 1.351 0.673 0 C-N-CA 122.835 2.357 . . . . 1.73 113.43 -176.582 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 143.86 64.56 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.742 -0.742 . . . . 1.84 112.681 177.146 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 50.0 m 66.36 116.14 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 121.372 0.606 . . . . 1.87 112.017 179.159 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 60.0 tp -59.47 -42.04 91.14 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 115.996 -0.547 . . . . 1.83 112.425 -178.543 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.619 ' HB3' ' HA ' ' A' ' 33' ' ' ARG . 8.4 p-10 -54.66 -37.86 66.23 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.75 -0.205 . . . . 2.11 111.286 178.472 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -66.05 -31.16 71.88 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.949 0.404 . . . . 3.11 110.7 178.308 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -67.11 -54.02 25.32 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.133 -0.485 . . . . 1.17 110.337 -179.048 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 84.6 mt -59.26 -38.88 81.19 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 115.76 -0.654 . . . . 1.31 110.838 175.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -59.75 -38.74 82.59 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.78 -0.645 . . . . 1.98 110.353 178.273 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . 0.41 HE21 ' HB3' ' A' ' 16' ' ' GLN . 0.9 OUTLIER -62.81 -41.62 99.37 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.62 -0.718 . . . . 2.33 110.786 177.61 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.617 ' CD1' ' HH2' ' A' ' 69' ' ' TRP . 7.0 t80 -68.47 -41.39 80.22 Favored 'General case' 0 C--N 1.333 -0.112 0 N-CA-C 109.807 -0.442 . . . . 1.05 109.807 -178.029 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.657 ' HA ' ' CE2' ' A' ' 23' ' ' PHE . . . -53.75 -46.87 71.03 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.05 -0.523 . . . . 1.15 111.691 177.06 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.68 -16.54 57.66 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.043 -0.526 . . . . 1.26 112.15 -178.027 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 76.3 t60 -61.36 -47.55 85.33 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.669 -0.241 . . . . 2.52 111.462 -179.288 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.46 ' HB3' ' CD1' ' A' ' 23' ' ' PHE . 32.5 t -118.77 -15.89 9.39 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 120.712 -0.395 . . . . 1.79 112.008 -178.676 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 74.9 61.01 3.19 Favored Glycine 0 C--N 1.331 0.259 0 C-N-CA 120.867 -0.682 . . . . 0.68 112.732 -179.485 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.657 ' CE2' ' HA ' ' A' ' 18' ' ' ALA . 3.1 p90 -112.8 169.21 9.07 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.999 0.428 . . . . 0.68 111.021 -179.103 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 14.8 m -89.66 101.38 14.07 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.457 0.646 . . . . 1.3 111.276 -176.354 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.577 HD23 ' HB ' ' A' ' 27' ' ' VAL . 2.8 tt -93.58 126.78 38.92 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.551 -0.75 . . . . 2.3 109.325 177.116 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.542 ' HB2' ' HA ' ' A' ' 70' ' ' THR . 8.5 m -98.99 91.15 4.89 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.162 -0.681 . . . . 1.67 109.162 179.843 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.721 HG23 HD21 ' A' ' 71' ' ' LEU . 7.3 p -117.62 135.78 56.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 115.911 -0.586 . . . . 1.52 111.533 -174.458 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 50.7 m-20 -78.19 112.81 15.54 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-N 115.882 -0.599 . . . . 2.38 109.74 174.675 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -64.68 66.74 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.977 -0.556 . . . . 2.45 112.02 177.524 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 20.4 p -170.28 -44.09 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.255 -0.429 . . . . 2.48 110.175 -179.074 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 91.0 mt -68.27 -52.58 32.29 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.951 -0.568 . . . . 1.92 111.351 -179.286 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 13.0 p -101.82 -19.2 15.41 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 112.615 0.598 . . . . 1.82 112.615 -176.265 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.619 ' HA ' ' HB3' ' A' ' 11' ' ' ASP . 16.1 tpp180 -59.9 119.16 7.2 Favored 'General case' 0 C--O 1.233 0.233 0 N-CA-C 110.115 -0.328 . . . . 5.19 110.115 -178.463 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 93.66 -115.85 5.06 Favored Glycine 0 N--CA 1.439 -1.165 0 N-CA-C 111.056 -0.818 . . . . 1.62 111.056 -177.041 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 9.3 mmmm 46.9 -165.84 0.02 OUTLIER 'General case' 0 N--CA 1.443 -0.775 0 CA-C-O 122.205 1.002 . . . . 3.17 111.654 -176.209 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 8.0 pt20 -150.16 132.71 15.75 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 114.887 -1.051 . . . . 2.52 108.673 165.029 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.55 ' O ' ' HA ' ' A' ' 7' ' ' PRO . 33.9 t -118.45 139.22 51.75 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 108.059 -1.089 . . . . 1.14 108.059 175.436 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 8.0 m120 -67.61 -14.46 62.96 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.091 -0.504 . . . . 1.28 111.065 -176.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 111.58 -169.53 13.25 Favored Glycine 0 N--CA 1.443 -0.882 0 C-N-CA 120.73 -0.747 . . . . 0.49 112.331 173.527 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.41 ' HB3' HD11 ' A' ' 5' ' ' ILE . 42.1 tp -160.16 125.64 4.02 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 108.349 -0.982 . . . . 1.36 108.349 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 39.4 t-80 -136.66 96.54 3.35 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 120.215 -0.594 . . . . 3.8 110.966 -178.544 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -168.79 -179.96 41.26 Favored Glycine 0 N--CA 1.448 -0.533 0 CA-C-N 115.398 -0.819 . . . . 0.55 111.239 175.157 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 1.008 ' HA ' ' H ' ' A' ' 2' ' ' GLN . 21.9 m-20 -84.97 74.63 10.49 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 108.656 -0.868 . . . . 2.18 108.656 173.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 22.5 m-85 -96.21 143.94 26.86 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.198 -0.91 . . . . 1.5 111.061 -174.086 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -94.1 -172.39 2.81 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.543 -0.753 . . . . 2.23 110.057 179.386 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.424 HG12 ' CZ2' ' A' ' 69' ' ' TRP . 59.8 t -52.34 -71.57 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.042 -0.526 . . . . 1.25 112.19 -178.095 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 21.1 mt-10 -63.88 -41.49 97.73 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.863 -0.608 . . . . 2.39 112.061 -172.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 4.2 p -72.11 -32.04 66.6 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.098 -0.501 . . . . 1.65 111.306 -172.251 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -75.2 -39.24 37.42 Favored Glycine 0 N--CA 1.447 -0.617 0 N-CA-C 111.114 -0.794 . . . . 0.4 111.114 -176.39 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.51 ' CB ' HG12 ' A' ' 61' ' ' VAL . 62.9 mt -72.66 -41.5 65.36 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.773 0.321 . . . . 1.63 110.58 -178.568 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 21.2 tt0 -54.8 -49.12 71.75 Favored 'General case' 0 C--O 1.222 -0.345 0 CA-C-N 115.808 -0.633 . . . . 3.01 111.009 -176.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 16.4 mm100 -65.09 -40.19 94.26 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.455 -0.339 . . . . 2.18 111.485 -178.622 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 90.0 mt -57.77 -34.95 70.13 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 112.1 0.407 . . . . 1.4 112.1 178.636 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 81.8 mt -102.42 -12.6 17.74 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.929 0.395 . . . . 2.78 111.645 -174.432 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -64.68 130.2 42.68 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.05 -0.523 . . . . 2.24 110.956 -177.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 100.41 -31.44 8.51 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.533 -0.842 . . . . 1.96 113.243 176.561 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 24.4 p -91.87 12.84 20.25 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 117.218 0.509 . . . . 2.28 111.343 -177.001 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 74.37 25.14 71.31 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.683 -0.77 . . . . 1.79 111.821 179.247 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 91.6 mt -123.42 156.01 36.32 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 109.939 -0.393 . . . . 1.82 109.939 -178.687 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . 0.509 ' HB2' ' HB1' ' A' ' 74' ' ' ALA . 38.2 mm-40 -152.59 172.78 16.08 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.409 -0.589 . . . . 3.26 109.409 176.496 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.51 HG12 ' CB ' ' A' ' 50' ' ' LEU . 10.8 p -139.89 148.96 22.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-O 120.821 0.343 . . . . 2.17 110.709 -178.616 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.527 ' HG3' HG21 ' A' ' 70' ' ' THR . 1.6 ptpp? -139.83 128.59 13.44 Favored Pre-proline 0 C--N 1.321 -0.671 0 N-CA-C 109.519 -0.548 . . . . 2.29 109.519 172.815 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -59.8 126.3 20.1 Favored 'Trans proline' 0 N--CA 1.462 -0.376 0 C-N-CA 122.309 2.006 . . . . 0.94 110.425 173.332 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -59.78 -44.35 93.96 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.527 -0.761 . . . . 2.32 109.903 -175.537 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 152.24 -65.13 0.36 Allowed Glycine 0 N--CA 1.445 -0.729 0 C-N-CA 120.701 -0.761 . . . . 1.69 111.722 176.028 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 12.8 t-20 -88.71 78.92 7.6 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.124 0.487 . . . . 3.67 110.043 -179.558 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 43.52 35.94 1.07 Allowed 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 124.482 1.113 . . . . 2.59 113.727 178.552 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 39.5 m -137.16 175.34 9.7 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 108.54 -0.911 . . . . 1.54 108.54 176.453 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' TRP . . . . . 0.617 ' HH2' ' CD1' ' A' ' 17' ' ' TYR . 54.9 m0 -137.52 167.1 22.33 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.952 0.406 . . . . 0.54 110.923 -169.877 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.542 ' HA ' ' HB2' ' A' ' 26' ' ' SER . 3.7 t -145.91 147.38 31.69 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.58 -0.737 . . . . 1.49 109.423 171.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.721 HD21 HG23 ' A' ' 27' ' ' VAL . 50.8 tp -91.62 105.71 17.94 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.144 0.497 . . . . 2.24 109.707 -178.03 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.449 ' HB2' ' HG2' ' A' ' 62' ' ' LYS . 12.7 tp10 -94.33 118.93 67.04 Favored Pre-proline 0 C--N 1.323 -0.577 0 CA-C-N 115.147 -0.933 . . . . 2.25 110.766 -176.642 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_exo -70.02 113.5 3.44 Favored 'Trans proline' 0 N--CA 1.456 -0.701 0 C-N-CA 121.647 1.564 . . . . 1.45 110.649 172.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.509 ' HB1' ' HB2' ' A' ' 60' ' ' GLN . . . . . . . . 0 C--N 1.322 -0.623 0 CA-C-N 116.109 -0.496 . . . . 2.07 109.891 -177.668 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . 0.653 ' HA ' ' HA ' ' A' ' 43' ' ' ASP . 77.0 mt-30 . . . . . 0 C--O 1.231 0.125 0 CA-C-O 121.668 0.747 . . . . 4.51 112.005 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 57.6 t -131.82 130.56 61.77 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 115.49 -0.777 . . . . 2.2 109.221 178.417 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 4.2 p-10 -131.52 121.61 24.76 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 108.882 -0.784 . . . . 2.75 108.882 -178.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.482 HG13 HD21 ' A' ' 53' ' ' LEU . 36.4 mm -116.95 129.11 74.04 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 CA-C-N 115.925 -0.579 . . . . 1.5 109.956 -178.256 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -73.56 156.52 88.62 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.069 -0.514 . . . . 1.99 109.86 177.6 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.524 ' HA ' ' O ' ' A' ' 37' ' ' SER . 7.6 Cg_exo -74.45 39.86 0.58 Allowed 'Trans proline' 0 CA--C 1.532 0.394 0 C-N-CA 123.132 2.555 . . . . 1.73 112.888 179.449 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -115.35 -162.71 13.65 Favored Glycine 0 N--CA 1.447 -0.615 0 C-N-CA 120.786 -0.721 . . . . 1.84 113.43 -176.792 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.513 ' HA ' ' HA ' ' A' ' 36' ' ' GLN . 15.7 m -55.77 132.21 48.72 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.222 0.534 . . . . 1.87 111.197 -176.933 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 59.9 tp -58.88 -28.66 66.35 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.165 -0.925 . . . . 1.83 111.055 -176.061 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -45.97 -48.05 16.55 Favored 'General case' 0 CA--C 1.52 -0.199 0 CA-C-O 121.059 0.457 . . . . 2.11 110.576 175.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 65.3 mttm -67.58 -24.13 65.48 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.772 -0.649 . . . . 3.11 111.811 -177.368 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -65.87 -64.03 0.95 Allowed 'General case' 0 C--O 1.233 0.233 0 N-CA-C 110.407 -0.22 . . . . 1.17 110.407 -179.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.801 ' H ' HD11 ' A' ' 14' ' ' LEU . 4.4 mp -58.56 -35.72 72.8 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 116.431 -0.35 . . . . 1.31 111.339 175.641 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -60.6 -46.69 89.32 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 121.07 0.462 . . . . 1.98 109.94 178.232 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . 0.436 HE21 ' HB3' ' A' ' 16' ' ' GLN . 1.0 OUTLIER -63.91 -43.21 96.66 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.509 -0.769 . . . . 2.33 110.435 178.028 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.457 ' O ' ' HB3' ' A' ' 20' ' ' HIS . 10.1 t80 -68.03 -40.46 82.92 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-O 120.76 0.314 . . . . 1.05 110.182 -177.791 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.789 ' HA ' ' CE2' ' A' ' 23' ' ' PHE . . . -54.5 -44.2 72.47 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 116.329 -0.396 . . . . 1.15 111.532 176.14 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.24 -17.96 59.83 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.053 -0.522 . . . . 1.26 111.988 -178.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . 0.457 ' HB3' ' O ' ' A' ' 17' ' ' TYR . 83.4 t60 -59.75 -54.88 41.18 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.532 -0.304 . . . . 2.52 111.266 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.562 ' HB3' ' CD1' ' A' ' 23' ' ' PHE . 22.7 t -114.45 -12.35 12.35 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.482 -0.487 . . . . 1.79 111.639 -177.438 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 75.92 49.63 8.56 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 121.062 -0.589 . . . . 0.68 112.754 179.229 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.789 ' CE2' ' HA ' ' A' ' 18' ' ' ALA . 1.8 p90 -103.76 158.11 16.61 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 110.222 -0.288 . . . . 0.68 110.222 -179.541 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.577 ' O ' ' HB3' ' A' ' 68' ' ' SER . 32.6 m -93.13 101.31 13.61 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.238 0.542 . . . . 1.3 111.878 -175.928 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.421 ' CB ' ' HB2' ' A' ' 69' ' ' TRP . 0.0 OUTLIER -99.43 150.27 22.34 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.385 -0.37 . . . . 2.3 110.115 174.053 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.585 ' HB2' ' HA ' ' A' ' 70' ' ' THR . 43.3 m -106.54 104.07 13.67 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.376 -0.375 . . . . 1.67 110.502 -177.389 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 14.9 p -123.57 143.82 35.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 N-CA-C 110.195 -0.298 . . . . 1.52 110.195 178.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.41 ' OD2' ' HG ' ' A' ' 31' ' ' LEU . 21.6 t70 -97.32 108.71 21.5 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.433 -0.349 . . . . 2.38 110.537 177.575 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.21 60.04 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 115.492 -0.777 . . . . 2.45 112.382 178.218 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 74.8 m -166.38 -36.6 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 123.188 0.595 . . . . 2.48 109.526 179.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.41 ' HG ' ' OD2' ' A' ' 28' ' ' ASP . 89.0 mt -68.0 -28.5 67.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.383 0.611 . . . . 1.92 110.087 176.034 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 5.0 p -97.69 18.38 15.74 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.528 -0.76 . . . . 1.82 111.262 179.11 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 53.5 ttp180 -63.85 108.35 1.44 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.661 -0.245 . . . . 5.19 110.415 -179.202 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 81.45 8.56 86.92 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.834 -0.698 . . . . 1.62 112.268 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 41.8 tptt -86.65 108.14 18.5 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.622 -0.51 . . . . 3.17 109.622 -179.047 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . 0.513 ' HA ' ' HA ' ' A' ' 9' ' ' SER . 46.2 mt-30 -109.84 158.88 17.72 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 110.092 -0.336 . . . . 2.52 110.092 -178.802 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.524 ' O ' ' HA ' ' A' ' 7' ' ' PRO . 7.2 t -128.63 127.55 42.45 Favored 'General case' 0 N--CA 1.445 -0.711 0 N-CA-C 107.863 -1.162 . . . . 1.14 107.863 175.158 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 8.7 m120 -64.25 -8.8 13.9 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 112.37 0.507 . . . . 1.28 112.37 -172.716 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 129.31 175.37 14.02 Favored Glycine 0 N--CA 1.444 -0.806 0 C-N-CA 120.152 -1.023 . . . . 0.49 112.876 169.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 54.1 tp -160.06 124.93 3.9 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 107.624 -1.25 . . . . 1.36 107.624 -179.376 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 52.9 m80 -136.42 97.95 3.71 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 120.26 -0.576 . . . . 3.8 111.438 -177.519 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -170.57 168.3 41.37 Favored Glycine 0 N--CA 1.447 -0.609 0 CA-C-N 115.199 -0.909 . . . . 0.55 110.866 174.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.653 ' HA ' ' HA ' ' A' ' 2' ' ' GLN . 24.2 t70 -78.89 100.18 7.1 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 108.828 -0.805 . . . . 2.18 108.828 170.069 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 43.8 m-85 -116.67 142.43 46.91 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.74 -0.664 . . . . 1.5 111.496 -173.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -92.48 -175.3 3.95 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.438 -0.801 . . . . 2.23 108.861 175.34 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 14.1 t -52.0 -69.73 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 121.193 0.52 . . . . 1.25 111.534 -174.592 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -56.47 -49.1 75.62 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.263 -0.88 . . . . 2.39 112.587 -173.531 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 4.6 t -71.73 -31.36 66.62 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.076 -0.511 . . . . 1.65 110.727 -171.358 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -75.91 -41.45 27.89 Favored Glycine 0 N--CA 1.445 -0.735 0 C-N-CA 120.608 -0.806 . . . . 0.4 111.833 -175.744 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.686 HD13 HG11 ' A' ' 61' ' ' VAL . 93.4 mt -74.03 -36.99 64.48 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.654 0.264 . . . . 1.63 110.422 -178.323 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 1.8 tp-100 -54.76 -47.97 73.23 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.324 -0.398 . . . . 3.01 111.648 179.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 -65.33 -38.53 90.41 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.612 -0.267 . . . . 2.18 111.363 -179.512 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.482 HD21 HG13 ' A' ' 5' ' ' ILE . 94.0 mt -59.23 -23.88 62.69 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 111.935 0.346 . . . . 1.4 111.935 176.651 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.763 HD21 HG23 ' A' ' 61' ' ' VAL . 96.2 mt -80.7 -14.04 58.48 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 111.946 0.35 . . . . 2.78 111.946 -176.631 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -62.66 115.34 4.21 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.158 0.504 . . . . 2.24 110.806 -178.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 110.25 16.52 10.31 Favored Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 120.784 -0.722 . . . . 1.96 112.029 -178.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 89.5 p -146.29 177.4 9.04 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.873 -0.417 . . . . 2.28 109.873 177.33 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -118.96 43.72 1.53 Allowed Glycine 0 N--CA 1.445 -0.741 0 N-CA-C 111.124 -0.791 . . . . 1.79 111.124 176.708 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.502 HD13 HD23 ' A' ' 71' ' ' LEU . 55.1 mt -117.75 174.59 6.09 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.385 -0.407 . . . . 1.82 110.164 -177.634 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 74.2 mt-30 -146.6 127.85 14.81 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.248 -0.649 . . . . 3.26 109.248 177.206 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.763 HG23 HD21 ' A' ' 54' ' ' LEU . 48.2 t -88.49 119.72 36.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 109.014 -0.736 . . . . 2.17 109.014 174.556 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -132.42 122.97 18.31 Favored Pre-proline 0 N--CA 1.441 -0.912 0 CA-C-N 116.493 -0.322 . . . . 2.29 110.134 -173.75 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . 0.581 ' HA ' ' HA ' ' A' ' 69' ' ' TRP . 44.7 Cg_exo -57.79 144.48 93.4 Favored 'Trans proline' 0 C--O 1.234 0.286 0 C-N-CA 122.977 2.452 . . . . 0.94 111.605 176.847 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -75.86 -47.55 25.03 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.616 -0.72 . . . . 2.32 109.843 -178.07 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 161.62 -46.8 0.37 Allowed Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.594 -0.812 . . . . 1.69 111.968 179.005 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 11.0 t30 -110.76 86.62 2.35 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 110.148 -0.315 . . . . 3.67 110.148 -179.482 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 39.11 42.49 0.72 Allowed 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 124.318 1.047 . . . . 2.59 113.313 178.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' SER . . . . . 0.577 ' HB3' ' O ' ' A' ' 24' ' ' THR . 50.1 m -142.06 174.84 10.23 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 108.745 -0.835 . . . . 1.54 108.745 176.173 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' TRP . . . . . 0.581 ' HA ' ' HA ' ' A' ' 63' ' ' PRO . 41.4 m0 -137.81 169.09 18.39 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.235 0.54 . . . . 0.54 110.345 -173.079 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.585 ' HA ' ' HB2' ' A' ' 26' ' ' SER . 11.7 t -148.89 141.93 24.85 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-N 115.368 -0.833 . . . . 1.49 109.064 168.076 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.502 HD23 HD13 ' A' ' 59' ' ' LEU . 60.8 tp -92.72 102.85 15.26 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.238 0.542 . . . . 2.24 109.76 178.823 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.414 ' HA ' ' HD3' ' A' ' 73' ' ' PRO . 33.0 tt0 -96.92 129.95 31.26 Favored Pre-proline 0 C--N 1.317 -0.817 0 CA-C-N 115.403 -0.817 . . . . 2.25 110.839 179.331 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 72' ' ' GLU . 12.0 Cg_exo -71.3 115.2 4.18 Favored 'Trans proline' 0 N--CA 1.459 -0.509 0 C-N-CA 122.432 2.088 . . . . 1.45 110.723 173.249 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.323 -0.551 0 CA-C-N 115.83 -0.623 . . . . 2.07 109.655 -177.329 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . 0.796 ' H ' ' HA ' ' A' ' 43' ' ' ASP . 0.0 OUTLIER . . . . . 0 CA--C 1.512 -0.488 0 CA-C-O 121.943 0.878 . . . . 4.51 109.806 . . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.489 HG12 ' CE2' ' A' ' 17' ' ' TYR . 14.2 m -148.85 152.17 12.42 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.174 0 CA-C-N 113.689 -1.596 . . . . 2.2 109.672 -178.92 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 69.9 m-20 -131.17 112.08 12.52 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.579 -0.526 . . . . 2.75 109.579 178.211 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.452 ' HB ' ' N ' ' A' ' 40' ' ' LEU . 48.5 mm -107.16 116.81 51.67 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 N-CA-C 109.821 -0.437 . . . . 1.5 109.821 -178.771 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -82.8 157.86 66.09 Favored Pre-proline 0 C--N 1.323 -0.563 0 CA-C-N 115.923 -0.58 . . . . 1.99 109.51 177.216 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.552 ' HA ' ' O ' ' A' ' 37' ' ' SER . 11.5 Cg_endo -58.71 145.49 95.67 Favored 'Trans proline' 0 N--CA 1.462 -0.376 0 C-N-CA 121.642 1.561 . . . . 1.73 109.879 168.504 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 148.71 -174.78 28.25 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.437 -0.887 . . . . 1.84 111.196 -169.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 47.1 t -63.37 128.82 37.57 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 117.029 0.414 . . . . 1.87 110.657 -179.016 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.411 HD11 ' HB2' ' A' ' 37' ' ' SER . 61.9 tp -61.7 -31.41 71.55 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.022 -0.535 . . . . 1.83 110.223 -179.59 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -49.39 -54.22 18.51 Favored 'General case' 0 CA--C 1.52 -0.178 0 CA-C-N 115.41 -0.814 . . . . 2.11 110.345 173.218 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.4 ' HD3' ' HA ' ' A' ' 12' ' ' LYS . 0.1 OUTLIER -69.81 -27.69 65.09 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.755 -0.657 . . . . 3.11 111.11 -178.863 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -66.51 -56.32 11.41 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-O 121.002 0.43 . . . . 1.17 110.224 -179.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 94.0 mt -60.18 -40.5 90.2 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.894 -0.594 . . . . 1.31 111.156 176.006 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -62.14 -35.85 80.03 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.027 0.441 . . . . 1.98 110.465 178.321 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -62.92 -43.52 98.58 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 116.067 -0.515 . . . . 2.33 109.876 176.641 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.622 ' OH ' ' HA ' ' A' ' 46' ' ' VAL . 44.9 t80 -70.02 -35.53 74.4 Favored 'General case' 0 C--O 1.224 -0.251 0 N-CA-C 109.996 -0.372 . . . . 1.05 109.996 -178.613 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.682 ' HA ' ' CE2' ' A' ' 23' ' ' PHE . . . -52.24 -39.85 60.87 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-O 120.695 0.283 . . . . 1.15 111.724 176.292 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.9 -15.58 55.67 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 112.478 0.548 . . . . 1.26 112.478 178.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 17.8 t-80 -57.85 -57.44 12.75 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 122.312 0.245 . . . . 2.52 111.316 -179.058 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.567 ' HB3' ' HD1' ' A' ' 23' ' ' PHE . 25.1 t -109.15 -12.47 14.81 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.069 0.462 . . . . 1.79 111.237 -179.493 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 74.35 53.69 6.63 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.87 -0.681 . . . . 0.68 112.428 -179.302 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.682 ' CE2' ' HA ' ' A' ' 18' ' ' ALA . 3.2 p90 -104.41 172.67 6.67 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.715 0.293 . . . . 0.68 110.497 -177.911 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 12.9 m -92.13 107.79 19.47 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.244 0.545 . . . . 1.3 111.678 -177.512 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.493 ' HG ' ' HE3' ' A' ' 69' ' ' TRP . 1.0 OUTLIER -98.18 126.08 43.5 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.953 -0.567 . . . . 2.3 110.178 177.549 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.43 ' HB2' HG22 ' A' ' 70' ' ' THR . 68.5 m -101.13 97.73 8.23 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.085 0.469 . . . . 1.67 110.146 178.15 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 6.4 p -147.98 133.58 11.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 115.56 -0.745 . . . . 1.52 110.171 179.272 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.509 ' HB2' ' CD1' ' A' ' 31' ' ' LEU . 50.2 m-20 -94.36 129.73 40.96 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.707 -0.479 . . . . 2.38 109.707 176.283 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -58.04 -10.78 2.01 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.581 -0.736 . . . . 2.45 112.704 -178.686 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 6.0 p -71.7 -41.99 67.94 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.718 0.294 . . . . 2.48 110.674 179.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.509 ' CD1' ' HB2' ' A' ' 28' ' ' ASP . 5.7 mp -63.79 -42.18 97.8 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.021 0.439 . . . . 1.92 111.329 179.013 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 2.5 p -91.67 13.36 18.28 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.026 -0.534 . . . . 1.82 111.668 -177.004 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.432 HH11 ' HD3' ' A' ' 33' ' ' ARG . 30.5 ttt180 -68.6 112.42 5.37 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.28 -0.418 . . . . 5.19 110.423 178.155 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 87.01 -0.79 86.41 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.783 -0.722 . . . . 1.62 112.013 -178.331 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 24.6 tptp -86.01 114.6 23.02 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 110.507 -0.183 . . . . 3.17 110.507 -178.589 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -106.41 164.32 12.13 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 110.112 -0.329 . . . . 2.52 110.112 176.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.552 ' O ' ' HA ' ' A' ' 7' ' ' PRO . 33.5 t -137.17 131.94 33.24 Favored 'General case' 0 N--CA 1.445 -0.719 0 N-CA-C 107.718 -1.216 . . . . 1.14 107.718 172.102 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.419 ' N ' HD21 ' A' ' 38' ' ' ASN . 0.9 OUTLIER -60.78 -21.61 63.24 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 112.761 0.652 . . . . 1.28 112.761 -176.367 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.41 ' HA2' HG23 ' A' ' 5' ' ' ILE . . . 128.37 -175.41 18.58 Favored Glycine 0 N--CA 1.446 -0.668 0 C-N-CA 120.033 -1.079 . . . . 0.49 113.201 172.845 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.452 ' N ' ' HB ' ' A' ' 5' ' ' ILE . 43.3 tp -160.0 127.69 4.66 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 107.798 -1.186 . . . . 1.36 107.798 -178.329 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 74.3 m80 -140.02 97.85 3.33 Favored 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 120.342 -0.543 . . . . 3.8 111.032 -178.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -169.4 175.75 43.58 Favored Glycine 0 N--CA 1.444 -0.808 0 C-N-CA 120.832 -0.699 . . . . 0.55 112.341 175.634 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.796 ' HA ' ' H ' ' A' ' 2' ' ' GLN . 14.7 t70 -88.61 76.1 8.18 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 107.526 -1.287 . . . . 2.18 107.526 170.616 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -96.98 149.29 22.07 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 114.844 -1.071 . . . . 1.5 112.953 -167.737 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 19.8 t0 -90.71 166.94 12.86 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.102 -0.954 . . . . 2.23 109.649 174.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.622 ' HA ' ' OH ' ' A' ' 17' ' ' TYR . 42.9 t -47.5 -73.08 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 N-CA-C 113.616 0.969 . . . . 1.25 113.616 -170.513 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -65.0 -29.5 70.42 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 112.467 0.543 . . . . 2.39 112.467 -174.129 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 16.6 m -71.29 -33.1 69.43 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.216 0.531 . . . . 1.65 110.556 -177.189 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -76.51 -33.47 47.78 Favored Glycine 0 N--CA 1.446 -0.688 0 N-CA-C 111.275 -0.73 . . . . 0.4 111.275 -178.329 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.681 ' HB3' HG13 ' A' ' 61' ' ' VAL . 85.7 mt -67.9 -42.37 81.26 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.916 0.389 . . . . 1.63 110.479 178.599 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -56.24 -38.81 71.6 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.846 -0.615 . . . . 3.01 111.083 179.084 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 32.2 mm-40 -62.29 -56.31 19.72 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.918 0.39 . . . . 2.18 111.299 177.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 86.7 mt -57.5 -33.76 68.37 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.917 -0.583 . . . . 1.4 112.092 -177.613 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 10.8 mp -98.98 13.88 31.12 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 112.362 0.505 . . . . 2.78 112.362 -175.306 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -60.23 111.14 1.42 Allowed 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.916 0.389 . . . . 2.24 111.175 177.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 66.02 39.18 94.69 Favored Glycine 0 C--N 1.332 0.311 0 CA-C-N 115.83 -0.623 . . . . 1.96 112.583 178.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 63.9 p -98.72 -17.13 18.69 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.812 0.339 . . . . 2.28 111.733 -176.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 81.05 6.67 89.28 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.57 -0.824 . . . . 1.79 111.154 -172.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.471 HD11 HD21 ' A' ' 71' ' ' LEU . 96.1 mt -113.79 165.8 12.19 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.157 -0.521 . . . . 1.82 110.335 -177.875 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 31.0 tt0 -145.35 117.93 8.59 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 108.823 -0.806 . . . . 3.26 108.823 179.067 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.681 HG13 ' HB3' ' A' ' 50' ' ' LEU . 7.5 p -92.71 129.61 43.02 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 N-CA-C 110.116 -0.328 . . . . 2.17 110.116 -179.605 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.483 ' NZ ' ' HG3' ' A' ' 72' ' ' GLU . 21.1 mtmm -130.5 122.38 19.79 Favored Pre-proline 0 C--N 1.322 -0.601 0 CA-C-N 116.354 -0.385 . . . . 2.29 110.736 179.361 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_exo -61.07 117.7 4.5 Favored 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 122.141 1.894 . . . . 0.94 109.895 169.456 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -62.2 -43.65 98.34 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.29 -0.868 . . . . 2.32 111.052 -170.323 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 152.95 -63.82 0.37 Allowed Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.476 -0.868 . . . . 1.69 112.155 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 7.3 m-20 -82.92 57.2 3.75 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.654 0.264 . . . . 3.67 111.134 -178.475 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 6.3 t30 56.18 44.24 25.38 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 121.595 0.712 . . . . 2.59 110.78 178.004 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 14.7 m -142.34 177.61 8.15 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 108.848 -0.797 . . . . 1.54 108.848 177.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' TRP . . . . . 0.551 ' HH2' ' CD1' ' A' ' 17' ' ' TYR . 48.1 m0 -136.73 155.59 49.65 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 116.582 -0.281 . . . . 0.54 110.488 -172.075 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.43 HG22 ' HB2' ' A' ' 26' ' ' SER . 1.6 p -139.47 132.43 29.4 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.143 -0.48 . . . . 1.49 109.753 173.463 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.471 HD21 HD11 ' A' ' 59' ' ' LEU . 51.7 tp -93.19 104.31 16.51 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.501 0.667 . . . . 2.24 110.651 -178.766 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.483 ' HG3' ' NZ ' ' A' ' 62' ' ' LYS . 37.9 mm-40 -90.73 124.29 62.69 Favored Pre-proline 0 C--N 1.319 -0.748 0 CA-C-N 114.701 -1.136 . . . . 2.25 110.75 177.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_exo -74.1 113.54 3.81 Favored 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 121.833 1.689 . . . . 1.45 110.542 171.365 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.332 -0.172 0 CA-C-N 116.031 -0.531 . . . . 2.07 110.581 -175.643 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 46.8 mt-30 . . . . . 0 C--O 1.235 0.328 0 CA-C-O 121.154 0.502 . . . . 4.51 110.288 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 40.7 t -134.75 145.13 32.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 115.53 -0.759 . . . . 2.2 109.6 -175.303 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 5.2 p30 -128.08 98.25 5.05 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-O 121.776 0.798 . . . . 2.75 109.337 179.322 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 50.0 mm -102.21 110.01 27.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 115.34 -0.845 . . . . 1.5 109.558 -178.434 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -78.86 149.02 73.38 Favored Pre-proline 0 C--N 1.319 -0.73 0 CA-C-N 115.587 -0.733 . . . . 1.99 109.692 -179.008 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -55.31 134.65 65.07 Favored 'Trans proline' 0 N--CA 1.461 -0.422 0 C-N-CA 121.961 1.774 . . . . 1.73 109.656 169.113 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 150.46 -177.23 28.66 Favored Glycine 0 N--CA 1.445 -0.767 0 N-CA-C 110.41 -1.076 . . . . 1.84 110.41 -169.256 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.578 ' HA ' ' HA ' ' A' ' 36' ' ' GLN . 10.2 t -65.31 140.29 58.67 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 117.266 0.533 . . . . 1.87 110.221 -178.615 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.471 HD11 ' HG3' ' A' ' 35' ' ' LYS . 12.6 mt -58.15 -27.27 63.64 Favored 'General case' 0 CA--C 1.52 -0.187 0 CA-C-N 116.332 -0.394 . . . . 1.83 110.513 177.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -49.28 -55.27 13.27 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 115.417 -0.81 . . . . 2.11 110.724 173.582 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 25.1 ttmm -66.07 -33.86 76.75 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.944 -0.571 . . . . 3.11 110.806 -179.778 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -65.6 -59.83 3.55 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.239 -0.437 . . . . 1.17 110.917 -176.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 93.7 mt -57.57 -38.47 74.86 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.149 -0.478 . . . . 1.31 111.31 178.219 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 54.2 t30 -60.45 -35.51 76.02 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.119 -0.492 . . . . 1.98 110.547 178.509 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 19.7 tm0? -61.19 -49.4 77.34 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.313 -0.403 . . . . 2.33 110.779 177.55 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -67.45 -42.64 82.74 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 109.309 -0.626 . . . . 1.05 109.309 -177.209 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.654 ' HA ' ' CZ ' ' A' ' 23' ' ' PHE . . . -53.44 -51.08 63.8 Favored 'General case' 0 CA--C 1.521 -0.157 0 CA-C-N 115.552 -0.749 . . . . 1.15 111.724 176.812 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.94 -26.29 68.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.236 -0.438 . . . . 1.26 111.507 -179.426 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 71.2 t60 -64.31 -50.34 68.21 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.265 -0.425 . . . . 2.52 111.722 -177.652 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.62 ' HB3' ' HD1' ' A' ' 23' ' ' PHE . 47.0 t -99.26 -16.79 18.39 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-O 121.142 0.496 . . . . 1.79 111.438 -177.6 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 74.27 48.67 14.02 Favored Glycine 0 N--CA 1.45 -0.427 0 CA-C-N 115.884 -0.598 . . . . 0.68 112.665 -178.709 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.654 ' CZ ' ' HA ' ' A' ' 18' ' ' ALA . 29.9 p90 -110.33 168.23 9.61 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.784 0.326 . . . . 0.68 110.184 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 12.9 m -93.01 109.15 20.6 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.166 0.508 . . . . 1.3 111.077 -178.429 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.0 tt -93.77 128.89 40.23 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.053 -0.721 . . . . 2.3 109.053 177.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 34.5 t -103.1 99.81 9.7 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.108 0.48 . . . . 1.67 110.211 -178.104 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.1 p -147.83 133.14 11.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 115.821 -0.627 . . . . 1.52 110.498 179.05 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 -98.32 135.71 39.53 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.957 -0.565 . . . . 2.38 110.218 177.297 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -56.4 -22.3 30.61 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 114.93 -1.032 . . . . 2.45 112.676 -174.639 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 14.3 m -69.01 -14.58 63.12 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.892 0.377 . . . . 2.48 111.219 -176.55 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 90.7 mt -98.18 -22.78 16.0 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.11 0.481 . . . . 1.92 110.584 -179.633 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 12.1 p -109.85 5.51 22.62 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.031 -0.531 . . . . 1.82 112.211 -175.401 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 7.0 ptp180 -63.81 107.21 1.15 Allowed 'General case' 0 N--CA 1.453 -0.302 0 CA-C-O 121.199 0.524 . . . . 5.19 111.128 -179.32 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 83.6 4.25 89.2 Favored Glycine 0 N--CA 1.446 -0.646 0 CA-C-N 115.789 -0.641 . . . . 1.62 111.9 -179.542 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.471 ' HG3' HD11 ' A' ' 10' ' ' LEU . 20.9 tptm -83.78 104.42 13.87 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.766 -0.457 . . . . 3.17 109.766 -178.543 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . 0.578 ' HA ' ' HA ' ' A' ' 9' ' ' SER . 55.4 tt0 -103.77 155.09 18.86 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.64 -0.504 . . . . 2.52 109.64 -177.33 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.401 ' HB2' ' HG ' ' A' ' 10' ' ' LEU . 10.2 t -124.81 134.57 52.71 Favored 'General case' 0 N--CA 1.445 -0.685 0 N-CA-C 107.863 -1.162 . . . . 1.14 107.863 171.532 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -64.85 -16.93 63.8 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.35 -0.386 . . . . 1.28 111.824 -179.751 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 123.27 175.45 14.52 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.647 -0.787 . . . . 0.49 112.607 173.208 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 49.1 tp -160.1 128.2 4.74 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 108.919 -0.771 . . . . 1.36 108.919 -178.688 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 54.7 m80 -138.69 97.86 3.44 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 120.388 -0.525 . . . . 3.8 111.119 179.611 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -169.73 178.15 42.84 Favored Glycine 0 N--CA 1.446 -0.635 0 CA-C-N 115.636 -0.711 . . . . 0.55 111.812 175.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -82.69 87.1 6.75 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.479 0.657 . . . . 2.18 109.383 170.581 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 56.6 m-85 -109.71 128.81 55.52 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.451 -0.795 . . . . 1.5 110.478 -177.699 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 52.1 m-20 -82.97 177.03 8.81 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 109.282 -0.636 . . . . 2.23 109.282 174.378 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.608 ' HB ' ' OE1' ' A' ' 47' ' ' GLU . 26.1 t -49.79 -70.31 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 N-CA-C 112.52 0.563 . . . . 1.25 112.52 -170.777 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.608 ' OE1' ' HB ' ' A' ' 46' ' ' VAL . 1.7 mp0 -56.46 -45.82 80.69 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.53 0.567 . . . . 2.39 112.53 -175.408 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 23.3 t -71.9 -35.1 69.62 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-O 121.036 0.446 . . . . 1.65 111.161 -171.524 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -76.19 -38.32 34.85 Favored Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 120.547 -0.835 . . . . 0.4 111.533 -175.672 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.554 ' HB3' HG11 ' A' ' 61' ' ' VAL . 96.5 mt -67.78 -39.12 84.11 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.971 0.415 . . . . 1.63 110.719 179.88 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -58.58 -41.57 86.02 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.55 -0.75 . . . . 3.01 111.044 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 5.9 tp-100 -66.94 -46.4 74.87 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.242 -0.436 . . . . 2.18 111.027 -179.779 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 91.8 mt -56.16 -32.24 64.12 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 113.129 0.788 . . . . 1.4 113.129 -176.314 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 65.3 mt -92.19 9.0 35.49 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.904 0.705 . . . . 2.78 112.904 -174.167 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -65.68 133.14 50.47 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 120.827 0.346 . . . . 2.24 110.38 179.542 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 107.99 4.43 33.64 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.799 -0.715 . . . . 1.96 111.806 -176.107 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 22.2 p -149.91 -173.27 4.38 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.848 -0.427 . . . . 2.28 109.848 177.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -118.76 30.24 5.99 Favored Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 120.82 -0.705 . . . . 1.79 111.539 -176.277 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.423 ' HA ' ' HA ' ' A' ' 73' ' ' PRO . 42.8 mt -98.71 166.73 11.18 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.551 -0.537 . . . . 1.82 109.551 179.666 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 35.1 tt0 -154.79 118.6 4.61 Favored 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 108.625 -0.88 . . . . 3.26 108.625 178.126 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.554 HG11 ' HB3' ' A' ' 50' ' ' LEU . 3.2 p -94.61 127.12 46.84 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 N-CA-C 109.132 -0.692 . . . . 2.17 109.132 177.861 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.438 ' HA ' ' HD3' ' A' ' 63' ' ' PRO . 47.5 mtmt -128.58 142.72 45.79 Favored Pre-proline 0 C--N 1.318 -0.777 0 CA-C-N 115.909 -0.587 . . . . 2.29 110.335 -170.809 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 62' ' ' LYS . 12.4 Cg_exo -70.24 120.97 7.58 Favored 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 122.596 2.197 . . . . 0.94 111.022 175.739 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.435 HD21 ' HB ' ' A' ' 70' ' ' THR . 95.2 mt -58.39 -38.87 78.23 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.459 -0.792 . . . . 2.32 111.77 -174.607 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 161.8 -71.46 0.21 Allowed Glycine 0 N--CA 1.446 -0.697 0 C-N-CA 120.683 -0.77 . . . . 1.69 111.367 177.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -59.98 -77.14 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.777 0.322 . . . . 3.67 111.054 179.456 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 62.8 t30 -167.1 56.08 0.08 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.544 0.688 . . . . 2.59 109.572 177.356 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' SER . . . . . 0.434 ' O ' ' HD1' ' A' ' 69' ' ' TRP . 24.2 m -146.45 173.99 11.79 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 108.379 -0.971 . . . . 1.54 108.379 176.27 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' TRP . . . . . 0.502 ' CZ2' HG11 ' A' ' 46' ' ' VAL . 52.4 m0 -140.0 164.78 29.11 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 109.716 -0.475 . . . . 0.54 109.716 -168.793 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.435 ' HB ' HD21 ' A' ' 64' ' ' LEU . 6.6 t -149.01 145.43 27.3 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.711 -0.477 . . . . 1.49 109.711 170.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 58.2 tp -95.49 103.09 14.95 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.148 0.499 . . . . 2.24 110.828 178.64 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -105.76 145.07 30.15 Favored Pre-proline 0 C--N 1.322 -0.611 0 CA-C-N 115.632 -0.713 . . . . 2.25 111.115 174.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.423 ' HA ' ' HA ' ' A' ' 59' ' ' LEU . 7.2 Cg_exo -74.61 115.0 4.16 Favored 'Trans proline' 0 N--CA 1.46 -0.498 0 C-N-CA 122.333 2.022 . . . . 1.45 110.722 170.348 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.268 0 CA-C-N 115.878 -0.601 . . . . 2.07 110.274 -175.591 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 . . . . . 0 CA--C 1.514 -0.407 0 CA-C-O 121.391 0.615 . . . . 4.51 110.642 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 23.2 m -132.35 143.62 39.37 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 CA-C-N 115.076 -0.965 . . . . 2.2 109.555 177.464 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 5.2 p30 -128.43 96.82 4.53 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 108.741 -0.837 . . . . 2.75 108.741 179.079 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.423 ' HB ' ' H ' ' A' ' 40' ' ' LEU . 25.5 mt -132.82 159.72 43.02 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 CA-C-N 115.298 -0.865 . . . . 1.5 109.073 -173.845 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . 0.686 ' HB3' ' HD2' ' A' ' 7' ' ' PRO . . . -164.67 172.15 4.93 Favored Pre-proline 0 C--N 1.319 -0.752 0 N-CA-C 108.419 -0.956 . . . . 1.99 108.419 -174.545 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.686 ' HD2' ' HB3' ' A' ' 6' ' ' ALA . 19.8 Cg_exo -30.49 126.75 0.07 OUTLIER 'Trans proline' 0 C--N 1.358 1.055 0 C-N-CA 124.001 3.134 . . . . 1.73 113.782 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 162.99 157.0 8.83 Favored Glycine 0 N--CA 1.445 -0.746 0 N-CA-C 110.33 -1.108 . . . . 1.84 110.33 -176.456 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.572 ' HA ' ' HA ' ' A' ' 36' ' ' GLN . 9.3 t -58.59 133.1 55.56 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 117.285 0.542 . . . . 1.87 110.038 179.857 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.719 HD22 ' HG ' ' A' ' 54' ' ' LEU . 62.2 tp -57.62 -30.49 65.39 Favored 'General case' 0 N--CA 1.462 0.131 0 CA-C-N 115.537 -0.756 . . . . 1.83 111.422 -173.26 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.55 ' CA ' ' HB ' ' A' ' 32' ' ' THR . 31.3 t70 -50.18 -56.77 9.67 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.627 -0.715 . . . . 2.11 111.367 176.808 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 37.3 ttmt -66.92 -26.99 67.13 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.549 -0.296 . . . . 3.11 110.96 -179.337 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.487 ' O ' ' HB3' ' A' ' 16' ' ' GLN . . . -65.84 -55.78 15.31 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.867 0.365 . . . . 1.17 110.467 179.335 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.592 HD12 HG21 ' A' ' 32' ' ' THR . 82.6 mt -59.18 -35.76 74.13 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.175 -0.466 . . . . 1.31 111.425 176.523 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -61.05 -39.61 90.48 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.933 -0.395 . . . . 1.98 109.933 176.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . 0.487 ' HB3' ' O ' ' A' ' 13' ' ' ALA . 41.0 tp60 -58.74 -45.26 90.08 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.672 -0.694 . . . . 2.33 111.379 175.94 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.609 ' O ' ' HB2' ' A' ' 20' ' ' HIS . 8.5 t80 -66.49 -45.24 80.27 Favored 'General case' 0 CA--C 1.514 -0.422 0 CA-C-O 121.044 0.45 . . . . 1.05 110.127 -179.157 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.713 ' HA ' ' CE2' ' A' ' 23' ' ' PHE . . . -50.46 -33.84 22.6 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.165 -0.925 . . . . 1.15 111.966 179.327 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.3 -10.09 14.7 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 116.089 -0.505 . . . . 1.26 112.241 178.262 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . 0.609 ' HB2' ' O ' ' A' ' 17' ' ' TYR . 0.0 OUTLIER -55.8 -61.44 2.36 Favored 'General case' 0 CA--C 1.518 -0.286 0 CA-C-O 120.899 0.38 . . . . 2.52 111.524 178.235 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.555 ' HB3' ' HD1' ' A' ' 23' ' ' PHE . 46.0 t -113.65 -15.56 12.48 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.02 0.438 . . . . 1.79 111.411 -177.678 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 77.8 55.71 4.07 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.628 -0.796 . . . . 0.68 111.307 -174.428 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.713 ' CE2' ' HA ' ' A' ' 18' ' ' ALA . 2.7 p90 -101.87 164.55 11.66 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.696 0.284 . . . . 0.68 110.459 -177.62 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.565 ' O ' ' HB3' ' A' ' 68' ' ' SER . 5.6 m -88.8 107.02 18.75 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.489 0.661 . . . . 1.3 111.25 -174.496 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.503 HD23 ' HB ' ' A' ' 27' ' ' VAL . 1.2 tt -93.22 132.62 37.22 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.569 -0.742 . . . . 2.3 109.311 178.399 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.652 ' HB2' ' HA ' ' A' ' 70' ' ' THR . 50.1 m -94.95 92.29 6.81 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.533 -0.543 . . . . 1.67 109.533 176.508 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.503 ' HB ' HD23 ' A' ' 25' ' ' LEU . 11.6 p -144.76 148.22 18.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.607 -0.724 . . . . 1.52 110.529 -174.972 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -111.91 139.08 47.7 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.196 -0.456 . . . . 2.38 109.94 178.713 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -64.05 64.8 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.29 0 O-C-N 123.76 0.662 . . . . 2.45 111.829 176.511 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 26.1 p -170.91 -42.65 0.02 OUTLIER 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 109.507 -0.553 . . . . 2.48 109.507 -178.394 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 72.9 mt -64.71 -40.87 96.09 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.217 -0.902 . . . . 1.92 110.687 178.666 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.592 HG21 HD12 ' A' ' 14' ' ' LEU . 0.9 OUTLIER -103.83 -12.54 16.86 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.757 -0.656 . . . . 1.82 112.473 -178.515 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 57.4 ttp180 -88.38 134.88 33.71 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.856 0.36 . . . . 5.19 110.658 -176.047 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 104.37 -51.43 0.8 Allowed Glycine 0 N--CA 1.448 -0.534 0 N-CA-C 111.512 -0.635 . . . . 1.62 111.512 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.971 ' HD2' ' H ' ' A' ' 35' ' ' LYS . 0.0 OUTLIER -76.9 132.09 38.92 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.437 -0.579 . . . . 3.17 109.437 175.586 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . 0.572 ' HA ' ' HA ' ' A' ' 9' ' ' SER . 71.3 mt-30 -104.38 161.83 13.74 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.193 -0.458 . . . . 2.52 110.84 -175.23 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 13.1 t -131.89 136.51 47.47 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 107.838 -1.171 . . . . 1.14 107.838 173.227 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -70.75 -0.75 9.55 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 112.377 0.51 . . . . 1.28 112.377 -176.647 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 99.97 -171.44 23.64 Favored Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.632 -0.794 . . . . 0.49 113.222 170.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.423 ' H ' ' HB ' ' A' ' 5' ' ' ILE . 64.1 tp -160.44 145.6 14.7 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 107.85 -1.167 . . . . 1.36 107.85 -178.812 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 10.0 t-160 -145.11 98.09 3.11 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.366 -0.534 . . . . 3.8 110.847 177.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -169.31 -175.4 38.51 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.849 -0.691 . . . . 0.55 112.392 175.485 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 28.6 t0 -89.99 88.13 7.18 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 108.422 -0.955 . . . . 2.18 108.422 173.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 31.7 m-85 -116.08 142.42 46.83 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.491 0.662 . . . . 1.5 112.362 -170.251 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -90.77 -179.78 5.6 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 114.694 -1.139 . . . . 2.23 109.612 174.782 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.491 HG12 ' CZ2' ' A' ' 69' ' ' TRP . 78.7 t -53.03 -71.99 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 N-CA-C 112.679 0.622 . . . . 1.25 112.679 -176.562 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -62.18 -41.36 98.26 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.751 0.648 . . . . 2.39 112.751 -169.184 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 23.3 t -74.4 -34.29 63.25 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.17 0.509 . . . . 1.65 110.672 -174.487 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -74.49 -41.42 36.52 Favored Glycine 0 N--CA 1.446 -0.662 0 C-N-CA 120.803 -0.713 . . . . 0.4 111.659 -176.126 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.435 HD11 ' CG1' ' A' ' 61' ' ' VAL . 68.3 mt -67.3 -34.52 77.55 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.711 0.291 . . . . 1.63 110.638 -179.491 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 7.3 tp60 -57.27 -48.86 77.81 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.101 -0.499 . . . . 3.01 110.679 178.571 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.93 ' HA ' HE21 ' A' ' 52' ' ' GLN . 0.0 OUTLIER -67.67 -42.48 82.08 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.415 -0.357 . . . . 2.18 111.065 -178.599 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 78.8 mt -57.0 -40.6 76.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.053 -0.521 . . . . 1.4 112.16 -179.335 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.719 ' HG ' HD22 ' A' ' 10' ' ' LEU . 10.1 mp -97.74 2.54 49.7 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 112.306 0.484 . . . . 2.78 112.306 -173.772 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -62.07 111.85 2.11 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.047 0.451 . . . . 2.24 110.481 179.424 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 97.88 -7.2 62.74 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 121.06 -0.59 . . . . 1.96 112.505 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.5 m -87.75 -12.91 43.81 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.818 0.342 . . . . 2.28 111.043 -176.314 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 76.16 20.21 77.64 Favored Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 120.678 -0.772 . . . . 1.79 111.942 -179.363 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.41 ' CB ' HD23 ' A' ' 54' ' ' LEU . 96.3 mt -124.02 166.26 16.05 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 110.183 -0.302 . . . . 1.82 110.183 -179.473 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 17.2 tp60 -147.89 118.59 7.53 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.486 -0.561 . . . . 3.26 109.486 178.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.56 HG21 ' CD2' ' A' ' 54' ' ' LEU . 59.9 t -91.64 127.29 44.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 N-CA-C 109.473 -0.566 . . . . 2.17 109.473 176.409 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 41.4 tttm -117.12 128.01 26.32 Favored Pre-proline 0 C--N 1.318 -0.797 0 CA-C-N 116.051 -0.522 . . . . 2.29 109.761 -179.016 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -60.17 120.68 8.59 Favored 'Trans proline' 0 N--CA 1.461 -0.431 0 C-N-CA 121.867 1.712 . . . . 0.94 110.008 171.648 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -68.06 -50.51 54.73 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.973 -0.558 . . . . 2.32 110.211 -173.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 151.79 -52.92 0.48 Allowed Glycine 0 N--CA 1.445 -0.732 0 C-N-CA 120.605 -0.807 . . . . 1.69 112.001 178.402 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 78.8 m-20 -87.94 57.95 4.58 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.747 0.308 . . . . 3.67 110.949 -176.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 67.0 t30 50.73 37.37 16.54 Favored 'General case' 0 N--CA 1.473 0.675 0 CA-C-N 115.659 -0.701 . . . . 2.59 110.89 -177.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' SER . . . . . 0.565 ' HB3' ' O ' ' A' ' 24' ' ' THR . 49.7 m -141.21 178.63 7.27 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 108.128 -1.064 . . . . 1.54 108.128 178.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' TRP . . . . . 0.491 ' CZ2' HG12 ' A' ' 46' ' ' VAL . 54.2 m0 -135.49 167.41 21.13 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.046 0.45 . . . . 0.54 110.669 -169.22 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.652 ' HA ' ' HB2' ' A' ' 26' ' ' SER . 6.9 t -141.3 139.79 33.71 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.205 -0.907 . . . . 1.49 108.97 173.625 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.476 HD22 HG23 ' A' ' 27' ' ' VAL . 48.9 tp -92.37 104.29 16.64 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.642 0.734 . . . . 2.24 109.69 178.506 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 28.0 mm-40 -88.71 119.61 70.03 Favored Pre-proline 0 C--N 1.313 -0.994 0 CA-C-N 114.509 -1.223 . . . . 2.25 110.843 -179.605 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_exo -66.77 113.6 2.82 Favored 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 121.698 1.598 . . . . 1.45 110.037 172.142 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.321 -0.659 0 CA-C-N 115.692 -0.685 . . . . 2.07 109.374 -176.619 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 . . . . . 0 N--CA 1.452 -0.341 0 CA-C-O 121.728 0.775 . . . . 4.51 111.434 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 60.5 t -91.81 121.56 42.43 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 N-CA-C 107.966 -1.124 . . . . 2.2 107.966 172.25 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -130.1 128.87 42.74 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 109.532 -0.544 . . . . 2.75 109.532 -174.204 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 75.2 mt -133.88 132.26 56.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 116.391 -0.368 . . . . 1.5 110.608 -177.581 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -70.82 153.46 94.8 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 115.538 -0.756 . . . . 1.99 110.775 179.687 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.577 ' HA ' ' O ' ' A' ' 37' ' ' SER . 5.5 Cg_exo -75.23 34.16 0.4 Allowed 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 123.299 2.666 . . . . 1.73 113.492 -179.027 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.413 ' HA2' ' HB3' ' A' ' 36' ' ' GLN . . . -159.14 140.22 6.72 Favored Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 120.403 -0.903 . . . . 1.84 113.322 -178.073 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.492 ' H ' ' HG2' ' A' ' 36' ' ' GLN . 0.1 OUTLIER 64.01 92.15 0.07 Allowed 'General case' 0 C--O 1.233 0.203 0 C-N-CA 123.455 0.702 . . . . 1.87 111.993 175.019 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.623 HD12 ' HB3' ' A' ' 53' ' ' LEU . 52.2 tp -64.01 -36.91 85.53 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.172 0.511 . . . . 1.83 110.533 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.439 ' HB3' ' HG1' ' A' ' 32' ' ' THR . 14.1 p-10 -55.34 -43.41 74.95 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.525 -0.761 . . . . 2.11 111.392 177.288 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 27.8 ttpp -71.27 -28.47 64.17 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.168 0.508 . . . . 3.11 110.006 178.431 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -67.5 -52.47 38.73 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.475 -0.784 . . . . 1.17 110.736 179.722 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 91.3 mt -57.39 -40.59 78.53 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 115.812 -0.631 . . . . 1.31 111.596 178.366 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 10.9 t30 -59.75 -37.11 78.08 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.14 -0.482 . . . . 1.98 110.334 179.53 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . 0.442 HE21 ' HB3' ' A' ' 16' ' ' GLN . 0.9 OUTLIER -63.41 -43.73 96.66 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.581 -0.736 . . . . 2.33 110.67 177.422 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.493 ' OH ' ' HA ' ' A' ' 46' ' ' VAL . 7.2 t80 -67.55 -45.61 75.17 Favored 'General case' 0 C--O 1.232 0.157 0 N-CA-C 109.846 -0.427 . . . . 1.05 109.846 -177.344 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.626 ' HA ' ' CZ ' ' A' ' 23' ' ' PHE . . . -53.98 -52.77 59.67 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 115.54 -0.754 . . . . 1.15 112.12 179.393 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.32 -30.59 71.7 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.911 0.386 . . . . 1.26 110.868 -178.337 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 75.1 t60 -65.85 -55.26 18.0 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.946 -0.57 . . . . 2.52 111.407 -178.183 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.567 ' HB3' ' CD1' ' A' ' 23' ' ' PHE . 34.9 t -90.82 0.67 57.39 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-O 120.786 0.327 . . . . 1.79 111.607 -173.465 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 64.68 36.53 93.25 Favored Glycine 0 CA--C 1.517 0.191 0 CA-C-N 116.19 -0.459 . . . . 0.68 113.785 175.074 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.626 ' CZ ' ' HA ' ' A' ' 18' ' ' ALA . 53.1 p90 -109.42 161.07 15.66 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.667 -0.494 . . . . 0.68 109.667 177.484 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 39.2 m -89.8 107.04 18.86 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.074 0.464 . . . . 1.3 110.077 178.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 6.9 tt -91.92 125.28 36.56 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.814 -0.63 . . . . 2.3 109.368 -179.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.583 ' O ' ' HA ' ' A' ' 70' ' ' THR . 14.6 t -111.54 97.56 6.83 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.352 0.596 . . . . 1.67 110.015 -178.62 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 6.6 p -91.72 130.64 40.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 109.279 -0.637 . . . . 1.52 109.279 177.274 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -69.83 105.92 2.95 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.403 -0.362 . . . . 2.38 110.642 -177.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 55.87 -90.86 0.03 OUTLIER 'General case' 0 C--O 1.232 0.176 0 O-C-N 124.152 0.908 . . . . 2.45 111.235 -176.458 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 2.3 t -171.32 56.22 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 108.933 -0.766 . . . . 2.48 108.933 176.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 90.3 mt -67.07 -17.16 64.76 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.55 -0.75 . . . . 1.92 111.136 -178.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.439 ' HG1' ' HB3' ' A' ' 11' ' ' ASP . 17.1 p -92.89 -1.74 56.47 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.05 -0.523 . . . . 1.82 111.214 -179.476 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 40.7 ttm180 -68.8 122.97 19.69 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.27 -0.423 . . . . 5.19 110.43 -179.753 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 99.05 -15.94 59.96 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.726 -0.75 . . . . 1.62 111.806 -178.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.899 ' HE3' ' HB3' ' A' ' 57' ' ' SER . 41.0 tttm -89.33 132.57 34.88 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-O 120.597 0.237 . . . . 3.17 110.362 177.404 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . 0.492 ' HG2' ' H ' ' A' ' 9' ' ' SER . 25.0 mt-30 -102.43 168.87 9.03 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 109.276 -0.638 . . . . 2.52 109.276 173.648 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.577 ' O ' ' HA ' ' A' ' 7' ' ' PRO . 22.9 t -139.33 124.02 18.48 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 106.823 -1.547 . . . . 1.14 106.823 173.273 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.417 ' N ' HD21 ' A' ' 38' ' ' ASN . 0.9 OUTLIER -55.19 -17.31 4.14 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 112.829 0.677 . . . . 1.28 112.829 -173.396 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 131.49 -178.93 17.48 Favored Glycine 0 N--CA 1.441 -1.012 0 C-N-CA 120.351 -0.928 . . . . 0.49 112.662 171.104 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 43.8 tp -160.35 122.72 3.28 Favored 'General case' 0 N--CA 1.445 -0.711 0 N-CA-C 107.275 -1.38 . . . . 1.36 107.275 -178.319 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 33.1 m-70 -142.5 97.82 3.19 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.176 0.513 . . . . 3.8 111.211 -178.056 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -171.75 178.19 44.15 Favored Glycine 0 N--CA 1.445 -0.701 0 CA-C-N 115.535 -0.757 . . . . 0.55 111.586 174.326 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -80.41 76.7 7.22 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 107.954 -1.128 . . . . 2.18 107.954 166.623 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -92.67 139.09 30.92 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 113.061 0.763 . . . . 1.5 113.061 -167.357 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -75.22 158.44 32.95 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 114.468 -1.242 . . . . 2.23 109.808 172.412 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.606 HG11 ' HZ2' ' A' ' 69' ' ' TRP . 85.0 t -49.32 -68.13 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 O-C-N 123.674 0.609 . . . . 1.25 112.056 -177.038 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -61.87 -31.56 71.85 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.141 -0.481 . . . . 2.39 112.148 -176.371 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 22.9 t -69.71 -35.03 74.69 Favored 'General case' 0 C--O 1.238 0.492 0 CA-C-O 121.308 0.575 . . . . 1.65 110.262 -176.669 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.506 ' O ' ' HG ' ' A' ' 53' ' ' LEU . . . -74.15 -30.8 60.39 Favored Glycine 0 N--CA 1.446 -0.668 0 N-CA-C 111.036 -0.826 . . . . 0.4 111.036 -177.479 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.61 HD23 ' CZ3' ' A' ' 69' ' ' TRP . 98.3 mt -70.71 -41.52 71.83 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.537 -0.331 . . . . 1.63 110.798 179.121 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -51.96 -46.52 64.81 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.07 -0.513 . . . . 3.01 111.232 178.507 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 13.2 mm100 -64.06 -45.81 87.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.741 0.305 . . . . 2.18 110.973 -179.711 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.623 ' HB3' HD12 ' A' ' 10' ' ' LEU . 79.9 mt -60.02 -32.24 70.7 Favored 'General case' 0 C--O 1.237 0.438 0 CA-C-N 116.115 -0.493 . . . . 1.4 111.874 179.068 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.437 HD13 ' O ' ' A' ' 54' ' ' LEU . 0.8 OUTLIER -70.06 -34.98 73.89 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.071 -0.513 . . . . 2.78 110.569 -177.926 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -55.9 110.14 0.69 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.205 -0.452 . . . . 2.24 110.752 -176.564 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 119.64 -2.7 13.65 Favored Glycine 0 N--CA 1.444 -0.8 0 C-N-CA 120.771 -0.728 . . . . 1.96 112.294 -179.235 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.899 ' HB3' ' HE3' ' A' ' 35' ' ' LYS . 68.9 p -121.35 169.46 10.58 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.923 0.392 . . . . 2.28 110.865 176.651 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -109.46 35.45 4.89 Favored Glycine 0 N--CA 1.445 -0.761 0 N-CA-C 110.112 -1.195 . . . . 1.79 110.112 175.16 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 27.4 mt -108.49 -179.35 3.85 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 114.805 -0.697 . . . . 1.82 109.138 -178.642 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 57.4 tp60 -142.57 119.47 11.26 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 108.483 -0.932 . . . . 3.26 108.483 173.654 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.599 HG11 ' HB3' ' A' ' 50' ' ' LEU . 3.7 p -85.1 117.8 30.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-O 121.446 0.641 . . . . 2.17 109.386 179.147 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 49.2 mtpt -123.47 124.94 26.19 Favored Pre-proline 0 C--N 1.32 -0.693 0 CA-C-N 115.828 -0.624 . . . . 2.29 110.139 -173.543 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_exo -60.4 118.49 5.37 Favored 'Trans proline' 0 N--CA 1.456 -0.71 0 C-N-CA 121.861 1.707 . . . . 0.94 109.886 171.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -57.13 -38.37 73.38 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.395 -0.821 . . . . 2.32 111.361 -171.137 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 160.55 -50.57 0.36 Allowed Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 119.812 -1.185 . . . . 1.69 112.949 176.554 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 3.4 p30 -116.66 71.85 0.8 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.174 0.512 . . . . 3.67 111.305 -176.644 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 58.6 t30 55.87 43.03 28.21 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 115.292 -0.867 . . . . 2.59 110.749 179.598 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' SER . . . . . 0.44 ' O ' ' HD1' ' A' ' 69' ' ' TRP . 42.4 t -139.61 173.04 11.95 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 107.369 -1.345 . . . . 1.54 107.369 177.215 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' TRP . . . . . 0.61 ' CZ3' HD23 ' A' ' 50' ' ' LEU . 30.1 m0 -141.62 160.87 39.28 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.445 -0.576 . . . . 0.54 109.445 -171.783 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.583 ' HA ' ' O ' ' A' ' 26' ' ' SER . 8.9 t -148.67 146.14 28.03 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.618 -0.512 . . . . 1.49 109.618 169.791 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -93.7 99.93 12.25 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.373 0.606 . . . . 2.24 109.471 176.122 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.424 ' HA ' ' HD3' ' A' ' 73' ' ' PRO . 33.2 tt0 -96.59 126.86 41.76 Favored Pre-proline 0 C--N 1.319 -0.749 0 CA-C-N 115.187 -0.915 . . . . 2.25 110.636 177.611 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 72' ' ' GLU . 7.1 Cg_exo -72.34 114.11 3.9 Favored 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 122.02 1.813 . . . . 1.45 111.103 177.227 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.322 -0.589 0 CA-C-N 115.721 -0.672 . . . . 2.07 109.87 -177.213 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 4.8 pp0? . . . . . 0 C--O 1.234 0.281 0 CA-C-O 120.972 0.415 . . . . 4.51 110.708 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 9.4 p -142.38 147.36 21.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 115.757 -0.656 . . . . 2.2 109.939 -176.054 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 47.2 m-80 -128.9 100.26 5.61 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.882 0.372 . . . . 2.75 110.001 -177.338 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.442 HD13 ' HB2' ' A' ' 13' ' ' ALA . 48.4 mm -108.69 127.45 65.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 116.121 -0.491 . . . . 1.5 110.856 -177.611 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . 0.485 ' HA ' ' HD3' ' A' ' 7' ' ' PRO . . . -67.78 139.52 93.61 Favored Pre-proline 0 C--N 1.331 -0.22 0 CA-C-N 116.21 -0.45 . . . . 1.99 110.725 178.607 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.485 ' HD3' ' HA ' ' A' ' 6' ' ' ALA . 14.6 Cg_exo -72.17 36.87 0.34 Allowed 'Trans proline' 0 CA--C 1.534 0.522 0 C-N-CA 123.818 3.012 . . . . 1.73 114.628 -176.219 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -175.22 45.93 0.13 Allowed Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 119.467 -1.349 . . . . 1.84 114.55 176.446 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.43 ' HA ' ' O ' ' A' ' 35' ' ' LYS . 32.1 t -177.78 101.75 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 117.342 0.571 . . . . 1.87 111.279 173.391 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.465 HD23 ' HG ' ' A' ' 57' ' ' SER . 53.7 tp -64.36 -37.29 86.99 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-O 121.328 0.585 . . . . 1.83 109.459 169.122 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -48.79 -60.95 2.31 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 114.849 -1.069 . . . . 2.11 111.366 177.281 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -68.22 -22.48 64.79 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.702 0.287 . . . . 3.11 111.068 179.45 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.442 ' HB2' HD13 ' A' ' 5' ' ' ILE . . . -63.73 -54.72 30.95 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.902 0.382 . . . . 1.17 110.475 179.778 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 93.3 mt -58.63 -39.06 79.45 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.618 -0.719 . . . . 1.31 110.696 176.514 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 55.8 t30 -61.68 -45.52 93.67 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.903 -0.59 . . . . 1.98 110.276 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . 0.447 HE21 ' HB3' ' A' ' 16' ' ' GLN . 0.9 OUTLIER -61.7 -45.61 93.26 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.934 -0.575 . . . . 2.33 110.892 177.489 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.438 ' HD1' ' HZ ' ' A' ' 23' ' ' PHE . 1.3 t80 -65.18 -43.15 92.6 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 109.719 -0.475 . . . . 1.05 109.719 -177.396 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.811 ' HA ' ' CE2' ' A' ' 23' ' ' PHE . . . -55.3 -49.34 72.38 Favored 'General case' 0 CA--C 1.519 -0.226 0 CA-C-N 115.564 -0.743 . . . . 1.15 111.551 178.211 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.64 -28.08 68.2 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.398 -0.365 . . . . 1.26 111.249 -178.72 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 42.3 t60 -58.69 -50.23 74.64 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.919 -0.582 . . . . 2.52 111.906 -176.581 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.482 ' HB3' ' CD1' ' A' ' 23' ' ' PHE . 8.2 t -109.79 1.61 19.45 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-O 121.207 0.527 . . . . 1.79 111.452 -178.514 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 62.11 47.54 89.19 Favored Glycine 0 CA--C 1.522 0.509 0 CA-C-N 115.638 -0.71 . . . . 0.68 114.366 175.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.811 ' CE2' ' HA ' ' A' ' 18' ' ' ALA . 3.6 p90 -104.96 166.59 10.27 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 117.238 0.519 . . . . 0.68 110.563 177.222 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 24.2 m -90.93 119.39 31.09 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.417 0.627 . . . . 1.3 112.183 -175.478 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.655 HD12 ' HE3' ' A' ' 69' ' ' TRP . 1.5 mm? -92.93 122.5 35.37 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.36 -0.836 . . . . 2.3 111.231 175.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 63.4 m -97.99 94.91 7.13 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.291 0.567 . . . . 1.67 109.603 175.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 11.2 p -139.07 140.51 38.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 115.611 -0.722 . . . . 1.52 110.846 -174.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.979 ' HB3' HD11 ' A' ' 31' ' ' LEU . 7.8 t70 -68.43 149.46 49.29 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.81 -0.632 . . . . 2.38 109.771 174.863 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -53.3 -16.39 1.29 Allowed 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 114.952 1.464 . . . . 2.45 114.952 -170.553 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 7.4 p -165.57 69.99 0.14 Allowed 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 114.003 1.112 . . . . 2.48 114.003 -176.386 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.979 HD11 ' HB3' ' A' ' 28' ' ' ASP . 2.7 mp -96.99 -34.2 11.28 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.585 0.707 . . . . 1.92 109.132 164.181 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 5.6 p -95.46 21.19 8.45 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 114.959 -1.019 . . . . 1.82 111.507 -178.189 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 32.8 ttt180 -66.28 105.63 1.48 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.033 0.444 . . . . 5.19 110.385 -176.623 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 77.24 22.91 69.68 Favored Glycine 0 N--CA 1.447 -0.598 0 CA-C-N 115.804 -0.634 . . . . 1.62 112.572 -179.069 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.43 ' O ' ' HA ' ' A' ' 9' ' ' SER . 8.8 tptp -76.33 156.41 33.36 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.678 -0.49 . . . . 3.17 109.678 178.456 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -139.36 140.61 37.53 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.075 0.464 . . . . 2.52 110.892 -177.669 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 9.4 t -140.04 133.21 29.66 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 107.427 -1.324 . . . . 1.14 107.427 175.103 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.472 ' C ' ' HA ' ' A' ' 7' ' ' PRO . 0.9 OUTLIER -60.47 -7.47 2.12 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 112.85 0.685 . . . . 1.28 112.85 -176.383 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 114.8 179.79 18.6 Favored Glycine 0 CA--C 1.503 -0.675 0 C-N-CA 120.509 -0.853 . . . . 0.49 112.652 167.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.434 ' N ' ' HB ' ' A' ' 5' ' ' ILE . 19.4 tp -160.96 123.05 3.07 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 107.681 -1.229 . . . . 1.36 107.681 -176.077 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 20.8 t-160 -144.57 97.49 3.04 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.356 0.598 . . . . 3.8 110.853 -178.125 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -169.67 -173.09 36.89 Favored Glycine 0 N--CA 1.445 -0.718 0 CA-C-N 115.228 -0.896 . . . . 0.55 110.919 177.262 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -88.89 82.26 6.77 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 109.559 -0.534 . . . . 2.18 109.559 171.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 73.6 m-85 -97.55 136.28 38.18 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.047 -0.524 . . . . 1.5 111.403 -175.6 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -86.6 173.6 9.44 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 108.801 -0.814 . . . . 2.23 108.801 176.119 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 52.9 t -52.56 -57.71 3.76 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 N-CA-C 111.928 0.344 . . . . 1.25 111.928 -173.111 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 51.5 mm-40 -62.86 -49.49 74.68 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-O 121.076 0.465 . . . . 2.39 111.809 -175.333 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 11.7 p -72.72 -24.18 60.95 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.892 -0.595 . . . . 1.65 111.286 -172.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.436 ' O ' ' HG ' ' A' ' 53' ' ' LEU . . . -75.87 -40.33 31.11 Favored Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 120.766 -0.73 . . . . 0.4 111.337 -178.263 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.495 ' HB3' HG11 ' A' ' 61' ' ' VAL . 95.4 mt -68.33 -45.09 73.86 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.811 0.338 . . . . 1.63 110.647 -178.757 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 42.6 tt0 -57.69 -42.94 84.69 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.818 -0.628 . . . . 3.01 110.865 -179.034 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 15.2 mm100 -66.44 -43.06 86.64 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.485 -0.325 . . . . 2.18 111.061 -179.37 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.436 ' HG ' ' O ' ' A' ' 49' ' ' GLY . 86.4 mt -57.64 -21.99 43.04 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 116.126 -0.488 . . . . 1.4 112.099 178.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.572 HD21 HG12 ' A' ' 61' ' ' VAL . 97.7 mt -70.23 -8.97 54.28 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 111.932 0.345 . . . . 2.78 111.932 -179.234 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -67.89 107.75 2.76 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.097 0.475 . . . . 2.24 110.164 178.756 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 116.94 2.17 18.85 Favored Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 120.827 -0.702 . . . . 1.96 112.055 -177.121 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.465 ' HG ' HD23 ' A' ' 10' ' ' LEU . 50.3 m -137.24 167.77 20.93 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.113 0.482 . . . . 2.28 111.307 179.642 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -116.97 15.29 13.69 Favored Glycine 0 N--CA 1.442 -0.927 0 N-CA-C 110.3 -1.12 . . . . 1.79 110.3 172.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.43 HD11 HD12 ' A' ' 71' ' ' LEU . 76.8 mt -92.29 179.48 5.54 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.339 -0.615 . . . . 1.82 109.339 179.577 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 30.9 tp60 -140.2 117.6 11.41 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.864 -0.421 . . . . 3.26 109.864 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.572 HG12 HD21 ' A' ' 54' ' ' LEU . 7.3 p -98.97 129.44 49.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 N-CA-C 109.623 -0.51 . . . . 2.17 109.623 175.79 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.807 ' HD3' ' HG3' ' A' ' 72' ' ' GLU . 20.4 ptmt -144.66 144.19 23.9 Favored Pre-proline 0 C--N 1.32 -0.712 0 CA-C-N 116.236 -0.438 . . . . 2.29 110.569 -176.865 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . 0.518 ' HA ' ' HA ' ' A' ' 69' ' ' TRP . 21.1 Cg_exo -67.1 140.6 54.62 Favored 'Trans proline' 0 N--CA 1.462 -0.33 0 C-N-CA 122.82 2.347 . . . . 0.94 111.807 175.872 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.499 HD23 ' HB ' ' A' ' 70' ' ' THR . 59.7 mt -65.71 -44.65 85.46 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.668 -0.696 . . . . 2.32 111.108 -179.379 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 178.52 -60.8 0.09 OUTLIER Glycine 0 N--CA 1.445 -0.762 0 C-N-CA 120.274 -0.965 . . . . 1.69 112.307 178.027 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . 0.414 HD21 ' HA ' ' A' ' 66' ' ' ASN . 3.7 m120 -91.84 -79.8 0.37 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.738 0.304 . . . . 3.67 111.477 -177.362 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -142.2 42.35 1.65 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.36 0.6 . . . . 2.59 110.916 -174.323 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 9.8 m -143.53 172.91 12.14 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 108.28 -1.007 . . . . 1.54 108.28 175.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' TRP . . . . . 0.655 ' HE3' HD12 ' A' ' 25' ' ' LEU . 55.0 m0 -136.68 167.86 20.6 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.55 -0.537 . . . . 0.54 109.55 -172.716 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.499 ' HB ' HD23 ' A' ' 64' ' ' LEU . 9.5 t -142.36 142.5 32.46 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.641 -0.503 . . . . 1.49 109.641 174.125 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.726 HD11 HD23 ' A' ' 31' ' ' LEU . 0.4 OUTLIER -93.7 101.04 13.17 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 108.985 -0.746 . . . . 2.24 108.985 176.44 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.807 ' HG3' ' HD3' ' A' ' 62' ' ' LYS . 10.5 mm-40 -87.78 119.54 70.6 Favored Pre-proline 0 C--N 1.318 -0.799 0 CA-C-N 114.72 -1.127 . . . . 2.25 111.264 178.499 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -88.01 113.58 0.83 Allowed 'Trans proline' 0 N--CA 1.447 -1.209 0 C-N-CA 122.154 1.903 . . . . 1.45 111.104 173.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.323 -0.582 0 CA-C-N 115.585 -0.734 . . . . 2.07 109.791 -178.835 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 . . . . . 0 N--CA 1.45 -0.426 0 CA-C-O 121.786 0.803 . . . . 4.51 112.262 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.76 ' HB ' ' HE1' ' A' ' 44' ' ' TYR . 41.5 t -145.91 152.7 13.86 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 N-CA-C 106.857 -1.535 . . . . 2.2 106.857 176.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 8.9 m120 -124.31 101.21 7.06 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.333 0.587 . . . . 2.75 109.766 -177.167 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 62.2 mt -116.63 147.51 19.97 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 115.371 -0.831 . . . . 1.5 109.291 -178.297 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . 0.688 ' HB1' ' HD2' ' A' ' 7' ' ' PRO . . . -162.56 167.19 12.58 Favored Pre-proline 0 C--N 1.319 -0.745 0 N-CA-C 108.588 -0.893 . . . . 1.99 108.588 -172.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.688 ' HD2' ' HB1' ' A' ' 6' ' ' ALA . 11.2 Cg_exo -32.85 131.58 0.1 Allowed 'Trans proline' 0 C--N 1.357 0.998 0 C-N-CA 124.183 3.255 . . . . 1.73 113.748 -175.326 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 156.0 171.57 22.53 Favored Glycine 0 N--CA 1.441 -1.0 0 N-CA-C 110.154 -1.178 . . . . 1.84 110.154 -174.25 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -67.59 137.76 55.93 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 108.95 -0.759 . . . . 1.87 108.95 178.918 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.409 HD13 ' HB3' ' A' ' 13' ' ' ALA . 49.8 tp -59.07 -27.13 65.24 Favored 'General case' 0 C--O 1.232 0.178 0 C-N-CA 122.675 0.39 . . . . 1.83 110.204 -178.161 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -49.53 -49.58 45.48 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.185 -0.916 . . . . 2.11 109.873 172.663 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 57.9 tttm -68.08 -32.14 72.25 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.561 -0.745 . . . . 3.11 110.882 -178.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.409 ' HB3' HD13 ' A' ' 10' ' ' LEU . . . -65.07 -52.48 55.41 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.878 0.371 . . . . 1.17 110.043 -179.902 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.441 HD23 HD13 ' A' ' 53' ' ' LEU . 91.5 mt -56.71 -40.6 75.95 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.707 -0.679 . . . . 1.31 110.485 173.676 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 9.3 t30 -62.23 -41.06 98.06 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.837 -0.62 . . . . 1.98 110.612 179.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 24.2 tp60 -59.45 -46.45 88.73 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.194 -0.457 . . . . 2.33 111.475 179.034 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.452 ' HD1' ' HZ ' ' A' ' 23' ' ' PHE . 1.6 t80 -67.74 -44.02 78.55 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 109.061 -0.718 . . . . 1.05 109.061 179.568 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.78 ' HA ' ' CE2' ' A' ' 23' ' ' PHE . . . -54.23 -53.7 49.95 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 114.894 -1.048 . . . . 1.15 111.823 179.225 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.98 -27.26 68.01 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.794 0.331 . . . . 1.26 111.225 -178.34 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 69.1 t60 -61.52 -49.46 76.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.034 -0.53 . . . . 2.52 111.399 -178.617 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.588 ' HB3' ' CD1' ' A' ' 23' ' ' PHE . 1.9 t -109.49 2.85 20.75 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-O 121.136 0.493 . . . . 1.79 111.485 -176.882 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 60.23 46.84 93.53 Favored Glycine 0 C--N 1.333 0.397 0 CA-C-N 115.56 -0.746 . . . . 0.68 114.366 174.221 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.907 ' HB3' ' HB3' ' A' ' 67' ' ' ASN . 5.8 p90 -106.47 167.06 10.1 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 117.273 0.536 . . . . 0.68 112.017 -179.824 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 6.7 m -94.14 112.88 24.74 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.206 -0.906 . . . . 1.3 112.055 -176.369 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.575 HD22 ' CE3' ' A' ' 69' ' ' TRP . 0.6 OUTLIER -88.43 123.68 33.21 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.213 -0.903 . . . . 2.3 111.341 176.828 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 20.7 t -103.05 91.14 3.99 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.152 -0.684 . . . . 1.67 109.152 176.44 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.7 p -146.78 135.96 16.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.017 -0.538 . . . . 1.52 110.922 -178.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.56 ' HB3' ' HG ' ' A' ' 31' ' ' LEU . 33.0 t70 -69.49 118.94 13.0 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-N 115.819 -0.628 . . . . 2.38 110.339 178.713 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.04 65.17 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.354 0 O-C-N 123.825 0.703 . . . . 2.45 112.172 177.391 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.422 ' HB3' ' OD2' ' A' ' 28' ' ' ASP . 34.3 t -172.68 -28.75 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.717 -0.674 . . . . 2.48 109.333 -179.111 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.56 ' HG ' ' HB3' ' A' ' 28' ' ' ASP . 98.1 mt -60.87 -51.26 70.05 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.757 -0.656 . . . . 1.92 111.133 178.699 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 6.9 t -101.99 11.31 38.69 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.194 -0.457 . . . . 1.82 111.394 -178.362 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 41.2 ttp180 -72.37 128.85 36.9 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.605 -0.271 . . . . 5.19 110.407 -177.643 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 88.15 -2.29 85.23 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.864 -0.684 . . . . 1.62 111.934 -179.606 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 32.5 tttp -88.95 139.2 30.69 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.644 -0.502 . . . . 3.17 109.644 179.627 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 65.4 mt-30 -128.98 150.68 50.29 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 110.044 -0.354 . . . . 2.52 110.044 -177.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 20.7 t -126.51 131.2 51.66 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 108.642 -0.873 . . . . 1.14 108.642 178.561 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.601 ' O ' ' HD3' ' A' ' 7' ' ' PRO . 9.2 m120 -73.04 -6.67 47.1 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 112.837 0.68 . . . . 1.28 112.837 -176.223 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 138.48 165.37 10.27 Favored Glycine 0 C--O 1.235 0.178 0 C-N-CA 119.903 -1.142 . . . . 0.49 114.049 168.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.727 ' HG ' ' OH ' ' A' ' 44' ' ' TYR . 57.1 tp -161.47 125.34 3.31 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 108.701 -0.852 . . . . 1.36 108.701 -178.606 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 15.4 p80 -145.45 109.0 4.67 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 112.254 0.465 . . . . 3.8 112.254 -179.049 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -168.92 -178.68 40.55 Favored Glycine 0 C--N 1.334 0.451 0 C-N-CA 120.511 -0.852 . . . . 0.55 112.932 170.625 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -86.39 110.64 19.84 Favored 'General case' 0 CA--C 1.517 -0.32 0 N-CA-C 107.801 -1.185 . . . . 2.18 107.801 167.255 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.76 ' HE1' ' HB ' ' A' ' 3' ' ' VAL . 51.0 m-85 -101.94 148.21 25.61 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.817 0.818 . . . . 1.5 113.015 -167.49 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 31.5 m-20 -92.92 144.21 25.49 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 106.137 -1.801 . . . . 2.23 106.137 156.275 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.458 ' O ' ' HG ' ' A' ' 50' ' ' LEU . 97.0 t -45.69 -63.14 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 N-CA-C 112.738 0.644 . . . . 1.25 112.738 -169.035 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -62.83 -32.11 73.25 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.883 0.373 . . . . 2.39 111.855 -176.131 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 62.5 m -71.08 -34.69 71.39 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.251 0.548 . . . . 1.65 111.075 -175.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -78.86 -27.22 57.05 Favored Glycine 0 N--CA 1.448 -0.525 0 N-CA-C 110.773 -0.931 . . . . 0.4 110.773 -176.539 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.721 ' HB3' HG12 ' A' ' 61' ' ' VAL . 87.6 mt -74.63 -36.18 62.9 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.282 -0.459 . . . . 1.63 110.461 179.702 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -59.1 -39.46 82.28 Favored 'General case' 0 N--CA 1.455 -0.186 0 CA-C-N 116.032 -0.531 . . . . 3.01 110.397 176.441 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 79.2 mm-40 -64.17 -38.92 92.79 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.859 0.362 . . . . 2.18 111.284 177.736 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.441 HD13 HD23 ' A' ' 14' ' ' LEU . 96.1 mt -60.0 -34.02 72.76 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.841 0.353 . . . . 1.4 111.395 177.303 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.445 HD23 ' HB2' ' A' ' 59' ' ' LEU . 96.1 mt -84.29 2.03 42.07 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 116.082 -0.508 . . . . 2.78 111.807 -176.646 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -62.23 114.86 3.7 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.037 -0.529 . . . . 2.24 111.146 -176.418 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 106.31 7.35 35.11 Favored Glycine 0 N--CA 1.45 -0.39 0 CA-C-N 116.005 -0.543 . . . . 1.96 112.533 179.341 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 20.3 p -143.24 -174.2 4.14 Favored 'General case' 0 C--N 1.324 -0.531 0 O-C-N 122.775 -0.25 . . . . 2.28 110.573 -178.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -132.05 44.91 1.16 Allowed Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 120.402 -0.904 . . . . 1.79 112.844 -175.508 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.553 ' HA ' ' H ' ' A' ' 74' ' ' ALA . 3.9 mp -100.65 177.28 5.05 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.824 -0.436 . . . . 1.82 109.824 171.773 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 26.8 tp60 -149.84 117.81 6.31 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 108.893 -0.78 . . . . 3.26 108.893 179.098 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.721 HG12 ' HB3' ' A' ' 50' ' ' LEU . 7.4 p -86.54 133.79 28.99 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 N-CA-C 109.655 -0.498 . . . . 2.17 109.655 178.36 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.426 ' HA ' ' HD3' ' A' ' 63' ' ' PRO . 55.1 mtpt -124.6 110.41 28.09 Favored Pre-proline 0 C--N 1.32 -0.688 0 N-CA-C 109.809 -0.441 . . . . 2.29 109.809 -178.141 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . 0.501 ' HA ' ' HA ' ' A' ' 69' ' ' TRP . 2.8 Cg_exo -76.65 144.77 25.37 Favored 'Trans proline' 0 N--CA 1.462 -0.344 0 C-N-CA 123.161 2.574 . . . . 0.94 112.868 -177.697 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -91.09 23.48 3.23 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.834 0.826 . . . . 2.32 109.474 175.15 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 84.38 -68.1 3.58 Favored Glycine 0 N--CA 1.447 -0.603 0 CA-C-N 114.493 -1.23 . . . . 1.69 113.053 175.172 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . 0.43 ' C ' ' H ' ' A' ' 68' ' ' SER . 58.9 t30 -85.47 74.95 10.25 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.705 0.288 . . . . 3.67 111.184 -175.106 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . 0.907 ' HB3' ' HB3' ' A' ' 23' ' ' PHE . 7.8 m-20 72.35 -26.43 0.18 Allowed 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 113.253 0.834 . . . . 2.59 113.253 170.26 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' SER . . . . . 0.43 ' H ' ' C ' ' A' ' 66' ' ' ASN . 15.2 m -85.81 146.45 26.76 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 110.274 -0.269 . . . . 1.54 110.274 -175.578 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' TRP . . . . . 0.575 ' CE3' HD22 ' A' ' 25' ' ' LEU . 6.6 m0 -140.03 168.73 19.15 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.0 -0.741 . . . . 0.54 109.0 -175.914 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 14.9 t -143.85 136.08 26.73 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.13 -0.692 . . . . 1.49 109.13 169.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 54.6 tp -95.11 102.85 14.68 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.079 0.466 . . . . 2.24 110.732 -177.381 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -95.14 128.5 38.59 Favored Pre-proline 0 C--N 1.319 -0.725 0 CA-C-N 115.402 -0.817 . . . . 2.25 110.687 174.597 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -73.99 115.49 4.34 Favored 'Trans proline' 0 N--CA 1.46 -0.482 0 C-N-CA 121.976 1.784 . . . . 1.45 110.893 174.428 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.553 ' H ' ' HA ' ' A' ' 59' ' ' LEU . . . . . . . . 0 CA--C 1.521 -0.147 0 CA-C-N 116.094 -0.503 . . . . 2.07 110.29 -176.291 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 31.8 tt0 . . . . . 0 N--CA 1.457 -0.106 0 CA-C-O 121.536 0.684 . . . . 4.51 111.545 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.418 ' CG2' ' HB2' ' A' ' 44' ' ' TYR . 58.2 t -104.34 128.54 57.75 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 CA-C-N 114.861 -1.063 . . . . 2.2 108.457 174.545 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 43.8 t30 -126.9 98.87 5.5 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.14 0.495 . . . . 2.75 109.677 -175.405 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.511 HG21 ' HA2' ' A' ' 39' ' ' GLY . 27.1 mm -123.57 156.17 30.08 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 CA-C-N 115.306 -0.861 . . . . 1.5 108.777 -177.295 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . 0.653 ' HB3' ' HD2' ' A' ' 7' ' ' PRO . . . -160.04 163.56 22.04 Favored Pre-proline 0 C--N 1.321 -0.657 0 N-CA-C 109.503 -0.554 . . . . 1.99 109.503 -177.35 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.653 ' HD2' ' HB3' ' A' ' 6' ' ' ALA . 6.6 Cg_exo -33.3 130.39 0.13 Allowed 'Trans proline' 0 C--N 1.357 1.002 0 C-N-CA 124.398 3.399 . . . . 1.73 113.314 -174.933 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 152.1 169.54 17.67 Favored Glycine 0 N--CA 1.44 -1.078 0 N-CA-C 110.96 -0.856 . . . . 1.84 110.96 -174.471 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.661 ' HA ' ' O ' ' A' ' 35' ' ' LYS . 53.9 m -61.48 141.56 57.61 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 120.815 0.34 . . . . 1.87 111.471 179.693 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.722 HD22 ' HB2' ' A' ' 57' ' ' SER . 43.8 tp -59.65 -35.77 75.08 Favored 'General case' 0 CA--C 1.52 -0.175 0 CA-C-O 121.104 0.478 . . . . 1.83 110.458 178.965 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.698 ' HB3' ' HB ' ' A' ' 32' ' ' THR . 2.0 p-10 -56.93 -31.77 65.29 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.305 -0.861 . . . . 2.11 111.256 175.735 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 29.0 ttpt -70.52 -41.06 73.08 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.227 0.537 . . . . 3.11 109.881 174.418 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -64.97 -55.38 19.41 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 115.424 -0.807 . . . . 1.17 110.972 -174.195 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.404 ' HB3' HD12 ' A' ' 25' ' ' LEU . 89.2 mt -58.06 -41.12 82.68 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.809 -0.632 . . . . 1.31 111.174 177.743 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 52.9 t30 -62.92 -40.29 97.18 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.223 -0.444 . . . . 1.98 110.288 179.102 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -62.57 -42.68 99.7 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.204 -0.453 . . . . 2.33 110.218 176.698 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.454 ' O ' ' HB3' ' A' ' 20' ' ' HIS . 4.9 t80 -65.58 -39.86 92.07 Favored 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 109.229 -0.656 . . . . 1.05 109.229 179.77 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.729 ' HA ' ' CZ ' ' A' ' 23' ' ' PHE . . . -55.56 -39.65 70.9 Favored 'General case' 0 CA--C 1.52 -0.184 0 CA-C-N 115.669 -0.696 . . . . 1.15 111.327 175.426 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.49 -30.09 71.27 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.202 -0.454 . . . . 1.26 111.212 179.272 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . 0.454 ' HB3' ' O ' ' A' ' 17' ' ' TYR . 62.8 t60 -60.55 -58.43 8.52 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 116.264 -0.425 . . . . 2.52 111.701 -177.905 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.529 ' HB3' ' HD1' ' A' ' 23' ' ' PHE . 11.4 t -98.38 -10.58 23.54 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-O 121.13 0.49 . . . . 1.79 111.739 -174.615 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 69.01 53.09 20.51 Favored Glycine 0 C--N 1.33 0.205 0 CA-C-N 115.833 -0.621 . . . . 0.68 113.232 179.62 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.729 ' CZ ' ' HA ' ' A' ' 18' ' ' ALA . 26.1 p90 -109.03 167.45 10.08 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.808 0.337 . . . . 0.68 110.535 179.264 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 25.3 m -92.9 109.73 21.18 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.439 0.638 . . . . 1.3 110.982 178.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.404 HD12 ' HB3' ' A' ' 14' ' ' LEU . 4.4 tt -91.64 128.09 37.34 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.433 -0.803 . . . . 2.3 109.299 179.7 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 25.4 t -99.09 100.2 11.31 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.07 0.462 . . . . 1.67 109.955 -179.319 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.3 p -129.34 130.86 67.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 115.987 -0.551 . . . . 1.52 110.552 -178.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.498 ' OD2' ' HB2' ' A' ' 30' ' ' SER . 23.7 t70 -75.46 123.83 26.11 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.663 -0.699 . . . . 2.38 110.816 178.791 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.62 49.75 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 113.338 0.866 . . . . 2.45 113.338 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.498 ' HB2' ' OD2' ' A' ' 28' ' ' ASP . 69.5 m -161.53 -28.12 0.05 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.847 0.356 . . . . 2.48 110.19 -179.696 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 75.9 mt -72.64 -43.79 62.76 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.51 0.672 . . . . 1.92 110.443 176.59 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.698 ' HB ' ' HB3' ' A' ' 11' ' ' ASP . 9.5 p -96.38 52.55 1.25 Allowed 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.726 -0.67 . . . . 1.82 112.279 -175.579 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 4.7 ptp180 -99.96 106.77 18.6 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-O 121.142 0.496 . . . . 5.19 111.042 175.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 70.77 46.61 45.01 Favored Glycine 0 N--CA 1.449 -0.474 0 CA-C-N 115.656 -0.702 . . . . 1.62 113.569 174.334 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.661 ' O ' ' HA ' ' A' ' 9' ' ' SER . 13.3 mptt -85.27 173.75 10.12 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 110.039 -0.356 . . . . 3.17 110.039 176.037 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 50.3 tt0 -149.84 134.85 17.92 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 120.778 0.323 . . . . 2.52 110.871 173.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 42.7 t -132.82 130.61 40.05 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 107.368 -1.345 . . . . 1.14 107.368 171.408 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.41 ' O ' ' HD3' ' A' ' 7' ' ' PRO . 0.1 OUTLIER -69.48 -7.75 40.77 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 113.122 0.786 . . . . 1.28 113.122 -173.89 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.511 ' HA2' HG21 ' A' ' 5' ' ' ILE . . . 117.4 -177.05 16.46 Favored Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 120.134 -1.032 . . . . 0.49 113.345 171.956 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.467 ' N ' ' HB ' ' A' ' 5' ' ' ILE . 60.4 tp -159.96 141.92 13.04 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 108.574 -0.899 . . . . 1.36 108.574 -178.414 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 50.8 t-80 -144.27 97.09 2.99 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.919 0.39 . . . . 3.8 110.658 179.72 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -170.46 177.88 43.41 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.973 -0.632 . . . . 0.55 111.837 175.071 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -92.7 99.99 12.58 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 108.44 -0.948 . . . . 2.18 108.44 171.316 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.418 ' HB2' ' CG2' ' A' ' 3' ' ' VAL . 25.6 m-85 -116.39 156.54 26.57 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 121.455 0.645 . . . . 1.5 112.227 -170.817 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -92.73 169.72 10.27 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 114.69 -1.141 . . . . 2.23 108.276 172.374 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.538 ' O ' ' HG ' ' A' ' 50' ' ' LEU . 78.1 t -48.01 -64.78 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 O-C-N 123.05 0.219 . . . . 1.25 111.438 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -61.53 -44.32 97.27 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 112.824 0.675 . . . . 2.39 112.824 -175.785 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 3.8 p -73.44 -31.06 63.6 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.037 0.446 . . . . 1.65 111.244 -173.418 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -72.48 -36.96 58.74 Favored Glycine 0 N--CA 1.446 -0.666 0 N-CA-C 111.233 -0.747 . . . . 0.4 111.233 179.56 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.538 ' HG ' ' O ' ' A' ' 46' ' ' VAL . 88.1 mt -71.61 -37.34 70.94 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.495 -0.352 . . . . 1.63 110.464 178.706 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -53.68 -47.42 70.44 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.866 -0.606 . . . . 3.01 110.576 179.307 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 14.1 mm100 -64.72 -42.27 95.36 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-O 120.807 0.337 . . . . 2.18 110.778 179.349 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 90.8 mt -59.75 -30.34 68.78 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 116.261 -0.427 . . . . 1.4 111.878 178.498 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.607 HD11 HG13 ' A' ' 61' ' ' VAL . 5.9 mp -72.73 -21.11 61.08 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.313 -0.403 . . . . 2.78 111.449 -179.457 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -71.94 86.98 1.01 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.139 0.495 . . . . 2.24 111.159 -177.234 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 113.1 -9.64 24.93 Favored Glycine 0 CA--C 1.52 0.365 0 CA-C-N 115.904 -0.589 . . . . 1.96 113.457 175.189 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.722 ' HB2' HD22 ' A' ' 10' ' ' LEU . 11.7 p -82.26 -24.72 34.61 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.961 0.381 . . . . 2.28 111.91 -175.577 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 88.57 5.1 75.53 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.918 -0.658 . . . . 1.79 112.664 176.748 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.557 HD11 HD21 ' A' ' 10' ' ' LEU . 95.8 mt -126.34 179.4 5.3 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.611 0.243 . . . . 1.82 110.86 -178.955 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 9.1 tt0 -147.39 118.97 7.96 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 109.163 -0.68 . . . . 3.26 109.163 179.597 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.607 HG13 HD11 ' A' ' 54' ' ' LEU . 7.7 p -98.43 128.02 50.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-O 121.215 0.531 . . . . 2.17 109.978 179.202 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.769 ' HE2' ' HB2' ' A' ' 72' ' ' GLU . 48.1 mtmt -109.36 130.12 23.13 Favored Pre-proline 0 C--N 1.322 -0.592 0 CA-C-N 116.146 -0.479 . . . . 2.29 110.719 -176.468 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -67.62 113.43 2.94 Favored 'Trans proline' 0 N--CA 1.457 -0.629 0 C-N-CA 122.102 1.868 . . . . 0.94 109.536 168.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 37.3 tp -60.04 -41.8 93.05 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.655 -0.702 . . . . 2.32 111.5 -171.102 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 165.67 -54.61 0.26 Allowed Glycine 0 N--CA 1.448 -0.556 0 N-CA-C 110.207 -1.157 . . . . 1.69 110.207 179.381 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 27.5 p-10 -86.32 -158.66 0.42 Allowed 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 108.935 -0.765 . . . . 3.67 108.935 171.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 20.1 p-10 -81.7 49.37 1.33 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.515 0.674 . . . . 2.59 110.796 176.108 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' SER . . . . . 0.459 ' O ' ' HD1' ' A' ' 69' ' ' TRP . 40.3 m -139.12 169.24 18.13 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 108.409 -0.96 . . . . 1.54 108.409 174.745 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' TRP . . . . . 0.459 ' HD1' ' O ' ' A' ' 68' ' ' SER . 45.0 m0 -140.12 171.35 14.31 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 110.035 -0.358 . . . . 0.54 110.035 -167.483 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.458 HG23 ' HE3' ' A' ' 62' ' ' LYS . 6.8 t -146.04 147.22 31.39 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.167 -0.47 . . . . 1.49 109.989 173.129 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -92.77 108.76 20.23 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.123 0.487 . . . . 2.24 110.992 -174.279 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.769 ' HB2' ' HE2' ' A' ' 62' ' ' LYS . 4.3 tp10 -93.21 122.23 63.72 Favored Pre-proline 0 C--N 1.322 -0.608 0 CA-C-N 115.345 -0.843 . . . . 2.25 110.539 175.091 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -84.43 113.47 1.71 Allowed 'Trans proline' 0 N--CA 1.453 -0.891 0 C-N-CA 121.863 1.709 . . . . 1.45 111.56 174.194 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.327 -0.389 0 CA-C-N 115.849 -0.614 . . . . 2.07 109.776 -178.363 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . 0.728 ' HB2' ' H ' ' A' ' 44' ' ' TYR . 7.9 mm100 . . . . . 0 N--CA 1.453 -0.308 0 CA-C-O 120.864 0.364 . . . . 4.51 111.952 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.413 HG22 ' O ' ' A' ' 42' ' ' GLY . 21.5 m -145.61 143.3 21.82 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-N 115.927 -0.579 . . . . 2.2 111.114 -178.638 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 4.5 p-10 -128.55 96.88 4.53 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 107.967 -1.123 . . . . 2.75 107.967 171.748 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 21.3 mt -130.86 157.41 43.15 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.761 0 CA-C-N 115.655 -0.702 . . . . 1.5 109.883 -170.055 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . 0.647 ' HB3' ' HD2' ' A' ' 7' ' ' PRO . . . -162.36 178.63 1.5 Allowed Pre-proline 0 C--N 1.321 -0.67 0 N-CA-C 108.224 -1.028 . . . . 1.99 108.224 -174.569 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.647 ' HD2' ' HB3' ' A' ' 6' ' ' ALA . 51.2 Cg_exo -39.33 129.38 1.6 Allowed 'Trans proline' 0 C--N 1.359 1.122 0 C-N-CA 122.685 2.257 . . . . 1.73 113.023 -178.383 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 163.41 161.85 13.34 Favored Glycine 0 N--CA 1.443 -0.872 0 N-CA-C 110.727 -0.949 . . . . 1.84 110.727 -174.664 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 37.2 p -61.61 137.69 58.26 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.951 0.376 . . . . 1.87 110.616 -178.127 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.449 HD22 ' HG ' ' A' ' 54' ' ' LEU . 64.0 tp -60.06 -32.43 70.93 Favored 'General case' 0 CA--C 1.52 -0.204 0 CA-C-O 121.102 0.477 . . . . 1.83 109.739 178.648 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.586 ' HB2' ' HB ' ' A' ' 32' ' ' THR . 11.4 t70 -50.32 -54.0 24.68 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.143 -0.935 . . . . 2.11 110.449 172.665 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 59.0 tttp -67.09 -32.38 73.49 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 116.213 -0.449 . . . . 3.11 110.949 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -64.26 -54.49 32.59 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.292 -0.413 . . . . 1.17 110.447 -177.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 85.5 mt -57.96 -41.92 83.9 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 115.854 -0.612 . . . . 1.31 111.071 176.165 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 12.9 t30 -62.65 -35.21 78.88 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.972 -0.558 . . . . 1.98 110.738 179.806 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . 0.475 HE21 ' HB3' ' A' ' 16' ' ' GLN . 0.8 OUTLIER -61.17 -46.74 89.27 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 116.392 -0.367 . . . . 2.33 110.875 175.865 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.641 ' HD1' ' HH2' ' A' ' 69' ' ' TRP . 34.2 t80 -67.64 -32.05 72.48 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 120.986 -0.286 . . . . 1.05 110.421 -176.9 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.813 ' HA ' ' CZ ' ' A' ' 23' ' ' PHE . . . -50.94 -34.89 30.57 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 112.114 0.412 . . . . 1.15 112.114 175.625 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.55 -15.71 52.3 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.305 -0.407 . . . . 1.26 111.93 179.579 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 30.8 t-80 -59.67 -67.85 0.34 Allowed 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 116.628 -0.26 . . . . 2.52 111.42 179.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.689 ' HB3' ' HD1' ' A' ' 23' ' ' PHE . 23.0 t -101.12 -6.65 24.05 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.797 0.332 . . . . 1.79 111.505 -174.927 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 70.32 46.74 47.69 Favored Glycine 0 C--N 1.334 0.418 0 C-N-CA 120.771 -0.728 . . . . 0.68 112.524 178.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.813 ' CZ ' ' HA ' ' A' ' 18' ' ' ALA . 11.6 p90 -100.68 170.21 8.51 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.697 0.284 . . . . 0.68 110.477 -175.856 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.473 ' O ' ' HB3' ' A' ' 68' ' ' SER . 24.0 m -91.67 111.19 22.6 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.129 0.49 . . . . 1.3 110.872 -178.38 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 5.2 tt -93.32 125.82 38.13 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 115.915 -0.584 . . . . 2.3 109.565 -179.736 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.594 ' HB2' ' HA ' ' A' ' 70' ' ' THR . 15.2 m -99.1 93.01 5.75 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.158 -0.474 . . . . 1.67 109.908 -179.021 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 9.7 p -113.64 141.57 29.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 115.994 -0.548 . . . . 1.52 109.758 -178.503 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.418 ' HB3' ' HG ' ' A' ' 31' ' ' LEU . 23.1 t70 -98.0 125.62 43.02 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 110.176 -0.305 . . . . 2.38 110.176 179.604 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.16 57.97 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.525 0 O-C-N 123.802 0.689 . . . . 2.45 112.622 179.066 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 25.9 t -173.04 -28.61 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.221 -0.445 . . . . 2.48 110.042 -179.732 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.418 ' HG ' ' HB3' ' A' ' 28' ' ' ASP . 86.3 mt -77.28 -33.69 55.74 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.328 -0.396 . . . . 1.92 111.361 -178.136 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.586 ' HB ' ' HB2' ' A' ' 11' ' ' ASP . 6.0 p -92.4 13.27 20.02 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.26 0.552 . . . . 1.82 111.25 179.455 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 39.5 ttm180 -73.16 114.22 11.1 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.635 -0.711 . . . . 5.19 110.266 179.646 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 84.08 21.18 57.77 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.74 -0.743 . . . . 1.62 111.875 179.688 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 12.7 mptt -107.53 124.04 49.32 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.117 0.484 . . . . 3.17 111.23 -179.001 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 6.8 tt0 -131.69 141.06 49.47 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.353 -0.839 . . . . 2.52 109.135 177.734 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 7.3 t -121.8 121.06 36.36 Favored 'General case' 0 N--CA 1.443 -0.823 0 N-CA-C 107.003 -1.48 . . . . 1.14 107.003 174.768 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 8.9 m-80 -70.65 -0.54 8.94 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 113.296 0.85 . . . . 1.28 113.296 -169.662 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 134.97 168.32 11.62 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 119.894 -1.145 . . . . 0.49 114.213 166.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.401 HD13 ' CE1' ' A' ' 44' ' ' TYR . 60.9 tp -160.59 131.71 5.62 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 107.883 -1.155 . . . . 1.36 107.883 179.825 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 39.1 t60 -144.5 97.84 3.1 Favored 'General case' 0 C--N 1.321 -0.635 0 C-N-CA 120.055 -0.658 . . . . 3.8 110.971 179.721 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.413 ' O ' HG22 ' A' ' 3' ' ' VAL . . . -169.63 175.78 43.71 Favored Glycine 0 N--CA 1.445 -0.749 0 CA-C-N 115.117 -0.947 . . . . 0.55 111.322 176.625 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.533 ' HA ' ' N ' ' A' ' 2' ' ' GLN . 12.2 t70 -83.65 94.41 8.1 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 108.216 -1.031 . . . . 2.18 108.216 171.564 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.728 ' H ' ' HB2' ' A' ' 2' ' ' GLN . 45.8 m-85 -115.1 126.57 54.82 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.111 0.481 . . . . 1.5 111.927 -174.718 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -67.97 170.21 8.65 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.254 -0.884 . . . . 2.23 109.915 174.085 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.607 HG11 ' HZ2' ' A' ' 69' ' ' TRP . 86.0 t -48.45 -65.55 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 O-C-N 123.549 0.531 . . . . 1.25 111.758 -175.387 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -59.02 -43.46 91.57 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 112.629 0.603 . . . . 2.39 112.629 -177.719 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 22.9 t -71.37 -33.21 69.35 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.097 0.475 . . . . 1.65 110.967 -172.513 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -73.73 -39.47 48.12 Favored Glycine 0 N--CA 1.445 -0.713 0 C-N-CA 120.735 -0.745 . . . . 0.4 111.496 -176.335 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.646 ' HB3' HG11 ' A' ' 61' ' ' VAL . 85.9 mt -67.95 -40.4 83.24 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.755 0.312 . . . . 1.63 110.857 -179.738 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . 0.437 HE21 ' HB3' ' A' ' 51' ' ' GLN . 0.9 OUTLIER -54.28 -50.13 67.98 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.929 -0.578 . . . . 3.01 111.03 179.22 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 25.4 tp60 -68.07 -40.61 82.67 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.395 -0.366 . . . . 2.18 111.226 -177.173 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.402 HD21 ' HA ' ' A' ' 53' ' ' LEU . 51.0 mt -56.6 -42.17 78.26 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.217 0.451 . . . . 1.4 112.217 -179.303 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.449 ' HG ' HD22 ' A' ' 10' ' ' LEU . 11.0 mp -85.14 -5.02 59.35 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 112.374 0.509 . . . . 2.78 112.374 -174.614 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -66.62 105.65 1.59 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.29 0.566 . . . . 2.24 109.769 178.752 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 133.6 -15.0 4.7 Favored Glycine 0 N--CA 1.447 -0.615 0 N-CA-C 110.66 -0.976 . . . . 1.96 110.66 -172.038 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 79.4 p -119.49 175.96 5.59 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.271 -0.64 . . . . 2.28 109.271 175.709 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -113.74 17.64 20.33 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.21 -0.995 . . . . 1.79 112.266 -177.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 98.6 mt -92.24 175.45 6.85 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 110.254 -0.276 . . . . 1.82 110.254 -179.137 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 27.2 mp0 -139.0 118.98 13.31 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.156 -0.683 . . . . 3.26 109.156 -179.464 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.646 HG11 ' HB3' ' A' ' 50' ' ' LEU . 7.5 p -98.54 127.11 51.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 N-CA-C 109.674 -0.491 . . . . 2.17 109.674 176.915 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.445 ' HA ' ' HD3' ' A' ' 63' ' ' PRO . 0.0 OUTLIER -140.55 137.06 17.09 Favored Pre-proline 0 C--N 1.323 -0.584 0 CA-C-N 116.234 -0.439 . . . . 2.29 110.962 -176.559 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . 0.467 ' HA ' ' HA ' ' A' ' 69' ' ' TRP . 28.4 Cg_exo -62.74 128.79 24.23 Favored 'Trans proline' 0 N--CA 1.462 -0.371 0 C-N-CA 122.915 2.41 . . . . 0.94 110.982 177.131 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -66.64 -43.76 83.77 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.702 -0.681 . . . . 2.32 109.732 -177.379 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 165.16 -60.42 0.24 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.564 -0.827 . . . . 1.69 112.276 176.336 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 50.5 t30 -86.12 68.85 10.41 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.997 0.427 . . . . 3.67 111.211 -175.597 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 66.4 t30 58.93 12.16 2.22 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-N 115.742 -0.663 . . . . 2.59 111.84 175.73 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' SER . . . . . 0.473 ' HB3' ' O ' ' A' ' 24' ' ' THR . 50.7 m -122.5 177.83 5.24 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 108.811 -0.811 . . . . 1.54 108.811 -173.844 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' TRP . . . . . 0.641 ' HH2' ' HD1' ' A' ' 17' ' ' TYR . 49.9 m0 -137.44 166.18 24.46 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.886 -0.413 . . . . 0.54 109.886 -167.357 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.594 ' HA ' ' HB2' ' A' ' 26' ' ' SER . 15.1 t -148.05 147.57 29.72 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 108.814 -0.81 . . . . 1.49 108.814 169.921 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 31.8 tp -92.23 103.84 16.27 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.442 0.639 . . . . 2.24 109.928 -179.192 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -88.11 119.49 70.38 Favored Pre-proline 0 C--N 1.319 -0.753 0 CA-C-N 114.918 -1.037 . . . . 2.25 111.19 -179.715 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -90.32 115.14 0.53 Allowed 'Trans proline' 0 N--CA 1.449 -1.143 0 C-N-CA 122.393 2.062 . . . . 1.45 112.33 177.404 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.323 -0.556 0 CA-C-N 115.725 -0.67 . . . . 2.07 109.487 176.31 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 32.9 mm-40 . . . . . 0 C--O 1.235 0.297 0 CA-C-O 120.86 0.362 . . . . 4.51 111.012 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 31.4 m -103.39 136.36 36.55 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-N 115.964 -0.562 . . . . 2.2 109.787 174.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -127.01 96.55 4.65 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 108.589 -0.893 . . . . 2.75 108.589 -179.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.472 HD12 ' HB3' ' A' ' 40' ' ' LEU . 50.5 mt -126.11 149.24 30.85 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 CA-C-N 115.763 -0.653 . . . . 1.5 110.153 -173.821 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . 0.541 ' HB3' ' HD2' ' A' ' 7' ' ' PRO . . . -162.96 168.12 10.83 Favored Pre-proline 0 C--N 1.323 -0.544 0 N-CA-C 108.844 -0.798 . . . . 1.99 108.844 -176.381 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.541 ' HD2' ' HB3' ' A' ' 6' ' ' ALA . 89.8 Cg_exo -44.56 133.48 9.89 Favored 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 122.806 2.337 . . . . 1.73 112.998 -178.103 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 154.91 41.56 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.635 -0.793 . . . . 1.84 112.062 178.299 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.598 ' HA ' ' HA ' ' A' ' 36' ' ' GLN . 20.2 m 66.98 138.92 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.281 0 CA-C-O 121.326 0.584 . . . . 1.87 110.699 -172.376 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.59 HD12 ' HB3' ' A' ' 53' ' ' LEU . 49.5 tp -58.37 -24.2 59.22 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.138 0.494 . . . . 1.83 110.27 177.284 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -48.06 -51.59 23.72 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.073 -0.967 . . . . 2.11 111.892 175.031 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.91 -25.47 66.39 Favored 'General case' 0 C--N 1.335 -0.063 0 C-N-CA 121.064 -0.255 . . . . 3.11 111.375 -176.397 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -65.42 -59.29 4.17 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.049 0.452 . . . . 1.17 110.073 178.796 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 86.9 mt -58.46 -37.38 75.36 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.675 -0.693 . . . . 1.31 110.905 176.428 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 47.4 t30 -60.94 -40.76 94.52 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.257 -0.429 . . . . 1.98 110.257 178.399 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -61.1 -47.87 84.28 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 116.028 -0.533 . . . . 2.33 110.541 178.548 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.511 ' O ' ' HB3' ' A' ' 20' ' ' HIS . 3.1 t80 -69.58 -43.93 71.86 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-O 120.871 0.367 . . . . 1.05 110.251 -177.653 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.591 ' HA ' ' CZ ' ' A' ' 23' ' ' PHE . . . -53.92 -53.48 52.11 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 115.912 -0.585 . . . . 1.15 112.275 -179.72 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.53 -22.55 66.4 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.804 0.335 . . . . 1.26 111.517 -178.817 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . 0.511 ' HB3' ' O ' ' A' ' 17' ' ' TYR . 77.9 t60 -65.73 -52.12 53.77 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.993 -0.549 . . . . 2.52 111.5 -179.866 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.414 ' HB2' ' CD1' ' A' ' 23' ' ' PHE . 19.7 m -108.13 -3.6 18.45 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 112.619 0.599 . . . . 1.79 112.619 -174.355 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 69.2 47.73 50.88 Favored Glycine 0 C--O 1.227 -0.295 0 CA-C-N 116.142 -0.481 . . . . 0.68 113.884 174.262 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.591 ' CZ ' ' HA ' ' A' ' 18' ' ' ALA . 13.3 p90 -110.78 162.93 14.29 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.84 0.32 . . . . 0.68 110.209 178.398 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.627 ' O ' ' HB3' ' A' ' 68' ' ' SER . 28.0 m -98.11 122.17 40.93 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.363 0.601 . . . . 1.3 112.173 -174.725 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.49 HD23 ' CE3' ' A' ' 69' ' ' TRP . 1.1 mm? -88.49 115.11 25.77 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.677 -0.692 . . . . 2.3 110.322 175.491 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 32.9 t -98.08 93.92 6.55 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.795 -0.638 . . . . 1.67 109.799 -179.653 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.706 HG22 HD11 ' A' ' 71' ' ' LEU . 7.2 p -148.16 141.71 18.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.768 -0.651 . . . . 1.52 110.655 -178.849 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -88.88 132.12 34.81 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.933 -0.576 . . . . 2.38 110.009 175.578 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.33 78.57 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.308 0 O-C-N 123.8 0.687 . . . . 2.45 111.863 179.658 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 74.1 m -165.83 -38.19 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 123.142 0.577 . . . . 2.48 109.556 -179.736 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 88.0 mt -75.24 -33.17 61.28 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.093 -0.503 . . . . 1.92 110.693 178.791 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 7.5 p -92.32 -10.93 36.54 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.329 -0.396 . . . . 1.82 110.948 177.526 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 53.1 ttp180 -64.69 107.12 1.33 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.815 -0.63 . . . . 5.19 110.143 179.87 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 102.51 17.66 18.83 Favored Glycine 0 N--CA 1.444 -0.806 0 C-N-CA 121.002 -0.618 . . . . 1.62 111.797 -177.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 12.9 mptt -107.5 122.26 46.3 Favored 'General case' 0 CA--C 1.514 -0.418 0 CA-C-O 121.106 0.479 . . . . 3.17 111.711 178.85 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . 0.598 ' HA ' ' HA ' ' A' ' 9' ' ' SER . 18.4 pt20 -138.24 133.66 33.43 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.564 -0.744 . . . . 2.52 109.168 173.593 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.425 ' O ' ' HA ' ' A' ' 7' ' ' PRO . 19.2 t -115.66 140.3 49.32 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.569 -0.53 . . . . 1.14 109.569 -176.567 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -71.0 2.9 3.81 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 112.162 0.431 . . . . 1.28 112.162 177.258 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.451 ' HA3' ' HA ' ' A' ' 6' ' ' ALA . . . 114.85 -178.03 17.72 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.775 -0.726 . . . . 0.49 113.445 166.331 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.472 ' HB3' HD12 ' A' ' 5' ' ' ILE . 56.1 tp -160.82 131.07 5.15 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 107.797 -1.186 . . . . 1.36 107.797 179.632 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 17.4 t-160 -143.4 99.89 3.51 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 120.07 -0.652 . . . . 3.8 111.71 -177.63 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -169.03 -169.68 32.7 Favored Glycine 0 N--CA 1.448 -0.545 0 CA-C-N 115.403 -0.817 . . . . 0.55 111.459 176.156 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -103.55 90.64 3.74 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 108.832 -0.803 . . . . 2.18 108.832 172.112 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 64.1 m-85 -110.47 151.86 27.02 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.61 -0.723 . . . . 1.5 110.584 -175.79 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -99.47 -171.94 2.16 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 108.302 -0.999 . . . . 2.23 108.302 174.218 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.412 ' O ' ' HG ' ' A' ' 50' ' ' LEU . 39.2 t -51.7 -71.0 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 N-CA-C 112.976 0.732 . . . . 1.25 112.976 -172.636 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.31 -47.45 82.22 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 113.266 0.839 . . . . 2.39 113.266 -169.102 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 7.5 t -73.97 -26.86 60.7 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.032 0.444 . . . . 1.65 110.75 -170.692 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -75.13 -38.94 38.56 Favored Glycine 0 N--CA 1.447 -0.626 0 N-CA-C 111.042 -0.823 . . . . 0.4 111.042 -178.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.744 HD12 HG12 ' A' ' 61' ' ' VAL . 80.7 mt -70.11 -41.53 73.87 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 115.441 -0.379 . . . . 1.63 110.261 179.068 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 55.3 tp60 -55.96 -38.06 69.87 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 116.102 -0.499 . . . . 3.01 111.524 -179.244 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 24.6 mm-40 -63.5 -45.64 89.75 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.857 0.361 . . . . 2.18 110.616 177.771 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.59 ' HB3' HD12 ' A' ' 10' ' ' LEU . 90.3 mt -60.94 -22.87 64.83 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.838 -0.619 . . . . 1.4 111.859 176.787 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.766 HD21 HG23 ' A' ' 61' ' ' VAL . 87.4 mt -85.28 -24.05 27.91 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.14 0.422 . . . . 2.78 112.14 -175.494 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -70.07 93.63 0.82 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.179 0.514 . . . . 2.24 110.905 -175.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 114.77 -10.45 21.2 Favored Glycine 0 N--CA 1.446 -0.69 0 CA-C-N 115.799 -0.637 . . . . 1.96 112.532 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.41 ' OG ' ' HA ' ' A' ' 54' ' ' LEU . 27.1 p -98.92 -12.12 21.0 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.883 0.373 . . . . 2.28 111.448 -178.547 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 71.3 28.39 70.0 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 121.0 -0.619 . . . . 1.79 112.892 175.72 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 94.8 mt -119.12 167.98 11.29 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.74 0.305 . . . . 1.82 110.857 -178.555 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . 0.442 ' HA ' HD11 ' A' ' 54' ' ' LEU . 62.8 tt0 -143.97 118.97 10.0 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.082 -0.71 . . . . 3.26 109.082 177.47 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.766 HG23 HD21 ' A' ' 54' ' ' LEU . 36.8 t -94.81 130.2 43.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 N-CA-C 110.044 -0.354 . . . . 2.17 110.044 -178.25 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 17.9 ptmt -131.67 127.61 21.47 Favored Pre-proline 0 C--N 1.317 -0.815 0 N-CA-C 109.624 -0.51 . . . . 2.29 109.624 179.015 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -60.15 132.92 46.85 Favored 'Trans proline' 0 N--CA 1.463 -0.279 0 C-N-CA 122.577 2.185 . . . . 0.94 111.191 177.612 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 42.7 tp -69.27 -40.31 77.87 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.713 -0.676 . . . . 2.32 110.925 -174.592 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 158.65 -44.48 0.47 Allowed Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.758 -0.735 . . . . 1.69 112.092 175.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 9.2 m120 -77.15 -89.39 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.394 0.616 . . . . 3.67 110.644 -179.481 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 30.4 p-10 -146.69 24.85 1.2 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.626 -0.715 . . . . 2.59 109.095 177.057 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' SER . . . . . 0.627 ' HB3' ' O ' ' A' ' 24' ' ' THR . 50.4 m -128.74 178.82 6.07 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 108.178 -1.045 . . . . 1.54 108.178 -171.784 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' TRP . . . . . 0.49 ' CE3' HD23 ' A' ' 25' ' ' LEU . 1.9 m0 -140.15 169.73 17.16 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 119.836 -0.746 . . . . 0.54 110.055 -170.864 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 9.6 t -140.97 144.03 34.85 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 108.722 -0.844 . . . . 1.49 108.722 171.654 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.706 HD11 HG22 ' A' ' 27' ' ' VAL . 52.0 mt -93.85 105.62 17.63 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.415 0.626 . . . . 2.24 111.484 -173.839 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 18.4 tt0 -89.44 129.48 47.14 Favored Pre-proline 0 C--N 1.318 -0.789 0 CA-C-N 115.051 -0.977 . . . . 2.25 110.347 174.108 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -79.12 114.68 3.39 Favored 'Trans proline' 0 N--CA 1.453 -0.875 0 C-N-CA 121.92 1.747 . . . . 1.45 111.325 177.75 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.322 -0.598 0 CA-C-N 115.654 -0.703 . . . . 2.07 110.446 -179.121 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 5.1 pm0 . . . . . 0 C--O 1.234 0.242 0 N-CA-C 109.353 -0.61 . . . . 4.51 109.353 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 33.7 m -137.39 152.74 27.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 120.73 0.3 . . . . 2.2 110.922 -175.645 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 31.7 m-80 -127.82 96.31 4.47 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 108.641 -0.874 . . . . 2.75 108.641 174.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.407 HG21 HD22 ' A' ' 53' ' ' LEU . 28.8 mm -119.69 149.71 22.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 N-CA-C 109.406 -0.591 . . . . 1.5 109.406 -176.423 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -163.4 162.15 17.54 Favored Pre-proline 0 C--N 1.323 -0.578 0 N-CA-C 109.488 -0.56 . . . . 1.99 109.488 -177.205 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.48 ' HA ' ' O ' ' A' ' 37' ' ' SER . 53.3 Cg_exo -52.23 130.54 35.92 Favored 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 122.95 2.433 . . . . 1.73 113.006 -175.976 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 158.69 48.03 0.01 OUTLIER Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 120.744 -0.741 . . . . 1.84 112.255 -178.345 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 19.8 m 67.81 126.81 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 123.155 0.582 . . . . 1.87 111.285 -177.167 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.593 HD13 ' HB3' ' A' ' 53' ' ' LEU . 67.1 tp -60.78 -36.01 77.89 Favored 'General case' 0 CA--C 1.521 -0.147 0 CA-C-N 116.109 -0.496 . . . . 1.83 110.482 179.589 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -49.23 -55.02 13.94 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.471 -0.786 . . . . 2.11 111.018 173.534 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 64.5 tttm -67.95 -27.67 66.8 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.944 0.402 . . . . 3.11 111.086 -178.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -66.08 -56.77 9.83 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.289 -0.414 . . . . 1.17 110.112 178.541 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 96.2 mt -59.42 -38.39 80.5 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 115.959 -0.564 . . . . 1.31 110.981 175.773 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -60.95 -38.58 86.39 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.937 -0.574 . . . . 1.98 110.397 179.254 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 6.3 tt0 -62.86 -40.03 96.23 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.994 -0.548 . . . . 2.33 110.648 176.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.506 ' HD1' ' HZ ' ' A' ' 23' ' ' PHE . 3.7 t80 -67.86 -41.68 82.5 Favored 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 108.477 -0.935 . . . . 1.05 108.477 179.813 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.721 ' HA ' ' CE2' ' A' ' 23' ' ' PHE . . . -55.2 -48.06 74.4 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.292 -0.867 . . . . 1.15 111.76 175.699 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.84 -25.1 67.31 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.242 -0.435 . . . . 1.26 111.544 -179.364 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 74.0 t60 -64.43 -49.01 73.18 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.282 -0.417 . . . . 2.52 111.602 -177.118 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 15.8 m -108.68 -11.24 15.1 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.584 -0.447 . . . . 1.79 112.116 -175.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 75.78 58.06 3.92 Favored Glycine 0 CA--C 1.519 0.322 0 CA-C-N 115.932 -0.576 . . . . 0.68 113.564 177.066 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.721 ' CE2' ' HA ' ' A' ' 18' ' ' ALA . 10.6 p90 -117.97 169.85 9.31 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.968 0.384 . . . . 0.68 111.028 178.524 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 13.3 m -92.18 118.18 30.59 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-O 121.201 0.524 . . . . 1.3 112.226 -172.193 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.658 HD21 ' CE3' ' A' ' 69' ' ' TRP . 1.5 mm? -99.32 138.98 35.65 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.71 -0.677 . . . . 2.3 110.742 175.056 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 44.4 m -125.41 100.74 6.63 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.075 0.464 . . . . 1.67 110.197 177.144 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 5.9 p -145.67 135.32 17.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.737 -0.665 . . . . 1.52 110.785 -177.865 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -98.98 129.01 45.25 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.076 -0.511 . . . . 2.38 109.724 177.81 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -54.36 -23.79 16.91 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 113.877 1.065 . . . . 2.45 113.877 -172.098 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 85.4 p -66.42 -27.49 67.88 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.12 0.486 . . . . 2.48 110.718 -175.278 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 96.7 mt -75.99 -47.13 26.13 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.551 -0.75 . . . . 1.92 111.13 -177.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 3.5 t -99.31 40.78 1.19 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.621 0.724 . . . . 1.82 110.706 -177.217 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.474 ' O ' ' HG3' ' A' ' 33' ' ' ARG . 8.6 ptp180 -63.25 105.89 0.8 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.656 -0.702 . . . . 5.19 111.039 179.546 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 63.01 19.44 61.31 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 121.088 -0.577 . . . . 1.62 112.377 179.656 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.619 ' HE3' ' HA ' ' A' ' 57' ' ' SER . 8.6 tptp -74.32 112.71 10.75 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.601 -0.518 . . . . 3.17 109.601 -177.149 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -103.87 156.65 17.66 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.731 0.301 . . . . 2.52 110.479 -177.122 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.48 ' O ' ' HA ' ' A' ' 7' ' ' PRO . 46.7 t -128.62 130.27 47.05 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 107.222 -1.399 . . . . 1.14 107.222 172.657 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 8.0 m120 -63.96 -15.23 58.76 Favored 'General case' 0 C--N 1.322 -0.606 0 O-C-N 123.441 0.463 . . . . 1.28 112.086 -173.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 123.36 172.31 13.78 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.901 -0.666 . . . . 0.49 112.159 172.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 31.4 tp -161.31 121.39 2.65 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.023 -0.732 . . . . 1.36 109.023 -177.338 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 19.2 t-80 -143.85 99.28 3.38 Favored 'General case' 0 C--N 1.321 -0.664 0 C-N-CA 120.205 -0.598 . . . . 3.8 110.892 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -168.27 -169.54 31.86 Favored Glycine 0 N--CA 1.446 -0.656 0 CA-C-N 115.451 -0.795 . . . . 0.55 111.917 178.252 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -78.35 85.98 4.45 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.518 -0.549 . . . . 2.18 109.518 174.789 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 67.5 m-85 -119.53 122.57 41.93 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.289 0.566 . . . . 1.5 111.628 -176.205 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -84.25 -174.49 5.31 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.278 -0.873 . . . . 2.23 108.798 173.758 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 47.3 t -51.88 -67.93 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 120.671 0.272 . . . . 1.25 111.499 -177.319 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -55.11 -41.76 72.07 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 112.815 0.672 . . . . 2.39 112.815 -176.105 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 22.1 m -71.69 -31.04 66.34 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.966 0.412 . . . . 1.65 111.34 -174.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.403 ' O ' ' HG ' ' A' ' 53' ' ' LEU . . . -71.82 -49.21 24.19 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.85 -0.691 . . . . 0.4 112.071 -175.705 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.427 ' O ' ' HG ' ' A' ' 54' ' ' LEU . 8.5 mp -65.57 -38.73 90.4 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 121.959 0.104 . . . . 1.63 111.208 -178.248 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 58.1 tt0 -53.27 -52.99 57.25 Favored 'General case' 0 C--N 1.331 -0.218 0 O-C-N 123.222 0.326 . . . . 3.01 111.752 179.743 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 12.5 mm100 -64.31 -41.9 96.62 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.882 0.373 . . . . 2.18 111.035 -177.808 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.593 ' HB3' HD13 ' A' ' 10' ' ' LEU . 88.0 mt -59.71 -21.48 60.71 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 115.905 -0.589 . . . . 1.4 112.417 -179.796 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.616 HD23 HG12 ' A' ' 61' ' ' VAL . 65.0 mt -75.36 -14.52 60.48 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.032 0.382 . . . . 2.78 112.032 -177.415 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -72.3 131.61 42.91 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.995 0.426 . . . . 2.24 110.09 -177.345 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 101.72 -17.45 54.81 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.889 -0.672 . . . . 1.96 111.526 -175.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.619 ' HA ' ' HE3' ' A' ' 35' ' ' LYS . 4.3 m -102.55 160.07 14.89 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-O 120.733 0.302 . . . . 2.28 110.203 178.501 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -107.27 35.75 4.83 Favored Glycine 0 N--CA 1.441 -0.984 0 N-CA-C 109.705 -1.358 . . . . 1.79 109.705 171.018 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.597 ' HB3' HD21 ' A' ' 71' ' ' LEU . 50.7 mt -126.57 174.31 8.78 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.265 -0.642 . . . . 1.82 109.265 -177.866 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 24.3 mt-30 -146.94 118.97 8.19 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.348 -0.612 . . . . 3.26 109.348 179.733 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.616 HG12 HD23 ' A' ' 54' ' ' LEU . 7.6 p -86.65 130.36 36.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 N-CA-C 109.667 -0.494 . . . . 2.17 109.667 179.153 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 26.8 ttpp -131.53 131.73 23.05 Favored Pre-proline 0 N--CA 1.442 -0.834 0 N-CA-C 109.816 -0.438 . . . . 2.29 109.816 -174.622 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -54.09 125.71 19.67 Favored 'Trans proline' 0 N--CA 1.463 -0.313 0 C-N-CA 122.418 2.079 . . . . 0.94 111.088 177.433 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.554 ' HG ' ' HB ' ' A' ' 70' ' ' THR . 0.7 OUTLIER -74.03 -63.66 1.17 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.46 -0.791 . . . . 2.32 110.254 -173.856 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -155.48 -107.07 0.27 Allowed Glycine 0 N--CA 1.445 -0.74 0 C-N-CA 120.755 -0.736 . . . . 1.69 111.961 177.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -80.81 94.55 6.45 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.571 0.225 . . . . 3.67 110.687 179.787 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . 0.566 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 2.8 t-20 58.08 39.6 26.06 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.404 0.621 . . . . 2.59 110.44 174.759 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' SER . . . . . 0.461 ' O ' ' HD1' ' A' ' 69' ' ' TRP . 15.2 p -135.82 169.13 18.06 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 109.457 -0.572 . . . . 1.54 109.457 179.235 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' TRP . . . . . 0.658 ' CE3' HD21 ' A' ' 25' ' ' LEU . 26.8 m0 -140.87 154.69 46.28 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 108.975 -0.75 . . . . 0.54 108.975 -175.354 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.554 ' HB ' ' HG ' ' A' ' 64' ' ' LEU . 8.6 t -137.73 138.13 39.01 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 108.802 -0.814 . . . . 1.49 108.802 175.002 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.597 HD21 ' HB3' ' A' ' 59' ' ' LEU . 6.5 tt -93.12 102.57 14.89 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.51 0.671 . . . . 2.24 109.799 -178.451 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.411 ' HA ' ' HD3' ' A' ' 73' ' ' PRO . 25.8 mm-40 -89.3 132.73 36.6 Favored Pre-proline 0 C--N 1.319 -0.738 0 CA-C-N 114.678 -1.146 . . . . 2.25 111.248 178.649 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 72' ' ' GLU . 7.7 Cg_exo -73.15 115.15 4.25 Favored 'Trans proline' 0 N--CA 1.461 -0.392 0 C-N-CA 122.677 2.251 . . . . 1.45 111.574 176.361 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.324 -0.532 0 CA-C-N 116.039 -0.528 . . . . 2.07 109.758 -178.102 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 19.6 pt20 . . . . . 0 N--CA 1.45 -0.467 0 CA-C-O 121.327 0.584 . . . . 4.51 110.841 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.623 ' O ' ' HA ' ' A' ' 41' ' ' HIS . 36.2 t -101.59 131.7 48.92 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.938 0 CA-C-N 115.301 -0.863 . . . . 2.2 108.859 174.492 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -129.48 109.49 11.09 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.229 0.537 . . . . 2.75 109.995 179.465 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.627 HD11 ' HB1' ' A' ' 13' ' ' ALA . 68.6 mt -131.02 127.06 60.58 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 115.932 -0.576 . . . . 1.5 110.537 -177.199 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -76.18 159.7 79.69 Favored Pre-proline 0 N--CA 1.45 -0.459 0 CA-C-N 115.916 -0.584 . . . . 1.99 109.657 177.446 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.525 ' HA ' ' O ' ' A' ' 37' ' ' SER . 44.7 Cg_endo -69.6 49.91 0.72 Allowed 'Trans proline' 0 CA--C 1.534 0.495 0 C-N-CA 122.915 2.41 . . . . 1.73 113.123 177.632 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -116.75 -150.06 9.25 Favored Glycine 0 C--O 1.226 -0.347 0 C-N-CA 121.241 -0.504 . . . . 1.84 112.574 -178.703 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.572 ' HA ' ' O ' ' A' ' 35' ' ' LYS . 22.8 p -62.54 125.47 24.05 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.162 0.506 . . . . 1.87 111.867 -176.294 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.777 ' HB3' ' HB3' ' A' ' 35' ' ' LYS . 70.3 tp -65.49 -32.4 73.98 Favored 'General case' 0 N--CA 1.456 -0.172 0 CA-C-N 115.64 -0.709 . . . . 1.83 109.696 178.758 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.566 ' OD2' ' HB ' ' A' ' 32' ' ' THR . 10.6 m-20 -50.5 -53.89 26.52 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.19 -0.914 . . . . 2.11 110.401 175.21 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -68.84 -26.66 65.27 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.772 -0.649 . . . . 3.11 110.638 177.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.627 ' HB1' HD11 ' A' ' 5' ' ' ILE . . . -67.36 -53.07 32.73 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.988 -0.551 . . . . 1.17 110.816 -178.85 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 87.2 mt -56.96 -43.73 81.88 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.116 -0.493 . . . . 1.31 110.873 177.026 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 52.9 t30 -62.4 -32.55 73.39 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.831 -0.622 . . . . 1.98 110.371 -179.64 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . 0.402 HE21 ' HB3' ' A' ' 16' ' ' GLN . 1.0 OUTLIER -62.16 -45.35 93.79 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.283 -0.417 . . . . 2.33 110.445 177.096 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 13.5 t80 -71.38 -41.36 69.78 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 109.65 -0.5 . . . . 1.05 109.65 -178.78 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.716 ' HA ' ' CE2' ' A' ' 23' ' ' PHE . . . -53.37 -53.41 51.47 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 115.501 -0.772 . . . . 1.15 112.141 178.194 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -64.54 -26.2 68.31 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.311 -0.404 . . . . 1.26 111.461 -178.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 70.5 t60 -64.8 -45.19 87.28 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.293 -0.412 . . . . 2.52 111.298 -176.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.469 ' HB2' ' CE1' ' A' ' 23' ' ' PHE . 24.5 m -101.04 -7.02 23.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.269 0.557 . . . . 1.79 111.594 -178.735 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 67.66 47.11 63.63 Favored Glycine 0 N--CA 1.449 -0.494 0 CA-C-N 115.309 -0.86 . . . . 0.68 114.023 176.791 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.716 ' CE2' ' HA ' ' A' ' 18' ' ' ALA . 5.9 p90 -109.21 160.73 15.87 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 117.389 0.595 . . . . 0.68 110.624 175.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.445 ' O ' ' HB3' ' A' ' 68' ' ' SER . 25.0 m -88.14 119.82 28.9 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.431 0.634 . . . . 1.3 112.529 -171.532 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.632 HD22 ' CE3' ' A' ' 69' ' ' TRP . 1.6 mm? -95.73 121.34 37.34 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.609 -0.723 . . . . 2.3 111.174 176.617 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 18.9 m -104.35 93.32 4.75 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.67 -0.492 . . . . 1.67 109.67 175.633 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.45 ' HB ' HD22 ' A' ' 71' ' ' LEU . 5.4 p -139.78 135.0 38.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.911 -0.586 . . . . 1.52 111.456 -174.289 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -92.52 117.54 30.05 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.819 -0.628 . . . . 2.38 110.085 175.221 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.48 76.67 0.01 OUTLIER 'General case' 0 C--O 1.232 0.165 0 CA-C-N 115.86 -0.609 . . . . 2.45 112.089 178.398 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 13.8 m -159.38 -50.31 0.06 Allowed 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 108.294 -1.002 . . . . 2.48 108.294 179.542 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 87.5 mt -62.93 -44.0 97.27 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 108.771 -0.825 . . . . 1.92 108.771 172.477 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.566 ' HB ' ' OD2' ' A' ' 11' ' ' ASP . 26.3 p -93.7 59.08 2.79 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-N 114.942 -1.026 . . . . 1.82 110.273 175.518 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 9.7 tpt180 -102.4 112.04 24.59 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.881 -0.599 . . . . 5.19 110.173 174.512 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 69.65 34.74 73.2 Favored Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 120.712 -0.756 . . . . 1.62 112.596 176.37 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.777 ' HB3' ' HB3' ' A' ' 10' ' ' LEU . 13.2 mptt -81.13 140.56 34.96 Favored 'General case' 0 CA--C 1.511 -0.529 0 N-CA-C 109.478 -0.564 . . . . 3.17 109.478 176.666 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 49.1 mt-30 -138.17 134.18 34.22 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 109.944 -0.391 . . . . 2.52 109.944 -179.764 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.525 ' O ' ' HA ' ' A' ' 7' ' ' PRO . 7.8 t -124.34 134.13 53.25 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.278 -0.638 . . . . 1.14 109.278 -178.584 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.44 ' N ' HD21 ' A' ' 38' ' ' ASN . 0.9 OUTLIER -60.08 -14.88 18.94 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 112.716 0.636 . . . . 1.28 112.716 -178.332 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 132.05 178.66 15.63 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.248 -0.977 . . . . 0.49 113.008 170.829 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.463 HD21 HG13 ' A' ' 3' ' ' VAL . 48.4 tp -160.44 122.01 3.1 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 108.135 -1.061 . . . . 1.36 108.135 -179.135 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' HIS . . . . . 0.623 ' HA ' ' O ' ' A' ' 3' ' ' VAL . 39.7 t-80 -145.37 99.84 3.36 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.213 -0.595 . . . . 3.8 111.972 179.215 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -169.37 178.14 42.63 Favored Glycine 0 N--CA 1.443 -0.892 0 N-CA-C 110.969 -0.852 . . . . 0.55 110.969 174.483 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -82.39 113.06 19.9 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 108.12 -1.067 . . . . 2.18 108.12 169.031 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 50.5 m-85 -128.89 131.13 47.58 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.074 0.464 . . . . 1.5 111.888 -173.501 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -66.15 160.37 24.24 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.256 -0.884 . . . . 2.23 109.219 169.288 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 47.2 t -49.03 -61.22 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 O-C-N 123.507 0.504 . . . . 1.25 111.502 -174.609 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.71 ' HA ' HD23 ' A' ' 50' ' ' LEU . 46.5 mt-10 -64.24 -40.18 95.48 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.256 -0.429 . . . . 2.39 111.695 -178.398 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 28.1 t -71.07 -30.4 66.53 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-O 120.892 0.377 . . . . 1.65 111.428 -170.81 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -81.18 -32.11 32.68 Favored Glycine 0 N--CA 1.447 -0.615 0 C-N-CA 120.531 -0.842 . . . . 0.4 111.526 -177.136 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.71 HD23 ' HA ' ' A' ' 47' ' ' GLU . 0.3 OUTLIER -80.59 -41.14 24.5 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 109.539 -0.541 . . . . 1.63 109.539 -178.198 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . 0.561 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 54.3 tt0 -53.95 -39.23 65.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.735 -0.666 . . . . 3.01 111.768 174.451 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 8.5 tp-100 -63.07 -46.64 86.48 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.377 -0.374 . . . . 2.18 110.133 178.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.438 ' HB3' HD11 ' A' ' 10' ' ' LEU . 95.8 mt -58.39 -21.71 51.34 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 115.803 -0.635 . . . . 1.4 112.344 178.375 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 87.2 mt -73.88 -24.71 59.76 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-O 120.685 0.278 . . . . 2.78 111.611 -178.036 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -73.5 113.55 10.73 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.115 0.483 . . . . 2.24 110.77 -176.693 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 127.67 -12.96 6.54 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.807 -0.711 . . . . 1.96 111.846 -179.05 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 70.6 p -118.12 175.1 5.84 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 110.005 -0.368 . . . . 2.28 110.005 179.041 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -113.13 33.25 5.67 Favored Glycine 0 N--CA 1.448 -0.541 0 N-CA-C 111.271 -0.732 . . . . 1.79 111.271 179.251 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 85.1 mt -119.99 179.31 4.3 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 108.872 -0.788 . . . . 1.82 108.872 178.829 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -149.87 119.11 6.8 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.091 0.472 . . . . 3.26 109.925 178.478 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 59.9 t -92.92 126.58 45.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 N-CA-C 109.08 -0.711 . . . . 2.17 109.08 176.547 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.463 ' HE2' ' HB2' ' A' ' 72' ' ' GLU . 50.9 mtmt -126.17 134.35 25.87 Favored Pre-proline 0 C--N 1.319 -0.751 0 N-CA-C 109.509 -0.552 . . . . 2.29 109.509 -177.812 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . 0.431 ' HA ' ' O ' ' A' ' 68' ' ' SER . 47.8 Cg_exo -56.32 117.86 4.58 Favored 'Trans proline' 0 N--CA 1.459 -0.557 0 C-N-CA 122.232 1.955 . . . . 0.94 110.825 173.679 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 55.6 tp -58.07 -42.41 85.48 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 114.917 -1.038 . . . . 2.32 112.079 -171.13 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -179.64 -86.64 0.07 OUTLIER Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 120.553 -0.832 . . . . 1.69 112.287 179.744 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 50.3 t30 -61.18 -76.03 0.06 Allowed 'General case' 0 C--N 1.33 -0.265 0 O-C-N 123.52 0.188 . . . . 3.67 111.138 -179.344 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 66.5 t30 -155.93 53.14 0.57 Allowed 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 121.662 0.744 . . . . 2.59 109.626 178.738 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' SER . . . . . 0.445 ' HB3' ' O ' ' A' ' 24' ' ' THR . 10.8 m -138.11 178.79 6.86 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 107.883 -1.154 . . . . 1.54 107.883 -179.328 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' TRP . . . . . 0.632 ' CE3' HD22 ' A' ' 25' ' ' LEU . 51.5 m0 -136.52 157.1 47.57 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.114 -0.698 . . . . 0.54 109.114 -176.364 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 13.8 t -142.6 147.81 36.45 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.752 0.311 . . . . 1.49 110.236 176.072 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.45 HD22 ' HB ' ' A' ' 27' ' ' VAL . 3.9 mm? -93.41 102.95 15.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.167 0.508 . . . . 2.24 111.253 179.457 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.463 ' HB2' ' HE2' ' A' ' 62' ' ' LYS . 17.8 mt-10 -106.25 131.42 21.74 Favored Pre-proline 0 C--N 1.32 -0.715 0 CA-C-N 115.328 -0.851 . . . . 2.25 111.182 172.538 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.447 ' HD3' ' HA ' ' A' ' 72' ' ' GLU . 24.0 Cg_exo -64.01 114.78 2.77 Favored 'Trans proline' 0 N--CA 1.456 -0.708 0 C-N-CA 122.249 1.966 . . . . 1.45 111.274 176.193 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.318 -0.77 0 CA-C-N 115.41 -0.814 . . . . 2.07 108.865 175.105 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . 0.633 ' HA ' ' HA ' ' A' ' 43' ' ' ASP . 8.0 tp-100 . . . . . 0 N--CA 1.466 0.346 0 CA-C-O 122.01 0.91 . . . . 4.51 111.69 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 60.3 t -101.43 131.44 49.22 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 CA-C-N 114.437 -1.256 . . . . 2.2 108.724 178.586 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 50.6 m-80 -123.41 99.54 6.38 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.069 0.462 . . . . 2.75 110.114 -173.592 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.421 HG23 ' N ' ' A' ' 6' ' ' ALA . 30.2 mt -130.49 160.29 41.77 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 N-CA-C 108.766 -0.828 . . . . 1.5 108.766 179.48 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . 0.656 ' HB2' ' HD2' ' A' ' 7' ' ' PRO . . . -164.6 172.87 4.31 Favored Pre-proline 0 C--N 1.323 -0.555 0 CA-C-O 118.815 -0.612 . . . . 1.99 109.448 -176.958 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.656 ' HD2' ' HB2' ' A' ' 6' ' ' ALA . 33.7 Cg_exo -36.97 130.49 0.49 Allowed 'Trans proline' 0 C--N 1.357 1.006 0 C-N-CA 123.297 2.665 . . . . 1.73 113.685 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 155.57 -177.16 32.87 Favored Glycine 0 N--CA 1.444 -0.767 0 N-CA-C 110.982 -0.847 . . . . 1.84 110.982 -177.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.573 ' HA ' ' O ' ' A' ' 35' ' ' LYS . 19.6 m -68.32 133.68 49.12 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 110.068 -0.345 . . . . 1.87 110.068 178.926 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 59.9 tp -58.8 -32.32 69.24 Favored 'General case' 0 C--O 1.23 0.071 0 CA-C-O 120.989 0.423 . . . . 1.83 110.727 179.58 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -49.64 -46.65 49.76 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.436 -0.802 . . . . 2.11 110.559 172.871 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 5.1 tmtm? -64.37 -35.03 79.55 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.658 -0.701 . . . . 3.11 110.066 -178.246 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -65.26 -59.41 4.1 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.155 -0.475 . . . . 1.17 110.961 -176.746 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 94.0 mt -59.61 -39.07 83.03 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.097 -0.501 . . . . 1.31 111.232 178.142 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 47.2 t30 -60.99 -38.39 85.84 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.966 0.412 . . . . 1.98 110.052 178.311 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . 0.403 HE21 ' HB3' ' A' ' 16' ' ' GLN . 0.9 OUTLIER -61.6 -44.05 97.73 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.974 -0.557 . . . . 2.33 110.663 177.054 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.417 ' CD1' ' HH2' ' A' ' 69' ' ' TRP . 3.9 t80 -68.53 -43.51 76.58 Favored 'General case' 0 N--CA 1.457 -0.106 0 N-CA-C 109.24 -0.652 . . . . 1.05 109.24 -179.503 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.679 ' HA ' ' CZ ' ' A' ' 23' ' ' PHE . . . -54.55 -49.16 70.96 Favored 'General case' 0 C--N 1.333 -0.109 0 CA-C-N 115.619 -0.719 . . . . 1.15 111.546 176.923 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -64.92 -24.98 67.69 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.403 -0.362 . . . . 1.26 111.515 -179.488 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 56.1 t60 -60.99 -50.95 71.29 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.342 -0.39 . . . . 2.52 111.305 -177.567 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.553 ' HB2' ' CD1' ' A' ' 23' ' ' PHE . 15.7 m -108.11 -1.5 20.33 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.993 0.425 . . . . 1.79 111.783 -177.245 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 62.24 46.62 93.56 Favored Glycine 0 C--N 1.332 0.339 0 CA-C-N 115.595 -0.729 . . . . 0.68 113.699 174.497 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.679 ' CZ ' ' HA ' ' A' ' 18' ' ' ALA . 14.4 p90 -105.12 172.79 6.6 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.842 0.321 . . . . 0.68 110.568 -179.419 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 47.6 m -91.71 106.19 18.29 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.34 0.59 . . . . 1.3 111.41 -179.514 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 3.6 tt -92.98 123.03 35.94 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.017 -0.735 . . . . 2.3 109.017 175.633 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.407 ' O ' ' HA ' ' A' ' 70' ' ' THR . 33.4 t -101.04 101.11 11.81 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.172 0.51 . . . . 1.67 110.064 -176.552 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.2 p -141.22 135.14 31.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.729 -0.669 . . . . 1.52 110.444 -179.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -81.83 123.3 28.68 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.857 -0.611 . . . . 2.38 110.406 177.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.14 82.77 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.805 -0.634 . . . . 2.45 111.954 178.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.516 ' HA ' ' NE ' ' A' ' 33' ' ' ARG . 55.5 p -172.44 -45.4 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.289 -0.414 . . . . 2.48 110.053 -179.706 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 93.5 mt -62.09 -44.61 96.3 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.584 -0.734 . . . . 1.92 112.227 -174.386 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.451 ' O ' ' HB2' ' A' ' 35' ' ' LYS . 30.0 p -97.86 2.55 49.4 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 112.206 0.447 . . . . 1.82 112.206 -176.265 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.516 ' NE ' ' HA ' ' A' ' 30' ' ' SER . 64.6 mtm180 -58.55 121.66 11.5 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-O 120.581 0.229 . . . . 5.19 111.442 -178.408 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 81.3 11.71 83.06 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 121.056 -0.593 . . . . 1.62 112.781 175.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.573 ' O ' ' HA ' ' A' ' 9' ' ' SER . 12.8 mptt -85.08 151.01 24.46 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.872 0.368 . . . . 3.17 110.817 -179.763 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 32.1 mm-40 -131.46 138.3 48.97 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 108.437 -0.949 . . . . 2.52 108.437 178.667 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.428 ' O ' ' HA ' ' A' ' 7' ' ' PRO . 34.6 t -131.6 141.66 49.71 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 109.186 -0.672 . . . . 1.14 109.186 179.236 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -77.1 -2.36 33.82 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.431 -0.349 . . . . 1.28 111.65 178.062 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . 0.407 ' HA2' HG23 ' A' ' 5' ' ' ILE . . . 98.02 -169.63 24.29 Favored Glycine 0 N--CA 1.445 -0.754 0 C-N-CA 120.421 -0.895 . . . . 0.49 113.619 170.714 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 54.8 tp -160.23 140.41 11.54 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 107.537 -1.283 . . . . 1.36 107.537 -179.28 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 17.4 t60 -144.52 99.54 3.38 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 120.195 -0.602 . . . . 3.8 111.241 -178.185 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -169.48 170.69 42.81 Favored Glycine 0 N--CA 1.448 -0.518 0 N-CA-C 110.547 -1.021 . . . . 0.55 110.547 175.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.633 ' HA ' ' HA ' ' A' ' 2' ' ' GLN . 44.2 t0 -86.0 91.77 8.49 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 108.607 -0.886 . . . . 2.18 108.607 175.84 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 25.6 m-85 -107.4 138.01 44.38 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.555 -0.748 . . . . 1.5 112.173 -170.131 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -75.33 165.56 24.97 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 108.449 -0.945 . . . . 2.23 108.449 169.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.463 HG11 ' HZ2' ' A' ' 69' ' ' TRP . 61.2 t -50.44 -70.31 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 112.356 0.502 . . . . 1.25 112.356 -174.383 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -61.33 -42.19 98.26 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 112.285 0.476 . . . . 2.39 112.285 -172.465 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 34.9 t -70.18 -26.21 63.8 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.878 0.37 . . . . 1.65 110.524 -175.221 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.435 ' O ' ' HG ' ' A' ' 53' ' ' LEU . . . -77.24 -36.08 35.96 Favored Glycine 0 N--CA 1.444 -0.826 0 N-CA-C 110.956 -0.858 . . . . 0.4 110.956 -179.664 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.659 ' HB3' HG12 ' A' ' 61' ' ' VAL . 92.8 mt -72.69 -43.62 62.83 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.76 0.314 . . . . 1.63 110.628 -179.38 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 57.0 tp60 -52.96 -50.06 64.86 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.837 -0.62 . . . . 3.01 111.575 178.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.458 ' HA ' ' OE1' ' A' ' 52' ' ' GLN . 12.8 mm-40 -65.86 -37.13 85.36 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.524 -0.307 . . . . 2.18 111.458 -178.039 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.435 ' HG ' ' O ' ' A' ' 49' ' ' GLY . 66.1 mt -57.88 -39.86 78.85 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.176 0.436 . . . . 1.4 112.176 179.327 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.54 HD22 ' HG ' ' A' ' 57' ' ' SER . 45.2 mt -105.39 16.84 24.93 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.257 0.466 . . . . 2.78 112.257 -174.856 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -68.15 94.58 0.52 Allowed 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 120.993 0.425 . . . . 2.24 111.188 -179.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 109.57 -7.01 31.8 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.919 -0.658 . . . . 1.96 113.565 176.621 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.54 ' HG ' HD22 ' A' ' 54' ' ' LEU . 60.4 p -83.72 -1.54 54.33 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 117.357 0.579 . . . . 2.28 111.705 -175.755 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 76.57 17.67 79.71 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.764 -0.732 . . . . 1.79 112.118 -179.739 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 96.7 mt -124.96 168.57 13.13 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.516 -0.342 . . . . 1.82 110.091 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 33.7 tt0 -150.69 118.64 6.24 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.18 -0.674 . . . . 3.26 109.18 175.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.659 HG12 ' HB3' ' A' ' 50' ' ' LEU . 7.2 p -109.73 129.67 64.2 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 N-CA-C 109.998 -0.371 . . . . 2.17 109.998 179.425 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 24.0 pttm -148.47 156.53 42.3 Favored Pre-proline 0 C--N 1.322 -0.628 0 N-CA-C 109.884 -0.413 . . . . 2.29 109.884 -177.126 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . 0.558 ' HA ' ' HA ' ' A' ' 69' ' ' TRP . 25.7 Cg_exo -63.93 148.17 91.77 Favored 'Trans proline' 0 N--CA 1.461 -0.392 0 C-N-CA 122.716 2.277 . . . . 0.94 111.904 176.706 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.473 HD22 ' HB ' ' A' ' 70' ' ' THR . 82.0 mt -65.68 -27.39 68.31 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.595 -0.73 . . . . 2.32 110.659 179.363 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 152.0 -19.95 0.86 Allowed Glycine 0 N--CA 1.451 -0.361 0 N-CA-C 109.674 -1.371 . . . . 1.69 109.674 -178.63 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 5.6 p30 -128.21 -157.87 0.84 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 114.414 -0.893 . . . . 3.67 109.314 174.865 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -77.07 45.48 0.44 Allowed 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 121.188 0.518 . . . . 2.59 112.158 -176.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 19.5 m -141.51 165.54 27.22 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 107.391 -1.337 . . . . 1.54 107.391 172.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' TRP . . . . . 0.558 ' HA ' ' HA ' ' A' ' 63' ' ' PRO . 52.8 m0 -133.83 166.81 21.81 Favored 'General case' 0 C--N 1.32 -0.716 0 C-N-CA 120.487 -0.485 . . . . 0.54 110.817 -166.38 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.473 ' HB ' HD22 ' A' ' 64' ' ' LEU . 8.9 t -146.49 143.98 29.32 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.419 -0.585 . . . . 1.49 109.419 171.782 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 35.9 tp -93.08 100.95 13.27 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-O 121.662 0.744 . . . . 2.24 109.26 176.153 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -94.75 130.29 33.63 Favored Pre-proline 0 C--N 1.316 -0.863 0 CA-C-N 114.838 -1.073 . . . . 2.25 111.267 -177.34 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_exo -69.98 113.37 3.39 Favored 'Trans proline' 0 N--CA 1.451 -0.995 0 C-N-CA 121.535 1.49 . . . . 1.45 110.714 174.153 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.321 -0.663 0 CA-C-N 115.665 -0.698 . . . . 2.07 109.192 179.572 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 19.6 pm0 . . . . . 0 N--CA 1.452 -0.362 0 CA-C-O 121.139 0.495 . . . . 4.51 110.582 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 12.4 p -149.19 156.08 7.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 115.589 -0.732 . . . . 2.2 109.302 -179.358 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 -127.26 108.9 11.28 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.93 0.395 . . . . 2.75 109.978 -178.449 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 60.8 mt -131.16 151.18 35.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 N-CA-C 108.89 -0.781 . . . . 1.5 108.89 -179.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . 0.663 ' HB1' ' HD2' ' A' ' 7' ' ' PRO . . . -162.17 174.1 3.96 Favored Pre-proline 0 C--N 1.322 -0.625 0 CA-C-O 118.436 -0.792 . . . . 1.99 108.956 -173.689 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.663 ' HD2' ' HB1' ' A' ' 6' ' ' ALA . 47.5 Cg_exo -38.48 135.53 0.71 Allowed 'Trans proline' 0 C--N 1.361 1.235 0 C-N-CA 123.227 2.618 . . . . 1.73 113.707 -176.264 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 153.13 168.59 17.23 Favored Glycine 0 N--CA 1.446 -0.686 0 N-CA-C 110.401 -1.08 . . . . 1.84 110.401 -173.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.409 ' HA ' ' HA ' ' A' ' 36' ' ' GLN . 4.7 t -67.74 138.11 55.98 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.619 -0.511 . . . . 1.87 109.619 -178.736 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 59.9 tp -58.12 -36.79 73.44 Favored 'General case' 0 CA--C 1.523 -0.083 0 CA-C-N 115.349 -0.841 . . . . 1.83 111.649 -173.222 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -54.59 -50.58 67.68 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.186 -0.461 . . . . 2.11 111.154 176.049 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . 0.649 ' O ' ' HG3' ' A' ' 16' ' ' GLN . 41.0 tttm -64.0 -35.43 80.69 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.473 0.178 . . . . 3.11 110.591 177.003 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.42 -52.56 63.08 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.829 0.347 . . . . 1.17 110.132 -178.484 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.601 ' HB3' HD13 ' A' ' 25' ' ' LEU . 77.5 mt -57.27 -38.52 74.02 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.779 -0.646 . . . . 1.31 110.899 174.324 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 17.9 t-20 -61.03 -37.75 83.69 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.107 -0.497 . . . . 1.98 111.06 179.336 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . 0.649 ' HG3' ' O ' ' A' ' 12' ' ' LYS . 18.6 mt-30 -62.3 -40.05 95.01 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.758 -0.201 . . . . 2.33 110.587 178.199 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.422 ' O ' ' HB3' ' A' ' 20' ' ' HIS . 5.0 t80 -68.38 -43.77 76.61 Favored 'General case' 0 CA--C 1.52 -0.196 0 CA-C-O 121.636 0.731 . . . . 1.05 109.169 177.433 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.678 ' HA ' ' CZ ' ' A' ' 23' ' ' PHE . . . -52.44 -46.22 66.34 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 114.707 -1.133 . . . . 1.15 111.317 176.521 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -64.52 -29.06 70.1 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.146 -0.479 . . . . 1.26 111.392 179.013 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . 0.422 ' HB3' ' O ' ' A' ' 17' ' ' TYR . 84.9 t60 -61.1 -55.06 36.94 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.056 -0.52 . . . . 2.52 111.51 -177.234 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.442 ' HB2' ' CD1' ' A' ' 23' ' ' PHE . 38.8 m -100.23 -9.21 22.66 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 112.134 0.42 . . . . 1.79 112.134 -177.456 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 69.42 55.67 9.79 Favored Glycine 0 N--CA 1.452 -0.286 0 CA-C-N 115.808 -0.633 . . . . 0.68 113.405 178.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.678 ' CZ ' ' HA ' ' A' ' 18' ' ' ALA . 15.5 p90 -112.67 166.54 11.25 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.77 0.319 . . . . 0.68 110.455 176.858 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 21.0 m -89.31 113.41 24.68 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.187 0.518 . . . . 1.3 111.012 -177.403 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.601 HD13 ' HB3' ' A' ' 14' ' ' LEU . 1.9 tt -99.91 136.7 39.42 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.384 -0.825 . . . . 2.3 109.588 179.002 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.656 ' HB2' ' HA ' ' A' ' 70' ' ' THR . 48.5 m -100.64 97.22 7.92 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 109.692 -0.484 . . . . 1.67 109.692 175.809 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.477 ' HB ' HD21 ' A' ' 25' ' ' LEU . 12.6 p -145.36 150.33 15.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.353 -0.385 . . . . 1.52 110.136 -177.505 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -130.42 122.82 28.48 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.402 -0.363 . . . . 2.38 110.448 -179.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.17 67.7 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.375 0 O-C-N 123.855 0.722 . . . . 2.45 112.286 177.433 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 30.2 t -170.62 -34.48 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.518 -0.549 . . . . 2.48 109.518 178.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 90.9 mt -69.13 -36.87 77.94 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.102 -0.499 . . . . 1.92 110.338 178.119 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 8.9 p -93.7 36.85 1.08 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.952 -0.567 . . . . 1.82 111.358 -179.822 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.49 105.92 2.38 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.914 0.388 . . . . 5.19 110.381 -176.579 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 87.62 17.37 58.54 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.835 -0.697 . . . . 1.62 112.062 -179.259 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.61 93.28 4.68 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.702 0.286 . . . . 3.17 110.249 179.735 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . 0.409 ' HA ' ' HA ' ' A' ' 9' ' ' SER . 49.0 mt-30 -102.69 158.09 16.49 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 110.249 -0.278 . . . . 2.52 110.249 179.529 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 32.9 t -127.2 135.56 50.82 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 108.736 -0.838 . . . . 1.14 108.736 178.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.413 ' N ' HD21 ' A' ' 38' ' ' ASN . 0.9 OUTLIER -67.51 -12.87 61.36 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 113.231 0.826 . . . . 1.28 113.231 -175.499 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 125.13 174.83 14.06 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.028 -1.082 . . . . 0.49 114.034 170.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 57.0 tp -161.25 120.2 2.5 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 108.238 -1.023 . . . . 1.36 108.238 -176.239 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 11.7 p80 -144.28 99.39 3.37 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 119.808 -0.757 . . . . 3.8 111.519 -179.786 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -169.01 -177.84 40.05 Favored Glycine 0 N--CA 1.443 -0.868 0 CA-C-N 115.158 -0.928 . . . . 0.55 111.131 177.833 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -88.87 77.02 7.84 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 108.897 -0.779 . . . . 2.18 108.897 172.269 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 28.9 m-85 -98.26 129.59 44.98 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.766 -0.652 . . . . 1.5 111.68 -173.138 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 32.4 t0 -70.55 162.56 28.62 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.308 -0.86 . . . . 2.23 109.047 173.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 46.4 t -47.92 -64.83 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 112.285 0.476 . . . . 1.25 112.285 -172.54 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 40.9 mm-40 -56.81 -36.55 70.05 Favored 'General case' 0 N--CA 1.464 0.242 0 N-CA-C 111.773 0.286 . . . . 2.39 111.773 -176.749 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 15.3 m -71.74 -33.67 68.89 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-O 120.97 0.414 . . . . 1.65 110.773 -174.684 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -67.75 -46.84 65.0 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.955 -0.64 . . . . 0.4 112.339 -175.192 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.564 HD12 ' CZ2' ' A' ' 69' ' ' TRP . 7.1 mp -68.9 -37.26 78.87 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 110.486 -0.19 . . . . 1.63 110.486 -178.225 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -54.82 -45.86 74.49 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.433 -0.348 . . . . 3.01 111.009 178.266 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 -65.66 -46.85 77.59 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.254 -0.43 . . . . 2.18 110.989 179.102 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 88.7 mt -57.14 -29.63 63.75 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 112.29 0.478 . . . . 1.4 112.29 -178.826 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.479 ' HG ' ' O ' ' A' ' 50' ' ' LEU . 95.0 mt -77.84 -7.32 56.5 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 112.079 0.4 . . . . 2.78 112.079 -176.839 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -66.72 93.87 0.27 Allowed 'General case' 0 C--O 1.233 0.207 0 CA-C-O 121.45 0.643 . . . . 2.24 110.973 -178.703 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 136.73 -25.33 3.1 Favored Glycine 0 N--CA 1.444 -0.8 0 C-N-CA 120.835 -0.698 . . . . 1.96 112.162 -178.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 33.3 p -97.82 171.02 8.57 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 110.031 -0.359 . . . . 2.28 110.031 177.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -111.21 -15.77 10.28 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.846 -0.693 . . . . 1.79 112.103 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.496 ' C ' HD11 ' A' ' 59' ' ' LEU . 2.1 pp -90.49 -178.16 5.25 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.788 -0.449 . . . . 1.82 109.788 178.255 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 94.6 mt-30 -143.08 120.66 11.76 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 118.365 0.53 . . . . 3.26 110.231 -167.493 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.441 HG23 HD13 ' A' ' 14' ' ' LEU . 21.6 t -97.38 128.25 48.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 N-CA-C 109.027 -0.731 . . . . 2.17 109.027 175.907 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 25.0 pttm -146.85 154.16 47.04 Favored Pre-proline 0 C--N 1.329 -0.312 0 C-N-CA 120.5 -0.48 . . . . 2.29 111.299 -178.777 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . 0.569 ' HA ' ' HA ' ' A' ' 69' ' ' TRP . 42.9 Cg_exo -58.57 133.7 56.14 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.984 2.456 . . . . 0.94 111.864 173.467 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 54.4 tp -67.62 -29.15 68.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.473 -0.785 . . . . 2.32 111.141 -175.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 166.44 -56.26 0.24 Allowed Glycine 0 N--CA 1.45 -0.427 0 N-CA-C 110.972 -0.851 . . . . 1.69 110.972 179.396 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 13.5 m120 -83.93 -164.48 0.93 Allowed 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 108.438 -0.949 . . . . 3.67 108.438 172.815 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 9.0 t30 -78.61 58.99 2.36 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.814 0.816 . . . . 2.59 109.904 177.291 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' SER . . . . . 0.462 ' O ' ' HA ' ' A' ' 63' ' ' PRO . 30.9 m -147.89 174.68 11.62 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 107.725 -1.213 . . . . 1.54 107.725 176.259 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' TRP . . . . . 0.569 ' HA ' ' HA ' ' A' ' 63' ' ' PRO . 53.7 m0 -137.8 166.5 23.84 Favored 'General case' 0 C--N 1.322 -0.603 0 C-N-CA 120.323 -0.551 . . . . 0.54 110.601 -165.32 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.656 ' HA ' ' HB2' ' A' ' 26' ' ' SER . 12.3 t -146.81 150.2 34.82 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.108 -0.496 . . . . 1.49 109.76 173.424 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 54.9 tp -92.95 104.82 17.02 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-O 121.813 0.816 . . . . 2.24 110.491 179.198 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 22.0 tt0 -91.3 118.89 68.74 Favored Pre-proline 0 C--N 1.316 -0.888 0 CA-C-N 114.185 -1.371 . . . . 2.25 111.526 179.482 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -84.65 115.18 1.8 Allowed 'Trans proline' 0 N--CA 1.452 -0.942 0 C-N-CA 122.874 2.383 . . . . 1.45 111.658 174.792 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.324 -0.504 0 CA-C-N 115.742 -0.663 . . . . 2.07 109.308 177.011 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 . . . . . 0 N--CA 1.455 -0.192 0 CA-C-O 121.128 0.49 . . . . 4.51 110.742 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . 0.437 HG23 ' HB2' ' A' ' 44' ' ' TYR . 62.8 t -127.42 136.3 60.93 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 115.433 -0.803 . . . . 2.2 109.349 179.617 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 17.7 m120 -127.96 97.86 4.94 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.453 -0.573 . . . . 2.75 109.453 -174.625 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.604 HG13 HD22 ' A' ' 53' ' ' LEU . 43.0 mm -122.93 155.91 28.48 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 N-CA-C 109.33 -0.619 . . . . 1.5 109.33 -178.515 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . 0.637 ' HB1' ' HD2' ' A' ' 7' ' ' PRO . . . -162.43 163.41 18.34 Favored Pre-proline 0 C--N 1.325 -0.492 0 N-CA-C 109.27 -0.641 . . . . 1.99 109.27 -176.781 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.637 ' HD2' ' HB1' ' A' ' 6' ' ' ALA . 9.4 Cg_endo -51.96 130.56 35.11 Favored 'Trans proline' 0 C--N 1.35 0.649 0 C-N-CA 122.831 2.354 . . . . 1.73 112.755 -175.33 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 163.15 42.81 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.408 0 CA-C-N 115.67 -0.695 . . . . 1.84 112.441 -178.111 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.76 ' HA ' ' HA ' ' A' ' 36' ' ' GLN . 65.1 m 66.44 131.49 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 121.496 0.665 . . . . 1.87 111.691 -178.706 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 64.1 tp -60.02 -35.4 74.99 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 115.924 -0.58 . . . . 1.83 111.031 -178.493 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.408 ' HB2' ' HB ' ' A' ' 32' ' ' THR . 33.8 t70 -50.6 -54.12 25.24 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 115.583 -0.735 . . . . 2.11 111.589 177.372 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 85.3 tttt -66.78 -32.01 73.02 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.693 -0.23 . . . . 3.11 110.755 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -63.29 -53.36 54.01 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.932 0.396 . . . . 1.17 110.548 -176.206 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 88.6 mt -58.98 -39.51 81.99 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 115.988 -0.551 . . . . 1.31 111.021 176.517 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 52.4 t30 -60.86 -39.7 90.13 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.209 -0.45 . . . . 1.98 110.703 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 -58.85 -51.11 71.42 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.044 -0.525 . . . . 2.33 111.421 177.843 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.474 ' CD1' ' HH2' ' A' ' 69' ' ' TRP . 32.4 t80 -67.26 -38.43 85.1 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.038 -0.727 . . . . 1.05 109.038 -175.739 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.84 ' HA ' ' CE2' ' A' ' 23' ' ' PHE . . . -55.7 -49.99 71.52 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 115.532 -0.758 . . . . 1.15 111.955 174.913 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.94 -23.64 67.42 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.211 -0.449 . . . . 1.26 111.588 -178.319 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 75.0 t60 -61.71 -48.06 82.45 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.027 -0.533 . . . . 2.52 111.498 -176.346 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.573 ' HB3' ' CD1' ' A' ' 23' ' ' PHE . 38.9 t -102.37 -4.5 25.44 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.882 0.372 . . . . 1.79 111.114 -179.691 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 68.3 47.02 60.72 Favored Glycine 0 CA--C 1.518 0.23 0 CA-C-N 115.702 -0.681 . . . . 0.68 113.622 177.864 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.84 ' CE2' ' HA ' ' A' ' 18' ' ' ALA . 10.3 p90 -106.65 159.66 16.04 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 122.538 -0.39 . . . . 0.68 110.294 176.9 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 22.4 m -88.28 119.5 28.75 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.943 -0.571 . . . . 1.3 111.91 -173.443 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.629 HD22 ' CE3' ' A' ' 69' ' ' TRP . 0.8 OUTLIER -94.8 143.88 26.1 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.636 -0.711 . . . . 2.3 111.278 178.351 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 36.2 t -115.53 92.15 3.83 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.114 -0.698 . . . . 1.67 109.114 173.035 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 6.9 p -148.64 125.54 2.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 115.903 -0.59 . . . . 1.52 110.0 -178.605 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -88.37 134.76 33.74 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 120.831 -0.347 . . . . 2.38 110.634 -177.776 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.7 70.67 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.255 0 O-C-N 124.043 0.839 . . . . 2.45 112.095 176.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 79.4 p -168.64 -42.96 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.478 -0.564 . . . . 2.48 109.478 178.662 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.404 ' O ' ' HD3' ' A' ' 35' ' ' LYS . 80.7 mt -66.97 -45.41 77.8 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.655 -0.702 . . . . 1.92 110.029 177.142 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.408 ' HB ' ' HB2' ' A' ' 11' ' ' ASP . 1.3 p -91.4 -3.32 56.81 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.489 -0.778 . . . . 1.82 111.592 -178.91 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 55.4 ttp180 -86.62 129.58 34.81 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.174 -0.466 . . . . 5.19 110.586 -178.003 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 107.35 -20.44 32.65 Favored Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 120.703 -0.76 . . . . 1.62 112.353 177.191 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.57 ' HD2' ' N ' ' A' ' 35' ' ' LYS . 0.0 OUTLIER -115.53 136.73 52.78 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-O 121.434 0.635 . . . . 3.17 111.664 -177.873 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . 0.76 ' HA ' ' HA ' ' A' ' 9' ' ' SER . 18.4 pt20 -103.34 156.15 17.95 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.343 -0.844 . . . . 2.52 111.397 -177.49 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 31.2 t -117.92 119.61 35.35 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 106.28 -1.748 . . . . 1.14 106.28 171.317 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.552 ' O ' ' HD3' ' A' ' 7' ' ' PRO . 21.9 m-80 -72.27 -6.77 45.42 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 113.131 0.789 . . . . 1.28 113.131 -167.607 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 127.7 175.62 14.16 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.052 -1.071 . . . . 0.49 113.357 165.756 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.456 ' HB3' ' HB ' ' A' ' 5' ' ' ILE . 67.3 tp -160.13 129.24 5.04 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 109.139 -0.689 . . . . 1.36 109.139 -177.962 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 44.5 m80 -138.15 96.7 3.24 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.171 0.51 . . . . 3.8 110.543 176.123 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -168.87 -169.42 32.25 Favored Glycine 0 N--CA 1.446 -0.693 0 CA-C-N 115.776 -0.647 . . . . 0.55 111.899 176.083 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -98.12 111.47 23.78 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 108.783 -0.821 . . . . 2.18 108.783 173.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.437 ' HB2' HG23 ' A' ' 3' ' ' VAL . 44.7 m-85 -133.54 134.29 43.2 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.289 0.566 . . . . 1.5 112.362 -170.15 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 47.3 t0 -85.9 170.3 12.48 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 108.477 -0.935 . . . . 2.23 108.477 172.617 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 48.7 t -46.85 -70.04 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 N-CA-C 112.574 0.583 . . . . 1.25 112.574 -172.364 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -57.89 -34.25 69.6 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 112.507 0.558 . . . . 2.39 112.507 -177.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 7.2 m -72.14 -39.92 68.45 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-O 121.203 0.525 . . . . 1.65 110.845 -174.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.495 ' O ' ' HG ' ' A' ' 53' ' ' LEU . . . -74.31 -41.76 36.96 Favored Glycine 0 N--CA 1.446 -0.636 0 CA-C-N 115.599 -0.728 . . . . 0.4 111.448 -174.942 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.525 ' O ' ' HG ' ' A' ' 54' ' ' LEU . 90.4 mt -62.29 -38.38 89.14 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.763 0.316 . . . . 1.63 110.831 -179.775 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 6.3 tp60 -57.12 -48.83 77.68 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 115.865 -0.607 . . . . 3.01 111.246 179.862 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.405 ' HG2' HD12 ' A' ' 40' ' ' LEU . 50.4 tp60 -69.0 -38.59 79.35 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.625 -0.261 . . . . 2.18 110.957 -179.146 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.604 HD22 HG13 ' A' ' 5' ' ' ILE . 82.4 mt -56.84 -29.35 62.76 Favored 'General case' 0 N--CA 1.464 0.254 0 N-CA-C 112.014 0.375 . . . . 1.4 112.014 179.369 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.525 ' HG ' ' O ' ' A' ' 50' ' ' LEU . 92.6 mt -78.35 -6.89 56.47 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.219 -0.446 . . . . 2.78 111.893 -176.449 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -66.35 119.07 10.93 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.04 0.447 . . . . 2.24 110.509 -177.161 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 111.98 -24.72 14.09 Favored Glycine 0 N--CA 1.446 -0.682 0 CA-C-N 115.757 -0.656 . . . . 1.96 111.635 -176.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 78.6 p -109.0 169.2 8.83 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.664 0.269 . . . . 2.28 110.302 -179.858 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -114.14 49.52 0.84 Allowed Glycine 0 N--CA 1.443 -0.841 0 N-CA-C 111.161 -0.776 . . . . 1.79 111.161 179.39 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 91.5 mt -124.34 174.96 7.39 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 120.694 0.283 . . . . 1.82 110.398 -178.602 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 8.5 tp-100 -148.86 118.48 7.0 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.264 -0.643 . . . . 3.26 109.264 176.604 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 3.8 p -94.65 123.04 46.61 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 N-CA-C 109.393 -0.595 . . . . 2.17 109.393 177.777 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.457 ' HA ' ' HD3' ' A' ' 63' ' ' PRO . 20.2 ptmt -122.64 134.08 24.77 Favored Pre-proline 0 C--N 1.32 -0.702 0 CA-C-O 120.84 0.352 . . . . 2.29 110.84 -172.73 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . 0.457 ' HD3' ' HA ' ' A' ' 62' ' ' LYS . 37.9 Cg_exo -62.26 129.0 25.44 Favored 'Trans proline' 0 N--CA 1.462 -0.338 0 C-N-CA 122.92 2.413 . . . . 0.94 111.64 176.36 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -68.32 -48.11 65.75 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.244 -0.889 . . . . 2.32 109.802 -177.41 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -175.37 -71.91 0.05 OUTLIER Glycine 0 N--CA 1.445 -0.756 0 C-N-CA 120.687 -0.768 . . . . 1.69 112.074 177.778 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -89.63 -77.9 0.38 Allowed 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.891 0.377 . . . . 3.67 111.098 -176.78 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . 0.455 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 27.2 p-10 -138.31 39.72 2.27 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.402 0.62 . . . . 2.59 111.001 -175.528 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' SER . . . . . 0.4 ' O ' ' HD1' ' A' ' 69' ' ' TRP . 35.2 t -138.65 166.51 24.17 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 108.124 -1.065 . . . . 1.54 108.124 177.287 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' TRP . . . . . 0.629 ' CE3' HD22 ' A' ' 25' ' ' LEU . 24.4 m0 -141.68 165.52 27.25 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 107.865 -1.161 . . . . 0.54 107.865 -174.508 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 12.7 t -145.02 150.06 36.22 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 109.432 -0.581 . . . . 1.49 109.432 172.383 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -93.37 102.68 14.93 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.318 0.58 . . . . 2.24 110.335 -176.446 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -97.04 123.49 53.07 Favored Pre-proline 0 C--N 1.321 -0.663 0 CA-C-N 115.197 -0.911 . . . . 2.25 110.294 173.757 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_exo -62.64 114.78 2.54 Favored 'Trans proline' 0 N--CA 1.461 -0.392 0 C-N-CA 122.403 2.069 . . . . 1.45 111.72 178.307 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.321 -0.646 0 N-CA-C 109.326 -0.62 . . . . 2.07 109.326 179.108 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 . . . . . 0 CA--C 1.522 -0.107 0 CA-C-O 120.853 0.359 . . . . 4.51 110.469 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 31.5 m -139.99 152.68 22.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.95 -0.568 . . . . 2.2 110.282 -178.479 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 19.1 p-10 -127.97 97.09 4.68 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.588 0.708 . . . . 2.75 109.374 176.095 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 66.1 mt -134.03 118.09 27.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.723 -0.671 . . . . 1.5 110.004 -177.293 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -81.17 170.79 14.1 Favored Pre-proline 0 C--N 1.323 -0.574 0 CA-C-N 115.562 -0.744 . . . . 1.99 109.431 -179.644 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -54.96 141.23 78.98 Favored 'Trans proline' 0 N--CA 1.458 -0.6 0 C-N-CA 121.374 1.382 . . . . 1.73 109.843 167.23 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.432 ' O ' ' HB2' ' A' ' 36' ' ' GLN . . . 173.68 -135.8 3.37 Favored Glycine 0 N--CA 1.446 -0.68 0 N-CA-C 110.575 -1.01 . . . . 1.84 110.575 -169.312 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.828 ' HA ' ' HA ' ' A' ' 36' ' ' GLN . 23.7 m -125.25 155.9 39.38 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 117.427 0.614 . . . . 1.87 110.407 178.097 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.604 HD23 ' HB2' ' A' ' 37' ' ' SER . 3.9 mm? -56.3 -39.3 72.5 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 118.074 0.397 . . . . 1.83 111.093 179.231 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -47.08 -56.09 7.16 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 115.27 -0.877 . . . . 2.11 111.822 178.561 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 3.3 tppp? -66.06 -31.14 71.84 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.796 -0.183 . . . . 3.11 111.171 -178.752 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -66.26 -57.86 6.62 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.054 0.454 . . . . 1.17 110.597 -177.278 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 95.4 mt -59.69 -39.17 83.63 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 115.871 -0.604 . . . . 1.31 111.315 177.243 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -57.38 -41.46 80.25 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.27 0.557 . . . . 1.98 110.038 177.031 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -63.46 -48.25 78.45 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.337 -0.847 . . . . 2.33 110.678 179.258 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -70.35 -37.82 74.7 Favored 'General case' 0 N--CA 1.456 -0.148 0 C-N-CA 120.894 -0.322 . . . . 1.05 111.27 -172.183 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.579 ' HA ' ' CZ ' ' A' ' 23' ' ' PHE . . . -47.91 -44.74 30.07 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-O 120.777 0.323 . . . . 1.15 111.652 176.478 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.59 -21.24 66.25 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.736 -0.666 . . . . 1.26 112.358 179.355 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 3.9 t-160 -58.96 -61.53 2.57 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 120.667 0.27 . . . . 2.52 111.45 -175.647 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.627 ' HB3' ' HD1' ' A' ' 23' ' ' PHE . 8.2 t -100.78 -9.07 22.08 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.916 0.389 . . . . 1.79 111.287 -177.764 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 73.33 56.54 5.57 Favored Glycine 0 C--N 1.331 0.284 0 C-N-CA 121.124 -0.56 . . . . 0.68 112.49 -179.714 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.627 ' HD1' ' HB3' ' A' ' 21' ' ' SER . 17.4 p90 -116.68 172.73 7.04 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.737 0.303 . . . . 0.68 110.935 -177.617 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.606 ' O ' ' HB3' ' A' ' 68' ' ' SER . 27.3 m -94.49 111.0 22.74 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-O 121.345 0.593 . . . . 1.3 111.088 -179.247 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 3.2 tt -93.72 117.77 30.53 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.216 -0.661 . . . . 2.3 109.216 177.752 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 73.5 m -104.65 103.13 12.72 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.97 -0.559 . . . . 1.67 111.341 -174.062 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.475 ' CG2' HD11 ' A' ' 71' ' ' LEU . 4.2 p -138.84 129.65 34.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 115.842 -0.617 . . . . 1.52 110.668 178.254 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -72.57 121.76 20.23 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.727 -0.67 . . . . 2.38 110.307 176.153 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.31 77.27 0.01 OUTLIER 'General case' 0 C--O 1.236 0.35 0 CA-C-N 115.778 -0.646 . . . . 2.45 111.984 177.693 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 30.6 t -175.47 -31.41 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.723 -0.671 . . . . 2.48 109.513 178.317 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 80.1 mt -63.11 -53.01 60.24 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.639 -0.71 . . . . 1.92 110.636 179.316 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 3.0 p -92.39 58.28 3.17 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.773 -0.649 . . . . 1.82 110.831 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 16.6 ptp180 -71.26 105.72 3.57 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 115.742 -0.663 . . . . 5.19 109.758 176.353 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 68.24 -93.25 0.28 Allowed Glycine 0 N--CA 1.45 -0.397 0 N-CA-C 110.633 -0.987 . . . . 1.62 110.633 -170.363 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.557 ' HG3' HD22 ' A' ' 10' ' ' LEU . 40.7 tptt 50.82 94.3 0.02 OUTLIER 'General case' 0 C--O 1.236 0.355 0 C-N-CA 123.779 0.831 . . . . 3.17 111.974 171.288 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . 0.828 ' HA ' ' HA ' ' A' ' 9' ' ' SER . 2.8 pt20 -101.37 153.81 19.34 Favored 'General case' 0 N--CA 1.447 -0.58 0 O-C-N 121.994 -0.441 . . . . 2.52 110.474 -174.804 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.604 ' HB2' HD23 ' A' ' 10' ' ' LEU . 32.8 t -128.08 138.66 52.63 Favored 'General case' 0 N--CA 1.446 -0.673 0 N-CA-C 108.469 -0.937 . . . . 1.14 108.469 -179.778 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.507 ' N ' HD21 ' A' ' 38' ' ' ASN . 0.9 OUTLIER -64.85 -8.96 17.39 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.997 -0.547 . . . . 1.28 112.143 -179.213 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 118.6 -177.39 16.43 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.868 -0.682 . . . . 0.49 112.634 171.554 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.405 HD13 ' HG2' ' A' ' 52' ' ' GLN . 63.3 tp -159.62 109.52 1.88 Allowed 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 108.605 -0.887 . . . . 1.36 108.605 -179.432 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 12.7 p80 -144.7 98.23 3.15 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 122.018 0.913 . . . . 3.8 111.332 -178.633 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -170.03 -169.82 33.68 Favored Glycine 0 N--CA 1.443 -0.888 0 CA-C-N 114.356 -1.293 . . . . 0.55 111.043 176.689 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 32.1 m-20 -82.43 75.36 9.34 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.116 -0.698 . . . . 2.18 109.116 173.36 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 79.8 m-85 -110.08 123.12 49.14 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.564 -0.744 . . . . 1.5 110.798 -178.144 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.401 ' CG ' ' H ' ' A' ' 46' ' ' VAL . 7.7 t70 -89.27 -163.1 0.94 Allowed 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 108.878 -0.786 . . . . 2.23 108.878 173.23 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.504 ' O ' ' HG ' ' A' ' 50' ' ' LEU . 37.5 t -53.09 -71.81 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 N-CA-C 112.751 0.648 . . . . 1.25 112.751 -172.367 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -61.83 -42.44 99.03 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 112.944 0.72 . . . . 2.39 112.944 -171.54 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 28.6 m -68.89 -29.99 68.39 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.158 0.504 . . . . 1.65 111.01 -173.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -80.07 -29.83 44.72 Favored Glycine 0 N--CA 1.445 -0.711 0 N-CA-C 110.9 -0.88 . . . . 0.4 110.9 -178.481 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.62 ' HB3' HG13 ' A' ' 61' ' ' VAL . 82.6 mt -74.73 -45.51 43.61 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 115.459 -0.371 . . . . 1.63 110.385 -179.369 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 24.2 tp60 -55.63 -41.46 73.56 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.97 -0.559 . . . . 3.01 111.27 178.413 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.915 ' HA ' HE21 ' A' ' 52' ' ' GLN . 0.0 OUTLIER -63.81 -48.36 77.16 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.613 -0.267 . . . . 2.18 111.028 -179.973 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 93.1 mt -58.71 -23.99 60.64 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 112.366 0.506 . . . . 1.4 112.366 -179.603 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.618 HD12 HG12 ' A' ' 61' ' ' VAL . 68.8 mt -78.31 -19.65 53.13 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 112.23 0.456 . . . . 2.78 112.23 -177.174 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -65.48 101.32 0.58 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.204 0.526 . . . . 2.24 110.802 -176.475 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 124.1 -3.7 9.05 Favored Glycine 0 N--CA 1.449 -0.482 0 CA-C-N 115.604 -0.726 . . . . 1.96 111.844 -177.345 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 6.9 m -118.09 170.69 8.65 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.758 0.313 . . . . 2.28 110.397 179.145 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -115.2 24.29 10.74 Favored Glycine 0 N--CA 1.442 -0.901 0 N-CA-C 110.44 -1.064 . . . . 1.79 110.44 172.64 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 85.6 mt -101.57 175.23 5.64 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 120.822 0.344 . . . . 1.82 110.108 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 72.1 mt-30 -133.84 118.32 17.85 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 109.334 -0.617 . . . . 3.26 109.334 174.411 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.62 HG13 ' HB3' ' A' ' 50' ' ' LEU . 6.1 p -86.44 113.42 24.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 N-CA-C 108.781 -0.822 . . . . 2.17 108.781 174.35 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 40.0 ttpt -136.22 130.57 18.34 Favored Pre-proline 0 C--N 1.314 -0.94 0 CA-C-N 115.642 -0.708 . . . . 2.29 110.213 -169.813 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . 0.531 ' HA ' ' HA ' ' A' ' 69' ' ' TRP . 51.4 Cg_exo -55.0 130.64 41.87 Favored 'Trans proline' 0 N--CA 1.461 -0.402 0 C-N-CA 122.318 2.012 . . . . 0.94 111.027 175.638 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.441 ' O ' HD12 ' A' ' 64' ' ' LEU . 2.8 tm? -62.64 -34.74 77.66 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.816 -0.629 . . . . 2.32 109.739 -176.545 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 177.07 -59.01 0.1 OUTLIER Glycine 0 N--CA 1.444 -0.824 0 N-CA-C 110.935 -0.866 . . . . 1.69 110.935 177.164 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 21.0 m-80 -140.17 126.74 20.3 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.599 -0.3 . . . . 3.67 110.703 178.003 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 47.8 t30 75.25 -36.87 0.32 Allowed 'General case' 0 N--CA 1.475 0.781 0 O-C-N 124.096 0.872 . . . . 2.59 112.881 173.556 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' SER . . . . . 0.606 ' HB3' ' O ' ' A' ' 24' ' ' THR . 69.0 m -114.17 178.61 4.22 Favored 'General case' 0 C--N 1.321 -0.638 0 O-C-N 122.231 -0.293 . . . . 1.54 110.396 -168.072 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' TRP . . . . . 0.531 ' HA ' ' HA ' ' A' ' 63' ' ' PRO . 40.0 m0 -139.16 167.81 21.24 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 120.825 0.345 . . . . 0.54 110.125 -169.224 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 14.3 t -149.95 150.56 32.02 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.348 -0.612 . . . . 1.49 109.348 169.082 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.518 HD22 ' HA ' ' A' ' 61' ' ' VAL . 25.9 mt -92.79 102.89 15.28 Favored 'General case' 0 CA--C 1.517 -0.317 0 C-N-CA 120.285 -0.566 . . . . 2.24 110.056 174.644 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.406 ' HA ' ' HD3' ' A' ' 73' ' ' PRO . 42.7 tt0 -87.36 119.48 70.85 Favored Pre-proline 0 C--N 1.317 -0.807 0 CA-C-N 115.098 -0.956 . . . . 2.25 110.528 177.493 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 72' ' ' GLU . 6.3 Cg_exo -75.25 114.07 3.92 Favored 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 122.341 2.027 . . . . 1.45 111.187 177.109 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.32 -0.698 0 N-CA-C 108.681 -0.859 . . . . 2.07 108.681 -179.771 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . 0.758 ' HA ' HE21 ' A' ' 2' ' ' GLN . 0.0 OUTLIER . . . . . 0 CA--C 1.513 -0.443 0 CA-C-O 121.523 0.678 . . . . 4.51 111.893 . . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 17.3 m -115.67 131.78 67.05 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 CA-C-N 114.64 -1.164 . . . . 2.2 111.46 -175.211 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 50.5 m-80 -130.74 97.58 4.39 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 108.386 -0.968 . . . . 2.75 108.386 174.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 56.6 mt -121.35 132.45 70.62 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-N 115.989 -0.55 . . . . 1.5 111.322 -170.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -75.01 157.73 85.12 Favored Pre-proline 0 C--N 1.326 -0.427 0 CA-C-N 115.68 -0.691 . . . . 1.99 109.872 177.781 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.441 ' HA ' ' O ' ' A' ' 37' ' ' SER . 11.6 Cg_exo -72.12 54.91 2.3 Favored 'Trans proline' 0 CA--C 1.533 0.46 0 C-N-CA 123.003 2.468 . . . . 1.73 112.835 179.031 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -125.05 -161.54 11.08 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.771 -0.728 . . . . 1.84 113.177 -178.083 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 18.7 m -47.01 125.88 8.19 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 123.566 0.746 . . . . 1.87 112.322 -177.227 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 68.0 tp -60.94 -29.54 69.69 Favored 'General case' 0 CA--C 1.522 -0.102 0 CA-C-N 115.412 -0.813 . . . . 1.83 110.756 -179.416 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.438 ' CA ' ' HB ' ' A' ' 32' ' ' THR . 22.9 t70 -51.43 -52.21 48.16 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.703 -0.68 . . . . 2.11 111.232 176.643 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 21.9 tptm -69.88 -25.54 63.76 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.497 -0.32 . . . . 3.11 110.616 -179.339 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.624 ' O ' ' HG3' ' A' ' 16' ' ' GLN . . . -65.12 -54.64 26.76 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.179 0.514 . . . . 1.17 109.943 179.017 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.658 ' HB3' HD11 ' A' ' 25' ' ' LEU . 95.9 mt -59.9 -35.73 75.48 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.834 -0.621 . . . . 1.31 110.397 174.155 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 24.1 t-20 -59.09 -47.22 86.07 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.554 -0.748 . . . . 1.98 110.992 -179.463 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . 0.624 ' HG3' ' O ' ' A' ' 13' ' ' ALA . 0.3 OUTLIER -65.43 -32.72 74.49 Favored 'General case' 0 C--O 1.232 0.176 0 C-N-CA 120.947 -0.301 . . . . 2.33 111.103 -177.587 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.465 ' N ' HE21 ' A' ' 16' ' ' GLN . 5.2 t80 -71.71 -42.82 66.91 Favored 'General case' 0 CA--C 1.527 0.071 0 N-CA-C 109.475 -0.565 . . . . 1.05 109.475 178.128 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.725 ' HA ' ' CZ ' ' A' ' 23' ' ' PHE . . . -53.68 -46.28 70.59 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 115.993 -0.548 . . . . 1.15 111.614 177.966 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.29 -21.88 66.52 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.185 -0.461 . . . . 1.26 111.708 -179.855 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 83.2 t60 -66.07 -52.5 48.3 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.717 -0.22 . . . . 2.52 111.321 -178.537 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.606 ' HB3' ' HD1' ' A' ' 23' ' ' PHE . 31.9 t -100.04 -17.56 17.43 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.064 0.459 . . . . 1.79 111.525 -175.399 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 75.77 48.28 10.5 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.945 -0.645 . . . . 0.68 112.912 -178.273 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.725 ' CZ ' ' HA ' ' A' ' 18' ' ' ALA . 25.3 p90 -107.83 166.14 10.92 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 110.082 -0.34 . . . . 0.68 110.082 -179.943 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.505 ' O ' ' HB3' ' A' ' 68' ' ' SER . 40.3 m -91.32 109.12 20.39 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.274 0.559 . . . . 1.3 111.234 -179.275 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.658 HD11 ' HB3' ' A' ' 14' ' ' LEU . 2.0 tt -92.33 122.83 35.17 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.153 -0.684 . . . . 2.3 109.153 177.248 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 25.5 t -100.83 98.4 8.91 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 120.793 0.33 . . . . 1.67 110.442 -175.288 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 8.2 p -149.14 141.89 18.0 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 CA-C-N 115.944 -0.571 . . . . 1.52 110.878 179.598 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -90.97 138.2 31.78 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.327 -0.397 . . . . 2.38 110.29 174.414 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.37 76.63 0.02 OUTLIER 'General case' 0 C--O 1.235 0.309 0 CA-C-N 116.025 -0.534 . . . . 2.45 111.939 176.757 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 22.3 p -166.84 -52.21 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.356 -0.383 . . . . 2.48 110.342 -179.139 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 84.6 mt -66.51 -44.79 81.56 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.162 -0.472 . . . . 1.92 110.649 179.188 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.438 ' HB ' ' CA ' ' A' ' 11' ' ' ASP . 4.0 p -91.83 -5.66 53.01 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.894 -0.594 . . . . 1.82 111.198 179.744 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' ARG . . . . . 0.406 ' C ' ' H ' ' A' ' 35' ' ' LYS . 28.0 ttp180 -82.49 129.38 34.9 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.609 -0.723 . . . . 5.19 110.568 -177.417 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 80.47 -29.97 2.53 Favored Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 121.172 -0.537 . . . . 1.62 112.2 178.202 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.5 ' HD3' ' C ' ' A' ' 35' ' ' LYS . 11.0 tmtt? -71.66 117.97 13.9 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 109.028 -0.73 . . . . 3.17 109.028 177.133 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -102.15 149.77 23.94 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.083 0.468 . . . . 2.52 110.466 -178.071 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.441 ' O ' ' HA ' ' A' ' 7' ' ' PRO . 0.4 OUTLIER -123.31 134.74 54.03 Favored 'General case' 0 N--CA 1.431 -1.408 0 N-CA-C 107.731 -1.211 . . . . 1.14 107.731 176.117 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . 0.419 ' HA ' ' HB3' ' A' ' 7' ' ' PRO . 0.9 OUTLIER -61.86 -2.0 0.77 Allowed 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 113.152 0.797 . . . . 1.28 113.152 -176.707 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 101.62 -171.55 22.09 Favored Glycine 0 CA--C 1.501 -0.807 0 C-N-CA 120.859 -0.686 . . . . 0.49 111.976 171.16 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 48.9 tp -161.4 134.74 6.45 Favored 'General case' 0 N--CA 1.444 -0.752 0 N-CA-C 107.443 -1.317 . . . . 1.36 107.443 -178.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 57.9 m80 -136.32 96.54 3.39 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.145 0.498 . . . . 3.8 110.658 178.554 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -170.49 176.13 44.15 Favored Glycine 0 N--CA 1.444 -0.81 0 CA-C-N 115.451 -0.795 . . . . 0.55 112.077 177.183 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.639 ' HA ' ' H ' ' A' ' 2' ' ' GLN . 5.3 p-10 -93.75 76.23 4.28 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.849 0.833 . . . . 2.18 108.875 170.988 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' TYR . . . . . 0.465 ' O ' ' HG2' ' A' ' 2' ' ' GLN . 38.8 m-85 -94.85 149.51 21.17 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.462 -0.79 . . . . 1.5 111.997 -173.214 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -85.49 179.12 7.2 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.467 -0.788 . . . . 2.23 109.347 173.693 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.478 ' O ' ' HG ' ' A' ' 50' ' ' LEU . 58.4 t -54.58 -71.99 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 N-CA-C 112.139 0.422 . . . . 1.25 112.139 -176.53 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -58.54 -41.71 86.16 Favored 'General case' 0 C--O 1.233 0.229 0 N-CA-C 112.568 0.581 . . . . 2.39 112.568 -175.431 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 1.3 p -71.38 -32.02 67.97 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.086 0.47 . . . . 1.65 111.004 -175.606 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.598 ' O ' ' HG ' ' A' ' 53' ' ' LEU . . . -73.84 -36.18 53.16 Favored Glycine 0 N--CA 1.442 -0.918 0 N-CA-C 111.089 -0.804 . . . . 0.4 111.089 179.673 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.483 HD21 HD13 ' A' ' 53' ' ' LEU . 91.2 mt -67.35 -40.62 85.87 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.617 -0.292 . . . . 1.63 110.479 -179.833 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 -55.18 -45.44 75.77 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.043 -0.526 . . . . 3.01 111.015 178.652 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 15.9 mm100 -68.52 -36.18 78.51 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.586 -0.279 . . . . 2.18 111.174 178.591 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.598 ' HG ' ' O ' ' A' ' 49' ' ' GLY . 80.1 mt -59.12 -21.03 58.66 Favored 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 112.033 0.382 . . . . 1.4 112.033 178.259 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 7.3 mp -75.95 15.93 0.48 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.904 0.383 . . . . 2.78 111.39 177.754 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . 0.422 ' H ' ' C ' ' A' ' 53' ' ' LEU . 21.8 t70 -56.71 111.51 1.03 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.722 -0.672 . . . . 2.24 111.138 176.486 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 65.27 23.64 70.08 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 121.067 -0.587 . . . . 1.96 112.543 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 50.9 m -99.86 148.63 24.24 Favored 'General case' 0 C--N 1.323 -0.579 0 O-C-N 122.545 -0.385 . . . . 2.28 110.735 179.642 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -111.66 28.32 9.6 Favored Glycine 0 N--CA 1.441 -0.988 0 N-CA-C 109.679 -1.369 . . . . 1.79 109.679 168.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.514 HD11 HD13 ' A' ' 71' ' ' LEU . 59.6 mt -121.82 179.8 4.37 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.122 -0.696 . . . . 1.82 109.122 -179.62 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 27.4 tt0 -151.23 121.48 7.26 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.699 -0.482 . . . . 3.26 109.699 178.245 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.423 HG13 HD22 ' A' ' 50' ' ' LEU . 7.3 p -93.51 137.11 23.38 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 N-CA-C 109.708 -0.479 . . . . 2.17 109.708 179.649 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.593 ' HZ2' ' HG3' ' A' ' 72' ' ' GLU . 15.6 mtmm -130.19 135.51 27.57 Favored Pre-proline 0 C--N 1.327 -0.396 0 C-N-CA 121.065 -0.254 . . . . 2.29 110.409 -179.218 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_exo -63.0 121.79 9.8 Favored 'Trans proline' 0 N--CA 1.458 -0.604 0 C-N-CA 122.407 2.071 . . . . 0.94 110.341 169.568 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 44.8 tp -62.57 -40.46 96.93 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.414 -0.812 . . . . 2.32 111.102 -174.149 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 134.49 -22.16 3.74 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.855 -0.688 . . . . 1.69 111.8 177.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 27.8 p-10 -106.95 41.65 1.43 Allowed 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.807 0.337 . . . . 3.67 110.582 -179.214 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 66.2 t30 56.33 36.06 26.88 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 121.684 0.754 . . . . 2.59 110.428 -177.024 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' SER . . . . . 0.505 ' HB3' ' O ' ' A' ' 24' ' ' THR . 68.5 m -141.55 177.88 7.84 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 107.857 -1.164 . . . . 1.54 107.857 176.104 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' TRP . . . . . 0.449 ' CH2' HD23 ' A' ' 50' ' ' LEU . 54.5 m0 -136.27 167.14 21.86 Favored 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 120.521 -0.472 . . . . 0.54 111.12 -167.154 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 3.8 t -145.46 142.42 29.26 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.402 -0.817 . . . . 1.49 109.722 174.831 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.514 HD13 HD11 ' A' ' 59' ' ' LEU . 0.7 OUTLIER -92.85 104.01 16.3 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.36 -0.607 . . . . 2.24 109.36 179.773 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.593 ' HG3' ' HZ2' ' A' ' 62' ' ' LYS . 4.5 mm-40 -88.28 120.63 70.55 Favored Pre-proline 0 C--N 1.319 -0.727 0 CA-C-N 115.009 -0.996 . . . . 2.25 110.968 -178.389 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.46 ' HD3' ' HA ' ' A' ' 72' ' ' GLU . 4.9 Cg_endo -86.97 115.03 1.15 Allowed 'Trans proline' 0 N--CA 1.453 -0.873 0 C-N-CA 123.005 2.47 . . . . 1.45 111.685 177.463 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.327 -0.382 0 CA-C-N 115.792 -0.64 . . . . 2.07 109.736 -179.928 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.195 0 CA-C-O 121.32 0.581 . . . . 4.29 110.862 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 11.7 pt20 -146.38 135.68 22.82 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.597 -0.728 . . . . 4.51 109.438 175.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.424 HG11 HG13 ' A' ' 5' ' ' ILE . 48.0 t -139.88 141.18 34.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.528 -0.305 . . . . 2.2 110.919 -174.879 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -129.35 110.49 11.97 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.313 0.578 . . . . 2.75 109.67 177.415 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.424 HG13 HG11 ' A' ' 3' ' ' VAL . 58.2 mt -137.33 156.79 33.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 N-CA-C 109.413 -0.588 . . . . 1.5 109.413 -178.129 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.629 ' HB1' ' HD2' ' A' ' 7' ' ' PRO . . . -161.69 163.45 19.54 Favored Pre-proline 0 C--N 1.324 -0.507 0 N-CA-C 109.796 -0.446 . . . . 1.99 109.796 -174.578 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.629 ' HD2' ' HB1' ' A' ' 6' ' ' ALA . 6.1 Cg_exo -38.4 135.63 0.68 Allowed 'Trans proline' 0 C--N 1.352 0.735 0 C-N-CA 124.317 3.345 . . . . 1.73 114.151 -176.623 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.439 ' O ' ' HB2' ' A' ' 9' ' ' SER . . . -178.05 -75.71 0.06 OUTLIER Glycine 0 N--CA 1.443 -0.859 0 N-CA-C 110.31 -1.116 . . . . 1.84 110.31 -179.637 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.439 ' HB2' ' O ' ' A' ' 8' ' ' GLY . 8.5 t 174.04 148.25 0.07 Allowed 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 107.277 -1.379 . . . . 1.87 107.277 175.389 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.517 HD21 HG22 ' A' ' 32' ' ' THR . 56.1 tp -56.09 -42.59 76.98 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 119.348 0.976 . . . . 1.83 111.304 -173.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -50.75 -55.52 16.33 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 115.795 -0.638 . . . . 2.11 112.006 177.873 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 55.7 mtmt -65.13 -27.51 68.78 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 111.719 0.266 . . . . 3.11 111.719 179.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -65.23 -54.88 22.78 Favored 'General case' 0 C--O 1.233 0.237 0 CA-C-O 120.952 0.406 . . . . 1.17 110.114 179.602 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 94.9 mt -59.36 -38.34 80.16 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 115.836 -0.62 . . . . 1.31 111.129 176.614 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 50.8 t-20 -60.0 -47.05 87.41 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.659 -0.497 . . . . 1.98 109.659 178.641 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.435 HE21 ' HB3' ' A' ' 16' ' ' GLN . 1.0 OUTLIER -61.74 -42.32 98.81 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.799 -0.637 . . . . 2.33 111.108 -179.982 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.462 ' HD1' ' HZ ' ' A' ' 23' ' ' PHE . 1.9 t80 -66.67 -39.55 88.22 Favored 'General case' 0 CA--C 1.53 0.187 0 N-CA-C 109.747 -0.464 . . . . 1.05 109.747 -177.837 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.75 ' HA ' ' CE2' ' A' ' 23' ' ' PHE . . . -52.71 -42.82 65.19 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.186 -0.461 . . . . 1.15 111.872 177.772 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.37 -22.88 67.15 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.221 -0.445 . . . . 1.26 111.851 -179.344 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . 0.429 ' HB3' ' O ' ' A' ' 17' ' ' TYR . 77.2 t60 -64.82 -62.9 1.28 Allowed 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.18 0.437 . . . . 2.52 112.18 -178.534 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.644 ' HB2' ' CD1' ' A' ' 23' ' ' PHE . 9.6 m -100.46 -4.65 28.43 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 112.543 0.572 . . . . 1.79 112.543 -172.676 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 67.27 47.49 63.65 Favored Glycine 0 CA--C 1.52 0.379 0 C-N-CA 121.099 -0.572 . . . . 0.68 113.419 177.642 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.75 ' CE2' ' HA ' ' A' ' 18' ' ' ALA . 3.7 p90 -104.61 171.4 7.35 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 110.152 -0.314 . . . . 0.68 110.152 178.285 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.405 ' O ' ' HB3' ' A' ' 68' ' ' SER . 24.0 m -97.06 122.69 40.34 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.255 0.55 . . . . 1.3 111.959 -175.237 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.651 HD21 ' CE3' ' A' ' 69' ' ' TRP . 1.5 mm? -96.27 143.35 27.43 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.56 -0.746 . . . . 2.3 111.07 178.148 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 8.0 t -123.03 91.37 3.47 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 108.943 -0.762 . . . . 1.67 108.943 172.43 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 6.0 p -148.76 138.26 15.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.929 -0.578 . . . . 1.52 110.581 -175.054 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -102.27 131.87 48.58 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.293 -0.412 . . . . 2.38 110.153 178.54 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.1 70.34 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.34 0 O-C-N 123.583 0.552 . . . . 2.45 112.215 178.338 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 50.0 p -163.98 -49.08 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.146 -0.479 . . . . 2.48 109.939 -177.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.417 ' O ' HD12 ' A' ' 59' ' ' LEU . 98.0 mt -63.63 -39.07 93.43 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.213 -0.449 . . . . 1.92 110.227 176.295 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.517 HG22 HD21 ' A' ' 10' ' ' LEU . 2.3 p -91.65 3.07 55.93 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.662 -0.699 . . . . 1.82 111.446 179.6 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 6.0 tpp180 -75.42 106.41 6.95 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.064 -0.516 . . . . 5.19 111.216 -174.189 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 119.27 -45.89 1.2 Allowed Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.346 -0.931 . . . . 1.62 113.808 172.33 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.782 ' HD2' ' H ' ' A' ' 35' ' ' LYS . 0.0 OUTLIER -67.94 137.08 54.9 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.545 0.688 . . . . 3.17 111.741 -174.355 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 5.3 tp-100 -102.73 152.84 20.76 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 114.921 -1.036 . . . . 2.52 110.073 -175.269 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 22.9 t -133.99 123.28 24.33 Favored 'General case' 0 N--CA 1.444 -0.743 0 N-CA-C 107.174 -1.417 . . . . 1.14 107.174 175.29 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 11.7 m120 -67.79 3.28 1.52 Allowed 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 112.907 0.706 . . . . 1.28 112.907 -173.591 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 107.35 -176.52 21.02 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.612 -0.804 . . . . 0.49 112.958 170.395 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.422 HD11 ' HB3' ' A' ' 52' ' ' GLN . 39.6 tp -160.3 122.89 3.33 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 108.778 -0.823 . . . . 1.36 108.778 -176.366 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 10.7 t-80 -144.48 98.59 3.22 Favored 'General case' 0 C--N 1.321 -0.664 0 C-N-CA 120.296 -0.561 . . . . 3.8 110.964 -179.202 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -168.91 -169.5 32.37 Favored Glycine 0 N--CA 1.446 -0.636 0 CA-C-N 115.264 -0.88 . . . . 0.55 111.627 177.04 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -81.99 76.75 8.87 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.242 -0.651 . . . . 2.18 109.242 175.305 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 78.8 m-85 -107.82 138.38 44.15 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.25 0.548 . . . . 1.5 111.707 -175.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -101.93 -170.35 1.81 Allowed 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 108.904 -0.776 . . . . 2.23 108.904 173.208 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 56.0 t -51.97 -71.31 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 112.739 0.644 . . . . 1.25 112.739 -173.321 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -64.4 -40.82 96.54 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 112.548 0.573 . . . . 2.39 112.548 -172.237 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 56.7 m -71.02 -25.9 62.88 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-O 120.919 0.39 . . . . 1.65 110.877 -174.518 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.47 ' O ' ' HG ' ' A' ' 53' ' ' LEU . . . -72.4 -37.71 58.61 Favored Glycine 0 N--CA 1.447 -0.621 0 C-N-CA 120.761 -0.733 . . . . 0.4 111.466 178.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.536 HD21 HG11 ' A' ' 61' ' ' VAL . 84.8 mt -67.53 -43.1 81.6 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.024 0.44 . . . . 1.63 110.86 -178.808 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 36.2 tt0 -56.99 -42.19 79.78 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.625 -0.716 . . . . 3.01 110.839 -179.39 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.422 ' HB3' HD11 ' A' ' 40' ' ' LEU . 25.6 mm-40 -70.0 -37.71 75.75 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 111.895 0.331 . . . . 2.18 111.895 176.205 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.47 ' HG ' ' O ' ' A' ' 49' ' ' GLY . 58.9 mt -58.47 -17.74 23.33 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 112.197 0.443 . . . . 1.4 112.197 178.852 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 79.6 mt -69.8 -12.31 61.53 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.443 -0.344 . . . . 2.78 111.007 177.517 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -67.4 109.55 3.22 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 121.041 0.448 . . . . 2.24 110.038 178.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 105.66 -6.65 41.51 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.925 -0.655 . . . . 1.96 112.109 -179.221 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 49.1 m -121.75 169.35 10.82 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.833 0.349 . . . . 2.28 110.845 -179.145 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.661 ' O ' ' HA ' ' A' ' 75' ' ' PRO . . . -121.21 15.62 9.34 Favored Glycine 0 N--CA 1.444 -0.813 0 N-CA-C 110.58 -1.008 . . . . 1.79 110.58 172.317 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.515 HD13 HD21 ' A' ' 71' ' ' LEU . 90.8 mt -92.56 -179.4 5.17 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.697 -0.482 . . . . 1.82 109.697 -178.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . 0.403 ' OE1' ' HB1' ' A' ' 74' ' ' ALA . 49.7 mt-30 -139.72 117.85 11.9 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 108.772 -0.825 . . . . 3.26 108.772 177.837 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.536 HG11 HD21 ' A' ' 50' ' ' LEU . 18.4 t -86.99 113.6 24.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 N-CA-C 109.095 -0.706 . . . . 2.17 109.095 177.084 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -115.95 116.86 40.08 Favored Pre-proline 0 C--N 1.32 -0.702 0 CA-C-N 116.333 -0.394 . . . . 2.29 110.027 -171.112 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_exo -52.7 121.8 9.82 Favored 'Trans proline' 0 N--CA 1.463 -0.284 0 C-N-CA 122.646 2.231 . . . . 0.94 111.551 176.508 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.566 ' H ' ' HA ' ' A' ' 69' ' ' TRP . 3.3 tm? -68.53 -53.8 20.79 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.673 -0.694 . . . . 2.32 109.523 -177.696 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 176.78 149.33 7.62 Favored Glycine 0 N--CA 1.441 -0.986 0 N-CA-C 110.484 -1.046 . . . . 1.69 110.484 178.16 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 91.2 m-20 65.47 -82.07 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 122.606 0.362 . . . . 3.67 111.239 -179.612 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -147.16 13.18 1.1 Allowed 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.404 -0.591 . . . . 2.59 109.404 -178.713 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.405 ' HB3' ' O ' ' A' ' 24' ' ' THR . 42.9 m -103.56 174.32 5.92 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 108.691 -0.855 . . . . 1.54 108.691 -174.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . 0.651 ' CE3' HD21 ' A' ' 25' ' ' LEU . 34.1 m0 -139.64 161.92 36.36 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 118.136 0.426 . . . . 0.54 109.874 -173.671 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 13.9 t -142.72 149.3 38.6 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 108.071 -1.085 . . . . 1.49 108.071 169.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.515 HD21 HD13 ' A' ' 59' ' ' LEU . 37.9 tp -92.45 105.52 17.69 Favored 'General case' 0 C--N 1.32 -0.694 0 C-N-CA 120.048 -0.661 . . . . 2.24 110.186 -178.377 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -87.2 118.79 70.45 Favored Pre-proline 0 C--N 1.317 -0.808 0 CA-C-N 114.699 -1.137 . . . . 2.25 110.024 -179.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -83.17 115.01 2.26 Favored 'Trans proline' 0 N--CA 1.45 -1.087 0 C-N-CA 122.341 2.027 . . . . 1.45 112.409 -178.552 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.722 ' HA ' ' HG3' ' A' ' 77' ' ' PRO . . . -162.58 62.0 1.22 Allowed Pre-proline 0 C--N 1.32 -0.704 0 CA-C-N 115.474 -0.784 . . . . 2.07 110.137 174.316 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.661 ' HA ' ' O ' ' A' ' 58' ' ' GLY . 5.0 Cg_exo -72.4 -75.72 0.01 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.532 0 C-N-CA 122.503 2.135 . . . . 2.85 111.347 -178.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.433 ' N ' ' HD3' ' A' ' 77' ' ' PRO . . . -143.41 56.34 4.51 Favored Pre-proline 0 C--N 1.32 -0.713 0 N-CA-C 108.265 -1.013 . . . . 4.66 108.265 168.1 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.722 ' HG3' ' HA ' ' A' ' 74' ' ' ALA . 60.4 Cg_endo -86.02 -7.86 8.05 Favored 'Trans proline' 0 N--CA 1.454 -0.824 0 C-N-CA 122.799 2.332 . . . . 4.26 111.088 -170.21 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.705 ' HD2' ' HB3' ' A' ' 80' ' ' ASP . 48.4 pttt 177.16 132.7 0.06 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 113.871 -1.513 . . . . 6.5 108.24 171.121 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -89.02 47.77 1.54 Allowed 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 122.136 0.97 . . . . 8.11 109.479 176.185 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . 0.705 ' HB3' ' HD2' ' A' ' 78' ' ' LYS . 17.9 t70 . . . . . 0 C--O 1.25 1.083 0 CA-C-N 114.338 -1.301 . . . . 9.05 109.58 -177.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.018 0 N-CA-C 110.177 -0.305 . . . . 4.29 110.177 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.97 96.96 1.78 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.697 0.76 . . . . 4.51 110.674 178.085 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 27.7 m -94.83 129.76 44.57 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-N 115.497 -0.774 . . . . 2.2 109.828 -177.474 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 40.1 m-80 -128.16 96.71 4.54 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.413 0.625 . . . . 2.75 109.329 -178.114 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.688 HD11 ' HB3' ' A' ' 40' ' ' LEU . 3.6 mp -105.0 112.39 38.43 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-N 115.279 -0.873 . . . . 1.5 109.563 -178.069 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -85.49 155.94 59.4 Favored Pre-proline 0 C--N 1.32 -0.705 0 CA-C-N 115.855 -0.611 . . . . 1.99 109.491 178.302 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.626 ' HA ' ' O ' ' A' ' 37' ' ' SER . 31.6 Cg_exo -58.88 136.07 71.08 Favored 'Trans proline' 0 C--O 1.234 0.323 0 C-N-CA 121.663 1.575 . . . . 1.73 109.858 169.779 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 149.2 49.9 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.011 -1.09 . . . . 1.84 111.893 -170.475 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.651 ' HA ' ' HA ' ' A' ' 36' ' ' GLN . 25.9 t 66.36 145.85 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 123.282 0.633 . . . . 1.87 112.1 -177.697 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.907 HD23 ' HB3' ' A' ' 37' ' ' SER . 3.0 mm? -57.52 -28.9 63.89 Favored 'General case' 0 N--CA 1.461 0.086 0 CA-C-N 115.784 -0.643 . . . . 1.83 109.987 172.547 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.632 ' HB2' ' HB ' ' A' ' 32' ' ' THR . 18.7 t70 -44.11 -62.48 1.13 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 114.549 -1.205 . . . . 2.11 111.796 178.563 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.427 ' HA ' ' HB3' ' A' ' 15' ' ' ASN . 36.5 ttpt -69.38 -19.93 63.83 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.423 -0.353 . . . . 3.11 111.535 -177.743 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -65.7 -56.45 12.0 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-O 121.134 0.493 . . . . 1.17 109.677 178.529 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 74.5 mt -57.86 -38.31 75.46 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.513 -0.767 . . . . 1.31 110.943 174.437 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.427 ' HB3' ' HA ' ' A' ' 12' ' ' LYS . 21.4 t-20 -58.83 -42.02 88.25 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.124 -0.489 . . . . 1.98 110.655 177.106 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.456 HE21 ' HB3' ' A' ' 16' ' ' GLN . 1.0 OUTLIER -60.63 -43.08 97.95 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.953 -0.567 . . . . 2.33 110.548 178.191 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.436 ' HD1' ' HZ ' ' A' ' 23' ' ' PHE . 0.3 OUTLIER -67.42 -51.14 55.31 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.767 0.317 . . . . 1.05 110.63 -179.094 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.74 ' HA ' ' CE2' ' A' ' 23' ' ' PHE . . . -52.26 -53.4 44.29 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 115.799 -0.637 . . . . 1.15 112.352 -177.598 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.77 -21.07 66.24 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.255 -0.429 . . . . 1.26 111.958 -177.245 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 32.0 t60 -65.26 -53.62 41.56 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 111.622 0.23 . . . . 2.52 111.622 -177.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.567 ' HB3' ' CD1' ' A' ' 23' ' ' PHE . 48.1 t -99.81 -7.63 25.18 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.064 0.459 . . . . 1.79 110.997 -178.109 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 76.3 44.27 17.96 Favored Glycine 0 N--CA 1.446 -0.687 0 CA-C-N 115.715 -0.675 . . . . 0.68 112.864 178.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.74 ' CE2' ' HA ' ' A' ' 18' ' ' ALA . 14.1 p90 -108.57 149.72 28.47 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.532 -0.544 . . . . 0.68 109.532 176.903 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 28.1 m -90.31 123.61 34.21 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.083 -0.508 . . . . 1.3 111.219 -174.392 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.599 HD11 ' HE3' ' A' ' 69' ' ' TRP . 0.9 OUTLIER -92.86 140.5 29.44 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.655 -0.702 . . . . 2.3 111.458 -179.914 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.514 ' HB3' ' HA ' ' A' ' 70' ' ' THR . 29.6 t -100.66 92.18 4.99 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.041 -0.725 . . . . 1.67 109.041 174.043 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.778 ' HB ' HD23 ' A' ' 71' ' ' LEU . 7.4 p -146.5 134.27 15.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.816 -0.629 . . . . 1.52 110.429 -178.729 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 -89.43 128.82 35.99 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.058 -0.519 . . . . 2.38 110.216 178.636 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.79 60.87 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.425 0 O-C-N 123.722 0.639 . . . . 2.45 111.667 173.36 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.768 ' HA ' ' HG3' ' A' ' 33' ' ' ARG . 68.7 m -165.28 -27.79 0.03 OUTLIER 'General case' 0 C--N 1.321 -0.642 0 C-N-CA 123.429 0.692 . . . . 2.48 109.406 -176.956 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 97.1 mt -73.29 -23.13 60.25 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.414 0.626 . . . . 1.92 109.585 173.513 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.632 ' HB ' ' HB2' ' A' ' 11' ' ' ASP . 17.5 p -98.45 13.0 33.27 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.167 -0.924 . . . . 1.82 111.212 179.527 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.768 ' HG3' ' HA ' ' A' ' 30' ' ' SER . 29.4 mtt180 -67.16 126.17 28.35 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.114 -0.494 . . . . 5.19 111.245 -179.429 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 67.58 17.27 68.68 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 121.038 -0.601 . . . . 1.62 112.275 178.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 5.8 mptp? -88.44 148.96 23.94 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.05 0.452 . . . . 3.17 110.572 178.606 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . 0.651 ' HA ' ' HA ' ' A' ' 9' ' ' SER . 15.0 pt20 -144.02 137.87 27.97 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.51 -0.768 . . . . 2.52 109.787 171.24 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.907 ' HB3' HD23 ' A' ' 10' ' ' LEU . 50.7 p -119.99 124.59 46.31 Favored 'General case' 0 N--CA 1.443 -0.784 0 N-CA-C 108.226 -1.027 . . . . 1.14 108.226 -177.066 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -57.26 -32.45 66.6 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 112.274 0.472 . . . . 1.28 112.274 -175.545 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 134.17 178.24 15.49 Favored Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 120.312 -0.947 . . . . 0.49 112.481 175.316 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.688 ' HB3' HD11 ' A' ' 5' ' ' ILE . 55.1 tp -160.14 126.12 4.15 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 107.603 -1.258 . . . . 1.36 107.603 -179.678 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 72.1 m80 -142.43 99.61 3.53 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.992 0.425 . . . . 3.8 111.439 -174.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -169.14 -170.13 33.35 Favored Glycine 0 N--CA 1.449 -0.459 0 N-CA-C 111.346 -0.702 . . . . 0.55 111.346 175.488 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -101.35 76.61 1.71 Allowed 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 108.353 -0.98 . . . . 2.18 108.353 171.543 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 26.6 m-85 -91.18 150.42 21.37 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.043 -0.98 . . . . 1.5 111.421 -173.735 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 50.4 m-20 -110.24 176.03 5.21 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 107.941 -1.133 . . . . 2.23 107.941 169.218 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 16.5 t -49.11 -62.49 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 N-CA-C 112.211 0.448 . . . . 1.25 112.211 -169.331 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 25.9 mm-40 -44.31 -60.44 1.92 Allowed 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 113.182 0.808 . . . . 2.39 113.182 179.667 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 10.2 m -69.04 -28.02 66.18 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.087 0.47 . . . . 1.65 110.904 -173.035 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.479 ' O ' ' HG ' ' A' ' 53' ' ' LEU . . . -74.4 -39.36 42.98 Favored Glycine 0 N--CA 1.444 -0.818 0 C-N-CA 120.765 -0.731 . . . . 0.4 111.853 -176.303 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.545 ' O ' ' HG ' ' A' ' 54' ' ' LEU . 84.0 mt -72.12 -41.38 67.29 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.563 0.221 . . . . 1.63 110.505 -178.187 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 -52.89 -51.16 62.17 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 116.254 -0.43 . . . . 3.01 111.7 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 25.8 mm-40 -64.42 -39.92 94.78 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.998 -0.281 . . . . 2.18 111.205 -179.13 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.479 ' HG ' ' O ' ' A' ' 49' ' ' GLY . 92.7 mt -59.32 -25.23 63.98 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.199 -0.455 . . . . 1.4 112.123 177.626 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.545 ' HG ' ' O ' ' A' ' 50' ' ' LEU . 96.7 mt -76.3 -14.06 60.12 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 111.922 0.341 . . . . 2.78 111.922 -176.394 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -82.88 103.9 12.7 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.989 0.423 . . . . 2.24 111.116 -177.263 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 78.9 20.71 69.94 Favored Glycine 0 N--CA 1.45 -0.379 0 CA-C-N 115.698 -0.683 . . . . 1.96 113.485 174.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.445 ' CB ' ' HG ' ' A' ' 10' ' ' LEU . 16.3 p -88.8 -32.49 17.83 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.934 0.397 . . . . 2.28 110.981 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.641 ' HA2' ' HA ' ' A' ' 75' ' ' PRO . . . 87.86 9.01 71.94 Favored Glycine 0 N--CA 1.444 -0.815 0 N-CA-C 111.3 -0.72 . . . . 1.79 111.3 -176.687 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.56 ' HB3' HD11 ' A' ' 71' ' ' LEU . 85.7 mt -129.71 171.55 12.54 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 120.854 0.359 . . . . 1.82 110.611 -176.275 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . 0.522 ' HB2' ' HB3' ' A' ' 74' ' ' ALA . 6.4 tt0 -136.16 118.84 16.04 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.177 -0.675 . . . . 3.26 109.177 176.192 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.417 ' H ' HD23 ' A' ' 54' ' ' LEU . 52.6 t -87.26 118.46 33.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-O 120.905 0.383 . . . . 2.17 110.69 -178.288 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.428 ' HE3' ' HB3' ' A' ' 62' ' ' LYS . 22.4 mmmt -125.69 117.92 24.45 Favored Pre-proline 0 C--N 1.325 -0.47 0 CA-C-N 115.944 -0.571 . . . . 2.29 110.172 177.663 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.424 ' HA ' ' HA ' ' A' ' 69' ' ' TRP . 41.7 Cg_exo -57.94 121.0 9.27 Favored 'Trans proline' 0 C--O 1.233 0.234 0 C-N-CA 122.351 2.034 . . . . 0.94 110.762 174.763 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -75.61 -57.98 3.56 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.784 -0.643 . . . . 2.32 110.831 -171.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -127.04 -98.68 1.04 Allowed Glycine 0 N--CA 1.445 -0.73 0 C-N-CA 120.195 -1.002 . . . . 1.69 112.395 -178.228 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -91.87 -74.07 0.52 Allowed 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.741 0.305 . . . . 3.67 110.929 -177.633 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 27.2 p-10 -122.19 34.87 5.03 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.186 0.517 . . . . 2.59 110.877 -178.143 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 47.0 t -126.66 169.21 13.37 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 108.713 -0.847 . . . . 1.54 108.713 179.315 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . 0.599 ' HE3' HD11 ' A' ' 25' ' ' LEU . 6.8 m0 -142.31 162.32 35.76 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 107.824 -1.176 . . . . 0.54 107.824 -173.529 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.514 ' HA ' ' HB3' ' A' ' 26' ' ' SER . 12.4 t -140.32 146.52 38.6 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 109.517 -0.549 . . . . 1.49 109.517 174.19 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.778 HD23 ' HB ' ' A' ' 27' ' ' VAL . 4.2 mm? -93.63 102.93 15.12 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.613 0.72 . . . . 2.24 110.751 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.43 ' HA ' ' HD3' ' A' ' 73' ' ' PRO . 24.9 mt-10 -86.65 126.28 64.4 Favored Pre-proline 0 C--N 1.319 -0.733 0 CA-C-N 114.744 -1.116 . . . . 2.25 109.54 173.658 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 72' ' ' GLU . 38.9 Cg_exo -60.81 114.46 2.16 Favored 'Trans proline' 0 N--CA 1.462 -0.378 0 C-N-CA 122.746 2.297 . . . . 1.45 111.897 -176.494 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.522 ' HB3' ' HB2' ' A' ' 60' ' ' GLN . . . -159.3 82.87 2.43 Favored Pre-proline 0 C--N 1.32 -0.686 0 CA-C-N 115.007 -0.997 . . . . 2.07 108.86 178.239 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.641 ' HA ' ' HA2' ' A' ' 58' ' ' GLY . 72.0 Cg_endo -76.53 55.55 4.79 Favored 'Trans proline' 0 C--O 1.235 0.357 0 C-N-CA 122.811 2.341 . . . . 2.85 113.172 -172.021 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.447 ' N ' ' HD3' ' A' ' 77' ' ' PRO . . . 54.1 59.39 11.95 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 115.84 -0.618 . . . . 4.66 110.149 -175.568 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.447 ' HD3' ' N ' ' A' ' 76' ' ' ALA . 59.4 Cg_endo -87.53 -179.51 2.68 Favored 'Trans proline' 0 N--CA 1.447 -1.215 0 C-N-CA 122.62 2.213 . . . . 4.26 111.361 -175.32 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 17.4 tptm -162.55 70.79 0.29 Allowed 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.268 0.556 . . . . 6.5 110.22 -178.714 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -96.47 -5.08 40.37 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 108.617 -0.883 . . . . 8.11 108.617 175.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 39.0 t70 . . . . . 0 C--O 1.249 1.047 0 CA-C-N 114.918 -1.037 . . . . 9.05 110.134 179.218 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 0.858 0 N-CA-C 109.97 -0.381 . . . . 4.29 109.97 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 1.008 ' H ' ' HA ' ' A' ' 43' ' ' ASP . 9.7 tt0 -82.75 -12.64 57.38 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.814 0.816 . . . . 4.51 110.198 -178.132 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 31.8 m -140.8 147.66 22.58 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 114.766 -1.106 . . . . 2.2 109.867 178.411 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 84.2 m-20 -129.2 102.56 6.51 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.465 -0.569 . . . . 2.75 109.465 179.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.41 HD11 ' HB3' ' A' ' 40' ' ' LEU . 56.6 mt -129.96 152.33 37.22 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 116.172 -0.467 . . . . 1.5 109.851 -174.774 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.482 ' HB3' ' HD2' ' A' ' 7' ' ' PRO . . . -163.95 167.46 10.83 Favored Pre-proline 0 C--N 1.327 -0.39 0 N-CA-C 110.112 -0.329 . . . . 1.99 110.112 -174.551 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.55 ' HA ' ' O ' ' A' ' 37' ' ' SER . 71.2 Cg_exo -49.31 136.86 31.48 Favored 'Trans proline' 0 C--N 1.351 0.673 0 C-N-CA 122.835 2.357 . . . . 1.73 113.43 -176.582 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 143.86 64.56 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.742 -0.742 . . . . 1.84 112.681 177.146 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 50.0 m 66.36 116.14 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 121.372 0.606 . . . . 1.87 112.017 179.159 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 60.0 tp -59.47 -42.04 91.14 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 115.996 -0.547 . . . . 1.83 112.425 -178.543 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.619 ' HB3' ' HA ' ' A' ' 33' ' ' ARG . 8.4 p-10 -54.66 -37.86 66.23 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.75 -0.205 . . . . 2.11 111.286 178.472 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -66.05 -31.16 71.88 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.949 0.404 . . . . 3.11 110.7 178.308 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -67.11 -54.02 25.32 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.133 -0.485 . . . . 1.17 110.337 -179.048 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 84.6 mt -59.26 -38.88 81.19 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 115.76 -0.654 . . . . 1.31 110.838 175.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -59.75 -38.74 82.59 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.78 -0.645 . . . . 1.98 110.353 178.273 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.41 HE21 ' HB3' ' A' ' 16' ' ' GLN . 0.9 OUTLIER -62.81 -41.62 99.37 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.62 -0.718 . . . . 2.33 110.786 177.61 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.617 ' CD1' ' HH2' ' A' ' 69' ' ' TRP . 7.0 t80 -68.47 -41.39 80.22 Favored 'General case' 0 C--N 1.333 -0.112 0 N-CA-C 109.807 -0.442 . . . . 1.05 109.807 -178.029 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.657 ' HA ' ' CE2' ' A' ' 23' ' ' PHE . . . -53.75 -46.87 71.03 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.05 -0.523 . . . . 1.15 111.691 177.06 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.68 -16.54 57.66 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.043 -0.526 . . . . 1.26 112.15 -178.027 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 76.3 t60 -61.36 -47.55 85.33 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.669 -0.241 . . . . 2.52 111.462 -179.288 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.46 ' HB3' ' CD1' ' A' ' 23' ' ' PHE . 32.5 t -118.77 -15.89 9.39 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 120.712 -0.395 . . . . 1.79 112.008 -178.676 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 74.9 61.01 3.19 Favored Glycine 0 C--N 1.331 0.259 0 C-N-CA 120.867 -0.682 . . . . 0.68 112.732 -179.485 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.657 ' CE2' ' HA ' ' A' ' 18' ' ' ALA . 3.1 p90 -112.8 169.21 9.07 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.999 0.428 . . . . 0.68 111.021 -179.103 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 14.8 m -89.66 101.38 14.07 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.457 0.646 . . . . 1.3 111.276 -176.354 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.577 HD23 ' HB ' ' A' ' 27' ' ' VAL . 2.8 tt -93.58 126.78 38.92 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.551 -0.75 . . . . 2.3 109.325 177.116 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.542 ' HB2' ' HA ' ' A' ' 70' ' ' THR . 8.5 m -98.99 91.15 4.89 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.162 -0.681 . . . . 1.67 109.162 179.843 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.721 HG23 HD21 ' A' ' 71' ' ' LEU . 7.3 p -117.62 135.78 56.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 115.911 -0.586 . . . . 1.52 111.533 -174.458 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 50.7 m-20 -78.19 112.81 15.54 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-N 115.882 -0.599 . . . . 2.38 109.74 174.675 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -64.68 66.74 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.977 -0.556 . . . . 2.45 112.02 177.524 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 20.4 p -170.28 -44.09 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.255 -0.429 . . . . 2.48 110.175 -179.074 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 91.0 mt -68.27 -52.58 32.29 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.951 -0.568 . . . . 1.92 111.351 -179.286 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 13.0 p -101.82 -19.2 15.41 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 112.615 0.598 . . . . 1.82 112.615 -176.265 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.619 ' HA ' ' HB3' ' A' ' 11' ' ' ASP . 16.1 tpp180 -59.9 119.16 7.2 Favored 'General case' 0 C--O 1.233 0.233 0 N-CA-C 110.115 -0.328 . . . . 5.19 110.115 -178.463 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 93.66 -115.85 5.06 Favored Glycine 0 N--CA 1.439 -1.165 0 N-CA-C 111.056 -0.818 . . . . 1.62 111.056 -177.041 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 9.3 mmmm 46.9 -165.84 0.02 OUTLIER 'General case' 0 N--CA 1.443 -0.775 0 CA-C-O 122.205 1.002 . . . . 3.17 111.654 -176.209 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 8.0 pt20 -150.16 132.71 15.75 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 114.887 -1.051 . . . . 2.52 108.673 165.029 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.55 ' O ' ' HA ' ' A' ' 7' ' ' PRO . 33.9 t -118.45 139.22 51.75 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 108.059 -1.089 . . . . 1.14 108.059 175.436 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 8.0 m120 -67.61 -14.46 62.96 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.091 -0.504 . . . . 1.28 111.065 -176.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 111.58 -169.53 13.25 Favored Glycine 0 N--CA 1.443 -0.882 0 C-N-CA 120.73 -0.747 . . . . 0.49 112.331 173.527 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.41 ' HB3' HD11 ' A' ' 5' ' ' ILE . 42.1 tp -160.16 125.64 4.02 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 108.349 -0.982 . . . . 1.36 108.349 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 39.4 t-80 -136.66 96.54 3.35 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 120.215 -0.594 . . . . 3.8 110.966 -178.544 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -168.79 -179.96 41.26 Favored Glycine 0 N--CA 1.448 -0.533 0 CA-C-N 115.398 -0.819 . . . . 0.55 111.239 175.157 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 1.008 ' HA ' ' H ' ' A' ' 2' ' ' GLN . 21.9 m-20 -84.97 74.63 10.49 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 108.656 -0.868 . . . . 2.18 108.656 173.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 22.5 m-85 -96.21 143.94 26.86 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.198 -0.91 . . . . 1.5 111.061 -174.086 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -94.1 -172.39 2.81 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.543 -0.753 . . . . 2.23 110.057 179.386 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.424 HG12 ' CZ2' ' A' ' 69' ' ' TRP . 59.8 t -52.34 -71.57 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.042 -0.526 . . . . 1.25 112.19 -178.095 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 21.1 mt-10 -63.88 -41.49 97.73 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.863 -0.608 . . . . 2.39 112.061 -172.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 4.2 p -72.11 -32.04 66.6 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.098 -0.501 . . . . 1.65 111.306 -172.251 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -75.2 -39.24 37.42 Favored Glycine 0 N--CA 1.447 -0.617 0 N-CA-C 111.114 -0.794 . . . . 0.4 111.114 -176.39 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.51 ' CB ' HG12 ' A' ' 61' ' ' VAL . 62.9 mt -72.66 -41.5 65.36 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.773 0.321 . . . . 1.63 110.58 -178.568 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 21.2 tt0 -54.8 -49.12 71.75 Favored 'General case' 0 C--O 1.222 -0.345 0 CA-C-N 115.808 -0.633 . . . . 3.01 111.009 -176.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 16.4 mm100 -65.09 -40.19 94.26 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.455 -0.339 . . . . 2.18 111.485 -178.622 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 90.0 mt -57.77 -34.95 70.13 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 112.1 0.407 . . . . 1.4 112.1 178.636 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 81.8 mt -102.42 -12.6 17.74 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.929 0.395 . . . . 2.78 111.645 -174.432 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -64.68 130.2 42.68 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.05 -0.523 . . . . 2.24 110.956 -177.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 100.41 -31.44 8.51 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.533 -0.842 . . . . 1.96 113.243 176.561 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 24.4 p -91.87 12.84 20.25 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 117.218 0.509 . . . . 2.28 111.343 -177.001 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.583 ' HA2' ' HA ' ' A' ' 75' ' ' PRO . . . 74.37 25.14 71.31 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.683 -0.77 . . . . 1.79 111.821 179.247 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 91.6 mt -123.42 156.01 36.32 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 109.939 -0.393 . . . . 1.82 109.939 -178.687 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . 0.509 ' HB2' ' HB1' ' A' ' 74' ' ' ALA . 38.2 mm-40 -152.59 172.78 16.08 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.409 -0.589 . . . . 3.26 109.409 176.496 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.51 HG12 ' CB ' ' A' ' 50' ' ' LEU . 10.8 p -139.89 148.96 22.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-O 120.821 0.343 . . . . 2.17 110.709 -178.616 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.527 ' HG3' HG21 ' A' ' 70' ' ' THR . 1.6 ptpp? -139.83 128.59 13.44 Favored Pre-proline 0 C--N 1.321 -0.671 0 N-CA-C 109.519 -0.548 . . . . 2.29 109.519 172.815 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -59.8 126.3 20.1 Favored 'Trans proline' 0 N--CA 1.462 -0.376 0 C-N-CA 122.309 2.006 . . . . 0.94 110.425 173.332 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -59.78 -44.35 93.96 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.527 -0.761 . . . . 2.32 109.903 -175.537 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 152.24 -65.13 0.36 Allowed Glycine 0 N--CA 1.445 -0.729 0 C-N-CA 120.701 -0.761 . . . . 1.69 111.722 176.028 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 12.8 t-20 -88.71 78.92 7.6 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.124 0.487 . . . . 3.67 110.043 -179.558 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 43.52 35.94 1.07 Allowed 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 124.482 1.113 . . . . 2.59 113.727 178.552 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 39.5 m -137.16 175.34 9.7 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 108.54 -0.911 . . . . 1.54 108.54 176.453 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . 0.617 ' HH2' ' CD1' ' A' ' 17' ' ' TYR . 54.9 m0 -137.52 167.1 22.33 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.952 0.406 . . . . 0.54 110.923 -169.877 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.542 ' HA ' ' HB2' ' A' ' 26' ' ' SER . 3.7 t -145.91 147.38 31.69 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.58 -0.737 . . . . 1.49 109.423 171.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.721 HD21 HG23 ' A' ' 27' ' ' VAL . 50.8 tp -91.62 105.71 17.94 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.144 0.497 . . . . 2.24 109.707 -178.03 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.449 ' HB2' ' HG2' ' A' ' 62' ' ' LYS . 12.7 tp10 -94.33 118.93 67.04 Favored Pre-proline 0 C--N 1.323 -0.577 0 CA-C-N 115.147 -0.933 . . . . 2.25 110.766 -176.642 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_exo -70.02 113.5 3.44 Favored 'Trans proline' 0 N--CA 1.456 -0.701 0 C-N-CA 121.647 1.564 . . . . 1.45 110.649 172.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.509 ' HB1' ' HB2' ' A' ' 60' ' ' GLN . . . -154.31 81.61 4.5 Favored Pre-proline 0 C--N 1.322 -0.623 0 CA-C-N 116.109 -0.496 . . . . 2.07 109.891 -177.668 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.583 ' HA ' ' HA2' ' A' ' 58' ' ' GLY . 6.3 Cg_exo -77.51 -70.64 0.02 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 122.699 2.266 . . . . 2.85 112.304 -176.417 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.42 ' N ' ' HD3' ' A' ' 77' ' ' PRO . . . -141.99 59.39 9.32 Favored Pre-proline 0 C--N 1.324 -0.518 0 N-CA-C 108.545 -0.909 . . . . 4.66 108.545 173.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.46 ' HG3' ' HA ' ' A' ' 74' ' ' ALA . 83.4 Cg_endo -96.62 145.6 0.97 Allowed 'Trans proline' 0 N--CA 1.444 -1.417 0 C-N-CA 123.179 2.586 . . . . 4.26 113.426 -167.149 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 68.2 mttm 69.05 116.98 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 115.244 -0.889 . . . . 6.5 112.447 176.284 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -130.12 -60.91 1.0 Allowed 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.497 -0.774 . . . . 8.11 109.298 174.201 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 34.4 t70 . . . . . 0 C--O 1.248 0.977 0 CA-C-O 118.558 -0.734 . . . . 9.05 110.023 179.219 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 0.989 0 N-CA-C 110.424 -0.213 . . . . 4.29 110.424 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.653 ' HA ' ' HA ' ' A' ' 43' ' ' ASP . 77.0 mt-30 65.93 149.03 0.04 OUTLIER 'General case' 0 C--O 1.231 0.125 0 CA-C-O 121.668 0.747 . . . . 4.51 112.005 -176.922 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 57.6 t -131.82 130.56 61.77 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 115.49 -0.777 . . . . 2.2 109.221 178.417 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 4.2 p-10 -131.52 121.61 24.76 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 108.882 -0.784 . . . . 2.75 108.882 -178.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.482 HG13 HD21 ' A' ' 53' ' ' LEU . 36.4 mm -116.95 129.11 74.04 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 CA-C-N 115.925 -0.579 . . . . 1.5 109.956 -178.256 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -73.56 156.52 88.62 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.069 -0.514 . . . . 1.99 109.86 177.6 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.524 ' HA ' ' O ' ' A' ' 37' ' ' SER . 7.6 Cg_exo -74.45 39.86 0.58 Allowed 'Trans proline' 0 CA--C 1.532 0.394 0 C-N-CA 123.132 2.555 . . . . 1.73 112.888 179.449 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -115.35 -162.71 13.65 Favored Glycine 0 N--CA 1.447 -0.615 0 C-N-CA 120.786 -0.721 . . . . 1.84 113.43 -176.792 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.513 ' HA ' ' HA ' ' A' ' 36' ' ' GLN . 15.7 m -55.77 132.21 48.72 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.222 0.534 . . . . 1.87 111.197 -176.933 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 59.9 tp -58.88 -28.66 66.35 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.165 -0.925 . . . . 1.83 111.055 -176.061 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -45.97 -48.05 16.55 Favored 'General case' 0 CA--C 1.52 -0.199 0 CA-C-O 121.059 0.457 . . . . 2.11 110.576 175.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 65.3 mttm -67.58 -24.13 65.48 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.772 -0.649 . . . . 3.11 111.811 -177.368 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -65.87 -64.03 0.95 Allowed 'General case' 0 C--O 1.233 0.233 0 N-CA-C 110.407 -0.22 . . . . 1.17 110.407 -179.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.801 ' H ' HD11 ' A' ' 14' ' ' LEU . 4.4 mp -58.56 -35.72 72.8 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 116.431 -0.35 . . . . 1.31 111.339 175.641 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -60.6 -46.69 89.32 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 121.07 0.462 . . . . 1.98 109.94 178.232 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.436 HE21 ' HB3' ' A' ' 16' ' ' GLN . 1.0 OUTLIER -63.91 -43.21 96.66 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.509 -0.769 . . . . 2.33 110.435 178.028 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.457 ' O ' ' HB3' ' A' ' 20' ' ' HIS . 10.1 t80 -68.03 -40.46 82.92 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-O 120.76 0.314 . . . . 1.05 110.182 -177.791 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.789 ' HA ' ' CE2' ' A' ' 23' ' ' PHE . . . -54.5 -44.2 72.47 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 116.329 -0.396 . . . . 1.15 111.532 176.14 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.24 -17.96 59.83 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.053 -0.522 . . . . 1.26 111.988 -178.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . 0.457 ' HB3' ' O ' ' A' ' 17' ' ' TYR . 83.4 t60 -59.75 -54.88 41.18 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.532 -0.304 . . . . 2.52 111.266 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.562 ' HB3' ' CD1' ' A' ' 23' ' ' PHE . 22.7 t -114.45 -12.35 12.35 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.482 -0.487 . . . . 1.79 111.639 -177.438 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 75.92 49.63 8.56 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 121.062 -0.589 . . . . 0.68 112.754 179.229 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.789 ' CE2' ' HA ' ' A' ' 18' ' ' ALA . 1.8 p90 -103.76 158.11 16.61 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 110.222 -0.288 . . . . 0.68 110.222 -179.541 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.577 ' O ' ' HB3' ' A' ' 68' ' ' SER . 32.6 m -93.13 101.31 13.61 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.238 0.542 . . . . 1.3 111.878 -175.928 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.421 ' CB ' ' HB2' ' A' ' 69' ' ' TRP . 0.0 OUTLIER -99.43 150.27 22.34 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.385 -0.37 . . . . 2.3 110.115 174.053 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.585 ' HB2' ' HA ' ' A' ' 70' ' ' THR . 43.3 m -106.54 104.07 13.67 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.376 -0.375 . . . . 1.67 110.502 -177.389 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 14.9 p -123.57 143.82 35.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 N-CA-C 110.195 -0.298 . . . . 1.52 110.195 178.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.41 ' OD2' ' HG ' ' A' ' 31' ' ' LEU . 21.6 t70 -97.32 108.71 21.5 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.433 -0.349 . . . . 2.38 110.537 177.575 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.21 60.04 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 115.492 -0.777 . . . . 2.45 112.382 178.218 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 74.8 m -166.38 -36.6 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 123.188 0.595 . . . . 2.48 109.526 179.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.41 ' HG ' ' OD2' ' A' ' 28' ' ' ASP . 89.0 mt -68.0 -28.5 67.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.383 0.611 . . . . 1.92 110.087 176.034 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 5.0 p -97.69 18.38 15.74 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.528 -0.76 . . . . 1.82 111.262 179.11 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 53.5 ttp180 -63.85 108.35 1.44 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.661 -0.245 . . . . 5.19 110.415 -179.202 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 81.45 8.56 86.92 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.834 -0.698 . . . . 1.62 112.268 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 41.8 tptt -86.65 108.14 18.5 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.622 -0.51 . . . . 3.17 109.622 -179.047 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . 0.513 ' HA ' ' HA ' ' A' ' 9' ' ' SER . 46.2 mt-30 -109.84 158.88 17.72 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 110.092 -0.336 . . . . 2.52 110.092 -178.802 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.524 ' O ' ' HA ' ' A' ' 7' ' ' PRO . 7.2 t -128.63 127.55 42.45 Favored 'General case' 0 N--CA 1.445 -0.711 0 N-CA-C 107.863 -1.162 . . . . 1.14 107.863 175.158 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 8.7 m120 -64.25 -8.8 13.9 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 112.37 0.507 . . . . 1.28 112.37 -172.716 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 129.31 175.37 14.02 Favored Glycine 0 N--CA 1.444 -0.806 0 C-N-CA 120.152 -1.023 . . . . 0.49 112.876 169.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 54.1 tp -160.06 124.93 3.9 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 107.624 -1.25 . . . . 1.36 107.624 -179.376 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 52.9 m80 -136.42 97.95 3.71 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 120.26 -0.576 . . . . 3.8 111.438 -177.519 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -170.57 168.3 41.37 Favored Glycine 0 N--CA 1.447 -0.609 0 CA-C-N 115.199 -0.909 . . . . 0.55 110.866 174.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.653 ' HA ' ' HA ' ' A' ' 2' ' ' GLN . 24.2 t70 -78.89 100.18 7.1 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 108.828 -0.805 . . . . 2.18 108.828 170.069 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 43.8 m-85 -116.67 142.43 46.91 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.74 -0.664 . . . . 1.5 111.496 -173.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -92.48 -175.3 3.95 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.438 -0.801 . . . . 2.23 108.861 175.34 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 14.1 t -52.0 -69.73 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 121.193 0.52 . . . . 1.25 111.534 -174.592 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -56.47 -49.1 75.62 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.263 -0.88 . . . . 2.39 112.587 -173.531 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 4.6 t -71.73 -31.36 66.62 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.076 -0.511 . . . . 1.65 110.727 -171.358 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -75.91 -41.45 27.89 Favored Glycine 0 N--CA 1.445 -0.735 0 C-N-CA 120.608 -0.806 . . . . 0.4 111.833 -175.744 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.686 HD13 HG11 ' A' ' 61' ' ' VAL . 93.4 mt -74.03 -36.99 64.48 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.654 0.264 . . . . 1.63 110.422 -178.323 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 1.8 tp-100 -54.76 -47.97 73.23 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.324 -0.398 . . . . 3.01 111.648 179.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 -65.33 -38.53 90.41 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.612 -0.267 . . . . 2.18 111.363 -179.512 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.482 HD21 HG13 ' A' ' 5' ' ' ILE . 94.0 mt -59.23 -23.88 62.69 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 111.935 0.346 . . . . 1.4 111.935 176.651 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.763 HD21 HG23 ' A' ' 61' ' ' VAL . 96.2 mt -80.7 -14.04 58.48 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 111.946 0.35 . . . . 2.78 111.946 -176.631 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -62.66 115.34 4.21 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.158 0.504 . . . . 2.24 110.806 -178.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 110.25 16.52 10.31 Favored Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 120.784 -0.722 . . . . 1.96 112.029 -178.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 89.5 p -146.29 177.4 9.04 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.873 -0.417 . . . . 2.28 109.873 177.33 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.489 ' HA3' ' HB3' ' A' ' 75' ' ' PRO . . . -118.96 43.72 1.53 Allowed Glycine 0 N--CA 1.445 -0.741 0 N-CA-C 111.124 -0.791 . . . . 1.79 111.124 176.708 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.502 HD13 HD23 ' A' ' 71' ' ' LEU . 55.1 mt -117.75 174.59 6.09 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.385 -0.407 . . . . 1.82 110.164 -177.634 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 74.2 mt-30 -146.6 127.85 14.81 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.248 -0.649 . . . . 3.26 109.248 177.206 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.763 HG23 HD21 ' A' ' 54' ' ' LEU . 48.2 t -88.49 119.72 36.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 109.014 -0.736 . . . . 2.17 109.014 174.556 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -132.42 122.97 18.31 Favored Pre-proline 0 N--CA 1.441 -0.912 0 CA-C-N 116.493 -0.322 . . . . 2.29 110.134 -173.75 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.581 ' HA ' ' HA ' ' A' ' 69' ' ' TRP . 44.7 Cg_exo -57.79 144.48 93.4 Favored 'Trans proline' 0 C--O 1.234 0.286 0 C-N-CA 122.977 2.452 . . . . 0.94 111.605 176.847 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -75.86 -47.55 25.03 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.616 -0.72 . . . . 2.32 109.843 -178.07 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 161.62 -46.8 0.37 Allowed Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.594 -0.812 . . . . 1.69 111.968 179.005 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 11.0 t30 -110.76 86.62 2.35 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 110.148 -0.315 . . . . 3.67 110.148 -179.482 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 39.11 42.49 0.72 Allowed 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 124.318 1.047 . . . . 2.59 113.313 178.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.577 ' HB3' ' O ' ' A' ' 24' ' ' THR . 50.1 m -142.06 174.84 10.23 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 108.745 -0.835 . . . . 1.54 108.745 176.173 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . 0.581 ' HA ' ' HA ' ' A' ' 63' ' ' PRO . 41.4 m0 -137.81 169.09 18.39 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.235 0.54 . . . . 0.54 110.345 -173.079 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.585 ' HA ' ' HB2' ' A' ' 26' ' ' SER . 11.7 t -148.89 141.93 24.85 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-N 115.368 -0.833 . . . . 1.49 109.064 168.076 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.502 HD23 HD13 ' A' ' 59' ' ' LEU . 60.8 tp -92.72 102.85 15.26 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.238 0.542 . . . . 2.24 109.76 178.823 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.414 ' HA ' ' HD3' ' A' ' 73' ' ' PRO . 33.0 tt0 -96.92 129.95 31.26 Favored Pre-proline 0 C--N 1.317 -0.817 0 CA-C-N 115.403 -0.817 . . . . 2.25 110.839 179.331 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 72' ' ' GLU . 12.0 Cg_exo -71.3 115.2 4.18 Favored 'Trans proline' 0 N--CA 1.459 -0.509 0 C-N-CA 122.432 2.088 . . . . 1.45 110.723 173.249 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -165.23 87.32 1.0 Allowed Pre-proline 0 C--N 1.323 -0.551 0 CA-C-N 115.83 -0.623 . . . . 2.07 109.655 -177.329 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.489 ' HB3' ' HA3' ' A' ' 58' ' ' GLY . 88.5 Cg_endo -84.04 46.88 2.1 Favored 'Trans proline' 0 N--CA 1.456 -0.723 0 C-N-CA 122.324 2.016 . . . . 2.85 112.651 -174.745 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 54.76 60.66 9.95 Favored Pre-proline 0 N--CA 1.462 0.158 0 CA-C-N 116.112 -0.495 . . . . 4.66 109.905 -176.615 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -82.83 114.34 2.3 Favored 'Trans proline' 0 N--CA 1.449 -1.106 0 C-N-CA 122.595 2.196 . . . . 4.26 112.267 -172.168 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.812 ' H ' ' HD2' ' A' ' 78' ' ' LYS . 1.7 mptt -81.89 -78.02 0.21 Allowed 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.488 -0.778 . . . . 6.5 109.128 -179.298 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -142.62 26.43 1.76 Allowed 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 107.675 -1.231 . . . . 8.11 107.675 170.23 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 . . . . . 0 C--O 1.244 0.778 0 CA-C-N 113.896 -1.502 . . . . 9.05 109.131 -177.498 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.033 0 N-CA-C 109.852 -0.425 . . . . 4.29 109.852 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.796 ' H ' ' HA ' ' A' ' 43' ' ' ASP . 0.0 OUTLIER -73.06 -36.36 66.87 Favored 'General case' 0 CA--C 1.512 -0.488 0 CA-C-O 121.943 0.878 . . . . 4.51 109.806 -176.863 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.489 HG12 ' CE2' ' A' ' 17' ' ' TYR . 14.2 m -148.85 152.17 12.42 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.174 0 CA-C-N 113.689 -1.596 . . . . 2.2 109.672 -178.92 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 69.9 m-20 -131.17 112.08 12.52 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.579 -0.526 . . . . 2.75 109.579 178.211 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.452 ' HB ' ' N ' ' A' ' 40' ' ' LEU . 48.5 mm -107.16 116.81 51.67 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 N-CA-C 109.821 -0.437 . . . . 1.5 109.821 -178.771 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -82.8 157.86 66.09 Favored Pre-proline 0 C--N 1.323 -0.563 0 CA-C-N 115.923 -0.58 . . . . 1.99 109.51 177.216 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.552 ' HA ' ' O ' ' A' ' 37' ' ' SER . 11.5 Cg_endo -58.71 145.49 95.67 Favored 'Trans proline' 0 N--CA 1.462 -0.376 0 C-N-CA 121.642 1.561 . . . . 1.73 109.879 168.504 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 148.71 -174.78 28.25 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.437 -0.887 . . . . 1.84 111.196 -169.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 47.1 t -63.37 128.82 37.57 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 117.029 0.414 . . . . 1.87 110.657 -179.016 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.411 HD11 ' HB2' ' A' ' 37' ' ' SER . 61.9 tp -61.7 -31.41 71.55 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.022 -0.535 . . . . 1.83 110.223 -179.59 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -49.39 -54.22 18.51 Favored 'General case' 0 CA--C 1.52 -0.178 0 CA-C-N 115.41 -0.814 . . . . 2.11 110.345 173.218 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.4 ' HD3' ' HA ' ' A' ' 12' ' ' LYS . 0.1 OUTLIER -69.81 -27.69 65.09 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.755 -0.657 . . . . 3.11 111.11 -178.863 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -66.51 -56.32 11.41 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-O 121.002 0.43 . . . . 1.17 110.224 -179.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 94.0 mt -60.18 -40.5 90.2 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.894 -0.594 . . . . 1.31 111.156 176.006 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -62.14 -35.85 80.03 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.027 0.441 . . . . 1.98 110.465 178.321 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -62.92 -43.52 98.58 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 116.067 -0.515 . . . . 2.33 109.876 176.641 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.622 ' OH ' ' HA ' ' A' ' 46' ' ' VAL . 44.9 t80 -70.02 -35.53 74.4 Favored 'General case' 0 C--O 1.224 -0.251 0 N-CA-C 109.996 -0.372 . . . . 1.05 109.996 -178.613 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.682 ' HA ' ' CE2' ' A' ' 23' ' ' PHE . . . -52.24 -39.85 60.87 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-O 120.695 0.283 . . . . 1.15 111.724 176.292 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.9 -15.58 55.67 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 112.478 0.548 . . . . 1.26 112.478 178.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 17.8 t-80 -57.85 -57.44 12.75 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 122.312 0.245 . . . . 2.52 111.316 -179.058 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.567 ' HB3' ' HD1' ' A' ' 23' ' ' PHE . 25.1 t -109.15 -12.47 14.81 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.069 0.462 . . . . 1.79 111.237 -179.493 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 74.35 53.69 6.63 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.87 -0.681 . . . . 0.68 112.428 -179.302 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.682 ' CE2' ' HA ' ' A' ' 18' ' ' ALA . 3.2 p90 -104.41 172.67 6.67 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.715 0.293 . . . . 0.68 110.497 -177.911 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 12.9 m -92.13 107.79 19.47 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.244 0.545 . . . . 1.3 111.678 -177.512 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.493 ' HG ' ' HE3' ' A' ' 69' ' ' TRP . 1.0 OUTLIER -98.18 126.08 43.5 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.953 -0.567 . . . . 2.3 110.178 177.549 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.43 ' HB2' HG22 ' A' ' 70' ' ' THR . 68.5 m -101.13 97.73 8.23 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.085 0.469 . . . . 1.67 110.146 178.15 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 6.4 p -147.98 133.58 11.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 115.56 -0.745 . . . . 1.52 110.171 179.272 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.509 ' HB2' ' CD1' ' A' ' 31' ' ' LEU . 50.2 m-20 -94.36 129.73 40.96 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.707 -0.479 . . . . 2.38 109.707 176.283 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -58.04 -10.78 2.01 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.581 -0.736 . . . . 2.45 112.704 -178.686 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 6.0 p -71.7 -41.99 67.94 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.718 0.294 . . . . 2.48 110.674 179.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.509 ' CD1' ' HB2' ' A' ' 28' ' ' ASP . 5.7 mp -63.79 -42.18 97.8 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.021 0.439 . . . . 1.92 111.329 179.013 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 2.5 p -91.67 13.36 18.28 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.026 -0.534 . . . . 1.82 111.668 -177.004 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.432 HH11 ' HD3' ' A' ' 33' ' ' ARG . 30.5 ttt180 -68.6 112.42 5.37 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.28 -0.418 . . . . 5.19 110.423 178.155 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 87.01 -0.79 86.41 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.783 -0.722 . . . . 1.62 112.013 -178.331 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 24.6 tptp -86.01 114.6 23.02 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 110.507 -0.183 . . . . 3.17 110.507 -178.589 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -106.41 164.32 12.13 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 110.112 -0.329 . . . . 2.52 110.112 176.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.552 ' O ' ' HA ' ' A' ' 7' ' ' PRO . 33.5 t -137.17 131.94 33.24 Favored 'General case' 0 N--CA 1.445 -0.719 0 N-CA-C 107.718 -1.216 . . . . 1.14 107.718 172.102 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.419 ' N ' HD21 ' A' ' 38' ' ' ASN . 0.9 OUTLIER -60.78 -21.61 63.24 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 112.761 0.652 . . . . 1.28 112.761 -176.367 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.41 ' HA2' HG23 ' A' ' 5' ' ' ILE . . . 128.37 -175.41 18.58 Favored Glycine 0 N--CA 1.446 -0.668 0 C-N-CA 120.033 -1.079 . . . . 0.49 113.201 172.845 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.452 ' N ' ' HB ' ' A' ' 5' ' ' ILE . 43.3 tp -160.0 127.69 4.66 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 107.798 -1.186 . . . . 1.36 107.798 -178.329 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 74.3 m80 -140.02 97.85 3.33 Favored 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 120.342 -0.543 . . . . 3.8 111.032 -178.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -169.4 175.75 43.58 Favored Glycine 0 N--CA 1.444 -0.808 0 C-N-CA 120.832 -0.699 . . . . 0.55 112.341 175.634 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.796 ' HA ' ' H ' ' A' ' 2' ' ' GLN . 14.7 t70 -88.61 76.1 8.18 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 107.526 -1.287 . . . . 2.18 107.526 170.616 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -96.98 149.29 22.07 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 114.844 -1.071 . . . . 1.5 112.953 -167.737 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 19.8 t0 -90.71 166.94 12.86 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.102 -0.954 . . . . 2.23 109.649 174.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.622 ' HA ' ' OH ' ' A' ' 17' ' ' TYR . 42.9 t -47.5 -73.08 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 N-CA-C 113.616 0.969 . . . . 1.25 113.616 -170.513 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -65.0 -29.5 70.42 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 112.467 0.543 . . . . 2.39 112.467 -174.129 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 16.6 m -71.29 -33.1 69.43 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.216 0.531 . . . . 1.65 110.556 -177.189 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -76.51 -33.47 47.78 Favored Glycine 0 N--CA 1.446 -0.688 0 N-CA-C 111.275 -0.73 . . . . 0.4 111.275 -178.329 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.681 ' HB3' HG13 ' A' ' 61' ' ' VAL . 85.7 mt -67.9 -42.37 81.26 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.916 0.389 . . . . 1.63 110.479 178.599 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -56.24 -38.81 71.6 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.846 -0.615 . . . . 3.01 111.083 179.084 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 32.2 mm-40 -62.29 -56.31 19.72 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.918 0.39 . . . . 2.18 111.299 177.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 86.7 mt -57.5 -33.76 68.37 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.917 -0.583 . . . . 1.4 112.092 -177.613 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 10.8 mp -98.98 13.88 31.12 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 112.362 0.505 . . . . 2.78 112.362 -175.306 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -60.23 111.14 1.42 Allowed 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.916 0.389 . . . . 2.24 111.175 177.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 66.02 39.18 94.69 Favored Glycine 0 C--N 1.332 0.311 0 CA-C-N 115.83 -0.623 . . . . 1.96 112.583 178.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 63.9 p -98.72 -17.13 18.69 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.812 0.339 . . . . 2.28 111.733 -176.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.883 ' HA2' ' HB3' ' A' ' 75' ' ' PRO . . . 81.05 6.67 89.28 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.57 -0.824 . . . . 1.79 111.154 -172.811 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.471 HD11 HD21 ' A' ' 71' ' ' LEU . 96.1 mt -113.79 165.8 12.19 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.157 -0.521 . . . . 1.82 110.335 -177.875 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 31.0 tt0 -145.35 117.93 8.59 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 108.823 -0.806 . . . . 3.26 108.823 179.067 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.681 HG13 ' HB3' ' A' ' 50' ' ' LEU . 7.5 p -92.71 129.61 43.02 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 N-CA-C 110.116 -0.328 . . . . 2.17 110.116 -179.605 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.483 ' NZ ' ' HG3' ' A' ' 72' ' ' GLU . 21.1 mtmm -130.5 122.38 19.79 Favored Pre-proline 0 C--N 1.322 -0.601 0 CA-C-N 116.354 -0.385 . . . . 2.29 110.736 179.361 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_exo -61.07 117.7 4.5 Favored 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 122.141 1.894 . . . . 0.94 109.895 169.456 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -62.2 -43.65 98.34 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.29 -0.868 . . . . 2.32 111.052 -170.323 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 152.95 -63.82 0.37 Allowed Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.476 -0.868 . . . . 1.69 112.155 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 7.3 m-20 -82.92 57.2 3.75 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.654 0.264 . . . . 3.67 111.134 -178.475 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 6.3 t30 56.18 44.24 25.38 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 121.595 0.712 . . . . 2.59 110.78 178.004 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 14.7 m -142.34 177.61 8.15 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 108.848 -0.797 . . . . 1.54 108.848 177.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . 0.551 ' HH2' ' CD1' ' A' ' 17' ' ' TYR . 48.1 m0 -136.73 155.59 49.65 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 116.582 -0.281 . . . . 0.54 110.488 -172.075 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.43 HG22 ' HB2' ' A' ' 26' ' ' SER . 1.6 p -139.47 132.43 29.4 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.143 -0.48 . . . . 1.49 109.753 173.463 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.471 HD21 HD11 ' A' ' 59' ' ' LEU . 51.7 tp -93.19 104.31 16.51 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.501 0.667 . . . . 2.24 110.651 -178.766 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.483 ' HG3' ' NZ ' ' A' ' 62' ' ' LYS . 37.9 mm-40 -90.73 124.29 62.69 Favored Pre-proline 0 C--N 1.319 -0.748 0 CA-C-N 114.701 -1.136 . . . . 2.25 110.75 177.925 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_exo -74.1 113.54 3.81 Favored 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 121.833 1.689 . . . . 1.45 110.542 171.365 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . 175.78 103.76 0.09 OUTLIER Pre-proline 0 C--N 1.332 -0.172 0 CA-C-N 116.031 -0.531 . . . . 2.07 110.581 -175.643 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.883 ' HB3' ' HA2' ' A' ' 58' ' ' GLY . 96.8 Cg_endo -80.19 43.76 1.59 Allowed 'Trans proline' 0 N--CA 1.461 -0.384 0 C-N-CA 122.558 2.172 . . . . 2.85 112.066 177.764 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 53.64 66.51 4.46 Favored Pre-proline 0 C--O 1.232 0.182 0 CA-C-N 115.65 -0.705 . . . . 4.66 110.409 -174.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -96.96 -178.97 0.38 Allowed 'Trans proline' 0 N--CA 1.449 -1.141 0 C-N-CA 123.717 2.945 . . . . 4.26 111.558 -173.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 13.8 tppt? -95.51 62.57 2.41 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 120.567 -0.453 . . . . 6.5 110.717 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 60.57 108.78 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 115.043 -0.981 . . . . 8.11 112.244 176.456 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 . . . . . 0 C--O 1.245 0.841 0 CA-C-O 118.494 -0.765 . . . . 9.05 110.572 179.063 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.024 0 N-CA-C 109.803 -0.443 . . . . 4.29 109.803 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 46.8 mt-30 -72.0 130.54 41.2 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.154 0.502 . . . . 4.51 110.288 179.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 40.7 t -134.75 145.13 32.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 115.53 -0.759 . . . . 2.2 109.6 -175.303 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 5.2 p30 -128.08 98.25 5.05 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-O 121.776 0.798 . . . . 2.75 109.337 179.322 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 50.0 mm -102.21 110.01 27.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 115.34 -0.845 . . . . 1.5 109.558 -178.434 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -78.86 149.02 73.38 Favored Pre-proline 0 C--N 1.319 -0.73 0 CA-C-N 115.587 -0.733 . . . . 1.99 109.692 -179.008 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -55.31 134.65 65.07 Favored 'Trans proline' 0 N--CA 1.461 -0.422 0 C-N-CA 121.961 1.774 . . . . 1.73 109.656 169.113 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 150.46 -177.23 28.66 Favored Glycine 0 N--CA 1.445 -0.767 0 N-CA-C 110.41 -1.076 . . . . 1.84 110.41 -169.256 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.578 ' HA ' ' HA ' ' A' ' 36' ' ' GLN . 10.2 t -65.31 140.29 58.67 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 117.266 0.533 . . . . 1.87 110.221 -178.615 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.471 HD11 ' HG3' ' A' ' 35' ' ' LYS . 12.6 mt -58.15 -27.27 63.64 Favored 'General case' 0 CA--C 1.52 -0.187 0 CA-C-N 116.332 -0.394 . . . . 1.83 110.513 177.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -49.28 -55.27 13.27 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 115.417 -0.81 . . . . 2.11 110.724 173.582 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 25.1 ttmm -66.07 -33.86 76.75 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.944 -0.571 . . . . 3.11 110.806 -179.778 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -65.6 -59.83 3.55 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.239 -0.437 . . . . 1.17 110.917 -176.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 93.7 mt -57.57 -38.47 74.86 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.149 -0.478 . . . . 1.31 111.31 178.219 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 54.2 t30 -60.45 -35.51 76.02 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.119 -0.492 . . . . 1.98 110.547 178.509 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 19.7 tm0? -61.19 -49.4 77.34 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.313 -0.403 . . . . 2.33 110.779 177.55 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -67.45 -42.64 82.74 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 109.309 -0.626 . . . . 1.05 109.309 -177.209 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.654 ' HA ' ' CZ ' ' A' ' 23' ' ' PHE . . . -53.44 -51.08 63.8 Favored 'General case' 0 CA--C 1.521 -0.157 0 CA-C-N 115.552 -0.749 . . . . 1.15 111.724 176.812 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.94 -26.29 68.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.236 -0.438 . . . . 1.26 111.507 -179.426 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 71.2 t60 -64.31 -50.34 68.21 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.265 -0.425 . . . . 2.52 111.722 -177.652 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.62 ' HB3' ' HD1' ' A' ' 23' ' ' PHE . 47.0 t -99.26 -16.79 18.39 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-O 121.142 0.496 . . . . 1.79 111.438 -177.6 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 74.27 48.67 14.02 Favored Glycine 0 N--CA 1.45 -0.427 0 CA-C-N 115.884 -0.598 . . . . 0.68 112.665 -178.709 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.654 ' CZ ' ' HA ' ' A' ' 18' ' ' ALA . 29.9 p90 -110.33 168.23 9.61 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.784 0.326 . . . . 0.68 110.184 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 12.9 m -93.01 109.15 20.6 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.166 0.508 . . . . 1.3 111.077 -178.429 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.0 tt -93.77 128.89 40.23 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.053 -0.721 . . . . 2.3 109.053 177.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 34.5 t -103.1 99.81 9.7 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.108 0.48 . . . . 1.67 110.211 -178.104 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.1 p -147.83 133.14 11.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 115.821 -0.627 . . . . 1.52 110.498 179.05 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 -98.32 135.71 39.53 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.957 -0.565 . . . . 2.38 110.218 177.297 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -56.4 -22.3 30.61 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 114.93 -1.032 . . . . 2.45 112.676 -174.639 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 14.3 m -69.01 -14.58 63.12 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.892 0.377 . . . . 2.48 111.219 -176.55 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 90.7 mt -98.18 -22.78 16.0 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.11 0.481 . . . . 1.92 110.584 -179.633 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 12.1 p -109.85 5.51 22.62 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.031 -0.531 . . . . 1.82 112.211 -175.401 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 7.0 ptp180 -63.81 107.21 1.15 Allowed 'General case' 0 N--CA 1.453 -0.302 0 CA-C-O 121.199 0.524 . . . . 5.19 111.128 -179.32 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 83.6 4.25 89.2 Favored Glycine 0 N--CA 1.446 -0.646 0 CA-C-N 115.789 -0.641 . . . . 1.62 111.9 -179.542 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.471 ' HG3' HD11 ' A' ' 10' ' ' LEU . 20.9 tptm -83.78 104.42 13.87 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.766 -0.457 . . . . 3.17 109.766 -178.543 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . 0.578 ' HA ' ' HA ' ' A' ' 9' ' ' SER . 55.4 tt0 -103.77 155.09 18.86 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.64 -0.504 . . . . 2.52 109.64 -177.33 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.401 ' HB2' ' HG ' ' A' ' 10' ' ' LEU . 10.2 t -124.81 134.57 52.71 Favored 'General case' 0 N--CA 1.445 -0.685 0 N-CA-C 107.863 -1.162 . . . . 1.14 107.863 171.532 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -64.85 -16.93 63.8 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.35 -0.386 . . . . 1.28 111.824 -179.751 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 123.27 175.45 14.52 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.647 -0.787 . . . . 0.49 112.607 173.208 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 49.1 tp -160.1 128.2 4.74 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 108.919 -0.771 . . . . 1.36 108.919 -178.688 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 54.7 m80 -138.69 97.86 3.44 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 120.388 -0.525 . . . . 3.8 111.119 179.611 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -169.73 178.15 42.84 Favored Glycine 0 N--CA 1.446 -0.635 0 CA-C-N 115.636 -0.711 . . . . 0.55 111.812 175.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -82.69 87.1 6.75 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.479 0.657 . . . . 2.18 109.383 170.581 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 56.6 m-85 -109.71 128.81 55.52 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.451 -0.795 . . . . 1.5 110.478 -177.699 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 52.1 m-20 -82.97 177.03 8.81 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 109.282 -0.636 . . . . 2.23 109.282 174.378 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.608 ' HB ' ' OE1' ' A' ' 47' ' ' GLU . 26.1 t -49.79 -70.31 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 N-CA-C 112.52 0.563 . . . . 1.25 112.52 -170.777 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.608 ' OE1' ' HB ' ' A' ' 46' ' ' VAL . 1.7 mp0 -56.46 -45.82 80.69 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.53 0.567 . . . . 2.39 112.53 -175.408 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 23.3 t -71.9 -35.1 69.62 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-O 121.036 0.446 . . . . 1.65 111.161 -171.524 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -76.19 -38.32 34.85 Favored Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 120.547 -0.835 . . . . 0.4 111.533 -175.672 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.554 ' HB3' HG11 ' A' ' 61' ' ' VAL . 96.5 mt -67.78 -39.12 84.11 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.971 0.415 . . . . 1.63 110.719 179.88 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -58.58 -41.57 86.02 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.55 -0.75 . . . . 3.01 111.044 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 5.9 tp-100 -66.94 -46.4 74.87 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.242 -0.436 . . . . 2.18 111.027 -179.779 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 91.8 mt -56.16 -32.24 64.12 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 113.129 0.788 . . . . 1.4 113.129 -176.314 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 65.3 mt -92.19 9.0 35.49 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.904 0.705 . . . . 2.78 112.904 -174.167 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -65.68 133.14 50.47 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 120.827 0.346 . . . . 2.24 110.38 179.542 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 107.99 4.43 33.64 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.799 -0.715 . . . . 1.96 111.806 -176.107 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 22.2 p -149.91 -173.27 4.38 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.848 -0.427 . . . . 2.28 109.848 177.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.642 ' HA2' ' HB3' ' A' ' 75' ' ' PRO . . . -118.76 30.24 5.99 Favored Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 120.82 -0.705 . . . . 1.79 111.539 -176.277 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.423 ' HA ' ' HA ' ' A' ' 73' ' ' PRO . 42.8 mt -98.71 166.73 11.18 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.551 -0.537 . . . . 1.82 109.551 179.666 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 35.1 tt0 -154.79 118.6 4.61 Favored 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 108.625 -0.88 . . . . 3.26 108.625 178.126 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.554 HG11 ' HB3' ' A' ' 50' ' ' LEU . 3.2 p -94.61 127.12 46.84 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 N-CA-C 109.132 -0.692 . . . . 2.17 109.132 177.861 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.438 ' HA ' ' HD3' ' A' ' 63' ' ' PRO . 47.5 mtmt -128.58 142.72 45.79 Favored Pre-proline 0 C--N 1.318 -0.777 0 CA-C-N 115.909 -0.587 . . . . 2.29 110.335 -170.809 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 62' ' ' LYS . 12.4 Cg_exo -70.24 120.97 7.58 Favored 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 122.596 2.197 . . . . 0.94 111.022 175.739 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.435 HD21 ' HB ' ' A' ' 70' ' ' THR . 95.2 mt -58.39 -38.87 78.23 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.459 -0.792 . . . . 2.32 111.77 -174.607 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 161.8 -71.46 0.21 Allowed Glycine 0 N--CA 1.446 -0.697 0 C-N-CA 120.683 -0.77 . . . . 1.69 111.367 177.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -59.98 -77.14 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.777 0.322 . . . . 3.67 111.054 179.456 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 62.8 t30 -167.1 56.08 0.08 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.544 0.688 . . . . 2.59 109.572 177.356 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.434 ' O ' ' HD1' ' A' ' 69' ' ' TRP . 24.2 m -146.45 173.99 11.79 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 108.379 -0.971 . . . . 1.54 108.379 176.27 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . 0.502 ' CZ2' HG11 ' A' ' 46' ' ' VAL . 52.4 m0 -140.0 164.78 29.11 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 109.716 -0.475 . . . . 0.54 109.716 -168.793 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.435 ' HB ' HD21 ' A' ' 64' ' ' LEU . 6.6 t -149.01 145.43 27.3 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.711 -0.477 . . . . 1.49 109.711 170.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 58.2 tp -95.49 103.09 14.95 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.148 0.499 . . . . 2.24 110.828 178.64 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -105.76 145.07 30.15 Favored Pre-proline 0 C--N 1.322 -0.611 0 CA-C-N 115.632 -0.713 . . . . 2.25 111.115 174.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.423 ' HA ' ' HA ' ' A' ' 59' ' ' LEU . 7.2 Cg_exo -74.61 115.0 4.16 Favored 'Trans proline' 0 N--CA 1.46 -0.498 0 C-N-CA 122.333 2.022 . . . . 1.45 110.722 170.348 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . 179.82 88.42 0.19 Allowed Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 115.878 -0.601 . . . . 2.07 110.274 -175.591 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.642 ' HB3' ' HA2' ' A' ' 58' ' ' GLY . 98.6 Cg_endo -79.41 42.35 1.28 Allowed 'Trans proline' 0 N--CA 1.462 -0.369 0 C-N-CA 122.526 2.151 . . . . 2.85 112.002 -177.604 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 56.07 64.99 4.63 Favored Pre-proline 0 C--O 1.231 0.121 0 CA-C-N 115.629 -0.714 . . . . 4.66 109.377 -171.316 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -84.61 139.7 7.87 Favored 'Trans proline' 0 N--CA 1.455 -0.772 0 C-N-CA 122.849 2.366 . . . . 4.26 112.933 -170.438 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 99.7 mttt 65.87 -168.78 0.2 Allowed 'General case' 0 C--O 1.235 0.342 0 CA-C-N 115.584 -0.735 . . . . 6.5 110.53 179.525 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -140.8 100.59 3.88 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 120.893 0.378 . . . . 8.11 110.598 -178.307 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 . . . . . 0 C--O 1.245 0.866 0 CA-C-O 118.315 -0.85 . . . . 9.05 109.637 174.462 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.057 0 N-CA-C 110.087 -0.338 . . . . 4.29 110.087 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -168.47 165.93 12.38 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.391 0.615 . . . . 4.51 110.642 171.43 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 23.2 m -132.35 143.62 39.37 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 CA-C-N 115.076 -0.965 . . . . 2.2 109.555 177.464 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 5.2 p30 -128.43 96.82 4.53 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 108.741 -0.837 . . . . 2.75 108.741 179.079 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.423 ' HB ' ' H ' ' A' ' 40' ' ' LEU . 25.5 mt -132.82 159.72 43.02 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 CA-C-N 115.298 -0.865 . . . . 1.5 109.073 -173.845 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.686 ' HB3' ' HD2' ' A' ' 7' ' ' PRO . . . -164.67 172.15 4.93 Favored Pre-proline 0 C--N 1.319 -0.752 0 N-CA-C 108.419 -0.956 . . . . 1.99 108.419 -174.545 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.686 ' HD2' ' HB3' ' A' ' 6' ' ' ALA . 19.8 Cg_exo -30.49 126.75 0.07 OUTLIER 'Trans proline' 0 C--N 1.358 1.055 0 C-N-CA 124.001 3.134 . . . . 1.73 113.782 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 162.99 157.0 8.83 Favored Glycine 0 N--CA 1.445 -0.746 0 N-CA-C 110.33 -1.108 . . . . 1.84 110.33 -176.456 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.572 ' HA ' ' HA ' ' A' ' 36' ' ' GLN . 9.3 t -58.59 133.1 55.56 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 117.285 0.542 . . . . 1.87 110.038 179.857 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.719 HD22 ' HG ' ' A' ' 54' ' ' LEU . 62.2 tp -57.62 -30.49 65.39 Favored 'General case' 0 N--CA 1.462 0.131 0 CA-C-N 115.537 -0.756 . . . . 1.83 111.422 -173.26 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.55 ' CA ' ' HB ' ' A' ' 32' ' ' THR . 31.3 t70 -50.18 -56.77 9.67 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.627 -0.715 . . . . 2.11 111.367 176.808 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 37.3 ttmt -66.92 -26.99 67.13 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.549 -0.296 . . . . 3.11 110.96 -179.337 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.487 ' O ' ' HB3' ' A' ' 16' ' ' GLN . . . -65.84 -55.78 15.31 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.867 0.365 . . . . 1.17 110.467 179.335 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.592 HD12 HG21 ' A' ' 32' ' ' THR . 82.6 mt -59.18 -35.76 74.13 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.175 -0.466 . . . . 1.31 111.425 176.523 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -61.05 -39.61 90.48 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.933 -0.395 . . . . 1.98 109.933 176.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.487 ' HB3' ' O ' ' A' ' 13' ' ' ALA . 41.0 tp60 -58.74 -45.26 90.08 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.672 -0.694 . . . . 2.33 111.379 175.94 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.609 ' O ' ' HB2' ' A' ' 20' ' ' HIS . 8.5 t80 -66.49 -45.24 80.27 Favored 'General case' 0 CA--C 1.514 -0.422 0 CA-C-O 121.044 0.45 . . . . 1.05 110.127 -179.157 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.713 ' HA ' ' CE2' ' A' ' 23' ' ' PHE . . . -50.46 -33.84 22.6 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.165 -0.925 . . . . 1.15 111.966 179.327 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.3 -10.09 14.7 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 116.089 -0.505 . . . . 1.26 112.241 178.262 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . 0.609 ' HB2' ' O ' ' A' ' 17' ' ' TYR . 0.0 OUTLIER -55.8 -61.44 2.36 Favored 'General case' 0 CA--C 1.518 -0.286 0 CA-C-O 120.899 0.38 . . . . 2.52 111.524 178.235 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.555 ' HB3' ' HD1' ' A' ' 23' ' ' PHE . 46.0 t -113.65 -15.56 12.48 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.02 0.438 . . . . 1.79 111.411 -177.678 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 77.8 55.71 4.07 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.628 -0.796 . . . . 0.68 111.307 -174.428 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.713 ' CE2' ' HA ' ' A' ' 18' ' ' ALA . 2.7 p90 -101.87 164.55 11.66 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.696 0.284 . . . . 0.68 110.459 -177.62 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.565 ' O ' ' HB3' ' A' ' 68' ' ' SER . 5.6 m -88.8 107.02 18.75 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.489 0.661 . . . . 1.3 111.25 -174.496 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.503 HD23 ' HB ' ' A' ' 27' ' ' VAL . 1.2 tt -93.22 132.62 37.22 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.569 -0.742 . . . . 2.3 109.311 178.399 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.652 ' HB2' ' HA ' ' A' ' 70' ' ' THR . 50.1 m -94.95 92.29 6.81 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.533 -0.543 . . . . 1.67 109.533 176.508 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.503 ' HB ' HD23 ' A' ' 25' ' ' LEU . 11.6 p -144.76 148.22 18.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.607 -0.724 . . . . 1.52 110.529 -174.972 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -111.91 139.08 47.7 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.196 -0.456 . . . . 2.38 109.94 178.713 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -64.05 64.8 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.29 0 O-C-N 123.76 0.662 . . . . 2.45 111.829 176.511 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 26.1 p -170.91 -42.65 0.02 OUTLIER 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 109.507 -0.553 . . . . 2.48 109.507 -178.394 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 72.9 mt -64.71 -40.87 96.09 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.217 -0.902 . . . . 1.92 110.687 178.666 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.592 HG21 HD12 ' A' ' 14' ' ' LEU . 0.9 OUTLIER -103.83 -12.54 16.86 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.757 -0.656 . . . . 1.82 112.473 -178.515 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 57.4 ttp180 -88.38 134.88 33.71 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.856 0.36 . . . . 5.19 110.658 -176.047 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 104.37 -51.43 0.8 Allowed Glycine 0 N--CA 1.448 -0.534 0 N-CA-C 111.512 -0.635 . . . . 1.62 111.512 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.971 ' HD2' ' H ' ' A' ' 35' ' ' LYS . 0.0 OUTLIER -76.9 132.09 38.92 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.437 -0.579 . . . . 3.17 109.437 175.586 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . 0.572 ' HA ' ' HA ' ' A' ' 9' ' ' SER . 71.3 mt-30 -104.38 161.83 13.74 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.193 -0.458 . . . . 2.52 110.84 -175.23 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 13.1 t -131.89 136.51 47.47 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 107.838 -1.171 . . . . 1.14 107.838 173.227 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -70.75 -0.75 9.55 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 112.377 0.51 . . . . 1.28 112.377 -176.647 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 99.97 -171.44 23.64 Favored Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.632 -0.794 . . . . 0.49 113.222 170.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.423 ' H ' ' HB ' ' A' ' 5' ' ' ILE . 64.1 tp -160.44 145.6 14.7 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 107.85 -1.167 . . . . 1.36 107.85 -178.812 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 10.0 t-160 -145.11 98.09 3.11 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.366 -0.534 . . . . 3.8 110.847 177.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -169.31 -175.4 38.51 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.849 -0.691 . . . . 0.55 112.392 175.485 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 28.6 t0 -89.99 88.13 7.18 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 108.422 -0.955 . . . . 2.18 108.422 173.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 31.7 m-85 -116.08 142.42 46.83 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.491 0.662 . . . . 1.5 112.362 -170.251 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -90.77 -179.78 5.6 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 114.694 -1.139 . . . . 2.23 109.612 174.782 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.491 HG12 ' CZ2' ' A' ' 69' ' ' TRP . 78.7 t -53.03 -71.99 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 N-CA-C 112.679 0.622 . . . . 1.25 112.679 -176.562 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -62.18 -41.36 98.26 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.751 0.648 . . . . 2.39 112.751 -169.184 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 23.3 t -74.4 -34.29 63.25 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.17 0.509 . . . . 1.65 110.672 -174.487 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -74.49 -41.42 36.52 Favored Glycine 0 N--CA 1.446 -0.662 0 C-N-CA 120.803 -0.713 . . . . 0.4 111.659 -176.126 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.435 HD11 ' CG1' ' A' ' 61' ' ' VAL . 68.3 mt -67.3 -34.52 77.55 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.711 0.291 . . . . 1.63 110.638 -179.491 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 7.3 tp60 -57.27 -48.86 77.81 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.101 -0.499 . . . . 3.01 110.679 178.571 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.93 ' HA ' HE21 ' A' ' 52' ' ' GLN . 0.0 OUTLIER -67.67 -42.48 82.08 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.415 -0.357 . . . . 2.18 111.065 -178.599 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 78.8 mt -57.0 -40.6 76.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.053 -0.521 . . . . 1.4 112.16 -179.335 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.719 ' HG ' HD22 ' A' ' 10' ' ' LEU . 10.1 mp -97.74 2.54 49.7 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 112.306 0.484 . . . . 2.78 112.306 -173.772 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -62.07 111.85 2.11 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.047 0.451 . . . . 2.24 110.481 179.424 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 97.88 -7.2 62.74 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 121.06 -0.59 . . . . 1.96 112.505 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.5 m -87.75 -12.91 43.81 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.818 0.342 . . . . 2.28 111.043 -176.314 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 76.16 20.21 77.64 Favored Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 120.678 -0.772 . . . . 1.79 111.942 -179.363 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.41 ' CB ' HD23 ' A' ' 54' ' ' LEU . 96.3 mt -124.02 166.26 16.05 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 110.183 -0.302 . . . . 1.82 110.183 -179.473 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 17.2 tp60 -147.89 118.59 7.53 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.486 -0.561 . . . . 3.26 109.486 178.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.56 HG21 ' CD2' ' A' ' 54' ' ' LEU . 59.9 t -91.64 127.29 44.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 N-CA-C 109.473 -0.566 . . . . 2.17 109.473 176.409 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 41.4 tttm -117.12 128.01 26.32 Favored Pre-proline 0 C--N 1.318 -0.797 0 CA-C-N 116.051 -0.522 . . . . 2.29 109.761 -179.016 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -60.17 120.68 8.59 Favored 'Trans proline' 0 N--CA 1.461 -0.431 0 C-N-CA 121.867 1.712 . . . . 0.94 110.008 171.648 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -68.06 -50.51 54.73 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.973 -0.558 . . . . 2.32 110.211 -173.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 151.79 -52.92 0.48 Allowed Glycine 0 N--CA 1.445 -0.732 0 C-N-CA 120.605 -0.807 . . . . 1.69 112.001 178.402 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 78.8 m-20 -87.94 57.95 4.58 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.747 0.308 . . . . 3.67 110.949 -176.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 67.0 t30 50.73 37.37 16.54 Favored 'General case' 0 N--CA 1.473 0.675 0 CA-C-N 115.659 -0.701 . . . . 2.59 110.89 -177.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.565 ' HB3' ' O ' ' A' ' 24' ' ' THR . 49.7 m -141.21 178.63 7.27 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 108.128 -1.064 . . . . 1.54 108.128 178.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . 0.491 ' CZ2' HG12 ' A' ' 46' ' ' VAL . 54.2 m0 -135.49 167.41 21.13 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.046 0.45 . . . . 0.54 110.669 -169.22 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.652 ' HA ' ' HB2' ' A' ' 26' ' ' SER . 6.9 t -141.3 139.79 33.71 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.205 -0.907 . . . . 1.49 108.97 173.625 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.476 HD22 HG23 ' A' ' 27' ' ' VAL . 48.9 tp -92.37 104.29 16.64 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.642 0.734 . . . . 2.24 109.69 178.506 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 28.0 mm-40 -88.71 119.61 70.03 Favored Pre-proline 0 C--N 1.313 -0.994 0 CA-C-N 114.509 -1.223 . . . . 2.25 110.843 -179.605 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_exo -66.77 113.6 2.82 Favored 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 121.698 1.598 . . . . 1.45 110.037 172.142 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -161.19 78.24 2.3 Favored Pre-proline 0 C--N 1.321 -0.659 0 CA-C-N 115.692 -0.685 . . . . 2.07 109.374 -176.619 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -79.32 -72.17 0.01 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.874 0 C-N-CA 122.297 1.998 . . . . 2.85 112.384 -174.434 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.425 ' HA ' ' HG2' ' A' ' 79' ' ' GLU . . . -136.89 66.52 55.38 Favored Pre-proline 0 C--N 1.317 -0.832 0 N-CA-C 107.886 -1.153 . . . . 4.66 107.886 171.649 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -93.83 -15.95 0.74 Allowed 'Trans proline' 0 N--CA 1.451 -1.018 0 C-N-CA 123.031 2.487 . . . . 4.26 113.512 -168.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 62.0 mttm -143.47 26.53 1.6 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.156 0.503 . . . . 6.5 110.148 175.691 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.425 ' HG2' ' HA ' ' A' ' 76' ' ' ALA . 11.4 mm-40 -96.96 -40.87 8.67 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.814 -0.63 . . . . 8.11 109.815 -175.838 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 13.1 t70 . . . . . 0 C--O 1.245 0.82 0 CA-C-N 115.38 -0.827 . . . . 9.05 109.221 -179.637 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.509 ' O ' ' HA ' ' A' ' 43' ' ' ASP . . . . . . . . 0 N--CA 1.478 0.959 0 CA-C-O 121.027 0.441 . . . . 4.29 109.964 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -69.29 105.12 2.43 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-O 121.728 0.775 . . . . 4.51 111.434 -178.327 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 60.5 t -91.81 121.56 42.43 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 N-CA-C 107.966 -1.124 . . . . 2.2 107.966 172.25 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -130.1 128.87 42.74 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 109.532 -0.544 . . . . 2.75 109.532 -174.204 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 75.2 mt -133.88 132.26 56.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 116.391 -0.368 . . . . 1.5 110.608 -177.581 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -70.82 153.46 94.8 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 115.538 -0.756 . . . . 1.99 110.775 179.687 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.577 ' HA ' ' O ' ' A' ' 37' ' ' SER . 5.5 Cg_exo -75.23 34.16 0.4 Allowed 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 123.299 2.666 . . . . 1.73 113.492 -179.027 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.413 ' HA2' ' HB3' ' A' ' 36' ' ' GLN . . . -159.14 140.22 6.72 Favored Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 120.403 -0.903 . . . . 1.84 113.322 -178.073 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.492 ' H ' ' HG2' ' A' ' 36' ' ' GLN . 0.1 OUTLIER 64.01 92.15 0.07 Allowed 'General case' 0 C--O 1.233 0.203 0 C-N-CA 123.455 0.702 . . . . 1.87 111.993 175.019 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.623 HD12 ' HB3' ' A' ' 53' ' ' LEU . 52.2 tp -64.01 -36.91 85.53 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.172 0.511 . . . . 1.83 110.533 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.439 ' HB3' ' HG1' ' A' ' 32' ' ' THR . 14.1 p-10 -55.34 -43.41 74.95 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.525 -0.761 . . . . 2.11 111.392 177.288 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 27.8 ttpp -71.27 -28.47 64.17 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.168 0.508 . . . . 3.11 110.006 178.431 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -67.5 -52.47 38.73 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.475 -0.784 . . . . 1.17 110.736 179.722 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 91.3 mt -57.39 -40.59 78.53 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 115.812 -0.631 . . . . 1.31 111.596 178.366 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 10.9 t30 -59.75 -37.11 78.08 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.14 -0.482 . . . . 1.98 110.334 179.53 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.442 HE21 ' HB3' ' A' ' 16' ' ' GLN . 0.9 OUTLIER -63.41 -43.73 96.66 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.581 -0.736 . . . . 2.33 110.67 177.422 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.493 ' OH ' ' HA ' ' A' ' 46' ' ' VAL . 7.2 t80 -67.55 -45.61 75.17 Favored 'General case' 0 C--O 1.232 0.157 0 N-CA-C 109.846 -0.427 . . . . 1.05 109.846 -177.344 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.626 ' HA ' ' CZ ' ' A' ' 23' ' ' PHE . . . -53.98 -52.77 59.67 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 115.54 -0.754 . . . . 1.15 112.12 179.393 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.32 -30.59 71.7 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.911 0.386 . . . . 1.26 110.868 -178.337 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 75.1 t60 -65.85 -55.26 18.0 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.946 -0.57 . . . . 2.52 111.407 -178.183 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.567 ' HB3' ' CD1' ' A' ' 23' ' ' PHE . 34.9 t -90.82 0.67 57.39 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-O 120.786 0.327 . . . . 1.79 111.607 -173.465 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 64.68 36.53 93.25 Favored Glycine 0 CA--C 1.517 0.191 0 CA-C-N 116.19 -0.459 . . . . 0.68 113.785 175.074 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.626 ' CZ ' ' HA ' ' A' ' 18' ' ' ALA . 53.1 p90 -109.42 161.07 15.66 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.667 -0.494 . . . . 0.68 109.667 177.484 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 39.2 m -89.8 107.04 18.86 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.074 0.464 . . . . 1.3 110.077 178.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 6.9 tt -91.92 125.28 36.56 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.814 -0.63 . . . . 2.3 109.368 -179.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.583 ' O ' ' HA ' ' A' ' 70' ' ' THR . 14.6 t -111.54 97.56 6.83 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.352 0.596 . . . . 1.67 110.015 -178.62 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 6.6 p -91.72 130.64 40.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 109.279 -0.637 . . . . 1.52 109.279 177.274 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -69.83 105.92 2.95 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.403 -0.362 . . . . 2.38 110.642 -177.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 55.87 -90.86 0.03 OUTLIER 'General case' 0 C--O 1.232 0.176 0 O-C-N 124.152 0.908 . . . . 2.45 111.235 -176.458 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 2.3 t -171.32 56.22 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 108.933 -0.766 . . . . 2.48 108.933 176.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 90.3 mt -67.07 -17.16 64.76 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.55 -0.75 . . . . 1.92 111.136 -178.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.439 ' HG1' ' HB3' ' A' ' 11' ' ' ASP . 17.1 p -92.89 -1.74 56.47 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.05 -0.523 . . . . 1.82 111.214 -179.476 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 40.7 ttm180 -68.8 122.97 19.69 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.27 -0.423 . . . . 5.19 110.43 -179.753 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 99.05 -15.94 59.96 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.726 -0.75 . . . . 1.62 111.806 -178.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.899 ' HE3' ' HB3' ' A' ' 57' ' ' SER . 41.0 tttm -89.33 132.57 34.88 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-O 120.597 0.237 . . . . 3.17 110.362 177.404 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . 0.492 ' HG2' ' H ' ' A' ' 9' ' ' SER . 25.0 mt-30 -102.43 168.87 9.03 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 109.276 -0.638 . . . . 2.52 109.276 173.648 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.577 ' O ' ' HA ' ' A' ' 7' ' ' PRO . 22.9 t -139.33 124.02 18.48 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 106.823 -1.547 . . . . 1.14 106.823 173.273 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.417 ' N ' HD21 ' A' ' 38' ' ' ASN . 0.9 OUTLIER -55.19 -17.31 4.14 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 112.829 0.677 . . . . 1.28 112.829 -173.396 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 131.49 -178.93 17.48 Favored Glycine 0 N--CA 1.441 -1.012 0 C-N-CA 120.351 -0.928 . . . . 0.49 112.662 171.104 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 43.8 tp -160.35 122.72 3.28 Favored 'General case' 0 N--CA 1.445 -0.711 0 N-CA-C 107.275 -1.38 . . . . 1.36 107.275 -178.319 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 33.1 m-70 -142.5 97.82 3.19 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.176 0.513 . . . . 3.8 111.211 -178.056 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -171.75 178.19 44.15 Favored Glycine 0 N--CA 1.445 -0.701 0 CA-C-N 115.535 -0.757 . . . . 0.55 111.586 174.326 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.509 ' HA ' ' O ' ' A' ' 1' ' ' ALA . 6.5 m-20 -80.41 76.7 7.22 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 107.954 -1.128 . . . . 2.18 107.954 166.623 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -92.67 139.09 30.92 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 113.061 0.763 . . . . 1.5 113.061 -167.357 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -75.22 158.44 32.95 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 114.468 -1.242 . . . . 2.23 109.808 172.412 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.606 HG11 ' HZ2' ' A' ' 69' ' ' TRP . 85.0 t -49.32 -68.13 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 O-C-N 123.674 0.609 . . . . 1.25 112.056 -177.038 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -61.87 -31.56 71.85 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.141 -0.481 . . . . 2.39 112.148 -176.371 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 22.9 t -69.71 -35.03 74.69 Favored 'General case' 0 C--O 1.238 0.492 0 CA-C-O 121.308 0.575 . . . . 1.65 110.262 -176.669 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.506 ' O ' ' HG ' ' A' ' 53' ' ' LEU . . . -74.15 -30.8 60.39 Favored Glycine 0 N--CA 1.446 -0.668 0 N-CA-C 111.036 -0.826 . . . . 0.4 111.036 -177.479 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.61 HD23 ' CZ3' ' A' ' 69' ' ' TRP . 98.3 mt -70.71 -41.52 71.83 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.537 -0.331 . . . . 1.63 110.798 179.121 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -51.96 -46.52 64.81 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.07 -0.513 . . . . 3.01 111.232 178.507 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 13.2 mm100 -64.06 -45.81 87.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.741 0.305 . . . . 2.18 110.973 -179.711 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.623 ' HB3' HD12 ' A' ' 10' ' ' LEU . 79.9 mt -60.02 -32.24 70.7 Favored 'General case' 0 C--O 1.237 0.438 0 CA-C-N 116.115 -0.493 . . . . 1.4 111.874 179.068 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.437 HD13 ' O ' ' A' ' 54' ' ' LEU . 0.8 OUTLIER -70.06 -34.98 73.89 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.071 -0.513 . . . . 2.78 110.569 -177.926 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -55.9 110.14 0.69 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.205 -0.452 . . . . 2.24 110.752 -176.564 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 119.64 -2.7 13.65 Favored Glycine 0 N--CA 1.444 -0.8 0 C-N-CA 120.771 -0.728 . . . . 1.96 112.294 -179.235 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.899 ' HB3' ' HE3' ' A' ' 35' ' ' LYS . 68.9 p -121.35 169.46 10.58 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.923 0.392 . . . . 2.28 110.865 176.651 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -109.46 35.45 4.89 Favored Glycine 0 N--CA 1.445 -0.761 0 N-CA-C 110.112 -1.195 . . . . 1.79 110.112 175.16 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 27.4 mt -108.49 -179.35 3.85 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 114.805 -0.697 . . . . 1.82 109.138 -178.642 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 57.4 tp60 -142.57 119.47 11.26 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 108.483 -0.932 . . . . 3.26 108.483 173.654 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.599 HG11 ' HB3' ' A' ' 50' ' ' LEU . 3.7 p -85.1 117.8 30.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-O 121.446 0.641 . . . . 2.17 109.386 179.147 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 49.2 mtpt -123.47 124.94 26.19 Favored Pre-proline 0 C--N 1.32 -0.693 0 CA-C-N 115.828 -0.624 . . . . 2.29 110.139 -173.543 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_exo -60.4 118.49 5.37 Favored 'Trans proline' 0 N--CA 1.456 -0.71 0 C-N-CA 121.861 1.707 . . . . 0.94 109.886 171.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -57.13 -38.37 73.38 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.395 -0.821 . . . . 2.32 111.361 -171.137 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 160.55 -50.57 0.36 Allowed Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 119.812 -1.185 . . . . 1.69 112.949 176.554 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 3.4 p30 -116.66 71.85 0.8 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.174 0.512 . . . . 3.67 111.305 -176.644 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 58.6 t30 55.87 43.03 28.21 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 115.292 -0.867 . . . . 2.59 110.749 179.598 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.44 ' O ' ' HD1' ' A' ' 69' ' ' TRP . 42.4 t -139.61 173.04 11.95 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 107.369 -1.345 . . . . 1.54 107.369 177.215 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . 0.61 ' CZ3' HD23 ' A' ' 50' ' ' LEU . 30.1 m0 -141.62 160.87 39.28 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.445 -0.576 . . . . 0.54 109.445 -171.783 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.583 ' HA ' ' O ' ' A' ' 26' ' ' SER . 8.9 t -148.67 146.14 28.03 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.618 -0.512 . . . . 1.49 109.618 169.791 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -93.7 99.93 12.25 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.373 0.606 . . . . 2.24 109.471 176.122 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.424 ' HA ' ' HD3' ' A' ' 73' ' ' PRO . 33.2 tt0 -96.59 126.86 41.76 Favored Pre-proline 0 C--N 1.319 -0.749 0 CA-C-N 115.187 -0.915 . . . . 2.25 110.636 177.611 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 72' ' ' GLU . 7.1 Cg_exo -72.34 114.11 3.9 Favored 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 122.02 1.813 . . . . 1.45 111.103 177.227 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -166.06 80.76 1.09 Allowed Pre-proline 0 C--N 1.322 -0.589 0 CA-C-N 115.721 -0.672 . . . . 2.07 109.87 -177.213 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -84.41 36.87 0.59 Allowed 'Trans proline' 0 N--CA 1.459 -0.5 0 C-N-CA 122.706 2.27 . . . . 2.85 112.497 -177.328 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 57.84 59.66 6.63 Favored Pre-proline 0 N--CA 1.463 0.186 0 CA-C-N 116.074 -0.512 . . . . 4.66 110.4 -174.553 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -85.2 10.5 3.71 Favored 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 122.762 2.308 . . . . 4.26 112.356 -173.513 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 23.0 tptm -70.79 -40.43 72.57 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.812 -0.631 . . . . 6.5 110.182 179.144 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -127.62 174.72 8.84 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.822 -0.626 . . . . 8.11 110.38 -177.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 26.2 t70 . . . . . 0 C--O 1.248 0.982 0 CA-C-O 118.572 -0.727 . . . . 9.05 109.549 176.732 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.962 0 CA-C-O 120.777 0.322 . . . . 4.29 110.805 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 4.8 pp0? -69.59 150.4 47.12 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.972 0.415 . . . . 4.51 110.708 -176.085 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 9.4 p -142.38 147.36 21.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 115.757 -0.656 . . . . 2.2 109.939 -176.054 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 47.2 m-80 -128.9 100.26 5.61 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.882 0.372 . . . . 2.75 110.001 -177.338 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.442 HD13 ' HB2' ' A' ' 13' ' ' ALA . 48.4 mm -108.69 127.45 65.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 116.121 -0.491 . . . . 1.5 110.856 -177.611 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.485 ' HA ' ' HD3' ' A' ' 7' ' ' PRO . . . -67.78 139.52 93.61 Favored Pre-proline 0 C--N 1.331 -0.22 0 CA-C-N 116.21 -0.45 . . . . 1.99 110.725 178.607 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.485 ' HD3' ' HA ' ' A' ' 6' ' ' ALA . 14.6 Cg_exo -72.17 36.87 0.34 Allowed 'Trans proline' 0 CA--C 1.534 0.522 0 C-N-CA 123.818 3.012 . . . . 1.73 114.628 -176.219 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -175.22 45.93 0.13 Allowed Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 119.467 -1.349 . . . . 1.84 114.55 176.446 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.43 ' HA ' ' O ' ' A' ' 35' ' ' LYS . 32.1 t -177.78 101.75 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 117.342 0.571 . . . . 1.87 111.279 173.391 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.465 HD23 ' HG ' ' A' ' 57' ' ' SER . 53.7 tp -64.36 -37.29 86.99 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-O 121.328 0.585 . . . . 1.83 109.459 169.122 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -48.79 -60.95 2.31 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 114.849 -1.069 . . . . 2.11 111.366 177.281 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -68.22 -22.48 64.79 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.702 0.287 . . . . 3.11 111.068 179.45 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.442 ' HB2' HD13 ' A' ' 5' ' ' ILE . . . -63.73 -54.72 30.95 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.902 0.382 . . . . 1.17 110.475 179.778 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 93.3 mt -58.63 -39.06 79.45 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.618 -0.719 . . . . 1.31 110.696 176.514 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 55.8 t30 -61.68 -45.52 93.67 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.903 -0.59 . . . . 1.98 110.276 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.447 HE21 ' HB3' ' A' ' 16' ' ' GLN . 0.9 OUTLIER -61.7 -45.61 93.26 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.934 -0.575 . . . . 2.33 110.892 177.489 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.438 ' HD1' ' HZ ' ' A' ' 23' ' ' PHE . 1.3 t80 -65.18 -43.15 92.6 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 109.719 -0.475 . . . . 1.05 109.719 -177.396 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.811 ' HA ' ' CE2' ' A' ' 23' ' ' PHE . . . -55.3 -49.34 72.38 Favored 'General case' 0 CA--C 1.519 -0.226 0 CA-C-N 115.564 -0.743 . . . . 1.15 111.551 178.211 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.64 -28.08 68.2 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.398 -0.365 . . . . 1.26 111.249 -178.72 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 42.3 t60 -58.69 -50.23 74.64 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.919 -0.582 . . . . 2.52 111.906 -176.581 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.482 ' HB3' ' CD1' ' A' ' 23' ' ' PHE . 8.2 t -109.79 1.61 19.45 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-O 121.207 0.527 . . . . 1.79 111.452 -178.514 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 62.11 47.54 89.19 Favored Glycine 0 CA--C 1.522 0.509 0 CA-C-N 115.638 -0.71 . . . . 0.68 114.366 175.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.811 ' CE2' ' HA ' ' A' ' 18' ' ' ALA . 3.6 p90 -104.96 166.59 10.27 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 117.238 0.519 . . . . 0.68 110.563 177.222 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 24.2 m -90.93 119.39 31.09 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.417 0.627 . . . . 1.3 112.183 -175.478 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.655 HD12 ' HE3' ' A' ' 69' ' ' TRP . 1.5 mm? -92.93 122.5 35.37 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.36 -0.836 . . . . 2.3 111.231 175.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 63.4 m -97.99 94.91 7.13 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.291 0.567 . . . . 1.67 109.603 175.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 11.2 p -139.07 140.51 38.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 115.611 -0.722 . . . . 1.52 110.846 -174.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.979 ' HB3' HD11 ' A' ' 31' ' ' LEU . 7.8 t70 -68.43 149.46 49.29 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.81 -0.632 . . . . 2.38 109.771 174.863 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -53.3 -16.39 1.29 Allowed 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 114.952 1.464 . . . . 2.45 114.952 -170.553 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 7.4 p -165.57 69.99 0.14 Allowed 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 114.003 1.112 . . . . 2.48 114.003 -176.386 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.979 HD11 ' HB3' ' A' ' 28' ' ' ASP . 2.7 mp -96.99 -34.2 11.28 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.585 0.707 . . . . 1.92 109.132 164.181 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 5.6 p -95.46 21.19 8.45 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 114.959 -1.019 . . . . 1.82 111.507 -178.189 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 32.8 ttt180 -66.28 105.63 1.48 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.033 0.444 . . . . 5.19 110.385 -176.623 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 77.24 22.91 69.68 Favored Glycine 0 N--CA 1.447 -0.598 0 CA-C-N 115.804 -0.634 . . . . 1.62 112.572 -179.069 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.43 ' O ' ' HA ' ' A' ' 9' ' ' SER . 8.8 tptp -76.33 156.41 33.36 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.678 -0.49 . . . . 3.17 109.678 178.456 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -139.36 140.61 37.53 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.075 0.464 . . . . 2.52 110.892 -177.669 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 9.4 t -140.04 133.21 29.66 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 107.427 -1.324 . . . . 1.14 107.427 175.103 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.472 ' C ' ' HA ' ' A' ' 7' ' ' PRO . 0.9 OUTLIER -60.47 -7.47 2.12 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 112.85 0.685 . . . . 1.28 112.85 -176.383 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 114.8 179.79 18.6 Favored Glycine 0 CA--C 1.503 -0.675 0 C-N-CA 120.509 -0.853 . . . . 0.49 112.652 167.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.434 ' N ' ' HB ' ' A' ' 5' ' ' ILE . 19.4 tp -160.96 123.05 3.07 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 107.681 -1.229 . . . . 1.36 107.681 -176.077 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 20.8 t-160 -144.57 97.49 3.04 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.356 0.598 . . . . 3.8 110.853 -178.125 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -169.67 -173.09 36.89 Favored Glycine 0 N--CA 1.445 -0.718 0 CA-C-N 115.228 -0.896 . . . . 0.55 110.919 177.262 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -88.89 82.26 6.77 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 109.559 -0.534 . . . . 2.18 109.559 171.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 73.6 m-85 -97.55 136.28 38.18 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.047 -0.524 . . . . 1.5 111.403 -175.6 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -86.6 173.6 9.44 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 108.801 -0.814 . . . . 2.23 108.801 176.119 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 52.9 t -52.56 -57.71 3.76 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 N-CA-C 111.928 0.344 . . . . 1.25 111.928 -173.111 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 51.5 mm-40 -62.86 -49.49 74.68 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-O 121.076 0.465 . . . . 2.39 111.809 -175.333 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 11.7 p -72.72 -24.18 60.95 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.892 -0.595 . . . . 1.65 111.286 -172.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.436 ' O ' ' HG ' ' A' ' 53' ' ' LEU . . . -75.87 -40.33 31.11 Favored Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 120.766 -0.73 . . . . 0.4 111.337 -178.263 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.495 ' HB3' HG11 ' A' ' 61' ' ' VAL . 95.4 mt -68.33 -45.09 73.86 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.811 0.338 . . . . 1.63 110.647 -178.757 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 42.6 tt0 -57.69 -42.94 84.69 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.818 -0.628 . . . . 3.01 110.865 -179.034 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 15.2 mm100 -66.44 -43.06 86.64 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.485 -0.325 . . . . 2.18 111.061 -179.37 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.436 ' HG ' ' O ' ' A' ' 49' ' ' GLY . 86.4 mt -57.64 -21.99 43.04 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 116.126 -0.488 . . . . 1.4 112.099 178.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.572 HD21 HG12 ' A' ' 61' ' ' VAL . 97.7 mt -70.23 -8.97 54.28 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 111.932 0.345 . . . . 2.78 111.932 -179.234 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -67.89 107.75 2.76 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.097 0.475 . . . . 2.24 110.164 178.756 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 116.94 2.17 18.85 Favored Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 120.827 -0.702 . . . . 1.96 112.055 -177.121 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.465 ' HG ' HD23 ' A' ' 10' ' ' LEU . 50.3 m -137.24 167.77 20.93 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.113 0.482 . . . . 2.28 111.307 179.642 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.432 ' O ' ' HA ' ' A' ' 75' ' ' PRO . . . -116.97 15.29 13.69 Favored Glycine 0 N--CA 1.442 -0.927 0 N-CA-C 110.3 -1.12 . . . . 1.79 110.3 172.866 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.43 HD11 HD12 ' A' ' 71' ' ' LEU . 76.8 mt -92.29 179.48 5.54 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.339 -0.615 . . . . 1.82 109.339 179.577 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 30.9 tp60 -140.2 117.6 11.41 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.864 -0.421 . . . . 3.26 109.864 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.572 HG12 HD21 ' A' ' 54' ' ' LEU . 7.3 p -98.97 129.44 49.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 N-CA-C 109.623 -0.51 . . . . 2.17 109.623 175.79 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.807 ' HD3' ' HG3' ' A' ' 72' ' ' GLU . 20.4 ptmt -144.66 144.19 23.9 Favored Pre-proline 0 C--N 1.32 -0.712 0 CA-C-N 116.236 -0.438 . . . . 2.29 110.569 -176.865 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.518 ' HA ' ' HA ' ' A' ' 69' ' ' TRP . 21.1 Cg_exo -67.1 140.6 54.62 Favored 'Trans proline' 0 N--CA 1.462 -0.33 0 C-N-CA 122.82 2.347 . . . . 0.94 111.807 175.872 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.499 HD23 ' HB ' ' A' ' 70' ' ' THR . 59.7 mt -65.71 -44.65 85.46 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.668 -0.696 . . . . 2.32 111.108 -179.379 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 178.52 -60.8 0.09 OUTLIER Glycine 0 N--CA 1.445 -0.762 0 C-N-CA 120.274 -0.965 . . . . 1.69 112.307 178.027 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . 0.414 HD21 ' HA ' ' A' ' 66' ' ' ASN . 3.7 m120 -91.84 -79.8 0.37 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.738 0.304 . . . . 3.67 111.477 -177.362 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -142.2 42.35 1.65 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.36 0.6 . . . . 2.59 110.916 -174.323 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 9.8 m -143.53 172.91 12.14 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 108.28 -1.007 . . . . 1.54 108.28 175.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . 0.655 ' HE3' HD12 ' A' ' 25' ' ' LEU . 55.0 m0 -136.68 167.86 20.6 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.55 -0.537 . . . . 0.54 109.55 -172.716 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.499 ' HB ' HD23 ' A' ' 64' ' ' LEU . 9.5 t -142.36 142.5 32.46 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.641 -0.503 . . . . 1.49 109.641 174.125 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.726 HD11 HD23 ' A' ' 31' ' ' LEU . 0.4 OUTLIER -93.7 101.04 13.17 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 108.985 -0.746 . . . . 2.24 108.985 176.44 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.807 ' HG3' ' HD3' ' A' ' 62' ' ' LYS . 10.5 mm-40 -87.78 119.54 70.6 Favored Pre-proline 0 C--N 1.318 -0.799 0 CA-C-N 114.72 -1.127 . . . . 2.25 111.264 178.499 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -88.01 113.58 0.83 Allowed 'Trans proline' 0 N--CA 1.447 -1.209 0 C-N-CA 122.154 1.903 . . . . 1.45 111.104 173.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.611 ' HA ' ' HG3' ' A' ' 77' ' ' PRO . . . -169.14 73.2 0.73 Allowed Pre-proline 0 C--N 1.323 -0.582 0 CA-C-N 115.585 -0.734 . . . . 2.07 109.791 -178.835 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.432 ' HA ' ' O ' ' A' ' 58' ' ' GLY . 6.0 Cg_exo -75.83 -75.51 0.01 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.696 0 C-N-CA 122.458 2.105 . . . . 2.85 111.461 -177.199 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -142.08 60.89 11.44 Favored Pre-proline 0 C--N 1.32 -0.714 0 N-CA-C 107.81 -1.181 . . . . 4.66 107.81 170.166 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.611 ' HG3' ' HA ' ' A' ' 74' ' ' ALA . 86.1 Cg_endo -89.35 4.12 5.25 Favored 'Trans proline' 0 N--CA 1.453 -0.88 0 C-N-CA 123.097 2.531 . . . . 4.26 113.19 -165.333 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 22.5 ttmm -141.0 85.6 1.99 Allowed 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 108.862 -0.792 . . . . 6.5 108.862 171.146 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -69.28 144.92 53.46 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 114.502 -1.227 . . . . 8.11 111.052 -174.556 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 30.9 t70 . . . . . 0 C--O 1.249 1.035 0 CA-C-O 118.108 -0.949 . . . . 9.05 110.985 -177.384 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 0.987 0 CA-C-O 121.246 0.546 . . . . 4.29 109.784 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -99.83 163.1 12.61 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.786 0.803 . . . . 4.51 112.262 -175.091 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.76 ' HB ' ' HE1' ' A' ' 44' ' ' TYR . 41.5 t -145.91 152.7 13.86 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 N-CA-C 106.857 -1.535 . . . . 2.2 106.857 176.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 8.9 m120 -124.31 101.21 7.06 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.333 0.587 . . . . 2.75 109.766 -177.167 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 62.2 mt -116.63 147.51 19.97 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 115.371 -0.831 . . . . 1.5 109.291 -178.297 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.688 ' HB1' ' HD2' ' A' ' 7' ' ' PRO . . . -162.56 167.19 12.58 Favored Pre-proline 0 C--N 1.319 -0.745 0 N-CA-C 108.588 -0.893 . . . . 1.99 108.588 -172.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.688 ' HD2' ' HB1' ' A' ' 6' ' ' ALA . 11.2 Cg_exo -32.85 131.58 0.1 Allowed 'Trans proline' 0 C--N 1.357 0.998 0 C-N-CA 124.183 3.255 . . . . 1.73 113.748 -175.326 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 156.0 171.57 22.53 Favored Glycine 0 N--CA 1.441 -1.0 0 N-CA-C 110.154 -1.178 . . . . 1.84 110.154 -174.25 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -67.59 137.76 55.93 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 108.95 -0.759 . . . . 1.87 108.95 178.918 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.409 HD13 ' HB3' ' A' ' 13' ' ' ALA . 49.8 tp -59.07 -27.13 65.24 Favored 'General case' 0 C--O 1.232 0.178 0 C-N-CA 122.675 0.39 . . . . 1.83 110.204 -178.161 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -49.53 -49.58 45.48 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.185 -0.916 . . . . 2.11 109.873 172.663 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 57.9 tttm -68.08 -32.14 72.25 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.561 -0.745 . . . . 3.11 110.882 -178.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.409 ' HB3' HD13 ' A' ' 10' ' ' LEU . . . -65.07 -52.48 55.41 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.878 0.371 . . . . 1.17 110.043 -179.902 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.441 HD23 HD13 ' A' ' 53' ' ' LEU . 91.5 mt -56.71 -40.6 75.95 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.707 -0.679 . . . . 1.31 110.485 173.676 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 9.3 t30 -62.23 -41.06 98.06 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.837 -0.62 . . . . 1.98 110.612 179.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 24.2 tp60 -59.45 -46.45 88.73 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.194 -0.457 . . . . 2.33 111.475 179.034 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.452 ' HD1' ' HZ ' ' A' ' 23' ' ' PHE . 1.6 t80 -67.74 -44.02 78.55 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 109.061 -0.718 . . . . 1.05 109.061 179.568 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.78 ' HA ' ' CE2' ' A' ' 23' ' ' PHE . . . -54.23 -53.7 49.95 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 114.894 -1.048 . . . . 1.15 111.823 179.225 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.98 -27.26 68.01 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.794 0.331 . . . . 1.26 111.225 -178.34 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 69.1 t60 -61.52 -49.46 76.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.034 -0.53 . . . . 2.52 111.399 -178.617 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.588 ' HB3' ' CD1' ' A' ' 23' ' ' PHE . 1.9 t -109.49 2.85 20.75 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-O 121.136 0.493 . . . . 1.79 111.485 -176.882 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 60.23 46.84 93.53 Favored Glycine 0 C--N 1.333 0.397 0 CA-C-N 115.56 -0.746 . . . . 0.68 114.366 174.221 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.907 ' HB3' ' HB3' ' A' ' 67' ' ' ASN . 5.8 p90 -106.47 167.06 10.1 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 117.273 0.536 . . . . 0.68 112.017 -179.824 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 6.7 m -94.14 112.88 24.74 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.206 -0.906 . . . . 1.3 112.055 -176.369 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.575 HD22 ' CE3' ' A' ' 69' ' ' TRP . 0.6 OUTLIER -88.43 123.68 33.21 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.213 -0.903 . . . . 2.3 111.341 176.828 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 20.7 t -103.05 91.14 3.99 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.152 -0.684 . . . . 1.67 109.152 176.44 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.7 p -146.78 135.96 16.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.017 -0.538 . . . . 1.52 110.922 -178.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.56 ' HB3' ' HG ' ' A' ' 31' ' ' LEU . 33.0 t70 -69.49 118.94 13.0 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-N 115.819 -0.628 . . . . 2.38 110.339 178.713 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.04 65.17 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.354 0 O-C-N 123.825 0.703 . . . . 2.45 112.172 177.391 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.422 ' HB3' ' OD2' ' A' ' 28' ' ' ASP . 34.3 t -172.68 -28.75 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.717 -0.674 . . . . 2.48 109.333 -179.111 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.56 ' HG ' ' HB3' ' A' ' 28' ' ' ASP . 98.1 mt -60.87 -51.26 70.05 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.757 -0.656 . . . . 1.92 111.133 178.699 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 6.9 t -101.99 11.31 38.69 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.194 -0.457 . . . . 1.82 111.394 -178.362 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 41.2 ttp180 -72.37 128.85 36.9 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.605 -0.271 . . . . 5.19 110.407 -177.643 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 88.15 -2.29 85.23 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.864 -0.684 . . . . 1.62 111.934 -179.606 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 32.5 tttp -88.95 139.2 30.69 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.644 -0.502 . . . . 3.17 109.644 179.627 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 65.4 mt-30 -128.98 150.68 50.29 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 110.044 -0.354 . . . . 2.52 110.044 -177.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 20.7 t -126.51 131.2 51.66 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 108.642 -0.873 . . . . 1.14 108.642 178.561 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.601 ' O ' ' HD3' ' A' ' 7' ' ' PRO . 9.2 m120 -73.04 -6.67 47.1 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 112.837 0.68 . . . . 1.28 112.837 -176.223 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 138.48 165.37 10.27 Favored Glycine 0 C--O 1.235 0.178 0 C-N-CA 119.903 -1.142 . . . . 0.49 114.049 168.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.727 ' HG ' ' OH ' ' A' ' 44' ' ' TYR . 57.1 tp -161.47 125.34 3.31 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 108.701 -0.852 . . . . 1.36 108.701 -178.606 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 15.4 p80 -145.45 109.0 4.67 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 112.254 0.465 . . . . 3.8 112.254 -179.049 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -168.92 -178.68 40.55 Favored Glycine 0 C--N 1.334 0.451 0 C-N-CA 120.511 -0.852 . . . . 0.55 112.932 170.625 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -86.39 110.64 19.84 Favored 'General case' 0 CA--C 1.517 -0.32 0 N-CA-C 107.801 -1.185 . . . . 2.18 107.801 167.255 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.76 ' HE1' ' HB ' ' A' ' 3' ' ' VAL . 51.0 m-85 -101.94 148.21 25.61 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.817 0.818 . . . . 1.5 113.015 -167.49 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 31.5 m-20 -92.92 144.21 25.49 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 106.137 -1.801 . . . . 2.23 106.137 156.275 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.458 ' O ' ' HG ' ' A' ' 50' ' ' LEU . 97.0 t -45.69 -63.14 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 N-CA-C 112.738 0.644 . . . . 1.25 112.738 -169.035 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -62.83 -32.11 73.25 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.883 0.373 . . . . 2.39 111.855 -176.131 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 62.5 m -71.08 -34.69 71.39 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.251 0.548 . . . . 1.65 111.075 -175.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -78.86 -27.22 57.05 Favored Glycine 0 N--CA 1.448 -0.525 0 N-CA-C 110.773 -0.931 . . . . 0.4 110.773 -176.539 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.721 ' HB3' HG12 ' A' ' 61' ' ' VAL . 87.6 mt -74.63 -36.18 62.9 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.282 -0.459 . . . . 1.63 110.461 179.702 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -59.1 -39.46 82.28 Favored 'General case' 0 N--CA 1.455 -0.186 0 CA-C-N 116.032 -0.531 . . . . 3.01 110.397 176.441 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 79.2 mm-40 -64.17 -38.92 92.79 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.859 0.362 . . . . 2.18 111.284 177.736 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.441 HD13 HD23 ' A' ' 14' ' ' LEU . 96.1 mt -60.0 -34.02 72.76 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.841 0.353 . . . . 1.4 111.395 177.303 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.445 HD23 ' HB2' ' A' ' 59' ' ' LEU . 96.1 mt -84.29 2.03 42.07 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 116.082 -0.508 . . . . 2.78 111.807 -176.646 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -62.23 114.86 3.7 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.037 -0.529 . . . . 2.24 111.146 -176.418 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 106.31 7.35 35.11 Favored Glycine 0 N--CA 1.45 -0.39 0 CA-C-N 116.005 -0.543 . . . . 1.96 112.533 179.341 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 20.3 p -143.24 -174.2 4.14 Favored 'General case' 0 C--N 1.324 -0.531 0 O-C-N 122.775 -0.25 . . . . 2.28 110.573 -178.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -132.05 44.91 1.16 Allowed Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 120.402 -0.904 . . . . 1.79 112.844 -175.508 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.553 ' HA ' ' H ' ' A' ' 74' ' ' ALA . 3.9 mp -100.65 177.28 5.05 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.824 -0.436 . . . . 1.82 109.824 171.773 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 26.8 tp60 -149.84 117.81 6.31 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 108.893 -0.78 . . . . 3.26 108.893 179.098 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.721 HG12 ' HB3' ' A' ' 50' ' ' LEU . 7.4 p -86.54 133.79 28.99 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 N-CA-C 109.655 -0.498 . . . . 2.17 109.655 178.36 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.426 ' HA ' ' HD3' ' A' ' 63' ' ' PRO . 55.1 mtpt -124.6 110.41 28.09 Favored Pre-proline 0 C--N 1.32 -0.688 0 N-CA-C 109.809 -0.441 . . . . 2.29 109.809 -178.141 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.501 ' HA ' ' HA ' ' A' ' 69' ' ' TRP . 2.8 Cg_exo -76.65 144.77 25.37 Favored 'Trans proline' 0 N--CA 1.462 -0.344 0 C-N-CA 123.161 2.574 . . . . 0.94 112.868 -177.697 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -91.09 23.48 3.23 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.834 0.826 . . . . 2.32 109.474 175.15 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 84.38 -68.1 3.58 Favored Glycine 0 N--CA 1.447 -0.603 0 CA-C-N 114.493 -1.23 . . . . 1.69 113.053 175.172 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . 0.43 ' C ' ' H ' ' A' ' 68' ' ' SER . 58.9 t30 -85.47 74.95 10.25 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.705 0.288 . . . . 3.67 111.184 -175.106 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . 0.907 ' HB3' ' HB3' ' A' ' 23' ' ' PHE . 7.8 m-20 72.35 -26.43 0.18 Allowed 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 113.253 0.834 . . . . 2.59 113.253 170.26 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.43 ' H ' ' C ' ' A' ' 66' ' ' ASN . 15.2 m -85.81 146.45 26.76 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 110.274 -0.269 . . . . 1.54 110.274 -175.578 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . 0.575 ' CE3' HD22 ' A' ' 25' ' ' LEU . 6.6 m0 -140.03 168.73 19.15 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.0 -0.741 . . . . 0.54 109.0 -175.914 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 14.9 t -143.85 136.08 26.73 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.13 -0.692 . . . . 1.49 109.13 169.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 54.6 tp -95.11 102.85 14.68 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.079 0.466 . . . . 2.24 110.732 -177.381 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -95.14 128.5 38.59 Favored Pre-proline 0 C--N 1.319 -0.725 0 CA-C-N 115.402 -0.817 . . . . 2.25 110.687 174.597 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -73.99 115.49 4.34 Favored 'Trans proline' 0 N--CA 1.46 -0.482 0 C-N-CA 121.976 1.784 . . . . 1.45 110.893 174.428 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.553 ' H ' ' HA ' ' A' ' 59' ' ' LEU . . . 176.48 123.11 0.16 Allowed Pre-proline 0 CA--C 1.521 -0.147 0 CA-C-N 116.094 -0.503 . . . . 2.07 110.29 -176.291 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_endo -84.64 37.43 0.62 Allowed 'Trans proline' 0 N--CA 1.456 -0.681 0 C-N-CA 122.704 2.269 . . . . 2.85 111.502 177.35 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.679 ' HB1' ' HB2' ' A' ' 79' ' ' GLU . . . 55.87 55.58 9.56 Favored Pre-proline 0 CA--C 1.53 0.193 0 CA-C-N 115.435 -0.802 . . . . 4.66 110.309 -174.777 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_endo -78.56 -9.93 15.95 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.506 2.137 . . . . 4.26 113.023 -169.724 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -118.09 -6.8 10.89 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.876 -0.602 . . . . 6.5 110.044 175.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.679 ' HB2' ' HB1' ' A' ' 76' ' ' ALA . 32.5 mm-40 -97.91 -37.96 9.6 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.735 -0.666 . . . . 8.11 109.728 -178.204 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 24.6 m-20 . . . . . 0 C--O 1.248 0.99 0 CA-C-O 118.185 -0.912 . . . . 9.05 110.815 -179.369 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.142 0 N-CA-C 110.177 -0.305 . . . . 4.29 110.177 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 31.8 tt0 -58.47 119.79 7.63 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.536 0.684 . . . . 4.51 111.545 -177.462 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.418 ' CG2' ' HB2' ' A' ' 44' ' ' TYR . 58.2 t -104.34 128.54 57.75 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 CA-C-N 114.861 -1.063 . . . . 2.2 108.457 174.545 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 43.8 t30 -126.9 98.87 5.5 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.14 0.495 . . . . 2.75 109.677 -175.405 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.511 HG21 ' HA2' ' A' ' 39' ' ' GLY . 27.1 mm -123.57 156.17 30.08 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 CA-C-N 115.306 -0.861 . . . . 1.5 108.777 -177.295 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.653 ' HB3' ' HD2' ' A' ' 7' ' ' PRO . . . -160.04 163.56 22.04 Favored Pre-proline 0 C--N 1.321 -0.657 0 N-CA-C 109.503 -0.554 . . . . 1.99 109.503 -177.35 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.653 ' HD2' ' HB3' ' A' ' 6' ' ' ALA . 6.6 Cg_exo -33.3 130.39 0.13 Allowed 'Trans proline' 0 C--N 1.357 1.002 0 C-N-CA 124.398 3.399 . . . . 1.73 113.314 -174.933 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 152.1 169.54 17.67 Favored Glycine 0 N--CA 1.44 -1.078 0 N-CA-C 110.96 -0.856 . . . . 1.84 110.96 -174.471 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.661 ' HA ' ' O ' ' A' ' 35' ' ' LYS . 53.9 m -61.48 141.56 57.61 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 120.815 0.34 . . . . 1.87 111.471 179.693 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.722 HD22 ' HB2' ' A' ' 57' ' ' SER . 43.8 tp -59.65 -35.77 75.08 Favored 'General case' 0 CA--C 1.52 -0.175 0 CA-C-O 121.104 0.478 . . . . 1.83 110.458 178.965 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.698 ' HB3' ' HB ' ' A' ' 32' ' ' THR . 2.0 p-10 -56.93 -31.77 65.29 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.305 -0.861 . . . . 2.11 111.256 175.735 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 29.0 ttpt -70.52 -41.06 73.08 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.227 0.537 . . . . 3.11 109.881 174.418 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -64.97 -55.38 19.41 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 115.424 -0.807 . . . . 1.17 110.972 -174.195 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.404 ' HB3' HD12 ' A' ' 25' ' ' LEU . 89.2 mt -58.06 -41.12 82.68 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.809 -0.632 . . . . 1.31 111.174 177.743 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 52.9 t30 -62.92 -40.29 97.18 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.223 -0.444 . . . . 1.98 110.288 179.102 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -62.57 -42.68 99.7 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.204 -0.453 . . . . 2.33 110.218 176.698 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.454 ' O ' ' HB3' ' A' ' 20' ' ' HIS . 4.9 t80 -65.58 -39.86 92.07 Favored 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 109.229 -0.656 . . . . 1.05 109.229 179.77 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.729 ' HA ' ' CZ ' ' A' ' 23' ' ' PHE . . . -55.56 -39.65 70.9 Favored 'General case' 0 CA--C 1.52 -0.184 0 CA-C-N 115.669 -0.696 . . . . 1.15 111.327 175.426 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.49 -30.09 71.27 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.202 -0.454 . . . . 1.26 111.212 179.272 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . 0.454 ' HB3' ' O ' ' A' ' 17' ' ' TYR . 62.8 t60 -60.55 -58.43 8.52 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 116.264 -0.425 . . . . 2.52 111.701 -177.905 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.529 ' HB3' ' HD1' ' A' ' 23' ' ' PHE . 11.4 t -98.38 -10.58 23.54 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-O 121.13 0.49 . . . . 1.79 111.739 -174.615 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 69.01 53.09 20.51 Favored Glycine 0 C--N 1.33 0.205 0 CA-C-N 115.833 -0.621 . . . . 0.68 113.232 179.62 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.729 ' CZ ' ' HA ' ' A' ' 18' ' ' ALA . 26.1 p90 -109.03 167.45 10.08 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.808 0.337 . . . . 0.68 110.535 179.264 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 25.3 m -92.9 109.73 21.18 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.439 0.638 . . . . 1.3 110.982 178.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.404 HD12 ' HB3' ' A' ' 14' ' ' LEU . 4.4 tt -91.64 128.09 37.34 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.433 -0.803 . . . . 2.3 109.299 179.7 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 25.4 t -99.09 100.2 11.31 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.07 0.462 . . . . 1.67 109.955 -179.319 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.3 p -129.34 130.86 67.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 115.987 -0.551 . . . . 1.52 110.552 -178.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.498 ' OD2' ' HB2' ' A' ' 30' ' ' SER . 23.7 t70 -75.46 123.83 26.11 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.663 -0.699 . . . . 2.38 110.816 178.791 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.62 49.75 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 113.338 0.866 . . . . 2.45 113.338 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.498 ' HB2' ' OD2' ' A' ' 28' ' ' ASP . 69.5 m -161.53 -28.12 0.05 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.847 0.356 . . . . 2.48 110.19 -179.696 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 75.9 mt -72.64 -43.79 62.76 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.51 0.672 . . . . 1.92 110.443 176.59 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.698 ' HB ' ' HB3' ' A' ' 11' ' ' ASP . 9.5 p -96.38 52.55 1.25 Allowed 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.726 -0.67 . . . . 1.82 112.279 -175.579 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 4.7 ptp180 -99.96 106.77 18.6 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-O 121.142 0.496 . . . . 5.19 111.042 175.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 70.77 46.61 45.01 Favored Glycine 0 N--CA 1.449 -0.474 0 CA-C-N 115.656 -0.702 . . . . 1.62 113.569 174.334 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.661 ' O ' ' HA ' ' A' ' 9' ' ' SER . 13.3 mptt -85.27 173.75 10.12 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 110.039 -0.356 . . . . 3.17 110.039 176.037 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 50.3 tt0 -149.84 134.85 17.92 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 120.778 0.323 . . . . 2.52 110.871 173.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 42.7 t -132.82 130.61 40.05 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 107.368 -1.345 . . . . 1.14 107.368 171.408 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.41 ' O ' ' HD3' ' A' ' 7' ' ' PRO . 0.1 OUTLIER -69.48 -7.75 40.77 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 113.122 0.786 . . . . 1.28 113.122 -173.89 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.511 ' HA2' HG21 ' A' ' 5' ' ' ILE . . . 117.4 -177.05 16.46 Favored Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 120.134 -1.032 . . . . 0.49 113.345 171.956 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.467 ' N ' ' HB ' ' A' ' 5' ' ' ILE . 60.4 tp -159.96 141.92 13.04 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 108.574 -0.899 . . . . 1.36 108.574 -178.414 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 50.8 t-80 -144.27 97.09 2.99 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.919 0.39 . . . . 3.8 110.658 179.72 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -170.46 177.88 43.41 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.973 -0.632 . . . . 0.55 111.837 175.071 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -92.7 99.99 12.58 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 108.44 -0.948 . . . . 2.18 108.44 171.316 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.418 ' HB2' ' CG2' ' A' ' 3' ' ' VAL . 25.6 m-85 -116.39 156.54 26.57 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 121.455 0.645 . . . . 1.5 112.227 -170.817 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -92.73 169.72 10.27 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 114.69 -1.141 . . . . 2.23 108.276 172.374 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.538 ' O ' ' HG ' ' A' ' 50' ' ' LEU . 78.1 t -48.01 -64.78 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 O-C-N 123.05 0.219 . . . . 1.25 111.438 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -61.53 -44.32 97.27 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 112.824 0.675 . . . . 2.39 112.824 -175.785 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 3.8 p -73.44 -31.06 63.6 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.037 0.446 . . . . 1.65 111.244 -173.418 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -72.48 -36.96 58.74 Favored Glycine 0 N--CA 1.446 -0.666 0 N-CA-C 111.233 -0.747 . . . . 0.4 111.233 179.56 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.538 ' HG ' ' O ' ' A' ' 46' ' ' VAL . 88.1 mt -71.61 -37.34 70.94 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.495 -0.352 . . . . 1.63 110.464 178.706 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -53.68 -47.42 70.44 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.866 -0.606 . . . . 3.01 110.576 179.307 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 14.1 mm100 -64.72 -42.27 95.36 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-O 120.807 0.337 . . . . 2.18 110.778 179.349 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 90.8 mt -59.75 -30.34 68.78 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 116.261 -0.427 . . . . 1.4 111.878 178.498 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.607 HD11 HG13 ' A' ' 61' ' ' VAL . 5.9 mp -72.73 -21.11 61.08 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.313 -0.403 . . . . 2.78 111.449 -179.457 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -71.94 86.98 1.01 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.139 0.495 . . . . 2.24 111.159 -177.234 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 113.1 -9.64 24.93 Favored Glycine 0 CA--C 1.52 0.365 0 CA-C-N 115.904 -0.589 . . . . 1.96 113.457 175.189 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.722 ' HB2' HD22 ' A' ' 10' ' ' LEU . 11.7 p -82.26 -24.72 34.61 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.961 0.381 . . . . 2.28 111.91 -175.577 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 88.57 5.1 75.53 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.918 -0.658 . . . . 1.79 112.664 176.748 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.557 HD11 HD21 ' A' ' 10' ' ' LEU . 95.8 mt -126.34 179.4 5.3 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.611 0.243 . . . . 1.82 110.86 -178.955 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 9.1 tt0 -147.39 118.97 7.96 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 109.163 -0.68 . . . . 3.26 109.163 179.597 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.607 HG13 HD11 ' A' ' 54' ' ' LEU . 7.7 p -98.43 128.02 50.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-O 121.215 0.531 . . . . 2.17 109.978 179.202 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.769 ' HE2' ' HB2' ' A' ' 72' ' ' GLU . 48.1 mtmt -109.36 130.12 23.13 Favored Pre-proline 0 C--N 1.322 -0.592 0 CA-C-N 116.146 -0.479 . . . . 2.29 110.719 -176.468 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -67.62 113.43 2.94 Favored 'Trans proline' 0 N--CA 1.457 -0.629 0 C-N-CA 122.102 1.868 . . . . 0.94 109.536 168.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 37.3 tp -60.04 -41.8 93.05 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.655 -0.702 . . . . 2.32 111.5 -171.102 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 165.67 -54.61 0.26 Allowed Glycine 0 N--CA 1.448 -0.556 0 N-CA-C 110.207 -1.157 . . . . 1.69 110.207 179.381 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 27.5 p-10 -86.32 -158.66 0.42 Allowed 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 108.935 -0.765 . . . . 3.67 108.935 171.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 20.1 p-10 -81.7 49.37 1.33 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.515 0.674 . . . . 2.59 110.796 176.108 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.459 ' O ' ' HD1' ' A' ' 69' ' ' TRP . 40.3 m -139.12 169.24 18.13 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 108.409 -0.96 . . . . 1.54 108.409 174.745 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . 0.459 ' HD1' ' O ' ' A' ' 68' ' ' SER . 45.0 m0 -140.12 171.35 14.31 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 110.035 -0.358 . . . . 0.54 110.035 -167.483 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.458 HG23 ' HE3' ' A' ' 62' ' ' LYS . 6.8 t -146.04 147.22 31.39 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.167 -0.47 . . . . 1.49 109.989 173.129 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -92.77 108.76 20.23 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.123 0.487 . . . . 2.24 110.992 -174.279 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.769 ' HB2' ' HE2' ' A' ' 62' ' ' LYS . 4.3 tp10 -93.21 122.23 63.72 Favored Pre-proline 0 C--N 1.322 -0.608 0 CA-C-N 115.345 -0.843 . . . . 2.25 110.539 175.091 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -84.43 113.47 1.71 Allowed 'Trans proline' 0 N--CA 1.453 -0.891 0 C-N-CA 121.863 1.709 . . . . 1.45 111.56 174.194 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . 178.7 106.48 0.15 Allowed Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 115.849 -0.614 . . . . 2.07 109.776 -178.363 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -83.31 -82.78 0.0 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 122.636 2.224 . . . . 2.85 112.667 -179.353 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -151.14 62.2 4.92 Favored Pre-proline 0 C--N 1.32 -0.707 0 N-CA-C 108.156 -1.053 . . . . 4.66 108.156 174.409 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_endo -91.52 14.55 1.85 Allowed 'Trans proline' 0 N--CA 1.453 -0.874 0 C-N-CA 123.086 2.524 . . . . 4.26 113.162 -165.461 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 60.9 tttm -113.71 157.19 22.52 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.546 -0.538 . . . . 6.5 109.546 178.696 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 64.56 30.84 12.66 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 121.108 0.48 . . . . 8.11 111.236 -176.713 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 28.4 t70 . . . . . 0 C--O 1.247 0.928 0 CA-C-O 118.467 -0.777 . . . . 9.05 109.708 176.736 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.942 0 N-CA-C 110.215 -0.291 . . . . 4.29 110.215 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.728 ' HB2' ' H ' ' A' ' 44' ' ' TYR . 7.9 mm100 -115.38 -8.81 12.22 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-O 120.864 0.364 . . . . 4.51 111.952 178.552 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.413 HG22 ' O ' ' A' ' 42' ' ' GLY . 21.5 m -145.61 143.3 21.82 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-N 115.927 -0.579 . . . . 2.2 111.114 -178.638 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 4.5 p-10 -128.55 96.88 4.53 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 107.967 -1.123 . . . . 2.75 107.967 171.748 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 21.3 mt -130.86 157.41 43.15 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.761 0 CA-C-N 115.655 -0.702 . . . . 1.5 109.883 -170.055 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.647 ' HB3' ' HD2' ' A' ' 7' ' ' PRO . . . -162.36 178.63 1.5 Allowed Pre-proline 0 C--N 1.321 -0.67 0 N-CA-C 108.224 -1.028 . . . . 1.99 108.224 -174.569 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.647 ' HD2' ' HB3' ' A' ' 6' ' ' ALA . 51.2 Cg_exo -39.33 129.38 1.6 Allowed 'Trans proline' 0 C--N 1.359 1.122 0 C-N-CA 122.685 2.257 . . . . 1.73 113.023 -178.383 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 163.41 161.85 13.34 Favored Glycine 0 N--CA 1.443 -0.872 0 N-CA-C 110.727 -0.949 . . . . 1.84 110.727 -174.664 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 37.2 p -61.61 137.69 58.26 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.951 0.376 . . . . 1.87 110.616 -178.127 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.449 HD22 ' HG ' ' A' ' 54' ' ' LEU . 64.0 tp -60.06 -32.43 70.93 Favored 'General case' 0 CA--C 1.52 -0.204 0 CA-C-O 121.102 0.477 . . . . 1.83 109.739 178.648 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.586 ' HB2' ' HB ' ' A' ' 32' ' ' THR . 11.4 t70 -50.32 -54.0 24.68 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.143 -0.935 . . . . 2.11 110.449 172.665 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 59.0 tttp -67.09 -32.38 73.49 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 116.213 -0.449 . . . . 3.11 110.949 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -64.26 -54.49 32.59 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.292 -0.413 . . . . 1.17 110.447 -177.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 85.5 mt -57.96 -41.92 83.9 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 115.854 -0.612 . . . . 1.31 111.071 176.165 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 12.9 t30 -62.65 -35.21 78.88 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.972 -0.558 . . . . 1.98 110.738 179.806 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.475 HE21 ' HB3' ' A' ' 16' ' ' GLN . 0.8 OUTLIER -61.17 -46.74 89.27 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 116.392 -0.367 . . . . 2.33 110.875 175.865 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.641 ' HD1' ' HH2' ' A' ' 69' ' ' TRP . 34.2 t80 -67.64 -32.05 72.48 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 120.986 -0.286 . . . . 1.05 110.421 -176.9 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.813 ' HA ' ' CZ ' ' A' ' 23' ' ' PHE . . . -50.94 -34.89 30.57 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 112.114 0.412 . . . . 1.15 112.114 175.625 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.55 -15.71 52.3 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.305 -0.407 . . . . 1.26 111.93 179.579 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 30.8 t-80 -59.67 -67.85 0.34 Allowed 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 116.628 -0.26 . . . . 2.52 111.42 179.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.689 ' HB3' ' HD1' ' A' ' 23' ' ' PHE . 23.0 t -101.12 -6.65 24.05 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.797 0.332 . . . . 1.79 111.505 -174.927 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 70.32 46.74 47.69 Favored Glycine 0 C--N 1.334 0.418 0 C-N-CA 120.771 -0.728 . . . . 0.68 112.524 178.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.813 ' CZ ' ' HA ' ' A' ' 18' ' ' ALA . 11.6 p90 -100.68 170.21 8.51 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.697 0.284 . . . . 0.68 110.477 -175.856 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.473 ' O ' ' HB3' ' A' ' 68' ' ' SER . 24.0 m -91.67 111.19 22.6 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.129 0.49 . . . . 1.3 110.872 -178.38 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 5.2 tt -93.32 125.82 38.13 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 115.915 -0.584 . . . . 2.3 109.565 -179.736 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.594 ' HB2' ' HA ' ' A' ' 70' ' ' THR . 15.2 m -99.1 93.01 5.75 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.158 -0.474 . . . . 1.67 109.908 -179.021 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 9.7 p -113.64 141.57 29.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 115.994 -0.548 . . . . 1.52 109.758 -178.503 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.418 ' HB3' ' HG ' ' A' ' 31' ' ' LEU . 23.1 t70 -98.0 125.62 43.02 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 110.176 -0.305 . . . . 2.38 110.176 179.604 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.16 57.97 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.525 0 O-C-N 123.802 0.689 . . . . 2.45 112.622 179.066 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 25.9 t -173.04 -28.61 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.221 -0.445 . . . . 2.48 110.042 -179.732 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.418 ' HG ' ' HB3' ' A' ' 28' ' ' ASP . 86.3 mt -77.28 -33.69 55.74 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.328 -0.396 . . . . 1.92 111.361 -178.136 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.586 ' HB ' ' HB2' ' A' ' 11' ' ' ASP . 6.0 p -92.4 13.27 20.02 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.26 0.552 . . . . 1.82 111.25 179.455 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 39.5 ttm180 -73.16 114.22 11.1 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.635 -0.711 . . . . 5.19 110.266 179.646 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 84.08 21.18 57.77 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.74 -0.743 . . . . 1.62 111.875 179.688 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 12.7 mptt -107.53 124.04 49.32 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.117 0.484 . . . . 3.17 111.23 -179.001 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 6.8 tt0 -131.69 141.06 49.47 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.353 -0.839 . . . . 2.52 109.135 177.734 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 7.3 t -121.8 121.06 36.36 Favored 'General case' 0 N--CA 1.443 -0.823 0 N-CA-C 107.003 -1.48 . . . . 1.14 107.003 174.768 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 8.9 m-80 -70.65 -0.54 8.94 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 113.296 0.85 . . . . 1.28 113.296 -169.662 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 134.97 168.32 11.62 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 119.894 -1.145 . . . . 0.49 114.213 166.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.401 HD13 ' CE1' ' A' ' 44' ' ' TYR . 60.9 tp -160.59 131.71 5.62 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 107.883 -1.155 . . . . 1.36 107.883 179.825 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 39.1 t60 -144.5 97.84 3.1 Favored 'General case' 0 C--N 1.321 -0.635 0 C-N-CA 120.055 -0.658 . . . . 3.8 110.971 179.721 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.413 ' O ' HG22 ' A' ' 3' ' ' VAL . . . -169.63 175.78 43.71 Favored Glycine 0 N--CA 1.445 -0.749 0 CA-C-N 115.117 -0.947 . . . . 0.55 111.322 176.625 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.533 ' HA ' ' N ' ' A' ' 2' ' ' GLN . 12.2 t70 -83.65 94.41 8.1 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 108.216 -1.031 . . . . 2.18 108.216 171.564 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.728 ' H ' ' HB2' ' A' ' 2' ' ' GLN . 45.8 m-85 -115.1 126.57 54.82 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.111 0.481 . . . . 1.5 111.927 -174.718 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -67.97 170.21 8.65 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.254 -0.884 . . . . 2.23 109.915 174.085 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.607 HG11 ' HZ2' ' A' ' 69' ' ' TRP . 86.0 t -48.45 -65.55 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 O-C-N 123.549 0.531 . . . . 1.25 111.758 -175.387 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -59.02 -43.46 91.57 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 112.629 0.603 . . . . 2.39 112.629 -177.719 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 22.9 t -71.37 -33.21 69.35 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.097 0.475 . . . . 1.65 110.967 -172.513 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -73.73 -39.47 48.12 Favored Glycine 0 N--CA 1.445 -0.713 0 C-N-CA 120.735 -0.745 . . . . 0.4 111.496 -176.335 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.646 ' HB3' HG11 ' A' ' 61' ' ' VAL . 85.9 mt -67.95 -40.4 83.24 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.755 0.312 . . . . 1.63 110.857 -179.738 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . 0.437 HE21 ' HB3' ' A' ' 51' ' ' GLN . 0.9 OUTLIER -54.28 -50.13 67.98 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.929 -0.578 . . . . 3.01 111.03 179.22 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 25.4 tp60 -68.07 -40.61 82.67 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.395 -0.366 . . . . 2.18 111.226 -177.173 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.402 HD21 ' HA ' ' A' ' 53' ' ' LEU . 51.0 mt -56.6 -42.17 78.26 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.217 0.451 . . . . 1.4 112.217 -179.303 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.449 ' HG ' HD22 ' A' ' 10' ' ' LEU . 11.0 mp -85.14 -5.02 59.35 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 112.374 0.509 . . . . 2.78 112.374 -174.614 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -66.62 105.65 1.59 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.29 0.566 . . . . 2.24 109.769 178.752 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 133.6 -15.0 4.7 Favored Glycine 0 N--CA 1.447 -0.615 0 N-CA-C 110.66 -0.976 . . . . 1.96 110.66 -172.038 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 79.4 p -119.49 175.96 5.59 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.271 -0.64 . . . . 2.28 109.271 175.709 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.437 ' O ' ' HA ' ' A' ' 75' ' ' PRO . . . -113.74 17.64 20.33 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.21 -0.995 . . . . 1.79 112.266 -177.874 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 98.6 mt -92.24 175.45 6.85 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 110.254 -0.276 . . . . 1.82 110.254 -179.137 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 27.2 mp0 -139.0 118.98 13.31 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.156 -0.683 . . . . 3.26 109.156 -179.464 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.646 HG11 ' HB3' ' A' ' 50' ' ' LEU . 7.5 p -98.54 127.11 51.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 N-CA-C 109.674 -0.491 . . . . 2.17 109.674 176.915 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.445 ' HA ' ' HD3' ' A' ' 63' ' ' PRO . 0.0 OUTLIER -140.55 137.06 17.09 Favored Pre-proline 0 C--N 1.323 -0.584 0 CA-C-N 116.234 -0.439 . . . . 2.29 110.962 -176.559 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.467 ' HA ' ' HA ' ' A' ' 69' ' ' TRP . 28.4 Cg_exo -62.74 128.79 24.23 Favored 'Trans proline' 0 N--CA 1.462 -0.371 0 C-N-CA 122.915 2.41 . . . . 0.94 110.982 177.131 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -66.64 -43.76 83.77 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.702 -0.681 . . . . 2.32 109.732 -177.379 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 165.16 -60.42 0.24 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.564 -0.827 . . . . 1.69 112.276 176.336 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 50.5 t30 -86.12 68.85 10.41 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.997 0.427 . . . . 3.67 111.211 -175.597 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 66.4 t30 58.93 12.16 2.22 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-N 115.742 -0.663 . . . . 2.59 111.84 175.73 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.473 ' HB3' ' O ' ' A' ' 24' ' ' THR . 50.7 m -122.5 177.83 5.24 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 108.811 -0.811 . . . . 1.54 108.811 -173.844 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . 0.641 ' HH2' ' HD1' ' A' ' 17' ' ' TYR . 49.9 m0 -137.44 166.18 24.46 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.886 -0.413 . . . . 0.54 109.886 -167.357 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.594 ' HA ' ' HB2' ' A' ' 26' ' ' SER . 15.1 t -148.05 147.57 29.72 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 108.814 -0.81 . . . . 1.49 108.814 169.921 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 31.8 tp -92.23 103.84 16.27 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.442 0.639 . . . . 2.24 109.928 -179.192 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -88.11 119.49 70.38 Favored Pre-proline 0 C--N 1.319 -0.753 0 CA-C-N 114.918 -1.037 . . . . 2.25 111.19 -179.715 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -90.32 115.14 0.53 Allowed 'Trans proline' 0 N--CA 1.449 -1.143 0 C-N-CA 122.393 2.062 . . . . 1.45 112.33 177.404 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -163.83 73.57 1.77 Allowed Pre-proline 0 C--N 1.323 -0.556 0 CA-C-N 115.725 -0.67 . . . . 2.07 109.487 176.31 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.497 ' HB2' ' H ' ' A' ' 76' ' ' ALA . 80.7 Cg_endo -85.92 -136.15 0.02 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.796 0 C-N-CA 122.407 2.072 . . . . 2.85 111.942 -172.514 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.497 ' H ' ' HB2' ' A' ' 75' ' ' PRO . . . -113.56 70.71 1.61 Allowed Pre-proline 0 C--N 1.324 -0.523 0 N-CA-C 109.058 -0.719 . . . . 4.66 109.058 172.402 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.486 ' HD3' ' C ' ' A' ' 75' ' ' PRO . 43.3 Cg_endo -91.21 60.53 1.16 Allowed 'Trans proline' 0 N--CA 1.453 -0.891 0 C-N-CA 123.012 2.475 . . . . 4.26 112.018 -169.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -124.1 13.82 9.07 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.267 -0.424 . . . . 6.5 111.512 -175.373 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -155.45 60.69 0.62 Allowed 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.636 -0.426 . . . . 8.11 111.503 -176.515 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 31.2 t70 . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.535 -0.745 . . . . 9.05 110.109 175.906 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.893 0 N-CA-C 109.95 -0.389 . . . . 4.29 109.95 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 32.9 mm-40 -74.0 110.76 8.54 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.86 0.362 . . . . 4.51 111.012 -178.859 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 31.4 m -103.39 136.36 36.55 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-N 115.964 -0.562 . . . . 2.2 109.787 174.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -127.01 96.55 4.65 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 108.589 -0.893 . . . . 2.75 108.589 -179.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.472 HD12 ' HB3' ' A' ' 40' ' ' LEU . 50.5 mt -126.11 149.24 30.85 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 CA-C-N 115.763 -0.653 . . . . 1.5 110.153 -173.821 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.541 ' HB3' ' HD2' ' A' ' 7' ' ' PRO . . . -162.96 168.12 10.83 Favored Pre-proline 0 C--N 1.323 -0.544 0 N-CA-C 108.844 -0.798 . . . . 1.99 108.844 -176.381 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.541 ' HD2' ' HB3' ' A' ' 6' ' ' ALA . 89.8 Cg_exo -44.56 133.48 9.89 Favored 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 122.806 2.337 . . . . 1.73 112.998 -178.103 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 154.91 41.56 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.635 -0.793 . . . . 1.84 112.062 178.299 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.598 ' HA ' ' HA ' ' A' ' 36' ' ' GLN . 20.2 m 66.98 138.92 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.281 0 CA-C-O 121.326 0.584 . . . . 1.87 110.699 -172.376 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.59 HD12 ' HB3' ' A' ' 53' ' ' LEU . 49.5 tp -58.37 -24.2 59.22 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.138 0.494 . . . . 1.83 110.27 177.284 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -48.06 -51.59 23.72 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.073 -0.967 . . . . 2.11 111.892 175.031 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.91 -25.47 66.39 Favored 'General case' 0 C--N 1.335 -0.063 0 C-N-CA 121.064 -0.255 . . . . 3.11 111.375 -176.397 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -65.42 -59.29 4.17 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.049 0.452 . . . . 1.17 110.073 178.796 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 86.9 mt -58.46 -37.38 75.36 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.675 -0.693 . . . . 1.31 110.905 176.428 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 47.4 t30 -60.94 -40.76 94.52 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.257 -0.429 . . . . 1.98 110.257 178.399 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -61.1 -47.87 84.28 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 116.028 -0.533 . . . . 2.33 110.541 178.548 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.511 ' O ' ' HB3' ' A' ' 20' ' ' HIS . 3.1 t80 -69.58 -43.93 71.86 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-O 120.871 0.367 . . . . 1.05 110.251 -177.653 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.591 ' HA ' ' CZ ' ' A' ' 23' ' ' PHE . . . -53.92 -53.48 52.11 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 115.912 -0.585 . . . . 1.15 112.275 -179.72 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.53 -22.55 66.4 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.804 0.335 . . . . 1.26 111.517 -178.817 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . 0.511 ' HB3' ' O ' ' A' ' 17' ' ' TYR . 77.9 t60 -65.73 -52.12 53.77 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.993 -0.549 . . . . 2.52 111.5 -179.866 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.414 ' HB2' ' CD1' ' A' ' 23' ' ' PHE . 19.7 m -108.13 -3.6 18.45 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 112.619 0.599 . . . . 1.79 112.619 -174.355 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 69.2 47.73 50.88 Favored Glycine 0 C--O 1.227 -0.295 0 CA-C-N 116.142 -0.481 . . . . 0.68 113.884 174.262 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.591 ' CZ ' ' HA ' ' A' ' 18' ' ' ALA . 13.3 p90 -110.78 162.93 14.29 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.84 0.32 . . . . 0.68 110.209 178.398 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.627 ' O ' ' HB3' ' A' ' 68' ' ' SER . 28.0 m -98.11 122.17 40.93 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.363 0.601 . . . . 1.3 112.173 -174.725 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.49 HD23 ' CE3' ' A' ' 69' ' ' TRP . 1.1 mm? -88.49 115.11 25.77 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.677 -0.692 . . . . 2.3 110.322 175.491 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 32.9 t -98.08 93.92 6.55 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.795 -0.638 . . . . 1.67 109.799 -179.653 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.706 HG22 HD11 ' A' ' 71' ' ' LEU . 7.2 p -148.16 141.71 18.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.768 -0.651 . . . . 1.52 110.655 -178.849 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -88.88 132.12 34.81 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.933 -0.576 . . . . 2.38 110.009 175.578 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.33 78.57 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.308 0 O-C-N 123.8 0.687 . . . . 2.45 111.863 179.658 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 74.1 m -165.83 -38.19 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 123.142 0.577 . . . . 2.48 109.556 -179.736 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 88.0 mt -75.24 -33.17 61.28 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.093 -0.503 . . . . 1.92 110.693 178.791 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 7.5 p -92.32 -10.93 36.54 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.329 -0.396 . . . . 1.82 110.948 177.526 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 53.1 ttp180 -64.69 107.12 1.33 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.815 -0.63 . . . . 5.19 110.143 179.87 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 102.51 17.66 18.83 Favored Glycine 0 N--CA 1.444 -0.806 0 C-N-CA 121.002 -0.618 . . . . 1.62 111.797 -177.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 12.9 mptt -107.5 122.26 46.3 Favored 'General case' 0 CA--C 1.514 -0.418 0 CA-C-O 121.106 0.479 . . . . 3.17 111.711 178.85 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . 0.598 ' HA ' ' HA ' ' A' ' 9' ' ' SER . 18.4 pt20 -138.24 133.66 33.43 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.564 -0.744 . . . . 2.52 109.168 173.593 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.425 ' O ' ' HA ' ' A' ' 7' ' ' PRO . 19.2 t -115.66 140.3 49.32 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.569 -0.53 . . . . 1.14 109.569 -176.567 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -71.0 2.9 3.81 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 112.162 0.431 . . . . 1.28 112.162 177.258 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.451 ' HA3' ' HA ' ' A' ' 6' ' ' ALA . . . 114.85 -178.03 17.72 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.775 -0.726 . . . . 0.49 113.445 166.331 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.472 ' HB3' HD12 ' A' ' 5' ' ' ILE . 56.1 tp -160.82 131.07 5.15 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 107.797 -1.186 . . . . 1.36 107.797 179.632 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 17.4 t-160 -143.4 99.89 3.51 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 120.07 -0.652 . . . . 3.8 111.71 -177.63 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -169.03 -169.68 32.7 Favored Glycine 0 N--CA 1.448 -0.545 0 CA-C-N 115.403 -0.817 . . . . 0.55 111.459 176.156 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -103.55 90.64 3.74 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 108.832 -0.803 . . . . 2.18 108.832 172.112 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 64.1 m-85 -110.47 151.86 27.02 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.61 -0.723 . . . . 1.5 110.584 -175.79 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -99.47 -171.94 2.16 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 108.302 -0.999 . . . . 2.23 108.302 174.218 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.412 ' O ' ' HG ' ' A' ' 50' ' ' LEU . 39.2 t -51.7 -71.0 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 N-CA-C 112.976 0.732 . . . . 1.25 112.976 -172.636 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.31 -47.45 82.22 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 113.266 0.839 . . . . 2.39 113.266 -169.102 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 7.5 t -73.97 -26.86 60.7 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.032 0.444 . . . . 1.65 110.75 -170.692 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -75.13 -38.94 38.56 Favored Glycine 0 N--CA 1.447 -0.626 0 N-CA-C 111.042 -0.823 . . . . 0.4 111.042 -178.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.744 HD12 HG12 ' A' ' 61' ' ' VAL . 80.7 mt -70.11 -41.53 73.87 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 115.441 -0.379 . . . . 1.63 110.261 179.068 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 55.3 tp60 -55.96 -38.06 69.87 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 116.102 -0.499 . . . . 3.01 111.524 -179.244 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 24.6 mm-40 -63.5 -45.64 89.75 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.857 0.361 . . . . 2.18 110.616 177.771 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.59 ' HB3' HD12 ' A' ' 10' ' ' LEU . 90.3 mt -60.94 -22.87 64.83 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.838 -0.619 . . . . 1.4 111.859 176.787 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.766 HD21 HG23 ' A' ' 61' ' ' VAL . 87.4 mt -85.28 -24.05 27.91 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.14 0.422 . . . . 2.78 112.14 -175.494 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -70.07 93.63 0.82 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.179 0.514 . . . . 2.24 110.905 -175.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 114.77 -10.45 21.2 Favored Glycine 0 N--CA 1.446 -0.69 0 CA-C-N 115.799 -0.637 . . . . 1.96 112.532 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.41 ' OG ' ' HA ' ' A' ' 54' ' ' LEU . 27.1 p -98.92 -12.12 21.0 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.883 0.373 . . . . 2.28 111.448 -178.547 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.565 ' HA2' ' HB3' ' A' ' 75' ' ' PRO . . . 71.3 28.39 70.0 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 121.0 -0.619 . . . . 1.79 112.892 175.72 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 94.8 mt -119.12 167.98 11.29 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.74 0.305 . . . . 1.82 110.857 -178.555 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . 0.442 ' HA ' HD11 ' A' ' 54' ' ' LEU . 62.8 tt0 -143.97 118.97 10.0 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.082 -0.71 . . . . 3.26 109.082 177.47 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.766 HG23 HD21 ' A' ' 54' ' ' LEU . 36.8 t -94.81 130.2 43.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 N-CA-C 110.044 -0.354 . . . . 2.17 110.044 -178.25 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 17.9 ptmt -131.67 127.61 21.47 Favored Pre-proline 0 C--N 1.317 -0.815 0 N-CA-C 109.624 -0.51 . . . . 2.29 109.624 179.015 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -60.15 132.92 46.85 Favored 'Trans proline' 0 N--CA 1.463 -0.279 0 C-N-CA 122.577 2.185 . . . . 0.94 111.191 177.612 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 42.7 tp -69.27 -40.31 77.87 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.713 -0.676 . . . . 2.32 110.925 -174.592 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 158.65 -44.48 0.47 Allowed Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.758 -0.735 . . . . 1.69 112.092 175.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 9.2 m120 -77.15 -89.39 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.394 0.616 . . . . 3.67 110.644 -179.481 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 30.4 p-10 -146.69 24.85 1.2 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.626 -0.715 . . . . 2.59 109.095 177.057 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.627 ' HB3' ' O ' ' A' ' 24' ' ' THR . 50.4 m -128.74 178.82 6.07 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 108.178 -1.045 . . . . 1.54 108.178 -171.784 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . 0.49 ' CE3' HD23 ' A' ' 25' ' ' LEU . 1.9 m0 -140.15 169.73 17.16 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 119.836 -0.746 . . . . 0.54 110.055 -170.864 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 9.6 t -140.97 144.03 34.85 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 108.722 -0.844 . . . . 1.49 108.722 171.654 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.706 HD11 HG22 ' A' ' 27' ' ' VAL . 52.0 mt -93.85 105.62 17.63 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.415 0.626 . . . . 2.24 111.484 -173.839 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 18.4 tt0 -89.44 129.48 47.14 Favored Pre-proline 0 C--N 1.318 -0.789 0 CA-C-N 115.051 -0.977 . . . . 2.25 110.347 174.108 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -79.12 114.68 3.39 Favored 'Trans proline' 0 N--CA 1.453 -0.875 0 C-N-CA 121.92 1.747 . . . . 1.45 111.325 177.75 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -172.93 94.99 0.36 Allowed Pre-proline 0 C--N 1.322 -0.598 0 CA-C-N 115.654 -0.703 . . . . 2.07 110.446 -179.121 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.565 ' HB3' ' HA2' ' A' ' 58' ' ' GLY . 97.1 Cg_endo -80.73 35.41 0.58 Allowed 'Trans proline' 0 N--CA 1.462 -0.369 0 C-N-CA 122.717 2.278 . . . . 2.85 111.809 178.755 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 58.46 64.41 3.59 Favored Pre-proline 0 C--N 1.332 -0.196 0 CA-C-N 115.786 -0.643 . . . . 4.66 109.411 -170.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -84.04 62.15 6.79 Favored 'Trans proline' 0 N--CA 1.455 -0.764 0 C-N-CA 122.939 2.426 . . . . 4.26 112.112 -173.492 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.61 59.12 1.46 Allowed 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.012 -0.995 . . . . 6.5 110.068 -178.933 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -58.54 110.02 0.9 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.59 -0.732 . . . . 8.11 110.823 -177.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 33.1 t70 . . . . . 0 C--O 1.248 1.003 0 CA-C-O 118.244 -0.884 . . . . 9.05 110.051 -178.15 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.957 0 CA-C-O 121.02 0.438 . . . . 4.29 111.047 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 5.1 pm0 -143.12 139.28 30.34 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.353 -0.61 . . . . 4.51 109.353 176.352 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 33.7 m -137.39 152.74 27.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 120.73 0.3 . . . . 2.2 110.922 -175.645 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 31.7 m-80 -127.82 96.31 4.47 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 108.641 -0.874 . . . . 2.75 108.641 174.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.407 HG21 HD22 ' A' ' 53' ' ' LEU . 28.8 mm -119.69 149.71 22.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 N-CA-C 109.406 -0.591 . . . . 1.5 109.406 -176.423 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -163.4 162.15 17.54 Favored Pre-proline 0 C--N 1.323 -0.578 0 N-CA-C 109.488 -0.56 . . . . 1.99 109.488 -177.205 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.48 ' HA ' ' O ' ' A' ' 37' ' ' SER . 53.3 Cg_exo -52.23 130.54 35.92 Favored 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 122.95 2.433 . . . . 1.73 113.006 -175.976 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 158.69 48.03 0.01 OUTLIER Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 120.744 -0.741 . . . . 1.84 112.255 -178.345 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 19.8 m 67.81 126.81 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 123.155 0.582 . . . . 1.87 111.285 -177.167 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.593 HD13 ' HB3' ' A' ' 53' ' ' LEU . 67.1 tp -60.78 -36.01 77.89 Favored 'General case' 0 CA--C 1.521 -0.147 0 CA-C-N 116.109 -0.496 . . . . 1.83 110.482 179.589 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -49.23 -55.02 13.94 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.471 -0.786 . . . . 2.11 111.018 173.534 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 64.5 tttm -67.95 -27.67 66.8 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.944 0.402 . . . . 3.11 111.086 -178.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -66.08 -56.77 9.83 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.289 -0.414 . . . . 1.17 110.112 178.541 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 96.2 mt -59.42 -38.39 80.5 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 115.959 -0.564 . . . . 1.31 110.981 175.773 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -60.95 -38.58 86.39 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.937 -0.574 . . . . 1.98 110.397 179.254 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 6.3 tt0 -62.86 -40.03 96.23 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.994 -0.548 . . . . 2.33 110.648 176.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.506 ' HD1' ' HZ ' ' A' ' 23' ' ' PHE . 3.7 t80 -67.86 -41.68 82.5 Favored 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 108.477 -0.935 . . . . 1.05 108.477 179.813 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.721 ' HA ' ' CE2' ' A' ' 23' ' ' PHE . . . -55.2 -48.06 74.4 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.292 -0.867 . . . . 1.15 111.76 175.699 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.84 -25.1 67.31 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.242 -0.435 . . . . 1.26 111.544 -179.364 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 74.0 t60 -64.43 -49.01 73.18 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.282 -0.417 . . . . 2.52 111.602 -177.118 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 15.8 m -108.68 -11.24 15.1 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.584 -0.447 . . . . 1.79 112.116 -175.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 75.78 58.06 3.92 Favored Glycine 0 CA--C 1.519 0.322 0 CA-C-N 115.932 -0.576 . . . . 0.68 113.564 177.066 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.721 ' CE2' ' HA ' ' A' ' 18' ' ' ALA . 10.6 p90 -117.97 169.85 9.31 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.968 0.384 . . . . 0.68 111.028 178.524 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 13.3 m -92.18 118.18 30.59 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-O 121.201 0.524 . . . . 1.3 112.226 -172.193 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.658 HD21 ' CE3' ' A' ' 69' ' ' TRP . 1.5 mm? -99.32 138.98 35.65 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.71 -0.677 . . . . 2.3 110.742 175.056 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 44.4 m -125.41 100.74 6.63 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.075 0.464 . . . . 1.67 110.197 177.144 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 5.9 p -145.67 135.32 17.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.737 -0.665 . . . . 1.52 110.785 -177.865 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -98.98 129.01 45.25 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.076 -0.511 . . . . 2.38 109.724 177.81 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -54.36 -23.79 16.91 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 113.877 1.065 . . . . 2.45 113.877 -172.098 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 85.4 p -66.42 -27.49 67.88 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.12 0.486 . . . . 2.48 110.718 -175.278 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 96.7 mt -75.99 -47.13 26.13 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.551 -0.75 . . . . 1.92 111.13 -177.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 3.5 t -99.31 40.78 1.19 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.621 0.724 . . . . 1.82 110.706 -177.217 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.474 ' O ' ' HG3' ' A' ' 33' ' ' ARG . 8.6 ptp180 -63.25 105.89 0.8 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.656 -0.702 . . . . 5.19 111.039 179.546 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 63.01 19.44 61.31 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 121.088 -0.577 . . . . 1.62 112.377 179.656 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.619 ' HE3' ' HA ' ' A' ' 57' ' ' SER . 8.6 tptp -74.32 112.71 10.75 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.601 -0.518 . . . . 3.17 109.601 -177.149 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -103.87 156.65 17.66 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.731 0.301 . . . . 2.52 110.479 -177.122 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.48 ' O ' ' HA ' ' A' ' 7' ' ' PRO . 46.7 t -128.62 130.27 47.05 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 107.222 -1.399 . . . . 1.14 107.222 172.657 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 8.0 m120 -63.96 -15.23 58.76 Favored 'General case' 0 C--N 1.322 -0.606 0 O-C-N 123.441 0.463 . . . . 1.28 112.086 -173.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 123.36 172.31 13.78 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.901 -0.666 . . . . 0.49 112.159 172.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 31.4 tp -161.31 121.39 2.65 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.023 -0.732 . . . . 1.36 109.023 -177.338 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 19.2 t-80 -143.85 99.28 3.38 Favored 'General case' 0 C--N 1.321 -0.664 0 C-N-CA 120.205 -0.598 . . . . 3.8 110.892 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -168.27 -169.54 31.86 Favored Glycine 0 N--CA 1.446 -0.656 0 CA-C-N 115.451 -0.795 . . . . 0.55 111.917 178.252 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -78.35 85.98 4.45 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.518 -0.549 . . . . 2.18 109.518 174.789 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 67.5 m-85 -119.53 122.57 41.93 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.289 0.566 . . . . 1.5 111.628 -176.205 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -84.25 -174.49 5.31 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.278 -0.873 . . . . 2.23 108.798 173.758 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 47.3 t -51.88 -67.93 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 120.671 0.272 . . . . 1.25 111.499 -177.319 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -55.11 -41.76 72.07 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 112.815 0.672 . . . . 2.39 112.815 -176.105 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 22.1 m -71.69 -31.04 66.34 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.966 0.412 . . . . 1.65 111.34 -174.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.403 ' O ' ' HG ' ' A' ' 53' ' ' LEU . . . -71.82 -49.21 24.19 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.85 -0.691 . . . . 0.4 112.071 -175.705 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.427 ' O ' ' HG ' ' A' ' 54' ' ' LEU . 8.5 mp -65.57 -38.73 90.4 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 121.959 0.104 . . . . 1.63 111.208 -178.248 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 58.1 tt0 -53.27 -52.99 57.25 Favored 'General case' 0 C--N 1.331 -0.218 0 O-C-N 123.222 0.326 . . . . 3.01 111.752 179.743 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 12.5 mm100 -64.31 -41.9 96.62 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.882 0.373 . . . . 2.18 111.035 -177.808 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.593 ' HB3' HD13 ' A' ' 10' ' ' LEU . 88.0 mt -59.71 -21.48 60.71 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 115.905 -0.589 . . . . 1.4 112.417 -179.796 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.616 HD23 HG12 ' A' ' 61' ' ' VAL . 65.0 mt -75.36 -14.52 60.48 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.032 0.382 . . . . 2.78 112.032 -177.415 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -72.3 131.61 42.91 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.995 0.426 . . . . 2.24 110.09 -177.345 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 101.72 -17.45 54.81 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.889 -0.672 . . . . 1.96 111.526 -175.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.619 ' HA ' ' HE3' ' A' ' 35' ' ' LYS . 4.3 m -102.55 160.07 14.89 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-O 120.733 0.302 . . . . 2.28 110.203 178.501 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -107.27 35.75 4.83 Favored Glycine 0 N--CA 1.441 -0.984 0 N-CA-C 109.705 -1.358 . . . . 1.79 109.705 171.018 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.597 ' HB3' HD21 ' A' ' 71' ' ' LEU . 50.7 mt -126.57 174.31 8.78 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.265 -0.642 . . . . 1.82 109.265 -177.866 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 24.3 mt-30 -146.94 118.97 8.19 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.348 -0.612 . . . . 3.26 109.348 179.733 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.616 HG12 HD23 ' A' ' 54' ' ' LEU . 7.6 p -86.65 130.36 36.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 N-CA-C 109.667 -0.494 . . . . 2.17 109.667 179.153 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 26.8 ttpp -131.53 131.73 23.05 Favored Pre-proline 0 N--CA 1.442 -0.834 0 N-CA-C 109.816 -0.438 . . . . 2.29 109.816 -174.622 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -54.09 125.71 19.67 Favored 'Trans proline' 0 N--CA 1.463 -0.313 0 C-N-CA 122.418 2.079 . . . . 0.94 111.088 177.433 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.554 ' HG ' ' HB ' ' A' ' 70' ' ' THR . 0.7 OUTLIER -74.03 -63.66 1.17 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.46 -0.791 . . . . 2.32 110.254 -173.856 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -155.48 -107.07 0.27 Allowed Glycine 0 N--CA 1.445 -0.74 0 C-N-CA 120.755 -0.736 . . . . 1.69 111.961 177.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -80.81 94.55 6.45 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.571 0.225 . . . . 3.67 110.687 179.787 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . 0.566 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 2.8 t-20 58.08 39.6 26.06 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.404 0.621 . . . . 2.59 110.44 174.759 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.461 ' O ' ' HD1' ' A' ' 69' ' ' TRP . 15.2 p -135.82 169.13 18.06 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 109.457 -0.572 . . . . 1.54 109.457 179.235 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . 0.658 ' CE3' HD21 ' A' ' 25' ' ' LEU . 26.8 m0 -140.87 154.69 46.28 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 108.975 -0.75 . . . . 0.54 108.975 -175.354 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.554 ' HB ' ' HG ' ' A' ' 64' ' ' LEU . 8.6 t -137.73 138.13 39.01 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 108.802 -0.814 . . . . 1.49 108.802 175.002 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.597 HD21 ' HB3' ' A' ' 59' ' ' LEU . 6.5 tt -93.12 102.57 14.89 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.51 0.671 . . . . 2.24 109.799 -178.451 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.411 ' HA ' ' HD3' ' A' ' 73' ' ' PRO . 25.8 mm-40 -89.3 132.73 36.6 Favored Pre-proline 0 C--N 1.319 -0.738 0 CA-C-N 114.678 -1.146 . . . . 2.25 111.248 178.649 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 72' ' ' GLU . 7.7 Cg_exo -73.15 115.15 4.25 Favored 'Trans proline' 0 N--CA 1.461 -0.392 0 C-N-CA 122.677 2.251 . . . . 1.45 111.574 176.361 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -167.88 92.02 0.66 Allowed Pre-proline 0 C--N 1.324 -0.532 0 CA-C-N 116.039 -0.528 . . . . 2.07 109.758 -178.102 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -79.28 -78.68 0.0 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.569 0 C-N-CA 122.543 2.162 . . . . 2.85 112.133 -178.42 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -142.55 62.83 13.5 Favored Pre-proline 0 C--N 1.321 -0.652 0 N-CA-C 108.147 -1.057 . . . . 4.66 108.147 171.241 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -94.78 30.15 0.23 Allowed 'Trans proline' 0 N--CA 1.451 -1.022 0 C-N-CA 123.408 2.739 . . . . 4.26 112.669 -168.43 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.54 ' HG2' ' HB3' ' A' ' 80' ' ' ASP . 27.6 ttpp -158.61 107.75 1.97 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.978 -0.556 . . . . 6.5 109.97 178.473 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 28.2 mm-40 -77.45 63.5 2.62 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.327 0.584 . . . . 8.11 109.907 176.69 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . 0.54 ' HB3' ' HG2' ' A' ' 78' ' ' LYS . 17.3 t70 . . . . . 0 C--O 1.246 0.904 0 CA-C-O 118.072 -0.966 . . . . 9.05 109.346 -176.559 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.43 ' O ' ' HA ' ' A' ' 43' ' ' ASP . . . . . . . . 0 N--CA 1.481 1.106 0 N-CA-C 110.152 -0.314 . . . . 4.29 110.152 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 19.6 pt20 -86.88 134.9 33.49 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.327 0.584 . . . . 4.51 110.841 -178.631 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.623 ' O ' ' HA ' ' A' ' 41' ' ' HIS . 36.2 t -101.59 131.7 48.92 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.938 0 CA-C-N 115.301 -0.863 . . . . 2.2 108.859 174.492 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -129.48 109.49 11.09 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.229 0.537 . . . . 2.75 109.995 179.465 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.627 HD11 ' HB1' ' A' ' 13' ' ' ALA . 68.6 mt -131.02 127.06 60.58 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 115.932 -0.576 . . . . 1.5 110.537 -177.199 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -76.18 159.7 79.69 Favored Pre-proline 0 N--CA 1.45 -0.459 0 CA-C-N 115.916 -0.584 . . . . 1.99 109.657 177.446 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.525 ' HA ' ' O ' ' A' ' 37' ' ' SER . 44.7 Cg_endo -69.6 49.91 0.72 Allowed 'Trans proline' 0 CA--C 1.534 0.495 0 C-N-CA 122.915 2.41 . . . . 1.73 113.123 177.632 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -116.75 -150.06 9.25 Favored Glycine 0 C--O 1.226 -0.347 0 C-N-CA 121.241 -0.504 . . . . 1.84 112.574 -178.703 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.572 ' HA ' ' O ' ' A' ' 35' ' ' LYS . 22.8 p -62.54 125.47 24.05 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.162 0.506 . . . . 1.87 111.867 -176.294 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.777 ' HB3' ' HB3' ' A' ' 35' ' ' LYS . 70.3 tp -65.49 -32.4 73.98 Favored 'General case' 0 N--CA 1.456 -0.172 0 CA-C-N 115.64 -0.709 . . . . 1.83 109.696 178.758 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.566 ' OD2' ' HB ' ' A' ' 32' ' ' THR . 10.6 m-20 -50.5 -53.89 26.52 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.19 -0.914 . . . . 2.11 110.401 175.21 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -68.84 -26.66 65.27 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.772 -0.649 . . . . 3.11 110.638 177.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.627 ' HB1' HD11 ' A' ' 5' ' ' ILE . . . -67.36 -53.07 32.73 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.988 -0.551 . . . . 1.17 110.816 -178.85 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 87.2 mt -56.96 -43.73 81.88 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.116 -0.493 . . . . 1.31 110.873 177.026 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 52.9 t30 -62.4 -32.55 73.39 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.831 -0.622 . . . . 1.98 110.371 -179.64 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.402 HE21 ' HB3' ' A' ' 16' ' ' GLN . 1.0 OUTLIER -62.16 -45.35 93.79 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.283 -0.417 . . . . 2.33 110.445 177.096 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 13.5 t80 -71.38 -41.36 69.78 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 109.65 -0.5 . . . . 1.05 109.65 -178.78 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.716 ' HA ' ' CE2' ' A' ' 23' ' ' PHE . . . -53.37 -53.41 51.47 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 115.501 -0.772 . . . . 1.15 112.141 178.194 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -64.54 -26.2 68.31 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.311 -0.404 . . . . 1.26 111.461 -178.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 70.5 t60 -64.8 -45.19 87.28 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.293 -0.412 . . . . 2.52 111.298 -176.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.469 ' HB2' ' CE1' ' A' ' 23' ' ' PHE . 24.5 m -101.04 -7.02 23.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.269 0.557 . . . . 1.79 111.594 -178.735 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 67.66 47.11 63.63 Favored Glycine 0 N--CA 1.449 -0.494 0 CA-C-N 115.309 -0.86 . . . . 0.68 114.023 176.791 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.716 ' CE2' ' HA ' ' A' ' 18' ' ' ALA . 5.9 p90 -109.21 160.73 15.87 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 117.389 0.595 . . . . 0.68 110.624 175.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.445 ' O ' ' HB3' ' A' ' 68' ' ' SER . 25.0 m -88.14 119.82 28.9 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.431 0.634 . . . . 1.3 112.529 -171.532 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.632 HD22 ' CE3' ' A' ' 69' ' ' TRP . 1.6 mm? -95.73 121.34 37.34 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.609 -0.723 . . . . 2.3 111.174 176.617 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 18.9 m -104.35 93.32 4.75 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.67 -0.492 . . . . 1.67 109.67 175.633 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.45 ' HB ' HD22 ' A' ' 71' ' ' LEU . 5.4 p -139.78 135.0 38.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.911 -0.586 . . . . 1.52 111.456 -174.289 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -92.52 117.54 30.05 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.819 -0.628 . . . . 2.38 110.085 175.221 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.48 76.67 0.01 OUTLIER 'General case' 0 C--O 1.232 0.165 0 CA-C-N 115.86 -0.609 . . . . 2.45 112.089 178.398 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 13.8 m -159.38 -50.31 0.06 Allowed 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 108.294 -1.002 . . . . 2.48 108.294 179.542 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 87.5 mt -62.93 -44.0 97.27 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 108.771 -0.825 . . . . 1.92 108.771 172.477 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.566 ' HB ' ' OD2' ' A' ' 11' ' ' ASP . 26.3 p -93.7 59.08 2.79 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-N 114.942 -1.026 . . . . 1.82 110.273 175.518 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 9.7 tpt180 -102.4 112.04 24.59 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.881 -0.599 . . . . 5.19 110.173 174.512 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 69.65 34.74 73.2 Favored Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 120.712 -0.756 . . . . 1.62 112.596 176.37 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.777 ' HB3' ' HB3' ' A' ' 10' ' ' LEU . 13.2 mptt -81.13 140.56 34.96 Favored 'General case' 0 CA--C 1.511 -0.529 0 N-CA-C 109.478 -0.564 . . . . 3.17 109.478 176.666 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 49.1 mt-30 -138.17 134.18 34.22 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 109.944 -0.391 . . . . 2.52 109.944 -179.764 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.525 ' O ' ' HA ' ' A' ' 7' ' ' PRO . 7.8 t -124.34 134.13 53.25 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.278 -0.638 . . . . 1.14 109.278 -178.584 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.44 ' N ' HD21 ' A' ' 38' ' ' ASN . 0.9 OUTLIER -60.08 -14.88 18.94 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 112.716 0.636 . . . . 1.28 112.716 -178.332 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 132.05 178.66 15.63 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.248 -0.977 . . . . 0.49 113.008 170.829 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.463 HD21 HG13 ' A' ' 3' ' ' VAL . 48.4 tp -160.44 122.01 3.1 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 108.135 -1.061 . . . . 1.36 108.135 -179.135 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . 0.623 ' HA ' ' O ' ' A' ' 3' ' ' VAL . 39.7 t-80 -145.37 99.84 3.36 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.213 -0.595 . . . . 3.8 111.972 179.215 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -169.37 178.14 42.63 Favored Glycine 0 N--CA 1.443 -0.892 0 N-CA-C 110.969 -0.852 . . . . 0.55 110.969 174.483 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.43 ' HA ' ' O ' ' A' ' 1' ' ' ALA . 11.9 t70 -82.39 113.06 19.9 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 108.12 -1.067 . . . . 2.18 108.12 169.031 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 50.5 m-85 -128.89 131.13 47.58 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.074 0.464 . . . . 1.5 111.888 -173.501 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -66.15 160.37 24.24 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.256 -0.884 . . . . 2.23 109.219 169.288 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 47.2 t -49.03 -61.22 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 O-C-N 123.507 0.504 . . . . 1.25 111.502 -174.609 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.71 ' HA ' HD23 ' A' ' 50' ' ' LEU . 46.5 mt-10 -64.24 -40.18 95.48 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.256 -0.429 . . . . 2.39 111.695 -178.398 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 28.1 t -71.07 -30.4 66.53 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-O 120.892 0.377 . . . . 1.65 111.428 -170.81 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -81.18 -32.11 32.68 Favored Glycine 0 N--CA 1.447 -0.615 0 C-N-CA 120.531 -0.842 . . . . 0.4 111.526 -177.136 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.71 HD23 ' HA ' ' A' ' 47' ' ' GLU . 0.3 OUTLIER -80.59 -41.14 24.5 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 109.539 -0.541 . . . . 1.63 109.539 -178.198 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . 0.561 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 54.3 tt0 -53.95 -39.23 65.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.735 -0.666 . . . . 3.01 111.768 174.451 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 8.5 tp-100 -63.07 -46.64 86.48 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.377 -0.374 . . . . 2.18 110.133 178.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.438 ' HB3' HD11 ' A' ' 10' ' ' LEU . 95.8 mt -58.39 -21.71 51.34 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 115.803 -0.635 . . . . 1.4 112.344 178.375 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 87.2 mt -73.88 -24.71 59.76 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-O 120.685 0.278 . . . . 2.78 111.611 -178.036 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -73.5 113.55 10.73 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.115 0.483 . . . . 2.24 110.77 -176.693 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 127.67 -12.96 6.54 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.807 -0.711 . . . . 1.96 111.846 -179.05 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 70.6 p -118.12 175.1 5.84 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 110.005 -0.368 . . . . 2.28 110.005 179.041 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.402 ' O ' ' HB3' ' A' ' 75' ' ' PRO . . . -113.13 33.25 5.67 Favored Glycine 0 N--CA 1.448 -0.541 0 N-CA-C 111.271 -0.732 . . . . 1.79 111.271 179.251 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 85.1 mt -119.99 179.31 4.3 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 108.872 -0.788 . . . . 1.82 108.872 178.829 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -149.87 119.11 6.8 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.091 0.472 . . . . 3.26 109.925 178.478 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 59.9 t -92.92 126.58 45.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 N-CA-C 109.08 -0.711 . . . . 2.17 109.08 176.547 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.463 ' HE2' ' HB2' ' A' ' 72' ' ' GLU . 50.9 mtmt -126.17 134.35 25.87 Favored Pre-proline 0 C--N 1.319 -0.751 0 N-CA-C 109.509 -0.552 . . . . 2.29 109.509 -177.812 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.431 ' HA ' ' O ' ' A' ' 68' ' ' SER . 47.8 Cg_exo -56.32 117.86 4.58 Favored 'Trans proline' 0 N--CA 1.459 -0.557 0 C-N-CA 122.232 1.955 . . . . 0.94 110.825 173.679 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 55.6 tp -58.07 -42.41 85.48 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 114.917 -1.038 . . . . 2.32 112.079 -171.13 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -179.64 -86.64 0.07 OUTLIER Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 120.553 -0.832 . . . . 1.69 112.287 179.744 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 50.3 t30 -61.18 -76.03 0.06 Allowed 'General case' 0 C--N 1.33 -0.265 0 O-C-N 123.52 0.188 . . . . 3.67 111.138 -179.344 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 66.5 t30 -155.93 53.14 0.57 Allowed 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 121.662 0.744 . . . . 2.59 109.626 178.738 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.445 ' HB3' ' O ' ' A' ' 24' ' ' THR . 10.8 m -138.11 178.79 6.86 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 107.883 -1.154 . . . . 1.54 107.883 -179.328 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . 0.632 ' CE3' HD22 ' A' ' 25' ' ' LEU . 51.5 m0 -136.52 157.1 47.57 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.114 -0.698 . . . . 0.54 109.114 -176.364 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 13.8 t -142.6 147.81 36.45 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.752 0.311 . . . . 1.49 110.236 176.072 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.45 HD22 ' HB ' ' A' ' 27' ' ' VAL . 3.9 mm? -93.41 102.95 15.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.167 0.508 . . . . 2.24 111.253 179.457 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.463 ' HB2' ' HE2' ' A' ' 62' ' ' LYS . 17.8 mt-10 -106.25 131.42 21.74 Favored Pre-proline 0 C--N 1.32 -0.715 0 CA-C-N 115.328 -0.851 . . . . 2.25 111.182 172.538 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.447 ' HD3' ' HA ' ' A' ' 72' ' ' GLU . 24.0 Cg_exo -64.01 114.78 2.77 Favored 'Trans proline' 0 N--CA 1.456 -0.708 0 C-N-CA 122.249 1.966 . . . . 1.45 111.274 176.193 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -141.91 63.51 16.25 Favored Pre-proline 0 C--N 1.318 -0.77 0 CA-C-N 115.41 -0.814 . . . . 2.07 108.865 175.105 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.402 ' HB3' ' O ' ' A' ' 58' ' ' GLY . 96.3 Cg_endo -84.92 63.96 6.32 Favored 'Trans proline' 0 N--CA 1.452 -0.957 0 C-N-CA 122.656 2.238 . . . . 2.85 112.316 -170.596 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 52.63 64.47 7.3 Favored Pre-proline 0 C--O 1.234 0.253 0 N-CA-C 109.35 -0.611 . . . . 4.66 109.35 -174.233 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -83.72 87.1 1.26 Allowed 'Trans proline' 0 N--CA 1.448 -1.202 0 C-N-CA 122.9 2.4 . . . . 4.26 112.551 -167.804 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.739 ' HE2' ' HA ' ' A' ' 78' ' ' LYS . 0.2 OUTLIER -81.7 57.0 3.21 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.457 -0.792 . . . . 6.5 109.047 176.966 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -68.53 -21.08 64.59 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.231 -0.895 . . . . 8.11 110.813 -175.795 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 15.1 t70 . . . . . 0 C--O 1.249 1.073 0 CA-C-O 118.163 -0.922 . . . . 9.05 109.24 172.258 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.077 0 N-CA-C 111.355 0.131 . . . . 4.29 111.355 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.633 ' HA ' ' HA ' ' A' ' 43' ' ' ASP . 8.0 tp-100 67.91 120.54 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 122.01 0.91 . . . . 4.51 111.69 -178.454 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 60.3 t -101.43 131.44 49.22 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 CA-C-N 114.437 -1.256 . . . . 2.2 108.724 178.586 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 50.6 m-80 -123.41 99.54 6.38 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.069 0.462 . . . . 2.75 110.114 -173.592 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.421 HG23 ' N ' ' A' ' 6' ' ' ALA . 30.2 mt -130.49 160.29 41.77 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 N-CA-C 108.766 -0.828 . . . . 1.5 108.766 179.48 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.656 ' HB2' ' HD2' ' A' ' 7' ' ' PRO . . . -164.6 172.87 4.31 Favored Pre-proline 0 C--N 1.323 -0.555 0 CA-C-O 118.815 -0.612 . . . . 1.99 109.448 -176.958 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.656 ' HD2' ' HB2' ' A' ' 6' ' ' ALA . 33.7 Cg_exo -36.97 130.49 0.49 Allowed 'Trans proline' 0 C--N 1.357 1.006 0 C-N-CA 123.297 2.665 . . . . 1.73 113.685 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 155.57 -177.16 32.87 Favored Glycine 0 N--CA 1.444 -0.767 0 N-CA-C 110.982 -0.847 . . . . 1.84 110.982 -177.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.573 ' HA ' ' O ' ' A' ' 35' ' ' LYS . 19.6 m -68.32 133.68 49.12 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 110.068 -0.345 . . . . 1.87 110.068 178.926 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 59.9 tp -58.8 -32.32 69.24 Favored 'General case' 0 C--O 1.23 0.071 0 CA-C-O 120.989 0.423 . . . . 1.83 110.727 179.58 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -49.64 -46.65 49.76 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.436 -0.802 . . . . 2.11 110.559 172.871 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 5.1 tmtm? -64.37 -35.03 79.55 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.658 -0.701 . . . . 3.11 110.066 -178.246 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -65.26 -59.41 4.1 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.155 -0.475 . . . . 1.17 110.961 -176.746 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 94.0 mt -59.61 -39.07 83.03 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.097 -0.501 . . . . 1.31 111.232 178.142 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 47.2 t30 -60.99 -38.39 85.84 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.966 0.412 . . . . 1.98 110.052 178.311 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.403 HE21 ' HB3' ' A' ' 16' ' ' GLN . 0.9 OUTLIER -61.6 -44.05 97.73 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.974 -0.557 . . . . 2.33 110.663 177.054 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.417 ' CD1' ' HH2' ' A' ' 69' ' ' TRP . 3.9 t80 -68.53 -43.51 76.58 Favored 'General case' 0 N--CA 1.457 -0.106 0 N-CA-C 109.24 -0.652 . . . . 1.05 109.24 -179.503 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.679 ' HA ' ' CZ ' ' A' ' 23' ' ' PHE . . . -54.55 -49.16 70.96 Favored 'General case' 0 C--N 1.333 -0.109 0 CA-C-N 115.619 -0.719 . . . . 1.15 111.546 176.923 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -64.92 -24.98 67.69 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.403 -0.362 . . . . 1.26 111.515 -179.488 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 56.1 t60 -60.99 -50.95 71.29 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.342 -0.39 . . . . 2.52 111.305 -177.567 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.553 ' HB2' ' CD1' ' A' ' 23' ' ' PHE . 15.7 m -108.11 -1.5 20.33 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.993 0.425 . . . . 1.79 111.783 -177.245 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 62.24 46.62 93.56 Favored Glycine 0 C--N 1.332 0.339 0 CA-C-N 115.595 -0.729 . . . . 0.68 113.699 174.497 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.679 ' CZ ' ' HA ' ' A' ' 18' ' ' ALA . 14.4 p90 -105.12 172.79 6.6 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.842 0.321 . . . . 0.68 110.568 -179.419 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 47.6 m -91.71 106.19 18.29 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.34 0.59 . . . . 1.3 111.41 -179.514 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 3.6 tt -92.98 123.03 35.94 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.017 -0.735 . . . . 2.3 109.017 175.633 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.407 ' O ' ' HA ' ' A' ' 70' ' ' THR . 33.4 t -101.04 101.11 11.81 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.172 0.51 . . . . 1.67 110.064 -176.552 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.2 p -141.22 135.14 31.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.729 -0.669 . . . . 1.52 110.444 -179.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -81.83 123.3 28.68 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.857 -0.611 . . . . 2.38 110.406 177.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.14 82.77 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.805 -0.634 . . . . 2.45 111.954 178.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.516 ' HA ' ' NE ' ' A' ' 33' ' ' ARG . 55.5 p -172.44 -45.4 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.289 -0.414 . . . . 2.48 110.053 -179.706 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 93.5 mt -62.09 -44.61 96.3 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.584 -0.734 . . . . 1.92 112.227 -174.386 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.451 ' O ' ' HB2' ' A' ' 35' ' ' LYS . 30.0 p -97.86 2.55 49.4 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 112.206 0.447 . . . . 1.82 112.206 -176.265 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.516 ' NE ' ' HA ' ' A' ' 30' ' ' SER . 64.6 mtm180 -58.55 121.66 11.5 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-O 120.581 0.229 . . . . 5.19 111.442 -178.408 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 81.3 11.71 83.06 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 121.056 -0.593 . . . . 1.62 112.781 175.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.573 ' O ' ' HA ' ' A' ' 9' ' ' SER . 12.8 mptt -85.08 151.01 24.46 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.872 0.368 . . . . 3.17 110.817 -179.763 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 32.1 mm-40 -131.46 138.3 48.97 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 108.437 -0.949 . . . . 2.52 108.437 178.667 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.428 ' O ' ' HA ' ' A' ' 7' ' ' PRO . 34.6 t -131.6 141.66 49.71 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 109.186 -0.672 . . . . 1.14 109.186 179.236 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -77.1 -2.36 33.82 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.431 -0.349 . . . . 1.28 111.65 178.062 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . 0.407 ' HA2' HG23 ' A' ' 5' ' ' ILE . . . 98.02 -169.63 24.29 Favored Glycine 0 N--CA 1.445 -0.754 0 C-N-CA 120.421 -0.895 . . . . 0.49 113.619 170.714 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 54.8 tp -160.23 140.41 11.54 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 107.537 -1.283 . . . . 1.36 107.537 -179.28 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 17.4 t60 -144.52 99.54 3.38 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 120.195 -0.602 . . . . 3.8 111.241 -178.185 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -169.48 170.69 42.81 Favored Glycine 0 N--CA 1.448 -0.518 0 N-CA-C 110.547 -1.021 . . . . 0.55 110.547 175.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.633 ' HA ' ' HA ' ' A' ' 2' ' ' GLN . 44.2 t0 -86.0 91.77 8.49 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 108.607 -0.886 . . . . 2.18 108.607 175.84 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 25.6 m-85 -107.4 138.01 44.38 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.555 -0.748 . . . . 1.5 112.173 -170.131 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -75.33 165.56 24.97 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 108.449 -0.945 . . . . 2.23 108.449 169.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.463 HG11 ' HZ2' ' A' ' 69' ' ' TRP . 61.2 t -50.44 -70.31 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 112.356 0.502 . . . . 1.25 112.356 -174.383 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -61.33 -42.19 98.26 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 112.285 0.476 . . . . 2.39 112.285 -172.465 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 34.9 t -70.18 -26.21 63.8 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.878 0.37 . . . . 1.65 110.524 -175.221 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.435 ' O ' ' HG ' ' A' ' 53' ' ' LEU . . . -77.24 -36.08 35.96 Favored Glycine 0 N--CA 1.444 -0.826 0 N-CA-C 110.956 -0.858 . . . . 0.4 110.956 -179.664 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.659 ' HB3' HG12 ' A' ' 61' ' ' VAL . 92.8 mt -72.69 -43.62 62.83 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.76 0.314 . . . . 1.63 110.628 -179.38 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 57.0 tp60 -52.96 -50.06 64.86 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.837 -0.62 . . . . 3.01 111.575 178.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.458 ' HA ' ' OE1' ' A' ' 52' ' ' GLN . 12.8 mm-40 -65.86 -37.13 85.36 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.524 -0.307 . . . . 2.18 111.458 -178.039 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.435 ' HG ' ' O ' ' A' ' 49' ' ' GLY . 66.1 mt -57.88 -39.86 78.85 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.176 0.436 . . . . 1.4 112.176 179.327 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.54 HD22 ' HG ' ' A' ' 57' ' ' SER . 45.2 mt -105.39 16.84 24.93 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.257 0.466 . . . . 2.78 112.257 -174.856 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -68.15 94.58 0.52 Allowed 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 120.993 0.425 . . . . 2.24 111.188 -179.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 109.57 -7.01 31.8 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.919 -0.658 . . . . 1.96 113.565 176.621 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.54 ' HG ' HD22 ' A' ' 54' ' ' LEU . 60.4 p -83.72 -1.54 54.33 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 117.357 0.579 . . . . 2.28 111.705 -175.755 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 76.57 17.67 79.71 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.764 -0.732 . . . . 1.79 112.118 -179.739 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 96.7 mt -124.96 168.57 13.13 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.516 -0.342 . . . . 1.82 110.091 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 33.7 tt0 -150.69 118.64 6.24 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.18 -0.674 . . . . 3.26 109.18 175.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.659 HG12 ' HB3' ' A' ' 50' ' ' LEU . 7.2 p -109.73 129.67 64.2 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 N-CA-C 109.998 -0.371 . . . . 2.17 109.998 179.425 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 24.0 pttm -148.47 156.53 42.3 Favored Pre-proline 0 C--N 1.322 -0.628 0 N-CA-C 109.884 -0.413 . . . . 2.29 109.884 -177.126 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.558 ' HA ' ' HA ' ' A' ' 69' ' ' TRP . 25.7 Cg_exo -63.93 148.17 91.77 Favored 'Trans proline' 0 N--CA 1.461 -0.392 0 C-N-CA 122.716 2.277 . . . . 0.94 111.904 176.706 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.473 HD22 ' HB ' ' A' ' 70' ' ' THR . 82.0 mt -65.68 -27.39 68.31 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.595 -0.73 . . . . 2.32 110.659 179.363 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 152.0 -19.95 0.86 Allowed Glycine 0 N--CA 1.451 -0.361 0 N-CA-C 109.674 -1.371 . . . . 1.69 109.674 -178.63 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 5.6 p30 -128.21 -157.87 0.84 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 114.414 -0.893 . . . . 3.67 109.314 174.865 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -77.07 45.48 0.44 Allowed 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 121.188 0.518 . . . . 2.59 112.158 -176.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 19.5 m -141.51 165.54 27.22 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 107.391 -1.337 . . . . 1.54 107.391 172.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . 0.558 ' HA ' ' HA ' ' A' ' 63' ' ' PRO . 52.8 m0 -133.83 166.81 21.81 Favored 'General case' 0 C--N 1.32 -0.716 0 C-N-CA 120.487 -0.485 . . . . 0.54 110.817 -166.38 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.473 ' HB ' HD22 ' A' ' 64' ' ' LEU . 8.9 t -146.49 143.98 29.32 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.419 -0.585 . . . . 1.49 109.419 171.782 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 35.9 tp -93.08 100.95 13.27 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-O 121.662 0.744 . . . . 2.24 109.26 176.153 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -94.75 130.29 33.63 Favored Pre-proline 0 C--N 1.316 -0.863 0 CA-C-N 114.838 -1.073 . . . . 2.25 111.267 -177.34 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_exo -69.98 113.37 3.39 Favored 'Trans proline' 0 N--CA 1.451 -0.995 0 C-N-CA 121.535 1.49 . . . . 1.45 110.714 174.153 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -152.07 75.64 7.37 Favored Pre-proline 0 C--N 1.321 -0.663 0 CA-C-N 115.665 -0.698 . . . . 2.07 109.192 179.572 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -87.34 35.64 0.44 Allowed 'Trans proline' 0 N--CA 1.454 -0.835 0 C-N-CA 122.62 2.213 . . . . 2.85 112.5 -173.767 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 55.78 56.9 10.16 Favored Pre-proline 0 C--O 1.232 0.14 0 O-C-N 123.803 0.689 . . . . 4.66 109.634 -172.795 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -71.26 102.02 1.2 Allowed 'Trans proline' 0 N--CA 1.458 -0.563 0 C-N-CA 122.495 2.13 . . . . 4.26 112.253 -168.732 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 57.02 31.42 19.89 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 115.35 -0.841 . . . . 6.5 109.875 -176.1 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -91.15 63.47 5.05 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.768 0.794 . . . . 8.11 110.558 -174.31 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 38.1 t70 . . . . . 0 C--O 1.252 1.222 0 CA-C-N 115.214 -0.903 . . . . 9.05 109.353 175.096 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.961 0 CA-C-O 121.0 0.429 . . . . 4.29 110.781 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 19.6 pm0 -81.43 151.2 28.0 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.139 0.495 . . . . 4.51 110.582 -178.326 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 12.4 p -149.19 156.08 7.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 115.589 -0.732 . . . . 2.2 109.302 -179.358 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 -127.26 108.9 11.28 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.93 0.395 . . . . 2.75 109.978 -178.449 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 60.8 mt -131.16 151.18 35.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 N-CA-C 108.89 -0.781 . . . . 1.5 108.89 -179.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.663 ' HB1' ' HD2' ' A' ' 7' ' ' PRO . . . -162.17 174.1 3.96 Favored Pre-proline 0 C--N 1.322 -0.625 0 CA-C-O 118.436 -0.792 . . . . 1.99 108.956 -173.689 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.663 ' HD2' ' HB1' ' A' ' 6' ' ' ALA . 47.5 Cg_exo -38.48 135.53 0.71 Allowed 'Trans proline' 0 C--N 1.361 1.235 0 C-N-CA 123.227 2.618 . . . . 1.73 113.707 -176.264 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 153.13 168.59 17.23 Favored Glycine 0 N--CA 1.446 -0.686 0 N-CA-C 110.401 -1.08 . . . . 1.84 110.401 -173.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.409 ' HA ' ' HA ' ' A' ' 36' ' ' GLN . 4.7 t -67.74 138.11 55.98 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.619 -0.511 . . . . 1.87 109.619 -178.736 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 59.9 tp -58.12 -36.79 73.44 Favored 'General case' 0 CA--C 1.523 -0.083 0 CA-C-N 115.349 -0.841 . . . . 1.83 111.649 -173.222 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -54.59 -50.58 67.68 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.186 -0.461 . . . . 2.11 111.154 176.049 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . 0.649 ' O ' ' HG3' ' A' ' 16' ' ' GLN . 41.0 tttm -64.0 -35.43 80.69 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.473 0.178 . . . . 3.11 110.591 177.003 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.42 -52.56 63.08 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.829 0.347 . . . . 1.17 110.132 -178.484 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.601 ' HB3' HD13 ' A' ' 25' ' ' LEU . 77.5 mt -57.27 -38.52 74.02 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.779 -0.646 . . . . 1.31 110.899 174.324 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 17.9 t-20 -61.03 -37.75 83.69 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.107 -0.497 . . . . 1.98 111.06 179.336 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.649 ' HG3' ' O ' ' A' ' 12' ' ' LYS . 18.6 mt-30 -62.3 -40.05 95.01 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.758 -0.201 . . . . 2.33 110.587 178.199 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.422 ' O ' ' HB3' ' A' ' 20' ' ' HIS . 5.0 t80 -68.38 -43.77 76.61 Favored 'General case' 0 CA--C 1.52 -0.196 0 CA-C-O 121.636 0.731 . . . . 1.05 109.169 177.433 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.678 ' HA ' ' CZ ' ' A' ' 23' ' ' PHE . . . -52.44 -46.22 66.34 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 114.707 -1.133 . . . . 1.15 111.317 176.521 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -64.52 -29.06 70.1 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.146 -0.479 . . . . 1.26 111.392 179.013 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . 0.422 ' HB3' ' O ' ' A' ' 17' ' ' TYR . 84.9 t60 -61.1 -55.06 36.94 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.056 -0.52 . . . . 2.52 111.51 -177.234 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.442 ' HB2' ' CD1' ' A' ' 23' ' ' PHE . 38.8 m -100.23 -9.21 22.66 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 112.134 0.42 . . . . 1.79 112.134 -177.456 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 69.42 55.67 9.79 Favored Glycine 0 N--CA 1.452 -0.286 0 CA-C-N 115.808 -0.633 . . . . 0.68 113.405 178.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.678 ' CZ ' ' HA ' ' A' ' 18' ' ' ALA . 15.5 p90 -112.67 166.54 11.25 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.77 0.319 . . . . 0.68 110.455 176.858 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 21.0 m -89.31 113.41 24.68 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.187 0.518 . . . . 1.3 111.012 -177.403 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.601 HD13 ' HB3' ' A' ' 14' ' ' LEU . 1.9 tt -99.91 136.7 39.42 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.384 -0.825 . . . . 2.3 109.588 179.002 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.656 ' HB2' ' HA ' ' A' ' 70' ' ' THR . 48.5 m -100.64 97.22 7.92 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 109.692 -0.484 . . . . 1.67 109.692 175.809 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.477 ' HB ' HD21 ' A' ' 25' ' ' LEU . 12.6 p -145.36 150.33 15.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.353 -0.385 . . . . 1.52 110.136 -177.505 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -130.42 122.82 28.48 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.402 -0.363 . . . . 2.38 110.448 -179.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.17 67.7 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.375 0 O-C-N 123.855 0.722 . . . . 2.45 112.286 177.433 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 30.2 t -170.62 -34.48 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.518 -0.549 . . . . 2.48 109.518 178.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 90.9 mt -69.13 -36.87 77.94 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.102 -0.499 . . . . 1.92 110.338 178.119 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 8.9 p -93.7 36.85 1.08 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.952 -0.567 . . . . 1.82 111.358 -179.822 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.49 105.92 2.38 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.914 0.388 . . . . 5.19 110.381 -176.579 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 87.62 17.37 58.54 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.835 -0.697 . . . . 1.62 112.062 -179.259 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.61 93.28 4.68 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.702 0.286 . . . . 3.17 110.249 179.735 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . 0.409 ' HA ' ' HA ' ' A' ' 9' ' ' SER . 49.0 mt-30 -102.69 158.09 16.49 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 110.249 -0.278 . . . . 2.52 110.249 179.529 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 32.9 t -127.2 135.56 50.82 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 108.736 -0.838 . . . . 1.14 108.736 178.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.413 ' N ' HD21 ' A' ' 38' ' ' ASN . 0.9 OUTLIER -67.51 -12.87 61.36 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 113.231 0.826 . . . . 1.28 113.231 -175.499 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 125.13 174.83 14.06 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.028 -1.082 . . . . 0.49 114.034 170.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 57.0 tp -161.25 120.2 2.5 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 108.238 -1.023 . . . . 1.36 108.238 -176.239 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 11.7 p80 -144.28 99.39 3.37 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 119.808 -0.757 . . . . 3.8 111.519 -179.786 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -169.01 -177.84 40.05 Favored Glycine 0 N--CA 1.443 -0.868 0 CA-C-N 115.158 -0.928 . . . . 0.55 111.131 177.833 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -88.87 77.02 7.84 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 108.897 -0.779 . . . . 2.18 108.897 172.269 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 28.9 m-85 -98.26 129.59 44.98 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.766 -0.652 . . . . 1.5 111.68 -173.138 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 32.4 t0 -70.55 162.56 28.62 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.308 -0.86 . . . . 2.23 109.047 173.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 46.4 t -47.92 -64.83 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 112.285 0.476 . . . . 1.25 112.285 -172.54 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 40.9 mm-40 -56.81 -36.55 70.05 Favored 'General case' 0 N--CA 1.464 0.242 0 N-CA-C 111.773 0.286 . . . . 2.39 111.773 -176.749 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 15.3 m -71.74 -33.67 68.89 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-O 120.97 0.414 . . . . 1.65 110.773 -174.684 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -67.75 -46.84 65.0 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.955 -0.64 . . . . 0.4 112.339 -175.192 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.564 HD12 ' CZ2' ' A' ' 69' ' ' TRP . 7.1 mp -68.9 -37.26 78.87 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 110.486 -0.19 . . . . 1.63 110.486 -178.225 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -54.82 -45.86 74.49 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.433 -0.348 . . . . 3.01 111.009 178.266 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 -65.66 -46.85 77.59 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.254 -0.43 . . . . 2.18 110.989 179.102 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 88.7 mt -57.14 -29.63 63.75 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 112.29 0.478 . . . . 1.4 112.29 -178.826 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.479 ' HG ' ' O ' ' A' ' 50' ' ' LEU . 95.0 mt -77.84 -7.32 56.5 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 112.079 0.4 . . . . 2.78 112.079 -176.839 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -66.72 93.87 0.27 Allowed 'General case' 0 C--O 1.233 0.207 0 CA-C-O 121.45 0.643 . . . . 2.24 110.973 -178.703 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 136.73 -25.33 3.1 Favored Glycine 0 N--CA 1.444 -0.8 0 C-N-CA 120.835 -0.698 . . . . 1.96 112.162 -178.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 33.3 p -97.82 171.02 8.57 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 110.031 -0.359 . . . . 2.28 110.031 177.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -111.21 -15.77 10.28 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.846 -0.693 . . . . 1.79 112.103 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.496 ' C ' HD11 ' A' ' 59' ' ' LEU . 2.1 pp -90.49 -178.16 5.25 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.788 -0.449 . . . . 1.82 109.788 178.255 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 94.6 mt-30 -143.08 120.66 11.76 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 118.365 0.53 . . . . 3.26 110.231 -167.493 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.441 HG23 HD13 ' A' ' 14' ' ' LEU . 21.6 t -97.38 128.25 48.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 N-CA-C 109.027 -0.731 . . . . 2.17 109.027 175.907 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 25.0 pttm -146.85 154.16 47.04 Favored Pre-proline 0 C--N 1.329 -0.312 0 C-N-CA 120.5 -0.48 . . . . 2.29 111.299 -178.777 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.569 ' HA ' ' HA ' ' A' ' 69' ' ' TRP . 42.9 Cg_exo -58.57 133.7 56.14 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.984 2.456 . . . . 0.94 111.864 173.467 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 54.4 tp -67.62 -29.15 68.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.473 -0.785 . . . . 2.32 111.141 -175.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 166.44 -56.26 0.24 Allowed Glycine 0 N--CA 1.45 -0.427 0 N-CA-C 110.972 -0.851 . . . . 1.69 110.972 179.396 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 13.5 m120 -83.93 -164.48 0.93 Allowed 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 108.438 -0.949 . . . . 3.67 108.438 172.815 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 9.0 t30 -78.61 58.99 2.36 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.814 0.816 . . . . 2.59 109.904 177.291 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.462 ' O ' ' HA ' ' A' ' 63' ' ' PRO . 30.9 m -147.89 174.68 11.62 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 107.725 -1.213 . . . . 1.54 107.725 176.259 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . 0.569 ' HA ' ' HA ' ' A' ' 63' ' ' PRO . 53.7 m0 -137.8 166.5 23.84 Favored 'General case' 0 C--N 1.322 -0.603 0 C-N-CA 120.323 -0.551 . . . . 0.54 110.601 -165.32 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.656 ' HA ' ' HB2' ' A' ' 26' ' ' SER . 12.3 t -146.81 150.2 34.82 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.108 -0.496 . . . . 1.49 109.76 173.424 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 54.9 tp -92.95 104.82 17.02 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-O 121.813 0.816 . . . . 2.24 110.491 179.198 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 22.0 tt0 -91.3 118.89 68.74 Favored Pre-proline 0 C--N 1.316 -0.888 0 CA-C-N 114.185 -1.371 . . . . 2.25 111.526 179.482 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -84.65 115.18 1.8 Allowed 'Trans proline' 0 N--CA 1.452 -0.942 0 C-N-CA 122.874 2.383 . . . . 1.45 111.658 174.792 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -164.05 76.35 1.64 Allowed Pre-proline 0 C--N 1.324 -0.504 0 CA-C-N 115.742 -0.663 . . . . 2.07 109.308 177.011 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.502 ' C ' ' HD3' ' A' ' 77' ' ' PRO . 45.0 Cg_endo -87.1 -90.36 0.0 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.803 0 C-N-CA 123.014 2.476 . . . . 2.85 113.612 -169.441 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -116.6 68.64 4.1 Favored Pre-proline 0 C--N 1.326 -0.42 0 N-CA-C 108.902 -0.777 . . . . 4.66 108.902 174.797 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.502 ' HD3' ' C ' ' A' ' 75' ' ' PRO . 36.5 Cg_endo -92.76 50.72 0.46 Allowed 'Trans proline' 0 N--CA 1.443 -1.481 0 C-N-CA 123.411 2.741 . . . . 4.26 111.383 -169.883 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 27.8 tptp -72.0 -50.48 28.27 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.157 -0.929 . . . . 6.5 110.356 177.835 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -110.58 101.57 10.23 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.814 -0.63 . . . . 8.11 111.213 -176.804 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 34.8 t70 . . . . . 0 C--O 1.251 1.142 0 CA-C-N 115.106 -0.952 . . . . 9.05 109.558 176.394 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.965 0 N-CA-C 110.093 -0.336 . . . . 4.29 110.093 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 -75.0 148.26 40.05 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.128 0.49 . . . . 4.51 110.742 -178.762 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . 0.437 HG23 ' HB2' ' A' ' 44' ' ' TYR . 62.8 t -127.42 136.3 60.93 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 115.433 -0.803 . . . . 2.2 109.349 179.617 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 17.7 m120 -127.96 97.86 4.94 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.453 -0.573 . . . . 2.75 109.453 -174.625 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.604 HG13 HD22 ' A' ' 53' ' ' LEU . 43.0 mm -122.93 155.91 28.48 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 N-CA-C 109.33 -0.619 . . . . 1.5 109.33 -178.515 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.637 ' HB1' ' HD2' ' A' ' 7' ' ' PRO . . . -162.43 163.41 18.34 Favored Pre-proline 0 C--N 1.325 -0.492 0 N-CA-C 109.27 -0.641 . . . . 1.99 109.27 -176.781 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.637 ' HD2' ' HB1' ' A' ' 6' ' ' ALA . 9.4 Cg_endo -51.96 130.56 35.11 Favored 'Trans proline' 0 C--N 1.35 0.649 0 C-N-CA 122.831 2.354 . . . . 1.73 112.755 -175.33 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 163.15 42.81 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.408 0 CA-C-N 115.67 -0.695 . . . . 1.84 112.441 -178.111 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.76 ' HA ' ' HA ' ' A' ' 36' ' ' GLN . 65.1 m 66.44 131.49 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 121.496 0.665 . . . . 1.87 111.691 -178.706 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 64.1 tp -60.02 -35.4 74.99 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 115.924 -0.58 . . . . 1.83 111.031 -178.493 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.408 ' HB2' ' HB ' ' A' ' 32' ' ' THR . 33.8 t70 -50.6 -54.12 25.24 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 115.583 -0.735 . . . . 2.11 111.589 177.372 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 85.3 tttt -66.78 -32.01 73.02 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.693 -0.23 . . . . 3.11 110.755 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -63.29 -53.36 54.01 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.932 0.396 . . . . 1.17 110.548 -176.206 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 88.6 mt -58.98 -39.51 81.99 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 115.988 -0.551 . . . . 1.31 111.021 176.517 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 52.4 t30 -60.86 -39.7 90.13 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.209 -0.45 . . . . 1.98 110.703 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 -58.85 -51.11 71.42 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.044 -0.525 . . . . 2.33 111.421 177.843 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.474 ' CD1' ' HH2' ' A' ' 69' ' ' TRP . 32.4 t80 -67.26 -38.43 85.1 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.038 -0.727 . . . . 1.05 109.038 -175.739 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.84 ' HA ' ' CE2' ' A' ' 23' ' ' PHE . . . -55.7 -49.99 71.52 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 115.532 -0.758 . . . . 1.15 111.955 174.913 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.94 -23.64 67.42 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.211 -0.449 . . . . 1.26 111.588 -178.319 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 75.0 t60 -61.71 -48.06 82.45 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.027 -0.533 . . . . 2.52 111.498 -176.346 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.573 ' HB3' ' CD1' ' A' ' 23' ' ' PHE . 38.9 t -102.37 -4.5 25.44 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.882 0.372 . . . . 1.79 111.114 -179.691 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 68.3 47.02 60.72 Favored Glycine 0 CA--C 1.518 0.23 0 CA-C-N 115.702 -0.681 . . . . 0.68 113.622 177.864 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.84 ' CE2' ' HA ' ' A' ' 18' ' ' ALA . 10.3 p90 -106.65 159.66 16.04 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 122.538 -0.39 . . . . 0.68 110.294 176.9 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 22.4 m -88.28 119.5 28.75 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.943 -0.571 . . . . 1.3 111.91 -173.443 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.629 HD22 ' CE3' ' A' ' 69' ' ' TRP . 0.8 OUTLIER -94.8 143.88 26.1 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.636 -0.711 . . . . 2.3 111.278 178.351 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 36.2 t -115.53 92.15 3.83 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.114 -0.698 . . . . 1.67 109.114 173.035 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 6.9 p -148.64 125.54 2.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 115.903 -0.59 . . . . 1.52 110.0 -178.605 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -88.37 134.76 33.74 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 120.831 -0.347 . . . . 2.38 110.634 -177.776 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.7 70.67 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.255 0 O-C-N 124.043 0.839 . . . . 2.45 112.095 176.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 79.4 p -168.64 -42.96 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.478 -0.564 . . . . 2.48 109.478 178.662 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.404 ' O ' ' HD3' ' A' ' 35' ' ' LYS . 80.7 mt -66.97 -45.41 77.8 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.655 -0.702 . . . . 1.92 110.029 177.142 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.408 ' HB ' ' HB2' ' A' ' 11' ' ' ASP . 1.3 p -91.4 -3.32 56.81 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.489 -0.778 . . . . 1.82 111.592 -178.91 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 55.4 ttp180 -86.62 129.58 34.81 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.174 -0.466 . . . . 5.19 110.586 -178.003 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 107.35 -20.44 32.65 Favored Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 120.703 -0.76 . . . . 1.62 112.353 177.191 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.57 ' HD2' ' N ' ' A' ' 35' ' ' LYS . 0.0 OUTLIER -115.53 136.73 52.78 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-O 121.434 0.635 . . . . 3.17 111.664 -177.873 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . 0.76 ' HA ' ' HA ' ' A' ' 9' ' ' SER . 18.4 pt20 -103.34 156.15 17.95 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.343 -0.844 . . . . 2.52 111.397 -177.49 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 31.2 t -117.92 119.61 35.35 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 106.28 -1.748 . . . . 1.14 106.28 171.317 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.552 ' O ' ' HD3' ' A' ' 7' ' ' PRO . 21.9 m-80 -72.27 -6.77 45.42 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 113.131 0.789 . . . . 1.28 113.131 -167.607 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 127.7 175.62 14.16 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.052 -1.071 . . . . 0.49 113.357 165.756 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.456 ' HB3' ' HB ' ' A' ' 5' ' ' ILE . 67.3 tp -160.13 129.24 5.04 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 109.139 -0.689 . . . . 1.36 109.139 -177.962 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 44.5 m80 -138.15 96.7 3.24 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.171 0.51 . . . . 3.8 110.543 176.123 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -168.87 -169.42 32.25 Favored Glycine 0 N--CA 1.446 -0.693 0 CA-C-N 115.776 -0.647 . . . . 0.55 111.899 176.083 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -98.12 111.47 23.78 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 108.783 -0.821 . . . . 2.18 108.783 173.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.437 ' HB2' HG23 ' A' ' 3' ' ' VAL . 44.7 m-85 -133.54 134.29 43.2 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.289 0.566 . . . . 1.5 112.362 -170.15 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 47.3 t0 -85.9 170.3 12.48 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 108.477 -0.935 . . . . 2.23 108.477 172.617 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 48.7 t -46.85 -70.04 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 N-CA-C 112.574 0.583 . . . . 1.25 112.574 -172.364 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -57.89 -34.25 69.6 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 112.507 0.558 . . . . 2.39 112.507 -177.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 7.2 m -72.14 -39.92 68.45 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-O 121.203 0.525 . . . . 1.65 110.845 -174.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.495 ' O ' ' HG ' ' A' ' 53' ' ' LEU . . . -74.31 -41.76 36.96 Favored Glycine 0 N--CA 1.446 -0.636 0 CA-C-N 115.599 -0.728 . . . . 0.4 111.448 -174.942 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.525 ' O ' ' HG ' ' A' ' 54' ' ' LEU . 90.4 mt -62.29 -38.38 89.14 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.763 0.316 . . . . 1.63 110.831 -179.775 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 6.3 tp60 -57.12 -48.83 77.68 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 115.865 -0.607 . . . . 3.01 111.246 179.862 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.405 ' HG2' HD12 ' A' ' 40' ' ' LEU . 50.4 tp60 -69.0 -38.59 79.35 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.625 -0.261 . . . . 2.18 110.957 -179.146 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.604 HD22 HG13 ' A' ' 5' ' ' ILE . 82.4 mt -56.84 -29.35 62.76 Favored 'General case' 0 N--CA 1.464 0.254 0 N-CA-C 112.014 0.375 . . . . 1.4 112.014 179.369 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.525 ' HG ' ' O ' ' A' ' 50' ' ' LEU . 92.6 mt -78.35 -6.89 56.47 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.219 -0.446 . . . . 2.78 111.893 -176.449 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -66.35 119.07 10.93 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.04 0.447 . . . . 2.24 110.509 -177.161 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 111.98 -24.72 14.09 Favored Glycine 0 N--CA 1.446 -0.682 0 CA-C-N 115.757 -0.656 . . . . 1.96 111.635 -176.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 78.6 p -109.0 169.2 8.83 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.664 0.269 . . . . 2.28 110.302 -179.858 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -114.14 49.52 0.84 Allowed Glycine 0 N--CA 1.443 -0.841 0 N-CA-C 111.161 -0.776 . . . . 1.79 111.161 179.39 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 91.5 mt -124.34 174.96 7.39 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 120.694 0.283 . . . . 1.82 110.398 -178.602 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 8.5 tp-100 -148.86 118.48 7.0 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.264 -0.643 . . . . 3.26 109.264 176.604 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 3.8 p -94.65 123.04 46.61 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 N-CA-C 109.393 -0.595 . . . . 2.17 109.393 177.777 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.457 ' HA ' ' HD3' ' A' ' 63' ' ' PRO . 20.2 ptmt -122.64 134.08 24.77 Favored Pre-proline 0 C--N 1.32 -0.702 0 CA-C-O 120.84 0.352 . . . . 2.29 110.84 -172.73 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.457 ' HD3' ' HA ' ' A' ' 62' ' ' LYS . 37.9 Cg_exo -62.26 129.0 25.44 Favored 'Trans proline' 0 N--CA 1.462 -0.338 0 C-N-CA 122.92 2.413 . . . . 0.94 111.64 176.36 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -68.32 -48.11 65.75 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.244 -0.889 . . . . 2.32 109.802 -177.41 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -175.37 -71.91 0.05 OUTLIER Glycine 0 N--CA 1.445 -0.756 0 C-N-CA 120.687 -0.768 . . . . 1.69 112.074 177.778 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -89.63 -77.9 0.38 Allowed 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.891 0.377 . . . . 3.67 111.098 -176.78 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . 0.455 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 27.2 p-10 -138.31 39.72 2.27 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.402 0.62 . . . . 2.59 111.001 -175.528 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.4 ' O ' ' HD1' ' A' ' 69' ' ' TRP . 35.2 t -138.65 166.51 24.17 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 108.124 -1.065 . . . . 1.54 108.124 177.287 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . 0.629 ' CE3' HD22 ' A' ' 25' ' ' LEU . 24.4 m0 -141.68 165.52 27.25 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 107.865 -1.161 . . . . 0.54 107.865 -174.508 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 12.7 t -145.02 150.06 36.22 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 109.432 -0.581 . . . . 1.49 109.432 172.383 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -93.37 102.68 14.93 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.318 0.58 . . . . 2.24 110.335 -176.446 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -97.04 123.49 53.07 Favored Pre-proline 0 C--N 1.321 -0.663 0 CA-C-N 115.197 -0.911 . . . . 2.25 110.294 173.757 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_exo -62.64 114.78 2.54 Favored 'Trans proline' 0 N--CA 1.461 -0.392 0 C-N-CA 122.403 2.069 . . . . 1.45 111.72 178.307 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -151.19 89.38 4.26 Favored Pre-proline 0 C--N 1.321 -0.646 0 N-CA-C 109.326 -0.62 . . . . 2.07 109.326 179.108 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -88.14 -80.43 0.0 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.255 0 C-N-CA 122.963 2.442 . . . . 2.85 112.77 -173.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -127.45 68.75 74.11 Favored Pre-proline 0 C--N 1.323 -0.553 0 N-CA-C 107.966 -1.124 . . . . 4.66 107.966 173.368 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_endo -90.14 66.78 1.89 Allowed 'Trans proline' 0 N--CA 1.447 -1.214 0 C-N-CA 123.467 2.778 . . . . 4.26 111.44 -168.068 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 44.3 mtmt -123.49 -173.16 2.67 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 114.602 -1.181 . . . . 6.5 109.953 -176.844 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -98.67 52.43 1.0 Allowed 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.933 0.873 . . . . 8.11 109.064 175.728 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 20.1 t70 . . . . . 0 C--O 1.248 1.01 0 CA-C-N 114.889 -1.051 . . . . 9.05 110.09 -174.61 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 0.788 0 CA-C-O 120.541 0.21 . . . . 4.29 110.619 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -155.69 149.92 25.72 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.853 0.359 . . . . 4.51 110.469 177.777 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 31.5 m -139.99 152.68 22.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.95 -0.568 . . . . 2.2 110.282 -178.479 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 19.1 p-10 -127.97 97.09 4.68 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.588 0.708 . . . . 2.75 109.374 176.095 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 66.1 mt -134.03 118.09 27.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.723 -0.671 . . . . 1.5 110.004 -177.293 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -81.17 170.79 14.1 Favored Pre-proline 0 C--N 1.323 -0.574 0 CA-C-N 115.562 -0.744 . . . . 1.99 109.431 -179.644 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -54.96 141.23 78.98 Favored 'Trans proline' 0 N--CA 1.458 -0.6 0 C-N-CA 121.374 1.382 . . . . 1.73 109.843 167.23 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.432 ' O ' ' HB2' ' A' ' 36' ' ' GLN . . . 173.68 -135.8 3.37 Favored Glycine 0 N--CA 1.446 -0.68 0 N-CA-C 110.575 -1.01 . . . . 1.84 110.575 -169.312 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.828 ' HA ' ' HA ' ' A' ' 36' ' ' GLN . 23.7 m -125.25 155.9 39.38 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 117.427 0.614 . . . . 1.87 110.407 178.097 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.604 HD23 ' HB2' ' A' ' 37' ' ' SER . 3.9 mm? -56.3 -39.3 72.5 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 118.074 0.397 . . . . 1.83 111.093 179.231 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -47.08 -56.09 7.16 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 115.27 -0.877 . . . . 2.11 111.822 178.561 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 3.3 tppp? -66.06 -31.14 71.84 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.796 -0.183 . . . . 3.11 111.171 -178.752 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -66.26 -57.86 6.62 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.054 0.454 . . . . 1.17 110.597 -177.278 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 95.4 mt -59.69 -39.17 83.63 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 115.871 -0.604 . . . . 1.31 111.315 177.243 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -57.38 -41.46 80.25 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.27 0.557 . . . . 1.98 110.038 177.031 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -63.46 -48.25 78.45 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.337 -0.847 . . . . 2.33 110.678 179.258 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -70.35 -37.82 74.7 Favored 'General case' 0 N--CA 1.456 -0.148 0 C-N-CA 120.894 -0.322 . . . . 1.05 111.27 -172.183 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.579 ' HA ' ' CZ ' ' A' ' 23' ' ' PHE . . . -47.91 -44.74 30.07 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-O 120.777 0.323 . . . . 1.15 111.652 176.478 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.59 -21.24 66.25 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.736 -0.666 . . . . 1.26 112.358 179.355 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 3.9 t-160 -58.96 -61.53 2.57 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 120.667 0.27 . . . . 2.52 111.45 -175.647 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.627 ' HB3' ' HD1' ' A' ' 23' ' ' PHE . 8.2 t -100.78 -9.07 22.08 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.916 0.389 . . . . 1.79 111.287 -177.764 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 73.33 56.54 5.57 Favored Glycine 0 C--N 1.331 0.284 0 C-N-CA 121.124 -0.56 . . . . 0.68 112.49 -179.714 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.627 ' HD1' ' HB3' ' A' ' 21' ' ' SER . 17.4 p90 -116.68 172.73 7.04 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.737 0.303 . . . . 0.68 110.935 -177.617 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.606 ' O ' ' HB3' ' A' ' 68' ' ' SER . 27.3 m -94.49 111.0 22.74 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-O 121.345 0.593 . . . . 1.3 111.088 -179.247 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 3.2 tt -93.72 117.77 30.53 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.216 -0.661 . . . . 2.3 109.216 177.752 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 73.5 m -104.65 103.13 12.72 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.97 -0.559 . . . . 1.67 111.341 -174.062 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.475 ' CG2' HD11 ' A' ' 71' ' ' LEU . 4.2 p -138.84 129.65 34.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 115.842 -0.617 . . . . 1.52 110.668 178.254 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -72.57 121.76 20.23 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.727 -0.67 . . . . 2.38 110.307 176.153 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.31 77.27 0.01 OUTLIER 'General case' 0 C--O 1.236 0.35 0 CA-C-N 115.778 -0.646 . . . . 2.45 111.984 177.693 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 30.6 t -175.47 -31.41 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.723 -0.671 . . . . 2.48 109.513 178.317 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 80.1 mt -63.11 -53.01 60.24 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.639 -0.71 . . . . 1.92 110.636 179.316 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 3.0 p -92.39 58.28 3.17 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.773 -0.649 . . . . 1.82 110.831 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 16.6 ptp180 -71.26 105.72 3.57 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 115.742 -0.663 . . . . 5.19 109.758 176.353 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 68.24 -93.25 0.28 Allowed Glycine 0 N--CA 1.45 -0.397 0 N-CA-C 110.633 -0.987 . . . . 1.62 110.633 -170.363 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.557 ' HG3' HD22 ' A' ' 10' ' ' LEU . 40.7 tptt 50.82 94.3 0.02 OUTLIER 'General case' 0 C--O 1.236 0.355 0 C-N-CA 123.779 0.831 . . . . 3.17 111.974 171.288 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . 0.828 ' HA ' ' HA ' ' A' ' 9' ' ' SER . 2.8 pt20 -101.37 153.81 19.34 Favored 'General case' 0 N--CA 1.447 -0.58 0 O-C-N 121.994 -0.441 . . . . 2.52 110.474 -174.804 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.604 ' HB2' HD23 ' A' ' 10' ' ' LEU . 32.8 t -128.08 138.66 52.63 Favored 'General case' 0 N--CA 1.446 -0.673 0 N-CA-C 108.469 -0.937 . . . . 1.14 108.469 -179.778 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.507 ' N ' HD21 ' A' ' 38' ' ' ASN . 0.9 OUTLIER -64.85 -8.96 17.39 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.997 -0.547 . . . . 1.28 112.143 -179.213 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 118.6 -177.39 16.43 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.868 -0.682 . . . . 0.49 112.634 171.554 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.405 HD13 ' HG2' ' A' ' 52' ' ' GLN . 63.3 tp -159.62 109.52 1.88 Allowed 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 108.605 -0.887 . . . . 1.36 108.605 -179.432 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 12.7 p80 -144.7 98.23 3.15 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 122.018 0.913 . . . . 3.8 111.332 -178.633 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -170.03 -169.82 33.68 Favored Glycine 0 N--CA 1.443 -0.888 0 CA-C-N 114.356 -1.293 . . . . 0.55 111.043 176.689 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 32.1 m-20 -82.43 75.36 9.34 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.116 -0.698 . . . . 2.18 109.116 173.36 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 79.8 m-85 -110.08 123.12 49.14 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.564 -0.744 . . . . 1.5 110.798 -178.144 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.401 ' CG ' ' H ' ' A' ' 46' ' ' VAL . 7.7 t70 -89.27 -163.1 0.94 Allowed 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 108.878 -0.786 . . . . 2.23 108.878 173.23 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.504 ' O ' ' HG ' ' A' ' 50' ' ' LEU . 37.5 t -53.09 -71.81 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 N-CA-C 112.751 0.648 . . . . 1.25 112.751 -172.367 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -61.83 -42.44 99.03 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 112.944 0.72 . . . . 2.39 112.944 -171.54 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 28.6 m -68.89 -29.99 68.39 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.158 0.504 . . . . 1.65 111.01 -173.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -80.07 -29.83 44.72 Favored Glycine 0 N--CA 1.445 -0.711 0 N-CA-C 110.9 -0.88 . . . . 0.4 110.9 -178.481 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.62 ' HB3' HG13 ' A' ' 61' ' ' VAL . 82.6 mt -74.73 -45.51 43.61 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 115.459 -0.371 . . . . 1.63 110.385 -179.369 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 24.2 tp60 -55.63 -41.46 73.56 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.97 -0.559 . . . . 3.01 111.27 178.413 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.915 ' HA ' HE21 ' A' ' 52' ' ' GLN . 0.0 OUTLIER -63.81 -48.36 77.16 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.613 -0.267 . . . . 2.18 111.028 -179.973 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 93.1 mt -58.71 -23.99 60.64 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 112.366 0.506 . . . . 1.4 112.366 -179.603 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.618 HD12 HG12 ' A' ' 61' ' ' VAL . 68.8 mt -78.31 -19.65 53.13 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 112.23 0.456 . . . . 2.78 112.23 -177.174 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -65.48 101.32 0.58 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.204 0.526 . . . . 2.24 110.802 -176.475 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 124.1 -3.7 9.05 Favored Glycine 0 N--CA 1.449 -0.482 0 CA-C-N 115.604 -0.726 . . . . 1.96 111.844 -177.345 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 6.9 m -118.09 170.69 8.65 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.758 0.313 . . . . 2.28 110.397 179.145 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -115.2 24.29 10.74 Favored Glycine 0 N--CA 1.442 -0.901 0 N-CA-C 110.44 -1.064 . . . . 1.79 110.44 172.64 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 85.6 mt -101.57 175.23 5.64 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 120.822 0.344 . . . . 1.82 110.108 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 72.1 mt-30 -133.84 118.32 17.85 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 109.334 -0.617 . . . . 3.26 109.334 174.411 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.62 HG13 ' HB3' ' A' ' 50' ' ' LEU . 6.1 p -86.44 113.42 24.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 N-CA-C 108.781 -0.822 . . . . 2.17 108.781 174.35 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 40.0 ttpt -136.22 130.57 18.34 Favored Pre-proline 0 C--N 1.314 -0.94 0 CA-C-N 115.642 -0.708 . . . . 2.29 110.213 -169.813 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . 0.531 ' HA ' ' HA ' ' A' ' 69' ' ' TRP . 51.4 Cg_exo -55.0 130.64 41.87 Favored 'Trans proline' 0 N--CA 1.461 -0.402 0 C-N-CA 122.318 2.012 . . . . 0.94 111.027 175.638 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.441 ' O ' HD12 ' A' ' 64' ' ' LEU . 2.8 tm? -62.64 -34.74 77.66 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.816 -0.629 . . . . 2.32 109.739 -176.545 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 177.07 -59.01 0.1 OUTLIER Glycine 0 N--CA 1.444 -0.824 0 N-CA-C 110.935 -0.866 . . . . 1.69 110.935 177.164 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 21.0 m-80 -140.17 126.74 20.3 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.599 -0.3 . . . . 3.67 110.703 178.003 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 47.8 t30 75.25 -36.87 0.32 Allowed 'General case' 0 N--CA 1.475 0.781 0 O-C-N 124.096 0.872 . . . . 2.59 112.881 173.556 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.606 ' HB3' ' O ' ' A' ' 24' ' ' THR . 69.0 m -114.17 178.61 4.22 Favored 'General case' 0 C--N 1.321 -0.638 0 O-C-N 122.231 -0.293 . . . . 1.54 110.396 -168.072 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . 0.531 ' HA ' ' HA ' ' A' ' 63' ' ' PRO . 40.0 m0 -139.16 167.81 21.24 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 120.825 0.345 . . . . 0.54 110.125 -169.224 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 14.3 t -149.95 150.56 32.02 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.348 -0.612 . . . . 1.49 109.348 169.082 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.518 HD22 ' HA ' ' A' ' 61' ' ' VAL . 25.9 mt -92.79 102.89 15.28 Favored 'General case' 0 CA--C 1.517 -0.317 0 C-N-CA 120.285 -0.566 . . . . 2.24 110.056 174.644 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.406 ' HA ' ' HD3' ' A' ' 73' ' ' PRO . 42.7 tt0 -87.36 119.48 70.85 Favored Pre-proline 0 C--N 1.317 -0.807 0 CA-C-N 115.098 -0.956 . . . . 2.25 110.528 177.493 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 72' ' ' GLU . 6.3 Cg_exo -75.25 114.07 3.92 Favored 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 122.341 2.027 . . . . 1.45 111.187 177.109 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -163.15 76.82 1.83 Allowed Pre-proline 0 C--N 1.32 -0.698 0 N-CA-C 108.681 -0.859 . . . . 2.07 108.681 -179.771 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -81.33 54.76 5.32 Favored 'Trans proline' 0 N--CA 1.459 -0.549 0 C-N-CA 122.714 2.276 . . . . 2.85 112.855 -170.608 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 52.59 68.15 3.32 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.277 0.561 . . . . 4.66 109.976 -174.802 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -91.59 146.29 3.29 Favored 'Trans proline' 0 N--CA 1.446 -1.274 0 C-N-CA 124.076 3.184 . . . . 4.26 111.138 -173.118 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.522 ' HB2' ' HZ2' ' A' ' 78' ' ' LYS . 3.4 mtmp? -126.84 -54.58 1.41 Allowed 'General case' 0 C--N 1.32 -0.695 0 C-N-CA 120.672 -0.411 . . . . 6.5 111.969 -167.916 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -156.85 26.64 0.32 Allowed 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 122.251 1.024 . . . . 8.11 108.37 174.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 . . . . . 0 C--O 1.245 0.832 0 CA-C-N 113.619 -1.628 . . . . 9.05 109.492 -172.862 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.061 0 N-CA-C 110.01 -0.367 . . . . 4.29 110.01 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.758 ' HA ' HE21 ' A' ' 2' ' ' GLN . 0.0 OUTLIER -68.98 -57.51 5.37 Favored 'General case' 0 CA--C 1.513 -0.443 0 CA-C-O 121.523 0.678 . . . . 4.51 111.893 -172.475 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 17.3 m -115.67 131.78 67.05 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 CA-C-N 114.64 -1.164 . . . . 2.2 111.46 -175.211 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 50.5 m-80 -130.74 97.58 4.39 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 108.386 -0.968 . . . . 2.75 108.386 174.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 56.6 mt -121.35 132.45 70.62 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-N 115.989 -0.55 . . . . 1.5 111.322 -170.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -75.01 157.73 85.12 Favored Pre-proline 0 C--N 1.326 -0.427 0 CA-C-N 115.68 -0.691 . . . . 1.99 109.872 177.781 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.441 ' HA ' ' O ' ' A' ' 37' ' ' SER . 11.6 Cg_exo -72.12 54.91 2.3 Favored 'Trans proline' 0 CA--C 1.533 0.46 0 C-N-CA 123.003 2.468 . . . . 1.73 112.835 179.031 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -125.05 -161.54 11.08 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.771 -0.728 . . . . 1.84 113.177 -178.083 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 18.7 m -47.01 125.88 8.19 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 123.566 0.746 . . . . 1.87 112.322 -177.227 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 68.0 tp -60.94 -29.54 69.69 Favored 'General case' 0 CA--C 1.522 -0.102 0 CA-C-N 115.412 -0.813 . . . . 1.83 110.756 -179.416 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.438 ' CA ' ' HB ' ' A' ' 32' ' ' THR . 22.9 t70 -51.43 -52.21 48.16 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.703 -0.68 . . . . 2.11 111.232 176.643 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 21.9 tptm -69.88 -25.54 63.76 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.497 -0.32 . . . . 3.11 110.616 -179.339 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.624 ' O ' ' HG3' ' A' ' 16' ' ' GLN . . . -65.12 -54.64 26.76 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.179 0.514 . . . . 1.17 109.943 179.017 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.658 ' HB3' HD11 ' A' ' 25' ' ' LEU . 95.9 mt -59.9 -35.73 75.48 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.834 -0.621 . . . . 1.31 110.397 174.155 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 24.1 t-20 -59.09 -47.22 86.07 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.554 -0.748 . . . . 1.98 110.992 -179.463 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.624 ' HG3' ' O ' ' A' ' 13' ' ' ALA . 0.3 OUTLIER -65.43 -32.72 74.49 Favored 'General case' 0 C--O 1.232 0.176 0 C-N-CA 120.947 -0.301 . . . . 2.33 111.103 -177.587 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.465 ' N ' HE21 ' A' ' 16' ' ' GLN . 5.2 t80 -71.71 -42.82 66.91 Favored 'General case' 0 CA--C 1.527 0.071 0 N-CA-C 109.475 -0.565 . . . . 1.05 109.475 178.128 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.725 ' HA ' ' CZ ' ' A' ' 23' ' ' PHE . . . -53.68 -46.28 70.59 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 115.993 -0.548 . . . . 1.15 111.614 177.966 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.29 -21.88 66.52 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.185 -0.461 . . . . 1.26 111.708 -179.855 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 83.2 t60 -66.07 -52.5 48.3 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.717 -0.22 . . . . 2.52 111.321 -178.537 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.606 ' HB3' ' HD1' ' A' ' 23' ' ' PHE . 31.9 t -100.04 -17.56 17.43 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.064 0.459 . . . . 1.79 111.525 -175.399 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 75.77 48.28 10.5 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.945 -0.645 . . . . 0.68 112.912 -178.273 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.725 ' CZ ' ' HA ' ' A' ' 18' ' ' ALA . 25.3 p90 -107.83 166.14 10.92 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 110.082 -0.34 . . . . 0.68 110.082 -179.943 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.505 ' O ' ' HB3' ' A' ' 68' ' ' SER . 40.3 m -91.32 109.12 20.39 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.274 0.559 . . . . 1.3 111.234 -179.275 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.658 HD11 ' HB3' ' A' ' 14' ' ' LEU . 2.0 tt -92.33 122.83 35.17 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.153 -0.684 . . . . 2.3 109.153 177.248 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 25.5 t -100.83 98.4 8.91 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 120.793 0.33 . . . . 1.67 110.442 -175.288 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 8.2 p -149.14 141.89 18.0 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 CA-C-N 115.944 -0.571 . . . . 1.52 110.878 179.598 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -90.97 138.2 31.78 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.327 -0.397 . . . . 2.38 110.29 174.414 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.37 76.63 0.02 OUTLIER 'General case' 0 C--O 1.235 0.309 0 CA-C-N 116.025 -0.534 . . . . 2.45 111.939 176.757 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 22.3 p -166.84 -52.21 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.356 -0.383 . . . . 2.48 110.342 -179.139 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 84.6 mt -66.51 -44.79 81.56 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.162 -0.472 . . . . 1.92 110.649 179.188 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.438 ' HB ' ' CA ' ' A' ' 11' ' ' ASP . 4.0 p -91.83 -5.66 53.01 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.894 -0.594 . . . . 1.82 111.198 179.744 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' ARG . . . . . 0.406 ' C ' ' H ' ' A' ' 35' ' ' LYS . 28.0 ttp180 -82.49 129.38 34.9 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.609 -0.723 . . . . 5.19 110.568 -177.417 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 80.47 -29.97 2.53 Favored Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 121.172 -0.537 . . . . 1.62 112.2 178.202 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.5 ' HD3' ' C ' ' A' ' 35' ' ' LYS . 11.0 tmtt? -71.66 117.97 13.9 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 109.028 -0.73 . . . . 3.17 109.028 177.133 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -102.15 149.77 23.94 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.083 0.468 . . . . 2.52 110.466 -178.071 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.441 ' O ' ' HA ' ' A' ' 7' ' ' PRO . 0.4 OUTLIER -123.31 134.74 54.03 Favored 'General case' 0 N--CA 1.431 -1.408 0 N-CA-C 107.731 -1.211 . . . . 1.14 107.731 176.117 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . 0.419 ' HA ' ' HB3' ' A' ' 7' ' ' PRO . 0.9 OUTLIER -61.86 -2.0 0.77 Allowed 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 113.152 0.797 . . . . 1.28 113.152 -176.707 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 101.62 -171.55 22.09 Favored Glycine 0 CA--C 1.501 -0.807 0 C-N-CA 120.859 -0.686 . . . . 0.49 111.976 171.16 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 48.9 tp -161.4 134.74 6.45 Favored 'General case' 0 N--CA 1.444 -0.752 0 N-CA-C 107.443 -1.317 . . . . 1.36 107.443 -178.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 57.9 m80 -136.32 96.54 3.39 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.145 0.498 . . . . 3.8 110.658 178.554 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -170.49 176.13 44.15 Favored Glycine 0 N--CA 1.444 -0.81 0 CA-C-N 115.451 -0.795 . . . . 0.55 112.077 177.183 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.639 ' HA ' ' H ' ' A' ' 2' ' ' GLN . 5.3 p-10 -93.75 76.23 4.28 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.849 0.833 . . . . 2.18 108.875 170.988 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' TYR . . . . . 0.465 ' O ' ' HG2' ' A' ' 2' ' ' GLN . 38.8 m-85 -94.85 149.51 21.17 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.462 -0.79 . . . . 1.5 111.997 -173.214 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -85.49 179.12 7.2 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.467 -0.788 . . . . 2.23 109.347 173.693 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.478 ' O ' ' HG ' ' A' ' 50' ' ' LEU . 58.4 t -54.58 -71.99 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 N-CA-C 112.139 0.422 . . . . 1.25 112.139 -176.53 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -58.54 -41.71 86.16 Favored 'General case' 0 C--O 1.233 0.229 0 N-CA-C 112.568 0.581 . . . . 2.39 112.568 -175.431 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 1.3 p -71.38 -32.02 67.97 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.086 0.47 . . . . 1.65 111.004 -175.606 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.598 ' O ' ' HG ' ' A' ' 53' ' ' LEU . . . -73.84 -36.18 53.16 Favored Glycine 0 N--CA 1.442 -0.918 0 N-CA-C 111.089 -0.804 . . . . 0.4 111.089 179.673 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.483 HD21 HD13 ' A' ' 53' ' ' LEU . 91.2 mt -67.35 -40.62 85.87 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.617 -0.292 . . . . 1.63 110.479 -179.833 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 -55.18 -45.44 75.77 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.043 -0.526 . . . . 3.01 111.015 178.652 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 15.9 mm100 -68.52 -36.18 78.51 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.586 -0.279 . . . . 2.18 111.174 178.591 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.598 ' HG ' ' O ' ' A' ' 49' ' ' GLY . 80.1 mt -59.12 -21.03 58.66 Favored 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 112.033 0.382 . . . . 1.4 112.033 178.259 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 7.3 mp -75.95 15.93 0.48 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.904 0.383 . . . . 2.78 111.39 177.754 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . 0.422 ' H ' ' C ' ' A' ' 53' ' ' LEU . 21.8 t70 -56.71 111.51 1.03 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.722 -0.672 . . . . 2.24 111.138 176.486 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 65.27 23.64 70.08 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 121.067 -0.587 . . . . 1.96 112.543 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 50.9 m -99.86 148.63 24.24 Favored 'General case' 0 C--N 1.323 -0.579 0 O-C-N 122.545 -0.385 . . . . 2.28 110.735 179.642 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -111.66 28.32 9.6 Favored Glycine 0 N--CA 1.441 -0.988 0 N-CA-C 109.679 -1.369 . . . . 1.79 109.679 168.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.514 HD11 HD13 ' A' ' 71' ' ' LEU . 59.6 mt -121.82 179.8 4.37 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.122 -0.696 . . . . 1.82 109.122 -179.62 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 27.4 tt0 -151.23 121.48 7.26 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.699 -0.482 . . . . 3.26 109.699 178.245 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.423 HG13 HD22 ' A' ' 50' ' ' LEU . 7.3 p -93.51 137.11 23.38 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 N-CA-C 109.708 -0.479 . . . . 2.17 109.708 179.649 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.593 ' HZ2' ' HG3' ' A' ' 72' ' ' GLU . 15.6 mtmm -130.19 135.51 27.57 Favored Pre-proline 0 C--N 1.327 -0.396 0 C-N-CA 121.065 -0.254 . . . . 2.29 110.409 -179.218 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_exo -63.0 121.79 9.8 Favored 'Trans proline' 0 N--CA 1.458 -0.604 0 C-N-CA 122.407 2.071 . . . . 0.94 110.341 169.568 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 44.8 tp -62.57 -40.46 96.93 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.414 -0.812 . . . . 2.32 111.102 -174.149 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 134.49 -22.16 3.74 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.855 -0.688 . . . . 1.69 111.8 177.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 27.8 p-10 -106.95 41.65 1.43 Allowed 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.807 0.337 . . . . 3.67 110.582 -179.214 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 66.2 t30 56.33 36.06 26.88 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 121.684 0.754 . . . . 2.59 110.428 -177.024 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' SER . . . . . 0.505 ' HB3' ' O ' ' A' ' 24' ' ' THR . 68.5 m -141.55 177.88 7.84 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 107.857 -1.164 . . . . 1.54 107.857 176.104 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' TRP . . . . . 0.449 ' CH2' HD23 ' A' ' 50' ' ' LEU . 54.5 m0 -136.27 167.14 21.86 Favored 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 120.521 -0.472 . . . . 0.54 111.12 -167.154 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 3.8 t -145.46 142.42 29.26 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.402 -0.817 . . . . 1.49 109.722 174.831 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.514 HD13 HD11 ' A' ' 59' ' ' LEU . 0.7 OUTLIER -92.85 104.01 16.3 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.36 -0.607 . . . . 2.24 109.36 179.773 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.593 ' HG3' ' HZ2' ' A' ' 62' ' ' LYS . 4.5 mm-40 -88.28 120.63 70.55 Favored Pre-proline 0 C--N 1.319 -0.727 0 CA-C-N 115.009 -0.996 . . . . 2.25 110.968 -178.389 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.46 ' HD3' ' HA ' ' A' ' 72' ' ' GLU . 4.9 Cg_endo -86.97 115.03 1.15 Allowed 'Trans proline' 0 N--CA 1.453 -0.873 0 C-N-CA 123.005 2.47 . . . . 1.45 111.685 177.463 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -172.82 85.93 0.41 Allowed Pre-proline 0 C--N 1.327 -0.382 0 CA-C-N 115.792 -0.64 . . . . 2.07 109.736 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . 0.502 ' HB2' ' H ' ' A' ' 76' ' ' ALA . 2.2 Cg_endo -80.37 -91.17 0.0 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.823 0 C-N-CA 122.398 2.065 . . . . 2.85 112.59 -175.088 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.502 ' H ' ' HB2' ' A' ' 75' ' ' PRO . . . -134.27 61.76 52.05 Favored Pre-proline 0 C--N 1.322 -0.593 0 N-CA-C 108.69 -0.856 . . . . 4.66 108.69 170.991 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -87.61 39.25 0.55 Allowed 'Trans proline' 0 N--CA 1.451 -0.988 0 C-N-CA 123.02 2.48 . . . . 4.26 112.182 -168.444 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 48.3 tptt -92.52 -51.01 5.33 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 115.735 -0.666 . . . . 6.5 110.037 178.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -89.34 -63.02 1.35 Allowed 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.94 -0.393 . . . . 8.11 109.94 178.836 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 38.1 t70 . . . . . 0 C--O 1.247 0.955 0 CA-C-O 118.327 -0.844 . . . . 9.05 110.202 177.005 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 11.7 pt20 . . . . . 0 C--O 1.233 0.207 0 N-CA-C 109.438 -0.579 . . . . 4.0 109.438 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.434 HG12 HG13 ' A' ' 5' ' ' ILE . 48.0 t -139.88 141.18 34.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.528 -0.305 . . . . 1.64 110.919 -174.879 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -129.35 110.49 11.97 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.313 0.578 . . . . 2.29 109.67 177.415 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.434 HG13 HG12 ' A' ' 3' ' ' VAL . 58.2 mt -137.33 156.79 33.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 N-CA-C 109.413 -0.588 . . . . 0.82 109.413 -178.129 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.616 ' HB1' ' HD2' ' A' ' 7' ' ' PRO . . . -161.69 163.45 19.54 Favored Pre-proline 0 C--N 1.324 -0.507 0 N-CA-C 109.796 -0.446 . . . . 1.38 109.796 -174.578 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.616 ' HD2' ' HB1' ' A' ' 6' ' ' ALA . 6.1 Cg_exo -38.4 135.63 0.68 Allowed 'Trans proline' 0 C--N 1.352 0.735 0 C-N-CA 124.317 3.345 . . . . 1.73 114.151 -176.623 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.442 ' O ' ' HB2' ' A' ' 9' ' ' SER . . . -178.05 -75.71 0.06 OUTLIER Glycine 0 N--CA 1.443 -0.859 0 N-CA-C 110.31 -1.116 . . . . 1.84 110.31 -179.637 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.442 ' HB2' ' O ' ' A' ' 8' ' ' GLY . 8.5 t 174.04 148.25 0.07 Allowed 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 107.277 -1.379 . . . . 1.61 107.277 175.389 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.52 HD23 HG22 ' A' ' 32' ' ' THR . 56.1 tp -56.09 -42.59 76.98 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 119.348 0.976 . . . . 1.19 111.304 -173.953 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -50.75 -55.52 16.33 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 115.795 -0.638 . . . . 2.11 112.006 177.873 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 55.7 mtmt -65.13 -27.51 68.78 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 111.719 0.266 . . . . 2.72 111.719 179.69 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -65.23 -54.88 22.78 Favored 'General case' 0 C--O 1.233 0.237 0 CA-C-O 120.952 0.406 . . . . 0.46 110.114 179.602 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 94.9 mt -59.36 -38.34 80.16 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 115.836 -0.62 . . . . 0.69 111.129 176.614 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 50.8 t-20 -60.0 -47.05 87.41 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.659 -0.497 . . . . 1.31 109.659 178.641 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 24.9 tm0? -61.74 -42.32 98.81 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.799 -0.637 . . . . 2.23 111.108 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.469 ' HD1' ' HZ ' ' A' ' 23' ' ' PHE . 1.9 t80 -66.67 -39.55 88.22 Favored 'General case' 0 CA--C 1.53 0.187 0 N-CA-C 109.747 -0.464 . . . . 0.65 109.747 -177.837 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.754 ' HA ' ' CE2' ' A' ' 23' ' ' PHE . . . -52.71 -42.82 65.19 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.186 -0.461 . . . . 0.37 111.872 177.772 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.37 -22.88 67.15 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.221 -0.445 . . . . 0.64 111.851 -179.344 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' HIS . . . . . 0.447 ' HB3' ' O ' ' A' ' 17' ' ' TYR . 77.2 t60 -64.82 -62.9 1.28 Allowed 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.18 0.437 . . . . 1.85 112.18 -178.534 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.657 ' HB2' ' CD1' ' A' ' 23' ' ' PHE . 9.6 m -100.46 -4.65 28.43 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 112.543 0.572 . . . . 1.67 112.543 -172.676 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 67.27 47.49 63.65 Favored Glycine 0 CA--C 1.52 0.379 0 C-N-CA 121.099 -0.572 . . . . 0.62 113.419 177.642 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.754 ' CE2' ' HA ' ' A' ' 18' ' ' ALA . 3.7 p90 -104.61 171.4 7.35 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 110.152 -0.314 . . . . 0.57 110.152 178.285 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 24.0 m -97.06 122.69 40.34 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.255 0.55 . . . . 0.68 111.959 -175.237 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.632 HD21 ' CE3' ' A' ' 69' ' ' TRP . 1.5 mm? -96.27 143.35 27.43 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.56 -0.746 . . . . 1.67 111.07 178.148 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 8.0 t -123.03 91.37 3.47 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 108.943 -0.762 . . . . 1.15 108.943 172.43 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 6.0 p -148.76 138.26 15.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.929 -0.578 . . . . 0.9 110.581 -175.054 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -102.27 131.87 48.58 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.293 -0.412 . . . . 2.38 110.153 178.54 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.1 70.34 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.34 0 O-C-N 123.583 0.552 . . . . 1.97 112.215 178.338 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 50.0 p -163.98 -49.08 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.146 -0.479 . . . . 2.22 109.939 -177.842 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.44 ' O ' HD11 ' A' ' 59' ' ' LEU . 98.0 mt -63.63 -39.07 93.43 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.213 -0.449 . . . . 1.38 110.227 176.295 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.52 HG22 HD23 ' A' ' 10' ' ' LEU . 2.3 p -91.65 3.07 55.93 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.662 -0.699 . . . . 1.44 111.446 179.6 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.4 HH11 ' HD2' ' A' ' 33' ' ' ARG . 6.0 tpp180 -75.42 106.41 6.95 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.064 -0.516 . . . . 4.63 111.216 -174.189 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 119.27 -45.89 1.2 Allowed Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.346 -0.931 . . . . 1.62 113.808 172.33 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.857 ' HD2' ' H ' ' A' ' 35' ' ' LYS . 0.0 OUTLIER -67.94 137.08 54.9 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.545 0.688 . . . . 2.75 111.741 -174.355 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 5.3 tp-100 -102.73 152.84 20.76 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 114.921 -1.036 . . . . 2.24 110.073 -175.269 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 22.9 t -133.99 123.28 24.33 Favored 'General case' 0 N--CA 1.444 -0.743 0 N-CA-C 107.174 -1.417 . . . . 1.02 107.174 175.29 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 76.6 m-20 -67.79 3.28 1.52 Allowed 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 112.907 0.706 . . . . 1.28 112.907 -173.591 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 107.35 -176.52 21.02 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.612 -0.804 . . . . 0.42 112.958 170.395 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.414 HD13 ' HB3' ' A' ' 52' ' ' GLN . 39.6 tp -160.3 122.89 3.33 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 108.778 -0.823 . . . . 0.7 108.778 -176.366 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 10.7 t-80 -144.48 98.59 3.22 Favored 'General case' 0 C--N 1.321 -0.664 0 C-N-CA 120.296 -0.561 . . . . 2.96 110.964 -179.202 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -168.91 -169.5 32.37 Favored Glycine 0 N--CA 1.446 -0.636 0 CA-C-N 115.264 -0.88 . . . . 0.55 111.627 177.04 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -81.99 76.75 8.87 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.242 -0.651 . . . . 2.18 109.242 175.305 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 78.8 m-85 -107.82 138.38 44.15 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.25 0.548 . . . . 1.41 111.707 -175.626 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -101.93 -170.35 1.81 Allowed 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 108.904 -0.776 . . . . 2.23 108.904 173.208 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 56.0 t -51.97 -71.31 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 112.739 0.644 . . . . 0.57 112.739 -173.321 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -64.4 -40.82 96.54 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 112.548 0.573 . . . . 2.39 112.548 -172.237 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 56.7 m -71.02 -25.9 62.88 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-O 120.919 0.39 . . . . 1.26 110.877 -174.518 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.483 ' O ' ' HG ' ' A' ' 53' ' ' LEU . . . -72.4 -37.71 58.61 Favored Glycine 0 N--CA 1.447 -0.621 0 C-N-CA 120.761 -0.733 . . . . 0.37 111.466 178.959 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.549 HD22 HG11 ' A' ' 61' ' ' VAL . 84.8 mt -67.53 -43.1 81.6 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.024 0.44 . . . . 1.09 110.86 -178.808 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 36.2 tt0 -56.99 -42.19 79.78 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.625 -0.716 . . . . 2.59 110.839 -179.39 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.414 ' HB3' HD13 ' A' ' 40' ' ' LEU . 25.6 mm-40 -70.0 -37.71 75.75 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 111.895 0.331 . . . . 1.75 111.895 176.205 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.483 ' HG ' ' O ' ' A' ' 49' ' ' GLY . 58.9 mt -58.47 -17.74 23.33 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 112.197 0.443 . . . . 0.73 112.197 178.852 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 79.6 mt -69.8 -12.31 61.53 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.443 -0.344 . . . . 2.16 111.007 177.517 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -67.4 109.55 3.22 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 121.041 0.448 . . . . 2.24 110.038 178.813 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 105.66 -6.65 41.51 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.925 -0.655 . . . . 1.7 112.109 -179.221 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 49.1 m -121.75 169.35 10.82 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.833 0.349 . . . . 2.28 110.845 -179.145 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -121.21 15.62 9.34 Favored Glycine 0 N--CA 1.444 -0.813 0 N-CA-C 110.58 -1.008 . . . . 1.58 110.58 172.317 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.527 HD13 HD21 ' A' ' 71' ' ' LEU . 90.8 mt -92.56 -179.4 5.17 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.697 -0.482 . . . . 1.42 109.697 -178.987 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' GLN . . . . . 0.411 ' OE1' ' HB3' ' A' ' 74' ' ' ALA . 49.7 mt-30 -139.72 117.85 11.9 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 108.772 -0.825 . . . . 2.67 108.772 177.837 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.549 HG11 HD22 ' A' ' 50' ' ' LEU . 18.4 t -86.99 113.6 24.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 N-CA-C 109.095 -0.706 . . . . 1.54 109.095 177.084 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -115.95 116.86 40.08 Favored Pre-proline 0 C--N 1.32 -0.702 0 CA-C-N 116.333 -0.394 . . . . 1.81 110.027 -171.112 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.452 ' HA ' ' HA ' ' A' ' 69' ' ' TRP . 58.8 Cg_exo -52.7 121.8 9.82 Favored 'Trans proline' 0 N--CA 1.463 -0.284 0 C-N-CA 122.646 2.231 . . . . 0.85 111.551 176.508 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.576 ' H ' ' HA ' ' A' ' 69' ' ' TRP . 3.3 tm? -68.53 -53.8 20.79 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.673 -0.694 . . . . 1.7 109.523 -177.696 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 176.78 149.33 7.62 Favored Glycine 0 N--CA 1.441 -0.986 0 N-CA-C 110.484 -1.046 . . . . 1.69 110.484 178.16 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 91.2 m-20 65.47 -82.07 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 122.606 0.362 . . . . 2.96 111.239 -179.612 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -147.16 13.18 1.1 Allowed 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.404 -0.591 . . . . 2.5 109.404 -178.713 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 42.9 m -103.56 174.32 5.92 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 108.691 -0.855 . . . . 1.3 108.691 -174.918 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' TRP . . . . . 0.632 ' CE3' HD21 ' A' ' 25' ' ' LEU . 34.1 m0 -139.64 161.92 36.36 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 118.136 0.426 . . . . 0.47 109.874 -173.671 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 13.9 t -142.72 149.3 38.6 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 108.071 -1.085 . . . . 0.83 108.071 169.846 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.527 HD21 HD13 ' A' ' 59' ' ' LEU . 37.9 tp -92.45 105.52 17.69 Favored 'General case' 0 C--N 1.32 -0.694 0 C-N-CA 120.048 -0.661 . . . . 1.71 110.186 -178.377 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -87.2 118.79 70.45 Favored Pre-proline 0 C--N 1.317 -0.808 0 CA-C-N 114.699 -1.137 . . . . 2.13 110.024 -179.791 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -83.17 115.01 2.26 Favored 'Trans proline' 0 N--CA 1.45 -1.087 0 C-N-CA 122.341 2.027 . . . . 1.36 112.409 -178.552 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.411 ' HB3' ' OE1' ' A' ' 60' ' ' GLN . . . . . . . . 0 C--N 1.32 -0.704 0 CA-C-N 115.474 -0.784 . . . . 1.89 110.137 174.316 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.454 -0.25 0 CA-C-O 121.697 0.76 . . . . 4.0 110.674 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 27.7 m -94.83 129.76 44.57 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-N 115.497 -0.774 . . . . 1.64 109.828 -177.474 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 40.1 m-80 -128.16 96.71 4.54 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.413 0.625 . . . . 2.29 109.329 -178.114 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.695 HD13 ' HB3' ' A' ' 40' ' ' LEU . 3.6 mp -105.0 112.39 38.43 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-N 115.279 -0.873 . . . . 0.82 109.563 -178.069 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -85.49 155.94 59.4 Favored Pre-proline 0 C--N 1.32 -0.705 0 CA-C-N 115.855 -0.611 . . . . 1.38 109.491 178.302 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.623 ' HA ' ' O ' ' A' ' 37' ' ' SER . 31.6 Cg_exo -58.88 136.07 71.08 Favored 'Trans proline' 0 C--O 1.234 0.323 0 C-N-CA 121.663 1.575 . . . . 1.73 109.858 169.779 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 149.2 49.9 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.011 -1.09 . . . . 1.84 111.893 -170.475 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.646 ' HA ' ' HA ' ' A' ' 36' ' ' GLN . 25.9 t 66.36 145.85 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 123.282 0.633 . . . . 1.61 112.1 -177.697 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.884 HD22 ' HB3' ' A' ' 37' ' ' SER . 3.0 mm? -57.52 -28.9 63.89 Favored 'General case' 0 N--CA 1.461 0.086 0 CA-C-N 115.784 -0.643 . . . . 1.19 109.987 172.547 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.644 ' HB2' ' HB ' ' A' ' 32' ' ' THR . 18.7 t70 -44.11 -62.48 1.13 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 114.549 -1.205 . . . . 2.11 111.796 178.563 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.45 ' HA ' ' HB3' ' A' ' 15' ' ' ASN . 36.5 ttpt -69.38 -19.93 63.83 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.423 -0.353 . . . . 2.72 111.535 -177.743 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -65.7 -56.45 12.0 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-O 121.134 0.493 . . . . 0.46 109.677 178.529 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 74.5 mt -57.86 -38.31 75.46 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.513 -0.767 . . . . 0.69 110.943 174.437 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ASN . . . . . 0.45 ' HB3' ' HA ' ' A' ' 12' ' ' LYS . 21.4 t-20 -58.83 -42.02 88.25 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.124 -0.489 . . . . 1.31 110.655 177.106 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 24.1 tm0? -60.63 -43.08 97.95 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.953 -0.567 . . . . 2.23 110.548 178.191 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.436 ' HD1' ' HZ ' ' A' ' 23' ' ' PHE . 0.3 OUTLIER -67.42 -51.14 55.31 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.767 0.317 . . . . 0.65 110.63 -179.094 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.741 ' HA ' ' CE2' ' A' ' 23' ' ' PHE . . . -52.26 -53.4 44.29 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 115.799 -0.637 . . . . 0.37 112.352 -177.598 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.77 -21.07 66.24 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.255 -0.429 . . . . 0.64 111.958 -177.245 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 61.0 t-80 -65.26 -53.62 41.56 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 111.622 0.23 . . . . 1.85 111.622 -177.689 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.571 ' HB3' ' CD1' ' A' ' 23' ' ' PHE . 48.1 t -99.81 -7.63 25.18 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.064 0.459 . . . . 1.67 110.997 -178.109 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 76.3 44.27 17.96 Favored Glycine 0 N--CA 1.446 -0.687 0 CA-C-N 115.715 -0.675 . . . . 0.62 112.864 178.947 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.741 ' CE2' ' HA ' ' A' ' 18' ' ' ALA . 14.1 p90 -108.57 149.72 28.47 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.532 -0.544 . . . . 0.57 109.532 176.903 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 28.1 m -90.31 123.61 34.21 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.083 -0.508 . . . . 0.68 111.219 -174.392 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.597 HD11 ' HE3' ' A' ' 69' ' ' TRP . 0.9 OUTLIER -92.86 140.5 29.44 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.655 -0.702 . . . . 1.67 111.458 -179.914 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.533 ' HB3' ' HA ' ' A' ' 70' ' ' THR . 29.6 t -100.66 92.18 4.99 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.041 -0.725 . . . . 1.15 109.041 174.043 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.825 ' HB ' HD23 ' A' ' 71' ' ' LEU . 7.4 p -146.5 134.27 15.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.816 -0.629 . . . . 0.9 110.429 -178.729 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 -89.43 128.82 35.99 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.058 -0.519 . . . . 2.38 110.216 178.636 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.79 60.87 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.425 0 O-C-N 123.722 0.639 . . . . 1.97 111.667 173.36 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.757 ' HA ' ' HG3' ' A' ' 33' ' ' ARG . 68.7 m -165.28 -27.79 0.03 OUTLIER 'General case' 0 C--N 1.321 -0.642 0 C-N-CA 123.429 0.692 . . . . 2.22 109.406 -176.956 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 97.1 mt -73.29 -23.13 60.25 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.414 0.626 . . . . 1.38 109.585 173.513 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.644 ' HB ' ' HB2' ' A' ' 11' ' ' ASP . 17.5 p -98.45 13.0 33.27 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.167 -0.924 . . . . 1.44 111.212 179.527 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.757 ' HG3' ' HA ' ' A' ' 30' ' ' SER . 29.4 mtt180 -67.16 126.17 28.35 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.114 -0.494 . . . . 4.63 111.245 -179.429 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 67.58 17.27 68.68 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 121.038 -0.601 . . . . 1.62 112.275 178.819 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 5.8 mptp? -88.44 148.96 23.94 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.05 0.452 . . . . 2.75 110.572 178.606 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' GLN . . . . . 0.646 ' HA ' ' HA ' ' A' ' 9' ' ' SER . 15.0 pt20 -144.02 137.87 27.97 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.51 -0.768 . . . . 2.24 109.787 171.24 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.884 ' HB3' HD22 ' A' ' 10' ' ' LEU . 50.7 p -119.99 124.59 46.31 Favored 'General case' 0 N--CA 1.443 -0.784 0 N-CA-C 108.226 -1.027 . . . . 1.02 108.226 -177.066 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -57.26 -32.45 66.6 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 112.274 0.472 . . . . 1.28 112.274 -175.545 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 134.17 178.24 15.49 Favored Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 120.312 -0.947 . . . . 0.42 112.481 175.316 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.695 ' HB3' HD13 ' A' ' 5' ' ' ILE . 55.1 tp -160.14 126.12 4.15 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 107.603 -1.258 . . . . 0.7 107.603 -179.678 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 72.1 m80 -142.43 99.61 3.53 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.992 0.425 . . . . 2.96 111.439 -174.878 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -169.14 -170.13 33.35 Favored Glycine 0 N--CA 1.449 -0.459 0 N-CA-C 111.346 -0.702 . . . . 0.55 111.346 175.488 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -101.35 76.61 1.71 Allowed 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 108.353 -0.98 . . . . 2.18 108.353 171.543 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 26.6 m-85 -91.18 150.42 21.37 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.043 -0.98 . . . . 1.41 111.421 -173.735 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 50.4 m-20 -110.24 176.03 5.21 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 107.941 -1.133 . . . . 2.23 107.941 169.218 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.413 HG23 ' H ' ' A' ' 46' ' ' VAL . 16.5 t -49.11 -62.49 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 N-CA-C 112.211 0.448 . . . . 0.57 112.211 -169.331 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 25.9 mm-40 -44.31 -60.44 1.92 Allowed 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 113.182 0.808 . . . . 2.39 113.182 179.667 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 10.2 m -69.04 -28.02 66.18 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.087 0.47 . . . . 1.26 110.904 -173.035 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.489 ' O ' ' HG ' ' A' ' 53' ' ' LEU . . . -74.4 -39.36 42.98 Favored Glycine 0 N--CA 1.444 -0.818 0 C-N-CA 120.765 -0.731 . . . . 0.37 111.853 -176.303 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.557 ' O ' ' HG ' ' A' ' 54' ' ' LEU . 84.0 mt -72.12 -41.38 67.29 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.563 0.221 . . . . 1.09 110.505 -178.187 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 -52.89 -51.16 62.17 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 116.254 -0.43 . . . . 2.59 111.7 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 25.8 mm-40 -64.42 -39.92 94.78 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.998 -0.281 . . . . 1.75 111.205 -179.13 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.489 ' HG ' ' O ' ' A' ' 49' ' ' GLY . 92.7 mt -59.32 -25.23 63.98 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.199 -0.455 . . . . 0.73 112.123 177.626 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.557 ' HG ' ' O ' ' A' ' 50' ' ' LEU . 96.7 mt -76.3 -14.06 60.12 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 111.922 0.341 . . . . 2.16 111.922 -176.394 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -82.88 103.9 12.7 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.989 0.423 . . . . 2.24 111.116 -177.263 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 78.9 20.71 69.94 Favored Glycine 0 N--CA 1.45 -0.379 0 CA-C-N 115.698 -0.683 . . . . 1.7 113.485 174.877 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.455 ' HB2' ' HG ' ' A' ' 10' ' ' LEU . 16.3 p -88.8 -32.49 17.83 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.934 0.397 . . . . 2.28 110.981 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 87.86 9.01 71.94 Favored Glycine 0 N--CA 1.444 -0.815 0 N-CA-C 111.3 -0.72 . . . . 1.58 111.3 -176.687 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.585 ' HB3' HD12 ' A' ' 71' ' ' LEU . 85.7 mt -129.71 171.55 12.54 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 120.854 0.359 . . . . 1.42 110.611 -176.275 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' GLN . . . . . 0.558 ' HB2' ' HB3' ' A' ' 74' ' ' ALA . 48.5 tt0 -136.16 118.84 16.04 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.177 -0.675 . . . . 2.67 109.177 176.192 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.468 ' H ' HD21 ' A' ' 54' ' ' LEU . 52.6 t -87.26 118.46 33.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-O 120.905 0.383 . . . . 1.54 110.69 -178.288 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.427 ' HE3' ' HB3' ' A' ' 62' ' ' LYS . 22.4 mmmt -125.69 117.92 24.45 Favored Pre-proline 0 C--N 1.325 -0.47 0 CA-C-N 115.944 -0.571 . . . . 1.81 110.172 177.663 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.511 ' HA ' ' HA ' ' A' ' 69' ' ' TRP . 41.7 Cg_exo -57.94 121.0 9.27 Favored 'Trans proline' 0 C--O 1.233 0.234 0 C-N-CA 122.351 2.034 . . . . 0.85 110.762 174.763 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -75.61 -57.98 3.56 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.784 -0.643 . . . . 1.7 110.831 -171.873 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -127.04 -98.68 1.04 Allowed Glycine 0 N--CA 1.445 -0.73 0 C-N-CA 120.195 -1.002 . . . . 1.69 112.395 -178.228 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 60.1 t30 -91.87 -74.07 0.52 Allowed 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.741 0.305 . . . . 2.96 110.929 -177.633 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 27.2 p-10 -122.19 34.87 5.03 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.186 0.517 . . . . 2.5 110.877 -178.143 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 47.0 t -126.66 169.21 13.37 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 108.713 -0.847 . . . . 1.3 108.713 179.315 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' TRP . . . . . 0.597 ' HE3' HD11 ' A' ' 25' ' ' LEU . 6.8 m0 -142.31 162.32 35.76 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 107.824 -1.176 . . . . 0.47 107.824 -173.529 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.533 ' HA ' ' HB3' ' A' ' 26' ' ' SER . 12.4 t -140.32 146.52 38.6 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 109.517 -0.549 . . . . 0.83 109.517 174.19 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.825 HD23 ' HB ' ' A' ' 27' ' ' VAL . 4.2 mm? -93.63 102.93 15.12 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.613 0.72 . . . . 1.71 110.751 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.434 ' HA ' ' HD3' ' A' ' 73' ' ' PRO . 24.9 mt-10 -86.65 126.28 64.4 Favored Pre-proline 0 C--N 1.319 -0.733 0 CA-C-N 114.744 -1.116 . . . . 2.13 109.54 173.658 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' ' 72' ' ' GLU . 38.9 Cg_exo -60.81 114.46 2.16 Favored 'Trans proline' 0 N--CA 1.462 -0.378 0 C-N-CA 122.746 2.297 . . . . 1.36 111.897 -176.494 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.558 ' HB3' ' HB2' ' A' ' 60' ' ' GLN . . . . . . . . 0 C--N 1.32 -0.686 0 CA-C-N 115.007 -0.997 . . . . 1.89 108.86 178.239 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 2' ' ' GLN . . . . . 0.712 ' N ' ' HA ' ' A' ' 43' ' ' ASP . 9.7 tt0 . . . . . 0 N--CA 1.452 -0.369 0 CA-C-O 121.814 0.816 . . . . 4.0 110.198 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 31.8 m -140.8 147.66 22.58 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 114.766 -1.106 . . . . 1.64 109.867 178.411 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 84.2 m-20 -129.2 102.56 6.51 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.465 -0.569 . . . . 2.29 109.465 179.768 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.433 HD12 ' HB3' ' A' ' 40' ' ' LEU . 56.6 mt -129.96 152.33 37.22 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 116.172 -0.467 . . . . 0.82 109.851 -174.774 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.506 ' HB1' ' HD2' ' A' ' 7' ' ' PRO . . . -163.95 167.46 10.83 Favored Pre-proline 0 C--N 1.327 -0.39 0 N-CA-C 110.112 -0.329 . . . . 1.38 110.112 -174.551 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.526 ' HA ' ' O ' ' A' ' 37' ' ' SER . 71.2 Cg_exo -49.31 136.86 31.48 Favored 'Trans proline' 0 C--N 1.351 0.673 0 C-N-CA 122.835 2.357 . . . . 1.73 113.43 -176.582 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 143.86 64.56 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.742 -0.742 . . . . 1.84 112.681 177.146 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 50.0 m 66.36 116.14 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 121.372 0.606 . . . . 1.61 112.017 179.159 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.402 HD21 HD23 ' A' ' 54' ' ' LEU . 60.0 tp -59.47 -42.04 91.14 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 115.996 -0.547 . . . . 1.19 112.425 -178.543 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.628 ' HB3' ' HA ' ' A' ' 33' ' ' ARG . 8.4 p-10 -54.66 -37.86 66.23 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.75 -0.205 . . . . 2.11 111.286 178.472 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -66.05 -31.16 71.88 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.949 0.404 . . . . 2.72 110.7 178.308 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -67.11 -54.02 25.32 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.133 -0.485 . . . . 0.46 110.337 -179.048 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.401 HD11 HD21 ' A' ' 54' ' ' LEU . 84.6 mt -59.26 -38.88 81.19 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 115.76 -0.654 . . . . 0.69 110.838 175.999 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -59.75 -38.74 82.59 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.78 -0.645 . . . . 1.31 110.353 178.273 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 20.6 tm0? -62.81 -41.62 99.37 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.62 -0.718 . . . . 2.23 110.786 177.61 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.618 ' CD1' ' HH2' ' A' ' 69' ' ' TRP . 7.0 t80 -68.47 -41.39 80.22 Favored 'General case' 0 C--N 1.333 -0.112 0 N-CA-C 109.807 -0.442 . . . . 0.65 109.807 -178.029 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.663 ' HA ' ' CE2' ' A' ' 23' ' ' PHE . . . -53.75 -46.87 71.03 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.05 -0.523 . . . . 0.37 111.691 177.06 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.68 -16.54 57.66 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.043 -0.526 . . . . 0.64 112.15 -178.027 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 76.3 t60 -61.36 -47.55 85.33 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.669 -0.241 . . . . 1.85 111.462 -179.288 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.463 ' HB3' ' CD1' ' A' ' 23' ' ' PHE . 32.5 t -118.77 -15.89 9.39 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 120.712 -0.395 . . . . 1.67 112.008 -178.676 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 74.9 61.01 3.19 Favored Glycine 0 C--N 1.331 0.259 0 C-N-CA 120.867 -0.682 . . . . 0.62 112.732 -179.485 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.663 ' CE2' ' HA ' ' A' ' 18' ' ' ALA . 3.1 p90 -112.8 169.21 9.07 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.999 0.428 . . . . 0.57 111.021 -179.103 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 14.8 m -89.66 101.38 14.07 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.457 0.646 . . . . 0.68 111.276 -176.354 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.592 HD22 ' HB ' ' A' ' 27' ' ' VAL . 2.8 tt -93.58 126.78 38.92 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.551 -0.75 . . . . 1.67 109.325 177.116 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.558 ' HB2' ' HA ' ' A' ' 70' ' ' THR . 8.5 m -98.99 91.15 4.89 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.162 -0.681 . . . . 1.15 109.162 179.843 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.746 HG23 HD22 ' A' ' 71' ' ' LEU . 7.3 p -117.62 135.78 56.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 115.911 -0.586 . . . . 0.9 111.533 -174.458 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 50.7 m-20 -78.19 112.81 15.54 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-N 115.882 -0.599 . . . . 2.38 109.74 174.675 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -64.68 66.74 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.977 -0.556 . . . . 1.97 112.02 177.524 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 20.4 p -170.28 -44.09 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.255 -0.429 . . . . 2.22 110.175 -179.074 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 91.0 mt -68.27 -52.58 32.29 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.951 -0.568 . . . . 1.38 111.351 -179.286 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 13.0 p -101.82 -19.2 15.41 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 112.615 0.598 . . . . 1.44 112.615 -176.265 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.628 ' HA ' ' HB3' ' A' ' 11' ' ' ASP . 16.1 tpp180 -59.9 119.16 7.2 Favored 'General case' 0 C--O 1.233 0.233 0 N-CA-C 110.115 -0.328 . . . . 4.63 110.115 -178.463 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 93.66 -115.85 5.06 Favored Glycine 0 N--CA 1.439 -1.165 0 N-CA-C 111.056 -0.818 . . . . 1.62 111.056 -177.041 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 9.3 mmmm 46.9 -165.84 0.02 OUTLIER 'General case' 0 N--CA 1.443 -0.775 0 CA-C-O 122.205 1.002 . . . . 2.75 111.654 -176.209 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 8.0 pt20 -150.16 132.71 15.75 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 114.887 -1.051 . . . . 2.24 108.673 165.029 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.526 ' O ' ' HA ' ' A' ' 7' ' ' PRO . 33.9 t -118.45 139.22 51.75 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 108.059 -1.089 . . . . 1.02 108.059 175.436 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 36.0 m-20 -67.61 -14.46 62.96 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.091 -0.504 . . . . 1.28 111.065 -176.853 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.409 ' HA2' HG22 ' A' ' 5' ' ' ILE . . . 111.58 -169.53 13.25 Favored Glycine 0 N--CA 1.443 -0.882 0 C-N-CA 120.73 -0.747 . . . . 0.42 112.331 173.527 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.433 ' HB3' HD12 ' A' ' 5' ' ' ILE . 42.1 tp -160.16 125.64 4.02 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 108.349 -0.982 . . . . 0.7 108.349 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 39.4 t-80 -136.66 96.54 3.35 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 120.215 -0.594 . . . . 2.96 110.966 -178.544 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -168.79 -179.96 41.26 Favored Glycine 0 N--CA 1.448 -0.533 0 CA-C-N 115.398 -0.819 . . . . 0.55 111.239 175.157 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.712 ' HA ' ' N ' ' A' ' 2' ' ' GLN . 21.9 m-20 -84.97 74.63 10.49 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 108.656 -0.868 . . . . 2.18 108.656 173.977 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 22.5 m-85 -96.21 143.94 26.86 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.198 -0.91 . . . . 1.41 111.061 -174.086 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -94.1 -172.39 2.81 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.543 -0.753 . . . . 2.23 110.057 179.386 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.434 HG13 ' HZ2' ' A' ' 69' ' ' TRP . 59.8 t -52.34 -71.57 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.042 -0.526 . . . . 0.57 112.19 -178.095 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 21.1 mt-10 -63.88 -41.49 97.73 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.863 -0.608 . . . . 2.39 112.061 -172.78 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 4.2 p -72.11 -32.04 66.6 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.098 -0.501 . . . . 1.26 111.306 -172.251 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -75.2 -39.24 37.42 Favored Glycine 0 N--CA 1.447 -0.617 0 N-CA-C 111.114 -0.794 . . . . 0.37 111.114 -176.39 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.521 ' CB ' HG11 ' A' ' 61' ' ' VAL . 62.9 mt -72.66 -41.5 65.36 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.773 0.321 . . . . 1.09 110.58 -178.568 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 21.2 tt0 -54.8 -49.12 71.75 Favored 'General case' 0 C--O 1.222 -0.345 0 CA-C-N 115.808 -0.633 . . . . 2.59 111.009 -176.929 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 85.8 mm-40 -65.09 -40.19 94.26 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.455 -0.339 . . . . 1.75 111.485 -178.622 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 90.0 mt -57.77 -34.95 70.13 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 112.1 0.407 . . . . 0.73 112.1 178.636 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.402 HD23 HD21 ' A' ' 10' ' ' LEU . 81.8 mt -102.42 -12.6 17.74 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.929 0.395 . . . . 2.16 111.645 -174.432 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -64.68 130.2 42.68 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.05 -0.523 . . . . 2.24 110.956 -177.833 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 100.41 -31.44 8.51 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.533 -0.842 . . . . 1.7 113.243 176.561 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 24.4 p -91.87 12.84 20.25 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 117.218 0.509 . . . . 2.28 111.343 -177.001 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 74.37 25.14 71.31 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.683 -0.77 . . . . 1.58 111.821 179.247 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 91.6 mt -123.42 156.01 36.32 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 109.939 -0.393 . . . . 1.42 109.939 -178.687 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' GLN . . . . . 0.532 ' HB2' ' HB3' ' A' ' 74' ' ' ALA . 38.2 mm-40 -152.59 172.78 16.08 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.409 -0.589 . . . . 2.67 109.409 176.496 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.521 HG11 ' CB ' ' A' ' 50' ' ' LEU . 10.8 p -139.89 148.96 22.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-O 120.821 0.343 . . . . 1.54 110.709 -178.616 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.546 ' HG3' HG23 ' A' ' 70' ' ' THR . 1.6 ptpp? -139.83 128.59 13.44 Favored Pre-proline 0 C--N 1.321 -0.671 0 N-CA-C 109.519 -0.548 . . . . 1.81 109.519 172.815 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -59.8 126.3 20.1 Favored 'Trans proline' 0 N--CA 1.462 -0.376 0 C-N-CA 122.309 2.006 . . . . 0.85 110.425 173.332 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.404 HD22 ' HA ' ' A' ' 64' ' ' LEU . 2.5 tm? -59.78 -44.35 93.96 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.527 -0.761 . . . . 1.7 109.903 -175.537 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 152.24 -65.13 0.36 Allowed Glycine 0 N--CA 1.445 -0.729 0 C-N-CA 120.701 -0.761 . . . . 1.69 111.722 176.028 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 12.8 t-20 -88.71 78.92 7.6 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.124 0.487 . . . . 2.96 110.043 -179.558 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 43.52 35.94 1.07 Allowed 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 124.482 1.113 . . . . 2.5 113.727 178.552 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 39.5 m -137.16 175.34 9.7 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 108.54 -0.911 . . . . 1.3 108.54 176.453 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' TRP . . . . . 0.618 ' HH2' ' CD1' ' A' ' 17' ' ' TYR . 54.9 m0 -137.52 167.1 22.33 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.952 0.406 . . . . 0.47 110.923 -169.877 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.558 ' HA ' ' HB2' ' A' ' 26' ' ' SER . 3.7 t -145.91 147.38 31.69 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.58 -0.737 . . . . 0.83 109.423 171.981 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.746 HD22 HG23 ' A' ' 27' ' ' VAL . 50.8 tp -91.62 105.71 17.94 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.144 0.497 . . . . 1.71 109.707 -178.03 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.482 ' HB2' ' HG2' ' A' ' 62' ' ' LYS . 12.7 tp10 -94.33 118.93 67.04 Favored Pre-proline 0 C--N 1.323 -0.577 0 CA-C-N 115.147 -0.933 . . . . 2.13 110.766 -176.642 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_exo -70.02 113.5 3.44 Favored 'Trans proline' 0 N--CA 1.456 -0.701 0 C-N-CA 121.647 1.564 . . . . 1.36 110.649 172.847 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.532 ' HB3' ' HB2' ' A' ' 60' ' ' GLN . . . . . . . . 0 C--N 1.322 -0.623 0 CA-C-N 116.109 -0.496 . . . . 1.89 109.891 -177.668 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 2' ' ' GLN . . . . . 0.693 ' HA ' ' HA ' ' A' ' 43' ' ' ASP . 77.0 mt-30 . . . . . 0 C--O 1.231 0.125 0 CA-C-O 121.668 0.747 . . . . 4.0 112.005 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 57.6 t -131.82 130.56 61.77 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 115.49 -0.777 . . . . 1.64 109.221 178.417 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 4.2 p-10 -131.52 121.61 24.76 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 108.882 -0.784 . . . . 2.29 108.882 -178.845 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.492 HG13 HD21 ' A' ' 53' ' ' LEU . 36.4 mm -116.95 129.11 74.04 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 CA-C-N 115.925 -0.579 . . . . 0.82 109.956 -178.256 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -73.56 156.52 88.62 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.069 -0.514 . . . . 1.38 109.86 177.6 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.585 ' HA ' ' O ' ' A' ' 37' ' ' SER . 7.6 Cg_exo -74.45 39.86 0.58 Allowed 'Trans proline' 0 CA--C 1.532 0.394 0 C-N-CA 123.132 2.555 . . . . 1.73 112.888 179.449 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -115.35 -162.71 13.65 Favored Glycine 0 N--CA 1.447 -0.615 0 C-N-CA 120.786 -0.721 . . . . 1.84 113.43 -176.792 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.541 ' HA ' ' HA ' ' A' ' 36' ' ' GLN . 15.7 m -55.77 132.21 48.72 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.222 0.534 . . . . 1.61 111.197 -176.933 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 59.9 tp -58.88 -28.66 66.35 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.165 -0.925 . . . . 1.19 111.055 -176.061 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -45.97 -48.05 16.55 Favored 'General case' 0 CA--C 1.52 -0.199 0 CA-C-O 121.059 0.457 . . . . 2.11 110.576 175.83 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 65.3 mttm -67.58 -24.13 65.48 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.772 -0.649 . . . . 2.72 111.811 -177.368 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -65.87 -64.03 0.95 Allowed 'General case' 0 C--O 1.233 0.233 0 N-CA-C 110.407 -0.22 . . . . 0.46 110.407 -179.804 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.811 ' H ' HD12 ' A' ' 14' ' ' LEU . 4.4 mp -58.56 -35.72 72.8 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 116.431 -0.35 . . . . 0.69 111.339 175.641 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -60.6 -46.69 89.32 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 121.07 0.462 . . . . 1.31 109.94 178.232 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 23.5 tm0? -63.91 -43.21 96.66 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.509 -0.769 . . . . 2.23 110.435 178.028 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.476 ' O ' ' HB3' ' A' ' 20' ' ' HIS . 10.1 t80 -68.03 -40.46 82.92 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-O 120.76 0.314 . . . . 0.65 110.182 -177.791 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.793 ' HA ' ' CE2' ' A' ' 23' ' ' PHE . . . -54.5 -44.2 72.47 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 116.329 -0.396 . . . . 0.37 111.532 176.14 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.24 -17.96 59.83 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.053 -0.522 . . . . 0.64 111.988 -178.787 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' HIS . . . . . 0.476 ' HB3' ' O ' ' A' ' 17' ' ' TYR . 83.4 t60 -59.75 -54.88 41.18 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.532 -0.304 . . . . 1.85 111.266 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.573 ' HB3' ' CD1' ' A' ' 23' ' ' PHE . 22.7 t -114.45 -12.35 12.35 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.482 -0.487 . . . . 1.67 111.639 -177.438 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 75.92 49.63 8.56 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 121.062 -0.589 . . . . 0.62 112.754 179.229 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.793 ' CE2' ' HA ' ' A' ' 18' ' ' ALA . 1.8 p90 -103.76 158.11 16.61 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 110.222 -0.288 . . . . 0.57 110.222 -179.541 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.568 ' O ' ' HB3' ' A' ' 68' ' ' SER . 32.6 m -93.13 101.31 13.61 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.238 0.542 . . . . 0.68 111.878 -175.928 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.433 ' HB2' ' HB2' ' A' ' 69' ' ' TRP . 0.0 OUTLIER -99.43 150.27 22.34 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.385 -0.37 . . . . 1.67 110.115 174.053 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.607 ' HB2' ' HA ' ' A' ' 70' ' ' THR . 43.3 m -106.54 104.07 13.67 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.376 -0.375 . . . . 1.15 110.502 -177.389 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 14.9 p -123.57 143.82 35.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 N-CA-C 110.195 -0.298 . . . . 0.9 110.195 178.974 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.419 ' OD2' ' HG ' ' A' ' 31' ' ' LEU . 21.6 t70 -97.32 108.71 21.5 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.433 -0.349 . . . . 2.38 110.537 177.575 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.21 60.04 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 115.492 -0.777 . . . . 1.97 112.382 178.218 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 74.8 m -166.38 -36.6 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 123.188 0.595 . . . . 2.22 109.526 179.869 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.419 ' HG ' ' OD2' ' A' ' 28' ' ' ASP . 89.0 mt -68.0 -28.5 67.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.383 0.611 . . . . 1.38 110.087 176.034 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 5.0 p -97.69 18.38 15.74 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.528 -0.76 . . . . 1.44 111.262 179.11 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 53.5 ttp180 -63.85 108.35 1.44 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.661 -0.245 . . . . 4.63 110.415 -179.202 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 81.45 8.56 86.92 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.834 -0.698 . . . . 1.62 112.268 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 41.8 tptt -86.65 108.14 18.5 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.622 -0.51 . . . . 2.75 109.622 -179.047 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' GLN . . . . . 0.541 ' HA ' ' HA ' ' A' ' 9' ' ' SER . 46.2 mt-30 -109.84 158.88 17.72 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 110.092 -0.336 . . . . 2.24 110.092 -178.802 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.585 ' O ' ' HA ' ' A' ' 7' ' ' PRO . 7.2 t -128.63 127.55 42.45 Favored 'General case' 0 N--CA 1.445 -0.711 0 N-CA-C 107.863 -1.162 . . . . 1.02 107.863 175.158 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 52.7 m-20 -64.25 -8.8 13.9 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 112.37 0.507 . . . . 1.28 112.37 -172.716 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 129.31 175.37 14.02 Favored Glycine 0 N--CA 1.444 -0.806 0 C-N-CA 120.152 -1.023 . . . . 0.42 112.876 169.743 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 54.1 tp -160.06 124.93 3.9 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 107.624 -1.25 . . . . 0.7 107.624 -179.376 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 52.9 m80 -136.42 97.95 3.71 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 120.26 -0.576 . . . . 2.96 111.438 -177.519 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -170.57 168.3 41.37 Favored Glycine 0 N--CA 1.447 -0.609 0 CA-C-N 115.199 -0.909 . . . . 0.55 110.866 174.835 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.693 ' HA ' ' HA ' ' A' ' 2' ' ' GLN . 24.2 t70 -78.89 100.18 7.1 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 108.828 -0.805 . . . . 2.18 108.828 170.069 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 43.8 m-85 -116.67 142.43 46.91 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.74 -0.664 . . . . 1.41 111.496 -173.996 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -92.48 -175.3 3.95 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.438 -0.801 . . . . 2.23 108.861 175.34 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 14.1 t -52.0 -69.73 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 121.193 0.52 . . . . 0.57 111.534 -174.592 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -56.47 -49.1 75.62 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.263 -0.88 . . . . 2.39 112.587 -173.531 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 4.6 t -71.73 -31.36 66.62 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.076 -0.511 . . . . 1.26 110.727 -171.358 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -75.91 -41.45 27.89 Favored Glycine 0 N--CA 1.445 -0.735 0 C-N-CA 120.608 -0.806 . . . . 0.37 111.833 -175.744 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.697 HD13 HG11 ' A' ' 61' ' ' VAL . 93.4 mt -74.03 -36.99 64.48 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.654 0.264 . . . . 1.09 110.422 -178.323 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 6.3 tp60 -54.76 -47.97 73.23 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.324 -0.398 . . . . 2.59 111.648 179.768 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 83.5 mm-40 -65.33 -38.53 90.41 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.612 -0.267 . . . . 1.75 111.363 -179.512 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.492 HD21 HG13 ' A' ' 5' ' ' ILE . 94.0 mt -59.23 -23.88 62.69 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 111.935 0.346 . . . . 0.73 111.935 176.651 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.782 HD21 HG23 ' A' ' 61' ' ' VAL . 96.2 mt -80.7 -14.04 58.48 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 111.946 0.35 . . . . 2.16 111.946 -176.631 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -62.66 115.34 4.21 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.158 0.504 . . . . 2.24 110.806 -178.851 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 110.25 16.52 10.31 Favored Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 120.784 -0.722 . . . . 1.7 112.029 -178.795 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 89.5 p -146.29 177.4 9.04 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.873 -0.417 . . . . 2.28 109.873 177.33 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -118.96 43.72 1.53 Allowed Glycine 0 N--CA 1.445 -0.741 0 N-CA-C 111.124 -0.791 . . . . 1.58 111.124 176.708 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.516 HD13 HD21 ' A' ' 71' ' ' LEU . 55.1 mt -117.75 174.59 6.09 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.385 -0.407 . . . . 1.42 110.164 -177.634 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 74.2 mt-30 -146.6 127.85 14.81 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.248 -0.649 . . . . 2.67 109.248 177.206 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.782 HG23 HD21 ' A' ' 54' ' ' LEU . 48.2 t -88.49 119.72 36.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 109.014 -0.736 . . . . 1.54 109.014 174.556 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -132.42 122.97 18.31 Favored Pre-proline 0 N--CA 1.441 -0.912 0 CA-C-N 116.493 -0.322 . . . . 1.81 110.134 -173.75 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.635 ' HA ' ' HA ' ' A' ' 69' ' ' TRP . 44.7 Cg_exo -57.79 144.48 93.4 Favored 'Trans proline' 0 C--O 1.234 0.286 0 C-N-CA 122.977 2.452 . . . . 0.85 111.605 176.847 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -75.86 -47.55 25.03 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.616 -0.72 . . . . 1.7 109.843 -178.07 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 161.62 -46.8 0.37 Allowed Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.594 -0.812 . . . . 1.69 111.968 179.005 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 11.0 t30 -110.76 86.62 2.35 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 110.148 -0.315 . . . . 2.96 110.148 -179.482 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 39.11 42.49 0.72 Allowed 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 124.318 1.047 . . . . 2.5 113.313 178.855 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.568 ' HB3' ' O ' ' A' ' 24' ' ' THR . 50.1 m -142.06 174.84 10.23 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 108.745 -0.835 . . . . 1.3 108.745 176.173 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' TRP . . . . . 0.635 ' HA ' ' HA ' ' A' ' 63' ' ' PRO . 41.4 m0 -137.81 169.09 18.39 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.235 0.54 . . . . 0.47 110.345 -173.079 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.607 ' HA ' ' HB2' ' A' ' 26' ' ' SER . 11.7 t -148.89 141.93 24.85 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-N 115.368 -0.833 . . . . 0.83 109.064 168.076 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.516 HD21 HD13 ' A' ' 59' ' ' LEU . 60.8 tp -92.72 102.85 15.26 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.238 0.542 . . . . 1.71 109.76 178.823 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.429 ' HA ' ' HD3' ' A' ' 73' ' ' PRO . 33.0 tt0 -96.92 129.95 31.26 Favored Pre-proline 0 C--N 1.317 -0.817 0 CA-C-N 115.403 -0.817 . . . . 2.13 110.839 179.331 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 72' ' ' GLU . 12.0 Cg_exo -71.3 115.2 4.18 Favored 'Trans proline' 0 N--CA 1.459 -0.509 0 C-N-CA 122.432 2.088 . . . . 1.36 110.723 173.249 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.323 -0.551 0 CA-C-N 115.83 -0.623 . . . . 1.89 109.655 -177.329 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 2' ' ' GLN . . . . . 0.746 ' HB2' ' HA ' ' A' ' 43' ' ' ASP . 0.0 OUTLIER . . . . . 0 CA--C 1.512 -0.488 0 CA-C-O 121.943 0.878 . . . . 4.0 109.806 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.499 HG11 ' CD2' ' A' ' 17' ' ' TYR . 14.2 m -148.85 152.17 12.42 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.174 0 CA-C-N 113.689 -1.596 . . . . 1.64 109.672 -178.92 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 69.9 m-20 -131.17 112.08 12.52 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.579 -0.526 . . . . 2.29 109.579 178.211 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.457 ' HB ' ' N ' ' A' ' 40' ' ' LEU . 48.5 mm -107.16 116.81 51.67 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 N-CA-C 109.821 -0.437 . . . . 0.82 109.821 -178.771 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -82.8 157.86 66.09 Favored Pre-proline 0 C--N 1.323 -0.563 0 CA-C-N 115.923 -0.58 . . . . 1.38 109.51 177.216 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.569 ' HA ' ' O ' ' A' ' 37' ' ' SER . 11.5 Cg_endo -58.71 145.49 95.67 Favored 'Trans proline' 0 N--CA 1.462 -0.376 0 C-N-CA 121.642 1.561 . . . . 1.73 109.879 168.504 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 148.71 -174.78 28.25 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.437 -0.887 . . . . 1.84 111.196 -169.753 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 47.1 t -63.37 128.82 37.57 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 117.029 0.414 . . . . 1.61 110.657 -179.016 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.41 HD13 ' HB2' ' A' ' 37' ' ' SER . 61.9 tp -61.7 -31.41 71.55 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.022 -0.535 . . . . 1.19 110.223 -179.59 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -49.39 -54.22 18.51 Favored 'General case' 0 CA--C 1.52 -0.178 0 CA-C-N 115.41 -0.814 . . . . 2.11 110.345 173.218 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.427 ' HD3' ' HA ' ' A' ' 12' ' ' LYS . 0.1 OUTLIER -69.81 -27.69 65.09 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.755 -0.657 . . . . 2.72 111.11 -178.863 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -66.51 -56.32 11.41 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-O 121.002 0.43 . . . . 0.46 110.224 -179.745 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 94.0 mt -60.18 -40.5 90.2 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.894 -0.594 . . . . 0.69 111.156 176.006 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -62.14 -35.85 80.03 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.027 0.441 . . . . 1.31 110.465 178.321 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 24.0 tm0? -62.92 -43.52 98.58 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 116.067 -0.515 . . . . 2.23 109.876 176.641 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.632 ' OH ' ' HA ' ' A' ' 46' ' ' VAL . 44.9 t80 -70.02 -35.53 74.4 Favored 'General case' 0 C--O 1.224 -0.251 0 N-CA-C 109.996 -0.372 . . . . 0.65 109.996 -178.613 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.685 ' HA ' ' CE2' ' A' ' 23' ' ' PHE . . . -52.24 -39.85 60.87 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-O 120.695 0.283 . . . . 0.37 111.724 176.292 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.9 -15.58 55.67 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 112.478 0.548 . . . . 0.64 112.478 178.796 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 17.8 t-80 -57.85 -57.44 12.75 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 122.312 0.245 . . . . 1.85 111.316 -179.058 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.573 ' HB3' ' HD1' ' A' ' 23' ' ' PHE . 25.1 t -109.15 -12.47 14.81 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.069 0.462 . . . . 1.67 111.237 -179.493 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 74.35 53.69 6.63 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.87 -0.681 . . . . 0.62 112.428 -179.302 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.685 ' CE2' ' HA ' ' A' ' 18' ' ' ALA . 3.2 p90 -104.41 172.67 6.67 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.715 0.293 . . . . 0.57 110.497 -177.911 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 12.9 m -92.13 107.79 19.47 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.244 0.545 . . . . 0.68 111.678 -177.512 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.469 ' HG ' ' HE3' ' A' ' 69' ' ' TRP . 1.0 OUTLIER -98.18 126.08 43.5 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.953 -0.567 . . . . 1.67 110.178 177.549 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.472 ' HB2' HG22 ' A' ' 70' ' ' THR . 68.5 m -101.13 97.73 8.23 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.085 0.469 . . . . 1.15 110.146 178.15 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 6.4 p -147.98 133.58 11.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 115.56 -0.745 . . . . 0.9 110.171 179.272 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.525 ' HB2' ' CD1' ' A' ' 31' ' ' LEU . 50.2 m-20 -94.36 129.73 40.96 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.707 -0.479 . . . . 2.38 109.707 176.283 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -58.04 -10.78 2.01 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.581 -0.736 . . . . 1.97 112.704 -178.686 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 6.0 p -71.7 -41.99 67.94 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.718 0.294 . . . . 2.22 110.674 179.797 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.556 ' H ' HD12 ' A' ' 31' ' ' LEU . 5.7 mp -63.79 -42.18 97.8 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.021 0.439 . . . . 1.38 111.329 179.013 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 2.5 p -91.67 13.36 18.28 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.026 -0.534 . . . . 1.44 111.668 -177.004 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.446 HH11 ' HD3' ' A' ' 33' ' ' ARG . 30.5 ttt180 -68.6 112.42 5.37 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.28 -0.418 . . . . 4.63 110.423 178.155 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 87.01 -0.79 86.41 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.783 -0.722 . . . . 1.62 112.013 -178.331 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 24.6 tptp -86.01 114.6 23.02 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 110.507 -0.183 . . . . 2.75 110.507 -178.589 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -106.41 164.32 12.13 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 110.112 -0.329 . . . . 2.24 110.112 176.785 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.569 ' O ' ' HA ' ' A' ' 7' ' ' PRO . 33.5 t -137.17 131.94 33.24 Favored 'General case' 0 N--CA 1.445 -0.719 0 N-CA-C 107.718 -1.216 . . . . 1.02 107.718 172.102 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 7.2 m-20 -60.78 -21.61 63.24 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 112.761 0.652 . . . . 1.28 112.761 -176.367 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.432 ' HA2' HG22 ' A' ' 5' ' ' ILE . . . 128.37 -175.41 18.58 Favored Glycine 0 N--CA 1.446 -0.668 0 C-N-CA 120.033 -1.079 . . . . 0.42 113.201 172.845 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.457 ' N ' ' HB ' ' A' ' 5' ' ' ILE . 43.3 tp -160.0 127.69 4.66 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 107.798 -1.186 . . . . 0.7 107.798 -178.329 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 74.3 m80 -140.02 97.85 3.33 Favored 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 120.342 -0.543 . . . . 2.96 111.032 -178.853 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -169.4 175.75 43.58 Favored Glycine 0 N--CA 1.444 -0.808 0 C-N-CA 120.832 -0.699 . . . . 0.55 112.341 175.634 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.746 ' HA ' ' HB2' ' A' ' 2' ' ' GLN . 14.7 t70 -88.61 76.1 8.18 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 107.526 -1.287 . . . . 2.18 107.526 170.616 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -96.98 149.29 22.07 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 114.844 -1.071 . . . . 1.41 112.953 -167.737 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 19.8 t0 -90.71 166.94 12.86 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.102 -0.954 . . . . 2.23 109.649 174.803 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.632 ' HA ' ' OH ' ' A' ' 17' ' ' TYR . 42.9 t -47.5 -73.08 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 N-CA-C 113.616 0.969 . . . . 0.57 113.616 -170.513 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -65.0 -29.5 70.42 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 112.467 0.543 . . . . 2.39 112.467 -174.129 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 16.6 m -71.29 -33.1 69.43 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.216 0.531 . . . . 1.26 110.556 -177.189 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -76.51 -33.47 47.78 Favored Glycine 0 N--CA 1.446 -0.688 0 N-CA-C 111.275 -0.73 . . . . 0.37 111.275 -178.329 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.706 ' HB3' HG11 ' A' ' 61' ' ' VAL . 85.7 mt -67.9 -42.37 81.26 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.916 0.389 . . . . 1.09 110.479 178.599 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -56.24 -38.81 71.6 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.846 -0.615 . . . . 2.59 111.083 179.084 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 32.2 mm-40 -62.29 -56.31 19.72 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.918 0.39 . . . . 1.75 111.299 177.865 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 86.7 mt -57.5 -33.76 68.37 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.917 -0.583 . . . . 0.73 112.092 -177.613 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 10.8 mp -98.98 13.88 31.12 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 112.362 0.505 . . . . 2.16 112.362 -175.306 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -60.23 111.14 1.42 Allowed 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.916 0.389 . . . . 2.24 111.175 177.904 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 66.02 39.18 94.69 Favored Glycine 0 C--N 1.332 0.311 0 CA-C-N 115.83 -0.623 . . . . 1.7 112.583 178.947 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 63.9 p -98.72 -17.13 18.69 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.812 0.339 . . . . 2.28 111.733 -176.909 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 81.05 6.67 89.28 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.57 -0.824 . . . . 1.58 111.154 -172.811 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.494 HD13 HD21 ' A' ' 71' ' ' LEU . 96.1 mt -113.79 165.8 12.19 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.157 -0.521 . . . . 1.42 110.335 -177.875 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 31.0 tt0 -145.35 117.93 8.59 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 108.823 -0.806 . . . . 2.67 108.823 179.067 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.706 HG11 ' HB3' ' A' ' 50' ' ' LEU . 7.5 p -92.71 129.61 43.02 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 N-CA-C 110.116 -0.328 . . . . 1.54 110.116 -179.605 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.506 ' HZ1' ' HG3' ' A' ' 72' ' ' GLU . 21.1 mtmm -130.5 122.38 19.79 Favored Pre-proline 0 C--N 1.322 -0.601 0 CA-C-N 116.354 -0.385 . . . . 1.81 110.736 179.361 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_exo -61.07 117.7 4.5 Favored 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 122.141 1.894 . . . . 0.85 109.895 169.456 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -62.2 -43.65 98.34 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.29 -0.868 . . . . 1.7 111.052 -170.323 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 152.95 -63.82 0.37 Allowed Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.476 -0.868 . . . . 1.69 112.155 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 7.3 m-20 -82.92 57.2 3.75 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.654 0.264 . . . . 2.96 111.134 -178.475 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 6.3 t30 56.18 44.24 25.38 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 121.595 0.712 . . . . 2.5 110.78 178.004 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 14.7 m -142.34 177.61 8.15 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 108.848 -0.797 . . . . 1.3 108.848 177.838 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' TRP . . . . . 0.548 ' HH2' ' CD1' ' A' ' 17' ' ' TYR . 48.1 m0 -136.73 155.59 49.65 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 116.582 -0.281 . . . . 0.47 110.488 -172.075 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.472 HG22 ' HB2' ' A' ' 26' ' ' SER . 1.6 p -139.47 132.43 29.4 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.143 -0.48 . . . . 0.83 109.753 173.463 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.494 HD21 HD13 ' A' ' 59' ' ' LEU . 51.7 tp -93.19 104.31 16.51 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.501 0.667 . . . . 1.71 110.651 -178.766 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.506 ' HG3' ' HZ1' ' A' ' 62' ' ' LYS . 37.9 mm-40 -90.73 124.29 62.69 Favored Pre-proline 0 C--N 1.319 -0.748 0 CA-C-N 114.701 -1.136 . . . . 2.13 110.75 177.925 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_exo -74.1 113.54 3.81 Favored 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 121.833 1.689 . . . . 1.36 110.542 171.365 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.332 -0.172 0 CA-C-N 116.031 -0.531 . . . . 1.89 110.581 -175.643 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 46.8 mt-30 . . . . . 0 C--O 1.235 0.328 0 CA-C-O 121.154 0.502 . . . . 4.0 110.288 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 40.7 t -134.75 145.13 32.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 115.53 -0.759 . . . . 1.64 109.6 -175.303 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 5.2 p30 -128.08 98.25 5.05 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-O 121.776 0.798 . . . . 2.29 109.337 179.322 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.42 ' HB ' ' HB3' ' A' ' 40' ' ' LEU . 50.0 mm -102.21 110.01 27.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 115.34 -0.845 . . . . 0.82 109.558 -178.434 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -78.86 149.02 73.38 Favored Pre-proline 0 C--N 1.319 -0.73 0 CA-C-N 115.587 -0.733 . . . . 1.38 109.692 -179.008 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -55.31 134.65 65.07 Favored 'Trans proline' 0 N--CA 1.461 -0.422 0 C-N-CA 121.961 1.774 . . . . 1.73 109.656 169.113 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 150.46 -177.23 28.66 Favored Glycine 0 N--CA 1.445 -0.767 0 N-CA-C 110.41 -1.076 . . . . 1.84 110.41 -169.256 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.589 ' HA ' ' HA ' ' A' ' 36' ' ' GLN . 10.2 t -65.31 140.29 58.67 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 117.266 0.533 . . . . 1.61 110.221 -178.615 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.503 HD12 ' HG3' ' A' ' 35' ' ' LYS . 12.6 mt -58.15 -27.27 63.64 Favored 'General case' 0 CA--C 1.52 -0.187 0 CA-C-N 116.332 -0.394 . . . . 1.19 110.513 177.958 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -49.28 -55.27 13.27 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 115.417 -0.81 . . . . 2.11 110.724 173.582 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 25.1 ttmm -66.07 -33.86 76.75 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.944 -0.571 . . . . 2.72 110.806 -179.778 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -65.6 -59.83 3.55 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.239 -0.437 . . . . 0.46 110.917 -176.889 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.402 ' HB3' ' CD1' ' A' ' 25' ' ' LEU . 93.7 mt -57.57 -38.47 74.86 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.149 -0.478 . . . . 0.69 111.31 178.219 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 54.2 t30 -60.45 -35.51 76.02 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.119 -0.492 . . . . 1.31 110.547 178.509 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 19.7 tm0? -61.19 -49.4 77.34 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.313 -0.403 . . . . 2.23 110.779 177.55 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -67.45 -42.64 82.74 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 109.309 -0.626 . . . . 0.65 109.309 -177.209 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.654 ' HA ' ' CZ ' ' A' ' 23' ' ' PHE . . . -53.44 -51.08 63.8 Favored 'General case' 0 CA--C 1.521 -0.157 0 CA-C-N 115.552 -0.749 . . . . 0.37 111.724 176.812 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.94 -26.29 68.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.236 -0.438 . . . . 0.64 111.507 -179.426 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 71.2 t60 -64.31 -50.34 68.21 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.265 -0.425 . . . . 1.85 111.722 -177.652 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.626 ' HB3' ' HD1' ' A' ' 23' ' ' PHE . 47.0 t -99.26 -16.79 18.39 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-O 121.142 0.496 . . . . 1.67 111.438 -177.6 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 74.27 48.67 14.02 Favored Glycine 0 N--CA 1.45 -0.427 0 CA-C-N 115.884 -0.598 . . . . 0.62 112.665 -178.709 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.654 ' CZ ' ' HA ' ' A' ' 18' ' ' ALA . 29.9 p90 -110.33 168.23 9.61 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.784 0.326 . . . . 0.57 110.184 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 12.9 m -93.01 109.15 20.6 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.166 0.508 . . . . 0.68 111.077 -178.429 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.402 ' CD1' ' HB3' ' A' ' 14' ' ' LEU . 2.0 tt -93.77 128.89 40.23 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.053 -0.721 . . . . 1.67 109.053 177.763 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 34.5 t -103.1 99.81 9.7 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.108 0.48 . . . . 1.15 110.211 -178.104 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.1 p -147.83 133.14 11.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 115.821 -0.627 . . . . 0.9 110.498 179.05 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 -98.32 135.71 39.53 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.957 -0.565 . . . . 2.38 110.218 177.297 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -56.4 -22.3 30.61 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 114.93 -1.032 . . . . 1.97 112.676 -174.639 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 14.3 m -69.01 -14.58 63.12 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.892 0.377 . . . . 2.22 111.219 -176.55 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 90.7 mt -98.18 -22.78 16.0 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.11 0.481 . . . . 1.38 110.584 -179.633 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 12.1 p -109.85 5.51 22.62 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.031 -0.531 . . . . 1.44 112.211 -175.401 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 7.0 ptp180 -63.81 107.21 1.15 Allowed 'General case' 0 N--CA 1.453 -0.302 0 CA-C-O 121.199 0.524 . . . . 4.63 111.128 -179.32 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 83.6 4.25 89.2 Favored Glycine 0 N--CA 1.446 -0.646 0 CA-C-N 115.789 -0.641 . . . . 1.62 111.9 -179.542 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.503 ' HG3' HD12 ' A' ' 10' ' ' LEU . 20.9 tptm -83.78 104.42 13.87 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.766 -0.457 . . . . 2.75 109.766 -178.543 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' GLN . . . . . 0.589 ' HA ' ' HA ' ' A' ' 9' ' ' SER . 55.4 tt0 -103.77 155.09 18.86 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.64 -0.504 . . . . 2.24 109.64 -177.33 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.408 ' HB2' ' HG ' ' A' ' 10' ' ' LEU . 10.2 t -124.81 134.57 52.71 Favored 'General case' 0 N--CA 1.445 -0.685 0 N-CA-C 107.863 -1.162 . . . . 1.02 107.863 171.532 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 -64.85 -16.93 63.8 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.35 -0.386 . . . . 1.28 111.824 -179.751 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 123.27 175.45 14.52 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.647 -0.787 . . . . 0.42 112.607 173.208 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.42 ' HB3' ' HB ' ' A' ' 5' ' ' ILE . 49.1 tp -160.1 128.2 4.74 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 108.919 -0.771 . . . . 0.7 108.919 -178.688 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 54.7 m80 -138.69 97.86 3.44 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 120.388 -0.525 . . . . 2.96 111.119 179.611 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -169.73 178.15 42.84 Favored Glycine 0 N--CA 1.446 -0.635 0 CA-C-N 115.636 -0.711 . . . . 0.55 111.812 175.876 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -82.69 87.1 6.75 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.479 0.657 . . . . 2.18 109.383 170.581 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 56.6 m-85 -109.71 128.81 55.52 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.451 -0.795 . . . . 1.41 110.478 -177.699 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 52.1 m-20 -82.97 177.03 8.81 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 109.282 -0.636 . . . . 2.23 109.282 174.378 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.62 ' HB ' ' OE1' ' A' ' 47' ' ' GLU . 26.1 t -49.79 -70.31 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 N-CA-C 112.52 0.563 . . . . 0.57 112.52 -170.777 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.62 ' OE1' ' HB ' ' A' ' 46' ' ' VAL . 1.7 mp0 -56.46 -45.82 80.69 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.53 0.567 . . . . 2.39 112.53 -175.408 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 23.3 t -71.9 -35.1 69.62 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-O 121.036 0.446 . . . . 1.26 111.161 -171.524 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -76.19 -38.32 34.85 Favored Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 120.547 -0.835 . . . . 0.37 111.533 -175.672 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.567 ' HB3' HG13 ' A' ' 61' ' ' VAL . 96.5 mt -67.78 -39.12 84.11 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.971 0.415 . . . . 1.09 110.719 179.88 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -58.58 -41.57 86.02 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.55 -0.75 . . . . 2.59 111.044 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 5.9 tp-100 -66.94 -46.4 74.87 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.242 -0.436 . . . . 1.75 111.027 -179.779 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 91.8 mt -56.16 -32.24 64.12 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 113.129 0.788 . . . . 0.73 113.129 -176.314 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 65.3 mt -92.19 9.0 35.49 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.904 0.705 . . . . 2.16 112.904 -174.167 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -65.68 133.14 50.47 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 120.827 0.346 . . . . 2.24 110.38 179.542 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 107.99 4.43 33.64 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.799 -0.715 . . . . 1.7 111.806 -176.107 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 22.2 p -149.91 -173.27 4.38 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.848 -0.427 . . . . 2.28 109.848 177.732 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -118.76 30.24 5.99 Favored Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 120.82 -0.705 . . . . 1.58 111.539 -176.277 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.463 ' HA ' ' HA ' ' A' ' 73' ' ' PRO . 42.8 mt -98.71 166.73 11.18 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.551 -0.537 . . . . 1.42 109.551 179.666 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 35.1 tt0 -154.79 118.6 4.61 Favored 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 108.625 -0.88 . . . . 2.67 108.625 178.126 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.567 HG13 ' HB3' ' A' ' 50' ' ' LEU . 3.2 p -94.61 127.12 46.84 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 N-CA-C 109.132 -0.692 . . . . 1.54 109.132 177.861 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.461 ' HA ' ' HD3' ' A' ' 63' ' ' PRO . 47.5 mtmt -128.58 142.72 45.79 Favored Pre-proline 0 C--N 1.318 -0.777 0 CA-C-N 115.909 -0.587 . . . . 1.81 110.335 -170.809 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.461 ' HD3' ' HA ' ' A' ' 62' ' ' LYS . 12.4 Cg_exo -70.24 120.97 7.58 Favored 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 122.596 2.197 . . . . 0.85 111.022 175.739 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.446 HD21 ' HB ' ' A' ' 70' ' ' THR . 95.2 mt -58.39 -38.87 78.23 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.459 -0.792 . . . . 1.7 111.77 -174.607 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 161.8 -71.46 0.21 Allowed Glycine 0 N--CA 1.446 -0.697 0 C-N-CA 120.683 -0.77 . . . . 1.69 111.367 177.851 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -59.98 -77.14 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.777 0.322 . . . . 2.96 111.054 179.456 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ASN . . . . . 0.406 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 62.8 t30 -167.1 56.08 0.08 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.544 0.688 . . . . 2.5 109.572 177.356 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.422 ' O ' ' HD1' ' A' ' 69' ' ' TRP . 24.2 m -146.45 173.99 11.79 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 108.379 -0.971 . . . . 1.3 108.379 176.27 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' TRP . . . . . 0.507 ' CZ2' HG13 ' A' ' 46' ' ' VAL . 52.4 m0 -140.0 164.78 29.11 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 109.716 -0.475 . . . . 0.47 109.716 -168.793 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.446 ' HB ' HD21 ' A' ' 64' ' ' LEU . 6.6 t -149.01 145.43 27.3 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.711 -0.477 . . . . 0.83 109.711 170.953 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 58.2 tp -95.49 103.09 14.95 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.148 0.499 . . . . 1.71 110.828 178.64 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.406 ' HA ' ' HD3' ' A' ' 73' ' ' PRO . 38.5 mt-10 -105.76 145.07 30.15 Favored Pre-proline 0 C--N 1.322 -0.611 0 CA-C-N 115.632 -0.713 . . . . 2.13 111.115 174.788 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.463 ' HA ' ' HA ' ' A' ' 59' ' ' LEU . 7.2 Cg_exo -74.61 115.0 4.16 Favored 'Trans proline' 0 N--CA 1.46 -0.498 0 C-N-CA 122.333 2.022 . . . . 1.36 110.722 170.348 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.268 0 CA-C-N 115.878 -0.601 . . . . 1.89 110.274 -175.591 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 9.0 pt20 . . . . . 0 CA--C 1.514 -0.407 0 CA-C-O 121.391 0.615 . . . . 4.0 110.642 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 23.2 m -132.35 143.62 39.37 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 CA-C-N 115.076 -0.965 . . . . 1.64 109.555 177.464 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 5.2 p30 -128.43 96.82 4.53 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 108.741 -0.837 . . . . 2.29 108.741 179.079 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.51 ' HB ' ' H ' ' A' ' 40' ' ' LEU . 25.5 mt -132.82 159.72 43.02 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 CA-C-N 115.298 -0.865 . . . . 0.82 109.073 -173.845 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.696 ' HB1' ' HD2' ' A' ' 7' ' ' PRO . . . -164.67 172.15 4.93 Favored Pre-proline 0 C--N 1.319 -0.752 0 N-CA-C 108.419 -0.956 . . . . 1.38 108.419 -174.545 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.696 ' HD2' ' HB1' ' A' ' 6' ' ' ALA . 19.8 Cg_exo -30.49 126.75 0.07 OUTLIER 'Trans proline' 0 C--N 1.358 1.055 0 C-N-CA 124.001 3.134 . . . . 1.73 113.782 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 162.99 157.0 8.83 Favored Glycine 0 N--CA 1.445 -0.746 0 N-CA-C 110.33 -1.108 . . . . 1.84 110.33 -176.456 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.582 ' HA ' ' HA ' ' A' ' 36' ' ' GLN . 9.3 t -58.59 133.1 55.56 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 117.285 0.542 . . . . 1.61 110.038 179.857 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.731 HD21 ' HG ' ' A' ' 54' ' ' LEU . 62.2 tp -57.62 -30.49 65.39 Favored 'General case' 0 N--CA 1.462 0.131 0 CA-C-N 115.537 -0.756 . . . . 1.19 111.422 -173.26 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.553 ' CA ' ' HB ' ' A' ' 32' ' ' THR . 31.3 t70 -50.18 -56.77 9.67 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.627 -0.715 . . . . 2.11 111.367 176.808 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 37.3 ttmt -66.92 -26.99 67.13 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.549 -0.296 . . . . 2.72 110.96 -179.337 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.497 ' O ' ' HB3' ' A' ' 16' ' ' GLN . . . -65.84 -55.78 15.31 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.867 0.365 . . . . 0.46 110.467 179.335 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.593 HD12 HG21 ' A' ' 32' ' ' THR . 82.6 mt -59.18 -35.76 74.13 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.175 -0.466 . . . . 0.69 111.425 176.523 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 54.8 t30 -61.05 -39.61 90.48 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.933 -0.395 . . . . 1.31 109.933 176.779 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' GLN . . . . . 0.497 ' HB3' ' O ' ' A' ' 13' ' ' ALA . 41.0 tp60 -58.74 -45.26 90.08 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.672 -0.694 . . . . 2.23 111.379 175.94 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.609 ' O ' ' HB2' ' A' ' 20' ' ' HIS . 8.5 t80 -66.49 -45.24 80.27 Favored 'General case' 0 CA--C 1.514 -0.422 0 CA-C-O 121.044 0.45 . . . . 0.65 110.127 -179.157 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.717 ' HA ' ' CE2' ' A' ' 23' ' ' PHE . . . -50.46 -33.84 22.6 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.165 -0.925 . . . . 0.37 111.966 179.327 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.3 -10.09 14.7 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 116.089 -0.505 . . . . 0.64 112.241 178.262 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' HIS . . . . . 0.609 ' HB2' ' O ' ' A' ' 17' ' ' TYR . 0.0 OUTLIER -55.8 -61.44 2.36 Favored 'General case' 0 CA--C 1.518 -0.286 0 CA-C-O 120.899 0.38 . . . . 1.85 111.524 178.235 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.569 ' HB3' ' HD1' ' A' ' 23' ' ' PHE . 46.0 t -113.65 -15.56 12.48 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.02 0.438 . . . . 1.67 111.411 -177.678 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 77.8 55.71 4.07 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.628 -0.796 . . . . 0.62 111.307 -174.428 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.717 ' CE2' ' HA ' ' A' ' 18' ' ' ALA . 2.7 p90 -101.87 164.55 11.66 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.696 0.284 . . . . 0.57 110.459 -177.62 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.566 ' O ' ' HB3' ' A' ' 68' ' ' SER . 5.6 m -88.8 107.02 18.75 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.489 0.661 . . . . 0.68 111.25 -174.496 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.51 HD22 ' HB ' ' A' ' 27' ' ' VAL . 1.2 tt -93.22 132.62 37.22 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.569 -0.742 . . . . 1.67 109.311 178.399 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.669 ' HB2' ' HA ' ' A' ' 70' ' ' THR . 50.1 m -94.95 92.29 6.81 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.533 -0.543 . . . . 1.15 109.533 176.508 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.51 ' HB ' HD22 ' A' ' 25' ' ' LEU . 11.6 p -144.76 148.22 18.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.607 -0.724 . . . . 0.9 110.529 -174.972 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -111.91 139.08 47.7 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.196 -0.456 . . . . 2.38 109.94 178.713 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -64.05 64.8 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.29 0 O-C-N 123.76 0.662 . . . . 1.97 111.829 176.511 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 26.1 p -170.91 -42.65 0.02 OUTLIER 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 109.507 -0.553 . . . . 2.22 109.507 -178.394 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 72.9 mt -64.71 -40.87 96.09 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.217 -0.902 . . . . 1.38 110.687 178.666 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.593 HG21 HD12 ' A' ' 14' ' ' LEU . 0.9 OUTLIER -103.83 -12.54 16.86 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.757 -0.656 . . . . 1.44 112.473 -178.515 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 57.4 ttp180 -88.38 134.88 33.71 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.856 0.36 . . . . 4.63 110.658 -176.047 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 104.37 -51.43 0.8 Allowed Glycine 0 N--CA 1.448 -0.534 0 N-CA-C 111.512 -0.635 . . . . 1.62 111.512 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.974 ' HD2' ' H ' ' A' ' 35' ' ' LYS . 0.0 OUTLIER -76.9 132.09 38.92 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.437 -0.579 . . . . 2.75 109.437 175.586 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 36' ' ' GLN . . . . . 0.582 ' HA ' ' HA ' ' A' ' 9' ' ' SER . 71.3 mt-30 -104.38 161.83 13.74 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.193 -0.458 . . . . 2.24 110.84 -175.23 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 13.1 t -131.89 136.51 47.47 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 107.838 -1.171 . . . . 1.02 107.838 173.227 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 -70.75 -0.75 9.55 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 112.377 0.51 . . . . 1.28 112.377 -176.647 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 99.97 -171.44 23.64 Favored Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.632 -0.794 . . . . 0.42 113.222 170.757 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.51 ' H ' ' HB ' ' A' ' 5' ' ' ILE . 64.1 tp -160.44 145.6 14.7 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 107.85 -1.167 . . . . 0.7 107.85 -178.812 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 10.0 t-160 -145.11 98.09 3.11 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.366 -0.534 . . . . 2.96 110.847 177.97 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -169.31 -175.4 38.51 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.849 -0.691 . . . . 0.55 112.392 175.485 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 28.6 t0 -89.99 88.13 7.18 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 108.422 -0.955 . . . . 2.18 108.422 173.798 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 31.7 m-85 -116.08 142.42 46.83 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.491 0.662 . . . . 1.41 112.362 -170.251 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -90.77 -179.78 5.6 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 114.694 -1.139 . . . . 2.23 109.612 174.782 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.467 HG13 ' CZ2' ' A' ' 69' ' ' TRP . 78.7 t -53.03 -71.99 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 N-CA-C 112.679 0.622 . . . . 0.57 112.679 -176.562 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -62.18 -41.36 98.26 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.751 0.648 . . . . 2.39 112.751 -169.184 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 23.3 t -74.4 -34.29 63.25 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.17 0.509 . . . . 1.26 110.672 -174.487 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -74.49 -41.42 36.52 Favored Glycine 0 N--CA 1.446 -0.662 0 C-N-CA 120.803 -0.713 . . . . 0.37 111.659 -176.126 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.447 HD13 ' CG1' ' A' ' 61' ' ' VAL . 68.3 mt -67.3 -34.52 77.55 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.711 0.291 . . . . 1.09 110.638 -179.491 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 7.3 tp60 -57.27 -48.86 77.81 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.101 -0.499 . . . . 2.59 110.679 178.571 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.51 ' HG2' HD13 ' A' ' 40' ' ' LEU . 6.8 tp60 -67.67 -42.48 82.08 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.415 -0.357 . . . . 1.75 111.065 -178.599 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 78.8 mt -57.0 -40.6 76.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.053 -0.521 . . . . 0.73 112.16 -179.335 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.731 ' HG ' HD21 ' A' ' 10' ' ' LEU . 10.1 mp -97.74 2.54 49.7 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 112.306 0.484 . . . . 2.16 112.306 -173.772 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -62.07 111.85 2.11 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.047 0.451 . . . . 2.24 110.481 179.424 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 97.88 -7.2 62.74 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 121.06 -0.59 . . . . 1.7 112.505 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.5 m -87.75 -12.91 43.81 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.818 0.342 . . . . 2.28 111.043 -176.314 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 76.16 20.21 77.64 Favored Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 120.678 -0.772 . . . . 1.58 111.942 -179.363 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.428 ' CB ' HD23 ' A' ' 54' ' ' LEU . 96.3 mt -124.02 166.26 16.05 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 110.183 -0.302 . . . . 1.42 110.183 -179.473 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 17.2 tp60 -147.89 118.59 7.53 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.486 -0.561 . . . . 2.67 109.486 178.935 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.571 HG23 ' CD2' ' A' ' 54' ' ' LEU . 59.9 t -91.64 127.29 44.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 N-CA-C 109.473 -0.566 . . . . 1.54 109.473 176.409 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 41.4 tttm -117.12 128.01 26.32 Favored Pre-proline 0 C--N 1.318 -0.797 0 CA-C-N 116.051 -0.522 . . . . 1.81 109.761 -179.016 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -60.17 120.68 8.59 Favored 'Trans proline' 0 N--CA 1.461 -0.431 0 C-N-CA 121.867 1.712 . . . . 0.85 110.008 171.648 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -68.06 -50.51 54.73 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.973 -0.558 . . . . 1.7 110.211 -173.95 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 151.79 -52.92 0.48 Allowed Glycine 0 N--CA 1.445 -0.732 0 C-N-CA 120.605 -0.807 . . . . 1.69 112.001 178.402 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 78.8 m-20 -87.94 57.95 4.58 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.747 0.308 . . . . 2.96 110.949 -176.913 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 67.0 t30 50.73 37.37 16.54 Favored 'General case' 0 N--CA 1.473 0.675 0 CA-C-N 115.659 -0.701 . . . . 2.5 110.89 -177.994 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.566 ' HB3' ' O ' ' A' ' 24' ' ' THR . 49.7 m -141.21 178.63 7.27 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 108.128 -1.064 . . . . 1.3 108.128 178.96 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' TRP . . . . . 0.479 ' HH2' ' CD1' ' A' ' 17' ' ' TYR . 54.2 m0 -135.49 167.41 21.13 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.046 0.45 . . . . 0.47 110.669 -169.22 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.669 ' HA ' ' HB2' ' A' ' 26' ' ' SER . 6.9 t -141.3 139.79 33.71 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.205 -0.907 . . . . 0.83 108.97 173.625 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.469 HD22 HG23 ' A' ' 27' ' ' VAL . 48.9 tp -92.37 104.29 16.64 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.642 0.734 . . . . 1.71 109.69 178.506 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 28.0 mm-40 -88.71 119.61 70.03 Favored Pre-proline 0 C--N 1.313 -0.994 0 CA-C-N 114.509 -1.223 . . . . 2.13 110.843 -179.605 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_exo -66.77 113.6 2.82 Favored 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 121.698 1.598 . . . . 1.36 110.037 172.142 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.321 -0.659 0 CA-C-N 115.692 -0.685 . . . . 1.89 109.374 -176.619 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 7.0 pt20 . . . . . 0 N--CA 1.452 -0.341 0 CA-C-O 121.728 0.775 . . . . 4.0 111.434 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 60.5 t -91.81 121.56 42.43 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 N-CA-C 107.966 -1.124 . . . . 1.64 107.966 172.25 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -130.1 128.87 42.74 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 109.532 -0.544 . . . . 2.29 109.532 -174.204 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 75.2 mt -133.88 132.26 56.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 116.391 -0.368 . . . . 0.82 110.608 -177.581 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -70.82 153.46 94.8 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 115.538 -0.756 . . . . 1.38 110.775 179.687 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.648 ' HA ' ' O ' ' A' ' 37' ' ' SER . 5.5 Cg_exo -75.23 34.16 0.4 Allowed 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 123.299 2.666 . . . . 1.73 113.492 -179.027 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.406 ' HA2' ' HB3' ' A' ' 36' ' ' GLN . . . -159.14 140.22 6.72 Favored Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 120.403 -0.903 . . . . 1.84 113.322 -178.073 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.516 ' H ' ' HG2' ' A' ' 36' ' ' GLN . 0.1 OUTLIER 64.01 92.15 0.07 Allowed 'General case' 0 C--O 1.233 0.203 0 C-N-CA 123.455 0.702 . . . . 1.61 111.993 175.019 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.663 HD11 ' HB3' ' A' ' 53' ' ' LEU . 52.2 tp -64.01 -36.91 85.53 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.172 0.511 . . . . 1.19 110.533 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 14.1 p-10 -55.34 -43.41 74.95 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.525 -0.761 . . . . 2.11 111.392 177.288 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 27.8 ttpp -71.27 -28.47 64.17 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.168 0.508 . . . . 2.72 110.006 178.431 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -67.5 -52.47 38.73 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.475 -0.784 . . . . 0.46 110.736 179.722 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 91.3 mt -57.39 -40.59 78.53 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 115.812 -0.631 . . . . 0.69 111.596 178.366 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 10.9 t30 -59.75 -37.11 78.08 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.14 -0.482 . . . . 1.31 110.334 179.53 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 18.2 tm0? -63.41 -43.73 96.66 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.581 -0.736 . . . . 2.23 110.67 177.422 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.507 ' OH ' ' HA ' ' A' ' 46' ' ' VAL . 7.2 t80 -67.55 -45.61 75.17 Favored 'General case' 0 C--O 1.232 0.157 0 N-CA-C 109.846 -0.427 . . . . 0.65 109.846 -177.344 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.628 ' HA ' ' CZ ' ' A' ' 23' ' ' PHE . . . -53.98 -52.77 59.67 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 115.54 -0.754 . . . . 0.37 112.12 179.393 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.32 -30.59 71.7 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.911 0.386 . . . . 0.64 110.868 -178.337 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 75.1 t60 -65.85 -55.26 18.0 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.946 -0.57 . . . . 1.85 111.407 -178.183 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.568 ' HB3' ' CD1' ' A' ' 23' ' ' PHE . 34.9 t -90.82 0.67 57.39 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-O 120.786 0.327 . . . . 1.67 111.607 -173.465 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 64.68 36.53 93.25 Favored Glycine 0 CA--C 1.517 0.191 0 CA-C-N 116.19 -0.459 . . . . 0.62 113.785 175.074 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.628 ' CZ ' ' HA ' ' A' ' 18' ' ' ALA . 53.1 p90 -109.42 161.07 15.66 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.667 -0.494 . . . . 0.57 109.667 177.484 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 39.2 m -89.8 107.04 18.86 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.074 0.464 . . . . 0.68 110.077 178.922 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 6.9 tt -91.92 125.28 36.56 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.814 -0.63 . . . . 1.67 109.368 -179.847 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.597 ' O ' ' HA ' ' A' ' 70' ' ' THR . 14.6 t -111.54 97.56 6.83 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.352 0.596 . . . . 1.15 110.015 -178.62 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 6.6 p -91.72 130.64 40.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 109.279 -0.637 . . . . 0.9 109.279 177.274 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -69.83 105.92 2.95 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.403 -0.362 . . . . 2.38 110.642 -177.822 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 55.87 -90.86 0.03 OUTLIER 'General case' 0 C--O 1.232 0.176 0 O-C-N 124.152 0.908 . . . . 1.97 111.235 -176.458 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 2.3 t -171.32 56.22 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 108.933 -0.766 . . . . 2.22 108.933 176.781 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 90.3 mt -67.07 -17.16 64.76 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.55 -0.75 . . . . 1.38 111.136 -178.989 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 17.1 p -92.89 -1.74 56.47 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.05 -0.523 . . . . 1.44 111.214 -179.476 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 40.7 ttm180 -68.8 122.97 19.69 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.27 -0.423 . . . . 4.63 110.43 -179.753 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 99.05 -15.94 59.96 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.726 -0.75 . . . . 1.62 111.806 -178.831 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.874 ' HE3' ' HB3' ' A' ' 57' ' ' SER . 41.0 tttm -89.33 132.57 34.88 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-O 120.597 0.237 . . . . 2.75 110.362 177.404 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' GLN . . . . . 0.516 ' HG2' ' H ' ' A' ' 9' ' ' SER . 90.0 mt-30 -102.43 168.87 9.03 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 109.276 -0.638 . . . . 2.24 109.276 173.648 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.648 ' O ' ' HA ' ' A' ' 7' ' ' PRO . 22.9 t -139.33 124.02 18.48 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 106.823 -1.547 . . . . 1.02 106.823 173.273 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 6.1 m-20 -55.19 -17.31 4.14 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 112.829 0.677 . . . . 1.28 112.829 -173.396 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 131.49 -178.93 17.48 Favored Glycine 0 N--CA 1.441 -1.012 0 C-N-CA 120.351 -0.928 . . . . 0.42 112.662 171.104 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 43.8 tp -160.35 122.72 3.28 Favored 'General case' 0 N--CA 1.445 -0.711 0 N-CA-C 107.275 -1.38 . . . . 0.7 107.275 -178.319 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 33.1 m-70 -142.5 97.82 3.19 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.176 0.513 . . . . 2.96 111.211 -178.056 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -171.75 178.19 44.15 Favored Glycine 0 N--CA 1.445 -0.701 0 CA-C-N 115.535 -0.757 . . . . 0.55 111.586 174.326 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -80.41 76.7 7.22 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 107.954 -1.128 . . . . 2.18 107.954 166.623 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -92.67 139.09 30.92 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 113.061 0.763 . . . . 1.41 113.061 -167.357 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -75.22 158.44 32.95 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 114.468 -1.242 . . . . 2.23 109.808 172.412 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.605 HG13 ' HZ2' ' A' ' 69' ' ' TRP . 85.0 t -49.32 -68.13 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 O-C-N 123.674 0.609 . . . . 0.57 112.056 -177.038 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -61.87 -31.56 71.85 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.141 -0.481 . . . . 2.39 112.148 -176.371 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 22.9 t -69.71 -35.03 74.69 Favored 'General case' 0 C--O 1.238 0.492 0 CA-C-O 121.308 0.575 . . . . 1.26 110.262 -176.669 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.517 ' O ' ' HG ' ' A' ' 53' ' ' LEU . . . -74.15 -30.8 60.39 Favored Glycine 0 N--CA 1.446 -0.668 0 N-CA-C 111.036 -0.826 . . . . 0.37 111.036 -177.479 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.621 ' HB3' HG11 ' A' ' 61' ' ' VAL . 98.3 mt -70.71 -41.52 71.83 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.537 -0.331 . . . . 1.09 110.798 179.121 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 58.9 tt0 -51.96 -46.52 64.81 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.07 -0.513 . . . . 2.59 111.232 178.507 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 13.2 mm100 -64.06 -45.81 87.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.741 0.305 . . . . 1.75 110.973 -179.711 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.663 ' HB3' HD11 ' A' ' 10' ' ' LEU . 79.9 mt -60.02 -32.24 70.7 Favored 'General case' 0 C--O 1.237 0.438 0 CA-C-N 116.115 -0.493 . . . . 0.73 111.874 179.068 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.449 HD13 ' O ' ' A' ' 54' ' ' LEU . 0.8 OUTLIER -70.06 -34.98 73.89 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.071 -0.513 . . . . 2.16 110.569 -177.926 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -55.9 110.14 0.69 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.205 -0.452 . . . . 2.24 110.752 -176.564 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 119.64 -2.7 13.65 Favored Glycine 0 N--CA 1.444 -0.8 0 C-N-CA 120.771 -0.728 . . . . 1.7 112.294 -179.235 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.874 ' HB3' ' HE3' ' A' ' 35' ' ' LYS . 68.9 p -121.35 169.46 10.58 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.923 0.392 . . . . 2.28 110.865 176.651 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -109.46 35.45 4.89 Favored Glycine 0 N--CA 1.445 -0.761 0 N-CA-C 110.112 -1.195 . . . . 1.58 110.112 175.16 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 27.4 mt -108.49 -179.35 3.85 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 114.805 -0.697 . . . . 1.42 109.138 -178.642 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 57.4 tp60 -142.57 119.47 11.26 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 108.483 -0.932 . . . . 2.67 108.483 173.654 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.621 HG11 ' HB3' ' A' ' 50' ' ' LEU . 3.7 p -85.1 117.8 30.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-O 121.446 0.641 . . . . 1.54 109.386 179.147 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 49.2 mtpt -123.47 124.94 26.19 Favored Pre-proline 0 C--N 1.32 -0.693 0 CA-C-N 115.828 -0.624 . . . . 1.81 110.139 -173.543 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_exo -60.4 118.49 5.37 Favored 'Trans proline' 0 N--CA 1.456 -0.71 0 C-N-CA 121.861 1.707 . . . . 0.85 109.886 171.795 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -57.13 -38.37 73.38 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.395 -0.821 . . . . 1.7 111.361 -171.137 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 160.55 -50.57 0.36 Allowed Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 119.812 -1.185 . . . . 1.69 112.949 176.554 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 3.4 p30 -116.66 71.85 0.8 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.174 0.512 . . . . 2.96 111.305 -176.644 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 58.6 t30 55.87 43.03 28.21 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 115.292 -0.867 . . . . 2.5 110.749 179.598 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.428 ' O ' ' HD1' ' A' ' 69' ' ' TRP . 42.4 t -139.61 173.04 11.95 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 107.369 -1.345 . . . . 1.3 107.369 177.215 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' TRP . . . . . 0.62 ' CZ3' HD21 ' A' ' 50' ' ' LEU . 30.1 m0 -141.62 160.87 39.28 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.445 -0.576 . . . . 0.47 109.445 -171.783 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.597 ' HA ' ' O ' ' A' ' 26' ' ' SER . 8.9 t -148.67 146.14 28.03 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.618 -0.512 . . . . 0.83 109.618 169.791 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -93.7 99.93 12.25 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.373 0.606 . . . . 1.71 109.471 176.122 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.447 ' HA ' ' HD3' ' A' ' 73' ' ' PRO . 33.2 tt0 -96.59 126.86 41.76 Favored Pre-proline 0 C--N 1.319 -0.749 0 CA-C-N 115.187 -0.915 . . . . 2.13 110.636 177.611 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.447 ' HD3' ' HA ' ' A' ' 72' ' ' GLU . 7.1 Cg_exo -72.34 114.11 3.9 Favored 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 122.02 1.813 . . . . 1.36 111.103 177.227 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.322 -0.589 0 CA-C-N 115.721 -0.672 . . . . 1.89 109.87 -177.213 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 4.8 pp0? . . . . . 0 C--O 1.234 0.281 0 CA-C-O 120.972 0.415 . . . . 4.0 110.708 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 9.4 p -142.38 147.36 21.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 115.757 -0.656 . . . . 1.64 109.939 -176.054 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 47.2 m-80 -128.9 100.26 5.61 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.882 0.372 . . . . 2.29 110.001 -177.338 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.459 ' HB ' ' H ' ' A' ' 40' ' ' LEU . 48.4 mm -108.69 127.45 65.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 116.121 -0.491 . . . . 0.82 110.856 -177.611 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.491 ' HA ' ' HD3' ' A' ' 7' ' ' PRO . . . -67.78 139.52 93.61 Favored Pre-proline 0 C--N 1.331 -0.22 0 CA-C-N 116.21 -0.45 . . . . 1.38 110.725 178.607 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.491 ' HD3' ' HA ' ' A' ' 6' ' ' ALA . 14.6 Cg_exo -72.17 36.87 0.34 Allowed 'Trans proline' 0 CA--C 1.534 0.522 0 C-N-CA 123.818 3.012 . . . . 1.73 114.628 -176.219 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -175.22 45.93 0.13 Allowed Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 119.467 -1.349 . . . . 1.84 114.55 176.446 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.441 ' HA ' ' O ' ' A' ' 35' ' ' LYS . 32.1 t -177.78 101.75 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 117.342 0.571 . . . . 1.61 111.279 173.391 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.418 ' CD1' ' HB3' ' A' ' 53' ' ' LEU . 53.7 tp -64.36 -37.29 86.99 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-O 121.328 0.585 . . . . 1.19 109.459 169.122 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -48.79 -60.95 2.31 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 114.849 -1.069 . . . . 2.11 111.366 177.281 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -68.22 -22.48 64.79 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.702 0.287 . . . . 2.72 111.068 179.45 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.407 ' HB1' HD12 ' A' ' 5' ' ' ILE . . . -63.73 -54.72 30.95 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.902 0.382 . . . . 0.46 110.475 179.778 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 93.3 mt -58.63 -39.06 79.45 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.618 -0.719 . . . . 0.69 110.696 176.514 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 55.8 t30 -61.68 -45.52 93.67 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.903 -0.59 . . . . 1.31 110.276 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 22.0 tm0? -61.7 -45.61 93.26 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.934 -0.575 . . . . 2.23 110.892 177.489 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.442 ' HD1' ' HZ ' ' A' ' 23' ' ' PHE . 1.3 t80 -65.18 -43.15 92.6 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 109.719 -0.475 . . . . 0.65 109.719 -177.396 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.816 ' HA ' ' CE2' ' A' ' 23' ' ' PHE . . . -55.3 -49.34 72.38 Favored 'General case' 0 CA--C 1.519 -0.226 0 CA-C-N 115.564 -0.743 . . . . 0.37 111.551 178.211 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.64 -28.08 68.2 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.398 -0.365 . . . . 0.64 111.249 -178.72 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 42.3 t60 -58.69 -50.23 74.64 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.919 -0.582 . . . . 1.85 111.906 -176.581 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.487 ' HB3' ' CD1' ' A' ' 23' ' ' PHE . 8.2 t -109.79 1.61 19.45 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-O 121.207 0.527 . . . . 1.67 111.452 -178.514 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 62.11 47.54 89.19 Favored Glycine 0 CA--C 1.522 0.509 0 CA-C-N 115.638 -0.71 . . . . 0.62 114.366 175.848 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.816 ' CE2' ' HA ' ' A' ' 18' ' ' ALA . 3.6 p90 -104.96 166.59 10.27 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 117.238 0.519 . . . . 0.57 110.563 177.222 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 24.2 m -90.93 119.39 31.09 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.417 0.627 . . . . 0.68 112.183 -175.478 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.649 HD11 ' HE3' ' A' ' 69' ' ' TRP . 1.5 mm? -92.93 122.5 35.37 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.36 -0.836 . . . . 1.67 111.231 175.957 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 63.4 m -97.99 94.91 7.13 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.291 0.567 . . . . 1.15 109.603 175.645 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 11.2 p -139.07 140.51 38.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 115.611 -0.722 . . . . 0.9 110.846 -174.743 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.982 ' HB3' HD11 ' A' ' 31' ' ' LEU . 7.8 t70 -68.43 149.46 49.29 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.81 -0.632 . . . . 2.38 109.771 174.863 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -53.3 -16.39 1.29 Allowed 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 114.952 1.464 . . . . 1.97 114.952 -170.553 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 7.4 p -165.57 69.99 0.14 Allowed 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 114.003 1.112 . . . . 2.22 114.003 -176.386 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.982 HD11 ' HB3' ' A' ' 28' ' ' ASP . 2.7 mp -96.99 -34.2 11.28 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.585 0.707 . . . . 1.38 109.132 164.181 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 5.6 p -95.46 21.19 8.45 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 114.959 -1.019 . . . . 1.44 111.507 -178.189 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 32.8 ttt180 -66.28 105.63 1.48 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.033 0.444 . . . . 4.63 110.385 -176.623 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 77.24 22.91 69.68 Favored Glycine 0 N--CA 1.447 -0.598 0 CA-C-N 115.804 -0.634 . . . . 1.62 112.572 -179.069 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.441 ' O ' ' HA ' ' A' ' 9' ' ' SER . 8.8 tptp -76.33 156.41 33.36 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.678 -0.49 . . . . 2.75 109.678 178.456 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -139.36 140.61 37.53 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.075 0.464 . . . . 2.24 110.892 -177.669 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 9.4 t -140.04 133.21 29.66 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 107.427 -1.324 . . . . 1.02 107.427 175.103 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.421 ' C ' ' HA ' ' A' ' 7' ' ' PRO . 6.3 m-20 -60.47 -7.47 2.12 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 112.85 0.685 . . . . 1.28 112.85 -176.383 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 114.8 179.79 18.6 Favored Glycine 0 CA--C 1.503 -0.675 0 C-N-CA 120.509 -0.853 . . . . 0.42 112.652 167.818 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.459 ' H ' ' HB ' ' A' ' 5' ' ' ILE . 19.4 tp -160.96 123.05 3.07 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 107.681 -1.229 . . . . 0.7 107.681 -176.077 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 20.8 t-160 -144.57 97.49 3.04 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.356 0.598 . . . . 2.96 110.853 -178.125 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -169.67 -173.09 36.89 Favored Glycine 0 N--CA 1.445 -0.718 0 CA-C-N 115.228 -0.896 . . . . 0.55 110.919 177.262 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -88.89 82.26 6.77 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 109.559 -0.534 . . . . 2.18 109.559 171.966 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 73.6 m-85 -97.55 136.28 38.18 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.047 -0.524 . . . . 1.41 111.403 -175.6 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -86.6 173.6 9.44 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 108.801 -0.814 . . . . 2.23 108.801 176.119 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 52.9 t -52.56 -57.71 3.76 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 N-CA-C 111.928 0.344 . . . . 0.57 111.928 -173.111 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 51.5 mm-40 -62.86 -49.49 74.68 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-O 121.076 0.465 . . . . 2.39 111.809 -175.333 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 11.7 p -72.72 -24.18 60.95 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.892 -0.595 . . . . 1.26 111.286 -172.798 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.45 ' O ' ' HG ' ' A' ' 53' ' ' LEU . . . -75.87 -40.33 31.11 Favored Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 120.766 -0.73 . . . . 0.37 111.337 -178.263 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.51 ' HB3' HG13 ' A' ' 61' ' ' VAL . 95.4 mt -68.33 -45.09 73.86 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.811 0.338 . . . . 1.09 110.647 -178.757 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 42.6 tt0 -57.69 -42.94 84.69 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.818 -0.628 . . . . 2.59 110.865 -179.034 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 87.3 mm-40 -66.44 -43.06 86.64 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.485 -0.325 . . . . 1.75 111.061 -179.37 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.45 ' HG ' ' O ' ' A' ' 49' ' ' GLY . 86.4 mt -57.64 -21.99 43.04 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 116.126 -0.488 . . . . 0.73 112.099 178.977 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.588 HD21 HG12 ' A' ' 61' ' ' VAL . 97.7 mt -70.23 -8.97 54.28 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 111.932 0.345 . . . . 2.16 111.932 -179.234 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -67.89 107.75 2.76 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.097 0.475 . . . . 2.24 110.164 178.756 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 116.94 2.17 18.85 Favored Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 120.827 -0.702 . . . . 1.7 112.055 -177.121 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 50.3 m -137.24 167.77 20.93 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.113 0.482 . . . . 2.28 111.307 179.642 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -116.97 15.29 13.69 Favored Glycine 0 N--CA 1.442 -0.927 0 N-CA-C 110.3 -1.12 . . . . 1.58 110.3 172.866 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.444 HD13 HD11 ' A' ' 71' ' ' LEU . 76.8 mt -92.29 179.48 5.54 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.339 -0.615 . . . . 1.42 109.339 179.577 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 7.5 tp-100 -140.2 117.6 11.41 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.864 -0.421 . . . . 2.67 109.864 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.588 HG12 HD21 ' A' ' 54' ' ' LEU . 7.3 p -98.97 129.44 49.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 N-CA-C 109.623 -0.51 . . . . 1.54 109.623 175.79 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.842 ' HD3' ' HG3' ' A' ' 72' ' ' GLU . 20.4 ptmt -144.66 144.19 23.9 Favored Pre-proline 0 C--N 1.32 -0.712 0 CA-C-N 116.236 -0.438 . . . . 1.81 110.569 -176.865 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.601 ' HA ' ' HA ' ' A' ' 69' ' ' TRP . 21.1 Cg_exo -67.1 140.6 54.62 Favored 'Trans proline' 0 N--CA 1.462 -0.33 0 C-N-CA 122.82 2.347 . . . . 0.85 111.807 175.872 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.523 HD21 ' HB ' ' A' ' 70' ' ' THR . 59.7 mt -65.71 -44.65 85.46 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.668 -0.696 . . . . 1.7 111.108 -179.379 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 178.52 -60.8 0.09 OUTLIER Glycine 0 N--CA 1.445 -0.762 0 C-N-CA 120.274 -0.965 . . . . 1.69 112.307 178.027 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 64.8 m-20 -91.84 -79.8 0.37 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.738 0.304 . . . . 2.96 111.477 -177.362 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 66.4 t30 -142.2 42.35 1.65 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.36 0.6 . . . . 2.5 110.916 -174.323 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 9.8 m -143.53 172.91 12.14 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 108.28 -1.007 . . . . 1.3 108.28 175.798 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' TRP . . . . . 0.649 ' HE3' HD11 ' A' ' 25' ' ' LEU . 55.0 m0 -136.68 167.86 20.6 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.55 -0.537 . . . . 0.47 109.55 -172.716 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.523 ' HB ' HD21 ' A' ' 64' ' ' LEU . 9.5 t -142.36 142.5 32.46 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.641 -0.503 . . . . 0.83 109.641 174.125 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.74 HD12 HD22 ' A' ' 31' ' ' LEU . 0.4 OUTLIER -93.7 101.04 13.17 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 108.985 -0.746 . . . . 1.71 108.985 176.44 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.842 ' HG3' ' HD3' ' A' ' 62' ' ' LYS . 10.5 mm-40 -87.78 119.54 70.6 Favored Pre-proline 0 C--N 1.318 -0.799 0 CA-C-N 114.72 -1.127 . . . . 2.13 111.264 178.499 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -88.01 113.58 0.83 Allowed 'Trans proline' 0 N--CA 1.447 -1.209 0 C-N-CA 122.154 1.903 . . . . 1.36 111.104 173.871 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.323 -0.582 0 CA-C-N 115.585 -0.734 . . . . 1.89 109.791 -178.835 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 . . . . . 0 N--CA 1.45 -0.426 0 CA-C-O 121.786 0.803 . . . . 4.0 112.262 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.743 ' HB ' ' HE1' ' A' ' 44' ' ' TYR . 41.5 t -145.91 152.7 13.86 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 N-CA-C 106.857 -1.535 . . . . 1.64 106.857 176.925 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 88.0 m-20 -124.31 101.21 7.06 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.333 0.587 . . . . 2.29 109.766 -177.167 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 62.2 mt -116.63 147.51 19.97 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 115.371 -0.831 . . . . 0.82 109.291 -178.297 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.701 ' HB1' ' HD2' ' A' ' 7' ' ' PRO . . . -162.56 167.19 12.58 Favored Pre-proline 0 C--N 1.319 -0.745 0 N-CA-C 108.588 -0.893 . . . . 1.38 108.588 -172.916 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.701 ' HD2' ' HB1' ' A' ' 6' ' ' ALA . 11.2 Cg_exo -32.85 131.58 0.1 Allowed 'Trans proline' 0 C--N 1.357 0.998 0 C-N-CA 124.183 3.255 . . . . 1.73 113.748 -175.326 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 156.0 171.57 22.53 Favored Glycine 0 N--CA 1.441 -1.0 0 N-CA-C 110.154 -1.178 . . . . 1.84 110.154 -174.25 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -67.59 137.76 55.93 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 108.95 -0.759 . . . . 1.61 108.95 178.918 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.433 HD12 ' HB3' ' A' ' 13' ' ' ALA . 49.8 tp -59.07 -27.13 65.24 Favored 'General case' 0 C--O 1.232 0.178 0 C-N-CA 122.675 0.39 . . . . 1.19 110.204 -178.161 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -49.53 -49.58 45.48 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.185 -0.916 . . . . 2.11 109.873 172.663 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 57.9 tttm -68.08 -32.14 72.25 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.561 -0.745 . . . . 2.72 110.882 -178.877 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.433 ' HB3' HD12 ' A' ' 10' ' ' LEU . . . -65.07 -52.48 55.41 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.878 0.371 . . . . 0.46 110.043 -179.902 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.452 HD23 HD13 ' A' ' 53' ' ' LEU . 91.5 mt -56.71 -40.6 75.95 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.707 -0.679 . . . . 0.69 110.485 173.676 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 9.3 t30 -62.23 -41.06 98.06 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.837 -0.62 . . . . 1.31 110.612 179.83 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 24.2 tp60 -59.45 -46.45 88.73 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.194 -0.457 . . . . 2.23 111.475 179.034 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.464 ' HD1' ' HZ ' ' A' ' 23' ' ' PHE . 1.6 t80 -67.74 -44.02 78.55 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 109.061 -0.718 . . . . 0.65 109.061 179.568 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.779 ' HA ' ' CE2' ' A' ' 23' ' ' PHE . . . -54.23 -53.7 49.95 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 114.894 -1.048 . . . . 0.37 111.823 179.225 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.98 -27.26 68.01 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.794 0.331 . . . . 0.64 111.225 -178.34 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' HIS . . . . . 0.402 ' HB3' ' O ' ' A' ' 17' ' ' TYR . 69.1 t60 -61.52 -49.46 76.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.034 -0.53 . . . . 1.85 111.399 -178.617 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.6 ' HB3' ' CD1' ' A' ' 23' ' ' PHE . 1.9 t -109.49 2.85 20.75 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-O 121.136 0.493 . . . . 1.67 111.485 -176.882 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 60.23 46.84 93.53 Favored Glycine 0 C--N 1.333 0.397 0 CA-C-N 115.56 -0.746 . . . . 0.62 114.366 174.221 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.925 ' HB3' ' HB3' ' A' ' 67' ' ' ASN . 5.8 p90 -106.47 167.06 10.1 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 117.273 0.536 . . . . 0.57 112.017 -179.824 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 6.7 m -94.14 112.88 24.74 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.206 -0.906 . . . . 0.68 112.055 -176.369 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.614 HD21 ' CE3' ' A' ' 69' ' ' TRP . 0.6 OUTLIER -88.43 123.68 33.21 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.213 -0.903 . . . . 1.67 111.341 176.828 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 20.7 t -103.05 91.14 3.99 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.152 -0.684 . . . . 1.15 109.152 176.44 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.7 p -146.78 135.96 16.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.017 -0.538 . . . . 0.9 110.922 -178.819 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.561 ' HB3' ' HG ' ' A' ' 31' ' ' LEU . 33.0 t70 -69.49 118.94 13.0 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-N 115.819 -0.628 . . . . 2.38 110.339 178.713 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.04 65.17 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.354 0 O-C-N 123.825 0.703 . . . . 1.97 112.172 177.391 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.437 ' HB3' ' OD2' ' A' ' 28' ' ' ASP . 34.3 t -172.68 -28.75 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.717 -0.674 . . . . 2.22 109.333 -179.111 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.561 ' HG ' ' HB3' ' A' ' 28' ' ' ASP . 98.1 mt -60.87 -51.26 70.05 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.757 -0.656 . . . . 1.38 111.133 178.699 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 6.9 t -101.99 11.31 38.69 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.194 -0.457 . . . . 1.44 111.394 -178.362 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 41.2 ttp180 -72.37 128.85 36.9 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.605 -0.271 . . . . 4.63 110.407 -177.643 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 88.15 -2.29 85.23 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.864 -0.684 . . . . 1.62 111.934 -179.606 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 32.5 tttp -88.95 139.2 30.69 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.644 -0.502 . . . . 2.75 109.644 179.627 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 65.4 mt-30 -128.98 150.68 50.29 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 110.044 -0.354 . . . . 2.24 110.044 -177.982 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 20.7 t -126.51 131.2 51.66 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 108.642 -0.873 . . . . 1.02 108.642 178.561 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.613 ' O ' ' HD3' ' A' ' 7' ' ' PRO . 65.1 m-20 -73.04 -6.67 47.1 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 112.837 0.68 . . . . 1.28 112.837 -176.223 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 138.48 165.37 10.27 Favored Glycine 0 C--O 1.235 0.178 0 C-N-CA 119.903 -1.142 . . . . 0.42 114.049 168.919 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.736 ' HG ' ' OH ' ' A' ' 44' ' ' TYR . 57.1 tp -161.47 125.34 3.31 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 108.701 -0.852 . . . . 0.7 108.701 -178.606 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 15.4 p80 -145.45 109.0 4.67 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 112.254 0.465 . . . . 2.96 112.254 -179.049 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -168.92 -178.68 40.55 Favored Glycine 0 C--N 1.334 0.451 0 C-N-CA 120.511 -0.852 . . . . 0.55 112.932 170.625 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -86.39 110.64 19.84 Favored 'General case' 0 CA--C 1.517 -0.32 0 N-CA-C 107.801 -1.185 . . . . 2.18 107.801 167.255 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.743 ' HE1' ' HB ' ' A' ' 3' ' ' VAL . 51.0 m-85 -101.94 148.21 25.61 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.817 0.818 . . . . 1.41 113.015 -167.49 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 31.5 m-20 -92.92 144.21 25.49 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 106.137 -1.801 . . . . 2.23 106.137 156.275 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.471 ' O ' ' HG ' ' A' ' 50' ' ' LEU . 97.0 t -45.69 -63.14 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 N-CA-C 112.738 0.644 . . . . 0.57 112.738 -169.035 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -62.83 -32.11 73.25 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.883 0.373 . . . . 2.39 111.855 -176.131 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 62.5 m -71.08 -34.69 71.39 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.251 0.548 . . . . 1.26 111.075 -175.813 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -78.86 -27.22 57.05 Favored Glycine 0 N--CA 1.448 -0.525 0 N-CA-C 110.773 -0.931 . . . . 0.37 110.773 -176.539 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.748 ' HB3' HG11 ' A' ' 61' ' ' VAL . 87.6 mt -74.63 -36.18 62.9 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.282 -0.459 . . . . 1.09 110.461 179.702 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -59.1 -39.46 82.28 Favored 'General case' 0 N--CA 1.455 -0.186 0 CA-C-N 116.032 -0.531 . . . . 2.59 110.397 176.441 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 79.2 mm-40 -64.17 -38.92 92.79 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.859 0.362 . . . . 1.75 111.284 177.736 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.452 HD13 HD23 ' A' ' 14' ' ' LEU . 96.1 mt -60.0 -34.02 72.76 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.841 0.353 . . . . 0.73 111.395 177.303 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.446 HD22 ' HB2' ' A' ' 59' ' ' LEU . 96.1 mt -84.29 2.03 42.07 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 116.082 -0.508 . . . . 2.16 111.807 -176.646 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -62.23 114.86 3.7 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.037 -0.529 . . . . 2.24 111.146 -176.418 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 106.31 7.35 35.11 Favored Glycine 0 N--CA 1.45 -0.39 0 CA-C-N 116.005 -0.543 . . . . 1.7 112.533 179.341 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 20.3 p -143.24 -174.2 4.14 Favored 'General case' 0 C--N 1.324 -0.531 0 O-C-N 122.775 -0.25 . . . . 2.28 110.573 -178.766 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -132.05 44.91 1.16 Allowed Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 120.402 -0.904 . . . . 1.58 112.844 -175.508 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.584 ' HA ' ' H ' ' A' ' 74' ' ' ALA . 3.9 mp -100.65 177.28 5.05 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.824 -0.436 . . . . 1.42 109.824 171.773 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 26.8 tp60 -149.84 117.81 6.31 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 108.893 -0.78 . . . . 2.67 108.893 179.098 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.748 HG11 ' HB3' ' A' ' 50' ' ' LEU . 7.4 p -86.54 133.79 28.99 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 N-CA-C 109.655 -0.498 . . . . 1.54 109.655 178.36 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.425 ' HA ' ' HD3' ' A' ' 63' ' ' PRO . 55.1 mtpt -124.6 110.41 28.09 Favored Pre-proline 0 C--N 1.32 -0.688 0 N-CA-C 109.809 -0.441 . . . . 1.81 109.809 -178.141 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.555 ' HA ' ' HA ' ' A' ' 69' ' ' TRP . 2.8 Cg_exo -76.65 144.77 25.37 Favored 'Trans proline' 0 N--CA 1.462 -0.344 0 C-N-CA 123.161 2.574 . . . . 0.85 112.868 -177.697 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -91.09 23.48 3.23 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.834 0.826 . . . . 1.7 109.474 175.15 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 84.38 -68.1 3.58 Favored Glycine 0 N--CA 1.447 -0.603 0 CA-C-N 114.493 -1.23 . . . . 1.69 113.053 175.172 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 58.9 t30 -85.47 74.95 10.25 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.705 0.288 . . . . 2.96 111.184 -175.106 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ASN . . . . . 0.925 ' HB3' ' HB3' ' A' ' 23' ' ' PHE . 7.8 m-20 72.35 -26.43 0.18 Allowed 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 113.253 0.834 . . . . 2.5 113.253 170.26 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 15.2 m -85.81 146.45 26.76 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 110.274 -0.269 . . . . 1.3 110.274 -175.578 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' TRP . . . . . 0.614 ' CE3' HD21 ' A' ' 25' ' ' LEU . 6.6 m0 -140.03 168.73 19.15 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.0 -0.741 . . . . 0.47 109.0 -175.914 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 14.9 t -143.85 136.08 26.73 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.13 -0.692 . . . . 0.83 109.13 169.942 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 54.6 tp -95.11 102.85 14.68 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.079 0.466 . . . . 1.71 110.732 -177.381 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -95.14 128.5 38.59 Favored Pre-proline 0 C--N 1.319 -0.725 0 CA-C-N 115.402 -0.817 . . . . 2.13 110.687 174.597 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -73.99 115.49 4.34 Favored 'Trans proline' 0 N--CA 1.46 -0.482 0 C-N-CA 121.976 1.784 . . . . 1.36 110.893 174.428 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.584 ' H ' ' HA ' ' A' ' 59' ' ' LEU . . . . . . . . 0 CA--C 1.521 -0.147 0 CA-C-N 116.094 -0.503 . . . . 1.89 110.29 -176.291 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 31.8 tt0 . . . . . 0 N--CA 1.457 -0.106 0 CA-C-O 121.536 0.684 . . . . 4.0 111.545 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.455 HG12 HG12 ' A' ' 5' ' ' ILE . 58.2 t -104.34 128.54 57.75 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 CA-C-N 114.861 -1.063 . . . . 1.64 108.457 174.545 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 43.8 t30 -126.9 98.87 5.5 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.14 0.495 . . . . 2.29 109.677 -175.405 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.615 HG22 ' HA2' ' A' ' 39' ' ' GLY . 27.1 mm -123.57 156.17 30.08 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 CA-C-N 115.306 -0.861 . . . . 0.82 108.777 -177.295 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.649 ' HB1' ' HD2' ' A' ' 7' ' ' PRO . . . -160.04 163.56 22.04 Favored Pre-proline 0 C--N 1.321 -0.657 0 N-CA-C 109.503 -0.554 . . . . 1.38 109.503 -177.35 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.649 ' HD2' ' HB1' ' A' ' 6' ' ' ALA . 6.6 Cg_exo -33.3 130.39 0.13 Allowed 'Trans proline' 0 C--N 1.357 1.002 0 C-N-CA 124.398 3.399 . . . . 1.73 113.314 -174.933 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 152.1 169.54 17.67 Favored Glycine 0 N--CA 1.44 -1.078 0 N-CA-C 110.96 -0.856 . . . . 1.84 110.96 -174.471 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.664 ' HB3' ' OD2' ' A' ' 11' ' ' ASP . 53.9 m -61.48 141.56 57.61 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 120.815 0.34 . . . . 1.61 111.471 179.693 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.75 HD22 ' HB2' ' A' ' 57' ' ' SER . 43.8 tp -59.65 -35.77 75.08 Favored 'General case' 0 CA--C 1.52 -0.175 0 CA-C-O 121.104 0.478 . . . . 1.19 110.458 178.965 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.706 ' HB3' ' HB ' ' A' ' 32' ' ' THR . 2.0 p-10 -56.93 -31.77 65.29 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.305 -0.861 . . . . 2.11 111.256 175.735 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 29.0 ttpt -70.52 -41.06 73.08 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.227 0.537 . . . . 2.72 109.881 174.418 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -64.97 -55.38 19.41 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 115.424 -0.807 . . . . 0.46 110.972 -174.195 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.439 ' HB3' HD11 ' A' ' 25' ' ' LEU . 89.2 mt -58.06 -41.12 82.68 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.809 -0.632 . . . . 0.69 111.174 177.743 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 52.9 t30 -62.92 -40.29 97.18 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.223 -0.444 . . . . 1.31 110.288 179.102 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 23.4 tm0? -62.57 -42.68 99.7 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.204 -0.453 . . . . 2.23 110.218 176.698 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.469 ' O ' ' HB3' ' A' ' 20' ' ' HIS . 4.9 t80 -65.58 -39.86 92.07 Favored 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 109.229 -0.656 . . . . 0.65 109.229 179.77 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.732 ' HA ' ' CZ ' ' A' ' 23' ' ' PHE . . . -55.56 -39.65 70.9 Favored 'General case' 0 CA--C 1.52 -0.184 0 CA-C-N 115.669 -0.696 . . . . 0.37 111.327 175.426 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.49 -30.09 71.27 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.202 -0.454 . . . . 0.64 111.212 179.272 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' HIS . . . . . 0.469 ' HB3' ' O ' ' A' ' 17' ' ' TYR . 62.8 t60 -60.55 -58.43 8.52 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 116.264 -0.425 . . . . 1.85 111.701 -177.905 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.538 ' HB3' ' HD1' ' A' ' 23' ' ' PHE . 11.4 t -98.38 -10.58 23.54 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-O 121.13 0.49 . . . . 1.67 111.739 -174.615 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 69.01 53.09 20.51 Favored Glycine 0 C--N 1.33 0.205 0 CA-C-N 115.833 -0.621 . . . . 0.62 113.232 179.62 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.732 ' CZ ' ' HA ' ' A' ' 18' ' ' ALA . 26.1 p90 -109.03 167.45 10.08 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.808 0.337 . . . . 0.57 110.535 179.264 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 25.3 m -92.9 109.73 21.18 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.439 0.638 . . . . 0.68 110.982 178.859 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.439 HD11 ' HB3' ' A' ' 14' ' ' LEU . 4.4 tt -91.64 128.09 37.34 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.433 -0.803 . . . . 1.67 109.299 179.7 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 25.4 t -99.09 100.2 11.31 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.07 0.462 . . . . 1.15 109.955 -179.319 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.429 HG23 ' HG ' ' A' ' 71' ' ' LEU . 7.3 p -129.34 130.86 67.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 115.987 -0.551 . . . . 0.9 110.552 -178.871 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.498 ' OD2' ' HB2' ' A' ' 30' ' ' SER . 23.7 t70 -75.46 123.83 26.11 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.663 -0.699 . . . . 2.38 110.816 178.791 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.62 49.75 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 113.338 0.866 . . . . 1.97 113.338 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.498 ' HB2' ' OD2' ' A' ' 28' ' ' ASP . 69.5 m -161.53 -28.12 0.05 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.847 0.356 . . . . 2.22 110.19 -179.696 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 75.9 mt -72.64 -43.79 62.76 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.51 0.672 . . . . 1.38 110.443 176.59 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.706 ' HB ' ' HB3' ' A' ' 11' ' ' ASP . 9.5 p -96.38 52.55 1.25 Allowed 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.726 -0.67 . . . . 1.44 112.279 -175.579 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 4.7 ptp180 -99.96 106.77 18.6 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-O 121.142 0.496 . . . . 4.63 111.042 175.996 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 70.77 46.61 45.01 Favored Glycine 0 N--CA 1.449 -0.474 0 CA-C-N 115.656 -0.702 . . . . 1.62 113.569 174.334 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.649 ' O ' ' HA ' ' A' ' 9' ' ' SER . 13.3 mptt -85.27 173.75 10.12 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 110.039 -0.356 . . . . 2.75 110.039 176.037 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 50.3 tt0 -149.84 134.85 17.92 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 120.778 0.323 . . . . 2.24 110.871 173.934 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 42.7 t -132.82 130.61 40.05 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 107.368 -1.345 . . . . 1.02 107.368 171.408 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.422 ' O ' ' HD3' ' A' ' 7' ' ' PRO . 1.0 OUTLIER -69.48 -7.75 40.77 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 113.122 0.786 . . . . 1.28 113.122 -173.89 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.615 ' HA2' HG22 ' A' ' 5' ' ' ILE . . . 117.4 -177.05 16.46 Favored Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 120.134 -1.032 . . . . 0.42 113.345 171.956 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.479 ' N ' ' HB ' ' A' ' 5' ' ' ILE . 60.4 tp -159.96 141.92 13.04 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 108.574 -0.899 . . . . 0.7 108.574 -178.414 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 50.8 t-80 -144.27 97.09 2.99 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.919 0.39 . . . . 2.96 110.658 179.72 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -170.46 177.88 43.41 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.973 -0.632 . . . . 0.55 111.837 175.071 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -92.7 99.99 12.58 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 108.44 -0.948 . . . . 2.18 108.44 171.316 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.44 ' HB2' ' CG2' ' A' ' 3' ' ' VAL . 25.6 m-85 -116.39 156.54 26.57 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 121.455 0.645 . . . . 1.41 112.227 -170.817 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -92.73 169.72 10.27 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 114.69 -1.141 . . . . 2.23 108.276 172.374 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.548 ' O ' ' HG ' ' A' ' 50' ' ' LEU . 78.1 t -48.01 -64.78 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 O-C-N 123.05 0.219 . . . . 0.57 111.438 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -61.53 -44.32 97.27 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 112.824 0.675 . . . . 2.39 112.824 -175.785 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 3.8 p -73.44 -31.06 63.6 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.037 0.446 . . . . 1.26 111.244 -173.418 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -72.48 -36.96 58.74 Favored Glycine 0 N--CA 1.446 -0.666 0 N-CA-C 111.233 -0.747 . . . . 0.37 111.233 179.56 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.548 ' HG ' ' O ' ' A' ' 46' ' ' VAL . 88.1 mt -71.61 -37.34 70.94 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.495 -0.352 . . . . 1.09 110.464 178.706 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -53.68 -47.42 70.44 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.866 -0.606 . . . . 2.59 110.576 179.307 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 14.1 mm100 -64.72 -42.27 95.36 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-O 120.807 0.337 . . . . 1.75 110.778 179.349 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.411 HD21 HG13 ' A' ' 5' ' ' ILE . 90.8 mt -59.75 -30.34 68.78 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 116.261 -0.427 . . . . 0.73 111.878 178.498 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.633 HD11 HG12 ' A' ' 61' ' ' VAL . 5.9 mp -72.73 -21.11 61.08 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.313 -0.403 . . . . 2.16 111.449 -179.457 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -71.94 86.98 1.01 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.139 0.495 . . . . 2.24 111.159 -177.234 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 113.1 -9.64 24.93 Favored Glycine 0 CA--C 1.52 0.365 0 CA-C-N 115.904 -0.589 . . . . 1.7 113.457 175.189 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.75 ' HB2' HD22 ' A' ' 10' ' ' LEU . 11.7 p -82.26 -24.72 34.61 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.961 0.381 . . . . 2.28 111.91 -175.577 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 88.57 5.1 75.53 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.918 -0.658 . . . . 1.58 112.664 176.748 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.571 HD12 HD23 ' A' ' 10' ' ' LEU . 95.8 mt -126.34 179.4 5.3 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.611 0.243 . . . . 1.42 110.86 -178.955 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 61.8 tt0 -147.39 118.97 7.96 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 109.163 -0.68 . . . . 2.67 109.163 179.597 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.633 HG12 HD11 ' A' ' 54' ' ' LEU . 7.7 p -98.43 128.02 50.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-O 121.215 0.531 . . . . 1.54 109.978 179.202 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.76 ' HE2' ' HB2' ' A' ' 72' ' ' GLU . 48.1 mtmt -109.36 130.12 23.13 Favored Pre-proline 0 C--N 1.322 -0.592 0 CA-C-N 116.146 -0.479 . . . . 1.81 110.719 -176.468 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -67.62 113.43 2.94 Favored 'Trans proline' 0 N--CA 1.457 -0.629 0 C-N-CA 122.102 1.868 . . . . 0.85 109.536 168.93 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 37.3 tp -60.04 -41.8 93.05 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.655 -0.702 . . . . 1.7 111.5 -171.102 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 165.67 -54.61 0.26 Allowed Glycine 0 N--CA 1.448 -0.556 0 N-CA-C 110.207 -1.157 . . . . 1.69 110.207 179.381 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 27.5 p-10 -86.32 -158.66 0.42 Allowed 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 108.935 -0.765 . . . . 2.96 108.935 171.925 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 20.1 p-10 -81.7 49.37 1.33 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.515 0.674 . . . . 2.5 110.796 176.108 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.443 ' O ' ' HD1' ' A' ' 69' ' ' TRP . 40.3 m -139.12 169.24 18.13 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 108.409 -0.96 . . . . 1.3 108.409 174.745 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' TRP . . . . . 0.443 ' HD1' ' O ' ' A' ' 68' ' ' SER . 45.0 m0 -140.12 171.35 14.31 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 110.035 -0.358 . . . . 0.47 110.035 -167.483 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.489 HG23 ' HE3' ' A' ' 62' ' ' LYS . 6.8 t -146.04 147.22 31.39 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.167 -0.47 . . . . 0.83 109.989 173.129 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.429 ' HG ' HG23 ' A' ' 27' ' ' VAL . 0.9 OUTLIER -92.77 108.76 20.23 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.123 0.487 . . . . 1.71 110.992 -174.279 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.76 ' HB2' ' HE2' ' A' ' 62' ' ' LYS . 4.3 tp10 -93.21 122.23 63.72 Favored Pre-proline 0 C--N 1.322 -0.608 0 CA-C-N 115.345 -0.843 . . . . 2.13 110.539 175.091 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -84.43 113.47 1.71 Allowed 'Trans proline' 0 N--CA 1.453 -0.891 0 C-N-CA 121.863 1.709 . . . . 1.36 111.56 174.194 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.327 -0.389 0 CA-C-N 115.849 -0.614 . . . . 1.89 109.776 -178.363 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 2' ' ' GLN . . . . . 0.716 ' HB2' ' H ' ' A' ' 44' ' ' TYR . 46.1 mm-40 . . . . . 0 N--CA 1.453 -0.308 0 CA-C-O 120.864 0.364 . . . . 4.0 111.952 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 21.5 m -145.61 143.3 21.82 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-N 115.927 -0.579 . . . . 1.64 111.114 -178.638 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 4.5 p-10 -128.55 96.88 4.53 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 107.967 -1.123 . . . . 2.29 107.967 171.748 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.411 HD12 ' HB3' ' A' ' 40' ' ' LEU . 21.3 mt -130.86 157.41 43.15 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.761 0 CA-C-N 115.655 -0.702 . . . . 0.82 109.883 -170.055 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.741 ' HB1' ' HD2' ' A' ' 7' ' ' PRO . . . -162.36 178.63 1.5 Allowed Pre-proline 0 C--N 1.321 -0.67 0 N-CA-C 108.224 -1.028 . . . . 1.38 108.224 -174.569 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.741 ' HD2' ' HB1' ' A' ' 6' ' ' ALA . 51.2 Cg_exo -39.33 129.38 1.6 Allowed 'Trans proline' 0 C--N 1.359 1.122 0 C-N-CA 122.685 2.257 . . . . 1.73 113.023 -178.383 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 163.41 161.85 13.34 Favored Glycine 0 N--CA 1.443 -0.872 0 N-CA-C 110.727 -0.949 . . . . 1.84 110.727 -174.664 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.409 ' HA ' ' O ' ' A' ' 35' ' ' LYS . 37.2 p -61.61 137.69 58.26 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.951 0.376 . . . . 1.61 110.616 -178.127 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.462 HD21 ' HG ' ' A' ' 54' ' ' LEU . 64.0 tp -60.06 -32.43 70.93 Favored 'General case' 0 CA--C 1.52 -0.204 0 CA-C-O 121.102 0.477 . . . . 1.19 109.739 178.648 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.593 ' HB2' ' HB ' ' A' ' 32' ' ' THR . 11.4 t70 -50.32 -54.0 24.68 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.143 -0.935 . . . . 2.11 110.449 172.665 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 59.0 tttp -67.09 -32.38 73.49 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 116.213 -0.449 . . . . 2.72 110.949 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -64.26 -54.49 32.59 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.292 -0.413 . . . . 0.46 110.447 -177.861 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 85.5 mt -57.96 -41.92 83.9 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 115.854 -0.612 . . . . 0.69 111.071 176.165 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 12.9 t30 -62.65 -35.21 78.88 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.972 -0.558 . . . . 1.31 110.738 179.806 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 14.9 tm0? -61.17 -46.74 89.27 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 116.392 -0.367 . . . . 2.23 110.875 175.865 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.645 ' HD1' ' HH2' ' A' ' 69' ' ' TRP . 34.2 t80 -67.64 -32.05 72.48 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 120.986 -0.286 . . . . 0.65 110.421 -176.9 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.83 ' HA ' ' CZ ' ' A' ' 23' ' ' PHE . . . -50.94 -34.89 30.57 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 112.114 0.412 . . . . 0.37 112.114 175.625 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.55 -15.71 52.3 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.305 -0.407 . . . . 0.64 111.93 179.579 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 30.8 t-80 -59.67 -67.85 0.34 Allowed 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 116.628 -0.26 . . . . 1.85 111.42 179.866 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.695 ' HB3' ' HD1' ' A' ' 23' ' ' PHE . 23.0 t -101.12 -6.65 24.05 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.797 0.332 . . . . 1.67 111.505 -174.927 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 70.32 46.74 47.69 Favored Glycine 0 C--N 1.334 0.418 0 C-N-CA 120.771 -0.728 . . . . 0.62 112.524 178.947 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.83 ' CZ ' ' HA ' ' A' ' 18' ' ' ALA . 11.6 p90 -100.68 170.21 8.51 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.697 0.284 . . . . 0.57 110.477 -175.856 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.47 ' O ' ' HB3' ' A' ' 68' ' ' SER . 24.0 m -91.67 111.19 22.6 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.129 0.49 . . . . 0.68 110.872 -178.38 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 5.2 tt -93.32 125.82 38.13 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 115.915 -0.584 . . . . 1.67 109.565 -179.736 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.629 ' HB2' ' HA ' ' A' ' 70' ' ' THR . 15.2 m -99.1 93.01 5.75 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.158 -0.474 . . . . 1.15 109.908 -179.021 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 9.7 p -113.64 141.57 29.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 115.994 -0.548 . . . . 0.9 109.758 -178.503 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.421 ' HB3' ' HG ' ' A' ' 31' ' ' LEU . 23.1 t70 -98.0 125.62 43.02 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 110.176 -0.305 . . . . 2.38 110.176 179.604 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.16 57.97 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.525 0 O-C-N 123.802 0.689 . . . . 1.97 112.622 179.066 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 25.9 t -173.04 -28.61 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.221 -0.445 . . . . 2.22 110.042 -179.732 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.421 ' HG ' ' HB3' ' A' ' 28' ' ' ASP . 86.3 mt -77.28 -33.69 55.74 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.328 -0.396 . . . . 1.38 111.361 -178.136 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.593 ' HB ' ' HB2' ' A' ' 11' ' ' ASP . 6.0 p -92.4 13.27 20.02 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.26 0.552 . . . . 1.44 111.25 179.455 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 39.5 ttm180 -73.16 114.22 11.1 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.635 -0.711 . . . . 4.63 110.266 179.646 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 84.08 21.18 57.77 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.74 -0.743 . . . . 1.62 111.875 179.688 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.409 ' O ' ' HA ' ' A' ' 9' ' ' SER . 12.7 mptt -107.53 124.04 49.32 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.117 0.484 . . . . 2.75 111.23 -179.001 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 42.4 tt0 -131.69 141.06 49.47 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.353 -0.839 . . . . 2.24 109.135 177.734 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 7.3 t -121.8 121.06 36.36 Favored 'General case' 0 N--CA 1.443 -0.823 0 N-CA-C 107.003 -1.48 . . . . 1.02 107.003 174.768 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 8.9 m-80 -70.65 -0.54 8.94 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 113.296 0.85 . . . . 1.28 113.296 -169.662 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 134.97 168.32 11.62 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 119.894 -1.145 . . . . 0.42 114.213 166.838 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.433 HD13 ' HG2' ' A' ' 52' ' ' GLN . 60.9 tp -160.59 131.71 5.62 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 107.883 -1.155 . . . . 0.7 107.883 179.825 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 39.1 t60 -144.5 97.84 3.1 Favored 'General case' 0 C--N 1.321 -0.635 0 C-N-CA 120.055 -0.658 . . . . 2.96 110.971 179.721 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -169.63 175.78 43.71 Favored Glycine 0 N--CA 1.445 -0.749 0 CA-C-N 115.117 -0.947 . . . . 0.55 111.322 176.625 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.528 ' HA ' ' N ' ' A' ' 2' ' ' GLN . 12.2 t70 -83.65 94.41 8.1 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 108.216 -1.031 . . . . 2.18 108.216 171.564 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.716 ' H ' ' HB2' ' A' ' 2' ' ' GLN . 45.8 m-85 -115.1 126.57 54.82 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.111 0.481 . . . . 1.41 111.927 -174.718 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -67.97 170.21 8.65 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.254 -0.884 . . . . 2.23 109.915 174.085 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.628 HG13 ' HZ2' ' A' ' 69' ' ' TRP . 86.0 t -48.45 -65.55 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 O-C-N 123.549 0.531 . . . . 0.57 111.758 -175.387 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -59.02 -43.46 91.57 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 112.629 0.603 . . . . 2.39 112.629 -177.719 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 22.9 t -71.37 -33.21 69.35 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.097 0.475 . . . . 1.26 110.967 -172.513 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -73.73 -39.47 48.12 Favored Glycine 0 N--CA 1.445 -0.713 0 C-N-CA 120.735 -0.745 . . . . 0.37 111.496 -176.335 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.654 ' HB3' HG11 ' A' ' 61' ' ' VAL . 85.9 mt -67.95 -40.4 83.24 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.755 0.312 . . . . 1.09 110.857 -179.738 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 15.6 tm0? -54.28 -50.13 67.98 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.929 -0.578 . . . . 2.59 111.03 179.22 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.433 ' HG2' HD13 ' A' ' 40' ' ' LEU . 25.4 tp60 -68.07 -40.61 82.67 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.395 -0.366 . . . . 1.75 111.226 -177.173 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 51.0 mt -56.6 -42.17 78.26 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.217 0.451 . . . . 0.73 112.217 -179.303 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.462 ' HG ' HD21 ' A' ' 10' ' ' LEU . 11.0 mp -85.14 -5.02 59.35 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 112.374 0.509 . . . . 2.16 112.374 -174.614 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -66.62 105.65 1.59 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.29 0.566 . . . . 2.24 109.769 178.752 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 133.6 -15.0 4.7 Favored Glycine 0 N--CA 1.447 -0.615 0 N-CA-C 110.66 -0.976 . . . . 1.7 110.66 -172.038 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 79.4 p -119.49 175.96 5.59 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.271 -0.64 . . . . 2.28 109.271 175.709 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -113.74 17.64 20.33 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.21 -0.995 . . . . 1.58 112.266 -177.874 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 98.6 mt -92.24 175.45 6.85 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 110.254 -0.276 . . . . 1.42 110.254 -179.137 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 27.2 mp0 -139.0 118.98 13.31 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.156 -0.683 . . . . 2.67 109.156 -179.464 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.654 HG11 ' HB3' ' A' ' 50' ' ' LEU . 7.5 p -98.54 127.11 51.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 N-CA-C 109.674 -0.491 . . . . 1.54 109.674 176.915 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.467 ' HA ' ' HD3' ' A' ' 63' ' ' PRO . 0.0 OUTLIER -140.55 137.06 17.09 Favored Pre-proline 0 C--N 1.323 -0.584 0 CA-C-N 116.234 -0.439 . . . . 1.81 110.962 -176.559 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.529 ' HA ' ' HA ' ' A' ' 69' ' ' TRP . 28.4 Cg_exo -62.74 128.79 24.23 Favored 'Trans proline' 0 N--CA 1.462 -0.371 0 C-N-CA 122.915 2.41 . . . . 0.85 110.982 177.131 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -66.64 -43.76 83.77 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.702 -0.681 . . . . 1.7 109.732 -177.379 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 165.16 -60.42 0.24 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.564 -0.827 . . . . 1.69 112.276 176.336 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 50.5 t30 -86.12 68.85 10.41 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.997 0.427 . . . . 2.96 111.211 -175.597 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 66.4 t30 58.93 12.16 2.22 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-N 115.742 -0.663 . . . . 2.5 111.84 175.73 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.47 ' HB3' ' O ' ' A' ' 24' ' ' THR . 50.7 m -122.5 177.83 5.24 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 108.811 -0.811 . . . . 1.3 108.811 -173.844 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' TRP . . . . . 0.645 ' HH2' ' HD1' ' A' ' 17' ' ' TYR . 49.9 m0 -137.44 166.18 24.46 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.886 -0.413 . . . . 0.47 109.886 -167.357 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.629 ' HA ' ' HB2' ' A' ' 26' ' ' SER . 15.1 t -148.05 147.57 29.72 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 108.814 -0.81 . . . . 0.83 108.814 169.921 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 31.8 tp -92.23 103.84 16.27 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.442 0.639 . . . . 1.71 109.928 -179.192 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -88.11 119.49 70.38 Favored Pre-proline 0 C--N 1.319 -0.753 0 CA-C-N 114.918 -1.037 . . . . 2.13 111.19 -179.715 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -90.32 115.14 0.53 Allowed 'Trans proline' 0 N--CA 1.449 -1.143 0 C-N-CA 122.393 2.062 . . . . 1.36 112.33 177.404 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.323 -0.556 0 CA-C-N 115.725 -0.67 . . . . 1.89 109.487 176.31 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 32.9 mm-40 . . . . . 0 C--O 1.235 0.297 0 CA-C-O 120.86 0.362 . . . . 4.0 111.012 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 31.4 m -103.39 136.36 36.55 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-N 115.964 -0.562 . . . . 1.64 109.787 174.928 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -127.01 96.55 4.65 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 108.589 -0.893 . . . . 2.29 108.589 -179.81 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.504 HD12 ' HB3' ' A' ' 40' ' ' LEU . 50.5 mt -126.11 149.24 30.85 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 CA-C-N 115.763 -0.653 . . . . 0.82 110.153 -173.821 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.564 ' HB1' ' HD2' ' A' ' 7' ' ' PRO . . . -162.96 168.12 10.83 Favored Pre-proline 0 C--N 1.323 -0.544 0 N-CA-C 108.844 -0.798 . . . . 1.38 108.844 -176.381 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.564 ' HD2' ' HB1' ' A' ' 6' ' ' ALA . 89.8 Cg_exo -44.56 133.48 9.89 Favored 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 122.806 2.337 . . . . 1.73 112.998 -178.103 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.401 ' O ' ' HG2' ' A' ' 12' ' ' LYS . . . 154.91 41.56 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.635 -0.793 . . . . 1.84 112.062 178.299 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.624 ' HA ' ' HA ' ' A' ' 36' ' ' GLN . 20.2 m 66.98 138.92 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.281 0 CA-C-O 121.326 0.584 . . . . 1.61 110.699 -172.376 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.596 HD11 ' HB3' ' A' ' 53' ' ' LEU . 49.5 tp -58.37 -24.2 59.22 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.138 0.494 . . . . 1.19 110.27 177.284 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -48.06 -51.59 23.72 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.073 -0.967 . . . . 2.11 111.892 175.031 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.451 ' HE3' ' HB2' ' A' ' 12' ' ' LYS . 0.0 OUTLIER -66.91 -25.47 66.39 Favored 'General case' 0 C--N 1.335 -0.063 0 C-N-CA 121.064 -0.255 . . . . 2.72 111.375 -176.397 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -65.42 -59.29 4.17 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.049 0.452 . . . . 0.46 110.073 178.796 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 86.9 mt -58.46 -37.38 75.36 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.675 -0.693 . . . . 0.69 110.905 176.428 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 47.4 t30 -60.94 -40.76 94.52 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.257 -0.429 . . . . 1.31 110.257 178.399 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -61.1 -47.87 84.28 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 116.028 -0.533 . . . . 2.23 110.541 178.548 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.53 ' O ' ' HB3' ' A' ' 20' ' ' HIS . 3.1 t80 -69.58 -43.93 71.86 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-O 120.871 0.367 . . . . 0.65 110.251 -177.653 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.604 ' HA ' ' CZ ' ' A' ' 23' ' ' PHE . . . -53.92 -53.48 52.11 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 115.912 -0.585 . . . . 0.37 112.275 -179.72 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.53 -22.55 66.4 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.804 0.335 . . . . 0.64 111.517 -178.817 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' HIS . . . . . 0.53 ' HB3' ' O ' ' A' ' 17' ' ' TYR . 77.9 t60 -65.73 -52.12 53.77 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.993 -0.549 . . . . 1.85 111.5 -179.866 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.43 ' HB2' ' CD1' ' A' ' 23' ' ' PHE . 19.7 m -108.13 -3.6 18.45 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 112.619 0.599 . . . . 1.67 112.619 -174.355 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 69.2 47.73 50.88 Favored Glycine 0 C--O 1.227 -0.295 0 CA-C-N 116.142 -0.481 . . . . 0.62 113.884 174.262 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.604 ' CZ ' ' HA ' ' A' ' 18' ' ' ALA . 13.3 p90 -110.78 162.93 14.29 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.84 0.32 . . . . 0.57 110.209 178.398 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.63 ' O ' ' HB3' ' A' ' 68' ' ' SER . 28.0 m -98.11 122.17 40.93 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.363 0.601 . . . . 0.68 112.173 -174.725 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.481 HD21 ' CE3' ' A' ' 69' ' ' TRP . 1.1 mm? -88.49 115.11 25.77 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.677 -0.692 . . . . 1.67 110.322 175.491 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 32.9 t -98.08 93.92 6.55 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.795 -0.638 . . . . 1.15 109.799 -179.653 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.752 HG21 HD12 ' A' ' 71' ' ' LEU . 7.2 p -148.16 141.71 18.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.768 -0.651 . . . . 0.9 110.655 -178.849 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -88.88 132.12 34.81 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.933 -0.576 . . . . 2.38 110.009 175.578 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.33 78.57 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.308 0 O-C-N 123.8 0.687 . . . . 1.97 111.863 179.658 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 74.1 m -165.83 -38.19 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 123.142 0.577 . . . . 2.22 109.556 -179.736 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 88.0 mt -75.24 -33.17 61.28 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.093 -0.503 . . . . 1.38 110.693 178.791 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 7.5 p -92.32 -10.93 36.54 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.329 -0.396 . . . . 1.44 110.948 177.526 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 53.1 ttp180 -64.69 107.12 1.33 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.815 -0.63 . . . . 4.63 110.143 179.87 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 102.51 17.66 18.83 Favored Glycine 0 N--CA 1.444 -0.806 0 C-N-CA 121.002 -0.618 . . . . 1.62 111.797 -177.942 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 12.9 mptt -107.5 122.26 46.3 Favored 'General case' 0 CA--C 1.514 -0.418 0 CA-C-O 121.106 0.479 . . . . 2.75 111.711 178.85 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' GLN . . . . . 0.624 ' HA ' ' HA ' ' A' ' 9' ' ' SER . 18.4 pt20 -138.24 133.66 33.43 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.564 -0.744 . . . . 2.24 109.168 173.593 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.424 ' O ' ' HA ' ' A' ' 7' ' ' PRO . 19.2 t -115.66 140.3 49.32 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.569 -0.53 . . . . 1.02 109.569 -176.567 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 5.9 m-20 -71.0 2.9 3.81 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 112.162 0.431 . . . . 1.28 112.162 177.258 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.46 ' HA3' ' HA ' ' A' ' 6' ' ' ALA . . . 114.85 -178.03 17.72 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.775 -0.726 . . . . 0.42 113.445 166.331 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.504 ' HB3' HD12 ' A' ' 5' ' ' ILE . 56.1 tp -160.82 131.07 5.15 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 107.797 -1.186 . . . . 0.7 107.797 179.632 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 17.4 t-160 -143.4 99.89 3.51 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 120.07 -0.652 . . . . 2.96 111.71 -177.63 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -169.03 -169.68 32.7 Favored Glycine 0 N--CA 1.448 -0.545 0 CA-C-N 115.403 -0.817 . . . . 0.55 111.459 176.156 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -103.55 90.64 3.74 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 108.832 -0.803 . . . . 2.18 108.832 172.112 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 64.1 m-85 -110.47 151.86 27.02 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.61 -0.723 . . . . 1.41 110.584 -175.79 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -99.47 -171.94 2.16 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 108.302 -0.999 . . . . 2.23 108.302 174.218 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.423 ' O ' ' HG ' ' A' ' 50' ' ' LEU . 39.2 t -51.7 -71.0 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 N-CA-C 112.976 0.732 . . . . 0.57 112.976 -172.636 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.31 -47.45 82.22 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 113.266 0.839 . . . . 2.39 113.266 -169.102 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 7.5 t -73.97 -26.86 60.7 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.032 0.444 . . . . 1.26 110.75 -170.692 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -75.13 -38.94 38.56 Favored Glycine 0 N--CA 1.447 -0.626 0 N-CA-C 111.042 -0.823 . . . . 0.37 111.042 -178.874 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.775 HD13 HG11 ' A' ' 61' ' ' VAL . 80.7 mt -70.11 -41.53 73.87 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 115.441 -0.379 . . . . 1.09 110.261 179.068 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 55.3 tp60 -55.96 -38.06 69.87 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 116.102 -0.499 . . . . 2.59 111.524 -179.244 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 24.6 mm-40 -63.5 -45.64 89.75 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.857 0.361 . . . . 1.75 110.616 177.771 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.596 ' HB3' HD11 ' A' ' 10' ' ' LEU . 90.3 mt -60.94 -22.87 64.83 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.838 -0.619 . . . . 0.73 111.859 176.787 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.782 HD21 HG23 ' A' ' 61' ' ' VAL . 87.4 mt -85.28 -24.05 27.91 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.14 0.422 . . . . 2.16 112.14 -175.494 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -70.07 93.63 0.82 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.179 0.514 . . . . 2.24 110.905 -175.961 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 114.77 -10.45 21.2 Favored Glycine 0 N--CA 1.446 -0.69 0 CA-C-N 115.799 -0.637 . . . . 1.7 112.532 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.429 ' OG ' ' HA ' ' A' ' 54' ' ' LEU . 27.1 p -98.92 -12.12 21.0 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.883 0.373 . . . . 2.28 111.448 -178.547 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 71.3 28.39 70.0 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 121.0 -0.619 . . . . 1.58 112.892 175.72 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 94.8 mt -119.12 167.98 11.29 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.74 0.305 . . . . 1.42 110.857 -178.555 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' GLN . . . . . 0.419 ' HA ' HD13 ' A' ' 54' ' ' LEU . 62.8 tt0 -143.97 118.97 10.0 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.082 -0.71 . . . . 2.67 109.082 177.47 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.782 HG23 HD21 ' A' ' 54' ' ' LEU . 36.8 t -94.81 130.2 43.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 N-CA-C 110.044 -0.354 . . . . 1.54 110.044 -178.25 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.414 ' HA ' ' HD3' ' A' ' 63' ' ' PRO . 17.9 ptmt -131.67 127.61 21.47 Favored Pre-proline 0 C--N 1.317 -0.815 0 N-CA-C 109.624 -0.51 . . . . 1.81 109.624 179.015 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 62' ' ' LYS . 32.2 Cg_exo -60.15 132.92 46.85 Favored 'Trans proline' 0 N--CA 1.463 -0.279 0 C-N-CA 122.577 2.185 . . . . 0.85 111.191 177.612 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 42.7 tp -69.27 -40.31 77.87 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.713 -0.676 . . . . 1.7 110.925 -174.592 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 158.65 -44.48 0.47 Allowed Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.758 -0.735 . . . . 1.69 112.092 175.876 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 9.2 m120 -77.15 -89.39 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.394 0.616 . . . . 2.96 110.644 -179.481 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 30.4 p-10 -146.69 24.85 1.2 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.626 -0.715 . . . . 2.5 109.095 177.057 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.63 ' HB3' ' O ' ' A' ' 24' ' ' THR . 50.4 m -128.74 178.82 6.07 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 108.178 -1.045 . . . . 1.3 108.178 -171.784 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' TRP . . . . . 0.481 ' CE3' HD21 ' A' ' 25' ' ' LEU . 1.9 m0 -140.15 169.73 17.16 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 119.836 -0.746 . . . . 0.47 110.055 -170.864 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 9.6 t -140.97 144.03 34.85 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 108.722 -0.844 . . . . 0.83 108.722 171.654 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.752 HD12 HG21 ' A' ' 27' ' ' VAL . 52.0 mt -93.85 105.62 17.63 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.415 0.626 . . . . 1.71 111.484 -173.839 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 18.4 tt0 -89.44 129.48 47.14 Favored Pre-proline 0 C--N 1.318 -0.789 0 CA-C-N 115.051 -0.977 . . . . 2.13 110.347 174.108 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -79.12 114.68 3.39 Favored 'Trans proline' 0 N--CA 1.453 -0.875 0 C-N-CA 121.92 1.747 . . . . 1.36 111.325 177.75 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.322 -0.598 0 CA-C-N 115.654 -0.703 . . . . 1.89 110.446 -179.121 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 5.1 pm0 . . . . . 0 C--O 1.234 0.242 0 N-CA-C 109.353 -0.61 . . . . 4.0 109.353 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 33.7 m -137.39 152.74 27.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 120.73 0.3 . . . . 1.64 110.922 -175.645 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 31.7 m-80 -127.82 96.31 4.47 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 108.641 -0.874 . . . . 2.29 108.641 174.991 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.421 HG21 HD21 ' A' ' 53' ' ' LEU . 28.8 mm -119.69 149.71 22.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 N-CA-C 109.406 -0.591 . . . . 0.82 109.406 -176.423 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -163.4 162.15 17.54 Favored Pre-proline 0 C--N 1.323 -0.578 0 N-CA-C 109.488 -0.56 . . . . 1.38 109.488 -177.205 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.452 ' HA ' ' O ' ' A' ' 37' ' ' SER . 53.3 Cg_exo -52.23 130.54 35.92 Favored 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 122.95 2.433 . . . . 1.73 113.006 -175.976 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 158.69 48.03 0.01 OUTLIER Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 120.744 -0.741 . . . . 1.84 112.255 -178.345 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 19.8 m 67.81 126.81 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 123.155 0.582 . . . . 1.61 111.285 -177.167 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.623 HD11 ' HB3' ' A' ' 53' ' ' LEU . 67.1 tp -60.78 -36.01 77.89 Favored 'General case' 0 CA--C 1.521 -0.147 0 CA-C-N 116.109 -0.496 . . . . 1.19 110.482 179.589 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -49.23 -55.02 13.94 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.471 -0.786 . . . . 2.11 111.018 173.534 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 64.5 tttm -67.95 -27.67 66.8 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.944 0.402 . . . . 2.72 111.086 -178.958 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -66.08 -56.77 9.83 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.289 -0.414 . . . . 0.46 110.112 178.541 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 96.2 mt -59.42 -38.39 80.5 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 115.959 -0.564 . . . . 0.69 110.981 175.773 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -60.95 -38.58 86.39 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.937 -0.574 . . . . 1.31 110.397 179.254 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 47.8 tt0 -62.86 -40.03 96.23 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.994 -0.548 . . . . 2.23 110.648 176.848 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.493 ' HD1' ' HZ ' ' A' ' 23' ' ' PHE . 3.7 t80 -67.86 -41.68 82.5 Favored 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 108.477 -0.935 . . . . 0.65 108.477 179.813 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.718 ' HA ' ' CE2' ' A' ' 23' ' ' PHE . . . -55.2 -48.06 74.4 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.292 -0.867 . . . . 0.37 111.76 175.699 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.84 -25.1 67.31 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.242 -0.435 . . . . 0.64 111.544 -179.364 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 74.0 t60 -64.43 -49.01 73.18 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.282 -0.417 . . . . 1.85 111.602 -177.118 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.406 ' HB2' ' CD1' ' A' ' 23' ' ' PHE . 15.8 m -108.68 -11.24 15.1 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.584 -0.447 . . . . 1.67 112.116 -175.896 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 75.78 58.06 3.92 Favored Glycine 0 CA--C 1.519 0.322 0 CA-C-N 115.932 -0.576 . . . . 0.62 113.564 177.066 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.718 ' CE2' ' HA ' ' A' ' 18' ' ' ALA . 10.6 p90 -117.97 169.85 9.31 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.968 0.384 . . . . 0.57 111.028 178.524 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 13.3 m -92.18 118.18 30.59 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-O 121.201 0.524 . . . . 0.68 112.226 -172.193 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.616 HD21 ' CE3' ' A' ' 69' ' ' TRP . 1.5 mm? -99.32 138.98 35.65 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.71 -0.677 . . . . 1.67 110.742 175.056 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 44.4 m -125.41 100.74 6.63 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.075 0.464 . . . . 1.15 110.197 177.144 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 5.9 p -145.67 135.32 17.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.737 -0.665 . . . . 0.9 110.785 -177.865 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -98.98 129.01 45.25 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.076 -0.511 . . . . 2.38 109.724 177.81 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -54.36 -23.79 16.91 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 113.877 1.065 . . . . 1.97 113.877 -172.098 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 85.4 p -66.42 -27.49 67.88 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.12 0.486 . . . . 2.22 110.718 -175.278 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 96.7 mt -75.99 -47.13 26.13 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.551 -0.75 . . . . 1.38 111.13 -177.922 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 3.5 t -99.31 40.78 1.19 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.621 0.724 . . . . 1.44 110.706 -177.217 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.479 ' O ' ' HG3' ' A' ' 33' ' ' ARG . 8.6 ptp180 -63.25 105.89 0.8 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.656 -0.702 . . . . 4.63 111.039 179.546 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 63.01 19.44 61.31 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 121.088 -0.577 . . . . 1.62 112.377 179.656 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.637 ' HE3' ' HA ' ' A' ' 57' ' ' SER . 8.6 tptp -74.32 112.71 10.75 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.601 -0.518 . . . . 2.75 109.601 -177.149 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -103.87 156.65 17.66 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.731 0.301 . . . . 2.24 110.479 -177.122 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.452 ' O ' ' HA ' ' A' ' 7' ' ' PRO . 46.7 t -128.62 130.27 47.05 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 107.222 -1.399 . . . . 1.02 107.222 172.657 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 35.0 m-20 -63.96 -15.23 58.76 Favored 'General case' 0 C--N 1.322 -0.606 0 O-C-N 123.441 0.463 . . . . 1.28 112.086 -173.983 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 123.36 172.31 13.78 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.901 -0.666 . . . . 0.42 112.159 172.957 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.411 ' HB3' ' HB ' ' A' ' 5' ' ' ILE . 31.4 tp -161.31 121.39 2.65 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.023 -0.732 . . . . 0.7 109.023 -177.338 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 19.2 t-80 -143.85 99.28 3.38 Favored 'General case' 0 C--N 1.321 -0.664 0 C-N-CA 120.205 -0.598 . . . . 2.96 110.892 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -168.27 -169.54 31.86 Favored Glycine 0 N--CA 1.446 -0.656 0 CA-C-N 115.451 -0.795 . . . . 0.55 111.917 178.252 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -78.35 85.98 4.45 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.518 -0.549 . . . . 2.18 109.518 174.789 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 67.5 m-85 -119.53 122.57 41.93 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.289 0.566 . . . . 1.41 111.628 -176.205 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -84.25 -174.49 5.31 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.278 -0.873 . . . . 2.23 108.798 173.758 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 47.3 t -51.88 -67.93 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 120.671 0.272 . . . . 0.57 111.499 -177.319 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -55.11 -41.76 72.07 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 112.815 0.672 . . . . 2.39 112.815 -176.105 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 22.1 m -71.69 -31.04 66.34 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.966 0.412 . . . . 1.26 111.34 -174.831 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.415 ' O ' ' HG ' ' A' ' 53' ' ' LEU . . . -71.82 -49.21 24.19 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.85 -0.691 . . . . 0.37 112.071 -175.705 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.441 ' O ' ' HG ' ' A' ' 54' ' ' LEU . 8.5 mp -65.57 -38.73 90.4 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 121.959 0.104 . . . . 1.09 111.208 -178.248 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 58.1 tt0 -53.27 -52.99 57.25 Favored 'General case' 0 C--N 1.331 -0.218 0 O-C-N 123.222 0.326 . . . . 2.59 111.752 179.743 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 12.5 mm100 -64.31 -41.9 96.62 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.882 0.373 . . . . 1.75 111.035 -177.808 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.623 ' HB3' HD11 ' A' ' 10' ' ' LEU . 88.0 mt -59.71 -21.48 60.71 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 115.905 -0.589 . . . . 0.73 112.417 -179.796 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.643 HD21 HG12 ' A' ' 61' ' ' VAL . 65.0 mt -75.36 -14.52 60.48 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.032 0.382 . . . . 2.16 112.032 -177.415 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -72.3 131.61 42.91 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.995 0.426 . . . . 2.24 110.09 -177.345 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 101.72 -17.45 54.81 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.889 -0.672 . . . . 1.7 111.526 -175.838 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.637 ' HA ' ' HE3' ' A' ' 35' ' ' LYS . 4.3 m -102.55 160.07 14.89 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-O 120.733 0.302 . . . . 2.28 110.203 178.501 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -107.27 35.75 4.83 Favored Glycine 0 N--CA 1.441 -0.984 0 N-CA-C 109.705 -1.358 . . . . 1.58 109.705 171.018 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.637 ' HB3' HD21 ' A' ' 71' ' ' LEU . 50.7 mt -126.57 174.31 8.78 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.265 -0.642 . . . . 1.42 109.265 -177.866 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 71.9 mt-30 -146.94 118.97 8.19 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.348 -0.612 . . . . 2.67 109.348 179.733 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.643 HG12 HD21 ' A' ' 54' ' ' LEU . 7.6 p -86.65 130.36 36.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 N-CA-C 109.667 -0.494 . . . . 1.54 109.667 179.153 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 26.8 ttpp -131.53 131.73 23.05 Favored Pre-proline 0 N--CA 1.442 -0.834 0 N-CA-C 109.816 -0.438 . . . . 1.81 109.816 -174.622 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -54.09 125.71 19.67 Favored 'Trans proline' 0 N--CA 1.463 -0.313 0 C-N-CA 122.418 2.079 . . . . 0.85 111.088 177.433 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.556 ' HG ' ' HB ' ' A' ' 70' ' ' THR . 0.7 OUTLIER -74.03 -63.66 1.17 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.46 -0.791 . . . . 1.7 110.254 -173.856 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -155.48 -107.07 0.27 Allowed Glycine 0 N--CA 1.445 -0.74 0 C-N-CA 120.755 -0.736 . . . . 1.69 111.961 177.901 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -80.81 94.55 6.45 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.571 0.225 . . . . 2.96 110.687 179.787 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' ASN . . . . . 0.591 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 2.8 t-20 58.08 39.6 26.06 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.404 0.621 . . . . 2.5 110.44 174.759 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.44 ' O ' ' HD1' ' A' ' 69' ' ' TRP . 15.2 p -135.82 169.13 18.06 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 109.457 -0.572 . . . . 1.3 109.457 179.235 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' TRP . . . . . 0.616 ' CE3' HD21 ' A' ' 25' ' ' LEU . 26.8 m0 -140.87 154.69 46.28 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 108.975 -0.75 . . . . 0.47 108.975 -175.354 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.556 ' HB ' ' HG ' ' A' ' 64' ' ' LEU . 8.6 t -137.73 138.13 39.01 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 108.802 -0.814 . . . . 0.83 108.802 175.002 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.637 HD21 ' HB3' ' A' ' 59' ' ' LEU . 6.5 tt -93.12 102.57 14.89 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.51 0.671 . . . . 1.71 109.799 -178.451 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.424 ' HA ' ' HD3' ' A' ' 73' ' ' PRO . 25.8 mm-40 -89.3 132.73 36.6 Favored Pre-proline 0 C--N 1.319 -0.738 0 CA-C-N 114.678 -1.146 . . . . 2.13 111.248 178.649 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 72' ' ' GLU . 7.7 Cg_exo -73.15 115.15 4.25 Favored 'Trans proline' 0 N--CA 1.461 -0.392 0 C-N-CA 122.677 2.251 . . . . 1.36 111.574 176.361 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.324 -0.532 0 CA-C-N 116.039 -0.528 . . . . 1.89 109.758 -178.102 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 19.6 pt20 . . . . . 0 N--CA 1.45 -0.467 0 CA-C-O 121.327 0.584 . . . . 4.0 110.841 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.63 ' O ' ' HA ' ' A' ' 41' ' ' HIS . 36.2 t -101.59 131.7 48.92 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.938 0 CA-C-N 115.301 -0.863 . . . . 1.64 108.859 174.492 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -129.48 109.49 11.09 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.229 0.537 . . . . 2.29 109.995 179.465 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.644 HD13 ' HB1' ' A' ' 13' ' ' ALA . 68.6 mt -131.02 127.06 60.58 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 115.932 -0.576 . . . . 0.82 110.537 -177.199 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -76.18 159.7 79.69 Favored Pre-proline 0 N--CA 1.45 -0.459 0 CA-C-N 115.916 -0.584 . . . . 1.38 109.657 177.446 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.587 ' HA ' ' O ' ' A' ' 37' ' ' SER . 44.7 Cg_endo -69.6 49.91 0.72 Allowed 'Trans proline' 0 CA--C 1.534 0.495 0 C-N-CA 122.915 2.41 . . . . 1.73 113.123 177.632 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -116.75 -150.06 9.25 Favored Glycine 0 C--O 1.226 -0.347 0 C-N-CA 121.241 -0.504 . . . . 1.84 112.574 -178.703 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.583 ' HA ' ' O ' ' A' ' 35' ' ' LYS . 22.8 p -62.54 125.47 24.05 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.162 0.506 . . . . 1.61 111.867 -176.294 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.804 ' HB3' ' HB3' ' A' ' 35' ' ' LYS . 70.3 tp -65.49 -32.4 73.98 Favored 'General case' 0 N--CA 1.456 -0.172 0 CA-C-N 115.64 -0.709 . . . . 1.19 109.696 178.758 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.579 ' OD2' ' HB ' ' A' ' 32' ' ' THR . 10.6 m-20 -50.5 -53.89 26.52 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.19 -0.914 . . . . 2.11 110.401 175.21 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -68.84 -26.66 65.27 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.772 -0.649 . . . . 2.72 110.638 177.999 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.644 ' HB1' HD13 ' A' ' 5' ' ' ILE . . . -67.36 -53.07 32.73 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.988 -0.551 . . . . 0.46 110.816 -178.85 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 87.2 mt -56.96 -43.73 81.88 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.116 -0.493 . . . . 0.69 110.873 177.026 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 52.9 t30 -62.4 -32.55 73.39 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.831 -0.622 . . . . 1.31 110.371 -179.64 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 22.1 tm0? -62.16 -45.35 93.79 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.283 -0.417 . . . . 2.23 110.445 177.096 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 13.5 t80 -71.38 -41.36 69.78 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 109.65 -0.5 . . . . 0.65 109.65 -178.78 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.709 ' HA ' ' CE2' ' A' ' 23' ' ' PHE . . . -53.37 -53.41 51.47 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 115.501 -0.772 . . . . 0.37 112.141 178.194 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -64.54 -26.2 68.31 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.311 -0.404 . . . . 0.64 111.461 -178.998 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 70.5 t60 -64.8 -45.19 87.28 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.293 -0.412 . . . . 1.85 111.298 -176.869 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.479 ' HB2' ' CE1' ' A' ' 23' ' ' PHE . 24.5 m -101.04 -7.02 23.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.269 0.557 . . . . 1.67 111.594 -178.735 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 67.66 47.11 63.63 Favored Glycine 0 N--CA 1.449 -0.494 0 CA-C-N 115.309 -0.86 . . . . 0.62 114.023 176.791 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.709 ' CE2' ' HA ' ' A' ' 18' ' ' ALA . 5.9 p90 -109.21 160.73 15.87 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 117.389 0.595 . . . . 0.57 110.624 175.981 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.447 ' O ' ' HB3' ' A' ' 68' ' ' SER . 25.0 m -88.14 119.82 28.9 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.431 0.634 . . . . 0.68 112.529 -171.532 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.577 HD21 ' CE3' ' A' ' 69' ' ' TRP . 1.6 mm? -95.73 121.34 37.34 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.609 -0.723 . . . . 1.67 111.174 176.617 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 18.9 m -104.35 93.32 4.75 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.67 -0.492 . . . . 1.15 109.67 175.633 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.479 ' HB ' HD23 ' A' ' 71' ' ' LEU . 5.4 p -139.78 135.0 38.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.911 -0.586 . . . . 0.9 111.456 -174.289 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -92.52 117.54 30.05 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.819 -0.628 . . . . 2.38 110.085 175.221 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.48 76.67 0.01 OUTLIER 'General case' 0 C--O 1.232 0.165 0 CA-C-N 115.86 -0.609 . . . . 1.97 112.089 178.398 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 13.8 m -159.38 -50.31 0.06 Allowed 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 108.294 -1.002 . . . . 2.22 108.294 179.542 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 87.5 mt -62.93 -44.0 97.27 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 108.771 -0.825 . . . . 1.38 108.771 172.477 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.579 ' HB ' ' OD2' ' A' ' 11' ' ' ASP . 26.3 p -93.7 59.08 2.79 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-N 114.942 -1.026 . . . . 1.44 110.273 175.518 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 9.7 tpt180 -102.4 112.04 24.59 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.881 -0.599 . . . . 4.63 110.173 174.512 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 69.65 34.74 73.2 Favored Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 120.712 -0.756 . . . . 1.62 112.596 176.37 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.804 ' HB3' ' HB3' ' A' ' 10' ' ' LEU . 13.2 mptt -81.13 140.56 34.96 Favored 'General case' 0 CA--C 1.511 -0.529 0 N-CA-C 109.478 -0.564 . . . . 2.75 109.478 176.666 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' GLN . . . . . 0.4 ' HA ' ' HA ' ' A' ' 9' ' ' SER . 49.1 mt-30 -138.17 134.18 34.22 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 109.944 -0.391 . . . . 2.24 109.944 -179.764 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.587 ' O ' ' HA ' ' A' ' 7' ' ' PRO . 7.8 t -124.34 134.13 53.25 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.278 -0.638 . . . . 1.02 109.278 -178.584 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 5.8 m-20 -60.08 -14.88 18.94 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 112.716 0.636 . . . . 1.28 112.716 -178.332 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 132.05 178.66 15.63 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.248 -0.977 . . . . 0.42 113.008 170.829 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.502 HD23 HG11 ' A' ' 3' ' ' VAL . 48.4 tp -160.44 122.01 3.1 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 108.135 -1.061 . . . . 0.7 108.135 -179.135 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' HIS . . . . . 0.63 ' HA ' ' O ' ' A' ' 3' ' ' VAL . 39.7 t-80 -145.37 99.84 3.36 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.213 -0.595 . . . . 2.96 111.972 179.215 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -169.37 178.14 42.63 Favored Glycine 0 N--CA 1.443 -0.892 0 N-CA-C 110.969 -0.852 . . . . 0.55 110.969 174.483 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -82.39 113.06 19.9 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 108.12 -1.067 . . . . 2.18 108.12 169.031 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 50.5 m-85 -128.89 131.13 47.58 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.074 0.464 . . . . 1.41 111.888 -173.501 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -66.15 160.37 24.24 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.256 -0.884 . . . . 2.23 109.219 169.288 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 47.2 t -49.03 -61.22 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 O-C-N 123.507 0.504 . . . . 0.57 111.502 -174.609 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.683 ' HA ' HD23 ' A' ' 50' ' ' LEU . 46.5 mt-10 -64.24 -40.18 95.48 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.256 -0.429 . . . . 2.39 111.695 -178.398 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 28.1 t -71.07 -30.4 66.53 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-O 120.892 0.377 . . . . 1.26 111.428 -170.81 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -81.18 -32.11 32.68 Favored Glycine 0 N--CA 1.447 -0.615 0 C-N-CA 120.531 -0.842 . . . . 0.37 111.526 -177.136 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.683 HD23 ' HA ' ' A' ' 47' ' ' GLU . 0.3 OUTLIER -80.59 -41.14 24.5 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 109.539 -0.541 . . . . 1.09 109.539 -178.198 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 51' ' ' GLN . . . . . 0.576 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 54.3 tt0 -53.95 -39.23 65.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.735 -0.666 . . . . 2.59 111.768 174.451 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 62.2 tp60 -63.07 -46.64 86.48 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.377 -0.374 . . . . 1.75 110.133 178.885 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.475 ' HB3' HD11 ' A' ' 10' ' ' LEU . 95.8 mt -58.39 -21.71 51.34 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 115.803 -0.635 . . . . 0.73 112.344 178.375 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.41 ' HG ' ' O ' ' A' ' 50' ' ' LEU . 87.2 mt -73.88 -24.71 59.76 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-O 120.685 0.278 . . . . 2.16 111.611 -178.036 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -73.5 113.55 10.73 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.115 0.483 . . . . 2.24 110.77 -176.693 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 127.67 -12.96 6.54 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.807 -0.711 . . . . 1.7 111.846 -179.05 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 70.6 p -118.12 175.1 5.84 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 110.005 -0.368 . . . . 2.28 110.005 179.041 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -113.13 33.25 5.67 Favored Glycine 0 N--CA 1.448 -0.541 0 N-CA-C 111.271 -0.732 . . . . 1.58 111.271 179.251 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 85.1 mt -119.99 179.31 4.3 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 108.872 -0.788 . . . . 1.42 108.872 178.829 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -149.87 119.11 6.8 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.091 0.472 . . . . 2.67 109.925 178.478 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 59.9 t -92.92 126.58 45.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 N-CA-C 109.08 -0.711 . . . . 1.54 109.08 176.547 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.487 ' HE2' ' HB2' ' A' ' 72' ' ' GLU . 50.9 mtmt -126.17 134.35 25.87 Favored Pre-proline 0 C--N 1.319 -0.751 0 N-CA-C 109.509 -0.552 . . . . 1.81 109.509 -177.812 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.475 ' HA ' ' O ' ' A' ' 68' ' ' SER . 47.8 Cg_exo -56.32 117.86 4.58 Favored 'Trans proline' 0 N--CA 1.459 -0.557 0 C-N-CA 122.232 1.955 . . . . 0.85 110.825 173.679 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 55.6 tp -58.07 -42.41 85.48 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 114.917 -1.038 . . . . 1.7 112.079 -171.13 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -179.64 -86.64 0.07 OUTLIER Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 120.553 -0.832 . . . . 1.69 112.287 179.744 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 50.3 t30 -61.18 -76.03 0.06 Allowed 'General case' 0 C--N 1.33 -0.265 0 O-C-N 123.52 0.188 . . . . 2.96 111.138 -179.344 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 66.5 t30 -155.93 53.14 0.57 Allowed 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 121.662 0.744 . . . . 2.5 109.626 178.738 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.475 ' O ' ' HA ' ' A' ' 63' ' ' PRO . 10.8 m -138.11 178.79 6.86 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 107.883 -1.154 . . . . 1.3 107.883 -179.328 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' TRP . . . . . 0.577 ' CE3' HD21 ' A' ' 25' ' ' LEU . 51.5 m0 -136.52 157.1 47.57 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.114 -0.698 . . . . 0.47 109.114 -176.364 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 13.8 t -142.6 147.81 36.45 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.752 0.311 . . . . 0.83 110.236 176.072 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.479 HD23 ' HB ' ' A' ' 27' ' ' VAL . 3.9 mm? -93.41 102.95 15.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.167 0.508 . . . . 1.71 111.253 179.457 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.487 ' HB2' ' HE2' ' A' ' 62' ' ' LYS . 17.8 mt-10 -106.25 131.42 21.74 Favored Pre-proline 0 C--N 1.32 -0.715 0 CA-C-N 115.328 -0.851 . . . . 2.13 111.182 172.538 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.455 ' HD3' ' HA ' ' A' ' 72' ' ' GLU . 24.0 Cg_exo -64.01 114.78 2.77 Favored 'Trans proline' 0 N--CA 1.456 -0.708 0 C-N-CA 122.249 1.966 . . . . 1.36 111.274 176.193 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.318 -0.77 0 CA-C-N 115.41 -0.814 . . . . 1.89 108.865 175.105 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 2' ' ' GLN . . . . . 0.663 ' HA ' ' HA ' ' A' ' 43' ' ' ASP . 60.6 tp60 . . . . . 0 N--CA 1.466 0.346 0 CA-C-O 122.01 0.91 . . . . 4.0 111.69 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 60.3 t -101.43 131.44 49.22 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 CA-C-N 114.437 -1.256 . . . . 1.64 108.724 178.586 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 50.6 m-80 -123.41 99.54 6.38 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.069 0.462 . . . . 2.29 110.114 -173.592 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.477 ' HB ' ' H ' ' A' ' 40' ' ' LEU . 30.2 mt -130.49 160.29 41.77 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 N-CA-C 108.766 -0.828 . . . . 0.82 108.766 179.48 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.7 ' HB1' ' HD2' ' A' ' 7' ' ' PRO . . . -164.6 172.87 4.31 Favored Pre-proline 0 C--N 1.323 -0.555 0 CA-C-O 118.815 -0.612 . . . . 1.38 109.448 -176.958 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.7 ' HD2' ' HB1' ' A' ' 6' ' ' ALA . 33.7 Cg_exo -36.97 130.49 0.49 Allowed 'Trans proline' 0 C--N 1.357 1.006 0 C-N-CA 123.297 2.665 . . . . 1.73 113.685 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 155.57 -177.16 32.87 Favored Glycine 0 N--CA 1.444 -0.767 0 N-CA-C 110.982 -0.847 . . . . 1.84 110.982 -177.886 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.588 ' HA ' ' O ' ' A' ' 35' ' ' LYS . 19.6 m -68.32 133.68 49.12 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 110.068 -0.345 . . . . 1.61 110.068 178.926 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 59.9 tp -58.8 -32.32 69.24 Favored 'General case' 0 C--O 1.23 0.071 0 CA-C-O 120.989 0.423 . . . . 1.19 110.727 179.58 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -49.64 -46.65 49.76 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.436 -0.802 . . . . 2.11 110.559 172.871 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 5.1 tmtm? -64.37 -35.03 79.55 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.658 -0.701 . . . . 2.72 110.066 -178.246 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -65.26 -59.41 4.1 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.155 -0.475 . . . . 0.46 110.961 -176.746 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 94.0 mt -59.61 -39.07 83.03 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.097 -0.501 . . . . 0.69 111.232 178.142 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 47.2 t30 -60.99 -38.39 85.84 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.966 0.412 . . . . 1.31 110.052 178.311 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 20.9 tm0? -61.6 -44.05 97.73 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.974 -0.557 . . . . 2.23 110.663 177.054 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.417 ' CD1' ' HH2' ' A' ' 69' ' ' TRP . 3.9 t80 -68.53 -43.51 76.58 Favored 'General case' 0 N--CA 1.457 -0.106 0 N-CA-C 109.24 -0.652 . . . . 0.65 109.24 -179.503 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.692 ' HA ' ' CZ ' ' A' ' 23' ' ' PHE . . . -54.55 -49.16 70.96 Favored 'General case' 0 C--N 1.333 -0.109 0 CA-C-N 115.619 -0.719 . . . . 0.37 111.546 176.923 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -64.92 -24.98 67.69 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.403 -0.362 . . . . 0.64 111.515 -179.488 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 56.1 t60 -60.99 -50.95 71.29 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.342 -0.39 . . . . 1.85 111.305 -177.567 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.564 ' HB2' ' CD1' ' A' ' 23' ' ' PHE . 15.7 m -108.11 -1.5 20.33 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.993 0.425 . . . . 1.67 111.783 -177.245 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 62.24 46.62 93.56 Favored Glycine 0 C--N 1.332 0.339 0 CA-C-N 115.595 -0.729 . . . . 0.62 113.699 174.497 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.692 ' CZ ' ' HA ' ' A' ' 18' ' ' ALA . 14.4 p90 -105.12 172.79 6.6 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.842 0.321 . . . . 0.57 110.568 -179.419 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 47.6 m -91.71 106.19 18.29 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.34 0.59 . . . . 0.68 111.41 -179.514 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 3.6 tt -92.98 123.03 35.94 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.017 -0.735 . . . . 1.67 109.017 175.633 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.407 ' O ' ' HA ' ' A' ' 70' ' ' THR . 33.4 t -101.04 101.11 11.81 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.172 0.51 . . . . 1.15 110.064 -176.552 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.2 p -141.22 135.14 31.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.729 -0.669 . . . . 0.9 110.444 -179.898 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -81.83 123.3 28.68 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.857 -0.611 . . . . 2.38 110.406 177.961 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.14 82.77 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.805 -0.634 . . . . 1.97 111.954 178.893 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.526 ' HA ' ' NE ' ' A' ' 33' ' ' ARG . 55.5 p -172.44 -45.4 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.289 -0.414 . . . . 2.22 110.053 -179.706 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 93.5 mt -62.09 -44.61 96.3 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.584 -0.734 . . . . 1.38 112.227 -174.386 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.461 ' O ' ' HB2' ' A' ' 35' ' ' LYS . 30.0 p -97.86 2.55 49.4 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 112.206 0.447 . . . . 1.44 112.206 -176.265 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' ARG . . . . . 0.526 ' NE ' ' HA ' ' A' ' 30' ' ' SER . 64.6 mtm180 -58.55 121.66 11.5 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-O 120.581 0.229 . . . . 4.63 111.442 -178.408 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 81.3 11.71 83.06 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 121.056 -0.593 . . . . 1.62 112.781 175.929 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.588 ' O ' ' HA ' ' A' ' 9' ' ' SER . 12.8 mptt -85.08 151.01 24.46 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.872 0.368 . . . . 2.75 110.817 -179.763 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 32.1 mm-40 -131.46 138.3 48.97 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 108.437 -0.949 . . . . 2.24 108.437 178.667 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.501 ' O ' ' HA ' ' A' ' 7' ' ' PRO . 34.6 t -131.6 141.66 49.71 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 109.186 -0.672 . . . . 1.02 109.186 179.236 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 6.1 m-20 -77.1 -2.36 33.82 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.431 -0.349 . . . . 1.28 111.65 178.062 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.472 ' HA2' HG22 ' A' ' 5' ' ' ILE . . . 98.02 -169.63 24.29 Favored Glycine 0 N--CA 1.445 -0.754 0 C-N-CA 120.421 -0.895 . . . . 0.42 113.619 170.714 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.477 ' H ' ' HB ' ' A' ' 5' ' ' ILE . 54.8 tp -160.23 140.41 11.54 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 107.537 -1.283 . . . . 0.7 107.537 -179.28 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 17.4 t60 -144.52 99.54 3.38 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 120.195 -0.602 . . . . 2.96 111.241 -178.185 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -169.48 170.69 42.81 Favored Glycine 0 N--CA 1.448 -0.518 0 N-CA-C 110.547 -1.021 . . . . 0.55 110.547 175.947 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.663 ' HA ' ' HA ' ' A' ' 2' ' ' GLN . 44.2 t0 -86.0 91.77 8.49 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 108.607 -0.886 . . . . 2.18 108.607 175.84 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 25.6 m-85 -107.4 138.01 44.38 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.555 -0.748 . . . . 1.41 112.173 -170.131 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -75.33 165.56 24.97 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 108.449 -0.945 . . . . 2.23 108.449 169.975 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.484 HG13 ' HZ2' ' A' ' 69' ' ' TRP . 61.2 t -50.44 -70.31 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 112.356 0.502 . . . . 0.57 112.356 -174.383 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -61.33 -42.19 98.26 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 112.285 0.476 . . . . 2.39 112.285 -172.465 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 34.9 t -70.18 -26.21 63.8 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.878 0.37 . . . . 1.26 110.524 -175.221 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.447 ' O ' ' HG ' ' A' ' 53' ' ' LEU . . . -77.24 -36.08 35.96 Favored Glycine 0 N--CA 1.444 -0.826 0 N-CA-C 110.956 -0.858 . . . . 0.37 110.956 -179.664 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.677 ' HB3' HG13 ' A' ' 61' ' ' VAL . 92.8 mt -72.69 -43.62 62.83 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.76 0.314 . . . . 1.09 110.628 -179.38 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 57.0 tp60 -52.96 -50.06 64.86 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.837 -0.62 . . . . 2.59 111.575 178.902 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.458 ' HA ' ' OE1' ' A' ' 52' ' ' GLN . 12.8 mm-40 -65.86 -37.13 85.36 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.524 -0.307 . . . . 1.75 111.458 -178.039 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.447 ' HG ' ' O ' ' A' ' 49' ' ' GLY . 66.1 mt -57.88 -39.86 78.85 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.176 0.436 . . . . 0.73 112.176 179.327 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.473 HD12 HG12 ' A' ' 61' ' ' VAL . 45.2 mt -105.39 16.84 24.93 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.257 0.466 . . . . 2.16 112.257 -174.856 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -68.15 94.58 0.52 Allowed 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 120.993 0.425 . . . . 2.24 111.188 -179.895 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 109.57 -7.01 31.8 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.919 -0.658 . . . . 1.7 113.565 176.621 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 60.4 p -83.72 -1.54 54.33 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 117.357 0.579 . . . . 2.28 111.705 -175.755 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 76.57 17.67 79.71 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.764 -0.732 . . . . 1.58 112.118 -179.739 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 96.7 mt -124.96 168.57 13.13 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.516 -0.342 . . . . 1.42 110.091 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 33.7 tt0 -150.69 118.64 6.24 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.18 -0.674 . . . . 2.67 109.18 175.915 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.677 HG13 ' HB3' ' A' ' 50' ' ' LEU . 7.2 p -109.73 129.67 64.2 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 N-CA-C 109.998 -0.371 . . . . 1.54 109.998 179.425 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 24.0 pttm -148.47 156.53 42.3 Favored Pre-proline 0 C--N 1.322 -0.628 0 N-CA-C 109.884 -0.413 . . . . 1.81 109.884 -177.126 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.615 ' HA ' ' HA ' ' A' ' 69' ' ' TRP . 25.7 Cg_exo -63.93 148.17 91.77 Favored 'Trans proline' 0 N--CA 1.461 -0.392 0 C-N-CA 122.716 2.277 . . . . 0.85 111.904 176.706 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.498 HD21 ' HB ' ' A' ' 70' ' ' THR . 82.0 mt -65.68 -27.39 68.31 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.595 -0.73 . . . . 1.7 110.659 179.363 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 152.0 -19.95 0.86 Allowed Glycine 0 N--CA 1.451 -0.361 0 N-CA-C 109.674 -1.371 . . . . 1.69 109.674 -178.63 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 5.6 p30 -128.21 -157.87 0.84 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 114.414 -0.893 . . . . 2.96 109.314 174.865 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -77.07 45.48 0.44 Allowed 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 121.188 0.518 . . . . 2.5 112.158 -176.918 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.401 ' O ' ' HA ' ' A' ' 63' ' ' PRO . 19.5 m -141.51 165.54 27.22 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 107.391 -1.337 . . . . 1.3 107.391 172.983 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' TRP . . . . . 0.615 ' HA ' ' HA ' ' A' ' 63' ' ' PRO . 52.8 m0 -133.83 166.81 21.81 Favored 'General case' 0 C--N 1.32 -0.716 0 C-N-CA 120.487 -0.485 . . . . 0.47 110.817 -166.38 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.498 ' HB ' HD21 ' A' ' 64' ' ' LEU . 8.9 t -146.49 143.98 29.32 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.419 -0.585 . . . . 0.83 109.419 171.782 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 35.9 tp -93.08 100.95 13.27 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-O 121.662 0.744 . . . . 1.71 109.26 176.153 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -94.75 130.29 33.63 Favored Pre-proline 0 C--N 1.316 -0.863 0 CA-C-N 114.838 -1.073 . . . . 2.13 111.267 -177.34 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_exo -69.98 113.37 3.39 Favored 'Trans proline' 0 N--CA 1.451 -0.995 0 C-N-CA 121.535 1.49 . . . . 1.36 110.714 174.153 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.321 -0.663 0 CA-C-N 115.665 -0.698 . . . . 1.89 109.192 179.572 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 2' ' ' GLN . . . . . 0.877 HE21 ' N ' ' A' ' 2' ' ' GLN . 0.0 OUTLIER . . . . . 0 N--CA 1.452 -0.362 0 CA-C-O 121.139 0.495 . . . . 4.0 110.582 . . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 12.4 p -149.19 156.08 7.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 115.589 -0.732 . . . . 1.64 109.302 -179.358 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 -127.26 108.9 11.28 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.93 0.395 . . . . 2.29 109.978 -178.449 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 60.8 mt -131.16 151.18 35.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 N-CA-C 108.89 -0.781 . . . . 0.82 108.89 -179.871 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.696 ' HB1' ' HD2' ' A' ' 7' ' ' PRO . . . -162.17 174.1 3.96 Favored Pre-proline 0 C--N 1.322 -0.625 0 CA-C-O 118.436 -0.792 . . . . 1.38 108.956 -173.689 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.696 ' HD2' ' HB1' ' A' ' 6' ' ' ALA . 47.5 Cg_exo -38.48 135.53 0.71 Allowed 'Trans proline' 0 C--N 1.361 1.235 0 C-N-CA 123.227 2.618 . . . . 1.73 113.707 -176.264 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 153.13 168.59 17.23 Favored Glycine 0 N--CA 1.446 -0.686 0 N-CA-C 110.401 -1.08 . . . . 1.84 110.401 -173.908 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.422 ' HA ' ' HA ' ' A' ' 36' ' ' GLN . 4.7 t -67.74 138.11 55.98 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.619 -0.511 . . . . 1.61 109.619 -178.736 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 59.9 tp -58.12 -36.79 73.44 Favored 'General case' 0 CA--C 1.523 -0.083 0 CA-C-N 115.349 -0.841 . . . . 1.19 111.649 -173.222 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -54.59 -50.58 67.68 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.186 -0.461 . . . . 2.11 111.154 176.049 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' LYS . . . . . 0.662 ' O ' ' HG3' ' A' ' 16' ' ' GLN . 41.0 tttm -64.0 -35.43 80.69 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.473 0.178 . . . . 2.72 110.591 177.003 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.42 -52.56 63.08 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.829 0.347 . . . . 0.46 110.132 -178.484 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.629 ' HB3' HD11 ' A' ' 25' ' ' LEU . 77.5 mt -57.27 -38.52 74.02 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.779 -0.646 . . . . 0.69 110.899 174.324 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 17.9 t-20 -61.03 -37.75 83.69 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.107 -0.497 . . . . 1.31 111.06 179.336 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' GLN . . . . . 0.662 ' HG3' ' O ' ' A' ' 12' ' ' LYS . 18.6 mt-30 -62.3 -40.05 95.01 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.758 -0.201 . . . . 2.23 110.587 178.199 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.44 ' O ' ' HB3' ' A' ' 20' ' ' HIS . 5.0 t80 -68.38 -43.77 76.61 Favored 'General case' 0 CA--C 1.52 -0.196 0 CA-C-O 121.636 0.731 . . . . 0.65 109.169 177.433 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.684 ' HA ' ' CZ ' ' A' ' 23' ' ' PHE . . . -52.44 -46.22 66.34 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 114.707 -1.133 . . . . 0.37 111.317 176.521 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -64.52 -29.06 70.1 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.146 -0.479 . . . . 0.64 111.392 179.013 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' HIS . . . . . 0.44 ' HB3' ' O ' ' A' ' 17' ' ' TYR . 84.9 t60 -61.1 -55.06 36.94 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.056 -0.52 . . . . 1.85 111.51 -177.234 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.456 ' HB2' ' CD1' ' A' ' 23' ' ' PHE . 38.8 m -100.23 -9.21 22.66 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 112.134 0.42 . . . . 1.67 112.134 -177.456 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 69.42 55.67 9.79 Favored Glycine 0 N--CA 1.452 -0.286 0 CA-C-N 115.808 -0.633 . . . . 0.62 113.405 178.914 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.684 ' CZ ' ' HA ' ' A' ' 18' ' ' ALA . 15.5 p90 -112.67 166.54 11.25 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.77 0.319 . . . . 0.57 110.455 176.858 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 21.0 m -89.31 113.41 24.68 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.187 0.518 . . . . 0.68 111.012 -177.403 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.629 HD11 ' HB3' ' A' ' 14' ' ' LEU . 1.9 tt -99.91 136.7 39.42 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.384 -0.825 . . . . 1.67 109.588 179.002 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.67 ' HB2' ' HA ' ' A' ' 70' ' ' THR . 48.5 m -100.64 97.22 7.92 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 109.692 -0.484 . . . . 1.15 109.692 175.809 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.487 ' HB ' HD22 ' A' ' 25' ' ' LEU . 12.6 p -145.36 150.33 15.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.353 -0.385 . . . . 0.9 110.136 -177.505 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -130.42 122.82 28.48 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.402 -0.363 . . . . 2.38 110.448 -179.921 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.17 67.7 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.375 0 O-C-N 123.855 0.722 . . . . 1.97 112.286 177.433 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 30.2 t -170.62 -34.48 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.518 -0.549 . . . . 2.22 109.518 178.931 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 90.9 mt -69.13 -36.87 77.94 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.102 -0.499 . . . . 1.38 110.338 178.119 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 8.9 p -93.7 36.85 1.08 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.952 -0.567 . . . . 1.44 111.358 -179.822 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.49 105.92 2.38 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.914 0.388 . . . . 4.63 110.381 -176.579 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 87.62 17.37 58.54 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.835 -0.697 . . . . 1.62 112.062 -179.259 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.61 93.28 4.68 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.702 0.286 . . . . 2.75 110.249 179.735 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' GLN . . . . . 0.422 ' HA ' ' HA ' ' A' ' 9' ' ' SER . 49.0 mt-30 -102.69 158.09 16.49 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 110.249 -0.278 . . . . 2.24 110.249 179.529 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 32.9 t -127.2 135.56 50.82 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 108.736 -0.838 . . . . 1.02 108.736 178.958 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 6.8 m-20 -67.51 -12.87 61.36 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 113.231 0.826 . . . . 1.28 113.231 -175.499 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.407 ' HA3' ' HA ' ' A' ' 6' ' ' ALA . . . 125.13 174.83 14.06 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.028 -1.082 . . . . 0.42 114.034 170.903 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 57.0 tp -161.25 120.2 2.5 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 108.238 -1.023 . . . . 0.7 108.238 -176.239 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 11.7 p80 -144.28 99.39 3.37 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 119.808 -0.757 . . . . 2.96 111.519 -179.786 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -169.01 -177.84 40.05 Favored Glycine 0 N--CA 1.443 -0.868 0 CA-C-N 115.158 -0.928 . . . . 0.55 111.131 177.833 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -88.87 77.02 7.84 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 108.897 -0.779 . . . . 2.18 108.897 172.269 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 28.9 m-85 -98.26 129.59 44.98 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.766 -0.652 . . . . 1.41 111.68 -173.138 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 32.4 t0 -70.55 162.56 28.62 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.308 -0.86 . . . . 2.23 109.047 173.857 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 46.4 t -47.92 -64.83 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 112.285 0.476 . . . . 0.57 112.285 -172.54 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 40.9 mm-40 -56.81 -36.55 70.05 Favored 'General case' 0 N--CA 1.464 0.242 0 N-CA-C 111.773 0.286 . . . . 2.39 111.773 -176.749 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 15.3 m -71.74 -33.67 68.89 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-O 120.97 0.414 . . . . 1.26 110.773 -174.684 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -67.75 -46.84 65.0 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.955 -0.64 . . . . 0.37 112.339 -175.192 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.572 HD11 ' CZ2' ' A' ' 69' ' ' TRP . 7.1 mp -68.9 -37.26 78.87 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 110.486 -0.19 . . . . 1.09 110.486 -178.225 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -54.82 -45.86 74.49 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.433 -0.348 . . . . 2.59 111.009 178.266 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 -65.66 -46.85 77.59 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.254 -0.43 . . . . 1.75 110.989 179.102 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 88.7 mt -57.14 -29.63 63.75 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 112.29 0.478 . . . . 0.73 112.29 -178.826 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.487 ' HG ' ' O ' ' A' ' 50' ' ' LEU . 95.0 mt -77.84 -7.32 56.5 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 112.079 0.4 . . . . 2.16 112.079 -176.839 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -66.72 93.87 0.27 Allowed 'General case' 0 C--O 1.233 0.207 0 CA-C-O 121.45 0.643 . . . . 2.24 110.973 -178.703 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 136.73 -25.33 3.1 Favored Glycine 0 N--CA 1.444 -0.8 0 C-N-CA 120.835 -0.698 . . . . 1.7 112.162 -178.985 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 33.3 p -97.82 171.02 8.57 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 110.031 -0.359 . . . . 2.28 110.031 177.99 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -111.21 -15.77 10.28 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.846 -0.693 . . . . 1.58 112.103 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 2.1 pp -90.49 -178.16 5.25 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.788 -0.449 . . . . 1.42 109.788 178.255 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 94.6 mt-30 -143.08 120.66 11.76 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 118.365 0.53 . . . . 2.67 110.231 -167.493 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.475 HG21 HD11 ' A' ' 14' ' ' LEU . 21.6 t -97.38 128.25 48.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 N-CA-C 109.027 -0.731 . . . . 1.54 109.027 175.907 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 25.0 pttm -146.85 154.16 47.04 Favored Pre-proline 0 C--N 1.329 -0.312 0 C-N-CA 120.5 -0.48 . . . . 1.81 111.299 -178.777 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.64 ' HA ' ' HA ' ' A' ' 69' ' ' TRP . 42.9 Cg_exo -58.57 133.7 56.14 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.984 2.456 . . . . 0.85 111.864 173.467 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 54.4 tp -67.62 -29.15 68.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.473 -0.785 . . . . 1.7 111.141 -175.98 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 166.44 -56.26 0.24 Allowed Glycine 0 N--CA 1.45 -0.427 0 N-CA-C 110.972 -0.851 . . . . 1.69 110.972 179.396 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 13.5 m120 -83.93 -164.48 0.93 Allowed 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 108.438 -0.949 . . . . 2.96 108.438 172.815 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 9.0 t30 -78.61 58.99 2.36 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.814 0.816 . . . . 2.5 109.904 177.291 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.467 ' O ' ' HA ' ' A' ' 63' ' ' PRO . 30.9 m -147.89 174.68 11.62 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 107.725 -1.213 . . . . 1.3 107.725 176.259 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' TRP . . . . . 0.64 ' HA ' ' HA ' ' A' ' 63' ' ' PRO . 53.7 m0 -137.8 166.5 23.84 Favored 'General case' 0 C--N 1.322 -0.603 0 C-N-CA 120.323 -0.551 . . . . 0.47 110.601 -165.32 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.67 ' HA ' ' HB2' ' A' ' 26' ' ' SER . 12.3 t -146.81 150.2 34.82 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.108 -0.496 . . . . 0.83 109.76 173.424 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 54.9 tp -92.95 104.82 17.02 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-O 121.813 0.816 . . . . 1.71 110.491 179.198 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.402 ' HA ' ' HD3' ' A' ' 73' ' ' PRO . 22.0 tt0 -91.3 118.89 68.74 Favored Pre-proline 0 C--N 1.316 -0.888 0 CA-C-N 114.185 -1.371 . . . . 2.13 111.526 179.482 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 72' ' ' GLU . 1.2 Cg_endo -84.65 115.18 1.8 Allowed 'Trans proline' 0 N--CA 1.452 -0.942 0 C-N-CA 122.874 2.383 . . . . 1.36 111.658 174.792 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.324 -0.504 0 CA-C-N 115.742 -0.663 . . . . 1.89 109.308 177.011 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 . . . . . 0 N--CA 1.455 -0.192 0 CA-C-O 121.128 0.49 . . . . 4.0 110.742 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.457 HG12 HG12 ' A' ' 5' ' ' ILE . 62.8 t -127.42 136.3 60.93 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 115.433 -0.803 . . . . 1.64 109.349 179.617 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 17.7 m120 -127.96 97.86 4.94 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.453 -0.573 . . . . 2.29 109.453 -174.625 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.624 HG13 HD21 ' A' ' 53' ' ' LEU . 43.0 mm -122.93 155.91 28.48 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 N-CA-C 109.33 -0.619 . . . . 0.82 109.33 -178.515 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.648 ' HB1' ' HD2' ' A' ' 7' ' ' PRO . . . -162.43 163.41 18.34 Favored Pre-proline 0 C--N 1.325 -0.492 0 N-CA-C 109.27 -0.641 . . . . 1.38 109.27 -176.781 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.648 ' HD2' ' HB1' ' A' ' 6' ' ' ALA . 9.4 Cg_endo -51.96 130.56 35.11 Favored 'Trans proline' 0 C--N 1.35 0.649 0 C-N-CA 122.831 2.354 . . . . 1.73 112.755 -175.33 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 163.15 42.81 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.408 0 CA-C-N 115.67 -0.695 . . . . 1.84 112.441 -178.111 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.79 ' HA ' ' HA ' ' A' ' 36' ' ' GLN . 65.1 m 66.44 131.49 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 121.496 0.665 . . . . 1.61 111.691 -178.706 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 64.1 tp -60.02 -35.4 74.99 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 115.924 -0.58 . . . . 1.19 111.031 -178.493 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -50.6 -54.12 25.24 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 115.583 -0.735 . . . . 2.11 111.589 177.372 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 85.3 tttt -66.78 -32.01 73.02 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.693 -0.23 . . . . 2.72 110.755 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -63.29 -53.36 54.01 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.932 0.396 . . . . 0.46 110.548 -176.206 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 88.6 mt -58.98 -39.51 81.99 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 115.988 -0.551 . . . . 0.69 111.021 176.517 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 52.4 t30 -60.86 -39.7 90.13 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.209 -0.45 . . . . 1.31 110.703 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 -58.85 -51.11 71.42 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.044 -0.525 . . . . 2.23 111.421 177.843 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.477 ' CD1' ' HH2' ' A' ' 69' ' ' TRP . 32.4 t80 -67.26 -38.43 85.1 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.038 -0.727 . . . . 0.65 109.038 -175.739 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.835 ' HA ' ' CE2' ' A' ' 23' ' ' PHE . . . -55.7 -49.99 71.52 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 115.532 -0.758 . . . . 0.37 111.955 174.913 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.94 -23.64 67.42 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.211 -0.449 . . . . 0.64 111.588 -178.319 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 75.0 t60 -61.71 -48.06 82.45 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.027 -0.533 . . . . 1.85 111.498 -176.346 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.578 ' HB3' ' CD1' ' A' ' 23' ' ' PHE . 38.9 t -102.37 -4.5 25.44 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.882 0.372 . . . . 1.67 111.114 -179.691 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 68.3 47.02 60.72 Favored Glycine 0 CA--C 1.518 0.23 0 CA-C-N 115.702 -0.681 . . . . 0.62 113.622 177.864 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.835 ' CE2' ' HA ' ' A' ' 18' ' ' ALA . 10.3 p90 -106.65 159.66 16.04 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 122.538 -0.39 . . . . 0.57 110.294 176.9 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 22.4 m -88.28 119.5 28.75 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.943 -0.571 . . . . 0.68 111.91 -173.443 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.629 HD21 ' CE3' ' A' ' 69' ' ' TRP . 0.8 OUTLIER -94.8 143.88 26.1 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.636 -0.711 . . . . 1.67 111.278 178.351 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 36.2 t -115.53 92.15 3.83 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.114 -0.698 . . . . 1.15 109.114 173.035 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 6.9 p -148.64 125.54 2.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 115.903 -0.59 . . . . 0.9 110.0 -178.605 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -88.37 134.76 33.74 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 120.831 -0.347 . . . . 2.38 110.634 -177.776 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.7 70.67 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.255 0 O-C-N 124.043 0.839 . . . . 1.97 112.095 176.945 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 79.4 p -168.64 -42.96 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.478 -0.564 . . . . 2.22 109.478 178.662 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.414 ' O ' ' HD3' ' A' ' 35' ' ' LYS . 80.7 mt -66.97 -45.41 77.8 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.655 -0.702 . . . . 1.38 110.029 177.142 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.3 p -91.4 -3.32 56.81 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.489 -0.778 . . . . 1.44 111.592 -178.91 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 55.4 ttp180 -86.62 129.58 34.81 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.174 -0.466 . . . . 4.63 110.586 -178.003 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 107.35 -20.44 32.65 Favored Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 120.703 -0.76 . . . . 1.62 112.353 177.191 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.548 ' HD2' ' N ' ' A' ' 35' ' ' LYS . 0.0 OUTLIER -115.53 136.73 52.78 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-O 121.434 0.635 . . . . 2.75 111.664 -177.873 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 36' ' ' GLN . . . . . 0.79 ' HA ' ' HA ' ' A' ' 9' ' ' SER . 18.4 pt20 -103.34 156.15 17.95 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.343 -0.844 . . . . 2.24 111.397 -177.49 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 31.2 t -117.92 119.61 35.35 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 106.28 -1.748 . . . . 1.02 106.28 171.317 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.558 ' O ' ' HD3' ' A' ' 7' ' ' PRO . 21.9 m-80 -72.27 -6.77 45.42 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 113.131 0.789 . . . . 1.28 113.131 -167.607 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' GLY . . . . . 0.427 ' HA2' HG22 ' A' ' 5' ' ' ILE . . . 127.7 175.62 14.16 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.052 -1.071 . . . . 0.42 113.357 165.756 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.473 ' HB3' ' HB ' ' A' ' 5' ' ' ILE . 67.3 tp -160.13 129.24 5.04 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 109.139 -0.689 . . . . 0.7 109.139 -177.962 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 44.5 m80 -138.15 96.7 3.24 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.171 0.51 . . . . 2.96 110.543 176.123 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -168.87 -169.42 32.25 Favored Glycine 0 N--CA 1.446 -0.693 0 CA-C-N 115.776 -0.647 . . . . 0.55 111.899 176.083 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -98.12 111.47 23.78 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 108.783 -0.821 . . . . 2.18 108.783 173.952 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.449 ' HB2' HG21 ' A' ' 3' ' ' VAL . 44.7 m-85 -133.54 134.29 43.2 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.289 0.566 . . . . 1.41 112.362 -170.15 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 47.3 t0 -85.9 170.3 12.48 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 108.477 -0.935 . . . . 2.23 108.477 172.617 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 48.7 t -46.85 -70.04 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 N-CA-C 112.574 0.583 . . . . 0.57 112.574 -172.364 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -57.89 -34.25 69.6 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 112.507 0.558 . . . . 2.39 112.507 -177.968 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 7.2 m -72.14 -39.92 68.45 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-O 121.203 0.525 . . . . 1.26 110.845 -174.99 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.508 ' O ' ' HG ' ' A' ' 53' ' ' LEU . . . -74.31 -41.76 36.96 Favored Glycine 0 N--CA 1.446 -0.636 0 CA-C-N 115.599 -0.728 . . . . 0.37 111.448 -174.942 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.533 ' O ' ' HG ' ' A' ' 54' ' ' LEU . 90.4 mt -62.29 -38.38 89.14 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.763 0.316 . . . . 1.09 110.831 -179.775 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 6.3 tp60 -57.12 -48.83 77.68 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 115.865 -0.607 . . . . 2.59 111.246 179.862 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.446 ' HG2' HD13 ' A' ' 40' ' ' LEU . 50.4 tp60 -69.0 -38.59 79.35 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.625 -0.261 . . . . 1.75 110.957 -179.146 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.624 HD21 HG13 ' A' ' 5' ' ' ILE . 82.4 mt -56.84 -29.35 62.76 Favored 'General case' 0 N--CA 1.464 0.254 0 N-CA-C 112.014 0.375 . . . . 0.73 112.014 179.369 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.533 ' HG ' ' O ' ' A' ' 50' ' ' LEU . 92.6 mt -78.35 -6.89 56.47 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.219 -0.446 . . . . 2.16 111.893 -176.449 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -66.35 119.07 10.93 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.04 0.447 . . . . 2.24 110.509 -177.161 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 111.98 -24.72 14.09 Favored Glycine 0 N--CA 1.446 -0.682 0 CA-C-N 115.757 -0.656 . . . . 1.7 111.635 -176.88 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 78.6 p -109.0 169.2 8.83 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.664 0.269 . . . . 2.28 110.302 -179.858 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -114.14 49.52 0.84 Allowed Glycine 0 N--CA 1.443 -0.841 0 N-CA-C 111.161 -0.776 . . . . 1.58 111.161 179.39 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.413 HD22 HD11 ' A' ' 71' ' ' LEU . 91.5 mt -124.34 174.96 7.39 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 120.694 0.283 . . . . 1.42 110.398 -178.602 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' GLN . . . . . 0.409 ' CB ' ' HB3' ' A' ' 74' ' ' ALA . 63.7 tp60 -148.86 118.48 7.0 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.264 -0.643 . . . . 2.67 109.264 176.604 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 3.8 p -94.65 123.04 46.61 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 N-CA-C 109.393 -0.595 . . . . 1.54 109.393 177.777 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.482 ' HA ' ' HD3' ' A' ' 63' ' ' PRO . 20.2 ptmt -122.64 134.08 24.77 Favored Pre-proline 0 C--N 1.32 -0.702 0 CA-C-O 120.84 0.352 . . . . 1.81 110.84 -172.73 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.482 ' HD3' ' HA ' ' A' ' 62' ' ' LYS . 37.9 Cg_exo -62.26 129.0 25.44 Favored 'Trans proline' 0 N--CA 1.462 -0.338 0 C-N-CA 122.92 2.413 . . . . 0.85 111.64 176.36 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -68.32 -48.11 65.75 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.244 -0.889 . . . . 1.7 109.802 -177.41 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -175.37 -71.91 0.05 OUTLIER Glycine 0 N--CA 1.445 -0.756 0 C-N-CA 120.687 -0.768 . . . . 1.69 112.074 177.778 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -89.63 -77.9 0.38 Allowed 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.891 0.377 . . . . 2.96 111.098 -176.78 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' ASN . . . . . 0.483 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 27.2 p-10 -138.31 39.72 2.27 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.402 0.62 . . . . 2.5 111.001 -175.528 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 35.2 t -138.65 166.51 24.17 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 108.124 -1.065 . . . . 1.3 108.124 177.287 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' TRP . . . . . 0.629 ' CE3' HD21 ' A' ' 25' ' ' LEU . 24.4 m0 -141.68 165.52 27.25 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 107.865 -1.161 . . . . 0.47 107.865 -174.508 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 12.7 t -145.02 150.06 36.22 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 109.432 -0.581 . . . . 0.83 109.432 172.383 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.413 HD11 HD22 ' A' ' 59' ' ' LEU . 1.0 OUTLIER -93.37 102.68 14.93 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.318 0.58 . . . . 1.71 110.335 -176.446 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -97.04 123.49 53.07 Favored Pre-proline 0 C--N 1.321 -0.663 0 CA-C-N 115.197 -0.911 . . . . 2.13 110.294 173.757 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_exo -62.64 114.78 2.54 Favored 'Trans proline' 0 N--CA 1.461 -0.392 0 C-N-CA 122.403 2.069 . . . . 1.36 111.72 178.307 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.409 ' HB3' ' CB ' ' A' ' 60' ' ' GLN . . . . . . . . 0 C--N 1.321 -0.646 0 N-CA-C 109.326 -0.62 . . . . 1.89 109.326 179.108 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 26.8 pt20 . . . . . 0 CA--C 1.522 -0.107 0 CA-C-O 120.853 0.359 . . . . 4.0 110.469 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 31.5 m -139.99 152.68 22.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.95 -0.568 . . . . 1.64 110.282 -178.479 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 19.1 p-10 -127.97 97.09 4.68 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.588 0.708 . . . . 2.29 109.374 176.095 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 66.1 mt -134.03 118.09 27.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.723 -0.671 . . . . 0.82 110.004 -177.293 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -81.17 170.79 14.1 Favored Pre-proline 0 C--N 1.323 -0.574 0 CA-C-N 115.562 -0.744 . . . . 1.38 109.431 -179.644 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -54.96 141.23 78.98 Favored 'Trans proline' 0 N--CA 1.458 -0.6 0 C-N-CA 121.374 1.382 . . . . 1.73 109.843 167.23 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.442 ' O ' ' HB2' ' A' ' 36' ' ' GLN . . . 173.68 -135.8 3.37 Favored Glycine 0 N--CA 1.446 -0.68 0 N-CA-C 110.575 -1.01 . . . . 1.84 110.575 -169.312 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.867 ' HA ' ' HA ' ' A' ' 36' ' ' GLN . 23.7 m -125.25 155.9 39.38 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 117.427 0.614 . . . . 1.61 110.407 178.097 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.615 HD22 ' HB2' ' A' ' 37' ' ' SER . 3.9 mm? -56.3 -39.3 72.5 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 118.074 0.397 . . . . 1.19 111.093 179.231 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -47.08 -56.09 7.16 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 115.27 -0.877 . . . . 2.11 111.822 178.561 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 3.3 tppp? -66.06 -31.14 71.84 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.796 -0.183 . . . . 2.72 111.171 -178.752 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -66.26 -57.86 6.62 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.054 0.454 . . . . 0.46 110.597 -177.278 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 95.4 mt -59.69 -39.17 83.63 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 115.871 -0.604 . . . . 0.69 111.315 177.243 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -57.38 -41.46 80.25 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.27 0.557 . . . . 1.31 110.038 177.031 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 22.4 tm0? -63.46 -48.25 78.45 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.337 -0.847 . . . . 2.23 110.678 179.258 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -70.35 -37.82 74.7 Favored 'General case' 0 N--CA 1.456 -0.148 0 C-N-CA 120.894 -0.322 . . . . 0.65 111.27 -172.183 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.594 ' HA ' ' CZ ' ' A' ' 23' ' ' PHE . . . -47.91 -44.74 30.07 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-O 120.777 0.323 . . . . 0.37 111.652 176.478 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.59 -21.24 66.25 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.736 -0.666 . . . . 0.64 112.358 179.355 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 3.9 t-160 -58.96 -61.53 2.57 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 120.667 0.27 . . . . 1.85 111.45 -175.647 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.636 ' HB3' ' HD1' ' A' ' 23' ' ' PHE . 8.2 t -100.78 -9.07 22.08 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.916 0.389 . . . . 1.67 111.287 -177.764 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 73.33 56.54 5.57 Favored Glycine 0 C--N 1.331 0.284 0 C-N-CA 121.124 -0.56 . . . . 0.62 112.49 -179.714 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.636 ' HD1' ' HB3' ' A' ' 21' ' ' SER . 17.4 p90 -116.68 172.73 7.04 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.737 0.303 . . . . 0.57 110.935 -177.617 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.603 ' O ' ' HB3' ' A' ' 68' ' ' SER . 27.3 m -94.49 111.0 22.74 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-O 121.345 0.593 . . . . 0.68 111.088 -179.247 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 3.2 tt -93.72 117.77 30.53 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.216 -0.661 . . . . 1.67 109.216 177.752 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 73.5 m -104.65 103.13 12.72 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.97 -0.559 . . . . 1.15 111.341 -174.062 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.479 ' CG2' HD12 ' A' ' 71' ' ' LEU . 4.2 p -138.84 129.65 34.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 115.842 -0.617 . . . . 0.9 110.668 178.254 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -72.57 121.76 20.23 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.727 -0.67 . . . . 2.38 110.307 176.153 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.31 77.27 0.01 OUTLIER 'General case' 0 C--O 1.236 0.35 0 CA-C-N 115.778 -0.646 . . . . 1.97 111.984 177.693 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 30.6 t -175.47 -31.41 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.723 -0.671 . . . . 2.22 109.513 178.317 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 80.1 mt -63.11 -53.01 60.24 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.639 -0.71 . . . . 1.38 110.636 179.316 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 3.0 p -92.39 58.28 3.17 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.773 -0.649 . . . . 1.44 110.831 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 16.6 ptp180 -71.26 105.72 3.57 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 115.742 -0.663 . . . . 4.63 109.758 176.353 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 68.24 -93.25 0.28 Allowed Glycine 0 N--CA 1.45 -0.397 0 N-CA-C 110.633 -0.987 . . . . 1.62 110.633 -170.363 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.587 ' HG3' HD23 ' A' ' 10' ' ' LEU . 40.7 tptt 50.82 94.3 0.02 OUTLIER 'General case' 0 C--O 1.236 0.355 0 C-N-CA 123.779 0.831 . . . . 2.75 111.974 171.288 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' GLN . . . . . 0.867 ' HA ' ' HA ' ' A' ' 9' ' ' SER . 26.6 pt20 -101.37 153.81 19.34 Favored 'General case' 0 N--CA 1.447 -0.58 0 O-C-N 121.994 -0.441 . . . . 2.24 110.474 -174.804 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.615 ' HB2' HD22 ' A' ' 10' ' ' LEU . 32.8 t -128.08 138.66 52.63 Favored 'General case' 0 N--CA 1.446 -0.673 0 N-CA-C 108.469 -0.937 . . . . 1.02 108.469 -179.778 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 6.4 m-20 -64.85 -8.96 17.39 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.997 -0.547 . . . . 1.28 112.143 -179.213 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 118.6 -177.39 16.43 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.868 -0.682 . . . . 0.42 112.634 171.554 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.437 HD13 ' HG2' ' A' ' 52' ' ' GLN . 63.3 tp -159.62 109.52 1.88 Allowed 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 108.605 -0.887 . . . . 0.7 108.605 -179.432 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 12.7 p80 -144.7 98.23 3.15 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 122.018 0.913 . . . . 2.96 111.332 -178.633 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -170.03 -169.82 33.68 Favored Glycine 0 N--CA 1.443 -0.888 0 CA-C-N 114.356 -1.293 . . . . 0.55 111.043 176.689 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 32.1 m-20 -82.43 75.36 9.34 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.116 -0.698 . . . . 2.18 109.116 173.36 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 79.8 m-85 -110.08 123.12 49.14 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.564 -0.744 . . . . 1.41 110.798 -178.144 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -89.27 -163.1 0.94 Allowed 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 108.878 -0.786 . . . . 2.23 108.878 173.23 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.516 ' O ' ' HG ' ' A' ' 50' ' ' LEU . 37.5 t -53.09 -71.81 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 N-CA-C 112.751 0.648 . . . . 0.57 112.751 -172.367 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -61.83 -42.44 99.03 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 112.944 0.72 . . . . 2.39 112.944 -171.54 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 28.6 m -68.89 -29.99 68.39 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.158 0.504 . . . . 1.26 111.01 -173.956 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -80.07 -29.83 44.72 Favored Glycine 0 N--CA 1.445 -0.711 0 N-CA-C 110.9 -0.88 . . . . 0.37 110.9 -178.481 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.621 ' HB3' HG11 ' A' ' 61' ' ' VAL . 82.6 mt -74.73 -45.51 43.61 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 115.459 -0.371 . . . . 1.09 110.385 -179.369 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 24.2 tp60 -55.63 -41.46 73.56 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.97 -0.559 . . . . 2.59 111.27 178.413 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' GLN . . . . . 0.437 ' HG2' HD13 ' A' ' 40' ' ' LEU . 6.7 tp60 -63.81 -48.36 77.16 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.613 -0.267 . . . . 1.75 111.028 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 93.1 mt -58.71 -23.99 60.64 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 112.366 0.506 . . . . 0.73 112.366 -179.603 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.608 HD11 HG12 ' A' ' 61' ' ' VAL . 68.8 mt -78.31 -19.65 53.13 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 112.23 0.456 . . . . 2.16 112.23 -177.174 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -65.48 101.32 0.58 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.204 0.526 . . . . 2.24 110.802 -176.475 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 124.1 -3.7 9.05 Favored Glycine 0 N--CA 1.449 -0.482 0 CA-C-N 115.604 -0.726 . . . . 1.7 111.844 -177.345 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 6.9 m -118.09 170.69 8.65 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.758 0.313 . . . . 2.28 110.397 179.145 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -115.2 24.29 10.74 Favored Glycine 0 N--CA 1.442 -0.901 0 N-CA-C 110.44 -1.064 . . . . 1.58 110.44 172.64 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 85.6 mt -101.57 175.23 5.64 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 120.822 0.344 . . . . 1.42 110.108 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 72.1 mt-30 -133.84 118.32 17.85 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 109.334 -0.617 . . . . 2.67 109.334 174.411 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.621 HG11 ' HB3' ' A' ' 50' ' ' LEU . 6.1 p -86.44 113.42 24.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 N-CA-C 108.781 -0.822 . . . . 1.54 108.781 174.35 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 40.0 ttpt -136.22 130.57 18.34 Favored Pre-proline 0 C--N 1.314 -0.94 0 CA-C-N 115.642 -0.708 . . . . 1.81 110.213 -169.813 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.609 ' HA ' ' HA ' ' A' ' 69' ' ' TRP . 51.4 Cg_exo -55.0 130.64 41.87 Favored 'Trans proline' 0 N--CA 1.461 -0.402 0 C-N-CA 122.318 2.012 . . . . 0.85 111.027 175.638 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.438 ' O ' HD13 ' A' ' 64' ' ' LEU . 2.8 tm? -62.64 -34.74 77.66 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.816 -0.629 . . . . 1.7 109.739 -176.545 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 177.07 -59.01 0.1 OUTLIER Glycine 0 N--CA 1.444 -0.824 0 N-CA-C 110.935 -0.866 . . . . 1.69 110.935 177.164 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 21.0 m-80 -140.17 126.74 20.3 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.599 -0.3 . . . . 2.96 110.703 178.003 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 47.8 t30 75.25 -36.87 0.32 Allowed 'General case' 0 N--CA 1.475 0.781 0 O-C-N 124.096 0.872 . . . . 2.5 112.881 173.556 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.603 ' HB3' ' O ' ' A' ' 24' ' ' THR . 69.0 m -114.17 178.61 4.22 Favored 'General case' 0 C--N 1.321 -0.638 0 O-C-N 122.231 -0.293 . . . . 1.3 110.396 -168.072 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' TRP . . . . . 0.609 ' HA ' ' HA ' ' A' ' 63' ' ' PRO . 40.0 m0 -139.16 167.81 21.24 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 120.825 0.345 . . . . 0.47 110.125 -169.224 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 14.3 t -149.95 150.56 32.02 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.348 -0.612 . . . . 0.83 109.348 169.082 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.559 HD23 ' HA ' ' A' ' 61' ' ' VAL . 25.9 mt -92.79 102.89 15.28 Favored 'General case' 0 CA--C 1.517 -0.317 0 C-N-CA 120.285 -0.566 . . . . 1.71 110.056 174.644 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.416 ' HA ' ' HD3' ' A' ' 73' ' ' PRO . 42.7 tt0 -87.36 119.48 70.85 Favored Pre-proline 0 C--N 1.317 -0.807 0 CA-C-N 115.098 -0.956 . . . . 2.13 110.528 177.493 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 72' ' ' GLU . 6.3 Cg_exo -75.25 114.07 3.92 Favored 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 122.341 2.027 . . . . 1.36 111.187 177.109 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.32 -0.698 0 N-CA-C 108.681 -0.859 . . . . 1.89 108.681 -179.771 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 2' ' ' GLN . . . . . 0.557 ' CB ' ' HA ' ' A' ' 43' ' ' ASP . 8.0 tp60 . . . . . 0 CA--C 1.513 -0.443 0 CA-C-O 121.523 0.678 . . . . 4.0 111.893 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 17.3 m -115.67 131.78 67.05 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 CA-C-N 114.64 -1.164 . . . . 1.64 111.46 -175.211 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 50.5 m-80 -130.74 97.58 4.39 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 108.386 -0.968 . . . . 2.29 108.386 174.952 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 56.6 mt -121.35 132.45 70.62 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-N 115.989 -0.55 . . . . 0.82 111.322 -170.907 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -75.01 157.73 85.12 Favored Pre-proline 0 C--N 1.326 -0.427 0 CA-C-N 115.68 -0.691 . . . . 1.38 109.872 177.781 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.496 ' HA ' ' O ' ' A' ' 37' ' ' SER . 11.6 Cg_exo -72.12 54.91 2.3 Favored 'Trans proline' 0 CA--C 1.533 0.46 0 C-N-CA 123.003 2.468 . . . . 1.73 112.835 179.031 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -125.05 -161.54 11.08 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.771 -0.728 . . . . 1.84 113.177 -178.083 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 18.7 m -47.01 125.88 8.19 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 123.566 0.746 . . . . 1.61 112.322 -177.227 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 68.0 tp -60.94 -29.54 69.69 Favored 'General case' 0 CA--C 1.522 -0.102 0 CA-C-N 115.412 -0.813 . . . . 1.19 110.756 -179.416 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.446 ' CA ' ' HB ' ' A' ' 32' ' ' THR . 22.9 t70 -51.43 -52.21 48.16 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.703 -0.68 . . . . 2.11 111.232 176.643 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 21.9 tptm -69.88 -25.54 63.76 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.497 -0.32 . . . . 2.72 110.616 -179.339 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.642 ' O ' ' HG3' ' A' ' 16' ' ' GLN . . . -65.12 -54.64 26.76 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.179 0.514 . . . . 0.46 109.943 179.017 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.687 ' HB3' HD11 ' A' ' 25' ' ' LEU . 95.9 mt -59.9 -35.73 75.48 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.834 -0.621 . . . . 0.69 110.397 174.155 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 24.1 t-20 -59.09 -47.22 86.07 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.554 -0.748 . . . . 1.31 110.992 -179.463 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' GLN . . . . . 0.642 ' HG3' ' O ' ' A' ' 13' ' ' ALA . 0.0 OUTLIER -65.43 -32.72 74.49 Favored 'General case' 0 C--O 1.232 0.176 0 C-N-CA 120.947 -0.301 . . . . 2.23 111.103 -177.587 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 5.2 t80 -71.71 -42.82 66.91 Favored 'General case' 0 CA--C 1.527 0.071 0 N-CA-C 109.475 -0.565 . . . . 0.65 109.475 178.128 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.731 ' HA ' ' CZ ' ' A' ' 23' ' ' PHE . . . -53.68 -46.28 70.59 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 115.993 -0.548 . . . . 0.37 111.614 177.966 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.29 -21.88 66.52 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.185 -0.461 . . . . 0.64 111.708 -179.855 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 83.2 t60 -66.07 -52.5 48.3 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.717 -0.22 . . . . 1.85 111.321 -178.537 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.606 ' HB3' ' HD1' ' A' ' 23' ' ' PHE . 31.9 t -100.04 -17.56 17.43 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.064 0.459 . . . . 1.67 111.525 -175.399 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 75.77 48.28 10.5 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.945 -0.645 . . . . 0.62 112.912 -178.273 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.731 ' CZ ' ' HA ' ' A' ' 18' ' ' ALA . 25.3 p90 -107.83 166.14 10.92 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 110.082 -0.34 . . . . 0.57 110.082 -179.943 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.505 ' O ' ' HB3' ' A' ' 68' ' ' SER . 40.3 m -91.32 109.12 20.39 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.274 0.559 . . . . 0.68 111.234 -179.275 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.687 HD11 ' HB3' ' A' ' 14' ' ' LEU . 2.0 tt -92.33 122.83 35.17 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.153 -0.684 . . . . 1.67 109.153 177.248 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 25.5 t -100.83 98.4 8.91 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 120.793 0.33 . . . . 1.15 110.442 -175.288 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 8.2 p -149.14 141.89 18.0 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 CA-C-N 115.944 -0.571 . . . . 0.9 110.878 179.598 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -90.97 138.2 31.78 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.327 -0.397 . . . . 2.38 110.29 174.414 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.37 76.63 0.02 OUTLIER 'General case' 0 C--O 1.235 0.309 0 CA-C-N 116.025 -0.534 . . . . 1.97 111.939 176.757 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 22.3 p -166.84 -52.21 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.356 -0.383 . . . . 2.22 110.342 -179.139 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.419 HD13 HD12 ' A' ' 71' ' ' LEU . 84.6 mt -66.51 -44.79 81.56 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.162 -0.472 . . . . 1.38 110.649 179.188 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.446 ' HB ' ' CA ' ' A' ' 11' ' ' ASP . 4.0 p -91.83 -5.66 53.01 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.894 -0.594 . . . . 1.44 111.198 179.744 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 28.0 ttp180 -82.49 129.38 34.9 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.609 -0.723 . . . . 4.63 110.568 -177.417 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 80.47 -29.97 2.53 Favored Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 121.172 -0.537 . . . . 1.62 112.2 178.202 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.505 ' HD3' ' C ' ' A' ' 35' ' ' LYS . 11.0 tmtt? -71.66 117.97 13.9 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 109.028 -0.73 . . . . 2.75 109.028 177.133 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -102.15 149.77 23.94 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.083 0.468 . . . . 2.24 110.466 -178.071 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.496 ' O ' ' HA ' ' A' ' 7' ' ' PRO . 0.4 OUTLIER -123.31 134.74 54.03 Favored 'General case' 0 N--CA 1.431 -1.408 0 N-CA-C 107.731 -1.211 . . . . 1.02 107.731 176.117 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.424 ' HA ' ' HB3' ' A' ' 7' ' ' PRO . 6.0 m-20 -61.86 -2.0 0.77 Allowed 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 113.152 0.797 . . . . 1.28 113.152 -176.707 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 101.62 -171.55 22.09 Favored Glycine 0 CA--C 1.501 -0.807 0 C-N-CA 120.859 -0.686 . . . . 0.42 111.976 171.16 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 48.9 tp -161.4 134.74 6.45 Favored 'General case' 0 N--CA 1.444 -0.752 0 N-CA-C 107.443 -1.317 . . . . 0.7 107.443 -178.91 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 57.9 m80 -136.32 96.54 3.39 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.145 0.498 . . . . 2.96 110.658 178.554 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -170.49 176.13 44.15 Favored Glycine 0 N--CA 1.444 -0.81 0 CA-C-N 115.451 -0.795 . . . . 0.55 112.077 177.183 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.557 ' HA ' ' CB ' ' A' ' 2' ' ' GLN . 5.3 p-10 -93.75 76.23 4.28 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.849 0.833 . . . . 2.18 108.875 170.988 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' TYR . . . . . 0.465 ' O ' ' HG2' ' A' ' 2' ' ' GLN . 38.8 m-85 -94.85 149.51 21.17 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.462 -0.79 . . . . 1.41 111.997 -173.214 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -85.49 179.12 7.2 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.467 -0.788 . . . . 2.23 109.347 173.693 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.489 ' O ' ' HG ' ' A' ' 50' ' ' LEU . 58.4 t -54.58 -71.99 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 N-CA-C 112.139 0.422 . . . . 0.57 112.139 -176.53 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -58.54 -41.71 86.16 Favored 'General case' 0 C--O 1.233 0.229 0 N-CA-C 112.568 0.581 . . . . 2.39 112.568 -175.431 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 1.3 p -71.38 -32.02 67.97 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.086 0.47 . . . . 1.26 111.004 -175.606 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.61 ' O ' ' HG ' ' A' ' 53' ' ' LEU . . . -73.84 -36.18 53.16 Favored Glycine 0 N--CA 1.442 -0.918 0 N-CA-C 111.089 -0.804 . . . . 0.37 111.089 179.673 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.501 HD23 HD12 ' A' ' 53' ' ' LEU . 91.2 mt -67.35 -40.62 85.87 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.617 -0.292 . . . . 1.09 110.479 -179.833 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 60.2 tp60 -55.18 -45.44 75.77 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.043 -0.526 . . . . 2.59 111.015 178.652 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 87.8 mm-40 -68.52 -36.18 78.51 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.586 -0.279 . . . . 1.75 111.174 178.591 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.61 ' HG ' ' O ' ' A' ' 49' ' ' GLY . 80.1 mt -59.12 -21.03 58.66 Favored 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 112.033 0.382 . . . . 0.73 112.033 178.259 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 7.3 mp -75.95 15.93 0.48 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.904 0.383 . . . . 2.16 111.39 177.754 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -56.71 111.51 1.03 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.722 -0.672 . . . . 2.24 111.138 176.486 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 65.27 23.64 70.08 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 121.067 -0.587 . . . . 1.7 112.543 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 50.9 m -99.86 148.63 24.24 Favored 'General case' 0 C--N 1.323 -0.579 0 O-C-N 122.545 -0.385 . . . . 2.28 110.735 179.642 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -111.66 28.32 9.6 Favored Glycine 0 N--CA 1.441 -0.988 0 N-CA-C 109.679 -1.369 . . . . 1.58 109.679 168.898 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.538 HD13 HD11 ' A' ' 71' ' ' LEU . 59.6 mt -121.82 179.8 4.37 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.122 -0.696 . . . . 1.42 109.122 -179.62 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 27.4 tt0 -151.23 121.48 7.26 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.699 -0.482 . . . . 2.67 109.699 178.245 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.441 HG11 HD22 ' A' ' 50' ' ' LEU . 7.3 p -93.51 137.11 23.38 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 N-CA-C 109.708 -0.479 . . . . 1.54 109.708 179.649 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.583 ' HG3' ' HG3' ' A' ' 72' ' ' GLU . 15.6 mtmm -130.19 135.51 27.57 Favored Pre-proline 0 C--N 1.327 -0.396 0 C-N-CA 121.065 -0.254 . . . . 1.81 110.409 -179.218 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_exo -63.0 121.79 9.8 Favored 'Trans proline' 0 N--CA 1.458 -0.604 0 C-N-CA 122.407 2.071 . . . . 0.85 110.341 169.568 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 44.8 tp -62.57 -40.46 96.93 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.414 -0.812 . . . . 1.7 111.102 -174.149 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 134.49 -22.16 3.74 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.855 -0.688 . . . . 1.69 111.8 177.942 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 27.8 p-10 -106.95 41.65 1.43 Allowed 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.807 0.337 . . . . 2.96 110.582 -179.214 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 66.2 t30 56.33 36.06 26.88 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 121.684 0.754 . . . . 2.5 110.428 -177.024 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' SER . . . . . 0.505 ' HB3' ' O ' ' A' ' 24' ' ' THR . 68.5 m -141.55 177.88 7.84 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 107.857 -1.164 . . . . 1.3 107.857 176.104 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' TRP . . . . . 0.463 ' CH2' HD21 ' A' ' 50' ' ' LEU . 54.5 m0 -136.27 167.14 21.86 Favored 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 120.521 -0.472 . . . . 0.47 111.12 -167.154 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 3.8 t -145.46 142.42 29.26 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.402 -0.817 . . . . 0.83 109.722 174.831 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.538 HD11 HD13 ' A' ' 59' ' ' LEU . 0.7 OUTLIER -92.85 104.01 16.3 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.36 -0.607 . . . . 1.71 109.36 179.773 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.583 ' HG3' ' HG3' ' A' ' 62' ' ' LYS . 4.5 mm-40 -88.28 120.63 70.55 Favored Pre-proline 0 C--N 1.319 -0.727 0 CA-C-N 115.009 -0.996 . . . . 2.13 110.968 -178.389 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.473 ' HD3' ' HA ' ' A' ' 72' ' ' GLU . 4.9 Cg_endo -86.97 115.03 1.15 Allowed 'Trans proline' 0 N--CA 1.453 -0.873 0 C-N-CA 123.005 2.47 . . . . 1.36 111.685 177.463 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.327 -0.382 0 CA-C-N 115.792 -0.64 . . . . 1.89 109.736 -179.928 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.195 0 CA-C-O 121.32 0.581 . . . . 3.81 110.862 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 11.7 pt20 -146.38 135.68 22.82 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.597 -0.728 . . . . 4.0 109.438 175.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.434 HG12 HG13 ' A' ' 5' ' ' ILE . 48.0 t -139.88 141.18 34.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.528 -0.305 . . . . 1.64 110.919 -174.879 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -129.35 110.49 11.97 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.313 0.578 . . . . 2.29 109.67 177.415 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.434 HG13 HG12 ' A' ' 3' ' ' VAL . 58.2 mt -137.33 156.79 33.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 N-CA-C 109.413 -0.588 . . . . 0.82 109.413 -178.129 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.616 ' HB1' ' HD2' ' A' ' 7' ' ' PRO . . . -161.69 163.45 19.54 Favored Pre-proline 0 C--N 1.324 -0.507 0 N-CA-C 109.796 -0.446 . . . . 1.38 109.796 -174.578 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.616 ' HD2' ' HB1' ' A' ' 6' ' ' ALA . 6.1 Cg_exo -38.4 135.63 0.68 Allowed 'Trans proline' 0 C--N 1.352 0.735 0 C-N-CA 124.317 3.345 . . . . 1.73 114.151 -176.623 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.442 ' O ' ' HB2' ' A' ' 9' ' ' SER . . . -178.05 -75.71 0.06 OUTLIER Glycine 0 N--CA 1.443 -0.859 0 N-CA-C 110.31 -1.116 . . . . 1.84 110.31 -179.637 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.442 ' HB2' ' O ' ' A' ' 8' ' ' GLY . 8.5 t 174.04 148.25 0.07 Allowed 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 107.277 -1.379 . . . . 1.61 107.277 175.389 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.52 HD23 HG22 ' A' ' 32' ' ' THR . 56.1 tp -56.09 -42.59 76.98 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 119.348 0.976 . . . . 1.19 111.304 -173.953 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -50.75 -55.52 16.33 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 115.795 -0.638 . . . . 2.11 112.006 177.873 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 55.7 mtmt -65.13 -27.51 68.78 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 111.719 0.266 . . . . 2.72 111.719 179.69 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -65.23 -54.88 22.78 Favored 'General case' 0 C--O 1.233 0.237 0 CA-C-O 120.952 0.406 . . . . 0.46 110.114 179.602 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 94.9 mt -59.36 -38.34 80.16 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 115.836 -0.62 . . . . 0.69 111.129 176.614 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 50.8 t-20 -60.0 -47.05 87.41 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.659 -0.497 . . . . 1.31 109.659 178.641 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 24.9 tm0? -61.74 -42.32 98.81 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.799 -0.637 . . . . 2.23 111.108 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.469 ' HD1' ' HZ ' ' A' ' 23' ' ' PHE . 1.9 t80 -66.67 -39.55 88.22 Favored 'General case' 0 CA--C 1.53 0.187 0 N-CA-C 109.747 -0.464 . . . . 0.65 109.747 -177.837 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.754 ' HA ' ' CE2' ' A' ' 23' ' ' PHE . . . -52.71 -42.82 65.19 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.186 -0.461 . . . . 0.37 111.872 177.772 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.37 -22.88 67.15 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.221 -0.445 . . . . 0.64 111.851 -179.344 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' HIS . . . . . 0.447 ' HB3' ' O ' ' A' ' 17' ' ' TYR . 77.2 t60 -64.82 -62.9 1.28 Allowed 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.18 0.437 . . . . 1.85 112.18 -178.534 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.657 ' HB2' ' CD1' ' A' ' 23' ' ' PHE . 9.6 m -100.46 -4.65 28.43 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 112.543 0.572 . . . . 1.67 112.543 -172.676 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 67.27 47.49 63.65 Favored Glycine 0 CA--C 1.52 0.379 0 C-N-CA 121.099 -0.572 . . . . 0.62 113.419 177.642 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.754 ' CE2' ' HA ' ' A' ' 18' ' ' ALA . 3.7 p90 -104.61 171.4 7.35 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 110.152 -0.314 . . . . 0.57 110.152 178.285 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 24.0 m -97.06 122.69 40.34 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.255 0.55 . . . . 0.68 111.959 -175.237 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.632 HD21 ' CE3' ' A' ' 69' ' ' TRP . 1.5 mm? -96.27 143.35 27.43 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.56 -0.746 . . . . 1.67 111.07 178.148 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 8.0 t -123.03 91.37 3.47 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 108.943 -0.762 . . . . 1.15 108.943 172.43 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 6.0 p -148.76 138.26 15.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.929 -0.578 . . . . 0.9 110.581 -175.054 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -102.27 131.87 48.58 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.293 -0.412 . . . . 2.38 110.153 178.54 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.1 70.34 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.34 0 O-C-N 123.583 0.552 . . . . 1.97 112.215 178.338 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 50.0 p -163.98 -49.08 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.146 -0.479 . . . . 2.22 109.939 -177.842 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.44 ' O ' HD11 ' A' ' 59' ' ' LEU . 98.0 mt -63.63 -39.07 93.43 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.213 -0.449 . . . . 1.38 110.227 176.295 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.52 HG22 HD23 ' A' ' 10' ' ' LEU . 2.3 p -91.65 3.07 55.93 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.662 -0.699 . . . . 1.44 111.446 179.6 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.4 HH11 ' HD2' ' A' ' 33' ' ' ARG . 6.0 tpp180 -75.42 106.41 6.95 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.064 -0.516 . . . . 4.63 111.216 -174.189 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 119.27 -45.89 1.2 Allowed Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.346 -0.931 . . . . 1.62 113.808 172.33 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.857 ' HD2' ' H ' ' A' ' 35' ' ' LYS . 0.0 OUTLIER -67.94 137.08 54.9 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.545 0.688 . . . . 2.75 111.741 -174.355 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 5.3 tp-100 -102.73 152.84 20.76 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 114.921 -1.036 . . . . 2.24 110.073 -175.269 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 22.9 t -133.99 123.28 24.33 Favored 'General case' 0 N--CA 1.444 -0.743 0 N-CA-C 107.174 -1.417 . . . . 1.02 107.174 175.29 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 76.6 m-20 -67.79 3.28 1.52 Allowed 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 112.907 0.706 . . . . 1.28 112.907 -173.591 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 107.35 -176.52 21.02 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.612 -0.804 . . . . 0.42 112.958 170.395 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.414 HD13 ' HB3' ' A' ' 52' ' ' GLN . 39.6 tp -160.3 122.89 3.33 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 108.778 -0.823 . . . . 0.7 108.778 -176.366 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 10.7 t-80 -144.48 98.59 3.22 Favored 'General case' 0 C--N 1.321 -0.664 0 C-N-CA 120.296 -0.561 . . . . 2.96 110.964 -179.202 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -168.91 -169.5 32.37 Favored Glycine 0 N--CA 1.446 -0.636 0 CA-C-N 115.264 -0.88 . . . . 0.55 111.627 177.04 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -81.99 76.75 8.87 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.242 -0.651 . . . . 2.18 109.242 175.305 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 78.8 m-85 -107.82 138.38 44.15 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.25 0.548 . . . . 1.41 111.707 -175.626 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -101.93 -170.35 1.81 Allowed 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 108.904 -0.776 . . . . 2.23 108.904 173.208 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 56.0 t -51.97 -71.31 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 112.739 0.644 . . . . 0.57 112.739 -173.321 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -64.4 -40.82 96.54 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 112.548 0.573 . . . . 2.39 112.548 -172.237 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 56.7 m -71.02 -25.9 62.88 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-O 120.919 0.39 . . . . 1.26 110.877 -174.518 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.483 ' O ' ' HG ' ' A' ' 53' ' ' LEU . . . -72.4 -37.71 58.61 Favored Glycine 0 N--CA 1.447 -0.621 0 C-N-CA 120.761 -0.733 . . . . 0.37 111.466 178.959 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.549 HD22 HG11 ' A' ' 61' ' ' VAL . 84.8 mt -67.53 -43.1 81.6 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.024 0.44 . . . . 1.09 110.86 -178.808 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 36.2 tt0 -56.99 -42.19 79.78 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.625 -0.716 . . . . 2.59 110.839 -179.39 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.414 ' HB3' HD13 ' A' ' 40' ' ' LEU . 25.6 mm-40 -70.0 -37.71 75.75 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 111.895 0.331 . . . . 1.75 111.895 176.205 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.483 ' HG ' ' O ' ' A' ' 49' ' ' GLY . 58.9 mt -58.47 -17.74 23.33 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 112.197 0.443 . . . . 0.73 112.197 178.852 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 79.6 mt -69.8 -12.31 61.53 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.443 -0.344 . . . . 2.16 111.007 177.517 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -67.4 109.55 3.22 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 121.041 0.448 . . . . 2.24 110.038 178.813 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 105.66 -6.65 41.51 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.925 -0.655 . . . . 1.7 112.109 -179.221 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 49.1 m -121.75 169.35 10.82 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.833 0.349 . . . . 2.28 110.845 -179.145 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.638 ' O ' ' HA ' ' A' ' 75' ' ' PRO . . . -121.21 15.62 9.34 Favored Glycine 0 N--CA 1.444 -0.813 0 N-CA-C 110.58 -1.008 . . . . 1.58 110.58 172.317 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.527 HD13 HD21 ' A' ' 71' ' ' LEU . 90.8 mt -92.56 -179.4 5.17 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.697 -0.482 . . . . 1.42 109.697 -178.987 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' GLN . . . . . 0.411 ' OE1' ' HB3' ' A' ' 74' ' ' ALA . 49.7 mt-30 -139.72 117.85 11.9 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 108.772 -0.825 . . . . 2.67 108.772 177.837 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.549 HG11 HD22 ' A' ' 50' ' ' LEU . 18.4 t -86.99 113.6 24.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 N-CA-C 109.095 -0.706 . . . . 1.54 109.095 177.084 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -115.95 116.86 40.08 Favored Pre-proline 0 C--N 1.32 -0.702 0 CA-C-N 116.333 -0.394 . . . . 1.81 110.027 -171.112 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.452 ' HA ' ' HA ' ' A' ' 69' ' ' TRP . 58.8 Cg_exo -52.7 121.8 9.82 Favored 'Trans proline' 0 N--CA 1.463 -0.284 0 C-N-CA 122.646 2.231 . . . . 0.85 111.551 176.508 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.576 ' H ' ' HA ' ' A' ' 69' ' ' TRP . 3.3 tm? -68.53 -53.8 20.79 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.673 -0.694 . . . . 1.7 109.523 -177.696 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 176.78 149.33 7.62 Favored Glycine 0 N--CA 1.441 -0.986 0 N-CA-C 110.484 -1.046 . . . . 1.69 110.484 178.16 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 91.2 m-20 65.47 -82.07 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 122.606 0.362 . . . . 2.96 111.239 -179.612 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -147.16 13.18 1.1 Allowed 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.404 -0.591 . . . . 2.5 109.404 -178.713 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 42.9 m -103.56 174.32 5.92 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 108.691 -0.855 . . . . 1.3 108.691 -174.918 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' TRP . . . . . 0.632 ' CE3' HD21 ' A' ' 25' ' ' LEU . 34.1 m0 -139.64 161.92 36.36 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 118.136 0.426 . . . . 0.47 109.874 -173.671 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 13.9 t -142.72 149.3 38.6 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 108.071 -1.085 . . . . 0.83 108.071 169.846 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.527 HD21 HD13 ' A' ' 59' ' ' LEU . 37.9 tp -92.45 105.52 17.69 Favored 'General case' 0 C--N 1.32 -0.694 0 C-N-CA 120.048 -0.661 . . . . 1.71 110.186 -178.377 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -87.2 118.79 70.45 Favored Pre-proline 0 C--N 1.317 -0.808 0 CA-C-N 114.699 -1.137 . . . . 2.13 110.024 -179.791 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -83.17 115.01 2.26 Favored 'Trans proline' 0 N--CA 1.45 -1.087 0 C-N-CA 122.341 2.027 . . . . 1.36 112.409 -178.552 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.753 ' HA ' ' HG3' ' A' ' 77' ' ' PRO . . . -162.58 62.0 1.22 Allowed Pre-proline 0 C--N 1.32 -0.704 0 CA-C-N 115.474 -0.784 . . . . 1.89 110.137 174.316 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.638 ' HA ' ' O ' ' A' ' 58' ' ' GLY . 5.0 Cg_exo -72.4 -75.72 0.01 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.532 0 C-N-CA 122.503 2.135 . . . . 2.73 111.347 -178.959 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.439 ' N ' ' HD3' ' A' ' 77' ' ' PRO . . . -143.41 56.34 4.51 Favored Pre-proline 0 C--N 1.32 -0.713 0 N-CA-C 108.265 -1.013 . . . . 4.21 108.265 168.1 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.753 ' HG3' ' HA ' ' A' ' 74' ' ' ALA . 60.4 Cg_endo -86.02 -7.86 8.05 Favored 'Trans proline' 0 N--CA 1.454 -0.824 0 C-N-CA 122.799 2.332 . . . . 4.26 111.088 -170.21 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.694 ' HD2' ' HB3' ' A' ' 80' ' ' ASP . 48.4 pttt 177.16 132.7 0.06 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 113.871 -1.513 . . . . 6.21 108.24 171.121 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -89.02 47.77 1.54 Allowed 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 122.136 0.97 . . . . 8.11 109.479 176.185 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.694 ' HB3' ' HD2' ' A' ' 78' ' ' LYS . 17.9 t70 . . . . . 0 C--O 1.25 1.083 0 CA-C-N 114.338 -1.301 . . . . 9.05 109.58 -177.959 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.018 0 N-CA-C 110.177 -0.305 . . . . 3.81 110.177 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.97 96.96 1.78 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.697 0.76 . . . . 4.0 110.674 178.085 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 27.7 m -94.83 129.76 44.57 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-N 115.497 -0.774 . . . . 1.64 109.828 -177.474 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 40.1 m-80 -128.16 96.71 4.54 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.413 0.625 . . . . 2.29 109.329 -178.114 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.695 HD13 ' HB3' ' A' ' 40' ' ' LEU . 3.6 mp -105.0 112.39 38.43 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-N 115.279 -0.873 . . . . 0.82 109.563 -178.069 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -85.49 155.94 59.4 Favored Pre-proline 0 C--N 1.32 -0.705 0 CA-C-N 115.855 -0.611 . . . . 1.38 109.491 178.302 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.623 ' HA ' ' O ' ' A' ' 37' ' ' SER . 31.6 Cg_exo -58.88 136.07 71.08 Favored 'Trans proline' 0 C--O 1.234 0.323 0 C-N-CA 121.663 1.575 . . . . 1.73 109.858 169.779 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 149.2 49.9 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.011 -1.09 . . . . 1.84 111.893 -170.475 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.646 ' HA ' ' HA ' ' A' ' 36' ' ' GLN . 25.9 t 66.36 145.85 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 123.282 0.633 . . . . 1.61 112.1 -177.697 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.884 HD22 ' HB3' ' A' ' 37' ' ' SER . 3.0 mm? -57.52 -28.9 63.89 Favored 'General case' 0 N--CA 1.461 0.086 0 CA-C-N 115.784 -0.643 . . . . 1.19 109.987 172.547 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.644 ' HB2' ' HB ' ' A' ' 32' ' ' THR . 18.7 t70 -44.11 -62.48 1.13 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 114.549 -1.205 . . . . 2.11 111.796 178.563 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.45 ' HA ' ' HB3' ' A' ' 15' ' ' ASN . 36.5 ttpt -69.38 -19.93 63.83 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.423 -0.353 . . . . 2.72 111.535 -177.743 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -65.7 -56.45 12.0 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-O 121.134 0.493 . . . . 0.46 109.677 178.529 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 74.5 mt -57.86 -38.31 75.46 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.513 -0.767 . . . . 0.69 110.943 174.437 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.45 ' HB3' ' HA ' ' A' ' 12' ' ' LYS . 21.4 t-20 -58.83 -42.02 88.25 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.124 -0.489 . . . . 1.31 110.655 177.106 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 24.1 tm0? -60.63 -43.08 97.95 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.953 -0.567 . . . . 2.23 110.548 178.191 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.436 ' HD1' ' HZ ' ' A' ' 23' ' ' PHE . 0.3 OUTLIER -67.42 -51.14 55.31 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.767 0.317 . . . . 0.65 110.63 -179.094 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.741 ' HA ' ' CE2' ' A' ' 23' ' ' PHE . . . -52.26 -53.4 44.29 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 115.799 -0.637 . . . . 0.37 112.352 -177.598 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.77 -21.07 66.24 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.255 -0.429 . . . . 0.64 111.958 -177.245 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 61.0 t-80 -65.26 -53.62 41.56 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 111.622 0.23 . . . . 1.85 111.622 -177.689 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.571 ' HB3' ' CD1' ' A' ' 23' ' ' PHE . 48.1 t -99.81 -7.63 25.18 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.064 0.459 . . . . 1.67 110.997 -178.109 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 76.3 44.27 17.96 Favored Glycine 0 N--CA 1.446 -0.687 0 CA-C-N 115.715 -0.675 . . . . 0.62 112.864 178.947 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.741 ' CE2' ' HA ' ' A' ' 18' ' ' ALA . 14.1 p90 -108.57 149.72 28.47 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.532 -0.544 . . . . 0.57 109.532 176.903 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 28.1 m -90.31 123.61 34.21 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.083 -0.508 . . . . 0.68 111.219 -174.392 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.597 HD11 ' HE3' ' A' ' 69' ' ' TRP . 0.9 OUTLIER -92.86 140.5 29.44 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.655 -0.702 . . . . 1.67 111.458 -179.914 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.533 ' HB3' ' HA ' ' A' ' 70' ' ' THR . 29.6 t -100.66 92.18 4.99 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.041 -0.725 . . . . 1.15 109.041 174.043 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.825 ' HB ' HD23 ' A' ' 71' ' ' LEU . 7.4 p -146.5 134.27 15.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.816 -0.629 . . . . 0.9 110.429 -178.729 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 -89.43 128.82 35.99 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.058 -0.519 . . . . 2.38 110.216 178.636 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.79 60.87 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.425 0 O-C-N 123.722 0.639 . . . . 1.97 111.667 173.36 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.757 ' HA ' ' HG3' ' A' ' 33' ' ' ARG . 68.7 m -165.28 -27.79 0.03 OUTLIER 'General case' 0 C--N 1.321 -0.642 0 C-N-CA 123.429 0.692 . . . . 2.22 109.406 -176.956 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 97.1 mt -73.29 -23.13 60.25 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.414 0.626 . . . . 1.38 109.585 173.513 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.644 ' HB ' ' HB2' ' A' ' 11' ' ' ASP . 17.5 p -98.45 13.0 33.27 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.167 -0.924 . . . . 1.44 111.212 179.527 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.757 ' HG3' ' HA ' ' A' ' 30' ' ' SER . 29.4 mtt180 -67.16 126.17 28.35 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.114 -0.494 . . . . 4.63 111.245 -179.429 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 67.58 17.27 68.68 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 121.038 -0.601 . . . . 1.62 112.275 178.819 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 5.8 mptp? -88.44 148.96 23.94 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.05 0.452 . . . . 2.75 110.572 178.606 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' GLN . . . . . 0.646 ' HA ' ' HA ' ' A' ' 9' ' ' SER . 15.0 pt20 -144.02 137.87 27.97 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.51 -0.768 . . . . 2.24 109.787 171.24 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.884 ' HB3' HD22 ' A' ' 10' ' ' LEU . 50.7 p -119.99 124.59 46.31 Favored 'General case' 0 N--CA 1.443 -0.784 0 N-CA-C 108.226 -1.027 . . . . 1.02 108.226 -177.066 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -57.26 -32.45 66.6 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 112.274 0.472 . . . . 1.28 112.274 -175.545 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 134.17 178.24 15.49 Favored Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 120.312 -0.947 . . . . 0.42 112.481 175.316 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.695 ' HB3' HD13 ' A' ' 5' ' ' ILE . 55.1 tp -160.14 126.12 4.15 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 107.603 -1.258 . . . . 0.7 107.603 -179.678 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 72.1 m80 -142.43 99.61 3.53 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.992 0.425 . . . . 2.96 111.439 -174.878 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -169.14 -170.13 33.35 Favored Glycine 0 N--CA 1.449 -0.459 0 N-CA-C 111.346 -0.702 . . . . 0.55 111.346 175.488 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -101.35 76.61 1.71 Allowed 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 108.353 -0.98 . . . . 2.18 108.353 171.543 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 26.6 m-85 -91.18 150.42 21.37 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.043 -0.98 . . . . 1.41 111.421 -173.735 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 50.4 m-20 -110.24 176.03 5.21 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 107.941 -1.133 . . . . 2.23 107.941 169.218 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.413 HG23 ' H ' ' A' ' 46' ' ' VAL . 16.5 t -49.11 -62.49 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 N-CA-C 112.211 0.448 . . . . 0.57 112.211 -169.331 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 25.9 mm-40 -44.31 -60.44 1.92 Allowed 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 113.182 0.808 . . . . 2.39 113.182 179.667 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 10.2 m -69.04 -28.02 66.18 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.087 0.47 . . . . 1.26 110.904 -173.035 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.489 ' O ' ' HG ' ' A' ' 53' ' ' LEU . . . -74.4 -39.36 42.98 Favored Glycine 0 N--CA 1.444 -0.818 0 C-N-CA 120.765 -0.731 . . . . 0.37 111.853 -176.303 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.557 ' O ' ' HG ' ' A' ' 54' ' ' LEU . 84.0 mt -72.12 -41.38 67.29 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.563 0.221 . . . . 1.09 110.505 -178.187 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 -52.89 -51.16 62.17 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 116.254 -0.43 . . . . 2.59 111.7 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 25.8 mm-40 -64.42 -39.92 94.78 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.998 -0.281 . . . . 1.75 111.205 -179.13 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.489 ' HG ' ' O ' ' A' ' 49' ' ' GLY . 92.7 mt -59.32 -25.23 63.98 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.199 -0.455 . . . . 0.73 112.123 177.626 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.557 ' HG ' ' O ' ' A' ' 50' ' ' LEU . 96.7 mt -76.3 -14.06 60.12 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 111.922 0.341 . . . . 2.16 111.922 -176.394 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -82.88 103.9 12.7 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.989 0.423 . . . . 2.24 111.116 -177.263 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 78.9 20.71 69.94 Favored Glycine 0 N--CA 1.45 -0.379 0 CA-C-N 115.698 -0.683 . . . . 1.7 113.485 174.877 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.455 ' HB2' ' HG ' ' A' ' 10' ' ' LEU . 16.3 p -88.8 -32.49 17.83 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.934 0.397 . . . . 2.28 110.981 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.662 ' HA2' ' HA ' ' A' ' 75' ' ' PRO . . . 87.86 9.01 71.94 Favored Glycine 0 N--CA 1.444 -0.815 0 N-CA-C 111.3 -0.72 . . . . 1.58 111.3 -176.687 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.585 ' HB3' HD12 ' A' ' 71' ' ' LEU . 85.7 mt -129.71 171.55 12.54 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 120.854 0.359 . . . . 1.42 110.611 -176.275 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' GLN . . . . . 0.558 ' HB2' ' HB3' ' A' ' 74' ' ' ALA . 48.5 tt0 -136.16 118.84 16.04 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.177 -0.675 . . . . 2.67 109.177 176.192 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.468 ' H ' HD21 ' A' ' 54' ' ' LEU . 52.6 t -87.26 118.46 33.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-O 120.905 0.383 . . . . 1.54 110.69 -178.288 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.427 ' HE3' ' HB3' ' A' ' 62' ' ' LYS . 22.4 mmmt -125.69 117.92 24.45 Favored Pre-proline 0 C--N 1.325 -0.47 0 CA-C-N 115.944 -0.571 . . . . 1.81 110.172 177.663 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.511 ' HA ' ' HA ' ' A' ' 69' ' ' TRP . 41.7 Cg_exo -57.94 121.0 9.27 Favored 'Trans proline' 0 C--O 1.233 0.234 0 C-N-CA 122.351 2.034 . . . . 0.85 110.762 174.763 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -75.61 -57.98 3.56 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.784 -0.643 . . . . 1.7 110.831 -171.873 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -127.04 -98.68 1.04 Allowed Glycine 0 N--CA 1.445 -0.73 0 C-N-CA 120.195 -1.002 . . . . 1.69 112.395 -178.228 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 60.1 t30 -91.87 -74.07 0.52 Allowed 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.741 0.305 . . . . 2.96 110.929 -177.633 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 27.2 p-10 -122.19 34.87 5.03 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.186 0.517 . . . . 2.5 110.877 -178.143 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 47.0 t -126.66 169.21 13.37 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 108.713 -0.847 . . . . 1.3 108.713 179.315 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' TRP . . . . . 0.597 ' HE3' HD11 ' A' ' 25' ' ' LEU . 6.8 m0 -142.31 162.32 35.76 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 107.824 -1.176 . . . . 0.47 107.824 -173.529 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.533 ' HA ' ' HB3' ' A' ' 26' ' ' SER . 12.4 t -140.32 146.52 38.6 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 109.517 -0.549 . . . . 0.83 109.517 174.19 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.825 HD23 ' HB ' ' A' ' 27' ' ' VAL . 4.2 mm? -93.63 102.93 15.12 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.613 0.72 . . . . 1.71 110.751 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.434 ' HA ' ' HD3' ' A' ' 73' ' ' PRO . 24.9 mt-10 -86.65 126.28 64.4 Favored Pre-proline 0 C--N 1.319 -0.733 0 CA-C-N 114.744 -1.116 . . . . 2.13 109.54 173.658 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' ' 72' ' ' GLU . 38.9 Cg_exo -60.81 114.46 2.16 Favored 'Trans proline' 0 N--CA 1.462 -0.378 0 C-N-CA 122.746 2.297 . . . . 1.36 111.897 -176.494 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.558 ' HB3' ' HB2' ' A' ' 60' ' ' GLN . . . -159.3 82.87 2.43 Favored Pre-proline 0 C--N 1.32 -0.686 0 CA-C-N 115.007 -0.997 . . . . 1.89 108.86 178.239 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.662 ' HA ' ' HA2' ' A' ' 58' ' ' GLY . 72.0 Cg_endo -76.53 55.55 4.79 Favored 'Trans proline' 0 C--O 1.235 0.357 0 C-N-CA 122.811 2.341 . . . . 2.73 113.172 -172.021 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.449 ' N ' ' HD3' ' A' ' 77' ' ' PRO . . . 54.1 59.39 11.95 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 115.84 -0.618 . . . . 4.21 110.149 -175.568 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.449 ' HD3' ' N ' ' A' ' 76' ' ' ALA . 59.4 Cg_endo -87.53 -179.51 2.68 Favored 'Trans proline' 0 N--CA 1.447 -1.215 0 C-N-CA 122.62 2.213 . . . . 4.26 111.361 -175.32 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.42 ' HD2' ' HA ' ' A' ' 78' ' ' LYS . 17.4 tptm -162.55 70.79 0.29 Allowed 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.268 0.556 . . . . 6.21 110.22 -178.714 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -96.47 -5.08 40.37 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 108.617 -0.883 . . . . 8.11 108.617 175.874 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 39.0 t70 . . . . . 0 C--O 1.249 1.047 0 CA-C-N 114.918 -1.037 . . . . 9.05 110.134 179.218 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 0.858 0 N-CA-C 109.97 -0.381 . . . . 3.81 109.97 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 1.023 ' H ' ' HA ' ' A' ' 43' ' ' ASP . 9.7 tt0 -82.75 -12.64 57.38 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.814 0.816 . . . . 4.0 110.198 -178.132 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 31.8 m -140.8 147.66 22.58 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 114.766 -1.106 . . . . 1.64 109.867 178.411 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 84.2 m-20 -129.2 102.56 6.51 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.465 -0.569 . . . . 2.29 109.465 179.768 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.433 HD12 ' HB3' ' A' ' 40' ' ' LEU . 56.6 mt -129.96 152.33 37.22 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 116.172 -0.467 . . . . 0.82 109.851 -174.774 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.506 ' HB1' ' HD2' ' A' ' 7' ' ' PRO . . . -163.95 167.46 10.83 Favored Pre-proline 0 C--N 1.327 -0.39 0 N-CA-C 110.112 -0.329 . . . . 1.38 110.112 -174.551 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.526 ' HA ' ' O ' ' A' ' 37' ' ' SER . 71.2 Cg_exo -49.31 136.86 31.48 Favored 'Trans proline' 0 C--N 1.351 0.673 0 C-N-CA 122.835 2.357 . . . . 1.73 113.43 -176.582 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 143.86 64.56 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.742 -0.742 . . . . 1.84 112.681 177.146 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 50.0 m 66.36 116.14 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 121.372 0.606 . . . . 1.61 112.017 179.159 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.402 HD21 HD23 ' A' ' 54' ' ' LEU . 60.0 tp -59.47 -42.04 91.14 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 115.996 -0.547 . . . . 1.19 112.425 -178.543 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.628 ' HB3' ' HA ' ' A' ' 33' ' ' ARG . 8.4 p-10 -54.66 -37.86 66.23 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.75 -0.205 . . . . 2.11 111.286 178.472 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -66.05 -31.16 71.88 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.949 0.404 . . . . 2.72 110.7 178.308 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -67.11 -54.02 25.32 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.133 -0.485 . . . . 0.46 110.337 -179.048 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.401 HD11 HD21 ' A' ' 54' ' ' LEU . 84.6 mt -59.26 -38.88 81.19 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 115.76 -0.654 . . . . 0.69 110.838 175.999 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -59.75 -38.74 82.59 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.78 -0.645 . . . . 1.31 110.353 178.273 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 20.6 tm0? -62.81 -41.62 99.37 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.62 -0.718 . . . . 2.23 110.786 177.61 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.618 ' CD1' ' HH2' ' A' ' 69' ' ' TRP . 7.0 t80 -68.47 -41.39 80.22 Favored 'General case' 0 C--N 1.333 -0.112 0 N-CA-C 109.807 -0.442 . . . . 0.65 109.807 -178.029 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.663 ' HA ' ' CE2' ' A' ' 23' ' ' PHE . . . -53.75 -46.87 71.03 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.05 -0.523 . . . . 0.37 111.691 177.06 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.68 -16.54 57.66 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.043 -0.526 . . . . 0.64 112.15 -178.027 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 76.3 t60 -61.36 -47.55 85.33 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.669 -0.241 . . . . 1.85 111.462 -179.288 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.463 ' HB3' ' CD1' ' A' ' 23' ' ' PHE . 32.5 t -118.77 -15.89 9.39 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 120.712 -0.395 . . . . 1.67 112.008 -178.676 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 74.9 61.01 3.19 Favored Glycine 0 C--N 1.331 0.259 0 C-N-CA 120.867 -0.682 . . . . 0.62 112.732 -179.485 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.663 ' CE2' ' HA ' ' A' ' 18' ' ' ALA . 3.1 p90 -112.8 169.21 9.07 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.999 0.428 . . . . 0.57 111.021 -179.103 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 14.8 m -89.66 101.38 14.07 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.457 0.646 . . . . 0.68 111.276 -176.354 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.592 HD22 ' HB ' ' A' ' 27' ' ' VAL . 2.8 tt -93.58 126.78 38.92 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.551 -0.75 . . . . 1.67 109.325 177.116 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.558 ' HB2' ' HA ' ' A' ' 70' ' ' THR . 8.5 m -98.99 91.15 4.89 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.162 -0.681 . . . . 1.15 109.162 179.843 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.746 HG23 HD22 ' A' ' 71' ' ' LEU . 7.3 p -117.62 135.78 56.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 115.911 -0.586 . . . . 0.9 111.533 -174.458 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 50.7 m-20 -78.19 112.81 15.54 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-N 115.882 -0.599 . . . . 2.38 109.74 174.675 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -64.68 66.74 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.977 -0.556 . . . . 1.97 112.02 177.524 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 20.4 p -170.28 -44.09 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.255 -0.429 . . . . 2.22 110.175 -179.074 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 91.0 mt -68.27 -52.58 32.29 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.951 -0.568 . . . . 1.38 111.351 -179.286 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 13.0 p -101.82 -19.2 15.41 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 112.615 0.598 . . . . 1.44 112.615 -176.265 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.628 ' HA ' ' HB3' ' A' ' 11' ' ' ASP . 16.1 tpp180 -59.9 119.16 7.2 Favored 'General case' 0 C--O 1.233 0.233 0 N-CA-C 110.115 -0.328 . . . . 4.63 110.115 -178.463 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 93.66 -115.85 5.06 Favored Glycine 0 N--CA 1.439 -1.165 0 N-CA-C 111.056 -0.818 . . . . 1.62 111.056 -177.041 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 9.3 mmmm 46.9 -165.84 0.02 OUTLIER 'General case' 0 N--CA 1.443 -0.775 0 CA-C-O 122.205 1.002 . . . . 2.75 111.654 -176.209 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 8.0 pt20 -150.16 132.71 15.75 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 114.887 -1.051 . . . . 2.24 108.673 165.029 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.526 ' O ' ' HA ' ' A' ' 7' ' ' PRO . 33.9 t -118.45 139.22 51.75 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 108.059 -1.089 . . . . 1.02 108.059 175.436 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 36.0 m-20 -67.61 -14.46 62.96 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.091 -0.504 . . . . 1.28 111.065 -176.853 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.409 ' HA2' HG22 ' A' ' 5' ' ' ILE . . . 111.58 -169.53 13.25 Favored Glycine 0 N--CA 1.443 -0.882 0 C-N-CA 120.73 -0.747 . . . . 0.42 112.331 173.527 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.433 ' HB3' HD12 ' A' ' 5' ' ' ILE . 42.1 tp -160.16 125.64 4.02 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 108.349 -0.982 . . . . 0.7 108.349 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 39.4 t-80 -136.66 96.54 3.35 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 120.215 -0.594 . . . . 2.96 110.966 -178.544 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -168.79 -179.96 41.26 Favored Glycine 0 N--CA 1.448 -0.533 0 CA-C-N 115.398 -0.819 . . . . 0.55 111.239 175.157 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 1.023 ' HA ' ' H ' ' A' ' 2' ' ' GLN . 21.9 m-20 -84.97 74.63 10.49 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 108.656 -0.868 . . . . 2.18 108.656 173.977 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 22.5 m-85 -96.21 143.94 26.86 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.198 -0.91 . . . . 1.41 111.061 -174.086 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -94.1 -172.39 2.81 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.543 -0.753 . . . . 2.23 110.057 179.386 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.434 HG13 ' HZ2' ' A' ' 69' ' ' TRP . 59.8 t -52.34 -71.57 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.042 -0.526 . . . . 0.57 112.19 -178.095 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 21.1 mt-10 -63.88 -41.49 97.73 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.863 -0.608 . . . . 2.39 112.061 -172.78 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 4.2 p -72.11 -32.04 66.6 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.098 -0.501 . . . . 1.26 111.306 -172.251 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -75.2 -39.24 37.42 Favored Glycine 0 N--CA 1.447 -0.617 0 N-CA-C 111.114 -0.794 . . . . 0.37 111.114 -176.39 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.521 ' CB ' HG11 ' A' ' 61' ' ' VAL . 62.9 mt -72.66 -41.5 65.36 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.773 0.321 . . . . 1.09 110.58 -178.568 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 21.2 tt0 -54.8 -49.12 71.75 Favored 'General case' 0 C--O 1.222 -0.345 0 CA-C-N 115.808 -0.633 . . . . 2.59 111.009 -176.929 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 85.8 mm-40 -65.09 -40.19 94.26 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.455 -0.339 . . . . 1.75 111.485 -178.622 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 90.0 mt -57.77 -34.95 70.13 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 112.1 0.407 . . . . 0.73 112.1 178.636 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.402 HD23 HD21 ' A' ' 10' ' ' LEU . 81.8 mt -102.42 -12.6 17.74 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.929 0.395 . . . . 2.16 111.645 -174.432 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -64.68 130.2 42.68 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.05 -0.523 . . . . 2.24 110.956 -177.833 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 100.41 -31.44 8.51 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.533 -0.842 . . . . 1.7 113.243 176.561 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 24.4 p -91.87 12.84 20.25 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 117.218 0.509 . . . . 2.28 111.343 -177.001 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.546 ' HA2' ' HA ' ' A' ' 75' ' ' PRO . . . 74.37 25.14 71.31 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.683 -0.77 . . . . 1.58 111.821 179.247 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 91.6 mt -123.42 156.01 36.32 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 109.939 -0.393 . . . . 1.42 109.939 -178.687 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' GLN . . . . . 0.532 ' HB2' ' HB3' ' A' ' 74' ' ' ALA . 38.2 mm-40 -152.59 172.78 16.08 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.409 -0.589 . . . . 2.67 109.409 176.496 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.521 HG11 ' CB ' ' A' ' 50' ' ' LEU . 10.8 p -139.89 148.96 22.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-O 120.821 0.343 . . . . 1.54 110.709 -178.616 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.546 ' HG3' HG23 ' A' ' 70' ' ' THR . 1.6 ptpp? -139.83 128.59 13.44 Favored Pre-proline 0 C--N 1.321 -0.671 0 N-CA-C 109.519 -0.548 . . . . 1.81 109.519 172.815 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -59.8 126.3 20.1 Favored 'Trans proline' 0 N--CA 1.462 -0.376 0 C-N-CA 122.309 2.006 . . . . 0.85 110.425 173.332 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.404 HD22 ' HA ' ' A' ' 64' ' ' LEU . 2.5 tm? -59.78 -44.35 93.96 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.527 -0.761 . . . . 1.7 109.903 -175.537 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 152.24 -65.13 0.36 Allowed Glycine 0 N--CA 1.445 -0.729 0 C-N-CA 120.701 -0.761 . . . . 1.69 111.722 176.028 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 12.8 t-20 -88.71 78.92 7.6 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.124 0.487 . . . . 2.96 110.043 -179.558 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 43.52 35.94 1.07 Allowed 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 124.482 1.113 . . . . 2.5 113.727 178.552 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 39.5 m -137.16 175.34 9.7 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 108.54 -0.911 . . . . 1.3 108.54 176.453 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' TRP . . . . . 0.618 ' HH2' ' CD1' ' A' ' 17' ' ' TYR . 54.9 m0 -137.52 167.1 22.33 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.952 0.406 . . . . 0.47 110.923 -169.877 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.558 ' HA ' ' HB2' ' A' ' 26' ' ' SER . 3.7 t -145.91 147.38 31.69 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.58 -0.737 . . . . 0.83 109.423 171.981 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.746 HD22 HG23 ' A' ' 27' ' ' VAL . 50.8 tp -91.62 105.71 17.94 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.144 0.497 . . . . 1.71 109.707 -178.03 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.482 ' HB2' ' HG2' ' A' ' 62' ' ' LYS . 12.7 tp10 -94.33 118.93 67.04 Favored Pre-proline 0 C--N 1.323 -0.577 0 CA-C-N 115.147 -0.933 . . . . 2.13 110.766 -176.642 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_exo -70.02 113.5 3.44 Favored 'Trans proline' 0 N--CA 1.456 -0.701 0 C-N-CA 121.647 1.564 . . . . 1.36 110.649 172.847 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.532 ' HB3' ' HB2' ' A' ' 60' ' ' GLN . . . -154.31 81.61 4.5 Favored Pre-proline 0 C--N 1.322 -0.623 0 CA-C-N 116.109 -0.496 . . . . 1.89 109.891 -177.668 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.546 ' HA ' ' HA2' ' A' ' 58' ' ' GLY . 6.3 Cg_exo -77.51 -70.64 0.02 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 122.699 2.266 . . . . 2.73 112.304 -176.417 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.413 ' N ' ' HD3' ' A' ' 77' ' ' PRO . . . -141.99 59.39 9.32 Favored Pre-proline 0 C--N 1.324 -0.518 0 N-CA-C 108.545 -0.909 . . . . 4.21 108.545 173.949 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.48 ' HG3' ' HA ' ' A' ' 74' ' ' ALA . 83.4 Cg_endo -96.62 145.6 0.97 Allowed 'Trans proline' 0 N--CA 1.444 -1.417 0 C-N-CA 123.179 2.586 . . . . 4.26 113.426 -167.149 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 68.2 mttm 69.05 116.98 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 115.244 -0.889 . . . . 6.21 112.447 176.284 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -130.12 -60.91 1.0 Allowed 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.497 -0.774 . . . . 8.11 109.298 174.201 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 34.4 t70 . . . . . 0 C--O 1.248 0.977 0 CA-C-O 118.558 -0.734 . . . . 9.05 110.023 179.219 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 0.989 0 N-CA-C 110.424 -0.213 . . . . 3.81 110.424 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.693 ' HA ' ' HA ' ' A' ' 43' ' ' ASP . 77.0 mt-30 65.93 149.03 0.04 OUTLIER 'General case' 0 C--O 1.231 0.125 0 CA-C-O 121.668 0.747 . . . . 4.0 112.005 -176.922 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 57.6 t -131.82 130.56 61.77 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 115.49 -0.777 . . . . 1.64 109.221 178.417 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 4.2 p-10 -131.52 121.61 24.76 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 108.882 -0.784 . . . . 2.29 108.882 -178.845 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.492 HG13 HD21 ' A' ' 53' ' ' LEU . 36.4 mm -116.95 129.11 74.04 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 CA-C-N 115.925 -0.579 . . . . 0.82 109.956 -178.256 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -73.56 156.52 88.62 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.069 -0.514 . . . . 1.38 109.86 177.6 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.585 ' HA ' ' O ' ' A' ' 37' ' ' SER . 7.6 Cg_exo -74.45 39.86 0.58 Allowed 'Trans proline' 0 CA--C 1.532 0.394 0 C-N-CA 123.132 2.555 . . . . 1.73 112.888 179.449 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -115.35 -162.71 13.65 Favored Glycine 0 N--CA 1.447 -0.615 0 C-N-CA 120.786 -0.721 . . . . 1.84 113.43 -176.792 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.541 ' HA ' ' HA ' ' A' ' 36' ' ' GLN . 15.7 m -55.77 132.21 48.72 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.222 0.534 . . . . 1.61 111.197 -176.933 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 59.9 tp -58.88 -28.66 66.35 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.165 -0.925 . . . . 1.19 111.055 -176.061 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -45.97 -48.05 16.55 Favored 'General case' 0 CA--C 1.52 -0.199 0 CA-C-O 121.059 0.457 . . . . 2.11 110.576 175.83 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 65.3 mttm -67.58 -24.13 65.48 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.772 -0.649 . . . . 2.72 111.811 -177.368 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -65.87 -64.03 0.95 Allowed 'General case' 0 C--O 1.233 0.233 0 N-CA-C 110.407 -0.22 . . . . 0.46 110.407 -179.804 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.811 ' H ' HD12 ' A' ' 14' ' ' LEU . 4.4 mp -58.56 -35.72 72.8 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 116.431 -0.35 . . . . 0.69 111.339 175.641 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -60.6 -46.69 89.32 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 121.07 0.462 . . . . 1.31 109.94 178.232 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 23.5 tm0? -63.91 -43.21 96.66 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.509 -0.769 . . . . 2.23 110.435 178.028 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.476 ' O ' ' HB3' ' A' ' 20' ' ' HIS . 10.1 t80 -68.03 -40.46 82.92 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-O 120.76 0.314 . . . . 0.65 110.182 -177.791 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.793 ' HA ' ' CE2' ' A' ' 23' ' ' PHE . . . -54.5 -44.2 72.47 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 116.329 -0.396 . . . . 0.37 111.532 176.14 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.24 -17.96 59.83 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.053 -0.522 . . . . 0.64 111.988 -178.787 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' HIS . . . . . 0.476 ' HB3' ' O ' ' A' ' 17' ' ' TYR . 83.4 t60 -59.75 -54.88 41.18 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.532 -0.304 . . . . 1.85 111.266 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.573 ' HB3' ' CD1' ' A' ' 23' ' ' PHE . 22.7 t -114.45 -12.35 12.35 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.482 -0.487 . . . . 1.67 111.639 -177.438 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 75.92 49.63 8.56 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 121.062 -0.589 . . . . 0.62 112.754 179.229 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.793 ' CE2' ' HA ' ' A' ' 18' ' ' ALA . 1.8 p90 -103.76 158.11 16.61 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 110.222 -0.288 . . . . 0.57 110.222 -179.541 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.568 ' O ' ' HB3' ' A' ' 68' ' ' SER . 32.6 m -93.13 101.31 13.61 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.238 0.542 . . . . 0.68 111.878 -175.928 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.433 ' HB2' ' HB2' ' A' ' 69' ' ' TRP . 0.0 OUTLIER -99.43 150.27 22.34 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.385 -0.37 . . . . 1.67 110.115 174.053 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.607 ' HB2' ' HA ' ' A' ' 70' ' ' THR . 43.3 m -106.54 104.07 13.67 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.376 -0.375 . . . . 1.15 110.502 -177.389 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 14.9 p -123.57 143.82 35.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 N-CA-C 110.195 -0.298 . . . . 0.9 110.195 178.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.419 ' OD2' ' HG ' ' A' ' 31' ' ' LEU . 21.6 t70 -97.32 108.71 21.5 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.433 -0.349 . . . . 2.38 110.537 177.575 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.21 60.04 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 115.492 -0.777 . . . . 1.97 112.382 178.218 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 74.8 m -166.38 -36.6 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 123.188 0.595 . . . . 2.22 109.526 179.869 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.419 ' HG ' ' OD2' ' A' ' 28' ' ' ASP . 89.0 mt -68.0 -28.5 67.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.383 0.611 . . . . 1.38 110.087 176.034 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 5.0 p -97.69 18.38 15.74 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.528 -0.76 . . . . 1.44 111.262 179.11 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 53.5 ttp180 -63.85 108.35 1.44 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.661 -0.245 . . . . 4.63 110.415 -179.202 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 81.45 8.56 86.92 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.834 -0.698 . . . . 1.62 112.268 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 41.8 tptt -86.65 108.14 18.5 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.622 -0.51 . . . . 2.75 109.622 -179.047 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' GLN . . . . . 0.541 ' HA ' ' HA ' ' A' ' 9' ' ' SER . 46.2 mt-30 -109.84 158.88 17.72 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 110.092 -0.336 . . . . 2.24 110.092 -178.802 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.585 ' O ' ' HA ' ' A' ' 7' ' ' PRO . 7.2 t -128.63 127.55 42.45 Favored 'General case' 0 N--CA 1.445 -0.711 0 N-CA-C 107.863 -1.162 . . . . 1.02 107.863 175.158 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 52.7 m-20 -64.25 -8.8 13.9 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 112.37 0.507 . . . . 1.28 112.37 -172.716 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 129.31 175.37 14.02 Favored Glycine 0 N--CA 1.444 -0.806 0 C-N-CA 120.152 -1.023 . . . . 0.42 112.876 169.743 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 54.1 tp -160.06 124.93 3.9 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 107.624 -1.25 . . . . 0.7 107.624 -179.376 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 52.9 m80 -136.42 97.95 3.71 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 120.26 -0.576 . . . . 2.96 111.438 -177.519 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -170.57 168.3 41.37 Favored Glycine 0 N--CA 1.447 -0.609 0 CA-C-N 115.199 -0.909 . . . . 0.55 110.866 174.835 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.693 ' HA ' ' HA ' ' A' ' 2' ' ' GLN . 24.2 t70 -78.89 100.18 7.1 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 108.828 -0.805 . . . . 2.18 108.828 170.069 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 43.8 m-85 -116.67 142.43 46.91 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.74 -0.664 . . . . 1.41 111.496 -173.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -92.48 -175.3 3.95 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.438 -0.801 . . . . 2.23 108.861 175.34 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 14.1 t -52.0 -69.73 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 121.193 0.52 . . . . 0.57 111.534 -174.592 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -56.47 -49.1 75.62 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.263 -0.88 . . . . 2.39 112.587 -173.531 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 4.6 t -71.73 -31.36 66.62 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.076 -0.511 . . . . 1.26 110.727 -171.358 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -75.91 -41.45 27.89 Favored Glycine 0 N--CA 1.445 -0.735 0 C-N-CA 120.608 -0.806 . . . . 0.37 111.833 -175.744 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.697 HD13 HG11 ' A' ' 61' ' ' VAL . 93.4 mt -74.03 -36.99 64.48 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.654 0.264 . . . . 1.09 110.422 -178.323 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 6.3 tp60 -54.76 -47.97 73.23 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.324 -0.398 . . . . 2.59 111.648 179.768 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 83.5 mm-40 -65.33 -38.53 90.41 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.612 -0.267 . . . . 1.75 111.363 -179.512 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.492 HD21 HG13 ' A' ' 5' ' ' ILE . 94.0 mt -59.23 -23.88 62.69 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 111.935 0.346 . . . . 0.73 111.935 176.651 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.782 HD21 HG23 ' A' ' 61' ' ' VAL . 96.2 mt -80.7 -14.04 58.48 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 111.946 0.35 . . . . 2.16 111.946 -176.631 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -62.66 115.34 4.21 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.158 0.504 . . . . 2.24 110.806 -178.851 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 110.25 16.52 10.31 Favored Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 120.784 -0.722 . . . . 1.7 112.029 -178.795 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 89.5 p -146.29 177.4 9.04 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.873 -0.417 . . . . 2.28 109.873 177.33 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.517 ' HA3' ' HB3' ' A' ' 75' ' ' PRO . . . -118.96 43.72 1.53 Allowed Glycine 0 N--CA 1.445 -0.741 0 N-CA-C 111.124 -0.791 . . . . 1.58 111.124 176.708 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.516 HD13 HD21 ' A' ' 71' ' ' LEU . 55.1 mt -117.75 174.59 6.09 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.385 -0.407 . . . . 1.42 110.164 -177.634 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 74.2 mt-30 -146.6 127.85 14.81 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.248 -0.649 . . . . 2.67 109.248 177.206 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.782 HG23 HD21 ' A' ' 54' ' ' LEU . 48.2 t -88.49 119.72 36.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 109.014 -0.736 . . . . 1.54 109.014 174.556 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -132.42 122.97 18.31 Favored Pre-proline 0 N--CA 1.441 -0.912 0 CA-C-N 116.493 -0.322 . . . . 1.81 110.134 -173.75 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.635 ' HA ' ' HA ' ' A' ' 69' ' ' TRP . 44.7 Cg_exo -57.79 144.48 93.4 Favored 'Trans proline' 0 C--O 1.234 0.286 0 C-N-CA 122.977 2.452 . . . . 0.85 111.605 176.847 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -75.86 -47.55 25.03 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.616 -0.72 . . . . 1.7 109.843 -178.07 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 161.62 -46.8 0.37 Allowed Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.594 -0.812 . . . . 1.69 111.968 179.005 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 11.0 t30 -110.76 86.62 2.35 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 110.148 -0.315 . . . . 2.96 110.148 -179.482 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 39.11 42.49 0.72 Allowed 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 124.318 1.047 . . . . 2.5 113.313 178.855 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.568 ' HB3' ' O ' ' A' ' 24' ' ' THR . 50.1 m -142.06 174.84 10.23 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 108.745 -0.835 . . . . 1.3 108.745 176.173 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' TRP . . . . . 0.635 ' HA ' ' HA ' ' A' ' 63' ' ' PRO . 41.4 m0 -137.81 169.09 18.39 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.235 0.54 . . . . 0.47 110.345 -173.079 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.607 ' HA ' ' HB2' ' A' ' 26' ' ' SER . 11.7 t -148.89 141.93 24.85 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-N 115.368 -0.833 . . . . 0.83 109.064 168.076 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.516 HD21 HD13 ' A' ' 59' ' ' LEU . 60.8 tp -92.72 102.85 15.26 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.238 0.542 . . . . 1.71 109.76 178.823 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.429 ' HA ' ' HD3' ' A' ' 73' ' ' PRO . 33.0 tt0 -96.92 129.95 31.26 Favored Pre-proline 0 C--N 1.317 -0.817 0 CA-C-N 115.403 -0.817 . . . . 2.13 110.839 179.331 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 72' ' ' GLU . 12.0 Cg_exo -71.3 115.2 4.18 Favored 'Trans proline' 0 N--CA 1.459 -0.509 0 C-N-CA 122.432 2.088 . . . . 1.36 110.723 173.249 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -165.23 87.32 1.0 Allowed Pre-proline 0 C--N 1.323 -0.551 0 CA-C-N 115.83 -0.623 . . . . 1.89 109.655 -177.329 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.517 ' HB3' ' HA3' ' A' ' 58' ' ' GLY . 88.5 Cg_endo -84.04 46.88 2.1 Favored 'Trans proline' 0 N--CA 1.456 -0.723 0 C-N-CA 122.324 2.016 . . . . 2.73 112.651 -174.745 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 54.76 60.66 9.95 Favored Pre-proline 0 N--CA 1.462 0.158 0 CA-C-N 116.112 -0.495 . . . . 4.21 109.905 -176.615 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -82.83 114.34 2.3 Favored 'Trans proline' 0 N--CA 1.449 -1.106 0 C-N-CA 122.595 2.196 . . . . 4.26 112.267 -172.168 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.873 ' H ' ' HD2' ' A' ' 78' ' ' LYS . 1.7 mptt -81.89 -78.02 0.21 Allowed 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.488 -0.778 . . . . 6.21 109.128 -179.298 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.412 ' H ' ' HB2' ' A' ' 78' ' ' LYS . 26.4 tt0 -142.62 26.43 1.76 Allowed 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 107.675 -1.231 . . . . 8.11 107.675 170.23 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 . . . . . 0 C--O 1.244 0.778 0 CA-C-N 113.896 -1.502 . . . . 9.05 109.131 -177.498 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.033 0 N-CA-C 109.852 -0.425 . . . . 3.81 109.852 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.835 ' H ' ' HA ' ' A' ' 43' ' ' ASP . 0.0 OUTLIER -73.06 -36.36 66.87 Favored 'General case' 0 CA--C 1.512 -0.488 0 CA-C-O 121.943 0.878 . . . . 4.0 109.806 -176.863 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.499 HG11 ' CD2' ' A' ' 17' ' ' TYR . 14.2 m -148.85 152.17 12.42 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.174 0 CA-C-N 113.689 -1.596 . . . . 1.64 109.672 -178.92 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 69.9 m-20 -131.17 112.08 12.52 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.579 -0.526 . . . . 2.29 109.579 178.211 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.457 ' HB ' ' N ' ' A' ' 40' ' ' LEU . 48.5 mm -107.16 116.81 51.67 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 N-CA-C 109.821 -0.437 . . . . 0.82 109.821 -178.771 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -82.8 157.86 66.09 Favored Pre-proline 0 C--N 1.323 -0.563 0 CA-C-N 115.923 -0.58 . . . . 1.38 109.51 177.216 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.569 ' HA ' ' O ' ' A' ' 37' ' ' SER . 11.5 Cg_endo -58.71 145.49 95.67 Favored 'Trans proline' 0 N--CA 1.462 -0.376 0 C-N-CA 121.642 1.561 . . . . 1.73 109.879 168.504 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 148.71 -174.78 28.25 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.437 -0.887 . . . . 1.84 111.196 -169.753 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 47.1 t -63.37 128.82 37.57 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 117.029 0.414 . . . . 1.61 110.657 -179.016 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.41 HD13 ' HB2' ' A' ' 37' ' ' SER . 61.9 tp -61.7 -31.41 71.55 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.022 -0.535 . . . . 1.19 110.223 -179.59 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -49.39 -54.22 18.51 Favored 'General case' 0 CA--C 1.52 -0.178 0 CA-C-N 115.41 -0.814 . . . . 2.11 110.345 173.218 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.427 ' HD3' ' HA ' ' A' ' 12' ' ' LYS . 0.1 OUTLIER -69.81 -27.69 65.09 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.755 -0.657 . . . . 2.72 111.11 -178.863 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -66.51 -56.32 11.41 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-O 121.002 0.43 . . . . 0.46 110.224 -179.745 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 94.0 mt -60.18 -40.5 90.2 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.894 -0.594 . . . . 0.69 111.156 176.006 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -62.14 -35.85 80.03 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.027 0.441 . . . . 1.31 110.465 178.321 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 24.0 tm0? -62.92 -43.52 98.58 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 116.067 -0.515 . . . . 2.23 109.876 176.641 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.632 ' OH ' ' HA ' ' A' ' 46' ' ' VAL . 44.9 t80 -70.02 -35.53 74.4 Favored 'General case' 0 C--O 1.224 -0.251 0 N-CA-C 109.996 -0.372 . . . . 0.65 109.996 -178.613 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.685 ' HA ' ' CE2' ' A' ' 23' ' ' PHE . . . -52.24 -39.85 60.87 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-O 120.695 0.283 . . . . 0.37 111.724 176.292 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.9 -15.58 55.67 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 112.478 0.548 . . . . 0.64 112.478 178.796 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 17.8 t-80 -57.85 -57.44 12.75 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 122.312 0.245 . . . . 1.85 111.316 -179.058 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.573 ' HB3' ' HD1' ' A' ' 23' ' ' PHE . 25.1 t -109.15 -12.47 14.81 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.069 0.462 . . . . 1.67 111.237 -179.493 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 74.35 53.69 6.63 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.87 -0.681 . . . . 0.62 112.428 -179.302 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.685 ' CE2' ' HA ' ' A' ' 18' ' ' ALA . 3.2 p90 -104.41 172.67 6.67 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.715 0.293 . . . . 0.57 110.497 -177.911 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 12.9 m -92.13 107.79 19.47 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.244 0.545 . . . . 0.68 111.678 -177.512 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.469 ' HG ' ' HE3' ' A' ' 69' ' ' TRP . 1.0 OUTLIER -98.18 126.08 43.5 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.953 -0.567 . . . . 1.67 110.178 177.549 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.472 ' HB2' HG22 ' A' ' 70' ' ' THR . 68.5 m -101.13 97.73 8.23 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.085 0.469 . . . . 1.15 110.146 178.15 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 6.4 p -147.98 133.58 11.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 115.56 -0.745 . . . . 0.9 110.171 179.272 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.525 ' HB2' ' CD1' ' A' ' 31' ' ' LEU . 50.2 m-20 -94.36 129.73 40.96 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.707 -0.479 . . . . 2.38 109.707 176.283 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -58.04 -10.78 2.01 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.581 -0.736 . . . . 1.97 112.704 -178.686 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 6.0 p -71.7 -41.99 67.94 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.718 0.294 . . . . 2.22 110.674 179.797 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.556 ' H ' HD12 ' A' ' 31' ' ' LEU . 5.7 mp -63.79 -42.18 97.8 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.021 0.439 . . . . 1.38 111.329 179.013 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 2.5 p -91.67 13.36 18.28 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.026 -0.534 . . . . 1.44 111.668 -177.004 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.446 HH11 ' HD3' ' A' ' 33' ' ' ARG . 30.5 ttt180 -68.6 112.42 5.37 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.28 -0.418 . . . . 4.63 110.423 178.155 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 87.01 -0.79 86.41 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.783 -0.722 . . . . 1.62 112.013 -178.331 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 24.6 tptp -86.01 114.6 23.02 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 110.507 -0.183 . . . . 2.75 110.507 -178.589 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -106.41 164.32 12.13 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 110.112 -0.329 . . . . 2.24 110.112 176.785 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.569 ' O ' ' HA ' ' A' ' 7' ' ' PRO . 33.5 t -137.17 131.94 33.24 Favored 'General case' 0 N--CA 1.445 -0.719 0 N-CA-C 107.718 -1.216 . . . . 1.02 107.718 172.102 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 7.2 m-20 -60.78 -21.61 63.24 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 112.761 0.652 . . . . 1.28 112.761 -176.367 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.432 ' HA2' HG22 ' A' ' 5' ' ' ILE . . . 128.37 -175.41 18.58 Favored Glycine 0 N--CA 1.446 -0.668 0 C-N-CA 120.033 -1.079 . . . . 0.42 113.201 172.845 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.457 ' N ' ' HB ' ' A' ' 5' ' ' ILE . 43.3 tp -160.0 127.69 4.66 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 107.798 -1.186 . . . . 0.7 107.798 -178.329 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 74.3 m80 -140.02 97.85 3.33 Favored 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 120.342 -0.543 . . . . 2.96 111.032 -178.853 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -169.4 175.75 43.58 Favored Glycine 0 N--CA 1.444 -0.808 0 C-N-CA 120.832 -0.699 . . . . 0.55 112.341 175.634 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.835 ' HA ' ' H ' ' A' ' 2' ' ' GLN . 14.7 t70 -88.61 76.1 8.18 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 107.526 -1.287 . . . . 2.18 107.526 170.616 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -96.98 149.29 22.07 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 114.844 -1.071 . . . . 1.41 112.953 -167.737 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 19.8 t0 -90.71 166.94 12.86 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.102 -0.954 . . . . 2.23 109.649 174.803 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.632 ' HA ' ' OH ' ' A' ' 17' ' ' TYR . 42.9 t -47.5 -73.08 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 N-CA-C 113.616 0.969 . . . . 0.57 113.616 -170.513 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -65.0 -29.5 70.42 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 112.467 0.543 . . . . 2.39 112.467 -174.129 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 16.6 m -71.29 -33.1 69.43 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.216 0.531 . . . . 1.26 110.556 -177.189 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -76.51 -33.47 47.78 Favored Glycine 0 N--CA 1.446 -0.688 0 N-CA-C 111.275 -0.73 . . . . 0.37 111.275 -178.329 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.706 ' HB3' HG11 ' A' ' 61' ' ' VAL . 85.7 mt -67.9 -42.37 81.26 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.916 0.389 . . . . 1.09 110.479 178.599 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -56.24 -38.81 71.6 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.846 -0.615 . . . . 2.59 111.083 179.084 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 32.2 mm-40 -62.29 -56.31 19.72 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.918 0.39 . . . . 1.75 111.299 177.865 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 86.7 mt -57.5 -33.76 68.37 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.917 -0.583 . . . . 0.73 112.092 -177.613 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 10.8 mp -98.98 13.88 31.12 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 112.362 0.505 . . . . 2.16 112.362 -175.306 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -60.23 111.14 1.42 Allowed 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.916 0.389 . . . . 2.24 111.175 177.904 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 66.02 39.18 94.69 Favored Glycine 0 C--N 1.332 0.311 0 CA-C-N 115.83 -0.623 . . . . 1.7 112.583 178.947 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 63.9 p -98.72 -17.13 18.69 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.812 0.339 . . . . 2.28 111.733 -176.909 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.875 ' HA2' ' HB3' ' A' ' 75' ' ' PRO . . . 81.05 6.67 89.28 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.57 -0.824 . . . . 1.58 111.154 -172.811 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.494 HD13 HD21 ' A' ' 71' ' ' LEU . 96.1 mt -113.79 165.8 12.19 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.157 -0.521 . . . . 1.42 110.335 -177.875 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 31.0 tt0 -145.35 117.93 8.59 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 108.823 -0.806 . . . . 2.67 108.823 179.067 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.706 HG11 ' HB3' ' A' ' 50' ' ' LEU . 7.5 p -92.71 129.61 43.02 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 N-CA-C 110.116 -0.328 . . . . 1.54 110.116 -179.605 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.506 ' HZ1' ' HG3' ' A' ' 72' ' ' GLU . 21.1 mtmm -130.5 122.38 19.79 Favored Pre-proline 0 C--N 1.322 -0.601 0 CA-C-N 116.354 -0.385 . . . . 1.81 110.736 179.361 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_exo -61.07 117.7 4.5 Favored 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 122.141 1.894 . . . . 0.85 109.895 169.456 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -62.2 -43.65 98.34 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.29 -0.868 . . . . 1.7 111.052 -170.323 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 152.95 -63.82 0.37 Allowed Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.476 -0.868 . . . . 1.69 112.155 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 7.3 m-20 -82.92 57.2 3.75 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.654 0.264 . . . . 2.96 111.134 -178.475 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 6.3 t30 56.18 44.24 25.38 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 121.595 0.712 . . . . 2.5 110.78 178.004 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 14.7 m -142.34 177.61 8.15 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 108.848 -0.797 . . . . 1.3 108.848 177.838 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' TRP . . . . . 0.548 ' HH2' ' CD1' ' A' ' 17' ' ' TYR . 48.1 m0 -136.73 155.59 49.65 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 116.582 -0.281 . . . . 0.47 110.488 -172.075 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.472 HG22 ' HB2' ' A' ' 26' ' ' SER . 1.6 p -139.47 132.43 29.4 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.143 -0.48 . . . . 0.83 109.753 173.463 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.494 HD21 HD13 ' A' ' 59' ' ' LEU . 51.7 tp -93.19 104.31 16.51 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.501 0.667 . . . . 1.71 110.651 -178.766 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.506 ' HG3' ' HZ1' ' A' ' 62' ' ' LYS . 37.9 mm-40 -90.73 124.29 62.69 Favored Pre-proline 0 C--N 1.319 -0.748 0 CA-C-N 114.701 -1.136 . . . . 2.13 110.75 177.925 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_exo -74.1 113.54 3.81 Favored 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 121.833 1.689 . . . . 1.36 110.542 171.365 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . 175.78 103.76 0.09 OUTLIER Pre-proline 0 C--N 1.332 -0.172 0 CA-C-N 116.031 -0.531 . . . . 1.89 110.581 -175.643 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.875 ' HB3' ' HA2' ' A' ' 58' ' ' GLY . 96.8 Cg_endo -80.19 43.76 1.59 Allowed 'Trans proline' 0 N--CA 1.461 -0.384 0 C-N-CA 122.558 2.172 . . . . 2.73 112.066 177.764 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 53.64 66.51 4.46 Favored Pre-proline 0 C--O 1.232 0.182 0 CA-C-N 115.65 -0.705 . . . . 4.21 110.409 -174.94 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -96.96 -178.97 0.38 Allowed 'Trans proline' 0 N--CA 1.449 -1.141 0 C-N-CA 123.717 2.945 . . . . 4.26 111.558 -173.942 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.401 ' HA ' ' HD3' ' A' ' 78' ' ' LYS . 13.8 tppt? -95.51 62.57 2.41 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 120.567 -0.453 . . . . 6.21 110.717 179.9 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 60.57 108.78 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 115.043 -0.981 . . . . 8.11 112.244 176.456 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 . . . . . 0 C--O 1.245 0.841 0 CA-C-O 118.494 -0.765 . . . . 9.05 110.572 179.063 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.024 0 N-CA-C 109.803 -0.443 . . . . 3.81 109.803 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 46.8 mt-30 -72.0 130.54 41.2 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.154 0.502 . . . . 4.0 110.288 179.763 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 40.7 t -134.75 145.13 32.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 115.53 -0.759 . . . . 1.64 109.6 -175.303 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 5.2 p30 -128.08 98.25 5.05 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-O 121.776 0.798 . . . . 2.29 109.337 179.322 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.42 ' HB ' ' HB3' ' A' ' 40' ' ' LEU . 50.0 mm -102.21 110.01 27.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 115.34 -0.845 . . . . 0.82 109.558 -178.434 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -78.86 149.02 73.38 Favored Pre-proline 0 C--N 1.319 -0.73 0 CA-C-N 115.587 -0.733 . . . . 1.38 109.692 -179.008 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -55.31 134.65 65.07 Favored 'Trans proline' 0 N--CA 1.461 -0.422 0 C-N-CA 121.961 1.774 . . . . 1.73 109.656 169.113 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 150.46 -177.23 28.66 Favored Glycine 0 N--CA 1.445 -0.767 0 N-CA-C 110.41 -1.076 . . . . 1.84 110.41 -169.256 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.589 ' HA ' ' HA ' ' A' ' 36' ' ' GLN . 10.2 t -65.31 140.29 58.67 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 117.266 0.533 . . . . 1.61 110.221 -178.615 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.503 HD12 ' HG3' ' A' ' 35' ' ' LYS . 12.6 mt -58.15 -27.27 63.64 Favored 'General case' 0 CA--C 1.52 -0.187 0 CA-C-N 116.332 -0.394 . . . . 1.19 110.513 177.958 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -49.28 -55.27 13.27 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 115.417 -0.81 . . . . 2.11 110.724 173.582 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 25.1 ttmm -66.07 -33.86 76.75 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.944 -0.571 . . . . 2.72 110.806 -179.778 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -65.6 -59.83 3.55 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.239 -0.437 . . . . 0.46 110.917 -176.889 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.402 ' HB3' ' CD1' ' A' ' 25' ' ' LEU . 93.7 mt -57.57 -38.47 74.86 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.149 -0.478 . . . . 0.69 111.31 178.219 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 54.2 t30 -60.45 -35.51 76.02 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.119 -0.492 . . . . 1.31 110.547 178.509 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 19.7 tm0? -61.19 -49.4 77.34 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.313 -0.403 . . . . 2.23 110.779 177.55 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -67.45 -42.64 82.74 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 109.309 -0.626 . . . . 0.65 109.309 -177.209 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.654 ' HA ' ' CZ ' ' A' ' 23' ' ' PHE . . . -53.44 -51.08 63.8 Favored 'General case' 0 CA--C 1.521 -0.157 0 CA-C-N 115.552 -0.749 . . . . 0.37 111.724 176.812 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.94 -26.29 68.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.236 -0.438 . . . . 0.64 111.507 -179.426 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 71.2 t60 -64.31 -50.34 68.21 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.265 -0.425 . . . . 1.85 111.722 -177.652 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.626 ' HB3' ' HD1' ' A' ' 23' ' ' PHE . 47.0 t -99.26 -16.79 18.39 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-O 121.142 0.496 . . . . 1.67 111.438 -177.6 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 74.27 48.67 14.02 Favored Glycine 0 N--CA 1.45 -0.427 0 CA-C-N 115.884 -0.598 . . . . 0.62 112.665 -178.709 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.654 ' CZ ' ' HA ' ' A' ' 18' ' ' ALA . 29.9 p90 -110.33 168.23 9.61 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.784 0.326 . . . . 0.57 110.184 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 12.9 m -93.01 109.15 20.6 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.166 0.508 . . . . 0.68 111.077 -178.429 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.402 ' CD1' ' HB3' ' A' ' 14' ' ' LEU . 2.0 tt -93.77 128.89 40.23 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.053 -0.721 . . . . 1.67 109.053 177.763 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 34.5 t -103.1 99.81 9.7 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.108 0.48 . . . . 1.15 110.211 -178.104 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.1 p -147.83 133.14 11.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 115.821 -0.627 . . . . 0.9 110.498 179.05 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 -98.32 135.71 39.53 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.957 -0.565 . . . . 2.38 110.218 177.297 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -56.4 -22.3 30.61 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 114.93 -1.032 . . . . 1.97 112.676 -174.639 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 14.3 m -69.01 -14.58 63.12 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.892 0.377 . . . . 2.22 111.219 -176.55 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 90.7 mt -98.18 -22.78 16.0 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.11 0.481 . . . . 1.38 110.584 -179.633 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 12.1 p -109.85 5.51 22.62 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.031 -0.531 . . . . 1.44 112.211 -175.401 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 7.0 ptp180 -63.81 107.21 1.15 Allowed 'General case' 0 N--CA 1.453 -0.302 0 CA-C-O 121.199 0.524 . . . . 4.63 111.128 -179.32 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 83.6 4.25 89.2 Favored Glycine 0 N--CA 1.446 -0.646 0 CA-C-N 115.789 -0.641 . . . . 1.62 111.9 -179.542 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.503 ' HG3' HD12 ' A' ' 10' ' ' LEU . 20.9 tptm -83.78 104.42 13.87 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.766 -0.457 . . . . 2.75 109.766 -178.543 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' GLN . . . . . 0.589 ' HA ' ' HA ' ' A' ' 9' ' ' SER . 55.4 tt0 -103.77 155.09 18.86 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.64 -0.504 . . . . 2.24 109.64 -177.33 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.408 ' HB2' ' HG ' ' A' ' 10' ' ' LEU . 10.2 t -124.81 134.57 52.71 Favored 'General case' 0 N--CA 1.445 -0.685 0 N-CA-C 107.863 -1.162 . . . . 1.02 107.863 171.532 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 5.5 m-20 -64.85 -16.93 63.8 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.35 -0.386 . . . . 1.28 111.824 -179.751 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 123.27 175.45 14.52 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.647 -0.787 . . . . 0.42 112.607 173.208 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.42 ' HB3' ' HB ' ' A' ' 5' ' ' ILE . 49.1 tp -160.1 128.2 4.74 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 108.919 -0.771 . . . . 0.7 108.919 -178.688 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 54.7 m80 -138.69 97.86 3.44 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 120.388 -0.525 . . . . 2.96 111.119 179.611 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -169.73 178.15 42.84 Favored Glycine 0 N--CA 1.446 -0.635 0 CA-C-N 115.636 -0.711 . . . . 0.55 111.812 175.876 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -82.69 87.1 6.75 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.479 0.657 . . . . 2.18 109.383 170.581 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 56.6 m-85 -109.71 128.81 55.52 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.451 -0.795 . . . . 1.41 110.478 -177.699 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 52.1 m-20 -82.97 177.03 8.81 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 109.282 -0.636 . . . . 2.23 109.282 174.378 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.62 ' HB ' ' OE1' ' A' ' 47' ' ' GLU . 26.1 t -49.79 -70.31 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 N-CA-C 112.52 0.563 . . . . 0.57 112.52 -170.777 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.62 ' OE1' ' HB ' ' A' ' 46' ' ' VAL . 1.7 mp0 -56.46 -45.82 80.69 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.53 0.567 . . . . 2.39 112.53 -175.408 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 23.3 t -71.9 -35.1 69.62 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-O 121.036 0.446 . . . . 1.26 111.161 -171.524 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -76.19 -38.32 34.85 Favored Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 120.547 -0.835 . . . . 0.37 111.533 -175.672 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.567 ' HB3' HG13 ' A' ' 61' ' ' VAL . 96.5 mt -67.78 -39.12 84.11 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.971 0.415 . . . . 1.09 110.719 179.88 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -58.58 -41.57 86.02 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.55 -0.75 . . . . 2.59 111.044 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 5.9 tp-100 -66.94 -46.4 74.87 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.242 -0.436 . . . . 1.75 111.027 -179.779 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 91.8 mt -56.16 -32.24 64.12 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 113.129 0.788 . . . . 0.73 113.129 -176.314 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 65.3 mt -92.19 9.0 35.49 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.904 0.705 . . . . 2.16 112.904 -174.167 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -65.68 133.14 50.47 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 120.827 0.346 . . . . 2.24 110.38 179.542 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 107.99 4.43 33.64 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.799 -0.715 . . . . 1.7 111.806 -176.107 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 22.2 p -149.91 -173.27 4.38 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.848 -0.427 . . . . 2.28 109.848 177.732 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.666 ' HA2' ' HB3' ' A' ' 75' ' ' PRO . . . -118.76 30.24 5.99 Favored Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 120.82 -0.705 . . . . 1.58 111.539 -176.277 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.463 ' HA ' ' HA ' ' A' ' 73' ' ' PRO . 42.8 mt -98.71 166.73 11.18 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.551 -0.537 . . . . 1.42 109.551 179.666 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 35.1 tt0 -154.79 118.6 4.61 Favored 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 108.625 -0.88 . . . . 2.67 108.625 178.126 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.567 HG13 ' HB3' ' A' ' 50' ' ' LEU . 3.2 p -94.61 127.12 46.84 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 N-CA-C 109.132 -0.692 . . . . 1.54 109.132 177.861 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.461 ' HA ' ' HD3' ' A' ' 63' ' ' PRO . 47.5 mtmt -128.58 142.72 45.79 Favored Pre-proline 0 C--N 1.318 -0.777 0 CA-C-N 115.909 -0.587 . . . . 1.81 110.335 -170.809 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.461 ' HD3' ' HA ' ' A' ' 62' ' ' LYS . 12.4 Cg_exo -70.24 120.97 7.58 Favored 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 122.596 2.197 . . . . 0.85 111.022 175.739 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.446 HD21 ' HB ' ' A' ' 70' ' ' THR . 95.2 mt -58.39 -38.87 78.23 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.459 -0.792 . . . . 1.7 111.77 -174.607 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 161.8 -71.46 0.21 Allowed Glycine 0 N--CA 1.446 -0.697 0 C-N-CA 120.683 -0.77 . . . . 1.69 111.367 177.851 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -59.98 -77.14 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.777 0.322 . . . . 2.96 111.054 179.456 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 0.406 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 62.8 t30 -167.1 56.08 0.08 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.544 0.688 . . . . 2.5 109.572 177.356 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.422 ' O ' ' HD1' ' A' ' 69' ' ' TRP . 24.2 m -146.45 173.99 11.79 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 108.379 -0.971 . . . . 1.3 108.379 176.27 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' TRP . . . . . 0.507 ' CZ2' HG13 ' A' ' 46' ' ' VAL . 52.4 m0 -140.0 164.78 29.11 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 109.716 -0.475 . . . . 0.47 109.716 -168.793 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.446 ' HB ' HD21 ' A' ' 64' ' ' LEU . 6.6 t -149.01 145.43 27.3 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.711 -0.477 . . . . 0.83 109.711 170.953 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 58.2 tp -95.49 103.09 14.95 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.148 0.499 . . . . 1.71 110.828 178.64 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.406 ' HA ' ' HD3' ' A' ' 73' ' ' PRO . 38.5 mt-10 -105.76 145.07 30.15 Favored Pre-proline 0 C--N 1.322 -0.611 0 CA-C-N 115.632 -0.713 . . . . 2.13 111.115 174.788 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.463 ' HA ' ' HA ' ' A' ' 59' ' ' LEU . 7.2 Cg_exo -74.61 115.0 4.16 Favored 'Trans proline' 0 N--CA 1.46 -0.498 0 C-N-CA 122.333 2.022 . . . . 1.36 110.722 170.348 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . 179.82 88.42 0.19 Allowed Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 115.878 -0.601 . . . . 1.89 110.274 -175.591 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.666 ' HB3' ' HA2' ' A' ' 58' ' ' GLY . 98.6 Cg_endo -79.41 42.35 1.28 Allowed 'Trans proline' 0 N--CA 1.462 -0.369 0 C-N-CA 122.526 2.151 . . . . 2.73 112.002 -177.604 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 56.07 64.99 4.63 Favored Pre-proline 0 C--O 1.231 0.121 0 CA-C-N 115.629 -0.714 . . . . 4.21 109.377 -171.316 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -84.61 139.7 7.87 Favored 'Trans proline' 0 N--CA 1.455 -0.772 0 C-N-CA 122.849 2.366 . . . . 4.26 112.933 -170.438 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 99.7 mttt 65.87 -168.78 0.2 Allowed 'General case' 0 C--O 1.235 0.342 0 CA-C-N 115.584 -0.735 . . . . 6.21 110.53 179.525 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -140.8 100.59 3.88 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 120.893 0.378 . . . . 8.11 110.598 -178.307 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 . . . . . 0 C--O 1.245 0.866 0 CA-C-O 118.315 -0.85 . . . . 9.05 109.637 174.462 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.057 0 N-CA-C 110.087 -0.338 . . . . 3.81 110.087 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 9.0 pt20 -168.47 165.93 12.38 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.391 0.615 . . . . 4.0 110.642 171.43 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 23.2 m -132.35 143.62 39.37 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 CA-C-N 115.076 -0.965 . . . . 1.64 109.555 177.464 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 5.2 p30 -128.43 96.82 4.53 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 108.741 -0.837 . . . . 2.29 108.741 179.079 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.51 ' HB ' ' H ' ' A' ' 40' ' ' LEU . 25.5 mt -132.82 159.72 43.02 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 CA-C-N 115.298 -0.865 . . . . 0.82 109.073 -173.845 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.696 ' HB1' ' HD2' ' A' ' 7' ' ' PRO . . . -164.67 172.15 4.93 Favored Pre-proline 0 C--N 1.319 -0.752 0 N-CA-C 108.419 -0.956 . . . . 1.38 108.419 -174.545 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.696 ' HD2' ' HB1' ' A' ' 6' ' ' ALA . 19.8 Cg_exo -30.49 126.75 0.07 OUTLIER 'Trans proline' 0 C--N 1.358 1.055 0 C-N-CA 124.001 3.134 . . . . 1.73 113.782 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 162.99 157.0 8.83 Favored Glycine 0 N--CA 1.445 -0.746 0 N-CA-C 110.33 -1.108 . . . . 1.84 110.33 -176.456 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.582 ' HA ' ' HA ' ' A' ' 36' ' ' GLN . 9.3 t -58.59 133.1 55.56 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 117.285 0.542 . . . . 1.61 110.038 179.857 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.731 HD21 ' HG ' ' A' ' 54' ' ' LEU . 62.2 tp -57.62 -30.49 65.39 Favored 'General case' 0 N--CA 1.462 0.131 0 CA-C-N 115.537 -0.756 . . . . 1.19 111.422 -173.26 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.553 ' CA ' ' HB ' ' A' ' 32' ' ' THR . 31.3 t70 -50.18 -56.77 9.67 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.627 -0.715 . . . . 2.11 111.367 176.808 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 37.3 ttmt -66.92 -26.99 67.13 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.549 -0.296 . . . . 2.72 110.96 -179.337 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.497 ' O ' ' HB3' ' A' ' 16' ' ' GLN . . . -65.84 -55.78 15.31 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.867 0.365 . . . . 0.46 110.467 179.335 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.593 HD12 HG21 ' A' ' 32' ' ' THR . 82.6 mt -59.18 -35.76 74.13 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.175 -0.466 . . . . 0.69 111.425 176.523 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 54.8 t30 -61.05 -39.61 90.48 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.933 -0.395 . . . . 1.31 109.933 176.779 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.497 ' HB3' ' O ' ' A' ' 13' ' ' ALA . 41.0 tp60 -58.74 -45.26 90.08 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.672 -0.694 . . . . 2.23 111.379 175.94 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.609 ' O ' ' HB2' ' A' ' 20' ' ' HIS . 8.5 t80 -66.49 -45.24 80.27 Favored 'General case' 0 CA--C 1.514 -0.422 0 CA-C-O 121.044 0.45 . . . . 0.65 110.127 -179.157 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.717 ' HA ' ' CE2' ' A' ' 23' ' ' PHE . . . -50.46 -33.84 22.6 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.165 -0.925 . . . . 0.37 111.966 179.327 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.3 -10.09 14.7 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 116.089 -0.505 . . . . 0.64 112.241 178.262 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' HIS . . . . . 0.609 ' HB2' ' O ' ' A' ' 17' ' ' TYR . 0.0 OUTLIER -55.8 -61.44 2.36 Favored 'General case' 0 CA--C 1.518 -0.286 0 CA-C-O 120.899 0.38 . . . . 1.85 111.524 178.235 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.569 ' HB3' ' HD1' ' A' ' 23' ' ' PHE . 46.0 t -113.65 -15.56 12.48 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.02 0.438 . . . . 1.67 111.411 -177.678 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 77.8 55.71 4.07 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.628 -0.796 . . . . 0.62 111.307 -174.428 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.717 ' CE2' ' HA ' ' A' ' 18' ' ' ALA . 2.7 p90 -101.87 164.55 11.66 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.696 0.284 . . . . 0.57 110.459 -177.62 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.566 ' O ' ' HB3' ' A' ' 68' ' ' SER . 5.6 m -88.8 107.02 18.75 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.489 0.661 . . . . 0.68 111.25 -174.496 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.51 HD22 ' HB ' ' A' ' 27' ' ' VAL . 1.2 tt -93.22 132.62 37.22 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.569 -0.742 . . . . 1.67 109.311 178.399 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.669 ' HB2' ' HA ' ' A' ' 70' ' ' THR . 50.1 m -94.95 92.29 6.81 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.533 -0.543 . . . . 1.15 109.533 176.508 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.51 ' HB ' HD22 ' A' ' 25' ' ' LEU . 11.6 p -144.76 148.22 18.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.607 -0.724 . . . . 0.9 110.529 -174.972 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -111.91 139.08 47.7 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.196 -0.456 . . . . 2.38 109.94 178.713 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -64.05 64.8 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.29 0 O-C-N 123.76 0.662 . . . . 1.97 111.829 176.511 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 26.1 p -170.91 -42.65 0.02 OUTLIER 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 109.507 -0.553 . . . . 2.22 109.507 -178.394 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 72.9 mt -64.71 -40.87 96.09 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.217 -0.902 . . . . 1.38 110.687 178.666 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.593 HG21 HD12 ' A' ' 14' ' ' LEU . 0.9 OUTLIER -103.83 -12.54 16.86 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.757 -0.656 . . . . 1.44 112.473 -178.515 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 57.4 ttp180 -88.38 134.88 33.71 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.856 0.36 . . . . 4.63 110.658 -176.047 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 104.37 -51.43 0.8 Allowed Glycine 0 N--CA 1.448 -0.534 0 N-CA-C 111.512 -0.635 . . . . 1.62 111.512 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.974 ' HD2' ' H ' ' A' ' 35' ' ' LYS . 0.0 OUTLIER -76.9 132.09 38.92 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.437 -0.579 . . . . 2.75 109.437 175.586 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 36' ' ' GLN . . . . . 0.582 ' HA ' ' HA ' ' A' ' 9' ' ' SER . 71.3 mt-30 -104.38 161.83 13.74 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.193 -0.458 . . . . 2.24 110.84 -175.23 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 13.1 t -131.89 136.51 47.47 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 107.838 -1.171 . . . . 1.02 107.838 173.227 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 -70.75 -0.75 9.55 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 112.377 0.51 . . . . 1.28 112.377 -176.647 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 99.97 -171.44 23.64 Favored Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.632 -0.794 . . . . 0.42 113.222 170.757 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.51 ' H ' ' HB ' ' A' ' 5' ' ' ILE . 64.1 tp -160.44 145.6 14.7 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 107.85 -1.167 . . . . 0.7 107.85 -178.812 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 10.0 t-160 -145.11 98.09 3.11 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.366 -0.534 . . . . 2.96 110.847 177.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -169.31 -175.4 38.51 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.849 -0.691 . . . . 0.55 112.392 175.485 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 28.6 t0 -89.99 88.13 7.18 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 108.422 -0.955 . . . . 2.18 108.422 173.798 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 31.7 m-85 -116.08 142.42 46.83 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.491 0.662 . . . . 1.41 112.362 -170.251 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -90.77 -179.78 5.6 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 114.694 -1.139 . . . . 2.23 109.612 174.782 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.467 HG13 ' CZ2' ' A' ' 69' ' ' TRP . 78.7 t -53.03 -71.99 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 N-CA-C 112.679 0.622 . . . . 0.57 112.679 -176.562 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -62.18 -41.36 98.26 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.751 0.648 . . . . 2.39 112.751 -169.184 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 23.3 t -74.4 -34.29 63.25 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.17 0.509 . . . . 1.26 110.672 -174.487 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -74.49 -41.42 36.52 Favored Glycine 0 N--CA 1.446 -0.662 0 C-N-CA 120.803 -0.713 . . . . 0.37 111.659 -176.126 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.447 HD13 ' CG1' ' A' ' 61' ' ' VAL . 68.3 mt -67.3 -34.52 77.55 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.711 0.291 . . . . 1.09 110.638 -179.491 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 7.3 tp60 -57.27 -48.86 77.81 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.101 -0.499 . . . . 2.59 110.679 178.571 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.51 ' HG2' HD13 ' A' ' 40' ' ' LEU . 6.8 tp60 -67.67 -42.48 82.08 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.415 -0.357 . . . . 1.75 111.065 -178.599 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 78.8 mt -57.0 -40.6 76.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.053 -0.521 . . . . 0.73 112.16 -179.335 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.731 ' HG ' HD21 ' A' ' 10' ' ' LEU . 10.1 mp -97.74 2.54 49.7 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 112.306 0.484 . . . . 2.16 112.306 -173.772 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -62.07 111.85 2.11 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.047 0.451 . . . . 2.24 110.481 179.424 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 97.88 -7.2 62.74 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 121.06 -0.59 . . . . 1.7 112.505 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.5 m -87.75 -12.91 43.81 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.818 0.342 . . . . 2.28 111.043 -176.314 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.428 ' HA2' ' HA ' ' A' ' 75' ' ' PRO . . . 76.16 20.21 77.64 Favored Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 120.678 -0.772 . . . . 1.58 111.942 -179.363 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.428 ' CB ' HD23 ' A' ' 54' ' ' LEU . 96.3 mt -124.02 166.26 16.05 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 110.183 -0.302 . . . . 1.42 110.183 -179.473 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 17.2 tp60 -147.89 118.59 7.53 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.486 -0.561 . . . . 2.67 109.486 178.935 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.571 HG23 ' CD2' ' A' ' 54' ' ' LEU . 59.9 t -91.64 127.29 44.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 N-CA-C 109.473 -0.566 . . . . 1.54 109.473 176.409 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 41.4 tttm -117.12 128.01 26.32 Favored Pre-proline 0 C--N 1.318 -0.797 0 CA-C-N 116.051 -0.522 . . . . 1.81 109.761 -179.016 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -60.17 120.68 8.59 Favored 'Trans proline' 0 N--CA 1.461 -0.431 0 C-N-CA 121.867 1.712 . . . . 0.85 110.008 171.648 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -68.06 -50.51 54.73 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.973 -0.558 . . . . 1.7 110.211 -173.95 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 151.79 -52.92 0.48 Allowed Glycine 0 N--CA 1.445 -0.732 0 C-N-CA 120.605 -0.807 . . . . 1.69 112.001 178.402 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 78.8 m-20 -87.94 57.95 4.58 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.747 0.308 . . . . 2.96 110.949 -176.913 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 67.0 t30 50.73 37.37 16.54 Favored 'General case' 0 N--CA 1.473 0.675 0 CA-C-N 115.659 -0.701 . . . . 2.5 110.89 -177.994 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.566 ' HB3' ' O ' ' A' ' 24' ' ' THR . 49.7 m -141.21 178.63 7.27 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 108.128 -1.064 . . . . 1.3 108.128 178.96 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' TRP . . . . . 0.479 ' HH2' ' CD1' ' A' ' 17' ' ' TYR . 54.2 m0 -135.49 167.41 21.13 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.046 0.45 . . . . 0.47 110.669 -169.22 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.669 ' HA ' ' HB2' ' A' ' 26' ' ' SER . 6.9 t -141.3 139.79 33.71 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.205 -0.907 . . . . 0.83 108.97 173.625 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.469 HD22 HG23 ' A' ' 27' ' ' VAL . 48.9 tp -92.37 104.29 16.64 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.642 0.734 . . . . 1.71 109.69 178.506 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 28.0 mm-40 -88.71 119.61 70.03 Favored Pre-proline 0 C--N 1.313 -0.994 0 CA-C-N 114.509 -1.223 . . . . 2.13 110.843 -179.605 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_exo -66.77 113.6 2.82 Favored 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 121.698 1.598 . . . . 1.36 110.037 172.142 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -161.19 78.24 2.3 Favored Pre-proline 0 C--N 1.321 -0.659 0 CA-C-N 115.692 -0.685 . . . . 1.89 109.374 -176.619 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.428 ' HA ' ' HA2' ' A' ' 58' ' ' GLY . 57.8 Cg_endo -79.32 -72.17 0.01 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.874 0 C-N-CA 122.297 1.998 . . . . 2.73 112.384 -174.434 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.479 ' HA ' ' HG2' ' A' ' 79' ' ' GLU . . . -136.89 66.52 55.38 Favored Pre-proline 0 C--N 1.317 -0.832 0 N-CA-C 107.886 -1.153 . . . . 4.21 107.886 171.649 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -93.83 -15.95 0.74 Allowed 'Trans proline' 0 N--CA 1.451 -1.018 0 C-N-CA 123.031 2.487 . . . . 4.26 113.512 -168.728 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 62.0 mttm -143.47 26.53 1.6 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.156 0.503 . . . . 6.21 110.148 175.691 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.479 ' HG2' ' HA ' ' A' ' 76' ' ' ALA . 11.4 mm-40 -96.96 -40.87 8.67 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.814 -0.63 . . . . 8.11 109.815 -175.838 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 13.1 t70 . . . . . 0 C--O 1.245 0.82 0 CA-C-N 115.38 -0.827 . . . . 9.05 109.221 -179.637 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.516 ' O ' ' HA ' ' A' ' 43' ' ' ASP . . . . . . . . 0 N--CA 1.478 0.959 0 CA-C-O 121.027 0.441 . . . . 3.81 109.964 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 7.0 pt20 -69.29 105.12 2.43 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-O 121.728 0.775 . . . . 4.0 111.434 -178.327 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 60.5 t -91.81 121.56 42.43 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 N-CA-C 107.966 -1.124 . . . . 1.64 107.966 172.25 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -130.1 128.87 42.74 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 109.532 -0.544 . . . . 2.29 109.532 -174.204 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 75.2 mt -133.88 132.26 56.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 116.391 -0.368 . . . . 0.82 110.608 -177.581 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -70.82 153.46 94.8 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 115.538 -0.756 . . . . 1.38 110.775 179.687 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.648 ' HA ' ' O ' ' A' ' 37' ' ' SER . 5.5 Cg_exo -75.23 34.16 0.4 Allowed 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 123.299 2.666 . . . . 1.73 113.492 -179.027 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.406 ' HA2' ' HB3' ' A' ' 36' ' ' GLN . . . -159.14 140.22 6.72 Favored Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 120.403 -0.903 . . . . 1.84 113.322 -178.073 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.516 ' H ' ' HG2' ' A' ' 36' ' ' GLN . 0.1 OUTLIER 64.01 92.15 0.07 Allowed 'General case' 0 C--O 1.233 0.203 0 C-N-CA 123.455 0.702 . . . . 1.61 111.993 175.019 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.663 HD11 ' HB3' ' A' ' 53' ' ' LEU . 52.2 tp -64.01 -36.91 85.53 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.172 0.511 . . . . 1.19 110.533 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 14.1 p-10 -55.34 -43.41 74.95 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.525 -0.761 . . . . 2.11 111.392 177.288 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 27.8 ttpp -71.27 -28.47 64.17 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.168 0.508 . . . . 2.72 110.006 178.431 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -67.5 -52.47 38.73 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.475 -0.784 . . . . 0.46 110.736 179.722 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 91.3 mt -57.39 -40.59 78.53 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 115.812 -0.631 . . . . 0.69 111.596 178.366 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 10.9 t30 -59.75 -37.11 78.08 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.14 -0.482 . . . . 1.31 110.334 179.53 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 18.2 tm0? -63.41 -43.73 96.66 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.581 -0.736 . . . . 2.23 110.67 177.422 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.507 ' OH ' ' HA ' ' A' ' 46' ' ' VAL . 7.2 t80 -67.55 -45.61 75.17 Favored 'General case' 0 C--O 1.232 0.157 0 N-CA-C 109.846 -0.427 . . . . 0.65 109.846 -177.344 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.628 ' HA ' ' CZ ' ' A' ' 23' ' ' PHE . . . -53.98 -52.77 59.67 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 115.54 -0.754 . . . . 0.37 112.12 179.393 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.32 -30.59 71.7 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.911 0.386 . . . . 0.64 110.868 -178.337 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 75.1 t60 -65.85 -55.26 18.0 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.946 -0.57 . . . . 1.85 111.407 -178.183 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.568 ' HB3' ' CD1' ' A' ' 23' ' ' PHE . 34.9 t -90.82 0.67 57.39 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-O 120.786 0.327 . . . . 1.67 111.607 -173.465 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 64.68 36.53 93.25 Favored Glycine 0 CA--C 1.517 0.191 0 CA-C-N 116.19 -0.459 . . . . 0.62 113.785 175.074 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.628 ' CZ ' ' HA ' ' A' ' 18' ' ' ALA . 53.1 p90 -109.42 161.07 15.66 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.667 -0.494 . . . . 0.57 109.667 177.484 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 39.2 m -89.8 107.04 18.86 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.074 0.464 . . . . 0.68 110.077 178.922 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 6.9 tt -91.92 125.28 36.56 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.814 -0.63 . . . . 1.67 109.368 -179.847 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.597 ' O ' ' HA ' ' A' ' 70' ' ' THR . 14.6 t -111.54 97.56 6.83 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.352 0.596 . . . . 1.15 110.015 -178.62 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 6.6 p -91.72 130.64 40.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 109.279 -0.637 . . . . 0.9 109.279 177.274 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -69.83 105.92 2.95 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.403 -0.362 . . . . 2.38 110.642 -177.822 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 55.87 -90.86 0.03 OUTLIER 'General case' 0 C--O 1.232 0.176 0 O-C-N 124.152 0.908 . . . . 1.97 111.235 -176.458 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 2.3 t -171.32 56.22 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 108.933 -0.766 . . . . 2.22 108.933 176.781 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 90.3 mt -67.07 -17.16 64.76 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.55 -0.75 . . . . 1.38 111.136 -178.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 17.1 p -92.89 -1.74 56.47 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.05 -0.523 . . . . 1.44 111.214 -179.476 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 40.7 ttm180 -68.8 122.97 19.69 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.27 -0.423 . . . . 4.63 110.43 -179.753 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 99.05 -15.94 59.96 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.726 -0.75 . . . . 1.62 111.806 -178.831 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.874 ' HE3' ' HB3' ' A' ' 57' ' ' SER . 41.0 tttm -89.33 132.57 34.88 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-O 120.597 0.237 . . . . 2.75 110.362 177.404 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' GLN . . . . . 0.516 ' HG2' ' H ' ' A' ' 9' ' ' SER . 90.0 mt-30 -102.43 168.87 9.03 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 109.276 -0.638 . . . . 2.24 109.276 173.648 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.648 ' O ' ' HA ' ' A' ' 7' ' ' PRO . 22.9 t -139.33 124.02 18.48 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 106.823 -1.547 . . . . 1.02 106.823 173.273 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 6.1 m-20 -55.19 -17.31 4.14 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 112.829 0.677 . . . . 1.28 112.829 -173.396 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 131.49 -178.93 17.48 Favored Glycine 0 N--CA 1.441 -1.012 0 C-N-CA 120.351 -0.928 . . . . 0.42 112.662 171.104 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 43.8 tp -160.35 122.72 3.28 Favored 'General case' 0 N--CA 1.445 -0.711 0 N-CA-C 107.275 -1.38 . . . . 0.7 107.275 -178.319 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 33.1 m-70 -142.5 97.82 3.19 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.176 0.513 . . . . 2.96 111.211 -178.056 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -171.75 178.19 44.15 Favored Glycine 0 N--CA 1.445 -0.701 0 CA-C-N 115.535 -0.757 . . . . 0.55 111.586 174.326 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.516 ' HA ' ' O ' ' A' ' 1' ' ' ALA . 6.5 m-20 -80.41 76.7 7.22 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 107.954 -1.128 . . . . 2.18 107.954 166.623 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -92.67 139.09 30.92 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 113.061 0.763 . . . . 1.41 113.061 -167.357 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -75.22 158.44 32.95 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 114.468 -1.242 . . . . 2.23 109.808 172.412 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.605 HG13 ' HZ2' ' A' ' 69' ' ' TRP . 85.0 t -49.32 -68.13 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 O-C-N 123.674 0.609 . . . . 0.57 112.056 -177.038 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -61.87 -31.56 71.85 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.141 -0.481 . . . . 2.39 112.148 -176.371 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 22.9 t -69.71 -35.03 74.69 Favored 'General case' 0 C--O 1.238 0.492 0 CA-C-O 121.308 0.575 . . . . 1.26 110.262 -176.669 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.517 ' O ' ' HG ' ' A' ' 53' ' ' LEU . . . -74.15 -30.8 60.39 Favored Glycine 0 N--CA 1.446 -0.668 0 N-CA-C 111.036 -0.826 . . . . 0.37 111.036 -177.479 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.621 ' HB3' HG11 ' A' ' 61' ' ' VAL . 98.3 mt -70.71 -41.52 71.83 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.537 -0.331 . . . . 1.09 110.798 179.121 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 58.9 tt0 -51.96 -46.52 64.81 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.07 -0.513 . . . . 2.59 111.232 178.507 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 13.2 mm100 -64.06 -45.81 87.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.741 0.305 . . . . 1.75 110.973 -179.711 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.663 ' HB3' HD11 ' A' ' 10' ' ' LEU . 79.9 mt -60.02 -32.24 70.7 Favored 'General case' 0 C--O 1.237 0.438 0 CA-C-N 116.115 -0.493 . . . . 0.73 111.874 179.068 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.449 HD13 ' O ' ' A' ' 54' ' ' LEU . 0.8 OUTLIER -70.06 -34.98 73.89 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.071 -0.513 . . . . 2.16 110.569 -177.926 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -55.9 110.14 0.69 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.205 -0.452 . . . . 2.24 110.752 -176.564 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 119.64 -2.7 13.65 Favored Glycine 0 N--CA 1.444 -0.8 0 C-N-CA 120.771 -0.728 . . . . 1.7 112.294 -179.235 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.874 ' HB3' ' HE3' ' A' ' 35' ' ' LYS . 68.9 p -121.35 169.46 10.58 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.923 0.392 . . . . 2.28 110.865 176.651 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -109.46 35.45 4.89 Favored Glycine 0 N--CA 1.445 -0.761 0 N-CA-C 110.112 -1.195 . . . . 1.58 110.112 175.16 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 27.4 mt -108.49 -179.35 3.85 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 114.805 -0.697 . . . . 1.42 109.138 -178.642 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 57.4 tp60 -142.57 119.47 11.26 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 108.483 -0.932 . . . . 2.67 108.483 173.654 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.621 HG11 ' HB3' ' A' ' 50' ' ' LEU . 3.7 p -85.1 117.8 30.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-O 121.446 0.641 . . . . 1.54 109.386 179.147 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 49.2 mtpt -123.47 124.94 26.19 Favored Pre-proline 0 C--N 1.32 -0.693 0 CA-C-N 115.828 -0.624 . . . . 1.81 110.139 -173.543 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_exo -60.4 118.49 5.37 Favored 'Trans proline' 0 N--CA 1.456 -0.71 0 C-N-CA 121.861 1.707 . . . . 0.85 109.886 171.795 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -57.13 -38.37 73.38 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.395 -0.821 . . . . 1.7 111.361 -171.137 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 160.55 -50.57 0.36 Allowed Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 119.812 -1.185 . . . . 1.69 112.949 176.554 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 3.4 p30 -116.66 71.85 0.8 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.174 0.512 . . . . 2.96 111.305 -176.644 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 58.6 t30 55.87 43.03 28.21 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 115.292 -0.867 . . . . 2.5 110.749 179.598 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.428 ' O ' ' HD1' ' A' ' 69' ' ' TRP . 42.4 t -139.61 173.04 11.95 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 107.369 -1.345 . . . . 1.3 107.369 177.215 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' TRP . . . . . 0.62 ' CZ3' HD21 ' A' ' 50' ' ' LEU . 30.1 m0 -141.62 160.87 39.28 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.445 -0.576 . . . . 0.47 109.445 -171.783 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.597 ' HA ' ' O ' ' A' ' 26' ' ' SER . 8.9 t -148.67 146.14 28.03 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.618 -0.512 . . . . 0.83 109.618 169.791 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -93.7 99.93 12.25 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.373 0.606 . . . . 1.71 109.471 176.122 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.447 ' HA ' ' HD3' ' A' ' 73' ' ' PRO . 33.2 tt0 -96.59 126.86 41.76 Favored Pre-proline 0 C--N 1.319 -0.749 0 CA-C-N 115.187 -0.915 . . . . 2.13 110.636 177.611 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.447 ' HD3' ' HA ' ' A' ' 72' ' ' GLU . 7.1 Cg_exo -72.34 114.11 3.9 Favored 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 122.02 1.813 . . . . 1.36 111.103 177.227 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -166.06 80.76 1.09 Allowed Pre-proline 0 C--N 1.322 -0.589 0 CA-C-N 115.721 -0.672 . . . . 1.89 109.87 -177.213 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -84.41 36.87 0.59 Allowed 'Trans proline' 0 N--CA 1.459 -0.5 0 C-N-CA 122.706 2.27 . . . . 2.73 112.497 -177.328 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 57.84 59.66 6.63 Favored Pre-proline 0 N--CA 1.463 0.186 0 CA-C-N 116.074 -0.512 . . . . 4.21 110.4 -174.553 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -85.2 10.5 3.71 Favored 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 122.762 2.308 . . . . 4.26 112.356 -173.513 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 23.0 tptm -70.79 -40.43 72.57 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.812 -0.631 . . . . 6.21 110.182 179.144 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -127.62 174.72 8.84 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.822 -0.626 . . . . 8.11 110.38 -177.832 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 26.2 t70 . . . . . 0 C--O 1.248 0.982 0 CA-C-O 118.572 -0.727 . . . . 9.05 109.549 176.732 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.962 0 CA-C-O 120.777 0.322 . . . . 3.81 110.805 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 4.8 pp0? -69.59 150.4 47.12 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.972 0.415 . . . . 4.0 110.708 -176.085 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 9.4 p -142.38 147.36 21.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 115.757 -0.656 . . . . 1.64 109.939 -176.054 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 47.2 m-80 -128.9 100.26 5.61 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.882 0.372 . . . . 2.29 110.001 -177.338 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.459 ' HB ' ' H ' ' A' ' 40' ' ' LEU . 48.4 mm -108.69 127.45 65.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 116.121 -0.491 . . . . 0.82 110.856 -177.611 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.491 ' HA ' ' HD3' ' A' ' 7' ' ' PRO . . . -67.78 139.52 93.61 Favored Pre-proline 0 C--N 1.331 -0.22 0 CA-C-N 116.21 -0.45 . . . . 1.38 110.725 178.607 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.491 ' HD3' ' HA ' ' A' ' 6' ' ' ALA . 14.6 Cg_exo -72.17 36.87 0.34 Allowed 'Trans proline' 0 CA--C 1.534 0.522 0 C-N-CA 123.818 3.012 . . . . 1.73 114.628 -176.219 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -175.22 45.93 0.13 Allowed Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 119.467 -1.349 . . . . 1.84 114.55 176.446 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.441 ' HA ' ' O ' ' A' ' 35' ' ' LYS . 32.1 t -177.78 101.75 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 117.342 0.571 . . . . 1.61 111.279 173.391 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.418 ' CD1' ' HB3' ' A' ' 53' ' ' LEU . 53.7 tp -64.36 -37.29 86.99 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-O 121.328 0.585 . . . . 1.19 109.459 169.122 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -48.79 -60.95 2.31 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 114.849 -1.069 . . . . 2.11 111.366 177.281 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -68.22 -22.48 64.79 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.702 0.287 . . . . 2.72 111.068 179.45 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.407 ' HB1' HD12 ' A' ' 5' ' ' ILE . . . -63.73 -54.72 30.95 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.902 0.382 . . . . 0.46 110.475 179.778 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 93.3 mt -58.63 -39.06 79.45 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.618 -0.719 . . . . 0.69 110.696 176.514 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 55.8 t30 -61.68 -45.52 93.67 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.903 -0.59 . . . . 1.31 110.276 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 22.0 tm0? -61.7 -45.61 93.26 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.934 -0.575 . . . . 2.23 110.892 177.489 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.442 ' HD1' ' HZ ' ' A' ' 23' ' ' PHE . 1.3 t80 -65.18 -43.15 92.6 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 109.719 -0.475 . . . . 0.65 109.719 -177.396 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.816 ' HA ' ' CE2' ' A' ' 23' ' ' PHE . . . -55.3 -49.34 72.38 Favored 'General case' 0 CA--C 1.519 -0.226 0 CA-C-N 115.564 -0.743 . . . . 0.37 111.551 178.211 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.64 -28.08 68.2 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.398 -0.365 . . . . 0.64 111.249 -178.72 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 42.3 t60 -58.69 -50.23 74.64 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.919 -0.582 . . . . 1.85 111.906 -176.581 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.487 ' HB3' ' CD1' ' A' ' 23' ' ' PHE . 8.2 t -109.79 1.61 19.45 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-O 121.207 0.527 . . . . 1.67 111.452 -178.514 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 62.11 47.54 89.19 Favored Glycine 0 CA--C 1.522 0.509 0 CA-C-N 115.638 -0.71 . . . . 0.62 114.366 175.848 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.816 ' CE2' ' HA ' ' A' ' 18' ' ' ALA . 3.6 p90 -104.96 166.59 10.27 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 117.238 0.519 . . . . 0.57 110.563 177.222 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 24.2 m -90.93 119.39 31.09 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.417 0.627 . . . . 0.68 112.183 -175.478 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.649 HD11 ' HE3' ' A' ' 69' ' ' TRP . 1.5 mm? -92.93 122.5 35.37 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.36 -0.836 . . . . 1.67 111.231 175.957 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 63.4 m -97.99 94.91 7.13 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.291 0.567 . . . . 1.15 109.603 175.645 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 11.2 p -139.07 140.51 38.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 115.611 -0.722 . . . . 0.9 110.846 -174.743 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.982 ' HB3' HD11 ' A' ' 31' ' ' LEU . 7.8 t70 -68.43 149.46 49.29 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.81 -0.632 . . . . 2.38 109.771 174.863 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -53.3 -16.39 1.29 Allowed 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 114.952 1.464 . . . . 1.97 114.952 -170.553 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 7.4 p -165.57 69.99 0.14 Allowed 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 114.003 1.112 . . . . 2.22 114.003 -176.386 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.982 HD11 ' HB3' ' A' ' 28' ' ' ASP . 2.7 mp -96.99 -34.2 11.28 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.585 0.707 . . . . 1.38 109.132 164.181 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 5.6 p -95.46 21.19 8.45 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 114.959 -1.019 . . . . 1.44 111.507 -178.189 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 32.8 ttt180 -66.28 105.63 1.48 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.033 0.444 . . . . 4.63 110.385 -176.623 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 77.24 22.91 69.68 Favored Glycine 0 N--CA 1.447 -0.598 0 CA-C-N 115.804 -0.634 . . . . 1.62 112.572 -179.069 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.441 ' O ' ' HA ' ' A' ' 9' ' ' SER . 8.8 tptp -76.33 156.41 33.36 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.678 -0.49 . . . . 2.75 109.678 178.456 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -139.36 140.61 37.53 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.075 0.464 . . . . 2.24 110.892 -177.669 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 9.4 t -140.04 133.21 29.66 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 107.427 -1.324 . . . . 1.02 107.427 175.103 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.421 ' C ' ' HA ' ' A' ' 7' ' ' PRO . 6.3 m-20 -60.47 -7.47 2.12 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 112.85 0.685 . . . . 1.28 112.85 -176.383 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 114.8 179.79 18.6 Favored Glycine 0 CA--C 1.503 -0.675 0 C-N-CA 120.509 -0.853 . . . . 0.42 112.652 167.818 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.459 ' H ' ' HB ' ' A' ' 5' ' ' ILE . 19.4 tp -160.96 123.05 3.07 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 107.681 -1.229 . . . . 0.7 107.681 -176.077 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 20.8 t-160 -144.57 97.49 3.04 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.356 0.598 . . . . 2.96 110.853 -178.125 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -169.67 -173.09 36.89 Favored Glycine 0 N--CA 1.445 -0.718 0 CA-C-N 115.228 -0.896 . . . . 0.55 110.919 177.262 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -88.89 82.26 6.77 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 109.559 -0.534 . . . . 2.18 109.559 171.966 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 73.6 m-85 -97.55 136.28 38.18 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.047 -0.524 . . . . 1.41 111.403 -175.6 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -86.6 173.6 9.44 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 108.801 -0.814 . . . . 2.23 108.801 176.119 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 52.9 t -52.56 -57.71 3.76 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 N-CA-C 111.928 0.344 . . . . 0.57 111.928 -173.111 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 51.5 mm-40 -62.86 -49.49 74.68 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-O 121.076 0.465 . . . . 2.39 111.809 -175.333 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 11.7 p -72.72 -24.18 60.95 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.892 -0.595 . . . . 1.26 111.286 -172.798 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.45 ' O ' ' HG ' ' A' ' 53' ' ' LEU . . . -75.87 -40.33 31.11 Favored Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 120.766 -0.73 . . . . 0.37 111.337 -178.263 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.51 ' HB3' HG13 ' A' ' 61' ' ' VAL . 95.4 mt -68.33 -45.09 73.86 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.811 0.338 . . . . 1.09 110.647 -178.757 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 42.6 tt0 -57.69 -42.94 84.69 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.818 -0.628 . . . . 2.59 110.865 -179.034 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 87.3 mm-40 -66.44 -43.06 86.64 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.485 -0.325 . . . . 1.75 111.061 -179.37 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.45 ' HG ' ' O ' ' A' ' 49' ' ' GLY . 86.4 mt -57.64 -21.99 43.04 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 116.126 -0.488 . . . . 0.73 112.099 178.977 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.588 HD21 HG12 ' A' ' 61' ' ' VAL . 97.7 mt -70.23 -8.97 54.28 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 111.932 0.345 . . . . 2.16 111.932 -179.234 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -67.89 107.75 2.76 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.097 0.475 . . . . 2.24 110.164 178.756 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 116.94 2.17 18.85 Favored Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 120.827 -0.702 . . . . 1.7 112.055 -177.121 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 50.3 m -137.24 167.77 20.93 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.113 0.482 . . . . 2.28 111.307 179.642 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -116.97 15.29 13.69 Favored Glycine 0 N--CA 1.442 -0.927 0 N-CA-C 110.3 -1.12 . . . . 1.58 110.3 172.866 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.444 HD13 HD11 ' A' ' 71' ' ' LEU . 76.8 mt -92.29 179.48 5.54 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.339 -0.615 . . . . 1.42 109.339 179.577 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 7.5 tp-100 -140.2 117.6 11.41 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.864 -0.421 . . . . 2.67 109.864 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.588 HG12 HD21 ' A' ' 54' ' ' LEU . 7.3 p -98.97 129.44 49.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 N-CA-C 109.623 -0.51 . . . . 1.54 109.623 175.79 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.842 ' HD3' ' HG3' ' A' ' 72' ' ' GLU . 20.4 ptmt -144.66 144.19 23.9 Favored Pre-proline 0 C--N 1.32 -0.712 0 CA-C-N 116.236 -0.438 . . . . 1.81 110.569 -176.865 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.601 ' HA ' ' HA ' ' A' ' 69' ' ' TRP . 21.1 Cg_exo -67.1 140.6 54.62 Favored 'Trans proline' 0 N--CA 1.462 -0.33 0 C-N-CA 122.82 2.347 . . . . 0.85 111.807 175.872 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.523 HD21 ' HB ' ' A' ' 70' ' ' THR . 59.7 mt -65.71 -44.65 85.46 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.668 -0.696 . . . . 1.7 111.108 -179.379 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 178.52 -60.8 0.09 OUTLIER Glycine 0 N--CA 1.445 -0.762 0 C-N-CA 120.274 -0.965 . . . . 1.69 112.307 178.027 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 64.8 m-20 -91.84 -79.8 0.37 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.738 0.304 . . . . 2.96 111.477 -177.362 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 66.4 t30 -142.2 42.35 1.65 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.36 0.6 . . . . 2.5 110.916 -174.323 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 9.8 m -143.53 172.91 12.14 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 108.28 -1.007 . . . . 1.3 108.28 175.798 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' TRP . . . . . 0.649 ' HE3' HD11 ' A' ' 25' ' ' LEU . 55.0 m0 -136.68 167.86 20.6 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.55 -0.537 . . . . 0.47 109.55 -172.716 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.523 ' HB ' HD21 ' A' ' 64' ' ' LEU . 9.5 t -142.36 142.5 32.46 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.641 -0.503 . . . . 0.83 109.641 174.125 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.74 HD12 HD22 ' A' ' 31' ' ' LEU . 0.4 OUTLIER -93.7 101.04 13.17 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 108.985 -0.746 . . . . 1.71 108.985 176.44 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.842 ' HG3' ' HD3' ' A' ' 62' ' ' LYS . 10.5 mm-40 -87.78 119.54 70.6 Favored Pre-proline 0 C--N 1.318 -0.799 0 CA-C-N 114.72 -1.127 . . . . 2.13 111.264 178.499 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -88.01 113.58 0.83 Allowed 'Trans proline' 0 N--CA 1.447 -1.209 0 C-N-CA 122.154 1.903 . . . . 1.36 111.104 173.871 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.63 ' HA ' ' HG3' ' A' ' 77' ' ' PRO . . . -169.14 73.2 0.73 Allowed Pre-proline 0 C--N 1.323 -0.582 0 CA-C-N 115.585 -0.734 . . . . 1.89 109.791 -178.835 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -75.83 -75.51 0.01 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.696 0 C-N-CA 122.458 2.105 . . . . 2.73 111.461 -177.199 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -142.08 60.89 11.44 Favored Pre-proline 0 C--N 1.32 -0.714 0 N-CA-C 107.81 -1.181 . . . . 4.21 107.81 170.166 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.63 ' HG3' ' HA ' ' A' ' 74' ' ' ALA . 86.1 Cg_endo -89.35 4.12 5.25 Favored 'Trans proline' 0 N--CA 1.453 -0.88 0 C-N-CA 123.097 2.531 . . . . 4.26 113.19 -165.333 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 22.5 ttmm -141.0 85.6 1.99 Allowed 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 108.862 -0.792 . . . . 6.21 108.862 171.146 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -69.28 144.92 53.46 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 114.502 -1.227 . . . . 8.11 111.052 -174.556 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 30.9 t70 . . . . . 0 C--O 1.249 1.035 0 CA-C-O 118.108 -0.949 . . . . 9.05 110.985 -177.384 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 0.987 0 CA-C-O 121.246 0.546 . . . . 3.81 109.784 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -99.83 163.1 12.61 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.786 0.803 . . . . 4.0 112.262 -175.091 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.743 ' HB ' ' HE1' ' A' ' 44' ' ' TYR . 41.5 t -145.91 152.7 13.86 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 N-CA-C 106.857 -1.535 . . . . 1.64 106.857 176.925 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 88.0 m-20 -124.31 101.21 7.06 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.333 0.587 . . . . 2.29 109.766 -177.167 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 62.2 mt -116.63 147.51 19.97 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 115.371 -0.831 . . . . 0.82 109.291 -178.297 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.701 ' HB1' ' HD2' ' A' ' 7' ' ' PRO . . . -162.56 167.19 12.58 Favored Pre-proline 0 C--N 1.319 -0.745 0 N-CA-C 108.588 -0.893 . . . . 1.38 108.588 -172.916 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.701 ' HD2' ' HB1' ' A' ' 6' ' ' ALA . 11.2 Cg_exo -32.85 131.58 0.1 Allowed 'Trans proline' 0 C--N 1.357 0.998 0 C-N-CA 124.183 3.255 . . . . 1.73 113.748 -175.326 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 156.0 171.57 22.53 Favored Glycine 0 N--CA 1.441 -1.0 0 N-CA-C 110.154 -1.178 . . . . 1.84 110.154 -174.25 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -67.59 137.76 55.93 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 108.95 -0.759 . . . . 1.61 108.95 178.918 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.433 HD12 ' HB3' ' A' ' 13' ' ' ALA . 49.8 tp -59.07 -27.13 65.24 Favored 'General case' 0 C--O 1.232 0.178 0 C-N-CA 122.675 0.39 . . . . 1.19 110.204 -178.161 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -49.53 -49.58 45.48 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.185 -0.916 . . . . 2.11 109.873 172.663 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 57.9 tttm -68.08 -32.14 72.25 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.561 -0.745 . . . . 2.72 110.882 -178.877 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.433 ' HB3' HD12 ' A' ' 10' ' ' LEU . . . -65.07 -52.48 55.41 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.878 0.371 . . . . 0.46 110.043 -179.902 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.452 HD23 HD13 ' A' ' 53' ' ' LEU . 91.5 mt -56.71 -40.6 75.95 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.707 -0.679 . . . . 0.69 110.485 173.676 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 9.3 t30 -62.23 -41.06 98.06 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.837 -0.62 . . . . 1.31 110.612 179.83 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 24.2 tp60 -59.45 -46.45 88.73 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.194 -0.457 . . . . 2.23 111.475 179.034 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.464 ' HD1' ' HZ ' ' A' ' 23' ' ' PHE . 1.6 t80 -67.74 -44.02 78.55 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 109.061 -0.718 . . . . 0.65 109.061 179.568 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.779 ' HA ' ' CE2' ' A' ' 23' ' ' PHE . . . -54.23 -53.7 49.95 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 114.894 -1.048 . . . . 0.37 111.823 179.225 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.98 -27.26 68.01 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.794 0.331 . . . . 0.64 111.225 -178.34 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' HIS . . . . . 0.402 ' HB3' ' O ' ' A' ' 17' ' ' TYR . 69.1 t60 -61.52 -49.46 76.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.034 -0.53 . . . . 1.85 111.399 -178.617 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.6 ' HB3' ' CD1' ' A' ' 23' ' ' PHE . 1.9 t -109.49 2.85 20.75 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-O 121.136 0.493 . . . . 1.67 111.485 -176.882 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 60.23 46.84 93.53 Favored Glycine 0 C--N 1.333 0.397 0 CA-C-N 115.56 -0.746 . . . . 0.62 114.366 174.221 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.925 ' HB3' ' HB3' ' A' ' 67' ' ' ASN . 5.8 p90 -106.47 167.06 10.1 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 117.273 0.536 . . . . 0.57 112.017 -179.824 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 6.7 m -94.14 112.88 24.74 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.206 -0.906 . . . . 0.68 112.055 -176.369 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.614 HD21 ' CE3' ' A' ' 69' ' ' TRP . 0.6 OUTLIER -88.43 123.68 33.21 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.213 -0.903 . . . . 1.67 111.341 176.828 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 20.7 t -103.05 91.14 3.99 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.152 -0.684 . . . . 1.15 109.152 176.44 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.7 p -146.78 135.96 16.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.017 -0.538 . . . . 0.9 110.922 -178.819 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.561 ' HB3' ' HG ' ' A' ' 31' ' ' LEU . 33.0 t70 -69.49 118.94 13.0 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-N 115.819 -0.628 . . . . 2.38 110.339 178.713 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.04 65.17 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.354 0 O-C-N 123.825 0.703 . . . . 1.97 112.172 177.391 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.437 ' HB3' ' OD2' ' A' ' 28' ' ' ASP . 34.3 t -172.68 -28.75 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.717 -0.674 . . . . 2.22 109.333 -179.111 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.561 ' HG ' ' HB3' ' A' ' 28' ' ' ASP . 98.1 mt -60.87 -51.26 70.05 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.757 -0.656 . . . . 1.38 111.133 178.699 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 6.9 t -101.99 11.31 38.69 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.194 -0.457 . . . . 1.44 111.394 -178.362 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 41.2 ttp180 -72.37 128.85 36.9 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.605 -0.271 . . . . 4.63 110.407 -177.643 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 88.15 -2.29 85.23 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.864 -0.684 . . . . 1.62 111.934 -179.606 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 32.5 tttp -88.95 139.2 30.69 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.644 -0.502 . . . . 2.75 109.644 179.627 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 65.4 mt-30 -128.98 150.68 50.29 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 110.044 -0.354 . . . . 2.24 110.044 -177.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 20.7 t -126.51 131.2 51.66 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 108.642 -0.873 . . . . 1.02 108.642 178.561 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.613 ' O ' ' HD3' ' A' ' 7' ' ' PRO . 65.1 m-20 -73.04 -6.67 47.1 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 112.837 0.68 . . . . 1.28 112.837 -176.223 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 138.48 165.37 10.27 Favored Glycine 0 C--O 1.235 0.178 0 C-N-CA 119.903 -1.142 . . . . 0.42 114.049 168.919 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.736 ' HG ' ' OH ' ' A' ' 44' ' ' TYR . 57.1 tp -161.47 125.34 3.31 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 108.701 -0.852 . . . . 0.7 108.701 -178.606 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 15.4 p80 -145.45 109.0 4.67 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 112.254 0.465 . . . . 2.96 112.254 -179.049 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -168.92 -178.68 40.55 Favored Glycine 0 C--N 1.334 0.451 0 C-N-CA 120.511 -0.852 . . . . 0.55 112.932 170.625 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -86.39 110.64 19.84 Favored 'General case' 0 CA--C 1.517 -0.32 0 N-CA-C 107.801 -1.185 . . . . 2.18 107.801 167.255 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.743 ' HE1' ' HB ' ' A' ' 3' ' ' VAL . 51.0 m-85 -101.94 148.21 25.61 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.817 0.818 . . . . 1.41 113.015 -167.49 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 31.5 m-20 -92.92 144.21 25.49 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 106.137 -1.801 . . . . 2.23 106.137 156.275 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.471 ' O ' ' HG ' ' A' ' 50' ' ' LEU . 97.0 t -45.69 -63.14 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 N-CA-C 112.738 0.644 . . . . 0.57 112.738 -169.035 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -62.83 -32.11 73.25 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.883 0.373 . . . . 2.39 111.855 -176.131 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 62.5 m -71.08 -34.69 71.39 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.251 0.548 . . . . 1.26 111.075 -175.813 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -78.86 -27.22 57.05 Favored Glycine 0 N--CA 1.448 -0.525 0 N-CA-C 110.773 -0.931 . . . . 0.37 110.773 -176.539 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.748 ' HB3' HG11 ' A' ' 61' ' ' VAL . 87.6 mt -74.63 -36.18 62.9 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.282 -0.459 . . . . 1.09 110.461 179.702 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -59.1 -39.46 82.28 Favored 'General case' 0 N--CA 1.455 -0.186 0 CA-C-N 116.032 -0.531 . . . . 2.59 110.397 176.441 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 79.2 mm-40 -64.17 -38.92 92.79 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.859 0.362 . . . . 1.75 111.284 177.736 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.452 HD13 HD23 ' A' ' 14' ' ' LEU . 96.1 mt -60.0 -34.02 72.76 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.841 0.353 . . . . 0.73 111.395 177.303 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.446 HD22 ' HB2' ' A' ' 59' ' ' LEU . 96.1 mt -84.29 2.03 42.07 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 116.082 -0.508 . . . . 2.16 111.807 -176.646 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -62.23 114.86 3.7 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.037 -0.529 . . . . 2.24 111.146 -176.418 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 106.31 7.35 35.11 Favored Glycine 0 N--CA 1.45 -0.39 0 CA-C-N 116.005 -0.543 . . . . 1.7 112.533 179.341 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 20.3 p -143.24 -174.2 4.14 Favored 'General case' 0 C--N 1.324 -0.531 0 O-C-N 122.775 -0.25 . . . . 2.28 110.573 -178.766 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -132.05 44.91 1.16 Allowed Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 120.402 -0.904 . . . . 1.58 112.844 -175.508 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.584 ' HA ' ' H ' ' A' ' 74' ' ' ALA . 3.9 mp -100.65 177.28 5.05 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.824 -0.436 . . . . 1.42 109.824 171.773 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 26.8 tp60 -149.84 117.81 6.31 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 108.893 -0.78 . . . . 2.67 108.893 179.098 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.748 HG11 ' HB3' ' A' ' 50' ' ' LEU . 7.4 p -86.54 133.79 28.99 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 N-CA-C 109.655 -0.498 . . . . 1.54 109.655 178.36 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.425 ' HA ' ' HD3' ' A' ' 63' ' ' PRO . 55.1 mtpt -124.6 110.41 28.09 Favored Pre-proline 0 C--N 1.32 -0.688 0 N-CA-C 109.809 -0.441 . . . . 1.81 109.809 -178.141 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.555 ' HA ' ' HA ' ' A' ' 69' ' ' TRP . 2.8 Cg_exo -76.65 144.77 25.37 Favored 'Trans proline' 0 N--CA 1.462 -0.344 0 C-N-CA 123.161 2.574 . . . . 0.85 112.868 -177.697 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -91.09 23.48 3.23 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.834 0.826 . . . . 1.7 109.474 175.15 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 84.38 -68.1 3.58 Favored Glycine 0 N--CA 1.447 -0.603 0 CA-C-N 114.493 -1.23 . . . . 1.69 113.053 175.172 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 58.9 t30 -85.47 74.95 10.25 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.705 0.288 . . . . 2.96 111.184 -175.106 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 0.925 ' HB3' ' HB3' ' A' ' 23' ' ' PHE . 7.8 m-20 72.35 -26.43 0.18 Allowed 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 113.253 0.834 . . . . 2.5 113.253 170.26 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 15.2 m -85.81 146.45 26.76 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 110.274 -0.269 . . . . 1.3 110.274 -175.578 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' TRP . . . . . 0.614 ' CE3' HD21 ' A' ' 25' ' ' LEU . 6.6 m0 -140.03 168.73 19.15 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.0 -0.741 . . . . 0.47 109.0 -175.914 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 14.9 t -143.85 136.08 26.73 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.13 -0.692 . . . . 0.83 109.13 169.942 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 54.6 tp -95.11 102.85 14.68 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.079 0.466 . . . . 1.71 110.732 -177.381 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -95.14 128.5 38.59 Favored Pre-proline 0 C--N 1.319 -0.725 0 CA-C-N 115.402 -0.817 . . . . 2.13 110.687 174.597 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -73.99 115.49 4.34 Favored 'Trans proline' 0 N--CA 1.46 -0.482 0 C-N-CA 121.976 1.784 . . . . 1.36 110.893 174.428 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.584 ' H ' ' HA ' ' A' ' 59' ' ' LEU . . . 176.48 123.11 0.16 Allowed Pre-proline 0 CA--C 1.521 -0.147 0 CA-C-N 116.094 -0.503 . . . . 1.89 110.29 -176.291 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 74' ' ' ALA . 5.1 Cg_endo -84.64 37.43 0.62 Allowed 'Trans proline' 0 N--CA 1.456 -0.681 0 C-N-CA 122.704 2.269 . . . . 2.73 111.502 177.35 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.685 ' HB1' ' HB2' ' A' ' 79' ' ' GLU . . . 55.87 55.58 9.56 Favored Pre-proline 0 CA--C 1.53 0.193 0 CA-C-N 115.435 -0.802 . . . . 4.21 110.309 -174.777 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_endo -78.56 -9.93 15.95 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.506 2.137 . . . . 4.26 113.023 -169.724 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -118.09 -6.8 10.89 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.876 -0.602 . . . . 6.21 110.044 175.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.685 ' HB2' ' HB1' ' A' ' 76' ' ' ALA . 32.5 mm-40 -97.91 -37.96 9.6 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.735 -0.666 . . . . 8.11 109.728 -178.204 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 24.6 m-20 . . . . . 0 C--O 1.248 0.99 0 CA-C-O 118.185 -0.912 . . . . 9.05 110.815 -179.369 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.142 0 N-CA-C 110.177 -0.305 . . . . 3.81 110.177 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 31.8 tt0 -58.47 119.79 7.63 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.536 0.684 . . . . 4.0 111.545 -177.462 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.455 HG12 HG12 ' A' ' 5' ' ' ILE . 58.2 t -104.34 128.54 57.75 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 CA-C-N 114.861 -1.063 . . . . 1.64 108.457 174.545 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 43.8 t30 -126.9 98.87 5.5 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.14 0.495 . . . . 2.29 109.677 -175.405 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.615 HG22 ' HA2' ' A' ' 39' ' ' GLY . 27.1 mm -123.57 156.17 30.08 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 CA-C-N 115.306 -0.861 . . . . 0.82 108.777 -177.295 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.649 ' HB1' ' HD2' ' A' ' 7' ' ' PRO . . . -160.04 163.56 22.04 Favored Pre-proline 0 C--N 1.321 -0.657 0 N-CA-C 109.503 -0.554 . . . . 1.38 109.503 -177.35 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.649 ' HD2' ' HB1' ' A' ' 6' ' ' ALA . 6.6 Cg_exo -33.3 130.39 0.13 Allowed 'Trans proline' 0 C--N 1.357 1.002 0 C-N-CA 124.398 3.399 . . . . 1.73 113.314 -174.933 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 152.1 169.54 17.67 Favored Glycine 0 N--CA 1.44 -1.078 0 N-CA-C 110.96 -0.856 . . . . 1.84 110.96 -174.471 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.664 ' HB3' ' OD2' ' A' ' 11' ' ' ASP . 53.9 m -61.48 141.56 57.61 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 120.815 0.34 . . . . 1.61 111.471 179.693 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.75 HD22 ' HB2' ' A' ' 57' ' ' SER . 43.8 tp -59.65 -35.77 75.08 Favored 'General case' 0 CA--C 1.52 -0.175 0 CA-C-O 121.104 0.478 . . . . 1.19 110.458 178.965 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.706 ' HB3' ' HB ' ' A' ' 32' ' ' THR . 2.0 p-10 -56.93 -31.77 65.29 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.305 -0.861 . . . . 2.11 111.256 175.735 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 29.0 ttpt -70.52 -41.06 73.08 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.227 0.537 . . . . 2.72 109.881 174.418 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -64.97 -55.38 19.41 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 115.424 -0.807 . . . . 0.46 110.972 -174.195 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.439 ' HB3' HD11 ' A' ' 25' ' ' LEU . 89.2 mt -58.06 -41.12 82.68 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.809 -0.632 . . . . 0.69 111.174 177.743 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 52.9 t30 -62.92 -40.29 97.18 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.223 -0.444 . . . . 1.31 110.288 179.102 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 23.4 tm0? -62.57 -42.68 99.7 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.204 -0.453 . . . . 2.23 110.218 176.698 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.469 ' O ' ' HB3' ' A' ' 20' ' ' HIS . 4.9 t80 -65.58 -39.86 92.07 Favored 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 109.229 -0.656 . . . . 0.65 109.229 179.77 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.732 ' HA ' ' CZ ' ' A' ' 23' ' ' PHE . . . -55.56 -39.65 70.9 Favored 'General case' 0 CA--C 1.52 -0.184 0 CA-C-N 115.669 -0.696 . . . . 0.37 111.327 175.426 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.49 -30.09 71.27 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.202 -0.454 . . . . 0.64 111.212 179.272 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' HIS . . . . . 0.469 ' HB3' ' O ' ' A' ' 17' ' ' TYR . 62.8 t60 -60.55 -58.43 8.52 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 116.264 -0.425 . . . . 1.85 111.701 -177.905 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.538 ' HB3' ' HD1' ' A' ' 23' ' ' PHE . 11.4 t -98.38 -10.58 23.54 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-O 121.13 0.49 . . . . 1.67 111.739 -174.615 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 69.01 53.09 20.51 Favored Glycine 0 C--N 1.33 0.205 0 CA-C-N 115.833 -0.621 . . . . 0.62 113.232 179.62 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.732 ' CZ ' ' HA ' ' A' ' 18' ' ' ALA . 26.1 p90 -109.03 167.45 10.08 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.808 0.337 . . . . 0.57 110.535 179.264 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 25.3 m -92.9 109.73 21.18 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.439 0.638 . . . . 0.68 110.982 178.859 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.439 HD11 ' HB3' ' A' ' 14' ' ' LEU . 4.4 tt -91.64 128.09 37.34 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.433 -0.803 . . . . 1.67 109.299 179.7 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 25.4 t -99.09 100.2 11.31 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.07 0.462 . . . . 1.15 109.955 -179.319 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.429 HG23 ' HG ' ' A' ' 71' ' ' LEU . 7.3 p -129.34 130.86 67.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 115.987 -0.551 . . . . 0.9 110.552 -178.871 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.498 ' OD2' ' HB2' ' A' ' 30' ' ' SER . 23.7 t70 -75.46 123.83 26.11 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.663 -0.699 . . . . 2.38 110.816 178.791 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.62 49.75 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 113.338 0.866 . . . . 1.97 113.338 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.498 ' HB2' ' OD2' ' A' ' 28' ' ' ASP . 69.5 m -161.53 -28.12 0.05 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.847 0.356 . . . . 2.22 110.19 -179.696 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 75.9 mt -72.64 -43.79 62.76 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.51 0.672 . . . . 1.38 110.443 176.59 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.706 ' HB ' ' HB3' ' A' ' 11' ' ' ASP . 9.5 p -96.38 52.55 1.25 Allowed 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.726 -0.67 . . . . 1.44 112.279 -175.579 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 4.7 ptp180 -99.96 106.77 18.6 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-O 121.142 0.496 . . . . 4.63 111.042 175.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 70.77 46.61 45.01 Favored Glycine 0 N--CA 1.449 -0.474 0 CA-C-N 115.656 -0.702 . . . . 1.62 113.569 174.334 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.649 ' O ' ' HA ' ' A' ' 9' ' ' SER . 13.3 mptt -85.27 173.75 10.12 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 110.039 -0.356 . . . . 2.75 110.039 176.037 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 50.3 tt0 -149.84 134.85 17.92 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 120.778 0.323 . . . . 2.24 110.871 173.934 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 42.7 t -132.82 130.61 40.05 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 107.368 -1.345 . . . . 1.02 107.368 171.408 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.422 ' O ' ' HD3' ' A' ' 7' ' ' PRO . 1.0 OUTLIER -69.48 -7.75 40.77 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 113.122 0.786 . . . . 1.28 113.122 -173.89 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.615 ' HA2' HG22 ' A' ' 5' ' ' ILE . . . 117.4 -177.05 16.46 Favored Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 120.134 -1.032 . . . . 0.42 113.345 171.956 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.479 ' N ' ' HB ' ' A' ' 5' ' ' ILE . 60.4 tp -159.96 141.92 13.04 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 108.574 -0.899 . . . . 0.7 108.574 -178.414 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 50.8 t-80 -144.27 97.09 2.99 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.919 0.39 . . . . 2.96 110.658 179.72 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -170.46 177.88 43.41 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.973 -0.632 . . . . 0.55 111.837 175.071 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -92.7 99.99 12.58 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 108.44 -0.948 . . . . 2.18 108.44 171.316 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.44 ' HB2' ' CG2' ' A' ' 3' ' ' VAL . 25.6 m-85 -116.39 156.54 26.57 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 121.455 0.645 . . . . 1.41 112.227 -170.817 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -92.73 169.72 10.27 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 114.69 -1.141 . . . . 2.23 108.276 172.374 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.548 ' O ' ' HG ' ' A' ' 50' ' ' LEU . 78.1 t -48.01 -64.78 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 O-C-N 123.05 0.219 . . . . 0.57 111.438 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -61.53 -44.32 97.27 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 112.824 0.675 . . . . 2.39 112.824 -175.785 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 3.8 p -73.44 -31.06 63.6 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.037 0.446 . . . . 1.26 111.244 -173.418 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -72.48 -36.96 58.74 Favored Glycine 0 N--CA 1.446 -0.666 0 N-CA-C 111.233 -0.747 . . . . 0.37 111.233 179.56 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.548 ' HG ' ' O ' ' A' ' 46' ' ' VAL . 88.1 mt -71.61 -37.34 70.94 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.495 -0.352 . . . . 1.09 110.464 178.706 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -53.68 -47.42 70.44 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.866 -0.606 . . . . 2.59 110.576 179.307 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 14.1 mm100 -64.72 -42.27 95.36 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-O 120.807 0.337 . . . . 1.75 110.778 179.349 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.411 HD21 HG13 ' A' ' 5' ' ' ILE . 90.8 mt -59.75 -30.34 68.78 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 116.261 -0.427 . . . . 0.73 111.878 178.498 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.633 HD11 HG12 ' A' ' 61' ' ' VAL . 5.9 mp -72.73 -21.11 61.08 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.313 -0.403 . . . . 2.16 111.449 -179.457 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -71.94 86.98 1.01 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.139 0.495 . . . . 2.24 111.159 -177.234 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 113.1 -9.64 24.93 Favored Glycine 0 CA--C 1.52 0.365 0 CA-C-N 115.904 -0.589 . . . . 1.7 113.457 175.189 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.75 ' HB2' HD22 ' A' ' 10' ' ' LEU . 11.7 p -82.26 -24.72 34.61 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.961 0.381 . . . . 2.28 111.91 -175.577 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 88.57 5.1 75.53 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.918 -0.658 . . . . 1.58 112.664 176.748 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.571 HD12 HD23 ' A' ' 10' ' ' LEU . 95.8 mt -126.34 179.4 5.3 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.611 0.243 . . . . 1.42 110.86 -178.955 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 61.8 tt0 -147.39 118.97 7.96 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 109.163 -0.68 . . . . 2.67 109.163 179.597 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.633 HG12 HD11 ' A' ' 54' ' ' LEU . 7.7 p -98.43 128.02 50.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-O 121.215 0.531 . . . . 1.54 109.978 179.202 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.76 ' HE2' ' HB2' ' A' ' 72' ' ' GLU . 48.1 mtmt -109.36 130.12 23.13 Favored Pre-proline 0 C--N 1.322 -0.592 0 CA-C-N 116.146 -0.479 . . . . 1.81 110.719 -176.468 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -67.62 113.43 2.94 Favored 'Trans proline' 0 N--CA 1.457 -0.629 0 C-N-CA 122.102 1.868 . . . . 0.85 109.536 168.93 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 37.3 tp -60.04 -41.8 93.05 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.655 -0.702 . . . . 1.7 111.5 -171.102 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 165.67 -54.61 0.26 Allowed Glycine 0 N--CA 1.448 -0.556 0 N-CA-C 110.207 -1.157 . . . . 1.69 110.207 179.381 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 27.5 p-10 -86.32 -158.66 0.42 Allowed 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 108.935 -0.765 . . . . 2.96 108.935 171.925 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 20.1 p-10 -81.7 49.37 1.33 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.515 0.674 . . . . 2.5 110.796 176.108 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.443 ' O ' ' HD1' ' A' ' 69' ' ' TRP . 40.3 m -139.12 169.24 18.13 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 108.409 -0.96 . . . . 1.3 108.409 174.745 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' TRP . . . . . 0.443 ' HD1' ' O ' ' A' ' 68' ' ' SER . 45.0 m0 -140.12 171.35 14.31 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 110.035 -0.358 . . . . 0.47 110.035 -167.483 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.489 HG23 ' HE3' ' A' ' 62' ' ' LYS . 6.8 t -146.04 147.22 31.39 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.167 -0.47 . . . . 0.83 109.989 173.129 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.429 ' HG ' HG23 ' A' ' 27' ' ' VAL . 0.9 OUTLIER -92.77 108.76 20.23 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.123 0.487 . . . . 1.71 110.992 -174.279 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.76 ' HB2' ' HE2' ' A' ' 62' ' ' LYS . 4.3 tp10 -93.21 122.23 63.72 Favored Pre-proline 0 C--N 1.322 -0.608 0 CA-C-N 115.345 -0.843 . . . . 2.13 110.539 175.091 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -84.43 113.47 1.71 Allowed 'Trans proline' 0 N--CA 1.453 -0.891 0 C-N-CA 121.863 1.709 . . . . 1.36 111.56 174.194 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . 178.7 106.48 0.15 Allowed Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 115.849 -0.614 . . . . 1.89 109.776 -178.363 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -83.31 -82.78 0.0 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 122.636 2.224 . . . . 2.73 112.667 -179.353 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -151.14 62.2 4.92 Favored Pre-proline 0 C--N 1.32 -0.707 0 N-CA-C 108.156 -1.053 . . . . 4.21 108.156 174.409 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_endo -91.52 14.55 1.85 Allowed 'Trans proline' 0 N--CA 1.453 -0.874 0 C-N-CA 123.086 2.524 . . . . 4.26 113.162 -165.461 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 60.9 tttm -113.71 157.19 22.52 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.546 -0.538 . . . . 6.21 109.546 178.696 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 64.56 30.84 12.66 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 121.108 0.48 . . . . 8.11 111.236 -176.713 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 28.4 t70 . . . . . 0 C--O 1.247 0.928 0 CA-C-O 118.467 -0.777 . . . . 9.05 109.708 176.736 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.942 0 N-CA-C 110.215 -0.291 . . . . 3.81 110.215 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.716 ' HB2' ' H ' ' A' ' 44' ' ' TYR . 46.1 mm-40 -115.38 -8.81 12.22 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-O 120.864 0.364 . . . . 4.0 111.952 178.552 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 21.5 m -145.61 143.3 21.82 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-N 115.927 -0.579 . . . . 1.64 111.114 -178.638 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 4.5 p-10 -128.55 96.88 4.53 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 107.967 -1.123 . . . . 2.29 107.967 171.748 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.411 HD12 ' HB3' ' A' ' 40' ' ' LEU . 21.3 mt -130.86 157.41 43.15 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.761 0 CA-C-N 115.655 -0.702 . . . . 0.82 109.883 -170.055 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.741 ' HB1' ' HD2' ' A' ' 7' ' ' PRO . . . -162.36 178.63 1.5 Allowed Pre-proline 0 C--N 1.321 -0.67 0 N-CA-C 108.224 -1.028 . . . . 1.38 108.224 -174.569 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.741 ' HD2' ' HB1' ' A' ' 6' ' ' ALA . 51.2 Cg_exo -39.33 129.38 1.6 Allowed 'Trans proline' 0 C--N 1.359 1.122 0 C-N-CA 122.685 2.257 . . . . 1.73 113.023 -178.383 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 163.41 161.85 13.34 Favored Glycine 0 N--CA 1.443 -0.872 0 N-CA-C 110.727 -0.949 . . . . 1.84 110.727 -174.664 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.409 ' HA ' ' O ' ' A' ' 35' ' ' LYS . 37.2 p -61.61 137.69 58.26 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.951 0.376 . . . . 1.61 110.616 -178.127 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.462 HD21 ' HG ' ' A' ' 54' ' ' LEU . 64.0 tp -60.06 -32.43 70.93 Favored 'General case' 0 CA--C 1.52 -0.204 0 CA-C-O 121.102 0.477 . . . . 1.19 109.739 178.648 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.593 ' HB2' ' HB ' ' A' ' 32' ' ' THR . 11.4 t70 -50.32 -54.0 24.68 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.143 -0.935 . . . . 2.11 110.449 172.665 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 59.0 tttp -67.09 -32.38 73.49 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 116.213 -0.449 . . . . 2.72 110.949 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -64.26 -54.49 32.59 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.292 -0.413 . . . . 0.46 110.447 -177.861 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 85.5 mt -57.96 -41.92 83.9 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 115.854 -0.612 . . . . 0.69 111.071 176.165 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 12.9 t30 -62.65 -35.21 78.88 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.972 -0.558 . . . . 1.31 110.738 179.806 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 14.9 tm0? -61.17 -46.74 89.27 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 116.392 -0.367 . . . . 2.23 110.875 175.865 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.645 ' HD1' ' HH2' ' A' ' 69' ' ' TRP . 34.2 t80 -67.64 -32.05 72.48 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 120.986 -0.286 . . . . 0.65 110.421 -176.9 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.83 ' HA ' ' CZ ' ' A' ' 23' ' ' PHE . . . -50.94 -34.89 30.57 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 112.114 0.412 . . . . 0.37 112.114 175.625 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.55 -15.71 52.3 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.305 -0.407 . . . . 0.64 111.93 179.579 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 30.8 t-80 -59.67 -67.85 0.34 Allowed 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 116.628 -0.26 . . . . 1.85 111.42 179.866 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.695 ' HB3' ' HD1' ' A' ' 23' ' ' PHE . 23.0 t -101.12 -6.65 24.05 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.797 0.332 . . . . 1.67 111.505 -174.927 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 70.32 46.74 47.69 Favored Glycine 0 C--N 1.334 0.418 0 C-N-CA 120.771 -0.728 . . . . 0.62 112.524 178.947 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.83 ' CZ ' ' HA ' ' A' ' 18' ' ' ALA . 11.6 p90 -100.68 170.21 8.51 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.697 0.284 . . . . 0.57 110.477 -175.856 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.47 ' O ' ' HB3' ' A' ' 68' ' ' SER . 24.0 m -91.67 111.19 22.6 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.129 0.49 . . . . 0.68 110.872 -178.38 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 5.2 tt -93.32 125.82 38.13 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 115.915 -0.584 . . . . 1.67 109.565 -179.736 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.629 ' HB2' ' HA ' ' A' ' 70' ' ' THR . 15.2 m -99.1 93.01 5.75 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.158 -0.474 . . . . 1.15 109.908 -179.021 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 9.7 p -113.64 141.57 29.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 115.994 -0.548 . . . . 0.9 109.758 -178.503 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.421 ' HB3' ' HG ' ' A' ' 31' ' ' LEU . 23.1 t70 -98.0 125.62 43.02 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 110.176 -0.305 . . . . 2.38 110.176 179.604 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.16 57.97 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.525 0 O-C-N 123.802 0.689 . . . . 1.97 112.622 179.066 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 25.9 t -173.04 -28.61 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.221 -0.445 . . . . 2.22 110.042 -179.732 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.421 ' HG ' ' HB3' ' A' ' 28' ' ' ASP . 86.3 mt -77.28 -33.69 55.74 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.328 -0.396 . . . . 1.38 111.361 -178.136 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.593 ' HB ' ' HB2' ' A' ' 11' ' ' ASP . 6.0 p -92.4 13.27 20.02 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.26 0.552 . . . . 1.44 111.25 179.455 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 39.5 ttm180 -73.16 114.22 11.1 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.635 -0.711 . . . . 4.63 110.266 179.646 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 84.08 21.18 57.77 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.74 -0.743 . . . . 1.62 111.875 179.688 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.409 ' O ' ' HA ' ' A' ' 9' ' ' SER . 12.7 mptt -107.53 124.04 49.32 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.117 0.484 . . . . 2.75 111.23 -179.001 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 42.4 tt0 -131.69 141.06 49.47 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.353 -0.839 . . . . 2.24 109.135 177.734 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 7.3 t -121.8 121.06 36.36 Favored 'General case' 0 N--CA 1.443 -0.823 0 N-CA-C 107.003 -1.48 . . . . 1.02 107.003 174.768 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 8.9 m-80 -70.65 -0.54 8.94 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 113.296 0.85 . . . . 1.28 113.296 -169.662 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 134.97 168.32 11.62 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 119.894 -1.145 . . . . 0.42 114.213 166.838 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.433 HD13 ' HG2' ' A' ' 52' ' ' GLN . 60.9 tp -160.59 131.71 5.62 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 107.883 -1.155 . . . . 0.7 107.883 179.825 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 39.1 t60 -144.5 97.84 3.1 Favored 'General case' 0 C--N 1.321 -0.635 0 C-N-CA 120.055 -0.658 . . . . 2.96 110.971 179.721 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -169.63 175.78 43.71 Favored Glycine 0 N--CA 1.445 -0.749 0 CA-C-N 115.117 -0.947 . . . . 0.55 111.322 176.625 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.528 ' HA ' ' N ' ' A' ' 2' ' ' GLN . 12.2 t70 -83.65 94.41 8.1 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 108.216 -1.031 . . . . 2.18 108.216 171.564 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.716 ' H ' ' HB2' ' A' ' 2' ' ' GLN . 45.8 m-85 -115.1 126.57 54.82 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.111 0.481 . . . . 1.41 111.927 -174.718 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -67.97 170.21 8.65 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.254 -0.884 . . . . 2.23 109.915 174.085 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.628 HG13 ' HZ2' ' A' ' 69' ' ' TRP . 86.0 t -48.45 -65.55 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 O-C-N 123.549 0.531 . . . . 0.57 111.758 -175.387 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -59.02 -43.46 91.57 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 112.629 0.603 . . . . 2.39 112.629 -177.719 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 22.9 t -71.37 -33.21 69.35 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.097 0.475 . . . . 1.26 110.967 -172.513 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -73.73 -39.47 48.12 Favored Glycine 0 N--CA 1.445 -0.713 0 C-N-CA 120.735 -0.745 . . . . 0.37 111.496 -176.335 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.654 ' HB3' HG11 ' A' ' 61' ' ' VAL . 85.9 mt -67.95 -40.4 83.24 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.755 0.312 . . . . 1.09 110.857 -179.738 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 15.6 tm0? -54.28 -50.13 67.98 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.929 -0.578 . . . . 2.59 111.03 179.22 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.433 ' HG2' HD13 ' A' ' 40' ' ' LEU . 25.4 tp60 -68.07 -40.61 82.67 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.395 -0.366 . . . . 1.75 111.226 -177.173 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 51.0 mt -56.6 -42.17 78.26 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.217 0.451 . . . . 0.73 112.217 -179.303 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.462 ' HG ' HD21 ' A' ' 10' ' ' LEU . 11.0 mp -85.14 -5.02 59.35 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 112.374 0.509 . . . . 2.16 112.374 -174.614 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -66.62 105.65 1.59 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.29 0.566 . . . . 2.24 109.769 178.752 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 133.6 -15.0 4.7 Favored Glycine 0 N--CA 1.447 -0.615 0 N-CA-C 110.66 -0.976 . . . . 1.7 110.66 -172.038 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 79.4 p -119.49 175.96 5.59 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.271 -0.64 . . . . 2.28 109.271 175.709 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -113.74 17.64 20.33 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.21 -0.995 . . . . 1.58 112.266 -177.874 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 98.6 mt -92.24 175.45 6.85 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 110.254 -0.276 . . . . 1.42 110.254 -179.137 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 27.2 mp0 -139.0 118.98 13.31 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.156 -0.683 . . . . 2.67 109.156 -179.464 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.654 HG11 ' HB3' ' A' ' 50' ' ' LEU . 7.5 p -98.54 127.11 51.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 N-CA-C 109.674 -0.491 . . . . 1.54 109.674 176.915 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.467 ' HA ' ' HD3' ' A' ' 63' ' ' PRO . 0.0 OUTLIER -140.55 137.06 17.09 Favored Pre-proline 0 C--N 1.323 -0.584 0 CA-C-N 116.234 -0.439 . . . . 1.81 110.962 -176.559 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.529 ' HA ' ' HA ' ' A' ' 69' ' ' TRP . 28.4 Cg_exo -62.74 128.79 24.23 Favored 'Trans proline' 0 N--CA 1.462 -0.371 0 C-N-CA 122.915 2.41 . . . . 0.85 110.982 177.131 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -66.64 -43.76 83.77 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.702 -0.681 . . . . 1.7 109.732 -177.379 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 165.16 -60.42 0.24 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.564 -0.827 . . . . 1.69 112.276 176.336 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 50.5 t30 -86.12 68.85 10.41 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.997 0.427 . . . . 2.96 111.211 -175.597 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 66.4 t30 58.93 12.16 2.22 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-N 115.742 -0.663 . . . . 2.5 111.84 175.73 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.47 ' HB3' ' O ' ' A' ' 24' ' ' THR . 50.7 m -122.5 177.83 5.24 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 108.811 -0.811 . . . . 1.3 108.811 -173.844 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' TRP . . . . . 0.645 ' HH2' ' HD1' ' A' ' 17' ' ' TYR . 49.9 m0 -137.44 166.18 24.46 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.886 -0.413 . . . . 0.47 109.886 -167.357 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.629 ' HA ' ' HB2' ' A' ' 26' ' ' SER . 15.1 t -148.05 147.57 29.72 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 108.814 -0.81 . . . . 0.83 108.814 169.921 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 31.8 tp -92.23 103.84 16.27 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.442 0.639 . . . . 1.71 109.928 -179.192 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -88.11 119.49 70.38 Favored Pre-proline 0 C--N 1.319 -0.753 0 CA-C-N 114.918 -1.037 . . . . 2.13 111.19 -179.715 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -90.32 115.14 0.53 Allowed 'Trans proline' 0 N--CA 1.449 -1.143 0 C-N-CA 122.393 2.062 . . . . 1.36 112.33 177.404 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -163.83 73.57 1.77 Allowed Pre-proline 0 C--N 1.323 -0.556 0 CA-C-N 115.725 -0.67 . . . . 1.89 109.487 176.31 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.492 ' C ' ' HD3' ' A' ' 77' ' ' PRO . 80.7 Cg_endo -85.92 -136.15 0.02 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.796 0 C-N-CA 122.407 2.072 . . . . 2.73 111.942 -172.514 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.416 ' H ' ' HB2' ' A' ' 75' ' ' PRO . . . -113.56 70.71 1.61 Allowed Pre-proline 0 C--N 1.324 -0.523 0 N-CA-C 109.058 -0.719 . . . . 4.21 109.058 172.402 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.492 ' HD3' ' C ' ' A' ' 75' ' ' PRO . 43.3 Cg_endo -91.21 60.53 1.16 Allowed 'Trans proline' 0 N--CA 1.453 -0.891 0 C-N-CA 123.012 2.475 . . . . 4.26 112.018 -169.954 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -124.1 13.82 9.07 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.267 -0.424 . . . . 6.21 111.512 -175.373 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -155.45 60.69 0.62 Allowed 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.636 -0.426 . . . . 8.11 111.503 -176.515 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 31.2 t70 . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.535 -0.745 . . . . 9.05 110.109 175.906 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.893 0 N-CA-C 109.95 -0.389 . . . . 3.81 109.95 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 32.9 mm-40 -74.0 110.76 8.54 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.86 0.362 . . . . 4.0 111.012 -178.859 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 31.4 m -103.39 136.36 36.55 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-N 115.964 -0.562 . . . . 1.64 109.787 174.928 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -127.01 96.55 4.65 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 108.589 -0.893 . . . . 2.29 108.589 -179.81 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.504 HD12 ' HB3' ' A' ' 40' ' ' LEU . 50.5 mt -126.11 149.24 30.85 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 CA-C-N 115.763 -0.653 . . . . 0.82 110.153 -173.821 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.564 ' HB1' ' HD2' ' A' ' 7' ' ' PRO . . . -162.96 168.12 10.83 Favored Pre-proline 0 C--N 1.323 -0.544 0 N-CA-C 108.844 -0.798 . . . . 1.38 108.844 -176.381 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.564 ' HD2' ' HB1' ' A' ' 6' ' ' ALA . 89.8 Cg_exo -44.56 133.48 9.89 Favored 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 122.806 2.337 . . . . 1.73 112.998 -178.103 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.401 ' O ' ' HG2' ' A' ' 12' ' ' LYS . . . 154.91 41.56 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.635 -0.793 . . . . 1.84 112.062 178.299 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.624 ' HA ' ' HA ' ' A' ' 36' ' ' GLN . 20.2 m 66.98 138.92 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.281 0 CA-C-O 121.326 0.584 . . . . 1.61 110.699 -172.376 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.596 HD11 ' HB3' ' A' ' 53' ' ' LEU . 49.5 tp -58.37 -24.2 59.22 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.138 0.494 . . . . 1.19 110.27 177.284 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -48.06 -51.59 23.72 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.073 -0.967 . . . . 2.11 111.892 175.031 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.451 ' HE3' ' HB2' ' A' ' 12' ' ' LYS . 0.0 OUTLIER -66.91 -25.47 66.39 Favored 'General case' 0 C--N 1.335 -0.063 0 C-N-CA 121.064 -0.255 . . . . 2.72 111.375 -176.397 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -65.42 -59.29 4.17 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.049 0.452 . . . . 0.46 110.073 178.796 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 86.9 mt -58.46 -37.38 75.36 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.675 -0.693 . . . . 0.69 110.905 176.428 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 47.4 t30 -60.94 -40.76 94.52 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.257 -0.429 . . . . 1.31 110.257 178.399 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -61.1 -47.87 84.28 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 116.028 -0.533 . . . . 2.23 110.541 178.548 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.53 ' O ' ' HB3' ' A' ' 20' ' ' HIS . 3.1 t80 -69.58 -43.93 71.86 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-O 120.871 0.367 . . . . 0.65 110.251 -177.653 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.604 ' HA ' ' CZ ' ' A' ' 23' ' ' PHE . . . -53.92 -53.48 52.11 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 115.912 -0.585 . . . . 0.37 112.275 -179.72 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.53 -22.55 66.4 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.804 0.335 . . . . 0.64 111.517 -178.817 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' HIS . . . . . 0.53 ' HB3' ' O ' ' A' ' 17' ' ' TYR . 77.9 t60 -65.73 -52.12 53.77 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.993 -0.549 . . . . 1.85 111.5 -179.866 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.43 ' HB2' ' CD1' ' A' ' 23' ' ' PHE . 19.7 m -108.13 -3.6 18.45 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 112.619 0.599 . . . . 1.67 112.619 -174.355 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 69.2 47.73 50.88 Favored Glycine 0 C--O 1.227 -0.295 0 CA-C-N 116.142 -0.481 . . . . 0.62 113.884 174.262 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.604 ' CZ ' ' HA ' ' A' ' 18' ' ' ALA . 13.3 p90 -110.78 162.93 14.29 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.84 0.32 . . . . 0.57 110.209 178.398 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.63 ' O ' ' HB3' ' A' ' 68' ' ' SER . 28.0 m -98.11 122.17 40.93 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.363 0.601 . . . . 0.68 112.173 -174.725 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.481 HD21 ' CE3' ' A' ' 69' ' ' TRP . 1.1 mm? -88.49 115.11 25.77 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.677 -0.692 . . . . 1.67 110.322 175.491 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 32.9 t -98.08 93.92 6.55 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.795 -0.638 . . . . 1.15 109.799 -179.653 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.752 HG21 HD12 ' A' ' 71' ' ' LEU . 7.2 p -148.16 141.71 18.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.768 -0.651 . . . . 0.9 110.655 -178.849 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -88.88 132.12 34.81 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.933 -0.576 . . . . 2.38 110.009 175.578 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.33 78.57 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.308 0 O-C-N 123.8 0.687 . . . . 1.97 111.863 179.658 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 74.1 m -165.83 -38.19 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 123.142 0.577 . . . . 2.22 109.556 -179.736 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 88.0 mt -75.24 -33.17 61.28 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.093 -0.503 . . . . 1.38 110.693 178.791 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 7.5 p -92.32 -10.93 36.54 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.329 -0.396 . . . . 1.44 110.948 177.526 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 53.1 ttp180 -64.69 107.12 1.33 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.815 -0.63 . . . . 4.63 110.143 179.87 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 102.51 17.66 18.83 Favored Glycine 0 N--CA 1.444 -0.806 0 C-N-CA 121.002 -0.618 . . . . 1.62 111.797 -177.942 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 12.9 mptt -107.5 122.26 46.3 Favored 'General case' 0 CA--C 1.514 -0.418 0 CA-C-O 121.106 0.479 . . . . 2.75 111.711 178.85 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' GLN . . . . . 0.624 ' HA ' ' HA ' ' A' ' 9' ' ' SER . 18.4 pt20 -138.24 133.66 33.43 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.564 -0.744 . . . . 2.24 109.168 173.593 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.424 ' O ' ' HA ' ' A' ' 7' ' ' PRO . 19.2 t -115.66 140.3 49.32 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.569 -0.53 . . . . 1.02 109.569 -176.567 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 5.9 m-20 -71.0 2.9 3.81 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 112.162 0.431 . . . . 1.28 112.162 177.258 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.46 ' HA3' ' HA ' ' A' ' 6' ' ' ALA . . . 114.85 -178.03 17.72 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.775 -0.726 . . . . 0.42 113.445 166.331 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.504 ' HB3' HD12 ' A' ' 5' ' ' ILE . 56.1 tp -160.82 131.07 5.15 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 107.797 -1.186 . . . . 0.7 107.797 179.632 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 17.4 t-160 -143.4 99.89 3.51 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 120.07 -0.652 . . . . 2.96 111.71 -177.63 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -169.03 -169.68 32.7 Favored Glycine 0 N--CA 1.448 -0.545 0 CA-C-N 115.403 -0.817 . . . . 0.55 111.459 176.156 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -103.55 90.64 3.74 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 108.832 -0.803 . . . . 2.18 108.832 172.112 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 64.1 m-85 -110.47 151.86 27.02 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.61 -0.723 . . . . 1.41 110.584 -175.79 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -99.47 -171.94 2.16 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 108.302 -0.999 . . . . 2.23 108.302 174.218 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.423 ' O ' ' HG ' ' A' ' 50' ' ' LEU . 39.2 t -51.7 -71.0 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 N-CA-C 112.976 0.732 . . . . 0.57 112.976 -172.636 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.31 -47.45 82.22 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 113.266 0.839 . . . . 2.39 113.266 -169.102 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 7.5 t -73.97 -26.86 60.7 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.032 0.444 . . . . 1.26 110.75 -170.692 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -75.13 -38.94 38.56 Favored Glycine 0 N--CA 1.447 -0.626 0 N-CA-C 111.042 -0.823 . . . . 0.37 111.042 -178.874 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.775 HD13 HG11 ' A' ' 61' ' ' VAL . 80.7 mt -70.11 -41.53 73.87 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 115.441 -0.379 . . . . 1.09 110.261 179.068 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 55.3 tp60 -55.96 -38.06 69.87 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 116.102 -0.499 . . . . 2.59 111.524 -179.244 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 24.6 mm-40 -63.5 -45.64 89.75 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.857 0.361 . . . . 1.75 110.616 177.771 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.596 ' HB3' HD11 ' A' ' 10' ' ' LEU . 90.3 mt -60.94 -22.87 64.83 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.838 -0.619 . . . . 0.73 111.859 176.787 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.782 HD21 HG23 ' A' ' 61' ' ' VAL . 87.4 mt -85.28 -24.05 27.91 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.14 0.422 . . . . 2.16 112.14 -175.494 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -70.07 93.63 0.82 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.179 0.514 . . . . 2.24 110.905 -175.961 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 114.77 -10.45 21.2 Favored Glycine 0 N--CA 1.446 -0.69 0 CA-C-N 115.799 -0.637 . . . . 1.7 112.532 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.429 ' OG ' ' HA ' ' A' ' 54' ' ' LEU . 27.1 p -98.92 -12.12 21.0 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.883 0.373 . . . . 2.28 111.448 -178.547 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.581 ' HA2' ' HB3' ' A' ' 75' ' ' PRO . . . 71.3 28.39 70.0 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 121.0 -0.619 . . . . 1.58 112.892 175.72 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 94.8 mt -119.12 167.98 11.29 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.74 0.305 . . . . 1.42 110.857 -178.555 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' GLN . . . . . 0.419 ' HA ' HD13 ' A' ' 54' ' ' LEU . 62.8 tt0 -143.97 118.97 10.0 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.082 -0.71 . . . . 2.67 109.082 177.47 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.782 HG23 HD21 ' A' ' 54' ' ' LEU . 36.8 t -94.81 130.2 43.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 N-CA-C 110.044 -0.354 . . . . 1.54 110.044 -178.25 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.414 ' HA ' ' HD3' ' A' ' 63' ' ' PRO . 17.9 ptmt -131.67 127.61 21.47 Favored Pre-proline 0 C--N 1.317 -0.815 0 N-CA-C 109.624 -0.51 . . . . 1.81 109.624 179.015 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 62' ' ' LYS . 32.2 Cg_exo -60.15 132.92 46.85 Favored 'Trans proline' 0 N--CA 1.463 -0.279 0 C-N-CA 122.577 2.185 . . . . 0.85 111.191 177.612 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 42.7 tp -69.27 -40.31 77.87 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.713 -0.676 . . . . 1.7 110.925 -174.592 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 158.65 -44.48 0.47 Allowed Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.758 -0.735 . . . . 1.69 112.092 175.876 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 9.2 m120 -77.15 -89.39 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.394 0.616 . . . . 2.96 110.644 -179.481 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 30.4 p-10 -146.69 24.85 1.2 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.626 -0.715 . . . . 2.5 109.095 177.057 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.63 ' HB3' ' O ' ' A' ' 24' ' ' THR . 50.4 m -128.74 178.82 6.07 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 108.178 -1.045 . . . . 1.3 108.178 -171.784 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' TRP . . . . . 0.481 ' CE3' HD21 ' A' ' 25' ' ' LEU . 1.9 m0 -140.15 169.73 17.16 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 119.836 -0.746 . . . . 0.47 110.055 -170.864 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 9.6 t -140.97 144.03 34.85 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 108.722 -0.844 . . . . 0.83 108.722 171.654 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.752 HD12 HG21 ' A' ' 27' ' ' VAL . 52.0 mt -93.85 105.62 17.63 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.415 0.626 . . . . 1.71 111.484 -173.839 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 18.4 tt0 -89.44 129.48 47.14 Favored Pre-proline 0 C--N 1.318 -0.789 0 CA-C-N 115.051 -0.977 . . . . 2.13 110.347 174.108 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -79.12 114.68 3.39 Favored 'Trans proline' 0 N--CA 1.453 -0.875 0 C-N-CA 121.92 1.747 . . . . 1.36 111.325 177.75 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -172.93 94.99 0.36 Allowed Pre-proline 0 C--N 1.322 -0.598 0 CA-C-N 115.654 -0.703 . . . . 1.89 110.446 -179.121 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.581 ' HB3' ' HA2' ' A' ' 58' ' ' GLY . 97.1 Cg_endo -80.73 35.41 0.58 Allowed 'Trans proline' 0 N--CA 1.462 -0.369 0 C-N-CA 122.717 2.278 . . . . 2.73 111.809 178.755 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 58.46 64.41 3.59 Favored Pre-proline 0 C--N 1.332 -0.196 0 CA-C-N 115.786 -0.643 . . . . 4.21 109.411 -170.842 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -84.04 62.15 6.79 Favored 'Trans proline' 0 N--CA 1.455 -0.764 0 C-N-CA 122.939 2.426 . . . . 4.26 112.112 -173.492 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.61 59.12 1.46 Allowed 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.012 -0.995 . . . . 6.21 110.068 -178.933 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -58.54 110.02 0.9 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.59 -0.732 . . . . 8.11 110.823 -177.806 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 33.1 t70 . . . . . 0 C--O 1.248 1.003 0 CA-C-O 118.244 -0.884 . . . . 9.05 110.051 -178.15 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.957 0 CA-C-O 121.02 0.438 . . . . 3.81 111.047 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 5.1 pm0 -143.12 139.28 30.34 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.353 -0.61 . . . . 4.0 109.353 176.352 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 33.7 m -137.39 152.74 27.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 120.73 0.3 . . . . 1.64 110.922 -175.645 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 31.7 m-80 -127.82 96.31 4.47 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 108.641 -0.874 . . . . 2.29 108.641 174.991 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.421 HG21 HD21 ' A' ' 53' ' ' LEU . 28.8 mm -119.69 149.71 22.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 N-CA-C 109.406 -0.591 . . . . 0.82 109.406 -176.423 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -163.4 162.15 17.54 Favored Pre-proline 0 C--N 1.323 -0.578 0 N-CA-C 109.488 -0.56 . . . . 1.38 109.488 -177.205 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.452 ' HA ' ' O ' ' A' ' 37' ' ' SER . 53.3 Cg_exo -52.23 130.54 35.92 Favored 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 122.95 2.433 . . . . 1.73 113.006 -175.976 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 158.69 48.03 0.01 OUTLIER Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 120.744 -0.741 . . . . 1.84 112.255 -178.345 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 19.8 m 67.81 126.81 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 123.155 0.582 . . . . 1.61 111.285 -177.167 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.623 HD11 ' HB3' ' A' ' 53' ' ' LEU . 67.1 tp -60.78 -36.01 77.89 Favored 'General case' 0 CA--C 1.521 -0.147 0 CA-C-N 116.109 -0.496 . . . . 1.19 110.482 179.589 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -49.23 -55.02 13.94 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.471 -0.786 . . . . 2.11 111.018 173.534 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 64.5 tttm -67.95 -27.67 66.8 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.944 0.402 . . . . 2.72 111.086 -178.958 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -66.08 -56.77 9.83 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.289 -0.414 . . . . 0.46 110.112 178.541 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 96.2 mt -59.42 -38.39 80.5 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 115.959 -0.564 . . . . 0.69 110.981 175.773 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -60.95 -38.58 86.39 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.937 -0.574 . . . . 1.31 110.397 179.254 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 47.8 tt0 -62.86 -40.03 96.23 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.994 -0.548 . . . . 2.23 110.648 176.848 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.493 ' HD1' ' HZ ' ' A' ' 23' ' ' PHE . 3.7 t80 -67.86 -41.68 82.5 Favored 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 108.477 -0.935 . . . . 0.65 108.477 179.813 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.718 ' HA ' ' CE2' ' A' ' 23' ' ' PHE . . . -55.2 -48.06 74.4 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.292 -0.867 . . . . 0.37 111.76 175.699 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.84 -25.1 67.31 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.242 -0.435 . . . . 0.64 111.544 -179.364 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 74.0 t60 -64.43 -49.01 73.18 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.282 -0.417 . . . . 1.85 111.602 -177.118 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.406 ' HB2' ' CD1' ' A' ' 23' ' ' PHE . 15.8 m -108.68 -11.24 15.1 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.584 -0.447 . . . . 1.67 112.116 -175.896 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 75.78 58.06 3.92 Favored Glycine 0 CA--C 1.519 0.322 0 CA-C-N 115.932 -0.576 . . . . 0.62 113.564 177.066 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.718 ' CE2' ' HA ' ' A' ' 18' ' ' ALA . 10.6 p90 -117.97 169.85 9.31 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.968 0.384 . . . . 0.57 111.028 178.524 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 13.3 m -92.18 118.18 30.59 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-O 121.201 0.524 . . . . 0.68 112.226 -172.193 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.616 HD21 ' CE3' ' A' ' 69' ' ' TRP . 1.5 mm? -99.32 138.98 35.65 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.71 -0.677 . . . . 1.67 110.742 175.056 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 44.4 m -125.41 100.74 6.63 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.075 0.464 . . . . 1.15 110.197 177.144 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 5.9 p -145.67 135.32 17.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.737 -0.665 . . . . 0.9 110.785 -177.865 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -98.98 129.01 45.25 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.076 -0.511 . . . . 2.38 109.724 177.81 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -54.36 -23.79 16.91 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 113.877 1.065 . . . . 1.97 113.877 -172.098 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 85.4 p -66.42 -27.49 67.88 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.12 0.486 . . . . 2.22 110.718 -175.278 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 96.7 mt -75.99 -47.13 26.13 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.551 -0.75 . . . . 1.38 111.13 -177.922 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 3.5 t -99.31 40.78 1.19 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.621 0.724 . . . . 1.44 110.706 -177.217 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.479 ' O ' ' HG3' ' A' ' 33' ' ' ARG . 8.6 ptp180 -63.25 105.89 0.8 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.656 -0.702 . . . . 4.63 111.039 179.546 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 63.01 19.44 61.31 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 121.088 -0.577 . . . . 1.62 112.377 179.656 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.637 ' HE3' ' HA ' ' A' ' 57' ' ' SER . 8.6 tptp -74.32 112.71 10.75 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.601 -0.518 . . . . 2.75 109.601 -177.149 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -103.87 156.65 17.66 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.731 0.301 . . . . 2.24 110.479 -177.122 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.452 ' O ' ' HA ' ' A' ' 7' ' ' PRO . 46.7 t -128.62 130.27 47.05 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 107.222 -1.399 . . . . 1.02 107.222 172.657 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 35.0 m-20 -63.96 -15.23 58.76 Favored 'General case' 0 C--N 1.322 -0.606 0 O-C-N 123.441 0.463 . . . . 1.28 112.086 -173.983 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 123.36 172.31 13.78 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.901 -0.666 . . . . 0.42 112.159 172.957 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.411 ' HB3' ' HB ' ' A' ' 5' ' ' ILE . 31.4 tp -161.31 121.39 2.65 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.023 -0.732 . . . . 0.7 109.023 -177.338 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 19.2 t-80 -143.85 99.28 3.38 Favored 'General case' 0 C--N 1.321 -0.664 0 C-N-CA 120.205 -0.598 . . . . 2.96 110.892 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -168.27 -169.54 31.86 Favored Glycine 0 N--CA 1.446 -0.656 0 CA-C-N 115.451 -0.795 . . . . 0.55 111.917 178.252 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -78.35 85.98 4.45 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.518 -0.549 . . . . 2.18 109.518 174.789 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 67.5 m-85 -119.53 122.57 41.93 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.289 0.566 . . . . 1.41 111.628 -176.205 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -84.25 -174.49 5.31 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.278 -0.873 . . . . 2.23 108.798 173.758 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 47.3 t -51.88 -67.93 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 120.671 0.272 . . . . 0.57 111.499 -177.319 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -55.11 -41.76 72.07 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 112.815 0.672 . . . . 2.39 112.815 -176.105 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 22.1 m -71.69 -31.04 66.34 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.966 0.412 . . . . 1.26 111.34 -174.831 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.415 ' O ' ' HG ' ' A' ' 53' ' ' LEU . . . -71.82 -49.21 24.19 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.85 -0.691 . . . . 0.37 112.071 -175.705 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.441 ' O ' ' HG ' ' A' ' 54' ' ' LEU . 8.5 mp -65.57 -38.73 90.4 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 121.959 0.104 . . . . 1.09 111.208 -178.248 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 58.1 tt0 -53.27 -52.99 57.25 Favored 'General case' 0 C--N 1.331 -0.218 0 O-C-N 123.222 0.326 . . . . 2.59 111.752 179.743 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 12.5 mm100 -64.31 -41.9 96.62 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.882 0.373 . . . . 1.75 111.035 -177.808 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.623 ' HB3' HD11 ' A' ' 10' ' ' LEU . 88.0 mt -59.71 -21.48 60.71 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 115.905 -0.589 . . . . 0.73 112.417 -179.796 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.643 HD21 HG12 ' A' ' 61' ' ' VAL . 65.0 mt -75.36 -14.52 60.48 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.032 0.382 . . . . 2.16 112.032 -177.415 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -72.3 131.61 42.91 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.995 0.426 . . . . 2.24 110.09 -177.345 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 101.72 -17.45 54.81 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.889 -0.672 . . . . 1.7 111.526 -175.838 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.637 ' HA ' ' HE3' ' A' ' 35' ' ' LYS . 4.3 m -102.55 160.07 14.89 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-O 120.733 0.302 . . . . 2.28 110.203 178.501 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -107.27 35.75 4.83 Favored Glycine 0 N--CA 1.441 -0.984 0 N-CA-C 109.705 -1.358 . . . . 1.58 109.705 171.018 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.637 ' HB3' HD21 ' A' ' 71' ' ' LEU . 50.7 mt -126.57 174.31 8.78 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.265 -0.642 . . . . 1.42 109.265 -177.866 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 71.9 mt-30 -146.94 118.97 8.19 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.348 -0.612 . . . . 2.67 109.348 179.733 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.643 HG12 HD21 ' A' ' 54' ' ' LEU . 7.6 p -86.65 130.36 36.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 N-CA-C 109.667 -0.494 . . . . 1.54 109.667 179.153 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 26.8 ttpp -131.53 131.73 23.05 Favored Pre-proline 0 N--CA 1.442 -0.834 0 N-CA-C 109.816 -0.438 . . . . 1.81 109.816 -174.622 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -54.09 125.71 19.67 Favored 'Trans proline' 0 N--CA 1.463 -0.313 0 C-N-CA 122.418 2.079 . . . . 0.85 111.088 177.433 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.556 ' HG ' ' HB ' ' A' ' 70' ' ' THR . 0.7 OUTLIER -74.03 -63.66 1.17 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.46 -0.791 . . . . 1.7 110.254 -173.856 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -155.48 -107.07 0.27 Allowed Glycine 0 N--CA 1.445 -0.74 0 C-N-CA 120.755 -0.736 . . . . 1.69 111.961 177.901 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -80.81 94.55 6.45 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.571 0.225 . . . . 2.96 110.687 179.787 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 0.591 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 2.8 t-20 58.08 39.6 26.06 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.404 0.621 . . . . 2.5 110.44 174.759 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.44 ' O ' ' HD1' ' A' ' 69' ' ' TRP . 15.2 p -135.82 169.13 18.06 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 109.457 -0.572 . . . . 1.3 109.457 179.235 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' TRP . . . . . 0.616 ' CE3' HD21 ' A' ' 25' ' ' LEU . 26.8 m0 -140.87 154.69 46.28 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 108.975 -0.75 . . . . 0.47 108.975 -175.354 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.556 ' HB ' ' HG ' ' A' ' 64' ' ' LEU . 8.6 t -137.73 138.13 39.01 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 108.802 -0.814 . . . . 0.83 108.802 175.002 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.637 HD21 ' HB3' ' A' ' 59' ' ' LEU . 6.5 tt -93.12 102.57 14.89 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.51 0.671 . . . . 1.71 109.799 -178.451 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.424 ' HA ' ' HD3' ' A' ' 73' ' ' PRO . 25.8 mm-40 -89.3 132.73 36.6 Favored Pre-proline 0 C--N 1.319 -0.738 0 CA-C-N 114.678 -1.146 . . . . 2.13 111.248 178.649 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 72' ' ' GLU . 7.7 Cg_exo -73.15 115.15 4.25 Favored 'Trans proline' 0 N--CA 1.461 -0.392 0 C-N-CA 122.677 2.251 . . . . 1.36 111.574 176.361 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -167.88 92.02 0.66 Allowed Pre-proline 0 C--N 1.324 -0.532 0 CA-C-N 116.039 -0.528 . . . . 1.89 109.758 -178.102 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -79.28 -78.68 0.0 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.569 0 C-N-CA 122.543 2.162 . . . . 2.73 112.133 -178.42 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -142.55 62.83 13.5 Favored Pre-proline 0 C--N 1.321 -0.652 0 N-CA-C 108.147 -1.057 . . . . 4.21 108.147 171.241 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -94.78 30.15 0.23 Allowed 'Trans proline' 0 N--CA 1.451 -1.022 0 C-N-CA 123.408 2.739 . . . . 4.26 112.669 -168.43 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.566 ' HG2' ' HB3' ' A' ' 80' ' ' ASP . 27.6 ttpp -158.61 107.75 1.97 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.978 -0.556 . . . . 6.21 109.97 178.473 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 28.2 mm-40 -77.45 63.5 2.62 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.327 0.584 . . . . 8.11 109.907 176.69 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.566 ' HB3' ' HG2' ' A' ' 78' ' ' LYS . 17.3 t70 . . . . . 0 C--O 1.246 0.904 0 CA-C-O 118.072 -0.966 . . . . 9.05 109.346 -176.559 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.442 ' O ' ' HA ' ' A' ' 43' ' ' ASP . . . . . . . . 0 N--CA 1.481 1.106 0 N-CA-C 110.152 -0.314 . . . . 3.81 110.152 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 19.6 pt20 -86.88 134.9 33.49 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.327 0.584 . . . . 4.0 110.841 -178.631 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.63 ' O ' ' HA ' ' A' ' 41' ' ' HIS . 36.2 t -101.59 131.7 48.92 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.938 0 CA-C-N 115.301 -0.863 . . . . 1.64 108.859 174.492 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -129.48 109.49 11.09 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.229 0.537 . . . . 2.29 109.995 179.465 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.644 HD13 ' HB1' ' A' ' 13' ' ' ALA . 68.6 mt -131.02 127.06 60.58 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 115.932 -0.576 . . . . 0.82 110.537 -177.199 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -76.18 159.7 79.69 Favored Pre-proline 0 N--CA 1.45 -0.459 0 CA-C-N 115.916 -0.584 . . . . 1.38 109.657 177.446 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.587 ' HA ' ' O ' ' A' ' 37' ' ' SER . 44.7 Cg_endo -69.6 49.91 0.72 Allowed 'Trans proline' 0 CA--C 1.534 0.495 0 C-N-CA 122.915 2.41 . . . . 1.73 113.123 177.632 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -116.75 -150.06 9.25 Favored Glycine 0 C--O 1.226 -0.347 0 C-N-CA 121.241 -0.504 . . . . 1.84 112.574 -178.703 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.583 ' HA ' ' O ' ' A' ' 35' ' ' LYS . 22.8 p -62.54 125.47 24.05 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.162 0.506 . . . . 1.61 111.867 -176.294 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.804 ' HB3' ' HB3' ' A' ' 35' ' ' LYS . 70.3 tp -65.49 -32.4 73.98 Favored 'General case' 0 N--CA 1.456 -0.172 0 CA-C-N 115.64 -0.709 . . . . 1.19 109.696 178.758 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.579 ' OD2' ' HB ' ' A' ' 32' ' ' THR . 10.6 m-20 -50.5 -53.89 26.52 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.19 -0.914 . . . . 2.11 110.401 175.21 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -68.84 -26.66 65.27 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.772 -0.649 . . . . 2.72 110.638 177.999 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.644 ' HB1' HD13 ' A' ' 5' ' ' ILE . . . -67.36 -53.07 32.73 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.988 -0.551 . . . . 0.46 110.816 -178.85 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 87.2 mt -56.96 -43.73 81.88 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.116 -0.493 . . . . 0.69 110.873 177.026 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 52.9 t30 -62.4 -32.55 73.39 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.831 -0.622 . . . . 1.31 110.371 -179.64 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 22.1 tm0? -62.16 -45.35 93.79 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.283 -0.417 . . . . 2.23 110.445 177.096 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 13.5 t80 -71.38 -41.36 69.78 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 109.65 -0.5 . . . . 0.65 109.65 -178.78 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.709 ' HA ' ' CE2' ' A' ' 23' ' ' PHE . . . -53.37 -53.41 51.47 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 115.501 -0.772 . . . . 0.37 112.141 178.194 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -64.54 -26.2 68.31 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.311 -0.404 . . . . 0.64 111.461 -178.998 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 70.5 t60 -64.8 -45.19 87.28 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.293 -0.412 . . . . 1.85 111.298 -176.869 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.479 ' HB2' ' CE1' ' A' ' 23' ' ' PHE . 24.5 m -101.04 -7.02 23.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.269 0.557 . . . . 1.67 111.594 -178.735 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 67.66 47.11 63.63 Favored Glycine 0 N--CA 1.449 -0.494 0 CA-C-N 115.309 -0.86 . . . . 0.62 114.023 176.791 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.709 ' CE2' ' HA ' ' A' ' 18' ' ' ALA . 5.9 p90 -109.21 160.73 15.87 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 117.389 0.595 . . . . 0.57 110.624 175.981 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.447 ' O ' ' HB3' ' A' ' 68' ' ' SER . 25.0 m -88.14 119.82 28.9 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.431 0.634 . . . . 0.68 112.529 -171.532 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.577 HD21 ' CE3' ' A' ' 69' ' ' TRP . 1.6 mm? -95.73 121.34 37.34 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.609 -0.723 . . . . 1.67 111.174 176.617 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 18.9 m -104.35 93.32 4.75 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.67 -0.492 . . . . 1.15 109.67 175.633 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.479 ' HB ' HD23 ' A' ' 71' ' ' LEU . 5.4 p -139.78 135.0 38.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.911 -0.586 . . . . 0.9 111.456 -174.289 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -92.52 117.54 30.05 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.819 -0.628 . . . . 2.38 110.085 175.221 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.48 76.67 0.01 OUTLIER 'General case' 0 C--O 1.232 0.165 0 CA-C-N 115.86 -0.609 . . . . 1.97 112.089 178.398 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 13.8 m -159.38 -50.31 0.06 Allowed 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 108.294 -1.002 . . . . 2.22 108.294 179.542 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 87.5 mt -62.93 -44.0 97.27 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 108.771 -0.825 . . . . 1.38 108.771 172.477 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.579 ' HB ' ' OD2' ' A' ' 11' ' ' ASP . 26.3 p -93.7 59.08 2.79 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-N 114.942 -1.026 . . . . 1.44 110.273 175.518 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 9.7 tpt180 -102.4 112.04 24.59 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.881 -0.599 . . . . 4.63 110.173 174.512 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 69.65 34.74 73.2 Favored Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 120.712 -0.756 . . . . 1.62 112.596 176.37 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.804 ' HB3' ' HB3' ' A' ' 10' ' ' LEU . 13.2 mptt -81.13 140.56 34.96 Favored 'General case' 0 CA--C 1.511 -0.529 0 N-CA-C 109.478 -0.564 . . . . 2.75 109.478 176.666 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' GLN . . . . . 0.4 ' HA ' ' HA ' ' A' ' 9' ' ' SER . 49.1 mt-30 -138.17 134.18 34.22 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 109.944 -0.391 . . . . 2.24 109.944 -179.764 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.587 ' O ' ' HA ' ' A' ' 7' ' ' PRO . 7.8 t -124.34 134.13 53.25 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.278 -0.638 . . . . 1.02 109.278 -178.584 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 5.8 m-20 -60.08 -14.88 18.94 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 112.716 0.636 . . . . 1.28 112.716 -178.332 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 132.05 178.66 15.63 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.248 -0.977 . . . . 0.42 113.008 170.829 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.502 HD23 HG11 ' A' ' 3' ' ' VAL . 48.4 tp -160.44 122.01 3.1 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 108.135 -1.061 . . . . 0.7 108.135 -179.135 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' HIS . . . . . 0.63 ' HA ' ' O ' ' A' ' 3' ' ' VAL . 39.7 t-80 -145.37 99.84 3.36 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.213 -0.595 . . . . 2.96 111.972 179.215 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -169.37 178.14 42.63 Favored Glycine 0 N--CA 1.443 -0.892 0 N-CA-C 110.969 -0.852 . . . . 0.55 110.969 174.483 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.442 ' HA ' ' O ' ' A' ' 1' ' ' ALA . 11.9 t70 -82.39 113.06 19.9 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 108.12 -1.067 . . . . 2.18 108.12 169.031 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 50.5 m-85 -128.89 131.13 47.58 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.074 0.464 . . . . 1.41 111.888 -173.501 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -66.15 160.37 24.24 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.256 -0.884 . . . . 2.23 109.219 169.288 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 47.2 t -49.03 -61.22 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 O-C-N 123.507 0.504 . . . . 0.57 111.502 -174.609 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.683 ' HA ' HD23 ' A' ' 50' ' ' LEU . 46.5 mt-10 -64.24 -40.18 95.48 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.256 -0.429 . . . . 2.39 111.695 -178.398 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 28.1 t -71.07 -30.4 66.53 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-O 120.892 0.377 . . . . 1.26 111.428 -170.81 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -81.18 -32.11 32.68 Favored Glycine 0 N--CA 1.447 -0.615 0 C-N-CA 120.531 -0.842 . . . . 0.37 111.526 -177.136 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.683 HD23 ' HA ' ' A' ' 47' ' ' GLU . 0.3 OUTLIER -80.59 -41.14 24.5 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 109.539 -0.541 . . . . 1.09 109.539 -178.198 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 51' ' ' GLN . . . . . 0.576 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 54.3 tt0 -53.95 -39.23 65.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.735 -0.666 . . . . 2.59 111.768 174.451 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 62.2 tp60 -63.07 -46.64 86.48 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.377 -0.374 . . . . 1.75 110.133 178.885 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.475 ' HB3' HD11 ' A' ' 10' ' ' LEU . 95.8 mt -58.39 -21.71 51.34 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 115.803 -0.635 . . . . 0.73 112.344 178.375 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.41 ' HG ' ' O ' ' A' ' 50' ' ' LEU . 87.2 mt -73.88 -24.71 59.76 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-O 120.685 0.278 . . . . 2.16 111.611 -178.036 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -73.5 113.55 10.73 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.115 0.483 . . . . 2.24 110.77 -176.693 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 127.67 -12.96 6.54 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.807 -0.711 . . . . 1.7 111.846 -179.05 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 70.6 p -118.12 175.1 5.84 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 110.005 -0.368 . . . . 2.28 110.005 179.041 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -113.13 33.25 5.67 Favored Glycine 0 N--CA 1.448 -0.541 0 N-CA-C 111.271 -0.732 . . . . 1.58 111.271 179.251 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 85.1 mt -119.99 179.31 4.3 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 108.872 -0.788 . . . . 1.42 108.872 178.829 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -149.87 119.11 6.8 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.091 0.472 . . . . 2.67 109.925 178.478 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 59.9 t -92.92 126.58 45.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 N-CA-C 109.08 -0.711 . . . . 1.54 109.08 176.547 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.487 ' HE2' ' HB2' ' A' ' 72' ' ' GLU . 50.9 mtmt -126.17 134.35 25.87 Favored Pre-proline 0 C--N 1.319 -0.751 0 N-CA-C 109.509 -0.552 . . . . 1.81 109.509 -177.812 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.475 ' HA ' ' O ' ' A' ' 68' ' ' SER . 47.8 Cg_exo -56.32 117.86 4.58 Favored 'Trans proline' 0 N--CA 1.459 -0.557 0 C-N-CA 122.232 1.955 . . . . 0.85 110.825 173.679 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 55.6 tp -58.07 -42.41 85.48 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 114.917 -1.038 . . . . 1.7 112.079 -171.13 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -179.64 -86.64 0.07 OUTLIER Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 120.553 -0.832 . . . . 1.69 112.287 179.744 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 50.3 t30 -61.18 -76.03 0.06 Allowed 'General case' 0 C--N 1.33 -0.265 0 O-C-N 123.52 0.188 . . . . 2.96 111.138 -179.344 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 66.5 t30 -155.93 53.14 0.57 Allowed 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 121.662 0.744 . . . . 2.5 109.626 178.738 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.475 ' O ' ' HA ' ' A' ' 63' ' ' PRO . 10.8 m -138.11 178.79 6.86 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 107.883 -1.154 . . . . 1.3 107.883 -179.328 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' TRP . . . . . 0.577 ' CE3' HD21 ' A' ' 25' ' ' LEU . 51.5 m0 -136.52 157.1 47.57 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.114 -0.698 . . . . 0.47 109.114 -176.364 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 13.8 t -142.6 147.81 36.45 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.752 0.311 . . . . 0.83 110.236 176.072 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.479 HD23 ' HB ' ' A' ' 27' ' ' VAL . 3.9 mm? -93.41 102.95 15.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.167 0.508 . . . . 1.71 111.253 179.457 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.487 ' HB2' ' HE2' ' A' ' 62' ' ' LYS . 17.8 mt-10 -106.25 131.42 21.74 Favored Pre-proline 0 C--N 1.32 -0.715 0 CA-C-N 115.328 -0.851 . . . . 2.13 111.182 172.538 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.455 ' HD3' ' HA ' ' A' ' 72' ' ' GLU . 24.0 Cg_exo -64.01 114.78 2.77 Favored 'Trans proline' 0 N--CA 1.456 -0.708 0 C-N-CA 122.249 1.966 . . . . 1.36 111.274 176.193 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -141.91 63.51 16.25 Favored Pre-proline 0 C--N 1.318 -0.77 0 CA-C-N 115.41 -0.814 . . . . 1.89 108.865 175.105 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -84.92 63.96 6.32 Favored 'Trans proline' 0 N--CA 1.452 -0.957 0 C-N-CA 122.656 2.238 . . . . 2.73 112.316 -170.596 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 52.63 64.47 7.3 Favored Pre-proline 0 C--O 1.234 0.253 0 N-CA-C 109.35 -0.611 . . . . 4.21 109.35 -174.233 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -83.72 87.1 1.26 Allowed 'Trans proline' 0 N--CA 1.448 -1.202 0 C-N-CA 122.9 2.4 . . . . 4.26 112.551 -167.804 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.758 ' HE2' ' HA ' ' A' ' 78' ' ' LYS . 0.2 OUTLIER -81.7 57.0 3.21 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.457 -0.792 . . . . 6.21 109.047 176.966 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -68.53 -21.08 64.59 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.231 -0.895 . . . . 8.11 110.813 -175.795 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 15.1 t70 . . . . . 0 C--O 1.249 1.073 0 CA-C-O 118.163 -0.922 . . . . 9.05 109.24 172.258 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.077 0 N-CA-C 111.355 0.131 . . . . 3.81 111.355 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.663 ' HA ' ' HA ' ' A' ' 43' ' ' ASP . 60.6 tp60 67.91 120.54 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 122.01 0.91 . . . . 4.0 111.69 -178.454 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 60.3 t -101.43 131.44 49.22 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 CA-C-N 114.437 -1.256 . . . . 1.64 108.724 178.586 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 50.6 m-80 -123.41 99.54 6.38 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.069 0.462 . . . . 2.29 110.114 -173.592 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.477 ' HB ' ' H ' ' A' ' 40' ' ' LEU . 30.2 mt -130.49 160.29 41.77 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 N-CA-C 108.766 -0.828 . . . . 0.82 108.766 179.48 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.7 ' HB1' ' HD2' ' A' ' 7' ' ' PRO . . . -164.6 172.87 4.31 Favored Pre-proline 0 C--N 1.323 -0.555 0 CA-C-O 118.815 -0.612 . . . . 1.38 109.448 -176.958 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.7 ' HD2' ' HB1' ' A' ' 6' ' ' ALA . 33.7 Cg_exo -36.97 130.49 0.49 Allowed 'Trans proline' 0 C--N 1.357 1.006 0 C-N-CA 123.297 2.665 . . . . 1.73 113.685 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 155.57 -177.16 32.87 Favored Glycine 0 N--CA 1.444 -0.767 0 N-CA-C 110.982 -0.847 . . . . 1.84 110.982 -177.886 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.588 ' HA ' ' O ' ' A' ' 35' ' ' LYS . 19.6 m -68.32 133.68 49.12 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 110.068 -0.345 . . . . 1.61 110.068 178.926 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 59.9 tp -58.8 -32.32 69.24 Favored 'General case' 0 C--O 1.23 0.071 0 CA-C-O 120.989 0.423 . . . . 1.19 110.727 179.58 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -49.64 -46.65 49.76 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.436 -0.802 . . . . 2.11 110.559 172.871 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 5.1 tmtm? -64.37 -35.03 79.55 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.658 -0.701 . . . . 2.72 110.066 -178.246 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -65.26 -59.41 4.1 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.155 -0.475 . . . . 0.46 110.961 -176.746 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 94.0 mt -59.61 -39.07 83.03 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.097 -0.501 . . . . 0.69 111.232 178.142 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 47.2 t30 -60.99 -38.39 85.84 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.966 0.412 . . . . 1.31 110.052 178.311 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 20.9 tm0? -61.6 -44.05 97.73 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.974 -0.557 . . . . 2.23 110.663 177.054 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.417 ' CD1' ' HH2' ' A' ' 69' ' ' TRP . 3.9 t80 -68.53 -43.51 76.58 Favored 'General case' 0 N--CA 1.457 -0.106 0 N-CA-C 109.24 -0.652 . . . . 0.65 109.24 -179.503 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.692 ' HA ' ' CZ ' ' A' ' 23' ' ' PHE . . . -54.55 -49.16 70.96 Favored 'General case' 0 C--N 1.333 -0.109 0 CA-C-N 115.619 -0.719 . . . . 0.37 111.546 176.923 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -64.92 -24.98 67.69 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.403 -0.362 . . . . 0.64 111.515 -179.488 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 56.1 t60 -60.99 -50.95 71.29 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.342 -0.39 . . . . 1.85 111.305 -177.567 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.564 ' HB2' ' CD1' ' A' ' 23' ' ' PHE . 15.7 m -108.11 -1.5 20.33 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.993 0.425 . . . . 1.67 111.783 -177.245 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 62.24 46.62 93.56 Favored Glycine 0 C--N 1.332 0.339 0 CA-C-N 115.595 -0.729 . . . . 0.62 113.699 174.497 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.692 ' CZ ' ' HA ' ' A' ' 18' ' ' ALA . 14.4 p90 -105.12 172.79 6.6 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.842 0.321 . . . . 0.57 110.568 -179.419 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 47.6 m -91.71 106.19 18.29 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.34 0.59 . . . . 0.68 111.41 -179.514 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 3.6 tt -92.98 123.03 35.94 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.017 -0.735 . . . . 1.67 109.017 175.633 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.407 ' O ' ' HA ' ' A' ' 70' ' ' THR . 33.4 t -101.04 101.11 11.81 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.172 0.51 . . . . 1.15 110.064 -176.552 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.2 p -141.22 135.14 31.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.729 -0.669 . . . . 0.9 110.444 -179.898 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -81.83 123.3 28.68 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.857 -0.611 . . . . 2.38 110.406 177.961 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.14 82.77 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.805 -0.634 . . . . 1.97 111.954 178.893 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.526 ' HA ' ' NE ' ' A' ' 33' ' ' ARG . 55.5 p -172.44 -45.4 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.289 -0.414 . . . . 2.22 110.053 -179.706 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 93.5 mt -62.09 -44.61 96.3 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.584 -0.734 . . . . 1.38 112.227 -174.386 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.461 ' O ' ' HB2' ' A' ' 35' ' ' LYS . 30.0 p -97.86 2.55 49.4 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 112.206 0.447 . . . . 1.44 112.206 -176.265 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ARG . . . . . 0.526 ' NE ' ' HA ' ' A' ' 30' ' ' SER . 64.6 mtm180 -58.55 121.66 11.5 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-O 120.581 0.229 . . . . 4.63 111.442 -178.408 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 81.3 11.71 83.06 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 121.056 -0.593 . . . . 1.62 112.781 175.929 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.588 ' O ' ' HA ' ' A' ' 9' ' ' SER . 12.8 mptt -85.08 151.01 24.46 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.872 0.368 . . . . 2.75 110.817 -179.763 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 32.1 mm-40 -131.46 138.3 48.97 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 108.437 -0.949 . . . . 2.24 108.437 178.667 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.501 ' O ' ' HA ' ' A' ' 7' ' ' PRO . 34.6 t -131.6 141.66 49.71 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 109.186 -0.672 . . . . 1.02 109.186 179.236 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 6.1 m-20 -77.1 -2.36 33.82 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.431 -0.349 . . . . 1.28 111.65 178.062 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.472 ' HA2' HG22 ' A' ' 5' ' ' ILE . . . 98.02 -169.63 24.29 Favored Glycine 0 N--CA 1.445 -0.754 0 C-N-CA 120.421 -0.895 . . . . 0.42 113.619 170.714 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.477 ' H ' ' HB ' ' A' ' 5' ' ' ILE . 54.8 tp -160.23 140.41 11.54 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 107.537 -1.283 . . . . 0.7 107.537 -179.28 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 17.4 t60 -144.52 99.54 3.38 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 120.195 -0.602 . . . . 2.96 111.241 -178.185 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -169.48 170.69 42.81 Favored Glycine 0 N--CA 1.448 -0.518 0 N-CA-C 110.547 -1.021 . . . . 0.55 110.547 175.947 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.663 ' HA ' ' HA ' ' A' ' 2' ' ' GLN . 44.2 t0 -86.0 91.77 8.49 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 108.607 -0.886 . . . . 2.18 108.607 175.84 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 25.6 m-85 -107.4 138.01 44.38 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.555 -0.748 . . . . 1.41 112.173 -170.131 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -75.33 165.56 24.97 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 108.449 -0.945 . . . . 2.23 108.449 169.975 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.484 HG13 ' HZ2' ' A' ' 69' ' ' TRP . 61.2 t -50.44 -70.31 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 112.356 0.502 . . . . 0.57 112.356 -174.383 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -61.33 -42.19 98.26 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 112.285 0.476 . . . . 2.39 112.285 -172.465 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 34.9 t -70.18 -26.21 63.8 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.878 0.37 . . . . 1.26 110.524 -175.221 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.447 ' O ' ' HG ' ' A' ' 53' ' ' LEU . . . -77.24 -36.08 35.96 Favored Glycine 0 N--CA 1.444 -0.826 0 N-CA-C 110.956 -0.858 . . . . 0.37 110.956 -179.664 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.677 ' HB3' HG13 ' A' ' 61' ' ' VAL . 92.8 mt -72.69 -43.62 62.83 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.76 0.314 . . . . 1.09 110.628 -179.38 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 57.0 tp60 -52.96 -50.06 64.86 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.837 -0.62 . . . . 2.59 111.575 178.902 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.458 ' HA ' ' OE1' ' A' ' 52' ' ' GLN . 12.8 mm-40 -65.86 -37.13 85.36 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.524 -0.307 . . . . 1.75 111.458 -178.039 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.447 ' HG ' ' O ' ' A' ' 49' ' ' GLY . 66.1 mt -57.88 -39.86 78.85 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.176 0.436 . . . . 0.73 112.176 179.327 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.473 HD12 HG12 ' A' ' 61' ' ' VAL . 45.2 mt -105.39 16.84 24.93 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.257 0.466 . . . . 2.16 112.257 -174.856 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -68.15 94.58 0.52 Allowed 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 120.993 0.425 . . . . 2.24 111.188 -179.895 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 109.57 -7.01 31.8 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.919 -0.658 . . . . 1.7 113.565 176.621 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 60.4 p -83.72 -1.54 54.33 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 117.357 0.579 . . . . 2.28 111.705 -175.755 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 76.57 17.67 79.71 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.764 -0.732 . . . . 1.58 112.118 -179.739 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 96.7 mt -124.96 168.57 13.13 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.516 -0.342 . . . . 1.42 110.091 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 33.7 tt0 -150.69 118.64 6.24 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.18 -0.674 . . . . 2.67 109.18 175.915 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.677 HG13 ' HB3' ' A' ' 50' ' ' LEU . 7.2 p -109.73 129.67 64.2 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 N-CA-C 109.998 -0.371 . . . . 1.54 109.998 179.425 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 24.0 pttm -148.47 156.53 42.3 Favored Pre-proline 0 C--N 1.322 -0.628 0 N-CA-C 109.884 -0.413 . . . . 1.81 109.884 -177.126 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.615 ' HA ' ' HA ' ' A' ' 69' ' ' TRP . 25.7 Cg_exo -63.93 148.17 91.77 Favored 'Trans proline' 0 N--CA 1.461 -0.392 0 C-N-CA 122.716 2.277 . . . . 0.85 111.904 176.706 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.498 HD21 ' HB ' ' A' ' 70' ' ' THR . 82.0 mt -65.68 -27.39 68.31 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.595 -0.73 . . . . 1.7 110.659 179.363 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 152.0 -19.95 0.86 Allowed Glycine 0 N--CA 1.451 -0.361 0 N-CA-C 109.674 -1.371 . . . . 1.69 109.674 -178.63 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 5.6 p30 -128.21 -157.87 0.84 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 114.414 -0.893 . . . . 2.96 109.314 174.865 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -77.07 45.48 0.44 Allowed 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 121.188 0.518 . . . . 2.5 112.158 -176.918 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.401 ' O ' ' HA ' ' A' ' 63' ' ' PRO . 19.5 m -141.51 165.54 27.22 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 107.391 -1.337 . . . . 1.3 107.391 172.983 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' TRP . . . . . 0.615 ' HA ' ' HA ' ' A' ' 63' ' ' PRO . 52.8 m0 -133.83 166.81 21.81 Favored 'General case' 0 C--N 1.32 -0.716 0 C-N-CA 120.487 -0.485 . . . . 0.47 110.817 -166.38 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.498 ' HB ' HD21 ' A' ' 64' ' ' LEU . 8.9 t -146.49 143.98 29.32 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.419 -0.585 . . . . 0.83 109.419 171.782 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 35.9 tp -93.08 100.95 13.27 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-O 121.662 0.744 . . . . 1.71 109.26 176.153 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -94.75 130.29 33.63 Favored Pre-proline 0 C--N 1.316 -0.863 0 CA-C-N 114.838 -1.073 . . . . 2.13 111.267 -177.34 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_exo -69.98 113.37 3.39 Favored 'Trans proline' 0 N--CA 1.451 -0.995 0 C-N-CA 121.535 1.49 . . . . 1.36 110.714 174.153 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -152.07 75.64 7.37 Favored Pre-proline 0 C--N 1.321 -0.663 0 CA-C-N 115.665 -0.698 . . . . 1.89 109.192 179.572 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -87.34 35.64 0.44 Allowed 'Trans proline' 0 N--CA 1.454 -0.835 0 C-N-CA 122.62 2.213 . . . . 2.73 112.5 -173.767 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 55.78 56.9 10.16 Favored Pre-proline 0 C--O 1.232 0.14 0 O-C-N 123.803 0.689 . . . . 4.21 109.634 -172.795 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -71.26 102.02 1.2 Allowed 'Trans proline' 0 N--CA 1.458 -0.563 0 C-N-CA 122.495 2.13 . . . . 4.26 112.253 -168.732 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 57.02 31.42 19.89 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 115.35 -0.841 . . . . 6.21 109.875 -176.1 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -91.15 63.47 5.05 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.768 0.794 . . . . 8.11 110.558 -174.31 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 38.1 t70 . . . . . 0 C--O 1.252 1.222 0 CA-C-N 115.214 -0.903 . . . . 9.05 109.353 175.096 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.961 0 CA-C-O 121.0 0.429 . . . . 3.81 110.781 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 19.6 pm0 -81.43 151.2 28.0 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.139 0.495 . . . . 4.0 110.582 -178.326 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 12.4 p -149.19 156.08 7.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 115.589 -0.732 . . . . 1.64 109.302 -179.358 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 -127.26 108.9 11.28 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.93 0.395 . . . . 2.29 109.978 -178.449 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 60.8 mt -131.16 151.18 35.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 N-CA-C 108.89 -0.781 . . . . 0.82 108.89 -179.871 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.696 ' HB1' ' HD2' ' A' ' 7' ' ' PRO . . . -162.17 174.1 3.96 Favored Pre-proline 0 C--N 1.322 -0.625 0 CA-C-O 118.436 -0.792 . . . . 1.38 108.956 -173.689 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.696 ' HD2' ' HB1' ' A' ' 6' ' ' ALA . 47.5 Cg_exo -38.48 135.53 0.71 Allowed 'Trans proline' 0 C--N 1.361 1.235 0 C-N-CA 123.227 2.618 . . . . 1.73 113.707 -176.264 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 153.13 168.59 17.23 Favored Glycine 0 N--CA 1.446 -0.686 0 N-CA-C 110.401 -1.08 . . . . 1.84 110.401 -173.908 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.422 ' HA ' ' HA ' ' A' ' 36' ' ' GLN . 4.7 t -67.74 138.11 55.98 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.619 -0.511 . . . . 1.61 109.619 -178.736 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 59.9 tp -58.12 -36.79 73.44 Favored 'General case' 0 CA--C 1.523 -0.083 0 CA-C-N 115.349 -0.841 . . . . 1.19 111.649 -173.222 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -54.59 -50.58 67.68 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.186 -0.461 . . . . 2.11 111.154 176.049 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' LYS . . . . . 0.662 ' O ' ' HG3' ' A' ' 16' ' ' GLN . 41.0 tttm -64.0 -35.43 80.69 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.473 0.178 . . . . 2.72 110.591 177.003 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.42 -52.56 63.08 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.829 0.347 . . . . 0.46 110.132 -178.484 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.629 ' HB3' HD11 ' A' ' 25' ' ' LEU . 77.5 mt -57.27 -38.52 74.02 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.779 -0.646 . . . . 0.69 110.899 174.324 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 17.9 t-20 -61.03 -37.75 83.69 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.107 -0.497 . . . . 1.31 111.06 179.336 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.662 ' HG3' ' O ' ' A' ' 12' ' ' LYS . 18.6 mt-30 -62.3 -40.05 95.01 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.758 -0.201 . . . . 2.23 110.587 178.199 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.44 ' O ' ' HB3' ' A' ' 20' ' ' HIS . 5.0 t80 -68.38 -43.77 76.61 Favored 'General case' 0 CA--C 1.52 -0.196 0 CA-C-O 121.636 0.731 . . . . 0.65 109.169 177.433 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.684 ' HA ' ' CZ ' ' A' ' 23' ' ' PHE . . . -52.44 -46.22 66.34 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 114.707 -1.133 . . . . 0.37 111.317 176.521 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -64.52 -29.06 70.1 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.146 -0.479 . . . . 0.64 111.392 179.013 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' HIS . . . . . 0.44 ' HB3' ' O ' ' A' ' 17' ' ' TYR . 84.9 t60 -61.1 -55.06 36.94 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.056 -0.52 . . . . 1.85 111.51 -177.234 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.456 ' HB2' ' CD1' ' A' ' 23' ' ' PHE . 38.8 m -100.23 -9.21 22.66 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 112.134 0.42 . . . . 1.67 112.134 -177.456 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 69.42 55.67 9.79 Favored Glycine 0 N--CA 1.452 -0.286 0 CA-C-N 115.808 -0.633 . . . . 0.62 113.405 178.914 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.684 ' CZ ' ' HA ' ' A' ' 18' ' ' ALA . 15.5 p90 -112.67 166.54 11.25 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.77 0.319 . . . . 0.57 110.455 176.858 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 21.0 m -89.31 113.41 24.68 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.187 0.518 . . . . 0.68 111.012 -177.403 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.629 HD11 ' HB3' ' A' ' 14' ' ' LEU . 1.9 tt -99.91 136.7 39.42 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.384 -0.825 . . . . 1.67 109.588 179.002 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.67 ' HB2' ' HA ' ' A' ' 70' ' ' THR . 48.5 m -100.64 97.22 7.92 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 109.692 -0.484 . . . . 1.15 109.692 175.809 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.487 ' HB ' HD22 ' A' ' 25' ' ' LEU . 12.6 p -145.36 150.33 15.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.353 -0.385 . . . . 0.9 110.136 -177.505 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -130.42 122.82 28.48 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.402 -0.363 . . . . 2.38 110.448 -179.921 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.17 67.7 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.375 0 O-C-N 123.855 0.722 . . . . 1.97 112.286 177.433 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 30.2 t -170.62 -34.48 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.518 -0.549 . . . . 2.22 109.518 178.931 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 90.9 mt -69.13 -36.87 77.94 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.102 -0.499 . . . . 1.38 110.338 178.119 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 8.9 p -93.7 36.85 1.08 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.952 -0.567 . . . . 1.44 111.358 -179.822 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.49 105.92 2.38 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.914 0.388 . . . . 4.63 110.381 -176.579 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 87.62 17.37 58.54 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.835 -0.697 . . . . 1.62 112.062 -179.259 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.61 93.28 4.68 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.702 0.286 . . . . 2.75 110.249 179.735 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' GLN . . . . . 0.422 ' HA ' ' HA ' ' A' ' 9' ' ' SER . 49.0 mt-30 -102.69 158.09 16.49 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 110.249 -0.278 . . . . 2.24 110.249 179.529 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 32.9 t -127.2 135.56 50.82 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 108.736 -0.838 . . . . 1.02 108.736 178.958 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 6.8 m-20 -67.51 -12.87 61.36 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 113.231 0.826 . . . . 1.28 113.231 -175.499 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.407 ' HA3' ' HA ' ' A' ' 6' ' ' ALA . . . 125.13 174.83 14.06 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.028 -1.082 . . . . 0.42 114.034 170.903 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 57.0 tp -161.25 120.2 2.5 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 108.238 -1.023 . . . . 0.7 108.238 -176.239 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 11.7 p80 -144.28 99.39 3.37 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 119.808 -0.757 . . . . 2.96 111.519 -179.786 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -169.01 -177.84 40.05 Favored Glycine 0 N--CA 1.443 -0.868 0 CA-C-N 115.158 -0.928 . . . . 0.55 111.131 177.833 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -88.87 77.02 7.84 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 108.897 -0.779 . . . . 2.18 108.897 172.269 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 28.9 m-85 -98.26 129.59 44.98 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.766 -0.652 . . . . 1.41 111.68 -173.138 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 32.4 t0 -70.55 162.56 28.62 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.308 -0.86 . . . . 2.23 109.047 173.857 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 46.4 t -47.92 -64.83 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 112.285 0.476 . . . . 0.57 112.285 -172.54 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 40.9 mm-40 -56.81 -36.55 70.05 Favored 'General case' 0 N--CA 1.464 0.242 0 N-CA-C 111.773 0.286 . . . . 2.39 111.773 -176.749 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 15.3 m -71.74 -33.67 68.89 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-O 120.97 0.414 . . . . 1.26 110.773 -174.684 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -67.75 -46.84 65.0 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.955 -0.64 . . . . 0.37 112.339 -175.192 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.572 HD11 ' CZ2' ' A' ' 69' ' ' TRP . 7.1 mp -68.9 -37.26 78.87 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 110.486 -0.19 . . . . 1.09 110.486 -178.225 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -54.82 -45.86 74.49 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.433 -0.348 . . . . 2.59 111.009 178.266 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 -65.66 -46.85 77.59 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.254 -0.43 . . . . 1.75 110.989 179.102 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 88.7 mt -57.14 -29.63 63.75 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 112.29 0.478 . . . . 0.73 112.29 -178.826 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.487 ' HG ' ' O ' ' A' ' 50' ' ' LEU . 95.0 mt -77.84 -7.32 56.5 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 112.079 0.4 . . . . 2.16 112.079 -176.839 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -66.72 93.87 0.27 Allowed 'General case' 0 C--O 1.233 0.207 0 CA-C-O 121.45 0.643 . . . . 2.24 110.973 -178.703 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 136.73 -25.33 3.1 Favored Glycine 0 N--CA 1.444 -0.8 0 C-N-CA 120.835 -0.698 . . . . 1.7 112.162 -178.985 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 33.3 p -97.82 171.02 8.57 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 110.031 -0.359 . . . . 2.28 110.031 177.99 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -111.21 -15.77 10.28 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.846 -0.693 . . . . 1.58 112.103 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 2.1 pp -90.49 -178.16 5.25 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.788 -0.449 . . . . 1.42 109.788 178.255 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 94.6 mt-30 -143.08 120.66 11.76 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 118.365 0.53 . . . . 2.67 110.231 -167.493 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.475 HG21 HD11 ' A' ' 14' ' ' LEU . 21.6 t -97.38 128.25 48.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 N-CA-C 109.027 -0.731 . . . . 1.54 109.027 175.907 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 25.0 pttm -146.85 154.16 47.04 Favored Pre-proline 0 C--N 1.329 -0.312 0 C-N-CA 120.5 -0.48 . . . . 1.81 111.299 -178.777 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.64 ' HA ' ' HA ' ' A' ' 69' ' ' TRP . 42.9 Cg_exo -58.57 133.7 56.14 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.984 2.456 . . . . 0.85 111.864 173.467 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 54.4 tp -67.62 -29.15 68.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.473 -0.785 . . . . 1.7 111.141 -175.98 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 166.44 -56.26 0.24 Allowed Glycine 0 N--CA 1.45 -0.427 0 N-CA-C 110.972 -0.851 . . . . 1.69 110.972 179.396 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 13.5 m120 -83.93 -164.48 0.93 Allowed 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 108.438 -0.949 . . . . 2.96 108.438 172.815 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 9.0 t30 -78.61 58.99 2.36 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.814 0.816 . . . . 2.5 109.904 177.291 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.467 ' O ' ' HA ' ' A' ' 63' ' ' PRO . 30.9 m -147.89 174.68 11.62 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 107.725 -1.213 . . . . 1.3 107.725 176.259 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' TRP . . . . . 0.64 ' HA ' ' HA ' ' A' ' 63' ' ' PRO . 53.7 m0 -137.8 166.5 23.84 Favored 'General case' 0 C--N 1.322 -0.603 0 C-N-CA 120.323 -0.551 . . . . 0.47 110.601 -165.32 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.67 ' HA ' ' HB2' ' A' ' 26' ' ' SER . 12.3 t -146.81 150.2 34.82 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.108 -0.496 . . . . 0.83 109.76 173.424 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 54.9 tp -92.95 104.82 17.02 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-O 121.813 0.816 . . . . 1.71 110.491 179.198 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.402 ' HA ' ' HD3' ' A' ' 73' ' ' PRO . 22.0 tt0 -91.3 118.89 68.74 Favored Pre-proline 0 C--N 1.316 -0.888 0 CA-C-N 114.185 -1.371 . . . . 2.13 111.526 179.482 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 72' ' ' GLU . 1.2 Cg_endo -84.65 115.18 1.8 Allowed 'Trans proline' 0 N--CA 1.452 -0.942 0 C-N-CA 122.874 2.383 . . . . 1.36 111.658 174.792 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -164.05 76.35 1.64 Allowed Pre-proline 0 C--N 1.324 -0.504 0 CA-C-N 115.742 -0.663 . . . . 1.89 109.308 177.011 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.511 ' O ' ' HD3' ' A' ' 77' ' ' PRO . 45.0 Cg_endo -87.1 -90.36 0.0 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.803 0 C-N-CA 123.014 2.476 . . . . 2.73 113.612 -169.441 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -116.6 68.64 4.1 Favored Pre-proline 0 C--N 1.326 -0.42 0 N-CA-C 108.902 -0.777 . . . . 4.21 108.902 174.797 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.511 ' HD3' ' O ' ' A' ' 75' ' ' PRO . 36.5 Cg_endo -92.76 50.72 0.46 Allowed 'Trans proline' 0 N--CA 1.443 -1.481 0 C-N-CA 123.411 2.741 . . . . 4.26 111.383 -169.883 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 27.8 tptp -72.0 -50.48 28.27 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.157 -0.929 . . . . 6.21 110.356 177.835 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -110.58 101.57 10.23 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.814 -0.63 . . . . 8.11 111.213 -176.804 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 34.8 t70 . . . . . 0 C--O 1.251 1.142 0 CA-C-N 115.106 -0.952 . . . . 9.05 109.558 176.394 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.965 0 N-CA-C 110.093 -0.336 . . . . 3.81 110.093 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 -75.0 148.26 40.05 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.128 0.49 . . . . 4.0 110.742 -178.762 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.457 HG12 HG12 ' A' ' 5' ' ' ILE . 62.8 t -127.42 136.3 60.93 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 115.433 -0.803 . . . . 1.64 109.349 179.617 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 17.7 m120 -127.96 97.86 4.94 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.453 -0.573 . . . . 2.29 109.453 -174.625 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.624 HG13 HD21 ' A' ' 53' ' ' LEU . 43.0 mm -122.93 155.91 28.48 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 N-CA-C 109.33 -0.619 . . . . 0.82 109.33 -178.515 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.648 ' HB1' ' HD2' ' A' ' 7' ' ' PRO . . . -162.43 163.41 18.34 Favored Pre-proline 0 C--N 1.325 -0.492 0 N-CA-C 109.27 -0.641 . . . . 1.38 109.27 -176.781 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.648 ' HD2' ' HB1' ' A' ' 6' ' ' ALA . 9.4 Cg_endo -51.96 130.56 35.11 Favored 'Trans proline' 0 C--N 1.35 0.649 0 C-N-CA 122.831 2.354 . . . . 1.73 112.755 -175.33 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 163.15 42.81 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.408 0 CA-C-N 115.67 -0.695 . . . . 1.84 112.441 -178.111 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.79 ' HA ' ' HA ' ' A' ' 36' ' ' GLN . 65.1 m 66.44 131.49 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 121.496 0.665 . . . . 1.61 111.691 -178.706 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 64.1 tp -60.02 -35.4 74.99 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 115.924 -0.58 . . . . 1.19 111.031 -178.493 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -50.6 -54.12 25.24 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 115.583 -0.735 . . . . 2.11 111.589 177.372 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 85.3 tttt -66.78 -32.01 73.02 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.693 -0.23 . . . . 2.72 110.755 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -63.29 -53.36 54.01 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.932 0.396 . . . . 0.46 110.548 -176.206 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 88.6 mt -58.98 -39.51 81.99 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 115.988 -0.551 . . . . 0.69 111.021 176.517 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 52.4 t30 -60.86 -39.7 90.13 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.209 -0.45 . . . . 1.31 110.703 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 -58.85 -51.11 71.42 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.044 -0.525 . . . . 2.23 111.421 177.843 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.477 ' CD1' ' HH2' ' A' ' 69' ' ' TRP . 32.4 t80 -67.26 -38.43 85.1 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.038 -0.727 . . . . 0.65 109.038 -175.739 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.835 ' HA ' ' CE2' ' A' ' 23' ' ' PHE . . . -55.7 -49.99 71.52 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 115.532 -0.758 . . . . 0.37 111.955 174.913 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.94 -23.64 67.42 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.211 -0.449 . . . . 0.64 111.588 -178.319 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 75.0 t60 -61.71 -48.06 82.45 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.027 -0.533 . . . . 1.85 111.498 -176.346 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.578 ' HB3' ' CD1' ' A' ' 23' ' ' PHE . 38.9 t -102.37 -4.5 25.44 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.882 0.372 . . . . 1.67 111.114 -179.691 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 68.3 47.02 60.72 Favored Glycine 0 CA--C 1.518 0.23 0 CA-C-N 115.702 -0.681 . . . . 0.62 113.622 177.864 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.835 ' CE2' ' HA ' ' A' ' 18' ' ' ALA . 10.3 p90 -106.65 159.66 16.04 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 122.538 -0.39 . . . . 0.57 110.294 176.9 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 22.4 m -88.28 119.5 28.75 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.943 -0.571 . . . . 0.68 111.91 -173.443 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.629 HD21 ' CE3' ' A' ' 69' ' ' TRP . 0.8 OUTLIER -94.8 143.88 26.1 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.636 -0.711 . . . . 1.67 111.278 178.351 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 36.2 t -115.53 92.15 3.83 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.114 -0.698 . . . . 1.15 109.114 173.035 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 6.9 p -148.64 125.54 2.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 115.903 -0.59 . . . . 0.9 110.0 -178.605 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -88.37 134.76 33.74 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 120.831 -0.347 . . . . 2.38 110.634 -177.776 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.7 70.67 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.255 0 O-C-N 124.043 0.839 . . . . 1.97 112.095 176.945 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 79.4 p -168.64 -42.96 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.478 -0.564 . . . . 2.22 109.478 178.662 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.414 ' O ' ' HD3' ' A' ' 35' ' ' LYS . 80.7 mt -66.97 -45.41 77.8 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.655 -0.702 . . . . 1.38 110.029 177.142 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.3 p -91.4 -3.32 56.81 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.489 -0.778 . . . . 1.44 111.592 -178.91 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 55.4 ttp180 -86.62 129.58 34.81 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.174 -0.466 . . . . 4.63 110.586 -178.003 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 107.35 -20.44 32.65 Favored Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 120.703 -0.76 . . . . 1.62 112.353 177.191 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.548 ' HD2' ' N ' ' A' ' 35' ' ' LYS . 0.0 OUTLIER -115.53 136.73 52.78 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-O 121.434 0.635 . . . . 2.75 111.664 -177.873 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 36' ' ' GLN . . . . . 0.79 ' HA ' ' HA ' ' A' ' 9' ' ' SER . 18.4 pt20 -103.34 156.15 17.95 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.343 -0.844 . . . . 2.24 111.397 -177.49 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 31.2 t -117.92 119.61 35.35 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 106.28 -1.748 . . . . 1.02 106.28 171.317 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.558 ' O ' ' HD3' ' A' ' 7' ' ' PRO . 21.9 m-80 -72.27 -6.77 45.42 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 113.131 0.789 . . . . 1.28 113.131 -167.607 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' GLY . . . . . 0.427 ' HA2' HG22 ' A' ' 5' ' ' ILE . . . 127.7 175.62 14.16 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.052 -1.071 . . . . 0.42 113.357 165.756 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.473 ' HB3' ' HB ' ' A' ' 5' ' ' ILE . 67.3 tp -160.13 129.24 5.04 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 109.139 -0.689 . . . . 0.7 109.139 -177.962 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 44.5 m80 -138.15 96.7 3.24 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.171 0.51 . . . . 2.96 110.543 176.123 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -168.87 -169.42 32.25 Favored Glycine 0 N--CA 1.446 -0.693 0 CA-C-N 115.776 -0.647 . . . . 0.55 111.899 176.083 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -98.12 111.47 23.78 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 108.783 -0.821 . . . . 2.18 108.783 173.952 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.449 ' HB2' HG21 ' A' ' 3' ' ' VAL . 44.7 m-85 -133.54 134.29 43.2 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.289 0.566 . . . . 1.41 112.362 -170.15 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 47.3 t0 -85.9 170.3 12.48 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 108.477 -0.935 . . . . 2.23 108.477 172.617 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 48.7 t -46.85 -70.04 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 N-CA-C 112.574 0.583 . . . . 0.57 112.574 -172.364 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -57.89 -34.25 69.6 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 112.507 0.558 . . . . 2.39 112.507 -177.968 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 7.2 m -72.14 -39.92 68.45 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-O 121.203 0.525 . . . . 1.26 110.845 -174.99 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.508 ' O ' ' HG ' ' A' ' 53' ' ' LEU . . . -74.31 -41.76 36.96 Favored Glycine 0 N--CA 1.446 -0.636 0 CA-C-N 115.599 -0.728 . . . . 0.37 111.448 -174.942 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.533 ' O ' ' HG ' ' A' ' 54' ' ' LEU . 90.4 mt -62.29 -38.38 89.14 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.763 0.316 . . . . 1.09 110.831 -179.775 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 6.3 tp60 -57.12 -48.83 77.68 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 115.865 -0.607 . . . . 2.59 111.246 179.862 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.446 ' HG2' HD13 ' A' ' 40' ' ' LEU . 50.4 tp60 -69.0 -38.59 79.35 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.625 -0.261 . . . . 1.75 110.957 -179.146 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.624 HD21 HG13 ' A' ' 5' ' ' ILE . 82.4 mt -56.84 -29.35 62.76 Favored 'General case' 0 N--CA 1.464 0.254 0 N-CA-C 112.014 0.375 . . . . 0.73 112.014 179.369 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.533 ' HG ' ' O ' ' A' ' 50' ' ' LEU . 92.6 mt -78.35 -6.89 56.47 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.219 -0.446 . . . . 2.16 111.893 -176.449 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -66.35 119.07 10.93 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.04 0.447 . . . . 2.24 110.509 -177.161 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 111.98 -24.72 14.09 Favored Glycine 0 N--CA 1.446 -0.682 0 CA-C-N 115.757 -0.656 . . . . 1.7 111.635 -176.88 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 78.6 p -109.0 169.2 8.83 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.664 0.269 . . . . 2.28 110.302 -179.858 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -114.14 49.52 0.84 Allowed Glycine 0 N--CA 1.443 -0.841 0 N-CA-C 111.161 -0.776 . . . . 1.58 111.161 179.39 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.413 HD22 HD11 ' A' ' 71' ' ' LEU . 91.5 mt -124.34 174.96 7.39 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 120.694 0.283 . . . . 1.42 110.398 -178.602 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' GLN . . . . . 0.409 ' CB ' ' HB3' ' A' ' 74' ' ' ALA . 63.7 tp60 -148.86 118.48 7.0 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.264 -0.643 . . . . 2.67 109.264 176.604 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 3.8 p -94.65 123.04 46.61 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 N-CA-C 109.393 -0.595 . . . . 1.54 109.393 177.777 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.482 ' HA ' ' HD3' ' A' ' 63' ' ' PRO . 20.2 ptmt -122.64 134.08 24.77 Favored Pre-proline 0 C--N 1.32 -0.702 0 CA-C-O 120.84 0.352 . . . . 1.81 110.84 -172.73 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.482 ' HD3' ' HA ' ' A' ' 62' ' ' LYS . 37.9 Cg_exo -62.26 129.0 25.44 Favored 'Trans proline' 0 N--CA 1.462 -0.338 0 C-N-CA 122.92 2.413 . . . . 0.85 111.64 176.36 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -68.32 -48.11 65.75 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.244 -0.889 . . . . 1.7 109.802 -177.41 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -175.37 -71.91 0.05 OUTLIER Glycine 0 N--CA 1.445 -0.756 0 C-N-CA 120.687 -0.768 . . . . 1.69 112.074 177.778 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -89.63 -77.9 0.38 Allowed 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.891 0.377 . . . . 2.96 111.098 -176.78 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' ASN . . . . . 0.483 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 27.2 p-10 -138.31 39.72 2.27 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.402 0.62 . . . . 2.5 111.001 -175.528 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 35.2 t -138.65 166.51 24.17 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 108.124 -1.065 . . . . 1.3 108.124 177.287 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' TRP . . . . . 0.629 ' CE3' HD21 ' A' ' 25' ' ' LEU . 24.4 m0 -141.68 165.52 27.25 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 107.865 -1.161 . . . . 0.47 107.865 -174.508 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 12.7 t -145.02 150.06 36.22 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 109.432 -0.581 . . . . 0.83 109.432 172.383 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.413 HD11 HD22 ' A' ' 59' ' ' LEU . 1.0 OUTLIER -93.37 102.68 14.93 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.318 0.58 . . . . 1.71 110.335 -176.446 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -97.04 123.49 53.07 Favored Pre-proline 0 C--N 1.321 -0.663 0 CA-C-N 115.197 -0.911 . . . . 2.13 110.294 173.757 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_exo -62.64 114.78 2.54 Favored 'Trans proline' 0 N--CA 1.461 -0.392 0 C-N-CA 122.403 2.069 . . . . 1.36 111.72 178.307 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.409 ' HB3' ' CB ' ' A' ' 60' ' ' GLN . . . -151.19 89.38 4.26 Favored Pre-proline 0 C--N 1.321 -0.646 0 N-CA-C 109.326 -0.62 . . . . 1.89 109.326 179.108 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -88.14 -80.43 0.0 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.255 0 C-N-CA 122.963 2.442 . . . . 2.73 112.77 -173.915 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -127.45 68.75 74.11 Favored Pre-proline 0 C--N 1.323 -0.553 0 N-CA-C 107.966 -1.124 . . . . 4.21 107.966 173.368 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_endo -90.14 66.78 1.89 Allowed 'Trans proline' 0 N--CA 1.447 -1.214 0 C-N-CA 123.467 2.778 . . . . 4.26 111.44 -168.068 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 44.3 mtmt -123.49 -173.16 2.67 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 114.602 -1.181 . . . . 6.21 109.953 -176.844 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -98.67 52.43 1.0 Allowed 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.933 0.873 . . . . 8.11 109.064 175.728 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 20.1 t70 . . . . . 0 C--O 1.248 1.01 0 CA-C-N 114.889 -1.051 . . . . 9.05 110.09 -174.61 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 0.788 0 CA-C-O 120.541 0.21 . . . . 3.81 110.619 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 26.8 pt20 -155.69 149.92 25.72 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.853 0.359 . . . . 4.0 110.469 177.777 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 31.5 m -139.99 152.68 22.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.95 -0.568 . . . . 1.64 110.282 -178.479 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 19.1 p-10 -127.97 97.09 4.68 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.588 0.708 . . . . 2.29 109.374 176.095 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 66.1 mt -134.03 118.09 27.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.723 -0.671 . . . . 0.82 110.004 -177.293 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -81.17 170.79 14.1 Favored Pre-proline 0 C--N 1.323 -0.574 0 CA-C-N 115.562 -0.744 . . . . 1.38 109.431 -179.644 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -54.96 141.23 78.98 Favored 'Trans proline' 0 N--CA 1.458 -0.6 0 C-N-CA 121.374 1.382 . . . . 1.73 109.843 167.23 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.442 ' O ' ' HB2' ' A' ' 36' ' ' GLN . . . 173.68 -135.8 3.37 Favored Glycine 0 N--CA 1.446 -0.68 0 N-CA-C 110.575 -1.01 . . . . 1.84 110.575 -169.312 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.867 ' HA ' ' HA ' ' A' ' 36' ' ' GLN . 23.7 m -125.25 155.9 39.38 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 117.427 0.614 . . . . 1.61 110.407 178.097 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.615 HD22 ' HB2' ' A' ' 37' ' ' SER . 3.9 mm? -56.3 -39.3 72.5 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 118.074 0.397 . . . . 1.19 111.093 179.231 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -47.08 -56.09 7.16 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 115.27 -0.877 . . . . 2.11 111.822 178.561 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 3.3 tppp? -66.06 -31.14 71.84 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.796 -0.183 . . . . 2.72 111.171 -178.752 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -66.26 -57.86 6.62 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.054 0.454 . . . . 0.46 110.597 -177.278 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 95.4 mt -59.69 -39.17 83.63 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 115.871 -0.604 . . . . 0.69 111.315 177.243 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -57.38 -41.46 80.25 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.27 0.557 . . . . 1.31 110.038 177.031 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 22.4 tm0? -63.46 -48.25 78.45 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.337 -0.847 . . . . 2.23 110.678 179.258 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -70.35 -37.82 74.7 Favored 'General case' 0 N--CA 1.456 -0.148 0 C-N-CA 120.894 -0.322 . . . . 0.65 111.27 -172.183 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.594 ' HA ' ' CZ ' ' A' ' 23' ' ' PHE . . . -47.91 -44.74 30.07 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-O 120.777 0.323 . . . . 0.37 111.652 176.478 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.59 -21.24 66.25 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.736 -0.666 . . . . 0.64 112.358 179.355 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 3.9 t-160 -58.96 -61.53 2.57 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 120.667 0.27 . . . . 1.85 111.45 -175.647 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.636 ' HB3' ' HD1' ' A' ' 23' ' ' PHE . 8.2 t -100.78 -9.07 22.08 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.916 0.389 . . . . 1.67 111.287 -177.764 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 73.33 56.54 5.57 Favored Glycine 0 C--N 1.331 0.284 0 C-N-CA 121.124 -0.56 . . . . 0.62 112.49 -179.714 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.636 ' HD1' ' HB3' ' A' ' 21' ' ' SER . 17.4 p90 -116.68 172.73 7.04 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.737 0.303 . . . . 0.57 110.935 -177.617 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.603 ' O ' ' HB3' ' A' ' 68' ' ' SER . 27.3 m -94.49 111.0 22.74 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-O 121.345 0.593 . . . . 0.68 111.088 -179.247 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 3.2 tt -93.72 117.77 30.53 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.216 -0.661 . . . . 1.67 109.216 177.752 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 73.5 m -104.65 103.13 12.72 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.97 -0.559 . . . . 1.15 111.341 -174.062 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.479 ' CG2' HD12 ' A' ' 71' ' ' LEU . 4.2 p -138.84 129.65 34.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 115.842 -0.617 . . . . 0.9 110.668 178.254 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -72.57 121.76 20.23 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.727 -0.67 . . . . 2.38 110.307 176.153 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.31 77.27 0.01 OUTLIER 'General case' 0 C--O 1.236 0.35 0 CA-C-N 115.778 -0.646 . . . . 1.97 111.984 177.693 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 30.6 t -175.47 -31.41 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.723 -0.671 . . . . 2.22 109.513 178.317 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 80.1 mt -63.11 -53.01 60.24 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.639 -0.71 . . . . 1.38 110.636 179.316 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 3.0 p -92.39 58.28 3.17 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.773 -0.649 . . . . 1.44 110.831 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 16.6 ptp180 -71.26 105.72 3.57 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 115.742 -0.663 . . . . 4.63 109.758 176.353 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 68.24 -93.25 0.28 Allowed Glycine 0 N--CA 1.45 -0.397 0 N-CA-C 110.633 -0.987 . . . . 1.62 110.633 -170.363 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.587 ' HG3' HD23 ' A' ' 10' ' ' LEU . 40.7 tptt 50.82 94.3 0.02 OUTLIER 'General case' 0 C--O 1.236 0.355 0 C-N-CA 123.779 0.831 . . . . 2.75 111.974 171.288 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' GLN . . . . . 0.867 ' HA ' ' HA ' ' A' ' 9' ' ' SER . 26.6 pt20 -101.37 153.81 19.34 Favored 'General case' 0 N--CA 1.447 -0.58 0 O-C-N 121.994 -0.441 . . . . 2.24 110.474 -174.804 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.615 ' HB2' HD22 ' A' ' 10' ' ' LEU . 32.8 t -128.08 138.66 52.63 Favored 'General case' 0 N--CA 1.446 -0.673 0 N-CA-C 108.469 -0.937 . . . . 1.02 108.469 -179.778 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 6.4 m-20 -64.85 -8.96 17.39 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.997 -0.547 . . . . 1.28 112.143 -179.213 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 118.6 -177.39 16.43 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.868 -0.682 . . . . 0.42 112.634 171.554 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.437 HD13 ' HG2' ' A' ' 52' ' ' GLN . 63.3 tp -159.62 109.52 1.88 Allowed 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 108.605 -0.887 . . . . 0.7 108.605 -179.432 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 12.7 p80 -144.7 98.23 3.15 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 122.018 0.913 . . . . 2.96 111.332 -178.633 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -170.03 -169.82 33.68 Favored Glycine 0 N--CA 1.443 -0.888 0 CA-C-N 114.356 -1.293 . . . . 0.55 111.043 176.689 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 32.1 m-20 -82.43 75.36 9.34 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.116 -0.698 . . . . 2.18 109.116 173.36 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 79.8 m-85 -110.08 123.12 49.14 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.564 -0.744 . . . . 1.41 110.798 -178.144 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -89.27 -163.1 0.94 Allowed 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 108.878 -0.786 . . . . 2.23 108.878 173.23 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.516 ' O ' ' HG ' ' A' ' 50' ' ' LEU . 37.5 t -53.09 -71.81 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 N-CA-C 112.751 0.648 . . . . 0.57 112.751 -172.367 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -61.83 -42.44 99.03 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 112.944 0.72 . . . . 2.39 112.944 -171.54 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 28.6 m -68.89 -29.99 68.39 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.158 0.504 . . . . 1.26 111.01 -173.956 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -80.07 -29.83 44.72 Favored Glycine 0 N--CA 1.445 -0.711 0 N-CA-C 110.9 -0.88 . . . . 0.37 110.9 -178.481 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.621 ' HB3' HG11 ' A' ' 61' ' ' VAL . 82.6 mt -74.73 -45.51 43.61 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 115.459 -0.371 . . . . 1.09 110.385 -179.369 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 24.2 tp60 -55.63 -41.46 73.56 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.97 -0.559 . . . . 2.59 111.27 178.413 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' GLN . . . . . 0.437 ' HG2' HD13 ' A' ' 40' ' ' LEU . 6.7 tp60 -63.81 -48.36 77.16 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.613 -0.267 . . . . 1.75 111.028 -179.973 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 93.1 mt -58.71 -23.99 60.64 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 112.366 0.506 . . . . 0.73 112.366 -179.603 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.608 HD11 HG12 ' A' ' 61' ' ' VAL . 68.8 mt -78.31 -19.65 53.13 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 112.23 0.456 . . . . 2.16 112.23 -177.174 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -65.48 101.32 0.58 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.204 0.526 . . . . 2.24 110.802 -176.475 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 124.1 -3.7 9.05 Favored Glycine 0 N--CA 1.449 -0.482 0 CA-C-N 115.604 -0.726 . . . . 1.7 111.844 -177.345 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 6.9 m -118.09 170.69 8.65 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.758 0.313 . . . . 2.28 110.397 179.145 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -115.2 24.29 10.74 Favored Glycine 0 N--CA 1.442 -0.901 0 N-CA-C 110.44 -1.064 . . . . 1.58 110.44 172.64 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 85.6 mt -101.57 175.23 5.64 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 120.822 0.344 . . . . 1.42 110.108 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 72.1 mt-30 -133.84 118.32 17.85 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 109.334 -0.617 . . . . 2.67 109.334 174.411 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.621 HG11 ' HB3' ' A' ' 50' ' ' LEU . 6.1 p -86.44 113.42 24.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 N-CA-C 108.781 -0.822 . . . . 1.54 108.781 174.35 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 40.0 ttpt -136.22 130.57 18.34 Favored Pre-proline 0 C--N 1.314 -0.94 0 CA-C-N 115.642 -0.708 . . . . 1.81 110.213 -169.813 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.609 ' HA ' ' HA ' ' A' ' 69' ' ' TRP . 51.4 Cg_exo -55.0 130.64 41.87 Favored 'Trans proline' 0 N--CA 1.461 -0.402 0 C-N-CA 122.318 2.012 . . . . 0.85 111.027 175.638 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.438 ' O ' HD13 ' A' ' 64' ' ' LEU . 2.8 tm? -62.64 -34.74 77.66 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.816 -0.629 . . . . 1.7 109.739 -176.545 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 177.07 -59.01 0.1 OUTLIER Glycine 0 N--CA 1.444 -0.824 0 N-CA-C 110.935 -0.866 . . . . 1.69 110.935 177.164 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 21.0 m-80 -140.17 126.74 20.3 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.599 -0.3 . . . . 2.96 110.703 178.003 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 47.8 t30 75.25 -36.87 0.32 Allowed 'General case' 0 N--CA 1.475 0.781 0 O-C-N 124.096 0.872 . . . . 2.5 112.881 173.556 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.603 ' HB3' ' O ' ' A' ' 24' ' ' THR . 69.0 m -114.17 178.61 4.22 Favored 'General case' 0 C--N 1.321 -0.638 0 O-C-N 122.231 -0.293 . . . . 1.3 110.396 -168.072 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' TRP . . . . . 0.609 ' HA ' ' HA ' ' A' ' 63' ' ' PRO . 40.0 m0 -139.16 167.81 21.24 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 120.825 0.345 . . . . 0.47 110.125 -169.224 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 14.3 t -149.95 150.56 32.02 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.348 -0.612 . . . . 0.83 109.348 169.082 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.559 HD23 ' HA ' ' A' ' 61' ' ' VAL . 25.9 mt -92.79 102.89 15.28 Favored 'General case' 0 CA--C 1.517 -0.317 0 C-N-CA 120.285 -0.566 . . . . 1.71 110.056 174.644 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.416 ' HA ' ' HD3' ' A' ' 73' ' ' PRO . 42.7 tt0 -87.36 119.48 70.85 Favored Pre-proline 0 C--N 1.317 -0.807 0 CA-C-N 115.098 -0.956 . . . . 2.13 110.528 177.493 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 72' ' ' GLU . 6.3 Cg_exo -75.25 114.07 3.92 Favored 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 122.341 2.027 . . . . 1.36 111.187 177.109 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -163.15 76.82 1.83 Allowed Pre-proline 0 C--N 1.32 -0.698 0 N-CA-C 108.681 -0.859 . . . . 1.89 108.681 -179.771 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -81.33 54.76 5.32 Favored 'Trans proline' 0 N--CA 1.459 -0.549 0 C-N-CA 122.714 2.276 . . . . 2.73 112.855 -170.608 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 52.59 68.15 3.32 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.277 0.561 . . . . 4.21 109.976 -174.802 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -91.59 146.29 3.29 Favored 'Trans proline' 0 N--CA 1.446 -1.274 0 C-N-CA 124.076 3.184 . . . . 4.26 111.138 -173.118 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.431 ' HB2' ' NZ ' ' A' ' 78' ' ' LYS . 3.4 mtmp? -126.84 -54.58 1.41 Allowed 'General case' 0 C--N 1.32 -0.695 0 C-N-CA 120.672 -0.411 . . . . 6.21 111.969 -167.916 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -156.85 26.64 0.32 Allowed 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 122.251 1.024 . . . . 8.11 108.37 174.986 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 . . . . . 0 C--O 1.245 0.832 0 CA-C-N 113.619 -1.628 . . . . 9.05 109.492 -172.862 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.061 0 N-CA-C 110.01 -0.367 . . . . 3.81 110.01 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.708 ' H ' ' HA ' ' A' ' 43' ' ' ASP . 8.0 tp60 -68.98 -57.51 5.37 Favored 'General case' 0 CA--C 1.513 -0.443 0 CA-C-O 121.523 0.678 . . . . 4.0 111.893 -172.475 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 17.3 m -115.67 131.78 67.05 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 CA-C-N 114.64 -1.164 . . . . 1.64 111.46 -175.211 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 50.5 m-80 -130.74 97.58 4.39 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 108.386 -0.968 . . . . 2.29 108.386 174.952 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 56.6 mt -121.35 132.45 70.62 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-N 115.989 -0.55 . . . . 0.82 111.322 -170.907 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -75.01 157.73 85.12 Favored Pre-proline 0 C--N 1.326 -0.427 0 CA-C-N 115.68 -0.691 . . . . 1.38 109.872 177.781 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.496 ' HA ' ' O ' ' A' ' 37' ' ' SER . 11.6 Cg_exo -72.12 54.91 2.3 Favored 'Trans proline' 0 CA--C 1.533 0.46 0 C-N-CA 123.003 2.468 . . . . 1.73 112.835 179.031 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -125.05 -161.54 11.08 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.771 -0.728 . . . . 1.84 113.177 -178.083 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 18.7 m -47.01 125.88 8.19 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 123.566 0.746 . . . . 1.61 112.322 -177.227 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 68.0 tp -60.94 -29.54 69.69 Favored 'General case' 0 CA--C 1.522 -0.102 0 CA-C-N 115.412 -0.813 . . . . 1.19 110.756 -179.416 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.446 ' CA ' ' HB ' ' A' ' 32' ' ' THR . 22.9 t70 -51.43 -52.21 48.16 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.703 -0.68 . . . . 2.11 111.232 176.643 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 21.9 tptm -69.88 -25.54 63.76 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.497 -0.32 . . . . 2.72 110.616 -179.339 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.642 ' O ' ' HG3' ' A' ' 16' ' ' GLN . . . -65.12 -54.64 26.76 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.179 0.514 . . . . 0.46 109.943 179.017 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.687 ' HB3' HD11 ' A' ' 25' ' ' LEU . 95.9 mt -59.9 -35.73 75.48 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.834 -0.621 . . . . 0.69 110.397 174.155 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 24.1 t-20 -59.09 -47.22 86.07 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.554 -0.748 . . . . 1.31 110.992 -179.463 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.642 ' HG3' ' O ' ' A' ' 13' ' ' ALA . 0.0 OUTLIER -65.43 -32.72 74.49 Favored 'General case' 0 C--O 1.232 0.176 0 C-N-CA 120.947 -0.301 . . . . 2.23 111.103 -177.587 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 5.2 t80 -71.71 -42.82 66.91 Favored 'General case' 0 CA--C 1.527 0.071 0 N-CA-C 109.475 -0.565 . . . . 0.65 109.475 178.128 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.731 ' HA ' ' CZ ' ' A' ' 23' ' ' PHE . . . -53.68 -46.28 70.59 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 115.993 -0.548 . . . . 0.37 111.614 177.966 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.29 -21.88 66.52 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.185 -0.461 . . . . 0.64 111.708 -179.855 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 83.2 t60 -66.07 -52.5 48.3 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.717 -0.22 . . . . 1.85 111.321 -178.537 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.606 ' HB3' ' HD1' ' A' ' 23' ' ' PHE . 31.9 t -100.04 -17.56 17.43 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.064 0.459 . . . . 1.67 111.525 -175.399 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 75.77 48.28 10.5 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.945 -0.645 . . . . 0.62 112.912 -178.273 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.731 ' CZ ' ' HA ' ' A' ' 18' ' ' ALA . 25.3 p90 -107.83 166.14 10.92 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 110.082 -0.34 . . . . 0.57 110.082 -179.943 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.505 ' O ' ' HB3' ' A' ' 68' ' ' SER . 40.3 m -91.32 109.12 20.39 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.274 0.559 . . . . 0.68 111.234 -179.275 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.687 HD11 ' HB3' ' A' ' 14' ' ' LEU . 2.0 tt -92.33 122.83 35.17 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.153 -0.684 . . . . 1.67 109.153 177.248 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 25.5 t -100.83 98.4 8.91 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 120.793 0.33 . . . . 1.15 110.442 -175.288 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 8.2 p -149.14 141.89 18.0 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 CA-C-N 115.944 -0.571 . . . . 0.9 110.878 179.598 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -90.97 138.2 31.78 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.327 -0.397 . . . . 2.38 110.29 174.414 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.37 76.63 0.02 OUTLIER 'General case' 0 C--O 1.235 0.309 0 CA-C-N 116.025 -0.534 . . . . 1.97 111.939 176.757 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 22.3 p -166.84 -52.21 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.356 -0.383 . . . . 2.22 110.342 -179.139 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.419 HD13 HD12 ' A' ' 71' ' ' LEU . 84.6 mt -66.51 -44.79 81.56 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.162 -0.472 . . . . 1.38 110.649 179.188 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.446 ' HB ' ' CA ' ' A' ' 11' ' ' ASP . 4.0 p -91.83 -5.66 53.01 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.894 -0.594 . . . . 1.44 111.198 179.744 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 28.0 ttp180 -82.49 129.38 34.9 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.609 -0.723 . . . . 4.63 110.568 -177.417 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 80.47 -29.97 2.53 Favored Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 121.172 -0.537 . . . . 1.62 112.2 178.202 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.505 ' HD3' ' C ' ' A' ' 35' ' ' LYS . 11.0 tmtt? -71.66 117.97 13.9 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 109.028 -0.73 . . . . 2.75 109.028 177.133 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -102.15 149.77 23.94 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.083 0.468 . . . . 2.24 110.466 -178.071 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.496 ' O ' ' HA ' ' A' ' 7' ' ' PRO . 0.4 OUTLIER -123.31 134.74 54.03 Favored 'General case' 0 N--CA 1.431 -1.408 0 N-CA-C 107.731 -1.211 . . . . 1.02 107.731 176.117 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.424 ' HA ' ' HB3' ' A' ' 7' ' ' PRO . 6.0 m-20 -61.86 -2.0 0.77 Allowed 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 113.152 0.797 . . . . 1.28 113.152 -176.707 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 101.62 -171.55 22.09 Favored Glycine 0 CA--C 1.501 -0.807 0 C-N-CA 120.859 -0.686 . . . . 0.42 111.976 171.16 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 48.9 tp -161.4 134.74 6.45 Favored 'General case' 0 N--CA 1.444 -0.752 0 N-CA-C 107.443 -1.317 . . . . 0.7 107.443 -178.91 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 57.9 m80 -136.32 96.54 3.39 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.145 0.498 . . . . 2.96 110.658 178.554 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -170.49 176.13 44.15 Favored Glycine 0 N--CA 1.444 -0.81 0 CA-C-N 115.451 -0.795 . . . . 0.55 112.077 177.183 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.708 ' HA ' ' H ' ' A' ' 2' ' ' GLN . 5.3 p-10 -93.75 76.23 4.28 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.849 0.833 . . . . 2.18 108.875 170.988 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' TYR . . . . . 0.465 ' O ' ' HG2' ' A' ' 2' ' ' GLN . 38.8 m-85 -94.85 149.51 21.17 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.462 -0.79 . . . . 1.41 111.997 -173.214 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -85.49 179.12 7.2 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.467 -0.788 . . . . 2.23 109.347 173.693 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.489 ' O ' ' HG ' ' A' ' 50' ' ' LEU . 58.4 t -54.58 -71.99 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 N-CA-C 112.139 0.422 . . . . 0.57 112.139 -176.53 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -58.54 -41.71 86.16 Favored 'General case' 0 C--O 1.233 0.229 0 N-CA-C 112.568 0.581 . . . . 2.39 112.568 -175.431 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 1.3 p -71.38 -32.02 67.97 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.086 0.47 . . . . 1.26 111.004 -175.606 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.61 ' O ' ' HG ' ' A' ' 53' ' ' LEU . . . -73.84 -36.18 53.16 Favored Glycine 0 N--CA 1.442 -0.918 0 N-CA-C 111.089 -0.804 . . . . 0.37 111.089 179.673 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.501 HD23 HD12 ' A' ' 53' ' ' LEU . 91.2 mt -67.35 -40.62 85.87 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.617 -0.292 . . . . 1.09 110.479 -179.833 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 60.2 tp60 -55.18 -45.44 75.77 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.043 -0.526 . . . . 2.59 111.015 178.652 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 87.8 mm-40 -68.52 -36.18 78.51 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.586 -0.279 . . . . 1.75 111.174 178.591 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.61 ' HG ' ' O ' ' A' ' 49' ' ' GLY . 80.1 mt -59.12 -21.03 58.66 Favored 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 112.033 0.382 . . . . 0.73 112.033 178.259 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 7.3 mp -75.95 15.93 0.48 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.904 0.383 . . . . 2.16 111.39 177.754 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -56.71 111.51 1.03 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.722 -0.672 . . . . 2.24 111.138 176.486 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 65.27 23.64 70.08 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 121.067 -0.587 . . . . 1.7 112.543 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 50.9 m -99.86 148.63 24.24 Favored 'General case' 0 C--N 1.323 -0.579 0 O-C-N 122.545 -0.385 . . . . 2.28 110.735 179.642 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -111.66 28.32 9.6 Favored Glycine 0 N--CA 1.441 -0.988 0 N-CA-C 109.679 -1.369 . . . . 1.58 109.679 168.898 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.538 HD13 HD11 ' A' ' 71' ' ' LEU . 59.6 mt -121.82 179.8 4.37 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.122 -0.696 . . . . 1.42 109.122 -179.62 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 27.4 tt0 -151.23 121.48 7.26 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.699 -0.482 . . . . 2.67 109.699 178.245 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.441 HG11 HD22 ' A' ' 50' ' ' LEU . 7.3 p -93.51 137.11 23.38 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 N-CA-C 109.708 -0.479 . . . . 1.54 109.708 179.649 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.583 ' HG3' ' HG3' ' A' ' 72' ' ' GLU . 15.6 mtmm -130.19 135.51 27.57 Favored Pre-proline 0 C--N 1.327 -0.396 0 C-N-CA 121.065 -0.254 . . . . 1.81 110.409 -179.218 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_exo -63.0 121.79 9.8 Favored 'Trans proline' 0 N--CA 1.458 -0.604 0 C-N-CA 122.407 2.071 . . . . 0.85 110.341 169.568 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 44.8 tp -62.57 -40.46 96.93 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.414 -0.812 . . . . 1.7 111.102 -174.149 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 134.49 -22.16 3.74 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.855 -0.688 . . . . 1.69 111.8 177.942 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 27.8 p-10 -106.95 41.65 1.43 Allowed 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.807 0.337 . . . . 2.96 110.582 -179.214 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 66.2 t30 56.33 36.06 26.88 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 121.684 0.754 . . . . 2.5 110.428 -177.024 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' SER . . . . . 0.505 ' HB3' ' O ' ' A' ' 24' ' ' THR . 68.5 m -141.55 177.88 7.84 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 107.857 -1.164 . . . . 1.3 107.857 176.104 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' TRP . . . . . 0.463 ' CH2' HD21 ' A' ' 50' ' ' LEU . 54.5 m0 -136.27 167.14 21.86 Favored 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 120.521 -0.472 . . . . 0.47 111.12 -167.154 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 3.8 t -145.46 142.42 29.26 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.402 -0.817 . . . . 0.83 109.722 174.831 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.538 HD11 HD13 ' A' ' 59' ' ' LEU . 0.7 OUTLIER -92.85 104.01 16.3 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.36 -0.607 . . . . 1.71 109.36 179.773 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.583 ' HG3' ' HG3' ' A' ' 62' ' ' LYS . 4.5 mm-40 -88.28 120.63 70.55 Favored Pre-proline 0 C--N 1.319 -0.727 0 CA-C-N 115.009 -0.996 . . . . 2.13 110.968 -178.389 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.473 ' HD3' ' HA ' ' A' ' 72' ' ' GLU . 4.9 Cg_endo -86.97 115.03 1.15 Allowed 'Trans proline' 0 N--CA 1.453 -0.873 0 C-N-CA 123.005 2.47 . . . . 1.36 111.685 177.463 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -172.82 85.93 0.41 Allowed Pre-proline 0 C--N 1.327 -0.382 0 CA-C-N 115.792 -0.64 . . . . 1.89 109.736 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.488 ' HB2' ' H ' ' A' ' 76' ' ' ALA . 2.2 Cg_endo -80.37 -91.17 0.0 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.823 0 C-N-CA 122.398 2.065 . . . . 2.73 112.59 -175.088 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.488 ' H ' ' HB2' ' A' ' 75' ' ' PRO . . . -134.27 61.76 52.05 Favored Pre-proline 0 C--N 1.322 -0.593 0 N-CA-C 108.69 -0.856 . . . . 4.21 108.69 170.991 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -87.61 39.25 0.55 Allowed 'Trans proline' 0 N--CA 1.451 -0.988 0 C-N-CA 123.02 2.48 . . . . 4.26 112.182 -168.444 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 48.3 tptt -92.52 -51.01 5.33 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 115.735 -0.666 . . . . 6.21 110.037 178.964 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -89.34 -63.02 1.35 Allowed 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.94 -0.393 . . . . 8.11 109.94 178.836 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 38.1 t70 . . . . . 0 C--O 1.247 0.955 0 CA-C-O 118.327 -0.844 . . . . 9.05 110.202 177.005 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 11.7 pt20 . . . . . 0 C--O 1.233 0.207 0 N-CA-C 109.438 -0.579 . . . . 4.0 109.438 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.434 HG12 HG13 ' A' ' 5' ' ' ILE . 48.0 t -139.88 141.18 34.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.528 -0.305 . . . . 1.6399999999999999 110.919 -174.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -129.35 110.49 11.97 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.313 0.578 . . . . 2.29 109.67 177.415 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.434 HG13 HG12 ' A' ' 3' ' ' VAL . 58.2 mt -137.33 156.79 33.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 N-CA-C 109.413 -0.588 . . . . 0.81999999999999995 109.413 -178.129 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.616 ' HB1' ' HD2' ' A' ' 7' ' ' PRO . . . -161.69 163.45 19.54 Favored Pre-proline 0 C--N 1.324 -0.507 0 N-CA-C 109.796 -0.446 . . . . 1.3799999999999999 109.796 -174.578 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.616 ' HD2' ' HB1' ' A' ' 6' ' ' ALA . 6.1 Cg_exo -38.4 135.63 0.68 Allowed 'Trans proline' 0 C--N 1.352 0.735 0 C-N-CA 124.317 3.345 . . . . 1.73 114.151 -176.623 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.442 ' O ' ' HB2' ' A' ' 9' ' ' SER . . . -178.05 -75.71 0.06 OUTLIER Glycine 0 N--CA 1.443 -0.859 0 N-CA-C 110.31 -1.116 . . . . 1.8400000000000001 110.31 -179.637 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.442 ' HB2' ' O ' ' A' ' 8' ' ' GLY . 8.5 t 174.04 148.25 0.07 Allowed 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 107.277 -1.379 . . . . 1.6100000000000001 107.277 175.389 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.52 HD23 HG22 ' A' ' 32' ' ' THR . 56.1 tp -56.09 -42.59 76.98 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 119.348 0.976 . . . . 1.1899999999999999 111.304 -173.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -50.75 -55.52 16.33 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 115.795 -0.638 . . . . 2.1099999999999999 112.006 177.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 55.7 mtmt -65.13 -27.51 68.78 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 111.719 0.266 . . . . 2.7200000000000002 111.719 179.69 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -65.23 -54.88 22.78 Favored 'General case' 0 C--O 1.233 0.237 0 CA-C-O 120.952 0.406 . . . . 0.46000000000000002 110.114 179.602 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 94.9 mt -59.36 -38.34 80.16 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 115.836 -0.62 . . . . 0.68999999999999995 111.129 176.614 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 50.8 t-20 -60.0 -47.05 87.41 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.659 -0.497 . . . . 1.3100000000000001 109.659 178.641 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.421 HE21 ' HB3' ' A' ' 16' ' ' GLN . 1.0 OUTLIER -61.74 -42.32 98.81 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.799 -0.637 . . . . 2.23 111.108 -179.982 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.469 ' HD1' ' HZ ' ' A' ' 23' ' ' PHE . 1.9 t80 -66.67 -39.55 88.22 Favored 'General case' 0 CA--C 1.53 0.187 0 N-CA-C 109.747 -0.464 . . . . 0.65000000000000002 109.747 -177.837 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.754 ' HA ' ' CE2' ' A' ' 23' ' ' PHE . . . -52.71 -42.82 65.19 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.186 -0.461 . . . . 0.37 111.872 177.772 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.37 -22.88 67.15 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.221 -0.445 . . . . 0.64000000000000001 111.851 -179.344 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . 0.447 ' HB3' ' O ' ' A' ' 17' ' ' TYR . 77.2 t60 -64.82 -62.9 1.28 Allowed 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.18 0.437 . . . . 1.8500000000000001 112.18 -178.534 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.657 ' HB2' ' CD1' ' A' ' 23' ' ' PHE . 9.6 m -100.46 -4.65 28.43 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 112.543 0.572 . . . . 1.6699999999999999 112.543 -172.676 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 67.27 47.49 63.65 Favored Glycine 0 CA--C 1.52 0.379 0 C-N-CA 121.099 -0.572 . . . . 0.62 113.419 177.642 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.754 ' CE2' ' HA ' ' A' ' 18' ' ' ALA . 3.7 p90 -104.61 171.4 7.35 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 110.152 -0.314 . . . . 0.56999999999999995 110.152 178.285 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 24.0 m -97.06 122.69 40.34 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.255 0.55 . . . . 0.68000000000000005 111.959 -175.237 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.632 HD21 ' CE3' ' A' ' 69' ' ' TRP . 1.5 mm? -96.27 143.35 27.43 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.56 -0.746 . . . . 1.6699999999999999 111.07 178.148 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 8.0 t -123.03 91.37 3.47 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 108.943 -0.762 . . . . 1.1499999999999999 108.943 172.43 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 6.0 p -148.76 138.26 15.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.929 -0.578 . . . . 0.90000000000000002 110.581 -175.054 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -102.27 131.87 48.58 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.293 -0.412 . . . . 2.3799999999999999 110.153 178.54 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.1 70.34 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.34 0 O-C-N 123.583 0.552 . . . . 1.97 112.215 178.338 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 50.0 p -163.98 -49.08 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.146 -0.479 . . . . 2.2200000000000002 109.939 -177.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.44 ' O ' HD11 ' A' ' 59' ' ' LEU . 98.0 mt -63.63 -39.07 93.43 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.213 -0.449 . . . . 1.3799999999999999 110.227 176.295 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.52 HG22 HD23 ' A' ' 10' ' ' LEU . 2.3 p -91.65 3.07 55.93 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.662 -0.699 . . . . 1.4399999999999999 111.446 179.6 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.4 HH11 ' HD2' ' A' ' 33' ' ' ARG . 6.0 tpp180 -75.42 106.41 6.95 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.064 -0.516 . . . . 4.6299999999999999 111.216 -174.189 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 119.27 -45.89 1.2 Allowed Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.346 -0.931 . . . . 1.6200000000000001 113.808 172.33 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.857 ' H ' ' HD2' ' A' ' 35' ' ' LYS . 0.0 OUTLIER -67.94 137.08 54.9 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.545 0.688 . . . . 2.75 111.741 -174.355 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 5.3 tp-100 -102.73 152.84 20.76 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 114.921 -1.036 . . . . 2.2400000000000002 110.073 -175.269 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 22.9 t -133.99 123.28 24.33 Favored 'General case' 0 N--CA 1.444 -0.743 0 N-CA-C 107.174 -1.417 . . . . 1.02 107.174 175.29 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 11.7 m120 -67.79 3.28 1.52 Allowed 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 112.907 0.706 . . . . 1.28 112.907 -173.591 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 107.35 -176.52 21.02 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.612 -0.804 . . . . 0.41999999999999998 112.958 170.395 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.414 HD13 ' HB3' ' A' ' 52' ' ' GLN . 39.6 tp -160.3 122.89 3.33 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 108.778 -0.823 . . . . 0.69999999999999996 108.778 -176.366 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 10.7 t-80 -144.48 98.59 3.22 Favored 'General case' 0 C--N 1.321 -0.664 0 C-N-CA 120.296 -0.561 . . . . 2.96 110.964 -179.202 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -168.91 -169.5 32.37 Favored Glycine 0 N--CA 1.446 -0.636 0 CA-C-N 115.264 -0.88 . . . . 0.55000000000000004 111.627 177.04 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -81.99 76.75 8.87 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.242 -0.651 . . . . 2.1800000000000002 109.242 175.305 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 78.8 m-85 -107.82 138.38 44.15 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.25 0.548 . . . . 1.4099999999999999 111.707 -175.626 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -101.93 -170.35 1.81 Allowed 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 108.904 -0.776 . . . . 2.23 108.904 173.208 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 56.0 t -51.97 -71.31 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 112.739 0.644 . . . . 0.56999999999999995 112.739 -173.321 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -64.4 -40.82 96.54 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 112.548 0.573 . . . . 2.3900000000000001 112.548 -172.237 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 56.7 m -71.02 -25.9 62.88 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-O 120.919 0.39 . . . . 1.26 110.877 -174.518 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.483 ' O ' ' HG ' ' A' ' 53' ' ' LEU . . . -72.4 -37.71 58.61 Favored Glycine 0 N--CA 1.447 -0.621 0 C-N-CA 120.761 -0.733 . . . . 0.37 111.466 178.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.549 HD22 HG11 ' A' ' 61' ' ' VAL . 84.8 mt -67.53 -43.1 81.6 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.024 0.44 . . . . 1.0900000000000001 110.86 -178.808 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 36.2 tt0 -56.99 -42.19 79.78 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.625 -0.716 . . . . 2.5899999999999999 110.839 -179.39 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.414 ' HB3' HD13 ' A' ' 40' ' ' LEU . 25.6 mm-40 -70.0 -37.71 75.75 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 111.895 0.331 . . . . 1.75 111.895 176.205 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.483 ' HG ' ' O ' ' A' ' 49' ' ' GLY . 58.9 mt -58.47 -17.74 23.33 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 112.197 0.443 . . . . 0.72999999999999998 112.197 178.852 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 79.6 mt -69.8 -12.31 61.53 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.443 -0.344 . . . . 2.1600000000000001 111.007 177.517 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -67.4 109.55 3.22 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 121.041 0.448 . . . . 2.2400000000000002 110.038 178.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 105.66 -6.65 41.51 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.925 -0.655 . . . . 1.7 112.109 -179.221 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 49.1 m -121.75 169.35 10.82 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.833 0.349 . . . . 2.2799999999999998 110.845 -179.145 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -121.21 15.62 9.34 Favored Glycine 0 N--CA 1.444 -0.813 0 N-CA-C 110.58 -1.008 . . . . 1.5800000000000001 110.58 172.317 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.527 HD13 HD21 ' A' ' 71' ' ' LEU . 90.8 mt -92.56 -179.4 5.17 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.697 -0.482 . . . . 1.4199999999999999 109.697 -178.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . 0.411 ' OE1' ' HB3' ' A' ' 74' ' ' ALA . 49.7 mt-30 -139.72 117.85 11.9 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 108.772 -0.825 . . . . 2.6699999999999999 108.772 177.837 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.549 HG11 HD22 ' A' ' 50' ' ' LEU . 18.4 t -86.99 113.6 24.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 N-CA-C 109.095 -0.706 . . . . 1.54 109.095 177.084 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -115.95 116.86 40.08 Favored Pre-proline 0 C--N 1.32 -0.702 0 CA-C-N 116.333 -0.394 . . . . 1.8100000000000001 110.027 -171.112 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.452 ' HA ' ' HA ' ' A' ' 69' ' ' TRP . 58.8 Cg_exo -52.7 121.8 9.82 Favored 'Trans proline' 0 N--CA 1.463 -0.284 0 C-N-CA 122.646 2.231 . . . . 0.84999999999999998 111.551 176.508 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.576 ' H ' ' HA ' ' A' ' 69' ' ' TRP . 3.3 tm? -68.53 -53.8 20.79 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.673 -0.694 . . . . 1.7 109.523 -177.696 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 176.78 149.33 7.62 Favored Glycine 0 N--CA 1.441 -0.986 0 N-CA-C 110.484 -1.046 . . . . 1.6899999999999999 110.484 178.16 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 91.2 m-20 65.47 -82.07 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 122.606 0.362 . . . . 2.96 111.239 -179.612 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -147.16 13.18 1.1 Allowed 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.404 -0.591 . . . . 2.5 109.404 -178.713 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 42.9 m -103.56 174.32 5.92 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 108.691 -0.855 . . . . 1.3 108.691 -174.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' TRP . . . . . 0.632 ' CE3' HD21 ' A' ' 25' ' ' LEU . 34.1 m0 -139.64 161.92 36.36 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 118.136 0.426 . . . . 0.46999999999999997 109.874 -173.671 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 13.9 t -142.72 149.3 38.6 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 108.071 -1.085 . . . . 0.82999999999999996 108.071 169.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.527 HD21 HD13 ' A' ' 59' ' ' LEU . 37.9 tp -92.45 105.52 17.69 Favored 'General case' 0 C--N 1.32 -0.694 0 C-N-CA 120.048 -0.661 . . . . 1.71 110.186 -178.377 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -87.2 118.79 70.45 Favored Pre-proline 0 C--N 1.317 -0.808 0 CA-C-N 114.699 -1.137 . . . . 2.1299999999999999 110.024 -179.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -83.17 115.01 2.26 Favored 'Trans proline' 0 N--CA 1.45 -1.087 0 C-N-CA 122.341 2.027 . . . . 1.3600000000000001 112.409 -178.552 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.411 ' HB3' ' OE1' ' A' ' 60' ' ' GLN . . . . . . . . 0 C--N 1.32 -0.704 0 CA-C-N 115.474 -0.784 . . . . 1.8899999999999999 110.137 174.316 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.454 -0.25 0 CA-C-O 121.697 0.76 . . . . 4.0 110.674 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 27.7 m -94.83 129.76 44.57 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-N 115.497 -0.774 . . . . 1.6399999999999999 109.828 -177.474 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 40.1 m-80 -128.16 96.71 4.54 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.413 0.625 . . . . 2.29 109.329 -178.114 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.695 HD13 ' HB3' ' A' ' 40' ' ' LEU . 3.6 mp -105.0 112.39 38.43 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-N 115.279 -0.873 . . . . 0.81999999999999995 109.563 -178.069 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -85.49 155.94 59.4 Favored Pre-proline 0 C--N 1.32 -0.705 0 CA-C-N 115.855 -0.611 . . . . 1.3799999999999999 109.491 178.302 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.623 ' HA ' ' O ' ' A' ' 37' ' ' SER . 31.6 Cg_exo -58.88 136.07 71.08 Favored 'Trans proline' 0 C--O 1.234 0.323 0 C-N-CA 121.663 1.575 . . . . 1.73 109.858 169.779 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 149.2 49.9 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.011 -1.09 . . . . 1.8400000000000001 111.893 -170.475 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.646 ' HA ' ' HA ' ' A' ' 36' ' ' GLN . 25.9 t 66.36 145.85 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 123.282 0.633 . . . . 1.6100000000000001 112.1 -177.697 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.884 HD22 ' HB3' ' A' ' 37' ' ' SER . 3.0 mm? -57.52 -28.9 63.89 Favored 'General case' 0 N--CA 1.461 0.086 0 CA-C-N 115.784 -0.643 . . . . 1.1899999999999999 109.987 172.547 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.644 ' HB2' ' HB ' ' A' ' 32' ' ' THR . 18.7 t70 -44.11 -62.48 1.13 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 114.549 -1.205 . . . . 2.1099999999999999 111.796 178.563 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.45 ' HA ' ' HB3' ' A' ' 15' ' ' ASN . 36.5 ttpt -69.38 -19.93 63.83 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.423 -0.353 . . . . 2.7200000000000002 111.535 -177.743 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -65.7 -56.45 12.0 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-O 121.134 0.493 . . . . 0.46000000000000002 109.677 178.529 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 74.5 mt -57.86 -38.31 75.46 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.513 -0.767 . . . . 0.68999999999999995 110.943 174.437 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.45 ' HB3' ' HA ' ' A' ' 12' ' ' LYS . 21.4 t-20 -58.83 -42.02 88.25 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.124 -0.489 . . . . 1.3100000000000001 110.655 177.106 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.434 HE21 ' HB3' ' A' ' 16' ' ' GLN . 1.0 OUTLIER -60.63 -43.08 97.95 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.953 -0.567 . . . . 2.23 110.548 178.191 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.436 ' HD1' ' HZ ' ' A' ' 23' ' ' PHE . 0.3 OUTLIER -67.42 -51.14 55.31 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.767 0.317 . . . . 0.65000000000000002 110.63 -179.094 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.741 ' HA ' ' CE2' ' A' ' 23' ' ' PHE . . . -52.26 -53.4 44.29 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 115.799 -0.637 . . . . 0.37 112.352 -177.598 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.77 -21.07 66.24 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.255 -0.429 . . . . 0.64000000000000001 111.958 -177.245 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 32.0 t60 -65.26 -53.62 41.56 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 111.622 0.23 . . . . 1.8500000000000001 111.622 -177.689 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.571 ' HB3' ' CD1' ' A' ' 23' ' ' PHE . 48.1 t -99.81 -7.63 25.18 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.064 0.459 . . . . 1.6699999999999999 110.997 -178.109 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 76.3 44.27 17.96 Favored Glycine 0 N--CA 1.446 -0.687 0 CA-C-N 115.715 -0.675 . . . . 0.62 112.864 178.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.741 ' CE2' ' HA ' ' A' ' 18' ' ' ALA . 14.1 p90 -108.57 149.72 28.47 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.532 -0.544 . . . . 0.56999999999999995 109.532 176.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 28.1 m -90.31 123.61 34.21 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.083 -0.508 . . . . 0.68000000000000005 111.219 -174.392 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.597 HD11 ' HE3' ' A' ' 69' ' ' TRP . 0.9 OUTLIER -92.86 140.5 29.44 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.655 -0.702 . . . . 1.6699999999999999 111.458 -179.914 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.533 ' HB3' ' HA ' ' A' ' 70' ' ' THR . 29.6 t -100.66 92.18 4.99 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.041 -0.725 . . . . 1.1499999999999999 109.041 174.043 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.825 ' HB ' HD23 ' A' ' 71' ' ' LEU . 7.4 p -146.5 134.27 15.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.816 -0.629 . . . . 0.90000000000000002 110.429 -178.729 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 -89.43 128.82 35.99 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.058 -0.519 . . . . 2.3799999999999999 110.216 178.636 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.79 60.87 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.425 0 O-C-N 123.722 0.639 . . . . 1.97 111.667 173.36 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.757 ' HA ' ' HG3' ' A' ' 33' ' ' ARG . 68.7 m -165.28 -27.79 0.03 OUTLIER 'General case' 0 C--N 1.321 -0.642 0 C-N-CA 123.429 0.692 . . . . 2.2200000000000002 109.406 -176.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 97.1 mt -73.29 -23.13 60.25 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.414 0.626 . . . . 1.3799999999999999 109.585 173.513 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.644 ' HB ' ' HB2' ' A' ' 11' ' ' ASP . 17.5 p -98.45 13.0 33.27 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.167 -0.924 . . . . 1.4399999999999999 111.212 179.527 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.757 ' HG3' ' HA ' ' A' ' 30' ' ' SER . 29.4 mtt180 -67.16 126.17 28.35 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.114 -0.494 . . . . 4.6299999999999999 111.245 -179.429 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 67.58 17.27 68.68 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 121.038 -0.601 . . . . 1.6200000000000001 112.275 178.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 5.8 mptp? -88.44 148.96 23.94 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.05 0.452 . . . . 2.75 110.572 178.606 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . 0.646 ' HA ' ' HA ' ' A' ' 9' ' ' SER . 15.0 pt20 -144.02 137.87 27.97 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.51 -0.768 . . . . 2.2400000000000002 109.787 171.24 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.884 ' HB3' HD22 ' A' ' 10' ' ' LEU . 50.7 p -119.99 124.59 46.31 Favored 'General case' 0 N--CA 1.443 -0.784 0 N-CA-C 108.226 -1.027 . . . . 1.02 108.226 -177.066 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -57.26 -32.45 66.6 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 112.274 0.472 . . . . 1.28 112.274 -175.545 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 134.17 178.24 15.49 Favored Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 120.312 -0.947 . . . . 0.41999999999999998 112.481 175.316 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.695 ' HB3' HD13 ' A' ' 5' ' ' ILE . 55.1 tp -160.14 126.12 4.15 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 107.603 -1.258 . . . . 0.69999999999999996 107.603 -179.678 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 72.1 m80 -142.43 99.61 3.53 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.992 0.425 . . . . 2.96 111.439 -174.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -169.14 -170.13 33.35 Favored Glycine 0 N--CA 1.449 -0.459 0 N-CA-C 111.346 -0.702 . . . . 0.55000000000000004 111.346 175.488 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -101.35 76.61 1.71 Allowed 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 108.353 -0.98 . . . . 2.1800000000000002 108.353 171.543 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 26.6 m-85 -91.18 150.42 21.37 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.043 -0.98 . . . . 1.4099999999999999 111.421 -173.735 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 50.4 m-20 -110.24 176.03 5.21 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 107.941 -1.133 . . . . 2.23 107.941 169.218 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.413 HG23 ' H ' ' A' ' 46' ' ' VAL . 16.5 t -49.11 -62.49 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 N-CA-C 112.211 0.448 . . . . 0.56999999999999995 112.211 -169.331 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 25.9 mm-40 -44.31 -60.44 1.92 Allowed 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 113.182 0.808 . . . . 2.3900000000000001 113.182 179.667 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 10.2 m -69.04 -28.02 66.18 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.087 0.47 . . . . 1.26 110.904 -173.035 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.489 ' O ' ' HG ' ' A' ' 53' ' ' LEU . . . -74.4 -39.36 42.98 Favored Glycine 0 N--CA 1.444 -0.818 0 C-N-CA 120.765 -0.731 . . . . 0.37 111.853 -176.303 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.557 ' O ' ' HG ' ' A' ' 54' ' ' LEU . 84.0 mt -72.12 -41.38 67.29 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.563 0.221 . . . . 1.0900000000000001 110.505 -178.187 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 -52.89 -51.16 62.17 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 116.254 -0.43 . . . . 2.5899999999999999 111.7 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 25.8 mm-40 -64.42 -39.92 94.78 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.998 -0.281 . . . . 1.75 111.205 -179.13 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.489 ' HG ' ' O ' ' A' ' 49' ' ' GLY . 92.7 mt -59.32 -25.23 63.98 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.199 -0.455 . . . . 0.72999999999999998 112.123 177.626 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.557 ' HG ' ' O ' ' A' ' 50' ' ' LEU . 96.7 mt -76.3 -14.06 60.12 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 111.922 0.341 . . . . 2.1600000000000001 111.922 -176.394 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -82.88 103.9 12.7 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.989 0.423 . . . . 2.2400000000000002 111.116 -177.263 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 78.9 20.71 69.94 Favored Glycine 0 N--CA 1.45 -0.379 0 CA-C-N 115.698 -0.683 . . . . 1.7 113.485 174.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.455 ' HB2' ' HG ' ' A' ' 10' ' ' LEU . 16.3 p -88.8 -32.49 17.83 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.934 0.397 . . . . 2.2799999999999998 110.981 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 87.86 9.01 71.94 Favored Glycine 0 N--CA 1.444 -0.815 0 N-CA-C 111.3 -0.72 . . . . 1.5800000000000001 111.3 -176.687 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.585 ' HB3' HD12 ' A' ' 71' ' ' LEU . 85.7 mt -129.71 171.55 12.54 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 120.854 0.359 . . . . 1.4199999999999999 110.611 -176.275 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . 0.558 ' HB2' ' HB3' ' A' ' 74' ' ' ALA . 6.4 tt0 -136.16 118.84 16.04 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.177 -0.675 . . . . 2.6699999999999999 109.177 176.192 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.468 ' H ' HD21 ' A' ' 54' ' ' LEU . 52.6 t -87.26 118.46 33.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-O 120.905 0.383 . . . . 1.54 110.69 -178.288 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.427 ' HE3' ' HB3' ' A' ' 62' ' ' LYS . 22.4 mmmt -125.69 117.92 24.45 Favored Pre-proline 0 C--N 1.325 -0.47 0 CA-C-N 115.944 -0.571 . . . . 1.8100000000000001 110.172 177.663 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.511 ' HA ' ' HA ' ' A' ' 69' ' ' TRP . 41.7 Cg_exo -57.94 121.0 9.27 Favored 'Trans proline' 0 C--O 1.233 0.234 0 C-N-CA 122.351 2.034 . . . . 0.84999999999999998 110.762 174.763 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -75.61 -57.98 3.56 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.784 -0.643 . . . . 1.7 110.831 -171.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -127.04 -98.68 1.04 Allowed Glycine 0 N--CA 1.445 -0.73 0 C-N-CA 120.195 -1.002 . . . . 1.6899999999999999 112.395 -178.228 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -91.87 -74.07 0.52 Allowed 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.741 0.305 . . . . 2.96 110.929 -177.633 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 27.2 p-10 -122.19 34.87 5.03 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.186 0.517 . . . . 2.5 110.877 -178.143 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 47.0 t -126.66 169.21 13.37 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 108.713 -0.847 . . . . 1.3 108.713 179.315 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' TRP . . . . . 0.597 ' HE3' HD11 ' A' ' 25' ' ' LEU . 6.8 m0 -142.31 162.32 35.76 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 107.824 -1.176 . . . . 0.46999999999999997 107.824 -173.529 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.533 ' HA ' ' HB3' ' A' ' 26' ' ' SER . 12.4 t -140.32 146.52 38.6 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 109.517 -0.549 . . . . 0.82999999999999996 109.517 174.19 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.825 HD23 ' HB ' ' A' ' 27' ' ' VAL . 4.2 mm? -93.63 102.93 15.12 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.613 0.72 . . . . 1.71 110.751 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.434 ' HA ' ' HD3' ' A' ' 73' ' ' PRO . 24.9 mt-10 -86.65 126.28 64.4 Favored Pre-proline 0 C--N 1.319 -0.733 0 CA-C-N 114.744 -1.116 . . . . 2.1299999999999999 109.54 173.658 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' ' 72' ' ' GLU . 38.9 Cg_exo -60.81 114.46 2.16 Favored 'Trans proline' 0 N--CA 1.462 -0.378 0 C-N-CA 122.746 2.297 . . . . 1.3600000000000001 111.897 -176.494 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.558 ' HB3' ' HB2' ' A' ' 60' ' ' GLN . . . . . . . . 0 C--N 1.32 -0.686 0 CA-C-N 115.007 -0.997 . . . . 1.8899999999999999 108.86 178.239 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . 0.712 ' N ' ' HA ' ' A' ' 43' ' ' ASP . 9.7 tt0 . . . . . 0 N--CA 1.452 -0.369 0 CA-C-O 121.814 0.816 . . . . 4.0 110.198 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 31.8 m -140.8 147.66 22.58 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 114.766 -1.106 . . . . 1.6399999999999999 109.867 178.411 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 84.2 m-20 -129.2 102.56 6.51 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.465 -0.569 . . . . 2.29 109.465 179.768 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.433 HD12 ' HB3' ' A' ' 40' ' ' LEU . 56.6 mt -129.96 152.33 37.22 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 116.172 -0.467 . . . . 0.81999999999999995 109.851 -174.774 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.506 ' HB1' ' HD2' ' A' ' 7' ' ' PRO . . . -163.95 167.46 10.83 Favored Pre-proline 0 C--N 1.327 -0.39 0 N-CA-C 110.112 -0.329 . . . . 1.3799999999999999 110.112 -174.551 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.526 ' HA ' ' O ' ' A' ' 37' ' ' SER . 71.2 Cg_exo -49.31 136.86 31.48 Favored 'Trans proline' 0 C--N 1.351 0.673 0 C-N-CA 122.835 2.357 . . . . 1.73 113.43 -176.582 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 143.86 64.56 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.742 -0.742 . . . . 1.8400000000000001 112.681 177.146 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 50.0 m 66.36 116.14 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 121.372 0.606 . . . . 1.6100000000000001 112.017 179.159 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.402 HD21 HD23 ' A' ' 54' ' ' LEU . 60.0 tp -59.47 -42.04 91.14 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 115.996 -0.547 . . . . 1.1899999999999999 112.425 -178.543 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.628 ' HB3' ' HA ' ' A' ' 33' ' ' ARG . 8.4 p-10 -54.66 -37.86 66.23 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.75 -0.205 . . . . 2.1099999999999999 111.286 178.472 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -66.05 -31.16 71.88 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.949 0.404 . . . . 2.7200000000000002 110.7 178.308 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -67.11 -54.02 25.32 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.133 -0.485 . . . . 0.46000000000000002 110.337 -179.048 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.401 HD11 HD21 ' A' ' 54' ' ' LEU . 84.6 mt -59.26 -38.88 81.19 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 115.76 -0.654 . . . . 0.68999999999999995 110.838 175.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -59.75 -38.74 82.59 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.78 -0.645 . . . . 1.3100000000000001 110.353 178.273 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -62.81 -41.62 99.37 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.62 -0.718 . . . . 2.23 110.786 177.61 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.618 ' CD1' ' HH2' ' A' ' 69' ' ' TRP . 7.0 t80 -68.47 -41.39 80.22 Favored 'General case' 0 C--N 1.333 -0.112 0 N-CA-C 109.807 -0.442 . . . . 0.65000000000000002 109.807 -178.029 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.663 ' HA ' ' CE2' ' A' ' 23' ' ' PHE . . . -53.75 -46.87 71.03 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.05 -0.523 . . . . 0.37 111.691 177.06 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.68 -16.54 57.66 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.043 -0.526 . . . . 0.64000000000000001 112.15 -178.027 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 76.3 t60 -61.36 -47.55 85.33 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.669 -0.241 . . . . 1.8500000000000001 111.462 -179.288 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.463 ' HB3' ' CD1' ' A' ' 23' ' ' PHE . 32.5 t -118.77 -15.89 9.39 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 120.712 -0.395 . . . . 1.6699999999999999 112.008 -178.676 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 74.9 61.01 3.19 Favored Glycine 0 C--N 1.331 0.259 0 C-N-CA 120.867 -0.682 . . . . 0.62 112.732 -179.485 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.663 ' CE2' ' HA ' ' A' ' 18' ' ' ALA . 3.1 p90 -112.8 169.21 9.07 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.999 0.428 . . . . 0.56999999999999995 111.021 -179.103 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 14.8 m -89.66 101.38 14.07 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.457 0.646 . . . . 0.68000000000000005 111.276 -176.354 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.592 HD22 ' HB ' ' A' ' 27' ' ' VAL . 2.8 tt -93.58 126.78 38.92 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.551 -0.75 . . . . 1.6699999999999999 109.325 177.116 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.558 ' HB2' ' HA ' ' A' ' 70' ' ' THR . 8.5 m -98.99 91.15 4.89 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.162 -0.681 . . . . 1.1499999999999999 109.162 179.843 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.746 HG23 HD22 ' A' ' 71' ' ' LEU . 7.3 p -117.62 135.78 56.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 115.911 -0.586 . . . . 0.90000000000000002 111.533 -174.458 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 50.7 m-20 -78.19 112.81 15.54 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-N 115.882 -0.599 . . . . 2.3799999999999999 109.74 174.675 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -64.68 66.74 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.977 -0.556 . . . . 1.97 112.02 177.524 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 20.4 p -170.28 -44.09 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.255 -0.429 . . . . 2.2200000000000002 110.175 -179.074 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 91.0 mt -68.27 -52.58 32.29 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.951 -0.568 . . . . 1.3799999999999999 111.351 -179.286 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 13.0 p -101.82 -19.2 15.41 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 112.615 0.598 . . . . 1.4399999999999999 112.615 -176.265 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.628 ' HA ' ' HB3' ' A' ' 11' ' ' ASP . 16.1 tpp180 -59.9 119.16 7.2 Favored 'General case' 0 C--O 1.233 0.233 0 N-CA-C 110.115 -0.328 . . . . 4.6299999999999999 110.115 -178.463 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 93.66 -115.85 5.06 Favored Glycine 0 N--CA 1.439 -1.165 0 N-CA-C 111.056 -0.818 . . . . 1.6200000000000001 111.056 -177.041 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 9.3 mmmm 46.9 -165.84 0.02 OUTLIER 'General case' 0 N--CA 1.443 -0.775 0 CA-C-O 122.205 1.002 . . . . 2.75 111.654 -176.209 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 8.0 pt20 -150.16 132.71 15.75 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 114.887 -1.051 . . . . 2.2400000000000002 108.673 165.029 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.526 ' O ' ' HA ' ' A' ' 7' ' ' PRO . 33.9 t -118.45 139.22 51.75 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 108.059 -1.089 . . . . 1.02 108.059 175.436 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 8.0 m120 -67.61 -14.46 62.96 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.091 -0.504 . . . . 1.28 111.065 -176.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.409 ' HA2' HG22 ' A' ' 5' ' ' ILE . . . 111.58 -169.53 13.25 Favored Glycine 0 N--CA 1.443 -0.882 0 C-N-CA 120.73 -0.747 . . . . 0.41999999999999998 112.331 173.527 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.433 ' HB3' HD12 ' A' ' 5' ' ' ILE . 42.1 tp -160.16 125.64 4.02 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 108.349 -0.982 . . . . 0.69999999999999996 108.349 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 39.4 t-80 -136.66 96.54 3.35 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 120.215 -0.594 . . . . 2.96 110.966 -178.544 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -168.79 -179.96 41.26 Favored Glycine 0 N--CA 1.448 -0.533 0 CA-C-N 115.398 -0.819 . . . . 0.55000000000000004 111.239 175.157 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.712 ' HA ' ' N ' ' A' ' 2' ' ' GLN . 21.9 m-20 -84.97 74.63 10.49 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 108.656 -0.868 . . . . 2.1800000000000002 108.656 173.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 22.5 m-85 -96.21 143.94 26.86 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.198 -0.91 . . . . 1.4099999999999999 111.061 -174.086 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -94.1 -172.39 2.81 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.543 -0.753 . . . . 2.23 110.057 179.386 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.434 HG13 ' HZ2' ' A' ' 69' ' ' TRP . 59.8 t -52.34 -71.57 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.042 -0.526 . . . . 0.56999999999999995 112.19 -178.095 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 21.1 mt-10 -63.88 -41.49 97.73 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.863 -0.608 . . . . 2.3900000000000001 112.061 -172.78 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 4.2 p -72.11 -32.04 66.6 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.098 -0.501 . . . . 1.26 111.306 -172.251 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -75.2 -39.24 37.42 Favored Glycine 0 N--CA 1.447 -0.617 0 N-CA-C 111.114 -0.794 . . . . 0.37 111.114 -176.39 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.521 ' CB ' HG11 ' A' ' 61' ' ' VAL . 62.9 mt -72.66 -41.5 65.36 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.773 0.321 . . . . 1.0900000000000001 110.58 -178.568 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 21.2 tt0 -54.8 -49.12 71.75 Favored 'General case' 0 C--O 1.222 -0.345 0 CA-C-N 115.808 -0.633 . . . . 2.5899999999999999 111.009 -176.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 16.4 mm100 -65.09 -40.19 94.26 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.455 -0.339 . . . . 1.75 111.485 -178.622 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 90.0 mt -57.77 -34.95 70.13 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 112.1 0.407 . . . . 0.72999999999999998 112.1 178.636 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.402 HD23 HD21 ' A' ' 10' ' ' LEU . 81.8 mt -102.42 -12.6 17.74 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.929 0.395 . . . . 2.1600000000000001 111.645 -174.432 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -64.68 130.2 42.68 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.05 -0.523 . . . . 2.2400000000000002 110.956 -177.833 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 100.41 -31.44 8.51 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.533 -0.842 . . . . 1.7 113.243 176.561 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 24.4 p -91.87 12.84 20.25 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 117.218 0.509 . . . . 2.2799999999999998 111.343 -177.001 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 74.37 25.14 71.31 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.683 -0.77 . . . . 1.5800000000000001 111.821 179.247 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 91.6 mt -123.42 156.01 36.32 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 109.939 -0.393 . . . . 1.4199999999999999 109.939 -178.687 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . 0.532 ' HB2' ' HB3' ' A' ' 74' ' ' ALA . 38.2 mm-40 -152.59 172.78 16.08 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.409 -0.589 . . . . 2.6699999999999999 109.409 176.496 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.521 HG11 ' CB ' ' A' ' 50' ' ' LEU . 10.8 p -139.89 148.96 22.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-O 120.821 0.343 . . . . 1.54 110.709 -178.616 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.546 ' HG3' HG23 ' A' ' 70' ' ' THR . 1.6 ptpp? -139.83 128.59 13.44 Favored Pre-proline 0 C--N 1.321 -0.671 0 N-CA-C 109.519 -0.548 . . . . 1.8100000000000001 109.519 172.815 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -59.8 126.3 20.1 Favored 'Trans proline' 0 N--CA 1.462 -0.376 0 C-N-CA 122.309 2.006 . . . . 0.84999999999999998 110.425 173.332 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.404 HD22 ' HA ' ' A' ' 64' ' ' LEU . 2.5 tm? -59.78 -44.35 93.96 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.527 -0.761 . . . . 1.7 109.903 -175.537 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 152.24 -65.13 0.36 Allowed Glycine 0 N--CA 1.445 -0.729 0 C-N-CA 120.701 -0.761 . . . . 1.6899999999999999 111.722 176.028 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 12.8 t-20 -88.71 78.92 7.6 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.124 0.487 . . . . 2.96 110.043 -179.558 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 43.52 35.94 1.07 Allowed 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 124.482 1.113 . . . . 2.5 113.727 178.552 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 39.5 m -137.16 175.34 9.7 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 108.54 -0.911 . . . . 1.3 108.54 176.453 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' TRP . . . . . 0.618 ' HH2' ' CD1' ' A' ' 17' ' ' TYR . 54.9 m0 -137.52 167.1 22.33 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.952 0.406 . . . . 0.46999999999999997 110.923 -169.877 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.558 ' HA ' ' HB2' ' A' ' 26' ' ' SER . 3.7 t -145.91 147.38 31.69 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.58 -0.737 . . . . 0.82999999999999996 109.423 171.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.746 HD22 HG23 ' A' ' 27' ' ' VAL . 50.8 tp -91.62 105.71 17.94 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.144 0.497 . . . . 1.71 109.707 -178.03 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.482 ' HB2' ' HG2' ' A' ' 62' ' ' LYS . 12.7 tp10 -94.33 118.93 67.04 Favored Pre-proline 0 C--N 1.323 -0.577 0 CA-C-N 115.147 -0.933 . . . . 2.1299999999999999 110.766 -176.642 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_exo -70.02 113.5 3.44 Favored 'Trans proline' 0 N--CA 1.456 -0.701 0 C-N-CA 121.647 1.564 . . . . 1.3600000000000001 110.649 172.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.532 ' HB3' ' HB2' ' A' ' 60' ' ' GLN . . . . . . . . 0 C--N 1.322 -0.623 0 CA-C-N 116.109 -0.496 . . . . 1.8899999999999999 109.891 -177.668 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . 0.693 ' HA ' ' HA ' ' A' ' 43' ' ' ASP . 77.0 mt-30 . . . . . 0 C--O 1.231 0.125 0 CA-C-O 121.668 0.747 . . . . 4.0 112.005 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 57.6 t -131.82 130.56 61.77 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 115.49 -0.777 . . . . 1.6399999999999999 109.221 178.417 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 4.2 p-10 -131.52 121.61 24.76 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 108.882 -0.784 . . . . 2.29 108.882 -178.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.492 HG13 HD21 ' A' ' 53' ' ' LEU . 36.4 mm -116.95 129.11 74.04 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 CA-C-N 115.925 -0.579 . . . . 0.81999999999999995 109.956 -178.256 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -73.56 156.52 88.62 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.069 -0.514 . . . . 1.3799999999999999 109.86 177.6 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.585 ' HA ' ' O ' ' A' ' 37' ' ' SER . 7.6 Cg_exo -74.45 39.86 0.58 Allowed 'Trans proline' 0 CA--C 1.532 0.394 0 C-N-CA 123.132 2.555 . . . . 1.73 112.888 179.449 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -115.35 -162.71 13.65 Favored Glycine 0 N--CA 1.447 -0.615 0 C-N-CA 120.786 -0.721 . . . . 1.8400000000000001 113.43 -176.792 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.541 ' HA ' ' HA ' ' A' ' 36' ' ' GLN . 15.7 m -55.77 132.21 48.72 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.222 0.534 . . . . 1.6100000000000001 111.197 -176.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 59.9 tp -58.88 -28.66 66.35 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.165 -0.925 . . . . 1.1899999999999999 111.055 -176.061 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -45.97 -48.05 16.55 Favored 'General case' 0 CA--C 1.52 -0.199 0 CA-C-O 121.059 0.457 . . . . 2.1099999999999999 110.576 175.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 65.3 mttm -67.58 -24.13 65.48 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.772 -0.649 . . . . 2.7200000000000002 111.811 -177.368 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -65.87 -64.03 0.95 Allowed 'General case' 0 C--O 1.233 0.233 0 N-CA-C 110.407 -0.22 . . . . 0.46000000000000002 110.407 -179.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.811 HD12 ' H ' ' A' ' 14' ' ' LEU . 4.4 mp -58.56 -35.72 72.8 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 116.431 -0.35 . . . . 0.68999999999999995 111.339 175.641 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -60.6 -46.69 89.32 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 121.07 0.462 . . . . 1.3100000000000001 109.94 178.232 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.422 HE21 ' HB3' ' A' ' 16' ' ' GLN . 1.0 OUTLIER -63.91 -43.21 96.66 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.509 -0.769 . . . . 2.23 110.435 178.028 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.476 ' O ' ' HB3' ' A' ' 20' ' ' HIS . 10.1 t80 -68.03 -40.46 82.92 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-O 120.76 0.314 . . . . 0.65000000000000002 110.182 -177.791 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.793 ' HA ' ' CE2' ' A' ' 23' ' ' PHE . . . -54.5 -44.2 72.47 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 116.329 -0.396 . . . . 0.37 111.532 176.14 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.24 -17.96 59.83 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.053 -0.522 . . . . 0.64000000000000001 111.988 -178.787 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . 0.476 ' HB3' ' O ' ' A' ' 17' ' ' TYR . 83.4 t60 -59.75 -54.88 41.18 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.532 -0.304 . . . . 1.8500000000000001 111.266 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.573 ' HB3' ' CD1' ' A' ' 23' ' ' PHE . 22.7 t -114.45 -12.35 12.35 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.482 -0.487 . . . . 1.6699999999999999 111.639 -177.438 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 75.92 49.63 8.56 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 121.062 -0.589 . . . . 0.62 112.754 179.229 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.793 ' CE2' ' HA ' ' A' ' 18' ' ' ALA . 1.8 p90 -103.76 158.11 16.61 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 110.222 -0.288 . . . . 0.56999999999999995 110.222 -179.541 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.568 ' O ' ' HB3' ' A' ' 68' ' ' SER . 32.6 m -93.13 101.31 13.61 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.238 0.542 . . . . 0.68000000000000005 111.878 -175.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.433 ' HB2' ' HB2' ' A' ' 69' ' ' TRP . 0.0 OUTLIER -99.43 150.27 22.34 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.385 -0.37 . . . . 1.6699999999999999 110.115 174.053 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.607 ' HB2' ' HA ' ' A' ' 70' ' ' THR . 43.3 m -106.54 104.07 13.67 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.376 -0.375 . . . . 1.1499999999999999 110.502 -177.389 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 14.9 p -123.57 143.82 35.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 N-CA-C 110.195 -0.298 . . . . 0.90000000000000002 110.195 178.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.419 ' OD2' ' HG ' ' A' ' 31' ' ' LEU . 21.6 t70 -97.32 108.71 21.5 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.433 -0.349 . . . . 2.3799999999999999 110.537 177.575 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.21 60.04 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 115.492 -0.777 . . . . 1.97 112.382 178.218 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 74.8 m -166.38 -36.6 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 123.188 0.595 . . . . 2.2200000000000002 109.526 179.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.419 ' HG ' ' OD2' ' A' ' 28' ' ' ASP . 89.0 mt -68.0 -28.5 67.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.383 0.611 . . . . 1.3799999999999999 110.087 176.034 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 5.0 p -97.69 18.38 15.74 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.528 -0.76 . . . . 1.4399999999999999 111.262 179.11 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 53.5 ttp180 -63.85 108.35 1.44 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.661 -0.245 . . . . 4.6299999999999999 110.415 -179.202 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 81.45 8.56 86.92 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.834 -0.698 . . . . 1.6200000000000001 112.268 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 41.8 tptt -86.65 108.14 18.5 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.622 -0.51 . . . . 2.75 109.622 -179.047 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . 0.541 ' HA ' ' HA ' ' A' ' 9' ' ' SER . 46.2 mt-30 -109.84 158.88 17.72 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 110.092 -0.336 . . . . 2.2400000000000002 110.092 -178.802 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.585 ' O ' ' HA ' ' A' ' 7' ' ' PRO . 7.2 t -128.63 127.55 42.45 Favored 'General case' 0 N--CA 1.445 -0.711 0 N-CA-C 107.863 -1.162 . . . . 1.02 107.863 175.158 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 8.7 m120 -64.25 -8.8 13.9 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 112.37 0.507 . . . . 1.28 112.37 -172.716 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 129.31 175.37 14.02 Favored Glycine 0 N--CA 1.444 -0.806 0 C-N-CA 120.152 -1.023 . . . . 0.41999999999999998 112.876 169.743 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 54.1 tp -160.06 124.93 3.9 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 107.624 -1.25 . . . . 0.69999999999999996 107.624 -179.376 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 52.9 m80 -136.42 97.95 3.71 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 120.26 -0.576 . . . . 2.96 111.438 -177.519 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -170.57 168.3 41.37 Favored Glycine 0 N--CA 1.447 -0.609 0 CA-C-N 115.199 -0.909 . . . . 0.55000000000000004 110.866 174.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.693 ' HA ' ' HA ' ' A' ' 2' ' ' GLN . 24.2 t70 -78.89 100.18 7.1 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 108.828 -0.805 . . . . 2.1800000000000002 108.828 170.069 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 43.8 m-85 -116.67 142.43 46.91 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.74 -0.664 . . . . 1.4099999999999999 111.496 -173.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -92.48 -175.3 3.95 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.438 -0.801 . . . . 2.23 108.861 175.34 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 14.1 t -52.0 -69.73 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 121.193 0.52 . . . . 0.56999999999999995 111.534 -174.592 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -56.47 -49.1 75.62 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.263 -0.88 . . . . 2.3900000000000001 112.587 -173.531 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 4.6 t -71.73 -31.36 66.62 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.076 -0.511 . . . . 1.26 110.727 -171.358 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -75.91 -41.45 27.89 Favored Glycine 0 N--CA 1.445 -0.735 0 C-N-CA 120.608 -0.806 . . . . 0.37 111.833 -175.744 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.697 HD13 HG11 ' A' ' 61' ' ' VAL . 93.4 mt -74.03 -36.99 64.48 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.654 0.264 . . . . 1.0900000000000001 110.422 -178.323 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 1.8 tp-100 -54.76 -47.97 73.23 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.324 -0.398 . . . . 2.5899999999999999 111.648 179.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 -65.33 -38.53 90.41 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.612 -0.267 . . . . 1.75 111.363 -179.512 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.492 HD21 HG13 ' A' ' 5' ' ' ILE . 94.0 mt -59.23 -23.88 62.69 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 111.935 0.346 . . . . 0.72999999999999998 111.935 176.651 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.782 HD21 HG23 ' A' ' 61' ' ' VAL . 96.2 mt -80.7 -14.04 58.48 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 111.946 0.35 . . . . 2.1600000000000001 111.946 -176.631 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -62.66 115.34 4.21 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.158 0.504 . . . . 2.2400000000000002 110.806 -178.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 110.25 16.52 10.31 Favored Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 120.784 -0.722 . . . . 1.7 112.029 -178.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 89.5 p -146.29 177.4 9.04 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.873 -0.417 . . . . 2.2799999999999998 109.873 177.33 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -118.96 43.72 1.53 Allowed Glycine 0 N--CA 1.445 -0.741 0 N-CA-C 111.124 -0.791 . . . . 1.5800000000000001 111.124 176.708 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.516 HD13 HD21 ' A' ' 71' ' ' LEU . 55.1 mt -117.75 174.59 6.09 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.385 -0.407 . . . . 1.4199999999999999 110.164 -177.634 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 74.2 mt-30 -146.6 127.85 14.81 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.248 -0.649 . . . . 2.6699999999999999 109.248 177.206 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.782 HG23 HD21 ' A' ' 54' ' ' LEU . 48.2 t -88.49 119.72 36.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 109.014 -0.736 . . . . 1.54 109.014 174.556 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -132.42 122.97 18.31 Favored Pre-proline 0 N--CA 1.441 -0.912 0 CA-C-N 116.493 -0.322 . . . . 1.8100000000000001 110.134 -173.75 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.635 ' HA ' ' HA ' ' A' ' 69' ' ' TRP . 44.7 Cg_exo -57.79 144.48 93.4 Favored 'Trans proline' 0 C--O 1.234 0.286 0 C-N-CA 122.977 2.452 . . . . 0.84999999999999998 111.605 176.847 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -75.86 -47.55 25.03 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.616 -0.72 . . . . 1.7 109.843 -178.07 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 161.62 -46.8 0.37 Allowed Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.594 -0.812 . . . . 1.6899999999999999 111.968 179.005 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 11.0 t30 -110.76 86.62 2.35 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 110.148 -0.315 . . . . 2.96 110.148 -179.482 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 39.11 42.49 0.72 Allowed 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 124.318 1.047 . . . . 2.5 113.313 178.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.568 ' HB3' ' O ' ' A' ' 24' ' ' THR . 50.1 m -142.06 174.84 10.23 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 108.745 -0.835 . . . . 1.3 108.745 176.173 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' TRP . . . . . 0.635 ' HA ' ' HA ' ' A' ' 63' ' ' PRO . 41.4 m0 -137.81 169.09 18.39 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.235 0.54 . . . . 0.46999999999999997 110.345 -173.079 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.607 ' HA ' ' HB2' ' A' ' 26' ' ' SER . 11.7 t -148.89 141.93 24.85 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-N 115.368 -0.833 . . . . 0.82999999999999996 109.064 168.076 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.516 HD21 HD13 ' A' ' 59' ' ' LEU . 60.8 tp -92.72 102.85 15.26 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.238 0.542 . . . . 1.71 109.76 178.823 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.429 ' HA ' ' HD3' ' A' ' 73' ' ' PRO . 33.0 tt0 -96.92 129.95 31.26 Favored Pre-proline 0 C--N 1.317 -0.817 0 CA-C-N 115.403 -0.817 . . . . 2.1299999999999999 110.839 179.331 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 72' ' ' GLU . 12.0 Cg_exo -71.3 115.2 4.18 Favored 'Trans proline' 0 N--CA 1.459 -0.509 0 C-N-CA 122.432 2.088 . . . . 1.3600000000000001 110.723 173.249 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.323 -0.551 0 CA-C-N 115.83 -0.623 . . . . 1.8899999999999999 109.655 -177.329 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . 0.746 ' HB2' ' HA ' ' A' ' 43' ' ' ASP . 0.0 OUTLIER . . . . . 0 CA--C 1.512 -0.488 0 CA-C-O 121.943 0.878 . . . . 4.0 109.806 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.499 HG11 ' CD2' ' A' ' 17' ' ' TYR . 14.2 m -148.85 152.17 12.42 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.174 0 CA-C-N 113.689 -1.596 . . . . 1.6399999999999999 109.672 -178.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 69.9 m-20 -131.17 112.08 12.52 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.579 -0.526 . . . . 2.29 109.579 178.211 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.457 ' HB ' ' N ' ' A' ' 40' ' ' LEU . 48.5 mm -107.16 116.81 51.67 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 N-CA-C 109.821 -0.437 . . . . 0.81999999999999995 109.821 -178.771 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -82.8 157.86 66.09 Favored Pre-proline 0 C--N 1.323 -0.563 0 CA-C-N 115.923 -0.58 . . . . 1.3799999999999999 109.51 177.216 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.569 ' HA ' ' O ' ' A' ' 37' ' ' SER . 11.5 Cg_endo -58.71 145.49 95.67 Favored 'Trans proline' 0 N--CA 1.462 -0.376 0 C-N-CA 121.642 1.561 . . . . 1.73 109.879 168.504 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 148.71 -174.78 28.25 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.437 -0.887 . . . . 1.8400000000000001 111.196 -169.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 47.1 t -63.37 128.82 37.57 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 117.029 0.414 . . . . 1.6100000000000001 110.657 -179.016 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.41 HD13 ' HB2' ' A' ' 37' ' ' SER . 61.9 tp -61.7 -31.41 71.55 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.022 -0.535 . . . . 1.1899999999999999 110.223 -179.59 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -49.39 -54.22 18.51 Favored 'General case' 0 CA--C 1.52 -0.178 0 CA-C-N 115.41 -0.814 . . . . 2.1099999999999999 110.345 173.218 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.427 ' HD3' ' HA ' ' A' ' 12' ' ' LYS . 0.1 OUTLIER -69.81 -27.69 65.09 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.755 -0.657 . . . . 2.7200000000000002 111.11 -178.863 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -66.51 -56.32 11.41 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-O 121.002 0.43 . . . . 0.46000000000000002 110.224 -179.745 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 94.0 mt -60.18 -40.5 90.2 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.894 -0.594 . . . . 0.68999999999999995 111.156 176.006 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -62.14 -35.85 80.03 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.027 0.441 . . . . 1.3100000000000001 110.465 178.321 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.409 ' HB3' HE21 ' A' ' 16' ' ' GLN . 1.0 OUTLIER -62.92 -43.52 98.58 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 116.067 -0.515 . . . . 2.23 109.876 176.641 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.632 ' OH ' ' HA ' ' A' ' 46' ' ' VAL . 44.9 t80 -70.02 -35.53 74.4 Favored 'General case' 0 C--O 1.224 -0.251 0 N-CA-C 109.996 -0.372 . . . . 0.65000000000000002 109.996 -178.613 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.685 ' HA ' ' CE2' ' A' ' 23' ' ' PHE . . . -52.24 -39.85 60.87 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-O 120.695 0.283 . . . . 0.37 111.724 176.292 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.9 -15.58 55.67 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 112.478 0.548 . . . . 0.64000000000000001 112.478 178.796 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 17.8 t-80 -57.85 -57.44 12.75 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 122.312 0.245 . . . . 1.8500000000000001 111.316 -179.058 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.573 ' HB3' ' HD1' ' A' ' 23' ' ' PHE . 25.1 t -109.15 -12.47 14.81 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.069 0.462 . . . . 1.6699999999999999 111.237 -179.493 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 74.35 53.69 6.63 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.87 -0.681 . . . . 0.62 112.428 -179.302 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.685 ' CE2' ' HA ' ' A' ' 18' ' ' ALA . 3.2 p90 -104.41 172.67 6.67 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.715 0.293 . . . . 0.56999999999999995 110.497 -177.911 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 12.9 m -92.13 107.79 19.47 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.244 0.545 . . . . 0.68000000000000005 111.678 -177.512 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.469 ' HG ' ' HE3' ' A' ' 69' ' ' TRP . 1.0 OUTLIER -98.18 126.08 43.5 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.953 -0.567 . . . . 1.6699999999999999 110.178 177.549 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.472 ' HB2' HG22 ' A' ' 70' ' ' THR . 68.5 m -101.13 97.73 8.23 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.085 0.469 . . . . 1.1499999999999999 110.146 178.15 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 6.4 p -147.98 133.58 11.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 115.56 -0.745 . . . . 0.90000000000000002 110.171 179.272 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.525 ' HB2' ' CD1' ' A' ' 31' ' ' LEU . 50.2 m-20 -94.36 129.73 40.96 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.707 -0.479 . . . . 2.3799999999999999 109.707 176.283 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -58.04 -10.78 2.01 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.581 -0.736 . . . . 1.97 112.704 -178.686 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 6.0 p -71.7 -41.99 67.94 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.718 0.294 . . . . 2.2200000000000002 110.674 179.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.556 ' H ' HD12 ' A' ' 31' ' ' LEU . 5.7 mp -63.79 -42.18 97.8 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.021 0.439 . . . . 1.3799999999999999 111.329 179.013 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 2.5 p -91.67 13.36 18.28 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.026 -0.534 . . . . 1.4399999999999999 111.668 -177.004 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.446 HH11 ' HD3' ' A' ' 33' ' ' ARG . 30.5 ttt180 -68.6 112.42 5.37 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.28 -0.418 . . . . 4.6299999999999999 110.423 178.155 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 87.01 -0.79 86.41 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.783 -0.722 . . . . 1.6200000000000001 112.013 -178.331 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 24.6 tptp -86.01 114.6 23.02 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 110.507 -0.183 . . . . 2.75 110.507 -178.589 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -106.41 164.32 12.13 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 110.112 -0.329 . . . . 2.2400000000000002 110.112 176.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.569 ' O ' ' HA ' ' A' ' 7' ' ' PRO . 33.5 t -137.17 131.94 33.24 Favored 'General case' 0 N--CA 1.445 -0.719 0 N-CA-C 107.718 -1.216 . . . . 1.02 107.718 172.102 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.424 ' N ' HD22 ' A' ' 38' ' ' ASN . 0.9 OUTLIER -60.78 -21.61 63.24 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 112.761 0.652 . . . . 1.28 112.761 -176.367 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.432 ' HA2' HG22 ' A' ' 5' ' ' ILE . . . 128.37 -175.41 18.58 Favored Glycine 0 N--CA 1.446 -0.668 0 C-N-CA 120.033 -1.079 . . . . 0.41999999999999998 113.201 172.845 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.457 ' N ' ' HB ' ' A' ' 5' ' ' ILE . 43.3 tp -160.0 127.69 4.66 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 107.798 -1.186 . . . . 0.69999999999999996 107.798 -178.329 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 74.3 m80 -140.02 97.85 3.33 Favored 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 120.342 -0.543 . . . . 2.96 111.032 -178.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -169.4 175.75 43.58 Favored Glycine 0 N--CA 1.444 -0.808 0 C-N-CA 120.832 -0.699 . . . . 0.55000000000000004 112.341 175.634 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.746 ' HA ' ' HB2' ' A' ' 2' ' ' GLN . 14.7 t70 -88.61 76.1 8.18 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 107.526 -1.287 . . . . 2.1800000000000002 107.526 170.616 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -96.98 149.29 22.07 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 114.844 -1.071 . . . . 1.4099999999999999 112.953 -167.737 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 19.8 t0 -90.71 166.94 12.86 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.102 -0.954 . . . . 2.23 109.649 174.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.632 ' HA ' ' OH ' ' A' ' 17' ' ' TYR . 42.9 t -47.5 -73.08 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 N-CA-C 113.616 0.969 . . . . 0.56999999999999995 113.616 -170.513 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -65.0 -29.5 70.42 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 112.467 0.543 . . . . 2.3900000000000001 112.467 -174.129 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 16.6 m -71.29 -33.1 69.43 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.216 0.531 . . . . 1.26 110.556 -177.189 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -76.51 -33.47 47.78 Favored Glycine 0 N--CA 1.446 -0.688 0 N-CA-C 111.275 -0.73 . . . . 0.37 111.275 -178.329 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.706 ' HB3' HG11 ' A' ' 61' ' ' VAL . 85.7 mt -67.9 -42.37 81.26 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.916 0.389 . . . . 1.0900000000000001 110.479 178.599 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -56.24 -38.81 71.6 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.846 -0.615 . . . . 2.5899999999999999 111.083 179.084 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 32.2 mm-40 -62.29 -56.31 19.72 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.918 0.39 . . . . 1.75 111.299 177.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 86.7 mt -57.5 -33.76 68.37 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.917 -0.583 . . . . 0.72999999999999998 112.092 -177.613 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 10.8 mp -98.98 13.88 31.12 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 112.362 0.505 . . . . 2.1600000000000001 112.362 -175.306 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -60.23 111.14 1.42 Allowed 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.916 0.389 . . . . 2.2400000000000002 111.175 177.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 66.02 39.18 94.69 Favored Glycine 0 C--N 1.332 0.311 0 CA-C-N 115.83 -0.623 . . . . 1.7 112.583 178.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 63.9 p -98.72 -17.13 18.69 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.812 0.339 . . . . 2.2799999999999998 111.733 -176.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 81.05 6.67 89.28 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.57 -0.824 . . . . 1.5800000000000001 111.154 -172.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.494 HD13 HD21 ' A' ' 71' ' ' LEU . 96.1 mt -113.79 165.8 12.19 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.157 -0.521 . . . . 1.4199999999999999 110.335 -177.875 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 31.0 tt0 -145.35 117.93 8.59 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 108.823 -0.806 . . . . 2.6699999999999999 108.823 179.067 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.706 HG11 ' HB3' ' A' ' 50' ' ' LEU . 7.5 p -92.71 129.61 43.02 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 N-CA-C 110.116 -0.328 . . . . 1.54 110.116 -179.605 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.506 ' HZ1' ' HG3' ' A' ' 72' ' ' GLU . 21.1 mtmm -130.5 122.38 19.79 Favored Pre-proline 0 C--N 1.322 -0.601 0 CA-C-N 116.354 -0.385 . . . . 1.8100000000000001 110.736 179.361 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_exo -61.07 117.7 4.5 Favored 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 122.141 1.894 . . . . 0.84999999999999998 109.895 169.456 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -62.2 -43.65 98.34 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.29 -0.868 . . . . 1.7 111.052 -170.323 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 152.95 -63.82 0.37 Allowed Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.476 -0.868 . . . . 1.6899999999999999 112.155 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 7.3 m-20 -82.92 57.2 3.75 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.654 0.264 . . . . 2.96 111.134 -178.475 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 6.3 t30 56.18 44.24 25.38 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 121.595 0.712 . . . . 2.5 110.78 178.004 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 14.7 m -142.34 177.61 8.15 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 108.848 -0.797 . . . . 1.3 108.848 177.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' TRP . . . . . 0.548 ' HH2' ' CD1' ' A' ' 17' ' ' TYR . 48.1 m0 -136.73 155.59 49.65 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 116.582 -0.281 . . . . 0.46999999999999997 110.488 -172.075 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.472 HG22 ' HB2' ' A' ' 26' ' ' SER . 1.6 p -139.47 132.43 29.4 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.143 -0.48 . . . . 0.82999999999999996 109.753 173.463 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.494 HD21 HD13 ' A' ' 59' ' ' LEU . 51.7 tp -93.19 104.31 16.51 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.501 0.667 . . . . 1.71 110.651 -178.766 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.506 ' HG3' ' HZ1' ' A' ' 62' ' ' LYS . 37.9 mm-40 -90.73 124.29 62.69 Favored Pre-proline 0 C--N 1.319 -0.748 0 CA-C-N 114.701 -1.136 . . . . 2.1299999999999999 110.75 177.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_exo -74.1 113.54 3.81 Favored 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 121.833 1.689 . . . . 1.3600000000000001 110.542 171.365 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.332 -0.172 0 CA-C-N 116.031 -0.531 . . . . 1.8899999999999999 110.581 -175.643 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 46.8 mt-30 . . . . . 0 C--O 1.235 0.328 0 CA-C-O 121.154 0.502 . . . . 4.0 110.288 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 40.7 t -134.75 145.13 32.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 115.53 -0.759 . . . . 1.6399999999999999 109.6 -175.303 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 5.2 p30 -128.08 98.25 5.05 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-O 121.776 0.798 . . . . 2.29 109.337 179.322 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.42 ' HB ' ' HB3' ' A' ' 40' ' ' LEU . 50.0 mm -102.21 110.01 27.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 115.34 -0.845 . . . . 0.81999999999999995 109.558 -178.434 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -78.86 149.02 73.38 Favored Pre-proline 0 C--N 1.319 -0.73 0 CA-C-N 115.587 -0.733 . . . . 1.3799999999999999 109.692 -179.008 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -55.31 134.65 65.07 Favored 'Trans proline' 0 N--CA 1.461 -0.422 0 C-N-CA 121.961 1.774 . . . . 1.73 109.656 169.113 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 150.46 -177.23 28.66 Favored Glycine 0 N--CA 1.445 -0.767 0 N-CA-C 110.41 -1.076 . . . . 1.8400000000000001 110.41 -169.256 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.589 ' HA ' ' HA ' ' A' ' 36' ' ' GLN . 10.2 t -65.31 140.29 58.67 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 117.266 0.533 . . . . 1.6100000000000001 110.221 -178.615 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.503 HD12 ' HG3' ' A' ' 35' ' ' LYS . 12.6 mt -58.15 -27.27 63.64 Favored 'General case' 0 CA--C 1.52 -0.187 0 CA-C-N 116.332 -0.394 . . . . 1.1899999999999999 110.513 177.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -49.28 -55.27 13.27 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 115.417 -0.81 . . . . 2.1099999999999999 110.724 173.582 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 25.1 ttmm -66.07 -33.86 76.75 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.944 -0.571 . . . . 2.7200000000000002 110.806 -179.778 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -65.6 -59.83 3.55 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.239 -0.437 . . . . 0.46000000000000002 110.917 -176.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.402 ' HB3' ' CD1' ' A' ' 25' ' ' LEU . 93.7 mt -57.57 -38.47 74.86 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.149 -0.478 . . . . 0.68999999999999995 111.31 178.219 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 54.2 t30 -60.45 -35.51 76.02 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.119 -0.492 . . . . 1.3100000000000001 110.547 178.509 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 19.7 tm0? -61.19 -49.4 77.34 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.313 -0.403 . . . . 2.23 110.779 177.55 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -67.45 -42.64 82.74 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 109.309 -0.626 . . . . 0.65000000000000002 109.309 -177.209 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.654 ' HA ' ' CZ ' ' A' ' 23' ' ' PHE . . . -53.44 -51.08 63.8 Favored 'General case' 0 CA--C 1.521 -0.157 0 CA-C-N 115.552 -0.749 . . . . 0.37 111.724 176.812 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.94 -26.29 68.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.236 -0.438 . . . . 0.64000000000000001 111.507 -179.426 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 71.2 t60 -64.31 -50.34 68.21 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.265 -0.425 . . . . 1.8500000000000001 111.722 -177.652 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.626 ' HB3' ' HD1' ' A' ' 23' ' ' PHE . 47.0 t -99.26 -16.79 18.39 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-O 121.142 0.496 . . . . 1.6699999999999999 111.438 -177.6 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 74.27 48.67 14.02 Favored Glycine 0 N--CA 1.45 -0.427 0 CA-C-N 115.884 -0.598 . . . . 0.62 112.665 -178.709 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.654 ' CZ ' ' HA ' ' A' ' 18' ' ' ALA . 29.9 p90 -110.33 168.23 9.61 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.784 0.326 . . . . 0.56999999999999995 110.184 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 12.9 m -93.01 109.15 20.6 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.166 0.508 . . . . 0.68000000000000005 111.077 -178.429 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.402 ' CD1' ' HB3' ' A' ' 14' ' ' LEU . 2.0 tt -93.77 128.89 40.23 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.053 -0.721 . . . . 1.6699999999999999 109.053 177.763 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 34.5 t -103.1 99.81 9.7 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.108 0.48 . . . . 1.1499999999999999 110.211 -178.104 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.1 p -147.83 133.14 11.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 115.821 -0.627 . . . . 0.90000000000000002 110.498 179.05 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 -98.32 135.71 39.53 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.957 -0.565 . . . . 2.3799999999999999 110.218 177.297 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -56.4 -22.3 30.61 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 114.93 -1.032 . . . . 1.97 112.676 -174.639 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 14.3 m -69.01 -14.58 63.12 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.892 0.377 . . . . 2.2200000000000002 111.219 -176.55 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 90.7 mt -98.18 -22.78 16.0 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.11 0.481 . . . . 1.3799999999999999 110.584 -179.633 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 12.1 p -109.85 5.51 22.62 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.031 -0.531 . . . . 1.4399999999999999 112.211 -175.401 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 7.0 ptp180 -63.81 107.21 1.15 Allowed 'General case' 0 N--CA 1.453 -0.302 0 CA-C-O 121.199 0.524 . . . . 4.6299999999999999 111.128 -179.32 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 83.6 4.25 89.2 Favored Glycine 0 N--CA 1.446 -0.646 0 CA-C-N 115.789 -0.641 . . . . 1.6200000000000001 111.9 -179.542 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.503 ' HG3' HD12 ' A' ' 10' ' ' LEU . 20.9 tptm -83.78 104.42 13.87 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.766 -0.457 . . . . 2.75 109.766 -178.543 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . 0.589 ' HA ' ' HA ' ' A' ' 9' ' ' SER . 55.4 tt0 -103.77 155.09 18.86 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.64 -0.504 . . . . 2.2400000000000002 109.64 -177.33 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.408 ' HB2' ' HG ' ' A' ' 10' ' ' LEU . 10.2 t -124.81 134.57 52.71 Favored 'General case' 0 N--CA 1.445 -0.685 0 N-CA-C 107.863 -1.162 . . . . 1.02 107.863 171.532 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -64.85 -16.93 63.8 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.35 -0.386 . . . . 1.28 111.824 -179.751 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 123.27 175.45 14.52 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.647 -0.787 . . . . 0.41999999999999998 112.607 173.208 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.42 ' HB3' ' HB ' ' A' ' 5' ' ' ILE . 49.1 tp -160.1 128.2 4.74 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 108.919 -0.771 . . . . 0.69999999999999996 108.919 -178.688 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 54.7 m80 -138.69 97.86 3.44 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 120.388 -0.525 . . . . 2.96 111.119 179.611 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -169.73 178.15 42.84 Favored Glycine 0 N--CA 1.446 -0.635 0 CA-C-N 115.636 -0.711 . . . . 0.55000000000000004 111.812 175.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -82.69 87.1 6.75 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.479 0.657 . . . . 2.1800000000000002 109.383 170.581 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 56.6 m-85 -109.71 128.81 55.52 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.451 -0.795 . . . . 1.4099999999999999 110.478 -177.699 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 52.1 m-20 -82.97 177.03 8.81 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 109.282 -0.636 . . . . 2.23 109.282 174.378 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.62 ' HB ' ' OE1' ' A' ' 47' ' ' GLU . 26.1 t -49.79 -70.31 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 N-CA-C 112.52 0.563 . . . . 0.56999999999999995 112.52 -170.777 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.62 ' OE1' ' HB ' ' A' ' 46' ' ' VAL . 1.7 mp0 -56.46 -45.82 80.69 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.53 0.567 . . . . 2.3900000000000001 112.53 -175.408 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 23.3 t -71.9 -35.1 69.62 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-O 121.036 0.446 . . . . 1.26 111.161 -171.524 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -76.19 -38.32 34.85 Favored Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 120.547 -0.835 . . . . 0.37 111.533 -175.672 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.567 ' HB3' HG13 ' A' ' 61' ' ' VAL . 96.5 mt -67.78 -39.12 84.11 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.971 0.415 . . . . 1.0900000000000001 110.719 179.88 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -58.58 -41.57 86.02 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.55 -0.75 . . . . 2.5899999999999999 111.044 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 5.9 tp-100 -66.94 -46.4 74.87 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.242 -0.436 . . . . 1.75 111.027 -179.779 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 91.8 mt -56.16 -32.24 64.12 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 113.129 0.788 . . . . 0.72999999999999998 113.129 -176.314 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 65.3 mt -92.19 9.0 35.49 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.904 0.705 . . . . 2.1600000000000001 112.904 -174.167 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -65.68 133.14 50.47 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 120.827 0.346 . . . . 2.2400000000000002 110.38 179.542 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 107.99 4.43 33.64 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.799 -0.715 . . . . 1.7 111.806 -176.107 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 22.2 p -149.91 -173.27 4.38 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.848 -0.427 . . . . 2.2799999999999998 109.848 177.732 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -118.76 30.24 5.99 Favored Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 120.82 -0.705 . . . . 1.5800000000000001 111.539 -176.277 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.463 ' HA ' ' HA ' ' A' ' 73' ' ' PRO . 42.8 mt -98.71 166.73 11.18 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.551 -0.537 . . . . 1.4199999999999999 109.551 179.666 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 35.1 tt0 -154.79 118.6 4.61 Favored 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 108.625 -0.88 . . . . 2.6699999999999999 108.625 178.126 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.567 HG13 ' HB3' ' A' ' 50' ' ' LEU . 3.2 p -94.61 127.12 46.84 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 N-CA-C 109.132 -0.692 . . . . 1.54 109.132 177.861 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.461 ' HA ' ' HD3' ' A' ' 63' ' ' PRO . 47.5 mtmt -128.58 142.72 45.79 Favored Pre-proline 0 C--N 1.318 -0.777 0 CA-C-N 115.909 -0.587 . . . . 1.8100000000000001 110.335 -170.809 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.461 ' HD3' ' HA ' ' A' ' 62' ' ' LYS . 12.4 Cg_exo -70.24 120.97 7.58 Favored 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 122.596 2.197 . . . . 0.84999999999999998 111.022 175.739 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.446 HD21 ' HB ' ' A' ' 70' ' ' THR . 95.2 mt -58.39 -38.87 78.23 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.459 -0.792 . . . . 1.7 111.77 -174.607 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 161.8 -71.46 0.21 Allowed Glycine 0 N--CA 1.446 -0.697 0 C-N-CA 120.683 -0.77 . . . . 1.6899999999999999 111.367 177.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -59.98 -77.14 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.777 0.322 . . . . 2.96 111.054 179.456 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . 0.406 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 62.8 t30 -167.1 56.08 0.08 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.544 0.688 . . . . 2.5 109.572 177.356 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.422 ' O ' ' HD1' ' A' ' 69' ' ' TRP . 24.2 m -146.45 173.99 11.79 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 108.379 -0.971 . . . . 1.3 108.379 176.27 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' TRP . . . . . 0.507 ' CZ2' HG13 ' A' ' 46' ' ' VAL . 52.4 m0 -140.0 164.78 29.11 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 109.716 -0.475 . . . . 0.46999999999999997 109.716 -168.793 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.446 ' HB ' HD21 ' A' ' 64' ' ' LEU . 6.6 t -149.01 145.43 27.3 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.711 -0.477 . . . . 0.82999999999999996 109.711 170.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 58.2 tp -95.49 103.09 14.95 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.148 0.499 . . . . 1.71 110.828 178.64 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.406 ' HA ' ' HD3' ' A' ' 73' ' ' PRO . 38.5 mt-10 -105.76 145.07 30.15 Favored Pre-proline 0 C--N 1.322 -0.611 0 CA-C-N 115.632 -0.713 . . . . 2.1299999999999999 111.115 174.788 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.463 ' HA ' ' HA ' ' A' ' 59' ' ' LEU . 7.2 Cg_exo -74.61 115.0 4.16 Favored 'Trans proline' 0 N--CA 1.46 -0.498 0 C-N-CA 122.333 2.022 . . . . 1.3600000000000001 110.722 170.348 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.268 0 CA-C-N 115.878 -0.601 . . . . 1.8899999999999999 110.274 -175.591 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 . . . . . 0 CA--C 1.514 -0.407 0 CA-C-O 121.391 0.615 . . . . 4.0 110.642 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 23.2 m -132.35 143.62 39.37 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 CA-C-N 115.076 -0.965 . . . . 1.6399999999999999 109.555 177.464 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 5.2 p30 -128.43 96.82 4.53 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 108.741 -0.837 . . . . 2.29 108.741 179.079 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.51 ' HB ' ' H ' ' A' ' 40' ' ' LEU . 25.5 mt -132.82 159.72 43.02 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 CA-C-N 115.298 -0.865 . . . . 0.81999999999999995 109.073 -173.845 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.696 ' HB1' ' HD2' ' A' ' 7' ' ' PRO . . . -164.67 172.15 4.93 Favored Pre-proline 0 C--N 1.319 -0.752 0 N-CA-C 108.419 -0.956 . . . . 1.3799999999999999 108.419 -174.545 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.696 ' HD2' ' HB1' ' A' ' 6' ' ' ALA . 19.8 Cg_exo -30.49 126.75 0.07 OUTLIER 'Trans proline' 0 C--N 1.358 1.055 0 C-N-CA 124.001 3.134 . . . . 1.73 113.782 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 162.99 157.0 8.83 Favored Glycine 0 N--CA 1.445 -0.746 0 N-CA-C 110.33 -1.108 . . . . 1.8400000000000001 110.33 -176.456 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.582 ' HA ' ' HA ' ' A' ' 36' ' ' GLN . 9.3 t -58.59 133.1 55.56 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 117.285 0.542 . . . . 1.6100000000000001 110.038 179.857 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.731 HD21 ' HG ' ' A' ' 54' ' ' LEU . 62.2 tp -57.62 -30.49 65.39 Favored 'General case' 0 N--CA 1.462 0.131 0 CA-C-N 115.537 -0.756 . . . . 1.1899999999999999 111.422 -173.26 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.553 ' CA ' ' HB ' ' A' ' 32' ' ' THR . 31.3 t70 -50.18 -56.77 9.67 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.627 -0.715 . . . . 2.1099999999999999 111.367 176.808 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 37.3 ttmt -66.92 -26.99 67.13 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.549 -0.296 . . . . 2.7200000000000002 110.96 -179.337 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.497 ' O ' ' HB3' ' A' ' 16' ' ' GLN . . . -65.84 -55.78 15.31 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.867 0.365 . . . . 0.46000000000000002 110.467 179.335 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.593 HD12 HG21 ' A' ' 32' ' ' THR . 82.6 mt -59.18 -35.76 74.13 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.175 -0.466 . . . . 0.68999999999999995 111.425 176.523 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -61.05 -39.61 90.48 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.933 -0.395 . . . . 1.3100000000000001 109.933 176.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.497 ' HB3' ' O ' ' A' ' 13' ' ' ALA . 41.0 tp60 -58.74 -45.26 90.08 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.672 -0.694 . . . . 2.23 111.379 175.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.609 ' O ' ' HB2' ' A' ' 20' ' ' HIS . 8.5 t80 -66.49 -45.24 80.27 Favored 'General case' 0 CA--C 1.514 -0.422 0 CA-C-O 121.044 0.45 . . . . 0.65000000000000002 110.127 -179.157 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.717 ' HA ' ' CE2' ' A' ' 23' ' ' PHE . . . -50.46 -33.84 22.6 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.165 -0.925 . . . . 0.37 111.966 179.327 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.3 -10.09 14.7 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 116.089 -0.505 . . . . 0.64000000000000001 112.241 178.262 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . 0.609 ' HB2' ' O ' ' A' ' 17' ' ' TYR . 0.0 OUTLIER -55.8 -61.44 2.36 Favored 'General case' 0 CA--C 1.518 -0.286 0 CA-C-O 120.899 0.38 . . . . 1.8500000000000001 111.524 178.235 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.569 ' HB3' ' HD1' ' A' ' 23' ' ' PHE . 46.0 t -113.65 -15.56 12.48 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.02 0.438 . . . . 1.6699999999999999 111.411 -177.678 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 77.8 55.71 4.07 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.628 -0.796 . . . . 0.62 111.307 -174.428 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.717 ' CE2' ' HA ' ' A' ' 18' ' ' ALA . 2.7 p90 -101.87 164.55 11.66 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.696 0.284 . . . . 0.56999999999999995 110.459 -177.62 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.566 ' O ' ' HB3' ' A' ' 68' ' ' SER . 5.6 m -88.8 107.02 18.75 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.489 0.661 . . . . 0.68000000000000005 111.25 -174.496 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.51 HD22 ' HB ' ' A' ' 27' ' ' VAL . 1.2 tt -93.22 132.62 37.22 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.569 -0.742 . . . . 1.6699999999999999 109.311 178.399 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.669 ' HB2' ' HA ' ' A' ' 70' ' ' THR . 50.1 m -94.95 92.29 6.81 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.533 -0.543 . . . . 1.1499999999999999 109.533 176.508 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.51 ' HB ' HD22 ' A' ' 25' ' ' LEU . 11.6 p -144.76 148.22 18.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.607 -0.724 . . . . 0.90000000000000002 110.529 -174.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -111.91 139.08 47.7 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.196 -0.456 . . . . 2.3799999999999999 109.94 178.713 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -64.05 64.8 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.29 0 O-C-N 123.76 0.662 . . . . 1.97 111.829 176.511 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 26.1 p -170.91 -42.65 0.02 OUTLIER 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 109.507 -0.553 . . . . 2.2200000000000002 109.507 -178.394 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 72.9 mt -64.71 -40.87 96.09 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.217 -0.902 . . . . 1.3799999999999999 110.687 178.666 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.593 HG21 HD12 ' A' ' 14' ' ' LEU . 0.9 OUTLIER -103.83 -12.54 16.86 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.757 -0.656 . . . . 1.4399999999999999 112.473 -178.515 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 57.4 ttp180 -88.38 134.88 33.71 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.856 0.36 . . . . 4.6299999999999999 110.658 -176.047 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 104.37 -51.43 0.8 Allowed Glycine 0 N--CA 1.448 -0.534 0 N-CA-C 111.512 -0.635 . . . . 1.6200000000000001 111.512 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.974 ' H ' ' HD2' ' A' ' 35' ' ' LYS . 0.0 OUTLIER -76.9 132.09 38.92 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.437 -0.579 . . . . 2.75 109.437 175.586 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . 0.582 ' HA ' ' HA ' ' A' ' 9' ' ' SER . 71.3 mt-30 -104.38 161.83 13.74 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.193 -0.458 . . . . 2.2400000000000002 110.84 -175.23 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 13.1 t -131.89 136.51 47.47 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 107.838 -1.171 . . . . 1.02 107.838 173.227 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -70.75 -0.75 9.55 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 112.377 0.51 . . . . 1.28 112.377 -176.647 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 99.97 -171.44 23.64 Favored Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.632 -0.794 . . . . 0.41999999999999998 113.222 170.757 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.51 ' H ' ' HB ' ' A' ' 5' ' ' ILE . 64.1 tp -160.44 145.6 14.7 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 107.85 -1.167 . . . . 0.69999999999999996 107.85 -178.812 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 10.0 t-160 -145.11 98.09 3.11 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.366 -0.534 . . . . 2.96 110.847 177.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -169.31 -175.4 38.51 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.849 -0.691 . . . . 0.55000000000000004 112.392 175.485 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 28.6 t0 -89.99 88.13 7.18 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 108.422 -0.955 . . . . 2.1800000000000002 108.422 173.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 31.7 m-85 -116.08 142.42 46.83 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.491 0.662 . . . . 1.4099999999999999 112.362 -170.251 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -90.77 -179.78 5.6 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 114.694 -1.139 . . . . 2.23 109.612 174.782 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.467 HG13 ' CZ2' ' A' ' 69' ' ' TRP . 78.7 t -53.03 -71.99 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 N-CA-C 112.679 0.622 . . . . 0.56999999999999995 112.679 -176.562 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -62.18 -41.36 98.26 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.751 0.648 . . . . 2.3900000000000001 112.751 -169.184 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 23.3 t -74.4 -34.29 63.25 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.17 0.509 . . . . 1.26 110.672 -174.487 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -74.49 -41.42 36.52 Favored Glycine 0 N--CA 1.446 -0.662 0 C-N-CA 120.803 -0.713 . . . . 0.37 111.659 -176.126 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.447 HD13 ' CG1' ' A' ' 61' ' ' VAL . 68.3 mt -67.3 -34.52 77.55 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.711 0.291 . . . . 1.0900000000000001 110.638 -179.491 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 7.3 tp60 -57.27 -48.86 77.81 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.101 -0.499 . . . . 2.5899999999999999 110.679 178.571 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.951 HE21 ' HA ' ' A' ' 52' ' ' GLN . 0.0 OUTLIER -67.67 -42.48 82.08 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.415 -0.357 . . . . 1.75 111.065 -178.599 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 78.8 mt -57.0 -40.6 76.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.053 -0.521 . . . . 0.72999999999999998 112.16 -179.335 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.731 ' HG ' HD21 ' A' ' 10' ' ' LEU . 10.1 mp -97.74 2.54 49.7 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 112.306 0.484 . . . . 2.1600000000000001 112.306 -173.772 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -62.07 111.85 2.11 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.047 0.451 . . . . 2.2400000000000002 110.481 179.424 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 97.88 -7.2 62.74 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 121.06 -0.59 . . . . 1.7 112.505 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.5 m -87.75 -12.91 43.81 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.818 0.342 . . . . 2.2799999999999998 111.043 -176.314 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 76.16 20.21 77.64 Favored Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 120.678 -0.772 . . . . 1.5800000000000001 111.942 -179.363 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.428 ' CB ' HD23 ' A' ' 54' ' ' LEU . 96.3 mt -124.02 166.26 16.05 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 110.183 -0.302 . . . . 1.4199999999999999 110.183 -179.473 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 17.2 tp60 -147.89 118.59 7.53 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.486 -0.561 . . . . 2.6699999999999999 109.486 178.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.571 HG23 ' CD2' ' A' ' 54' ' ' LEU . 59.9 t -91.64 127.29 44.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 N-CA-C 109.473 -0.566 . . . . 1.54 109.473 176.409 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 41.4 tttm -117.12 128.01 26.32 Favored Pre-proline 0 C--N 1.318 -0.797 0 CA-C-N 116.051 -0.522 . . . . 1.8100000000000001 109.761 -179.016 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -60.17 120.68 8.59 Favored 'Trans proline' 0 N--CA 1.461 -0.431 0 C-N-CA 121.867 1.712 . . . . 0.84999999999999998 110.008 171.648 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -68.06 -50.51 54.73 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.973 -0.558 . . . . 1.7 110.211 -173.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 151.79 -52.92 0.48 Allowed Glycine 0 N--CA 1.445 -0.732 0 C-N-CA 120.605 -0.807 . . . . 1.6899999999999999 112.001 178.402 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 78.8 m-20 -87.94 57.95 4.58 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.747 0.308 . . . . 2.96 110.949 -176.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 67.0 t30 50.73 37.37 16.54 Favored 'General case' 0 N--CA 1.473 0.675 0 CA-C-N 115.659 -0.701 . . . . 2.5 110.89 -177.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.566 ' HB3' ' O ' ' A' ' 24' ' ' THR . 49.7 m -141.21 178.63 7.27 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 108.128 -1.064 . . . . 1.3 108.128 178.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' TRP . . . . . 0.479 ' HH2' ' CD1' ' A' ' 17' ' ' TYR . 54.2 m0 -135.49 167.41 21.13 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.046 0.45 . . . . 0.46999999999999997 110.669 -169.22 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.669 ' HA ' ' HB2' ' A' ' 26' ' ' SER . 6.9 t -141.3 139.79 33.71 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.205 -0.907 . . . . 0.82999999999999996 108.97 173.625 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.469 HD22 HG23 ' A' ' 27' ' ' VAL . 48.9 tp -92.37 104.29 16.64 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.642 0.734 . . . . 1.71 109.69 178.506 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 28.0 mm-40 -88.71 119.61 70.03 Favored Pre-proline 0 C--N 1.313 -0.994 0 CA-C-N 114.509 -1.223 . . . . 2.1299999999999999 110.843 -179.605 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_exo -66.77 113.6 2.82 Favored 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 121.698 1.598 . . . . 1.3600000000000001 110.037 172.142 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.321 -0.659 0 CA-C-N 115.692 -0.685 . . . . 1.8899999999999999 109.374 -176.619 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 . . . . . 0 N--CA 1.452 -0.341 0 CA-C-O 121.728 0.775 . . . . 4.0 111.434 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 60.5 t -91.81 121.56 42.43 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 N-CA-C 107.966 -1.124 . . . . 1.6399999999999999 107.966 172.25 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -130.1 128.87 42.74 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 109.532 -0.544 . . . . 2.29 109.532 -174.204 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 75.2 mt -133.88 132.26 56.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 116.391 -0.368 . . . . 0.81999999999999995 110.608 -177.581 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -70.82 153.46 94.8 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 115.538 -0.756 . . . . 1.3799999999999999 110.775 179.687 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.648 ' HA ' ' O ' ' A' ' 37' ' ' SER . 5.5 Cg_exo -75.23 34.16 0.4 Allowed 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 123.299 2.666 . . . . 1.73 113.492 -179.027 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.406 ' HA2' ' HB3' ' A' ' 36' ' ' GLN . . . -159.14 140.22 6.72 Favored Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 120.403 -0.903 . . . . 1.8400000000000001 113.322 -178.073 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.516 ' H ' ' HG2' ' A' ' 36' ' ' GLN . 0.1 OUTLIER 64.01 92.15 0.07 Allowed 'General case' 0 C--O 1.233 0.203 0 C-N-CA 123.455 0.702 . . . . 1.6100000000000001 111.993 175.019 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.663 HD11 ' HB3' ' A' ' 53' ' ' LEU . 52.2 tp -64.01 -36.91 85.53 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.172 0.511 . . . . 1.1899999999999999 110.533 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 14.1 p-10 -55.34 -43.41 74.95 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.525 -0.761 . . . . 2.1099999999999999 111.392 177.288 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 27.8 ttpp -71.27 -28.47 64.17 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.168 0.508 . . . . 2.7200000000000002 110.006 178.431 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -67.5 -52.47 38.73 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.475 -0.784 . . . . 0.46000000000000002 110.736 179.722 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 91.3 mt -57.39 -40.59 78.53 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 115.812 -0.631 . . . . 0.68999999999999995 111.596 178.366 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 10.9 t30 -59.75 -37.11 78.08 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.14 -0.482 . . . . 1.3100000000000001 110.334 179.53 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.424 HE21 ' HB3' ' A' ' 16' ' ' GLN . 0.9 OUTLIER -63.41 -43.73 96.66 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.581 -0.736 . . . . 2.23 110.67 177.422 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.507 ' OH ' ' HA ' ' A' ' 46' ' ' VAL . 7.2 t80 -67.55 -45.61 75.17 Favored 'General case' 0 C--O 1.232 0.157 0 N-CA-C 109.846 -0.427 . . . . 0.65000000000000002 109.846 -177.344 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.628 ' HA ' ' CZ ' ' A' ' 23' ' ' PHE . . . -53.98 -52.77 59.67 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 115.54 -0.754 . . . . 0.37 112.12 179.393 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.32 -30.59 71.7 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.911 0.386 . . . . 0.64000000000000001 110.868 -178.337 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 75.1 t60 -65.85 -55.26 18.0 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.946 -0.57 . . . . 1.8500000000000001 111.407 -178.183 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.568 ' HB3' ' CD1' ' A' ' 23' ' ' PHE . 34.9 t -90.82 0.67 57.39 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-O 120.786 0.327 . . . . 1.6699999999999999 111.607 -173.465 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 64.68 36.53 93.25 Favored Glycine 0 CA--C 1.517 0.191 0 CA-C-N 116.19 -0.459 . . . . 0.62 113.785 175.074 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.628 ' CZ ' ' HA ' ' A' ' 18' ' ' ALA . 53.1 p90 -109.42 161.07 15.66 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.667 -0.494 . . . . 0.56999999999999995 109.667 177.484 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 39.2 m -89.8 107.04 18.86 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.074 0.464 . . . . 0.68000000000000005 110.077 178.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 6.9 tt -91.92 125.28 36.56 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.814 -0.63 . . . . 1.6699999999999999 109.368 -179.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.597 ' O ' ' HA ' ' A' ' 70' ' ' THR . 14.6 t -111.54 97.56 6.83 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.352 0.596 . . . . 1.1499999999999999 110.015 -178.62 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 6.6 p -91.72 130.64 40.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 109.279 -0.637 . . . . 0.90000000000000002 109.279 177.274 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -69.83 105.92 2.95 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.403 -0.362 . . . . 2.3799999999999999 110.642 -177.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 55.87 -90.86 0.03 OUTLIER 'General case' 0 C--O 1.232 0.176 0 O-C-N 124.152 0.908 . . . . 1.97 111.235 -176.458 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 2.3 t -171.32 56.22 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 108.933 -0.766 . . . . 2.2200000000000002 108.933 176.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 90.3 mt -67.07 -17.16 64.76 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.55 -0.75 . . . . 1.3799999999999999 111.136 -178.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 17.1 p -92.89 -1.74 56.47 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.05 -0.523 . . . . 1.4399999999999999 111.214 -179.476 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 40.7 ttm180 -68.8 122.97 19.69 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.27 -0.423 . . . . 4.6299999999999999 110.43 -179.753 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 99.05 -15.94 59.96 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.726 -0.75 . . . . 1.6200000000000001 111.806 -178.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.874 ' HE3' ' HB3' ' A' ' 57' ' ' SER . 41.0 tttm -89.33 132.57 34.88 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-O 120.597 0.237 . . . . 2.75 110.362 177.404 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . 0.516 ' HG2' ' H ' ' A' ' 9' ' ' SER . 25.0 mt-30 -102.43 168.87 9.03 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 109.276 -0.638 . . . . 2.2400000000000002 109.276 173.648 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.648 ' O ' ' HA ' ' A' ' 7' ' ' PRO . 22.9 t -139.33 124.02 18.48 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 106.823 -1.547 . . . . 1.02 106.823 173.273 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.428 ' N ' HD22 ' A' ' 38' ' ' ASN . 0.9 OUTLIER -55.19 -17.31 4.14 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 112.829 0.677 . . . . 1.28 112.829 -173.396 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 131.49 -178.93 17.48 Favored Glycine 0 N--CA 1.441 -1.012 0 C-N-CA 120.351 -0.928 . . . . 0.41999999999999998 112.662 171.104 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 43.8 tp -160.35 122.72 3.28 Favored 'General case' 0 N--CA 1.445 -0.711 0 N-CA-C 107.275 -1.38 . . . . 0.69999999999999996 107.275 -178.319 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 33.1 m-70 -142.5 97.82 3.19 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.176 0.513 . . . . 2.96 111.211 -178.056 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -171.75 178.19 44.15 Favored Glycine 0 N--CA 1.445 -0.701 0 CA-C-N 115.535 -0.757 . . . . 0.55000000000000004 111.586 174.326 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -80.41 76.7 7.22 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 107.954 -1.128 . . . . 2.1800000000000002 107.954 166.623 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -92.67 139.09 30.92 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 113.061 0.763 . . . . 1.4099999999999999 113.061 -167.357 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -75.22 158.44 32.95 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 114.468 -1.242 . . . . 2.23 109.808 172.412 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.605 HG13 ' HZ2' ' A' ' 69' ' ' TRP . 85.0 t -49.32 -68.13 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 O-C-N 123.674 0.609 . . . . 0.56999999999999995 112.056 -177.038 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -61.87 -31.56 71.85 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.141 -0.481 . . . . 2.3900000000000001 112.148 -176.371 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 22.9 t -69.71 -35.03 74.69 Favored 'General case' 0 C--O 1.238 0.492 0 CA-C-O 121.308 0.575 . . . . 1.26 110.262 -176.669 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.517 ' O ' ' HG ' ' A' ' 53' ' ' LEU . . . -74.15 -30.8 60.39 Favored Glycine 0 N--CA 1.446 -0.668 0 N-CA-C 111.036 -0.826 . . . . 0.37 111.036 -177.479 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.621 ' HB3' HG11 ' A' ' 61' ' ' VAL . 98.3 mt -70.71 -41.52 71.83 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.537 -0.331 . . . . 1.0900000000000001 110.798 179.121 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -51.96 -46.52 64.81 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.07 -0.513 . . . . 2.5899999999999999 111.232 178.507 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 13.2 mm100 -64.06 -45.81 87.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.741 0.305 . . . . 1.75 110.973 -179.711 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.663 ' HB3' HD11 ' A' ' 10' ' ' LEU . 79.9 mt -60.02 -32.24 70.7 Favored 'General case' 0 C--O 1.237 0.438 0 CA-C-N 116.115 -0.493 . . . . 0.72999999999999998 111.874 179.068 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.449 ' O ' HD13 ' A' ' 54' ' ' LEU . 0.8 OUTLIER -70.06 -34.98 73.89 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.071 -0.513 . . . . 2.1600000000000001 110.569 -177.926 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -55.9 110.14 0.69 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.205 -0.452 . . . . 2.2400000000000002 110.752 -176.564 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 119.64 -2.7 13.65 Favored Glycine 0 N--CA 1.444 -0.8 0 C-N-CA 120.771 -0.728 . . . . 1.7 112.294 -179.235 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.874 ' HB3' ' HE3' ' A' ' 35' ' ' LYS . 68.9 p -121.35 169.46 10.58 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.923 0.392 . . . . 2.2799999999999998 110.865 176.651 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -109.46 35.45 4.89 Favored Glycine 0 N--CA 1.445 -0.761 0 N-CA-C 110.112 -1.195 . . . . 1.5800000000000001 110.112 175.16 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 27.4 mt -108.49 -179.35 3.85 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 114.805 -0.697 . . . . 1.4199999999999999 109.138 -178.642 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 57.4 tp60 -142.57 119.47 11.26 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 108.483 -0.932 . . . . 2.6699999999999999 108.483 173.654 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.621 HG11 ' HB3' ' A' ' 50' ' ' LEU . 3.7 p -85.1 117.8 30.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-O 121.446 0.641 . . . . 1.54 109.386 179.147 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 49.2 mtpt -123.47 124.94 26.19 Favored Pre-proline 0 C--N 1.32 -0.693 0 CA-C-N 115.828 -0.624 . . . . 1.8100000000000001 110.139 -173.543 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_exo -60.4 118.49 5.37 Favored 'Trans proline' 0 N--CA 1.456 -0.71 0 C-N-CA 121.861 1.707 . . . . 0.84999999999999998 109.886 171.795 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -57.13 -38.37 73.38 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.395 -0.821 . . . . 1.7 111.361 -171.137 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 160.55 -50.57 0.36 Allowed Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 119.812 -1.185 . . . . 1.6899999999999999 112.949 176.554 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 3.4 p30 -116.66 71.85 0.8 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.174 0.512 . . . . 2.96 111.305 -176.644 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 58.6 t30 55.87 43.03 28.21 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 115.292 -0.867 . . . . 2.5 110.749 179.598 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.428 ' O ' ' HD1' ' A' ' 69' ' ' TRP . 42.4 t -139.61 173.04 11.95 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 107.369 -1.345 . . . . 1.3 107.369 177.215 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' TRP . . . . . 0.62 ' CZ3' HD21 ' A' ' 50' ' ' LEU . 30.1 m0 -141.62 160.87 39.28 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.445 -0.576 . . . . 0.46999999999999997 109.445 -171.783 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.597 ' HA ' ' O ' ' A' ' 26' ' ' SER . 8.9 t -148.67 146.14 28.03 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.618 -0.512 . . . . 0.82999999999999996 109.618 169.791 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -93.7 99.93 12.25 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.373 0.606 . . . . 1.71 109.471 176.122 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.447 ' HA ' ' HD3' ' A' ' 73' ' ' PRO . 33.2 tt0 -96.59 126.86 41.76 Favored Pre-proline 0 C--N 1.319 -0.749 0 CA-C-N 115.187 -0.915 . . . . 2.1299999999999999 110.636 177.611 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.447 ' HD3' ' HA ' ' A' ' 72' ' ' GLU . 7.1 Cg_exo -72.34 114.11 3.9 Favored 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 122.02 1.813 . . . . 1.3600000000000001 111.103 177.227 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.322 -0.589 0 CA-C-N 115.721 -0.672 . . . . 1.8899999999999999 109.87 -177.213 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 4.8 pp0? . . . . . 0 C--O 1.234 0.281 0 CA-C-O 120.972 0.415 . . . . 4.0 110.708 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 9.4 p -142.38 147.36 21.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 115.757 -0.656 . . . . 1.6399999999999999 109.939 -176.054 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 47.2 m-80 -128.9 100.26 5.61 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.882 0.372 . . . . 2.29 110.001 -177.338 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.459 ' HB ' ' H ' ' A' ' 40' ' ' LEU . 48.4 mm -108.69 127.45 65.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 116.121 -0.491 . . . . 0.81999999999999995 110.856 -177.611 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.491 ' HA ' ' HD3' ' A' ' 7' ' ' PRO . . . -67.78 139.52 93.61 Favored Pre-proline 0 C--N 1.331 -0.22 0 CA-C-N 116.21 -0.45 . . . . 1.3799999999999999 110.725 178.607 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.491 ' HD3' ' HA ' ' A' ' 6' ' ' ALA . 14.6 Cg_exo -72.17 36.87 0.34 Allowed 'Trans proline' 0 CA--C 1.534 0.522 0 C-N-CA 123.818 3.012 . . . . 1.73 114.628 -176.219 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -175.22 45.93 0.13 Allowed Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 119.467 -1.349 . . . . 1.8400000000000001 114.55 176.446 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.441 ' HA ' ' O ' ' A' ' 35' ' ' LYS . 32.1 t -177.78 101.75 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 117.342 0.571 . . . . 1.6100000000000001 111.279 173.391 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.418 ' CD1' ' HB3' ' A' ' 53' ' ' LEU . 53.7 tp -64.36 -37.29 86.99 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-O 121.328 0.585 . . . . 1.1899999999999999 109.459 169.122 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -48.79 -60.95 2.31 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 114.849 -1.069 . . . . 2.1099999999999999 111.366 177.281 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -68.22 -22.48 64.79 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.702 0.287 . . . . 2.7200000000000002 111.068 179.45 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.407 ' HB1' HD12 ' A' ' 5' ' ' ILE . . . -63.73 -54.72 30.95 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.902 0.382 . . . . 0.46000000000000002 110.475 179.778 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 93.3 mt -58.63 -39.06 79.45 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.618 -0.719 . . . . 0.68999999999999995 110.696 176.514 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 55.8 t30 -61.68 -45.52 93.67 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.903 -0.59 . . . . 1.3100000000000001 110.276 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.427 HE21 ' HB3' ' A' ' 16' ' ' GLN . 0.9 OUTLIER -61.7 -45.61 93.26 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.934 -0.575 . . . . 2.23 110.892 177.489 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.442 ' HD1' ' HZ ' ' A' ' 23' ' ' PHE . 1.3 t80 -65.18 -43.15 92.6 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 109.719 -0.475 . . . . 0.65000000000000002 109.719 -177.396 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.816 ' HA ' ' CE2' ' A' ' 23' ' ' PHE . . . -55.3 -49.34 72.38 Favored 'General case' 0 CA--C 1.519 -0.226 0 CA-C-N 115.564 -0.743 . . . . 0.37 111.551 178.211 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.64 -28.08 68.2 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.398 -0.365 . . . . 0.64000000000000001 111.249 -178.72 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 42.3 t60 -58.69 -50.23 74.64 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.919 -0.582 . . . . 1.8500000000000001 111.906 -176.581 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.487 ' HB3' ' CD1' ' A' ' 23' ' ' PHE . 8.2 t -109.79 1.61 19.45 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-O 121.207 0.527 . . . . 1.6699999999999999 111.452 -178.514 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 62.11 47.54 89.19 Favored Glycine 0 CA--C 1.522 0.509 0 CA-C-N 115.638 -0.71 . . . . 0.62 114.366 175.848 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.816 ' CE2' ' HA ' ' A' ' 18' ' ' ALA . 3.6 p90 -104.96 166.59 10.27 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 117.238 0.519 . . . . 0.56999999999999995 110.563 177.222 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 24.2 m -90.93 119.39 31.09 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.417 0.627 . . . . 0.68000000000000005 112.183 -175.478 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.649 HD11 ' HE3' ' A' ' 69' ' ' TRP . 1.5 mm? -92.93 122.5 35.37 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.36 -0.836 . . . . 1.6699999999999999 111.231 175.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 63.4 m -97.99 94.91 7.13 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.291 0.567 . . . . 1.1499999999999999 109.603 175.645 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 11.2 p -139.07 140.51 38.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 115.611 -0.722 . . . . 0.90000000000000002 110.846 -174.743 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.982 ' HB3' HD11 ' A' ' 31' ' ' LEU . 7.8 t70 -68.43 149.46 49.29 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.81 -0.632 . . . . 2.3799999999999999 109.771 174.863 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -53.3 -16.39 1.29 Allowed 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 114.952 1.464 . . . . 1.97 114.952 -170.553 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 7.4 p -165.57 69.99 0.14 Allowed 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 114.003 1.112 . . . . 2.2200000000000002 114.003 -176.386 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.982 HD11 ' HB3' ' A' ' 28' ' ' ASP . 2.7 mp -96.99 -34.2 11.28 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.585 0.707 . . . . 1.3799999999999999 109.132 164.181 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 5.6 p -95.46 21.19 8.45 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 114.959 -1.019 . . . . 1.4399999999999999 111.507 -178.189 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 32.8 ttt180 -66.28 105.63 1.48 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.033 0.444 . . . . 4.6299999999999999 110.385 -176.623 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 77.24 22.91 69.68 Favored Glycine 0 N--CA 1.447 -0.598 0 CA-C-N 115.804 -0.634 . . . . 1.6200000000000001 112.572 -179.069 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.441 ' O ' ' HA ' ' A' ' 9' ' ' SER . 8.8 tptp -76.33 156.41 33.36 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.678 -0.49 . . . . 2.75 109.678 178.456 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -139.36 140.61 37.53 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.075 0.464 . . . . 2.2400000000000002 110.892 -177.669 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 9.4 t -140.04 133.21 29.66 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 107.427 -1.324 . . . . 1.02 107.427 175.103 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.421 ' C ' ' HA ' ' A' ' 7' ' ' PRO . 0.9 OUTLIER -60.47 -7.47 2.12 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 112.85 0.685 . . . . 1.28 112.85 -176.383 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 114.8 179.79 18.6 Favored Glycine 0 CA--C 1.503 -0.675 0 C-N-CA 120.509 -0.853 . . . . 0.41999999999999998 112.652 167.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.459 ' H ' ' HB ' ' A' ' 5' ' ' ILE . 19.4 tp -160.96 123.05 3.07 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 107.681 -1.229 . . . . 0.69999999999999996 107.681 -176.077 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 20.8 t-160 -144.57 97.49 3.04 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.356 0.598 . . . . 2.96 110.853 -178.125 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -169.67 -173.09 36.89 Favored Glycine 0 N--CA 1.445 -0.718 0 CA-C-N 115.228 -0.896 . . . . 0.55000000000000004 110.919 177.262 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -88.89 82.26 6.77 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 109.559 -0.534 . . . . 2.1800000000000002 109.559 171.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 73.6 m-85 -97.55 136.28 38.18 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.047 -0.524 . . . . 1.4099999999999999 111.403 -175.6 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -86.6 173.6 9.44 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 108.801 -0.814 . . . . 2.23 108.801 176.119 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 52.9 t -52.56 -57.71 3.76 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 N-CA-C 111.928 0.344 . . . . 0.56999999999999995 111.928 -173.111 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 51.5 mm-40 -62.86 -49.49 74.68 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-O 121.076 0.465 . . . . 2.3900000000000001 111.809 -175.333 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 11.7 p -72.72 -24.18 60.95 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.892 -0.595 . . . . 1.26 111.286 -172.798 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.45 ' O ' ' HG ' ' A' ' 53' ' ' LEU . . . -75.87 -40.33 31.11 Favored Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 120.766 -0.73 . . . . 0.37 111.337 -178.263 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.51 ' HB3' HG13 ' A' ' 61' ' ' VAL . 95.4 mt -68.33 -45.09 73.86 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.811 0.338 . . . . 1.0900000000000001 110.647 -178.757 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 42.6 tt0 -57.69 -42.94 84.69 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.818 -0.628 . . . . 2.5899999999999999 110.865 -179.034 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 15.2 mm100 -66.44 -43.06 86.64 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.485 -0.325 . . . . 1.75 111.061 -179.37 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.45 ' HG ' ' O ' ' A' ' 49' ' ' GLY . 86.4 mt -57.64 -21.99 43.04 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 116.126 -0.488 . . . . 0.72999999999999998 112.099 178.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.588 HD21 HG12 ' A' ' 61' ' ' VAL . 97.7 mt -70.23 -8.97 54.28 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 111.932 0.345 . . . . 2.1600000000000001 111.932 -179.234 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -67.89 107.75 2.76 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.097 0.475 . . . . 2.2400000000000002 110.164 178.756 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 116.94 2.17 18.85 Favored Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 120.827 -0.702 . . . . 1.7 112.055 -177.121 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 50.3 m -137.24 167.77 20.93 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.113 0.482 . . . . 2.2799999999999998 111.307 179.642 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -116.97 15.29 13.69 Favored Glycine 0 N--CA 1.442 -0.927 0 N-CA-C 110.3 -1.12 . . . . 1.5800000000000001 110.3 172.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.444 HD13 HD11 ' A' ' 71' ' ' LEU . 76.8 mt -92.29 179.48 5.54 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.339 -0.615 . . . . 1.4199999999999999 109.339 179.577 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 30.9 tp60 -140.2 117.6 11.41 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.864 -0.421 . . . . 2.6699999999999999 109.864 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.588 HG12 HD21 ' A' ' 54' ' ' LEU . 7.3 p -98.97 129.44 49.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 N-CA-C 109.623 -0.51 . . . . 1.54 109.623 175.79 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.842 ' HD3' ' HG3' ' A' ' 72' ' ' GLU . 20.4 ptmt -144.66 144.19 23.9 Favored Pre-proline 0 C--N 1.32 -0.712 0 CA-C-N 116.236 -0.438 . . . . 1.8100000000000001 110.569 -176.865 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.601 ' HA ' ' HA ' ' A' ' 69' ' ' TRP . 21.1 Cg_exo -67.1 140.6 54.62 Favored 'Trans proline' 0 N--CA 1.462 -0.33 0 C-N-CA 122.82 2.347 . . . . 0.84999999999999998 111.807 175.872 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.523 HD21 ' HB ' ' A' ' 70' ' ' THR . 59.7 mt -65.71 -44.65 85.46 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.668 -0.696 . . . . 1.7 111.108 -179.379 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 178.52 -60.8 0.09 OUTLIER Glycine 0 N--CA 1.445 -0.762 0 C-N-CA 120.274 -0.965 . . . . 1.6899999999999999 112.307 178.027 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . 0.406 HD22 ' HA ' ' A' ' 66' ' ' ASN . 3.7 m120 -91.84 -79.8 0.37 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.738 0.304 . . . . 2.96 111.477 -177.362 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -142.2 42.35 1.65 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.36 0.6 . . . . 2.5 110.916 -174.323 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 9.8 m -143.53 172.91 12.14 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 108.28 -1.007 . . . . 1.3 108.28 175.798 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' TRP . . . . . 0.649 ' HE3' HD11 ' A' ' 25' ' ' LEU . 55.0 m0 -136.68 167.86 20.6 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.55 -0.537 . . . . 0.46999999999999997 109.55 -172.716 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.523 ' HB ' HD21 ' A' ' 64' ' ' LEU . 9.5 t -142.36 142.5 32.46 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.641 -0.503 . . . . 0.82999999999999996 109.641 174.125 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.74 HD12 HD22 ' A' ' 31' ' ' LEU . 0.4 OUTLIER -93.7 101.04 13.17 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 108.985 -0.746 . . . . 1.71 108.985 176.44 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.842 ' HG3' ' HD3' ' A' ' 62' ' ' LYS . 10.5 mm-40 -87.78 119.54 70.6 Favored Pre-proline 0 C--N 1.318 -0.799 0 CA-C-N 114.72 -1.127 . . . . 2.1299999999999999 111.264 178.499 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -88.01 113.58 0.83 Allowed 'Trans proline' 0 N--CA 1.447 -1.209 0 C-N-CA 122.154 1.903 . . . . 1.3600000000000001 111.104 173.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.323 -0.582 0 CA-C-N 115.585 -0.734 . . . . 1.8899999999999999 109.791 -178.835 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 . . . . . 0 N--CA 1.45 -0.426 0 CA-C-O 121.786 0.803 . . . . 4.0 112.262 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.743 ' HB ' ' HE1' ' A' ' 44' ' ' TYR . 41.5 t -145.91 152.7 13.86 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 N-CA-C 106.857 -1.535 . . . . 1.6399999999999999 106.857 176.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 8.9 m120 -124.31 101.21 7.06 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.333 0.587 . . . . 2.29 109.766 -177.167 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 62.2 mt -116.63 147.51 19.97 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 115.371 -0.831 . . . . 0.81999999999999995 109.291 -178.297 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.701 ' HB1' ' HD2' ' A' ' 7' ' ' PRO . . . -162.56 167.19 12.58 Favored Pre-proline 0 C--N 1.319 -0.745 0 N-CA-C 108.588 -0.893 . . . . 1.3799999999999999 108.588 -172.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.701 ' HD2' ' HB1' ' A' ' 6' ' ' ALA . 11.2 Cg_exo -32.85 131.58 0.1 Allowed 'Trans proline' 0 C--N 1.357 0.998 0 C-N-CA 124.183 3.255 . . . . 1.73 113.748 -175.326 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 156.0 171.57 22.53 Favored Glycine 0 N--CA 1.441 -1.0 0 N-CA-C 110.154 -1.178 . . . . 1.8400000000000001 110.154 -174.25 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -67.59 137.76 55.93 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 108.95 -0.759 . . . . 1.6100000000000001 108.95 178.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.433 HD12 ' HB3' ' A' ' 13' ' ' ALA . 49.8 tp -59.07 -27.13 65.24 Favored 'General case' 0 C--O 1.232 0.178 0 C-N-CA 122.675 0.39 . . . . 1.1899999999999999 110.204 -178.161 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -49.53 -49.58 45.48 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.185 -0.916 . . . . 2.1099999999999999 109.873 172.663 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 57.9 tttm -68.08 -32.14 72.25 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.561 -0.745 . . . . 2.7200000000000002 110.882 -178.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.433 ' HB3' HD12 ' A' ' 10' ' ' LEU . . . -65.07 -52.48 55.41 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.878 0.371 . . . . 0.46000000000000002 110.043 -179.902 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.452 HD23 HD13 ' A' ' 53' ' ' LEU . 91.5 mt -56.71 -40.6 75.95 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.707 -0.679 . . . . 0.68999999999999995 110.485 173.676 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 9.3 t30 -62.23 -41.06 98.06 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.837 -0.62 . . . . 1.3100000000000001 110.612 179.83 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 24.2 tp60 -59.45 -46.45 88.73 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.194 -0.457 . . . . 2.23 111.475 179.034 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.464 ' HD1' ' HZ ' ' A' ' 23' ' ' PHE . 1.6 t80 -67.74 -44.02 78.55 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 109.061 -0.718 . . . . 0.65000000000000002 109.061 179.568 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.779 ' HA ' ' CE2' ' A' ' 23' ' ' PHE . . . -54.23 -53.7 49.95 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 114.894 -1.048 . . . . 0.37 111.823 179.225 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.98 -27.26 68.01 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.794 0.331 . . . . 0.64000000000000001 111.225 -178.34 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . 0.402 ' HB3' ' O ' ' A' ' 17' ' ' TYR . 69.1 t60 -61.52 -49.46 76.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.034 -0.53 . . . . 1.8500000000000001 111.399 -178.617 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.6 ' HB3' ' CD1' ' A' ' 23' ' ' PHE . 1.9 t -109.49 2.85 20.75 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-O 121.136 0.493 . . . . 1.6699999999999999 111.485 -176.882 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 60.23 46.84 93.53 Favored Glycine 0 C--N 1.333 0.397 0 CA-C-N 115.56 -0.746 . . . . 0.62 114.366 174.221 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.925 ' HB3' ' HB3' ' A' ' 67' ' ' ASN . 5.8 p90 -106.47 167.06 10.1 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 117.273 0.536 . . . . 0.56999999999999995 112.017 -179.824 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 6.7 m -94.14 112.88 24.74 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.206 -0.906 . . . . 0.68000000000000005 112.055 -176.369 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.614 HD21 ' CE3' ' A' ' 69' ' ' TRP . 0.6 OUTLIER -88.43 123.68 33.21 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.213 -0.903 . . . . 1.6699999999999999 111.341 176.828 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 20.7 t -103.05 91.14 3.99 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.152 -0.684 . . . . 1.1499999999999999 109.152 176.44 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.7 p -146.78 135.96 16.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.017 -0.538 . . . . 0.90000000000000002 110.922 -178.819 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.561 ' HB3' ' HG ' ' A' ' 31' ' ' LEU . 33.0 t70 -69.49 118.94 13.0 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-N 115.819 -0.628 . . . . 2.3799999999999999 110.339 178.713 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.04 65.17 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.354 0 O-C-N 123.825 0.703 . . . . 1.97 112.172 177.391 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.437 ' HB3' ' OD2' ' A' ' 28' ' ' ASP . 34.3 t -172.68 -28.75 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.717 -0.674 . . . . 2.2200000000000002 109.333 -179.111 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.561 ' HG ' ' HB3' ' A' ' 28' ' ' ASP . 98.1 mt -60.87 -51.26 70.05 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.757 -0.656 . . . . 1.3799999999999999 111.133 178.699 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 6.9 t -101.99 11.31 38.69 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.194 -0.457 . . . . 1.4399999999999999 111.394 -178.362 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 41.2 ttp180 -72.37 128.85 36.9 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.605 -0.271 . . . . 4.6299999999999999 110.407 -177.643 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 88.15 -2.29 85.23 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.864 -0.684 . . . . 1.6200000000000001 111.934 -179.606 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 32.5 tttp -88.95 139.2 30.69 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.644 -0.502 . . . . 2.75 109.644 179.627 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 65.4 mt-30 -128.98 150.68 50.29 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 110.044 -0.354 . . . . 2.2400000000000002 110.044 -177.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 20.7 t -126.51 131.2 51.66 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 108.642 -0.873 . . . . 1.02 108.642 178.561 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.613 ' O ' ' HD3' ' A' ' 7' ' ' PRO . 9.2 m120 -73.04 -6.67 47.1 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 112.837 0.68 . . . . 1.28 112.837 -176.223 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 138.48 165.37 10.27 Favored Glycine 0 C--O 1.235 0.178 0 C-N-CA 119.903 -1.142 . . . . 0.41999999999999998 114.049 168.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.736 ' HG ' ' OH ' ' A' ' 44' ' ' TYR . 57.1 tp -161.47 125.34 3.31 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 108.701 -0.852 . . . . 0.69999999999999996 108.701 -178.606 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 15.4 p80 -145.45 109.0 4.67 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 112.254 0.465 . . . . 2.96 112.254 -179.049 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -168.92 -178.68 40.55 Favored Glycine 0 C--N 1.334 0.451 0 C-N-CA 120.511 -0.852 . . . . 0.55000000000000004 112.932 170.625 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -86.39 110.64 19.84 Favored 'General case' 0 CA--C 1.517 -0.32 0 N-CA-C 107.801 -1.185 . . . . 2.1800000000000002 107.801 167.255 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.743 ' HE1' ' HB ' ' A' ' 3' ' ' VAL . 51.0 m-85 -101.94 148.21 25.61 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.817 0.818 . . . . 1.4099999999999999 113.015 -167.49 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 31.5 m-20 -92.92 144.21 25.49 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 106.137 -1.801 . . . . 2.23 106.137 156.275 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.471 ' O ' ' HG ' ' A' ' 50' ' ' LEU . 97.0 t -45.69 -63.14 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 N-CA-C 112.738 0.644 . . . . 0.56999999999999995 112.738 -169.035 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -62.83 -32.11 73.25 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.883 0.373 . . . . 2.3900000000000001 111.855 -176.131 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 62.5 m -71.08 -34.69 71.39 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.251 0.548 . . . . 1.26 111.075 -175.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -78.86 -27.22 57.05 Favored Glycine 0 N--CA 1.448 -0.525 0 N-CA-C 110.773 -0.931 . . . . 0.37 110.773 -176.539 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.748 ' HB3' HG11 ' A' ' 61' ' ' VAL . 87.6 mt -74.63 -36.18 62.9 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.282 -0.459 . . . . 1.0900000000000001 110.461 179.702 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -59.1 -39.46 82.28 Favored 'General case' 0 N--CA 1.455 -0.186 0 CA-C-N 116.032 -0.531 . . . . 2.5899999999999999 110.397 176.441 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 79.2 mm-40 -64.17 -38.92 92.79 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.859 0.362 . . . . 1.75 111.284 177.736 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.452 HD13 HD23 ' A' ' 14' ' ' LEU . 96.1 mt -60.0 -34.02 72.76 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.841 0.353 . . . . 0.72999999999999998 111.395 177.303 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.446 HD22 ' HB2' ' A' ' 59' ' ' LEU . 96.1 mt -84.29 2.03 42.07 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 116.082 -0.508 . . . . 2.1600000000000001 111.807 -176.646 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -62.23 114.86 3.7 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.037 -0.529 . . . . 2.2400000000000002 111.146 -176.418 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 106.31 7.35 35.11 Favored Glycine 0 N--CA 1.45 -0.39 0 CA-C-N 116.005 -0.543 . . . . 1.7 112.533 179.341 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 20.3 p -143.24 -174.2 4.14 Favored 'General case' 0 C--N 1.324 -0.531 0 O-C-N 122.775 -0.25 . . . . 2.2799999999999998 110.573 -178.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -132.05 44.91 1.16 Allowed Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 120.402 -0.904 . . . . 1.5800000000000001 112.844 -175.508 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.584 ' HA ' ' H ' ' A' ' 74' ' ' ALA . 3.9 mp -100.65 177.28 5.05 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.824 -0.436 . . . . 1.4199999999999999 109.824 171.773 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 26.8 tp60 -149.84 117.81 6.31 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 108.893 -0.78 . . . . 2.6699999999999999 108.893 179.098 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.748 HG11 ' HB3' ' A' ' 50' ' ' LEU . 7.4 p -86.54 133.79 28.99 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 N-CA-C 109.655 -0.498 . . . . 1.54 109.655 178.36 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.425 ' HA ' ' HD3' ' A' ' 63' ' ' PRO . 55.1 mtpt -124.6 110.41 28.09 Favored Pre-proline 0 C--N 1.32 -0.688 0 N-CA-C 109.809 -0.441 . . . . 1.8100000000000001 109.809 -178.141 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.555 ' HA ' ' HA ' ' A' ' 69' ' ' TRP . 2.8 Cg_exo -76.65 144.77 25.37 Favored 'Trans proline' 0 N--CA 1.462 -0.344 0 C-N-CA 123.161 2.574 . . . . 0.84999999999999998 112.868 -177.697 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -91.09 23.48 3.23 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.834 0.826 . . . . 1.7 109.474 175.15 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 84.38 -68.1 3.58 Favored Glycine 0 N--CA 1.447 -0.603 0 CA-C-N 114.493 -1.23 . . . . 1.6899999999999999 113.053 175.172 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 58.9 t30 -85.47 74.95 10.25 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.705 0.288 . . . . 2.96 111.184 -175.106 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . 0.925 ' HB3' ' HB3' ' A' ' 23' ' ' PHE . 7.8 m-20 72.35 -26.43 0.18 Allowed 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 113.253 0.834 . . . . 2.5 113.253 170.26 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 15.2 m -85.81 146.45 26.76 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 110.274 -0.269 . . . . 1.3 110.274 -175.578 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' TRP . . . . . 0.614 ' CE3' HD21 ' A' ' 25' ' ' LEU . 6.6 m0 -140.03 168.73 19.15 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.0 -0.741 . . . . 0.46999999999999997 109.0 -175.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 14.9 t -143.85 136.08 26.73 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.13 -0.692 . . . . 0.82999999999999996 109.13 169.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 54.6 tp -95.11 102.85 14.68 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.079 0.466 . . . . 1.71 110.732 -177.381 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -95.14 128.5 38.59 Favored Pre-proline 0 C--N 1.319 -0.725 0 CA-C-N 115.402 -0.817 . . . . 2.1299999999999999 110.687 174.597 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -73.99 115.49 4.34 Favored 'Trans proline' 0 N--CA 1.46 -0.482 0 C-N-CA 121.976 1.784 . . . . 1.3600000000000001 110.893 174.428 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.584 ' H ' ' HA ' ' A' ' 59' ' ' LEU . . . . . . . . 0 CA--C 1.521 -0.147 0 CA-C-N 116.094 -0.503 . . . . 1.8899999999999999 110.29 -176.291 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 31.8 tt0 . . . . . 0 N--CA 1.457 -0.106 0 CA-C-O 121.536 0.684 . . . . 4.0 111.545 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.455 HG12 HG12 ' A' ' 5' ' ' ILE . 58.2 t -104.34 128.54 57.75 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 CA-C-N 114.861 -1.063 . . . . 1.6399999999999999 108.457 174.545 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 43.8 t30 -126.9 98.87 5.5 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.14 0.495 . . . . 2.29 109.677 -175.405 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.615 HG22 ' HA2' ' A' ' 39' ' ' GLY . 27.1 mm -123.57 156.17 30.08 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 CA-C-N 115.306 -0.861 . . . . 0.81999999999999995 108.777 -177.295 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.649 ' HB1' ' HD2' ' A' ' 7' ' ' PRO . . . -160.04 163.56 22.04 Favored Pre-proline 0 C--N 1.321 -0.657 0 N-CA-C 109.503 -0.554 . . . . 1.3799999999999999 109.503 -177.35 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.649 ' HD2' ' HB1' ' A' ' 6' ' ' ALA . 6.6 Cg_exo -33.3 130.39 0.13 Allowed 'Trans proline' 0 C--N 1.357 1.002 0 C-N-CA 124.398 3.399 . . . . 1.73 113.314 -174.933 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 152.1 169.54 17.67 Favored Glycine 0 N--CA 1.44 -1.078 0 N-CA-C 110.96 -0.856 . . . . 1.8400000000000001 110.96 -174.471 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.664 ' HB3' ' OD2' ' A' ' 11' ' ' ASP . 53.9 m -61.48 141.56 57.61 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 120.815 0.34 . . . . 1.6100000000000001 111.471 179.693 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.75 HD22 ' HB2' ' A' ' 57' ' ' SER . 43.8 tp -59.65 -35.77 75.08 Favored 'General case' 0 CA--C 1.52 -0.175 0 CA-C-O 121.104 0.478 . . . . 1.1899999999999999 110.458 178.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.706 ' HB3' ' HB ' ' A' ' 32' ' ' THR . 2.0 p-10 -56.93 -31.77 65.29 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.305 -0.861 . . . . 2.1099999999999999 111.256 175.735 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 29.0 ttpt -70.52 -41.06 73.08 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.227 0.537 . . . . 2.7200000000000002 109.881 174.418 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -64.97 -55.38 19.41 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 115.424 -0.807 . . . . 0.46000000000000002 110.972 -174.195 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.439 ' HB3' HD11 ' A' ' 25' ' ' LEU . 89.2 mt -58.06 -41.12 82.68 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.809 -0.632 . . . . 0.68999999999999995 111.174 177.743 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 52.9 t30 -62.92 -40.29 97.18 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.223 -0.444 . . . . 1.3100000000000001 110.288 179.102 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -62.57 -42.68 99.7 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.204 -0.453 . . . . 2.23 110.218 176.698 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.469 ' O ' ' HB3' ' A' ' 20' ' ' HIS . 4.9 t80 -65.58 -39.86 92.07 Favored 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 109.229 -0.656 . . . . 0.65000000000000002 109.229 179.77 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.732 ' HA ' ' CZ ' ' A' ' 23' ' ' PHE . . . -55.56 -39.65 70.9 Favored 'General case' 0 CA--C 1.52 -0.184 0 CA-C-N 115.669 -0.696 . . . . 0.37 111.327 175.426 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.49 -30.09 71.27 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.202 -0.454 . . . . 0.64000000000000001 111.212 179.272 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . 0.469 ' HB3' ' O ' ' A' ' 17' ' ' TYR . 62.8 t60 -60.55 -58.43 8.52 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 116.264 -0.425 . . . . 1.8500000000000001 111.701 -177.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.538 ' HB3' ' HD1' ' A' ' 23' ' ' PHE . 11.4 t -98.38 -10.58 23.54 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-O 121.13 0.49 . . . . 1.6699999999999999 111.739 -174.615 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 69.01 53.09 20.51 Favored Glycine 0 C--N 1.33 0.205 0 CA-C-N 115.833 -0.621 . . . . 0.62 113.232 179.62 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.732 ' CZ ' ' HA ' ' A' ' 18' ' ' ALA . 26.1 p90 -109.03 167.45 10.08 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.808 0.337 . . . . 0.56999999999999995 110.535 179.264 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 25.3 m -92.9 109.73 21.18 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.439 0.638 . . . . 0.68000000000000005 110.982 178.859 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.439 HD11 ' HB3' ' A' ' 14' ' ' LEU . 4.4 tt -91.64 128.09 37.34 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.433 -0.803 . . . . 1.6699999999999999 109.299 179.7 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 25.4 t -99.09 100.2 11.31 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.07 0.462 . . . . 1.1499999999999999 109.955 -179.319 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.429 HG23 ' HG ' ' A' ' 71' ' ' LEU . 7.3 p -129.34 130.86 67.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 115.987 -0.551 . . . . 0.90000000000000002 110.552 -178.871 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.498 ' OD2' ' HB2' ' A' ' 30' ' ' SER . 23.7 t70 -75.46 123.83 26.11 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.663 -0.699 . . . . 2.3799999999999999 110.816 178.791 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.62 49.75 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 113.338 0.866 . . . . 1.97 113.338 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.498 ' HB2' ' OD2' ' A' ' 28' ' ' ASP . 69.5 m -161.53 -28.12 0.05 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.847 0.356 . . . . 2.2200000000000002 110.19 -179.696 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 75.9 mt -72.64 -43.79 62.76 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.51 0.672 . . . . 1.3799999999999999 110.443 176.59 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.706 ' HB ' ' HB3' ' A' ' 11' ' ' ASP . 9.5 p -96.38 52.55 1.25 Allowed 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.726 -0.67 . . . . 1.4399999999999999 112.279 -175.579 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 4.7 ptp180 -99.96 106.77 18.6 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-O 121.142 0.496 . . . . 4.6299999999999999 111.042 175.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 70.77 46.61 45.01 Favored Glycine 0 N--CA 1.449 -0.474 0 CA-C-N 115.656 -0.702 . . . . 1.6200000000000001 113.569 174.334 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.649 ' O ' ' HA ' ' A' ' 9' ' ' SER . 13.3 mptt -85.27 173.75 10.12 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 110.039 -0.356 . . . . 2.75 110.039 176.037 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 50.3 tt0 -149.84 134.85 17.92 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 120.778 0.323 . . . . 2.2400000000000002 110.871 173.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 42.7 t -132.82 130.61 40.05 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 107.368 -1.345 . . . . 1.02 107.368 171.408 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.422 ' O ' ' HD3' ' A' ' 7' ' ' PRO . 0.1 OUTLIER -69.48 -7.75 40.77 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 113.122 0.786 . . . . 1.28 113.122 -173.89 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.615 ' HA2' HG22 ' A' ' 5' ' ' ILE . . . 117.4 -177.05 16.46 Favored Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 120.134 -1.032 . . . . 0.41999999999999998 113.345 171.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.479 ' N ' ' HB ' ' A' ' 5' ' ' ILE . 60.4 tp -159.96 141.92 13.04 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 108.574 -0.899 . . . . 0.69999999999999996 108.574 -178.414 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 50.8 t-80 -144.27 97.09 2.99 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.919 0.39 . . . . 2.96 110.658 179.72 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -170.46 177.88 43.41 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.973 -0.632 . . . . 0.55000000000000004 111.837 175.071 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -92.7 99.99 12.58 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 108.44 -0.948 . . . . 2.1800000000000002 108.44 171.316 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.44 ' HB2' ' CG2' ' A' ' 3' ' ' VAL . 25.6 m-85 -116.39 156.54 26.57 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 121.455 0.645 . . . . 1.4099999999999999 112.227 -170.817 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -92.73 169.72 10.27 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 114.69 -1.141 . . . . 2.23 108.276 172.374 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.548 ' O ' ' HG ' ' A' ' 50' ' ' LEU . 78.1 t -48.01 -64.78 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 O-C-N 123.05 0.219 . . . . 0.56999999999999995 111.438 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -61.53 -44.32 97.27 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 112.824 0.675 . . . . 2.3900000000000001 112.824 -175.785 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 3.8 p -73.44 -31.06 63.6 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.037 0.446 . . . . 1.26 111.244 -173.418 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -72.48 -36.96 58.74 Favored Glycine 0 N--CA 1.446 -0.666 0 N-CA-C 111.233 -0.747 . . . . 0.37 111.233 179.56 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.548 ' HG ' ' O ' ' A' ' 46' ' ' VAL . 88.1 mt -71.61 -37.34 70.94 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.495 -0.352 . . . . 1.0900000000000001 110.464 178.706 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -53.68 -47.42 70.44 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.866 -0.606 . . . . 2.5899999999999999 110.576 179.307 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 14.1 mm100 -64.72 -42.27 95.36 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-O 120.807 0.337 . . . . 1.75 110.778 179.349 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.411 HD21 HG13 ' A' ' 5' ' ' ILE . 90.8 mt -59.75 -30.34 68.78 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 116.261 -0.427 . . . . 0.72999999999999998 111.878 178.498 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.633 HD11 HG12 ' A' ' 61' ' ' VAL . 5.9 mp -72.73 -21.11 61.08 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.313 -0.403 . . . . 2.1600000000000001 111.449 -179.457 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -71.94 86.98 1.01 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.139 0.495 . . . . 2.2400000000000002 111.159 -177.234 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 113.1 -9.64 24.93 Favored Glycine 0 CA--C 1.52 0.365 0 CA-C-N 115.904 -0.589 . . . . 1.7 113.457 175.189 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.75 ' HB2' HD22 ' A' ' 10' ' ' LEU . 11.7 p -82.26 -24.72 34.61 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.961 0.381 . . . . 2.2799999999999998 111.91 -175.577 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 88.57 5.1 75.53 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.918 -0.658 . . . . 1.5800000000000001 112.664 176.748 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.571 HD12 HD23 ' A' ' 10' ' ' LEU . 95.8 mt -126.34 179.4 5.3 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.611 0.243 . . . . 1.4199999999999999 110.86 -178.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 9.1 tt0 -147.39 118.97 7.96 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 109.163 -0.68 . . . . 2.6699999999999999 109.163 179.597 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.633 HG12 HD11 ' A' ' 54' ' ' LEU . 7.7 p -98.43 128.02 50.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-O 121.215 0.531 . . . . 1.54 109.978 179.202 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.76 ' HE2' ' HB2' ' A' ' 72' ' ' GLU . 48.1 mtmt -109.36 130.12 23.13 Favored Pre-proline 0 C--N 1.322 -0.592 0 CA-C-N 116.146 -0.479 . . . . 1.8100000000000001 110.719 -176.468 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -67.62 113.43 2.94 Favored 'Trans proline' 0 N--CA 1.457 -0.629 0 C-N-CA 122.102 1.868 . . . . 0.84999999999999998 109.536 168.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 37.3 tp -60.04 -41.8 93.05 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.655 -0.702 . . . . 1.7 111.5 -171.102 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 165.67 -54.61 0.26 Allowed Glycine 0 N--CA 1.448 -0.556 0 N-CA-C 110.207 -1.157 . . . . 1.6899999999999999 110.207 179.381 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 27.5 p-10 -86.32 -158.66 0.42 Allowed 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 108.935 -0.765 . . . . 2.96 108.935 171.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 20.1 p-10 -81.7 49.37 1.33 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.515 0.674 . . . . 2.5 110.796 176.108 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.443 ' O ' ' HD1' ' A' ' 69' ' ' TRP . 40.3 m -139.12 169.24 18.13 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 108.409 -0.96 . . . . 1.3 108.409 174.745 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' TRP . . . . . 0.443 ' HD1' ' O ' ' A' ' 68' ' ' SER . 45.0 m0 -140.12 171.35 14.31 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 110.035 -0.358 . . . . 0.46999999999999997 110.035 -167.483 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.489 HG23 ' HE3' ' A' ' 62' ' ' LYS . 6.8 t -146.04 147.22 31.39 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.167 -0.47 . . . . 0.82999999999999996 109.989 173.129 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.429 ' HG ' HG23 ' A' ' 27' ' ' VAL . 0.9 OUTLIER -92.77 108.76 20.23 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.123 0.487 . . . . 1.71 110.992 -174.279 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.76 ' HB2' ' HE2' ' A' ' 62' ' ' LYS . 4.3 tp10 -93.21 122.23 63.72 Favored Pre-proline 0 C--N 1.322 -0.608 0 CA-C-N 115.345 -0.843 . . . . 2.1299999999999999 110.539 175.091 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -84.43 113.47 1.71 Allowed 'Trans proline' 0 N--CA 1.453 -0.891 0 C-N-CA 121.863 1.709 . . . . 1.3600000000000001 111.56 174.194 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.327 -0.389 0 CA-C-N 115.849 -0.614 . . . . 1.8899999999999999 109.776 -178.363 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . 0.716 ' HB2' ' H ' ' A' ' 44' ' ' TYR . 7.9 mm100 . . . . . 0 N--CA 1.453 -0.308 0 CA-C-O 120.864 0.364 . . . . 4.0 111.952 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 21.5 m -145.61 143.3 21.82 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-N 115.927 -0.579 . . . . 1.6399999999999999 111.114 -178.638 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 4.5 p-10 -128.55 96.88 4.53 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 107.967 -1.123 . . . . 2.29 107.967 171.748 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.411 HD12 ' HB3' ' A' ' 40' ' ' LEU . 21.3 mt -130.86 157.41 43.15 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.761 0 CA-C-N 115.655 -0.702 . . . . 0.81999999999999995 109.883 -170.055 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.741 ' HB1' ' HD2' ' A' ' 7' ' ' PRO . . . -162.36 178.63 1.5 Allowed Pre-proline 0 C--N 1.321 -0.67 0 N-CA-C 108.224 -1.028 . . . . 1.3799999999999999 108.224 -174.569 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.741 ' HD2' ' HB1' ' A' ' 6' ' ' ALA . 51.2 Cg_exo -39.33 129.38 1.6 Allowed 'Trans proline' 0 C--N 1.359 1.122 0 C-N-CA 122.685 2.257 . . . . 1.73 113.023 -178.383 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 163.41 161.85 13.34 Favored Glycine 0 N--CA 1.443 -0.872 0 N-CA-C 110.727 -0.949 . . . . 1.8400000000000001 110.727 -174.664 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.409 ' HA ' ' O ' ' A' ' 35' ' ' LYS . 37.2 p -61.61 137.69 58.26 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.951 0.376 . . . . 1.6100000000000001 110.616 -178.127 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.462 HD21 ' HG ' ' A' ' 54' ' ' LEU . 64.0 tp -60.06 -32.43 70.93 Favored 'General case' 0 CA--C 1.52 -0.204 0 CA-C-O 121.102 0.477 . . . . 1.1899999999999999 109.739 178.648 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.593 ' HB2' ' HB ' ' A' ' 32' ' ' THR . 11.4 t70 -50.32 -54.0 24.68 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.143 -0.935 . . . . 2.1099999999999999 110.449 172.665 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 59.0 tttp -67.09 -32.38 73.49 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 116.213 -0.449 . . . . 2.7200000000000002 110.949 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -64.26 -54.49 32.59 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.292 -0.413 . . . . 0.46000000000000002 110.447 -177.861 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 85.5 mt -57.96 -41.92 83.9 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 115.854 -0.612 . . . . 0.68999999999999995 111.071 176.165 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 12.9 t30 -62.65 -35.21 78.88 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.972 -0.558 . . . . 1.3100000000000001 110.738 179.806 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.453 HE21 ' HB3' ' A' ' 16' ' ' GLN . 0.8 OUTLIER -61.17 -46.74 89.27 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 116.392 -0.367 . . . . 2.23 110.875 175.865 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.645 ' HD1' ' HH2' ' A' ' 69' ' ' TRP . 34.2 t80 -67.64 -32.05 72.48 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 120.986 -0.286 . . . . 0.65000000000000002 110.421 -176.9 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.83 ' HA ' ' CZ ' ' A' ' 23' ' ' PHE . . . -50.94 -34.89 30.57 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 112.114 0.412 . . . . 0.37 112.114 175.625 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.55 -15.71 52.3 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.305 -0.407 . . . . 0.64000000000000001 111.93 179.579 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 30.8 t-80 -59.67 -67.85 0.34 Allowed 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 116.628 -0.26 . . . . 1.8500000000000001 111.42 179.866 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.695 ' HB3' ' HD1' ' A' ' 23' ' ' PHE . 23.0 t -101.12 -6.65 24.05 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.797 0.332 . . . . 1.6699999999999999 111.505 -174.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 70.32 46.74 47.69 Favored Glycine 0 C--N 1.334 0.418 0 C-N-CA 120.771 -0.728 . . . . 0.62 112.524 178.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.83 ' CZ ' ' HA ' ' A' ' 18' ' ' ALA . 11.6 p90 -100.68 170.21 8.51 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.697 0.284 . . . . 0.56999999999999995 110.477 -175.856 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.47 ' O ' ' HB3' ' A' ' 68' ' ' SER . 24.0 m -91.67 111.19 22.6 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.129 0.49 . . . . 0.68000000000000005 110.872 -178.38 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 5.2 tt -93.32 125.82 38.13 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 115.915 -0.584 . . . . 1.6699999999999999 109.565 -179.736 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.629 ' HB2' ' HA ' ' A' ' 70' ' ' THR . 15.2 m -99.1 93.01 5.75 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.158 -0.474 . . . . 1.1499999999999999 109.908 -179.021 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 9.7 p -113.64 141.57 29.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 115.994 -0.548 . . . . 0.90000000000000002 109.758 -178.503 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.421 ' HB3' ' HG ' ' A' ' 31' ' ' LEU . 23.1 t70 -98.0 125.62 43.02 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 110.176 -0.305 . . . . 2.3799999999999999 110.176 179.604 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.16 57.97 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.525 0 O-C-N 123.802 0.689 . . . . 1.97 112.622 179.066 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 25.9 t -173.04 -28.61 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.221 -0.445 . . . . 2.2200000000000002 110.042 -179.732 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.421 ' HG ' ' HB3' ' A' ' 28' ' ' ASP . 86.3 mt -77.28 -33.69 55.74 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.328 -0.396 . . . . 1.3799999999999999 111.361 -178.136 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.593 ' HB ' ' HB2' ' A' ' 11' ' ' ASP . 6.0 p -92.4 13.27 20.02 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.26 0.552 . . . . 1.4399999999999999 111.25 179.455 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 39.5 ttm180 -73.16 114.22 11.1 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.635 -0.711 . . . . 4.6299999999999999 110.266 179.646 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 84.08 21.18 57.77 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.74 -0.743 . . . . 1.6200000000000001 111.875 179.688 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.409 ' O ' ' HA ' ' A' ' 9' ' ' SER . 12.7 mptt -107.53 124.04 49.32 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.117 0.484 . . . . 2.75 111.23 -179.001 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 6.8 tt0 -131.69 141.06 49.47 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.353 -0.839 . . . . 2.2400000000000002 109.135 177.734 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 7.3 t -121.8 121.06 36.36 Favored 'General case' 0 N--CA 1.443 -0.823 0 N-CA-C 107.003 -1.48 . . . . 1.02 107.003 174.768 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 8.9 m-80 -70.65 -0.54 8.94 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 113.296 0.85 . . . . 1.28 113.296 -169.662 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 134.97 168.32 11.62 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 119.894 -1.145 . . . . 0.41999999999999998 114.213 166.838 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.433 HD13 ' HG2' ' A' ' 52' ' ' GLN . 60.9 tp -160.59 131.71 5.62 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 107.883 -1.155 . . . . 0.69999999999999996 107.883 179.825 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 39.1 t60 -144.5 97.84 3.1 Favored 'General case' 0 C--N 1.321 -0.635 0 C-N-CA 120.055 -0.658 . . . . 2.96 110.971 179.721 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -169.63 175.78 43.71 Favored Glycine 0 N--CA 1.445 -0.749 0 CA-C-N 115.117 -0.947 . . . . 0.55000000000000004 111.322 176.625 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.528 ' HA ' ' N ' ' A' ' 2' ' ' GLN . 12.2 t70 -83.65 94.41 8.1 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 108.216 -1.031 . . . . 2.1800000000000002 108.216 171.564 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.716 ' H ' ' HB2' ' A' ' 2' ' ' GLN . 45.8 m-85 -115.1 126.57 54.82 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.111 0.481 . . . . 1.4099999999999999 111.927 -174.718 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -67.97 170.21 8.65 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.254 -0.884 . . . . 2.23 109.915 174.085 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.628 HG13 ' HZ2' ' A' ' 69' ' ' TRP . 86.0 t -48.45 -65.55 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 O-C-N 123.549 0.531 . . . . 0.56999999999999995 111.758 -175.387 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -59.02 -43.46 91.57 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 112.629 0.603 . . . . 2.3900000000000001 112.629 -177.719 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 22.9 t -71.37 -33.21 69.35 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.097 0.475 . . . . 1.26 110.967 -172.513 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -73.73 -39.47 48.12 Favored Glycine 0 N--CA 1.445 -0.713 0 C-N-CA 120.735 -0.745 . . . . 0.37 111.496 -176.335 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.654 ' HB3' HG11 ' A' ' 61' ' ' VAL . 85.9 mt -67.95 -40.4 83.24 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.755 0.312 . . . . 1.0900000000000001 110.857 -179.738 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . 0.424 HE21 ' HB3' ' A' ' 51' ' ' GLN . 0.9 OUTLIER -54.28 -50.13 67.98 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.929 -0.578 . . . . 2.5899999999999999 111.03 179.22 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.433 ' HG2' HD13 ' A' ' 40' ' ' LEU . 25.4 tp60 -68.07 -40.61 82.67 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.395 -0.366 . . . . 1.75 111.226 -177.173 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 51.0 mt -56.6 -42.17 78.26 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.217 0.451 . . . . 0.72999999999999998 112.217 -179.303 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.462 ' HG ' HD21 ' A' ' 10' ' ' LEU . 11.0 mp -85.14 -5.02 59.35 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 112.374 0.509 . . . . 2.1600000000000001 112.374 -174.614 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -66.62 105.65 1.59 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.29 0.566 . . . . 2.2400000000000002 109.769 178.752 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 133.6 -15.0 4.7 Favored Glycine 0 N--CA 1.447 -0.615 0 N-CA-C 110.66 -0.976 . . . . 1.7 110.66 -172.038 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 79.4 p -119.49 175.96 5.59 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.271 -0.64 . . . . 2.2799999999999998 109.271 175.709 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -113.74 17.64 20.33 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.21 -0.995 . . . . 1.5800000000000001 112.266 -177.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 98.6 mt -92.24 175.45 6.85 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 110.254 -0.276 . . . . 1.4199999999999999 110.254 -179.137 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 27.2 mp0 -139.0 118.98 13.31 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.156 -0.683 . . . . 2.6699999999999999 109.156 -179.464 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.654 HG11 ' HB3' ' A' ' 50' ' ' LEU . 7.5 p -98.54 127.11 51.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 N-CA-C 109.674 -0.491 . . . . 1.54 109.674 176.915 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.467 ' HA ' ' HD3' ' A' ' 63' ' ' PRO . 0.0 OUTLIER -140.55 137.06 17.09 Favored Pre-proline 0 C--N 1.323 -0.584 0 CA-C-N 116.234 -0.439 . . . . 1.8100000000000001 110.962 -176.559 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.529 ' HA ' ' HA ' ' A' ' 69' ' ' TRP . 28.4 Cg_exo -62.74 128.79 24.23 Favored 'Trans proline' 0 N--CA 1.462 -0.371 0 C-N-CA 122.915 2.41 . . . . 0.84999999999999998 110.982 177.131 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -66.64 -43.76 83.77 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.702 -0.681 . . . . 1.7 109.732 -177.379 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 165.16 -60.42 0.24 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.564 -0.827 . . . . 1.6899999999999999 112.276 176.336 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 50.5 t30 -86.12 68.85 10.41 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.997 0.427 . . . . 2.96 111.211 -175.597 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 66.4 t30 58.93 12.16 2.22 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-N 115.742 -0.663 . . . . 2.5 111.84 175.73 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.47 ' HB3' ' O ' ' A' ' 24' ' ' THR . 50.7 m -122.5 177.83 5.24 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 108.811 -0.811 . . . . 1.3 108.811 -173.844 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' TRP . . . . . 0.645 ' HH2' ' HD1' ' A' ' 17' ' ' TYR . 49.9 m0 -137.44 166.18 24.46 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.886 -0.413 . . . . 0.46999999999999997 109.886 -167.357 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.629 ' HA ' ' HB2' ' A' ' 26' ' ' SER . 15.1 t -148.05 147.57 29.72 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 108.814 -0.81 . . . . 0.82999999999999996 108.814 169.921 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 31.8 tp -92.23 103.84 16.27 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.442 0.639 . . . . 1.71 109.928 -179.192 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -88.11 119.49 70.38 Favored Pre-proline 0 C--N 1.319 -0.753 0 CA-C-N 114.918 -1.037 . . . . 2.1299999999999999 111.19 -179.715 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -90.32 115.14 0.53 Allowed 'Trans proline' 0 N--CA 1.449 -1.143 0 C-N-CA 122.393 2.062 . . . . 1.3600000000000001 112.33 177.404 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.323 -0.556 0 CA-C-N 115.725 -0.67 . . . . 1.8899999999999999 109.487 176.31 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 32.9 mm-40 . . . . . 0 C--O 1.235 0.297 0 CA-C-O 120.86 0.362 . . . . 4.0 111.012 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 31.4 m -103.39 136.36 36.55 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-N 115.964 -0.562 . . . . 1.6399999999999999 109.787 174.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -127.01 96.55 4.65 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 108.589 -0.893 . . . . 2.29 108.589 -179.81 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.504 HD12 ' HB3' ' A' ' 40' ' ' LEU . 50.5 mt -126.11 149.24 30.85 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 CA-C-N 115.763 -0.653 . . . . 0.81999999999999995 110.153 -173.821 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.564 ' HB1' ' HD2' ' A' ' 7' ' ' PRO . . . -162.96 168.12 10.83 Favored Pre-proline 0 C--N 1.323 -0.544 0 N-CA-C 108.844 -0.798 . . . . 1.3799999999999999 108.844 -176.381 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.564 ' HD2' ' HB1' ' A' ' 6' ' ' ALA . 89.8 Cg_exo -44.56 133.48 9.89 Favored 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 122.806 2.337 . . . . 1.73 112.998 -178.103 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.401 ' O ' ' HG2' ' A' ' 12' ' ' LYS . . . 154.91 41.56 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.635 -0.793 . . . . 1.8400000000000001 112.062 178.299 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.624 ' HA ' ' HA ' ' A' ' 36' ' ' GLN . 20.2 m 66.98 138.92 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.281 0 CA-C-O 121.326 0.584 . . . . 1.6100000000000001 110.699 -172.376 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.596 HD11 ' HB3' ' A' ' 53' ' ' LEU . 49.5 tp -58.37 -24.2 59.22 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.138 0.494 . . . . 1.1899999999999999 110.27 177.284 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -48.06 -51.59 23.72 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.073 -0.967 . . . . 2.1099999999999999 111.892 175.031 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.451 ' HE3' ' HB2' ' A' ' 12' ' ' LYS . 0.0 OUTLIER -66.91 -25.47 66.39 Favored 'General case' 0 C--N 1.335 -0.063 0 C-N-CA 121.064 -0.255 . . . . 2.7200000000000002 111.375 -176.397 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -65.42 -59.29 4.17 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.049 0.452 . . . . 0.46000000000000002 110.073 178.796 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 86.9 mt -58.46 -37.38 75.36 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.675 -0.693 . . . . 0.68999999999999995 110.905 176.428 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 47.4 t30 -60.94 -40.76 94.52 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.257 -0.429 . . . . 1.3100000000000001 110.257 178.399 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -61.1 -47.87 84.28 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 116.028 -0.533 . . . . 2.23 110.541 178.548 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.53 ' O ' ' HB3' ' A' ' 20' ' ' HIS . 3.1 t80 -69.58 -43.93 71.86 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-O 120.871 0.367 . . . . 0.65000000000000002 110.251 -177.653 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.604 ' HA ' ' CZ ' ' A' ' 23' ' ' PHE . . . -53.92 -53.48 52.11 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 115.912 -0.585 . . . . 0.37 112.275 -179.72 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.53 -22.55 66.4 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.804 0.335 . . . . 0.64000000000000001 111.517 -178.817 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . 0.53 ' HB3' ' O ' ' A' ' 17' ' ' TYR . 77.9 t60 -65.73 -52.12 53.77 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.993 -0.549 . . . . 1.8500000000000001 111.5 -179.866 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.43 ' HB2' ' CD1' ' A' ' 23' ' ' PHE . 19.7 m -108.13 -3.6 18.45 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 112.619 0.599 . . . . 1.6699999999999999 112.619 -174.355 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 69.2 47.73 50.88 Favored Glycine 0 C--O 1.227 -0.295 0 CA-C-N 116.142 -0.481 . . . . 0.62 113.884 174.262 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.604 ' CZ ' ' HA ' ' A' ' 18' ' ' ALA . 13.3 p90 -110.78 162.93 14.29 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.84 0.32 . . . . 0.56999999999999995 110.209 178.398 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.63 ' O ' ' HB3' ' A' ' 68' ' ' SER . 28.0 m -98.11 122.17 40.93 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.363 0.601 . . . . 0.68000000000000005 112.173 -174.725 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.481 HD21 ' CE3' ' A' ' 69' ' ' TRP . 1.1 mm? -88.49 115.11 25.77 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.677 -0.692 . . . . 1.6699999999999999 110.322 175.491 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 32.9 t -98.08 93.92 6.55 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.795 -0.638 . . . . 1.1499999999999999 109.799 -179.653 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.752 HG21 HD12 ' A' ' 71' ' ' LEU . 7.2 p -148.16 141.71 18.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.768 -0.651 . . . . 0.90000000000000002 110.655 -178.849 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -88.88 132.12 34.81 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.933 -0.576 . . . . 2.3799999999999999 110.009 175.578 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.33 78.57 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.308 0 O-C-N 123.8 0.687 . . . . 1.97 111.863 179.658 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 74.1 m -165.83 -38.19 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 123.142 0.577 . . . . 2.2200000000000002 109.556 -179.736 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 88.0 mt -75.24 -33.17 61.28 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.093 -0.503 . . . . 1.3799999999999999 110.693 178.791 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 7.5 p -92.32 -10.93 36.54 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.329 -0.396 . . . . 1.4399999999999999 110.948 177.526 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 53.1 ttp180 -64.69 107.12 1.33 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.815 -0.63 . . . . 4.6299999999999999 110.143 179.87 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 102.51 17.66 18.83 Favored Glycine 0 N--CA 1.444 -0.806 0 C-N-CA 121.002 -0.618 . . . . 1.6200000000000001 111.797 -177.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 12.9 mptt -107.5 122.26 46.3 Favored 'General case' 0 CA--C 1.514 -0.418 0 CA-C-O 121.106 0.479 . . . . 2.75 111.711 178.85 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . 0.624 ' HA ' ' HA ' ' A' ' 9' ' ' SER . 18.4 pt20 -138.24 133.66 33.43 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.564 -0.744 . . . . 2.2400000000000002 109.168 173.593 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.424 ' O ' ' HA ' ' A' ' 7' ' ' PRO . 19.2 t -115.66 140.3 49.32 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.569 -0.53 . . . . 1.02 109.569 -176.567 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.402 ' N ' HD22 ' A' ' 38' ' ' ASN . 0.9 OUTLIER -71.0 2.9 3.81 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 112.162 0.431 . . . . 1.28 112.162 177.258 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.46 ' HA3' ' HA ' ' A' ' 6' ' ' ALA . . . 114.85 -178.03 17.72 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.775 -0.726 . . . . 0.41999999999999998 113.445 166.331 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.504 ' HB3' HD12 ' A' ' 5' ' ' ILE . 56.1 tp -160.82 131.07 5.15 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 107.797 -1.186 . . . . 0.69999999999999996 107.797 179.632 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 17.4 t-160 -143.4 99.89 3.51 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 120.07 -0.652 . . . . 2.96 111.71 -177.63 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -169.03 -169.68 32.7 Favored Glycine 0 N--CA 1.448 -0.545 0 CA-C-N 115.403 -0.817 . . . . 0.55000000000000004 111.459 176.156 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -103.55 90.64 3.74 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 108.832 -0.803 . . . . 2.1800000000000002 108.832 172.112 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 64.1 m-85 -110.47 151.86 27.02 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.61 -0.723 . . . . 1.4099999999999999 110.584 -175.79 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -99.47 -171.94 2.16 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 108.302 -0.999 . . . . 2.23 108.302 174.218 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.423 ' O ' ' HG ' ' A' ' 50' ' ' LEU . 39.2 t -51.7 -71.0 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 N-CA-C 112.976 0.732 . . . . 0.56999999999999995 112.976 -172.636 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.31 -47.45 82.22 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 113.266 0.839 . . . . 2.3900000000000001 113.266 -169.102 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 7.5 t -73.97 -26.86 60.7 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.032 0.444 . . . . 1.26 110.75 -170.692 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -75.13 -38.94 38.56 Favored Glycine 0 N--CA 1.447 -0.626 0 N-CA-C 111.042 -0.823 . . . . 0.37 111.042 -178.874 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.775 HD13 HG11 ' A' ' 61' ' ' VAL . 80.7 mt -70.11 -41.53 73.87 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 115.441 -0.379 . . . . 1.0900000000000001 110.261 179.068 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 55.3 tp60 -55.96 -38.06 69.87 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 116.102 -0.499 . . . . 2.5899999999999999 111.524 -179.244 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 24.6 mm-40 -63.5 -45.64 89.75 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.857 0.361 . . . . 1.75 110.616 177.771 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.596 ' HB3' HD11 ' A' ' 10' ' ' LEU . 90.3 mt -60.94 -22.87 64.83 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.838 -0.619 . . . . 0.72999999999999998 111.859 176.787 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.782 HD21 HG23 ' A' ' 61' ' ' VAL . 87.4 mt -85.28 -24.05 27.91 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.14 0.422 . . . . 2.1600000000000001 112.14 -175.494 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -70.07 93.63 0.82 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.179 0.514 . . . . 2.2400000000000002 110.905 -175.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 114.77 -10.45 21.2 Favored Glycine 0 N--CA 1.446 -0.69 0 CA-C-N 115.799 -0.637 . . . . 1.7 112.532 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.429 ' OG ' ' HA ' ' A' ' 54' ' ' LEU . 27.1 p -98.92 -12.12 21.0 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.883 0.373 . . . . 2.2799999999999998 111.448 -178.547 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 71.3 28.39 70.0 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 121.0 -0.619 . . . . 1.5800000000000001 112.892 175.72 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 94.8 mt -119.12 167.98 11.29 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.74 0.305 . . . . 1.4199999999999999 110.857 -178.555 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . 0.419 ' HA ' HD13 ' A' ' 54' ' ' LEU . 62.8 tt0 -143.97 118.97 10.0 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.082 -0.71 . . . . 2.6699999999999999 109.082 177.47 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.782 HG23 HD21 ' A' ' 54' ' ' LEU . 36.8 t -94.81 130.2 43.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 N-CA-C 110.044 -0.354 . . . . 1.54 110.044 -178.25 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.414 ' HA ' ' HD3' ' A' ' 63' ' ' PRO . 17.9 ptmt -131.67 127.61 21.47 Favored Pre-proline 0 C--N 1.317 -0.815 0 N-CA-C 109.624 -0.51 . . . . 1.8100000000000001 109.624 179.015 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 62' ' ' LYS . 32.2 Cg_exo -60.15 132.92 46.85 Favored 'Trans proline' 0 N--CA 1.463 -0.279 0 C-N-CA 122.577 2.185 . . . . 0.84999999999999998 111.191 177.612 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 42.7 tp -69.27 -40.31 77.87 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.713 -0.676 . . . . 1.7 110.925 -174.592 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 158.65 -44.48 0.47 Allowed Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.758 -0.735 . . . . 1.6899999999999999 112.092 175.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 9.2 m120 -77.15 -89.39 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.394 0.616 . . . . 2.96 110.644 -179.481 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 30.4 p-10 -146.69 24.85 1.2 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.626 -0.715 . . . . 2.5 109.095 177.057 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.63 ' HB3' ' O ' ' A' ' 24' ' ' THR . 50.4 m -128.74 178.82 6.07 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 108.178 -1.045 . . . . 1.3 108.178 -171.784 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' TRP . . . . . 0.481 ' CE3' HD21 ' A' ' 25' ' ' LEU . 1.9 m0 -140.15 169.73 17.16 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 119.836 -0.746 . . . . 0.46999999999999997 110.055 -170.864 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 9.6 t -140.97 144.03 34.85 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 108.722 -0.844 . . . . 0.82999999999999996 108.722 171.654 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.752 HD12 HG21 ' A' ' 27' ' ' VAL . 52.0 mt -93.85 105.62 17.63 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.415 0.626 . . . . 1.71 111.484 -173.839 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 18.4 tt0 -89.44 129.48 47.14 Favored Pre-proline 0 C--N 1.318 -0.789 0 CA-C-N 115.051 -0.977 . . . . 2.1299999999999999 110.347 174.108 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -79.12 114.68 3.39 Favored 'Trans proline' 0 N--CA 1.453 -0.875 0 C-N-CA 121.92 1.747 . . . . 1.3600000000000001 111.325 177.75 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.322 -0.598 0 CA-C-N 115.654 -0.703 . . . . 1.8899999999999999 110.446 -179.121 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 5.1 pm0 . . . . . 0 C--O 1.234 0.242 0 N-CA-C 109.353 -0.61 . . . . 4.0 109.353 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 33.7 m -137.39 152.74 27.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 120.73 0.3 . . . . 1.6399999999999999 110.922 -175.645 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 31.7 m-80 -127.82 96.31 4.47 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 108.641 -0.874 . . . . 2.29 108.641 174.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.421 HG21 HD21 ' A' ' 53' ' ' LEU . 28.8 mm -119.69 149.71 22.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 N-CA-C 109.406 -0.591 . . . . 0.81999999999999995 109.406 -176.423 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -163.4 162.15 17.54 Favored Pre-proline 0 C--N 1.323 -0.578 0 N-CA-C 109.488 -0.56 . . . . 1.3799999999999999 109.488 -177.205 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.452 ' HA ' ' O ' ' A' ' 37' ' ' SER . 53.3 Cg_exo -52.23 130.54 35.92 Favored 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 122.95 2.433 . . . . 1.73 113.006 -175.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 158.69 48.03 0.01 OUTLIER Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 120.744 -0.741 . . . . 1.8400000000000001 112.255 -178.345 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 19.8 m 67.81 126.81 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 123.155 0.582 . . . . 1.6100000000000001 111.285 -177.167 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.623 HD11 ' HB3' ' A' ' 53' ' ' LEU . 67.1 tp -60.78 -36.01 77.89 Favored 'General case' 0 CA--C 1.521 -0.147 0 CA-C-N 116.109 -0.496 . . . . 1.1899999999999999 110.482 179.589 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -49.23 -55.02 13.94 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.471 -0.786 . . . . 2.1099999999999999 111.018 173.534 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 64.5 tttm -67.95 -27.67 66.8 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.944 0.402 . . . . 2.7200000000000002 111.086 -178.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -66.08 -56.77 9.83 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.289 -0.414 . . . . 0.46000000000000002 110.112 178.541 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 96.2 mt -59.42 -38.39 80.5 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 115.959 -0.564 . . . . 0.68999999999999995 110.981 175.773 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -60.95 -38.58 86.39 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.937 -0.574 . . . . 1.3100000000000001 110.397 179.254 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 6.3 tt0 -62.86 -40.03 96.23 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.994 -0.548 . . . . 2.23 110.648 176.848 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.493 ' HD1' ' HZ ' ' A' ' 23' ' ' PHE . 3.7 t80 -67.86 -41.68 82.5 Favored 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 108.477 -0.935 . . . . 0.65000000000000002 108.477 179.813 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.718 ' HA ' ' CE2' ' A' ' 23' ' ' PHE . . . -55.2 -48.06 74.4 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.292 -0.867 . . . . 0.37 111.76 175.699 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.84 -25.1 67.31 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.242 -0.435 . . . . 0.64000000000000001 111.544 -179.364 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 74.0 t60 -64.43 -49.01 73.18 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.282 -0.417 . . . . 1.8500000000000001 111.602 -177.118 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.406 ' HB2' ' CD1' ' A' ' 23' ' ' PHE . 15.8 m -108.68 -11.24 15.1 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.584 -0.447 . . . . 1.6699999999999999 112.116 -175.896 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 75.78 58.06 3.92 Favored Glycine 0 CA--C 1.519 0.322 0 CA-C-N 115.932 -0.576 . . . . 0.62 113.564 177.066 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.718 ' CE2' ' HA ' ' A' ' 18' ' ' ALA . 10.6 p90 -117.97 169.85 9.31 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.968 0.384 . . . . 0.56999999999999995 111.028 178.524 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 13.3 m -92.18 118.18 30.59 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-O 121.201 0.524 . . . . 0.68000000000000005 112.226 -172.193 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.616 HD21 ' CE3' ' A' ' 69' ' ' TRP . 1.5 mm? -99.32 138.98 35.65 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.71 -0.677 . . . . 1.6699999999999999 110.742 175.056 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 44.4 m -125.41 100.74 6.63 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.075 0.464 . . . . 1.1499999999999999 110.197 177.144 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 5.9 p -145.67 135.32 17.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.737 -0.665 . . . . 0.90000000000000002 110.785 -177.865 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -98.98 129.01 45.25 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.076 -0.511 . . . . 2.3799999999999999 109.724 177.81 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -54.36 -23.79 16.91 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 113.877 1.065 . . . . 1.97 113.877 -172.098 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 85.4 p -66.42 -27.49 67.88 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.12 0.486 . . . . 2.2200000000000002 110.718 -175.278 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 96.7 mt -75.99 -47.13 26.13 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.551 -0.75 . . . . 1.3799999999999999 111.13 -177.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 3.5 t -99.31 40.78 1.19 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.621 0.724 . . . . 1.4399999999999999 110.706 -177.217 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.479 ' O ' ' HG3' ' A' ' 33' ' ' ARG . 8.6 ptp180 -63.25 105.89 0.8 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.656 -0.702 . . . . 4.6299999999999999 111.039 179.546 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 63.01 19.44 61.31 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 121.088 -0.577 . . . . 1.6200000000000001 112.377 179.656 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.637 ' HE3' ' HA ' ' A' ' 57' ' ' SER . 8.6 tptp -74.32 112.71 10.75 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.601 -0.518 . . . . 2.75 109.601 -177.149 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -103.87 156.65 17.66 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.731 0.301 . . . . 2.2400000000000002 110.479 -177.122 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.452 ' O ' ' HA ' ' A' ' 7' ' ' PRO . 46.7 t -128.62 130.27 47.05 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 107.222 -1.399 . . . . 1.02 107.222 172.657 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 8.0 m120 -63.96 -15.23 58.76 Favored 'General case' 0 C--N 1.322 -0.606 0 O-C-N 123.441 0.463 . . . . 1.28 112.086 -173.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 123.36 172.31 13.78 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.901 -0.666 . . . . 0.41999999999999998 112.159 172.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.411 ' HB3' ' HB ' ' A' ' 5' ' ' ILE . 31.4 tp -161.31 121.39 2.65 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.023 -0.732 . . . . 0.69999999999999996 109.023 -177.338 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 19.2 t-80 -143.85 99.28 3.38 Favored 'General case' 0 C--N 1.321 -0.664 0 C-N-CA 120.205 -0.598 . . . . 2.96 110.892 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -168.27 -169.54 31.86 Favored Glycine 0 N--CA 1.446 -0.656 0 CA-C-N 115.451 -0.795 . . . . 0.55000000000000004 111.917 178.252 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -78.35 85.98 4.45 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.518 -0.549 . . . . 2.1800000000000002 109.518 174.789 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 67.5 m-85 -119.53 122.57 41.93 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.289 0.566 . . . . 1.4099999999999999 111.628 -176.205 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -84.25 -174.49 5.31 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.278 -0.873 . . . . 2.23 108.798 173.758 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 47.3 t -51.88 -67.93 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 120.671 0.272 . . . . 0.56999999999999995 111.499 -177.319 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -55.11 -41.76 72.07 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 112.815 0.672 . . . . 2.3900000000000001 112.815 -176.105 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 22.1 m -71.69 -31.04 66.34 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.966 0.412 . . . . 1.26 111.34 -174.831 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.415 ' O ' ' HG ' ' A' ' 53' ' ' LEU . . . -71.82 -49.21 24.19 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.85 -0.691 . . . . 0.37 112.071 -175.705 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.441 ' O ' ' HG ' ' A' ' 54' ' ' LEU . 8.5 mp -65.57 -38.73 90.4 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 121.959 0.104 . . . . 1.0900000000000001 111.208 -178.248 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 58.1 tt0 -53.27 -52.99 57.25 Favored 'General case' 0 C--N 1.331 -0.218 0 O-C-N 123.222 0.326 . . . . 2.5899999999999999 111.752 179.743 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 12.5 mm100 -64.31 -41.9 96.62 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.882 0.373 . . . . 1.75 111.035 -177.808 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.623 ' HB3' HD11 ' A' ' 10' ' ' LEU . 88.0 mt -59.71 -21.48 60.71 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 115.905 -0.589 . . . . 0.72999999999999998 112.417 -179.796 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.643 HD21 HG12 ' A' ' 61' ' ' VAL . 65.0 mt -75.36 -14.52 60.48 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.032 0.382 . . . . 2.1600000000000001 112.032 -177.415 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -72.3 131.61 42.91 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.995 0.426 . . . . 2.2400000000000002 110.09 -177.345 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 101.72 -17.45 54.81 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.889 -0.672 . . . . 1.7 111.526 -175.838 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.637 ' HA ' ' HE3' ' A' ' 35' ' ' LYS . 4.3 m -102.55 160.07 14.89 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-O 120.733 0.302 . . . . 2.2799999999999998 110.203 178.501 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -107.27 35.75 4.83 Favored Glycine 0 N--CA 1.441 -0.984 0 N-CA-C 109.705 -1.358 . . . . 1.5800000000000001 109.705 171.018 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.637 ' HB3' HD21 ' A' ' 71' ' ' LEU . 50.7 mt -126.57 174.31 8.78 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.265 -0.642 . . . . 1.4199999999999999 109.265 -177.866 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 24.3 mt-30 -146.94 118.97 8.19 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.348 -0.612 . . . . 2.6699999999999999 109.348 179.733 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.643 HG12 HD21 ' A' ' 54' ' ' LEU . 7.6 p -86.65 130.36 36.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 N-CA-C 109.667 -0.494 . . . . 1.54 109.667 179.153 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 26.8 ttpp -131.53 131.73 23.05 Favored Pre-proline 0 N--CA 1.442 -0.834 0 N-CA-C 109.816 -0.438 . . . . 1.8100000000000001 109.816 -174.622 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -54.09 125.71 19.67 Favored 'Trans proline' 0 N--CA 1.463 -0.313 0 C-N-CA 122.418 2.079 . . . . 0.84999999999999998 111.088 177.433 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.556 ' HG ' ' HB ' ' A' ' 70' ' ' THR . 0.7 OUTLIER -74.03 -63.66 1.17 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.46 -0.791 . . . . 1.7 110.254 -173.856 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -155.48 -107.07 0.27 Allowed Glycine 0 N--CA 1.445 -0.74 0 C-N-CA 120.755 -0.736 . . . . 1.6899999999999999 111.961 177.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -80.81 94.55 6.45 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.571 0.225 . . . . 2.96 110.687 179.787 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . 0.591 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 2.8 t-20 58.08 39.6 26.06 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.404 0.621 . . . . 2.5 110.44 174.759 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.44 ' O ' ' HD1' ' A' ' 69' ' ' TRP . 15.2 p -135.82 169.13 18.06 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 109.457 -0.572 . . . . 1.3 109.457 179.235 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' TRP . . . . . 0.616 ' CE3' HD21 ' A' ' 25' ' ' LEU . 26.8 m0 -140.87 154.69 46.28 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 108.975 -0.75 . . . . 0.46999999999999997 108.975 -175.354 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.556 ' HB ' ' HG ' ' A' ' 64' ' ' LEU . 8.6 t -137.73 138.13 39.01 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 108.802 -0.814 . . . . 0.82999999999999996 108.802 175.002 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.637 HD21 ' HB3' ' A' ' 59' ' ' LEU . 6.5 tt -93.12 102.57 14.89 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.51 0.671 . . . . 1.71 109.799 -178.451 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.424 ' HA ' ' HD3' ' A' ' 73' ' ' PRO . 25.8 mm-40 -89.3 132.73 36.6 Favored Pre-proline 0 C--N 1.319 -0.738 0 CA-C-N 114.678 -1.146 . . . . 2.1299999999999999 111.248 178.649 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 72' ' ' GLU . 7.7 Cg_exo -73.15 115.15 4.25 Favored 'Trans proline' 0 N--CA 1.461 -0.392 0 C-N-CA 122.677 2.251 . . . . 1.3600000000000001 111.574 176.361 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.324 -0.532 0 CA-C-N 116.039 -0.528 . . . . 1.8899999999999999 109.758 -178.102 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 19.6 pt20 . . . . . 0 N--CA 1.45 -0.467 0 CA-C-O 121.327 0.584 . . . . 4.0 110.841 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.63 ' O ' ' HA ' ' A' ' 41' ' ' HIS . 36.2 t -101.59 131.7 48.92 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.938 0 CA-C-N 115.301 -0.863 . . . . 1.6399999999999999 108.859 174.492 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -129.48 109.49 11.09 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.229 0.537 . . . . 2.29 109.995 179.465 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.644 HD13 ' HB1' ' A' ' 13' ' ' ALA . 68.6 mt -131.02 127.06 60.58 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 115.932 -0.576 . . . . 0.81999999999999995 110.537 -177.199 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -76.18 159.7 79.69 Favored Pre-proline 0 N--CA 1.45 -0.459 0 CA-C-N 115.916 -0.584 . . . . 1.3799999999999999 109.657 177.446 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.587 ' HA ' ' O ' ' A' ' 37' ' ' SER . 44.7 Cg_endo -69.6 49.91 0.72 Allowed 'Trans proline' 0 CA--C 1.534 0.495 0 C-N-CA 122.915 2.41 . . . . 1.73 113.123 177.632 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -116.75 -150.06 9.25 Favored Glycine 0 C--O 1.226 -0.347 0 C-N-CA 121.241 -0.504 . . . . 1.8400000000000001 112.574 -178.703 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.583 ' HA ' ' O ' ' A' ' 35' ' ' LYS . 22.8 p -62.54 125.47 24.05 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.162 0.506 . . . . 1.6100000000000001 111.867 -176.294 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.804 ' HB3' ' HB3' ' A' ' 35' ' ' LYS . 70.3 tp -65.49 -32.4 73.98 Favored 'General case' 0 N--CA 1.456 -0.172 0 CA-C-N 115.64 -0.709 . . . . 1.1899999999999999 109.696 178.758 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.579 ' OD2' ' HB ' ' A' ' 32' ' ' THR . 10.6 m-20 -50.5 -53.89 26.52 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.19 -0.914 . . . . 2.1099999999999999 110.401 175.21 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -68.84 -26.66 65.27 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.772 -0.649 . . . . 2.7200000000000002 110.638 177.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.644 ' HB1' HD13 ' A' ' 5' ' ' ILE . . . -67.36 -53.07 32.73 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.988 -0.551 . . . . 0.46000000000000002 110.816 -178.85 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 87.2 mt -56.96 -43.73 81.88 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.116 -0.493 . . . . 0.68999999999999995 110.873 177.026 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 52.9 t30 -62.4 -32.55 73.39 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.831 -0.622 . . . . 1.3100000000000001 110.371 -179.64 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -62.16 -45.35 93.79 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.283 -0.417 . . . . 2.23 110.445 177.096 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 13.5 t80 -71.38 -41.36 69.78 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 109.65 -0.5 . . . . 0.65000000000000002 109.65 -178.78 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.709 ' HA ' ' CE2' ' A' ' 23' ' ' PHE . . . -53.37 -53.41 51.47 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 115.501 -0.772 . . . . 0.37 112.141 178.194 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -64.54 -26.2 68.31 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.311 -0.404 . . . . 0.64000000000000001 111.461 -178.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 70.5 t60 -64.8 -45.19 87.28 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.293 -0.412 . . . . 1.8500000000000001 111.298 -176.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.479 ' HB2' ' CE1' ' A' ' 23' ' ' PHE . 24.5 m -101.04 -7.02 23.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.269 0.557 . . . . 1.6699999999999999 111.594 -178.735 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 67.66 47.11 63.63 Favored Glycine 0 N--CA 1.449 -0.494 0 CA-C-N 115.309 -0.86 . . . . 0.62 114.023 176.791 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.709 ' CE2' ' HA ' ' A' ' 18' ' ' ALA . 5.9 p90 -109.21 160.73 15.87 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 117.389 0.595 . . . . 0.56999999999999995 110.624 175.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.447 ' O ' ' HB3' ' A' ' 68' ' ' SER . 25.0 m -88.14 119.82 28.9 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.431 0.634 . . . . 0.68000000000000005 112.529 -171.532 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.577 HD21 ' CE3' ' A' ' 69' ' ' TRP . 1.6 mm? -95.73 121.34 37.34 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.609 -0.723 . . . . 1.6699999999999999 111.174 176.617 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 18.9 m -104.35 93.32 4.75 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.67 -0.492 . . . . 1.1499999999999999 109.67 175.633 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.479 ' HB ' HD23 ' A' ' 71' ' ' LEU . 5.4 p -139.78 135.0 38.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.911 -0.586 . . . . 0.90000000000000002 111.456 -174.289 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -92.52 117.54 30.05 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.819 -0.628 . . . . 2.3799999999999999 110.085 175.221 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.48 76.67 0.01 OUTLIER 'General case' 0 C--O 1.232 0.165 0 CA-C-N 115.86 -0.609 . . . . 1.97 112.089 178.398 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 13.8 m -159.38 -50.31 0.06 Allowed 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 108.294 -1.002 . . . . 2.2200000000000002 108.294 179.542 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 87.5 mt -62.93 -44.0 97.27 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 108.771 -0.825 . . . . 1.3799999999999999 108.771 172.477 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.579 ' HB ' ' OD2' ' A' ' 11' ' ' ASP . 26.3 p -93.7 59.08 2.79 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-N 114.942 -1.026 . . . . 1.4399999999999999 110.273 175.518 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 9.7 tpt180 -102.4 112.04 24.59 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.881 -0.599 . . . . 4.6299999999999999 110.173 174.512 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 69.65 34.74 73.2 Favored Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 120.712 -0.756 . . . . 1.6200000000000001 112.596 176.37 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.804 ' HB3' ' HB3' ' A' ' 10' ' ' LEU . 13.2 mptt -81.13 140.56 34.96 Favored 'General case' 0 CA--C 1.511 -0.529 0 N-CA-C 109.478 -0.564 . . . . 2.75 109.478 176.666 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . 0.4 ' HA ' ' HA ' ' A' ' 9' ' ' SER . 49.1 mt-30 -138.17 134.18 34.22 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 109.944 -0.391 . . . . 2.2400000000000002 109.944 -179.764 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.587 ' O ' ' HA ' ' A' ' 7' ' ' PRO . 7.8 t -124.34 134.13 53.25 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.278 -0.638 . . . . 1.02 109.278 -178.584 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.442 ' N ' HD22 ' A' ' 38' ' ' ASN . 0.9 OUTLIER -60.08 -14.88 18.94 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 112.716 0.636 . . . . 1.28 112.716 -178.332 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 132.05 178.66 15.63 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.248 -0.977 . . . . 0.41999999999999998 113.008 170.829 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.502 HD23 HG11 ' A' ' 3' ' ' VAL . 48.4 tp -160.44 122.01 3.1 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 108.135 -1.061 . . . . 0.69999999999999996 108.135 -179.135 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' HIS . . . . . 0.63 ' HA ' ' O ' ' A' ' 3' ' ' VAL . 39.7 t-80 -145.37 99.84 3.36 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.213 -0.595 . . . . 2.96 111.972 179.215 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -169.37 178.14 42.63 Favored Glycine 0 N--CA 1.443 -0.892 0 N-CA-C 110.969 -0.852 . . . . 0.55000000000000004 110.969 174.483 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -82.39 113.06 19.9 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 108.12 -1.067 . . . . 2.1800000000000002 108.12 169.031 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 50.5 m-85 -128.89 131.13 47.58 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.074 0.464 . . . . 1.4099999999999999 111.888 -173.501 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -66.15 160.37 24.24 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.256 -0.884 . . . . 2.23 109.219 169.288 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 47.2 t -49.03 -61.22 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 O-C-N 123.507 0.504 . . . . 0.56999999999999995 111.502 -174.609 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.683 ' HA ' HD23 ' A' ' 50' ' ' LEU . 46.5 mt-10 -64.24 -40.18 95.48 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.256 -0.429 . . . . 2.3900000000000001 111.695 -178.398 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 28.1 t -71.07 -30.4 66.53 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-O 120.892 0.377 . . . . 1.26 111.428 -170.81 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -81.18 -32.11 32.68 Favored Glycine 0 N--CA 1.447 -0.615 0 C-N-CA 120.531 -0.842 . . . . 0.37 111.526 -177.136 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.683 HD23 ' HA ' ' A' ' 47' ' ' GLU . 0.3 OUTLIER -80.59 -41.14 24.5 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 109.539 -0.541 . . . . 1.0900000000000001 109.539 -178.198 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . 0.576 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 54.3 tt0 -53.95 -39.23 65.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.735 -0.666 . . . . 2.5899999999999999 111.768 174.451 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 8.5 tp-100 -63.07 -46.64 86.48 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.377 -0.374 . . . . 1.75 110.133 178.885 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.475 ' HB3' HD11 ' A' ' 10' ' ' LEU . 95.8 mt -58.39 -21.71 51.34 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 115.803 -0.635 . . . . 0.72999999999999998 112.344 178.375 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.41 ' HG ' ' O ' ' A' ' 50' ' ' LEU . 87.2 mt -73.88 -24.71 59.76 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-O 120.685 0.278 . . . . 2.1600000000000001 111.611 -178.036 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -73.5 113.55 10.73 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.115 0.483 . . . . 2.2400000000000002 110.77 -176.693 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 127.67 -12.96 6.54 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.807 -0.711 . . . . 1.7 111.846 -179.05 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 70.6 p -118.12 175.1 5.84 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 110.005 -0.368 . . . . 2.2799999999999998 110.005 179.041 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -113.13 33.25 5.67 Favored Glycine 0 N--CA 1.448 -0.541 0 N-CA-C 111.271 -0.732 . . . . 1.5800000000000001 111.271 179.251 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 85.1 mt -119.99 179.31 4.3 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 108.872 -0.788 . . . . 1.4199999999999999 108.872 178.829 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -149.87 119.11 6.8 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.091 0.472 . . . . 2.6699999999999999 109.925 178.478 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 59.9 t -92.92 126.58 45.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 N-CA-C 109.08 -0.711 . . . . 1.54 109.08 176.547 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.487 ' HE2' ' HB2' ' A' ' 72' ' ' GLU . 50.9 mtmt -126.17 134.35 25.87 Favored Pre-proline 0 C--N 1.319 -0.751 0 N-CA-C 109.509 -0.552 . . . . 1.8100000000000001 109.509 -177.812 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.475 ' HA ' ' O ' ' A' ' 68' ' ' SER . 47.8 Cg_exo -56.32 117.86 4.58 Favored 'Trans proline' 0 N--CA 1.459 -0.557 0 C-N-CA 122.232 1.955 . . . . 0.84999999999999998 110.825 173.679 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 55.6 tp -58.07 -42.41 85.48 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 114.917 -1.038 . . . . 1.7 112.079 -171.13 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -179.64 -86.64 0.07 OUTLIER Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 120.553 -0.832 . . . . 1.6899999999999999 112.287 179.744 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 50.3 t30 -61.18 -76.03 0.06 Allowed 'General case' 0 C--N 1.33 -0.265 0 O-C-N 123.52 0.188 . . . . 2.96 111.138 -179.344 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 66.5 t30 -155.93 53.14 0.57 Allowed 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 121.662 0.744 . . . . 2.5 109.626 178.738 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.475 ' O ' ' HA ' ' A' ' 63' ' ' PRO . 10.8 m -138.11 178.79 6.86 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 107.883 -1.154 . . . . 1.3 107.883 -179.328 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' TRP . . . . . 0.577 ' CE3' HD21 ' A' ' 25' ' ' LEU . 51.5 m0 -136.52 157.1 47.57 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.114 -0.698 . . . . 0.46999999999999997 109.114 -176.364 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 13.8 t -142.6 147.81 36.45 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.752 0.311 . . . . 0.82999999999999996 110.236 176.072 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.479 HD23 ' HB ' ' A' ' 27' ' ' VAL . 3.9 mm? -93.41 102.95 15.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.167 0.508 . . . . 1.71 111.253 179.457 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.487 ' HB2' ' HE2' ' A' ' 62' ' ' LYS . 17.8 mt-10 -106.25 131.42 21.74 Favored Pre-proline 0 C--N 1.32 -0.715 0 CA-C-N 115.328 -0.851 . . . . 2.1299999999999999 111.182 172.538 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.455 ' HD3' ' HA ' ' A' ' 72' ' ' GLU . 24.0 Cg_exo -64.01 114.78 2.77 Favored 'Trans proline' 0 N--CA 1.456 -0.708 0 C-N-CA 122.249 1.966 . . . . 1.3600000000000001 111.274 176.193 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.318 -0.77 0 CA-C-N 115.41 -0.814 . . . . 1.8899999999999999 108.865 175.105 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . 0.663 ' HA ' ' HA ' ' A' ' 43' ' ' ASP . 8.0 tp-100 . . . . . 0 N--CA 1.466 0.346 0 CA-C-O 122.01 0.91 . . . . 4.0 111.69 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 60.3 t -101.43 131.44 49.22 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 CA-C-N 114.437 -1.256 . . . . 1.6399999999999999 108.724 178.586 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 50.6 m-80 -123.41 99.54 6.38 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.069 0.462 . . . . 2.29 110.114 -173.592 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.477 ' HB ' ' H ' ' A' ' 40' ' ' LEU . 30.2 mt -130.49 160.29 41.77 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 N-CA-C 108.766 -0.828 . . . . 0.81999999999999995 108.766 179.48 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.7 ' HB1' ' HD2' ' A' ' 7' ' ' PRO . . . -164.6 172.87 4.31 Favored Pre-proline 0 C--N 1.323 -0.555 0 CA-C-O 118.815 -0.612 . . . . 1.3799999999999999 109.448 -176.958 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.7 ' HD2' ' HB1' ' A' ' 6' ' ' ALA . 33.7 Cg_exo -36.97 130.49 0.49 Allowed 'Trans proline' 0 C--N 1.357 1.006 0 C-N-CA 123.297 2.665 . . . . 1.73 113.685 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 155.57 -177.16 32.87 Favored Glycine 0 N--CA 1.444 -0.767 0 N-CA-C 110.982 -0.847 . . . . 1.8400000000000001 110.982 -177.886 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.588 ' HA ' ' O ' ' A' ' 35' ' ' LYS . 19.6 m -68.32 133.68 49.12 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 110.068 -0.345 . . . . 1.6100000000000001 110.068 178.926 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 59.9 tp -58.8 -32.32 69.24 Favored 'General case' 0 C--O 1.23 0.071 0 CA-C-O 120.989 0.423 . . . . 1.1899999999999999 110.727 179.58 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -49.64 -46.65 49.76 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.436 -0.802 . . . . 2.1099999999999999 110.559 172.871 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 5.1 tmtm? -64.37 -35.03 79.55 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.658 -0.701 . . . . 2.7200000000000002 110.066 -178.246 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -65.26 -59.41 4.1 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.155 -0.475 . . . . 0.46000000000000002 110.961 -176.746 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 94.0 mt -59.61 -39.07 83.03 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.097 -0.501 . . . . 0.68999999999999995 111.232 178.142 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 47.2 t30 -60.99 -38.39 85.84 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.966 0.412 . . . . 1.3100000000000001 110.052 178.311 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.445 HE21 ' HB3' ' A' ' 16' ' ' GLN . 0.9 OUTLIER -61.6 -44.05 97.73 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.974 -0.557 . . . . 2.23 110.663 177.054 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.417 ' CD1' ' HH2' ' A' ' 69' ' ' TRP . 3.9 t80 -68.53 -43.51 76.58 Favored 'General case' 0 N--CA 1.457 -0.106 0 N-CA-C 109.24 -0.652 . . . . 0.65000000000000002 109.24 -179.503 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.692 ' HA ' ' CZ ' ' A' ' 23' ' ' PHE . . . -54.55 -49.16 70.96 Favored 'General case' 0 C--N 1.333 -0.109 0 CA-C-N 115.619 -0.719 . . . . 0.37 111.546 176.923 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -64.92 -24.98 67.69 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.403 -0.362 . . . . 0.64000000000000001 111.515 -179.488 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 56.1 t60 -60.99 -50.95 71.29 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.342 -0.39 . . . . 1.8500000000000001 111.305 -177.567 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.564 ' HB2' ' CD1' ' A' ' 23' ' ' PHE . 15.7 m -108.11 -1.5 20.33 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.993 0.425 . . . . 1.6699999999999999 111.783 -177.245 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 62.24 46.62 93.56 Favored Glycine 0 C--N 1.332 0.339 0 CA-C-N 115.595 -0.729 . . . . 0.62 113.699 174.497 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.692 ' CZ ' ' HA ' ' A' ' 18' ' ' ALA . 14.4 p90 -105.12 172.79 6.6 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.842 0.321 . . . . 0.56999999999999995 110.568 -179.419 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 47.6 m -91.71 106.19 18.29 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.34 0.59 . . . . 0.68000000000000005 111.41 -179.514 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 3.6 tt -92.98 123.03 35.94 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.017 -0.735 . . . . 1.6699999999999999 109.017 175.633 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.407 ' O ' ' HA ' ' A' ' 70' ' ' THR . 33.4 t -101.04 101.11 11.81 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.172 0.51 . . . . 1.1499999999999999 110.064 -176.552 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.2 p -141.22 135.14 31.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.729 -0.669 . . . . 0.90000000000000002 110.444 -179.898 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -81.83 123.3 28.68 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.857 -0.611 . . . . 2.3799999999999999 110.406 177.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.14 82.77 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.805 -0.634 . . . . 1.97 111.954 178.893 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.526 ' HA ' ' NE ' ' A' ' 33' ' ' ARG . 55.5 p -172.44 -45.4 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.289 -0.414 . . . . 2.2200000000000002 110.053 -179.706 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 93.5 mt -62.09 -44.61 96.3 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.584 -0.734 . . . . 1.3799999999999999 112.227 -174.386 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.461 ' O ' ' HB2' ' A' ' 35' ' ' LYS . 30.0 p -97.86 2.55 49.4 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 112.206 0.447 . . . . 1.4399999999999999 112.206 -176.265 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . 0.526 ' NE ' ' HA ' ' A' ' 30' ' ' SER . 64.6 mtm180 -58.55 121.66 11.5 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-O 120.581 0.229 . . . . 4.6299999999999999 111.442 -178.408 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 81.3 11.71 83.06 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 121.056 -0.593 . . . . 1.6200000000000001 112.781 175.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.588 ' O ' ' HA ' ' A' ' 9' ' ' SER . 12.8 mptt -85.08 151.01 24.46 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.872 0.368 . . . . 2.75 110.817 -179.763 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 32.1 mm-40 -131.46 138.3 48.97 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 108.437 -0.949 . . . . 2.2400000000000002 108.437 178.667 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.501 ' O ' ' HA ' ' A' ' 7' ' ' PRO . 34.6 t -131.6 141.66 49.71 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 109.186 -0.672 . . . . 1.02 109.186 179.236 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -77.1 -2.36 33.82 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.431 -0.349 . . . . 1.28 111.65 178.062 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.472 ' HA2' HG22 ' A' ' 5' ' ' ILE . . . 98.02 -169.63 24.29 Favored Glycine 0 N--CA 1.445 -0.754 0 C-N-CA 120.421 -0.895 . . . . 0.41999999999999998 113.619 170.714 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.477 ' H ' ' HB ' ' A' ' 5' ' ' ILE . 54.8 tp -160.23 140.41 11.54 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 107.537 -1.283 . . . . 0.69999999999999996 107.537 -179.28 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 17.4 t60 -144.52 99.54 3.38 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 120.195 -0.602 . . . . 2.96 111.241 -178.185 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -169.48 170.69 42.81 Favored Glycine 0 N--CA 1.448 -0.518 0 N-CA-C 110.547 -1.021 . . . . 0.55000000000000004 110.547 175.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.663 ' HA ' ' HA ' ' A' ' 2' ' ' GLN . 44.2 t0 -86.0 91.77 8.49 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 108.607 -0.886 . . . . 2.1800000000000002 108.607 175.84 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 25.6 m-85 -107.4 138.01 44.38 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.555 -0.748 . . . . 1.4099999999999999 112.173 -170.131 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -75.33 165.56 24.97 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 108.449 -0.945 . . . . 2.23 108.449 169.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.484 HG13 ' HZ2' ' A' ' 69' ' ' TRP . 61.2 t -50.44 -70.31 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 112.356 0.502 . . . . 0.56999999999999995 112.356 -174.383 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -61.33 -42.19 98.26 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 112.285 0.476 . . . . 2.3900000000000001 112.285 -172.465 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 34.9 t -70.18 -26.21 63.8 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.878 0.37 . . . . 1.26 110.524 -175.221 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.447 ' O ' ' HG ' ' A' ' 53' ' ' LEU . . . -77.24 -36.08 35.96 Favored Glycine 0 N--CA 1.444 -0.826 0 N-CA-C 110.956 -0.858 . . . . 0.37 110.956 -179.664 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.677 ' HB3' HG13 ' A' ' 61' ' ' VAL . 92.8 mt -72.69 -43.62 62.83 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.76 0.314 . . . . 1.0900000000000001 110.628 -179.38 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 57.0 tp60 -52.96 -50.06 64.86 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.837 -0.62 . . . . 2.5899999999999999 111.575 178.902 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.458 ' HA ' ' OE1' ' A' ' 52' ' ' GLN . 12.8 mm-40 -65.86 -37.13 85.36 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.524 -0.307 . . . . 1.75 111.458 -178.039 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.447 ' HG ' ' O ' ' A' ' 49' ' ' GLY . 66.1 mt -57.88 -39.86 78.85 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.176 0.436 . . . . 0.72999999999999998 112.176 179.327 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.473 HD12 HG12 ' A' ' 61' ' ' VAL . 45.2 mt -105.39 16.84 24.93 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.257 0.466 . . . . 2.1600000000000001 112.257 -174.856 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -68.15 94.58 0.52 Allowed 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 120.993 0.425 . . . . 2.2400000000000002 111.188 -179.895 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 109.57 -7.01 31.8 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.919 -0.658 . . . . 1.7 113.565 176.621 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 60.4 p -83.72 -1.54 54.33 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 117.357 0.579 . . . . 2.2799999999999998 111.705 -175.755 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 76.57 17.67 79.71 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.764 -0.732 . . . . 1.5800000000000001 112.118 -179.739 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 96.7 mt -124.96 168.57 13.13 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.516 -0.342 . . . . 1.4199999999999999 110.091 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 33.7 tt0 -150.69 118.64 6.24 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.18 -0.674 . . . . 2.6699999999999999 109.18 175.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.677 HG13 ' HB3' ' A' ' 50' ' ' LEU . 7.2 p -109.73 129.67 64.2 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 N-CA-C 109.998 -0.371 . . . . 1.54 109.998 179.425 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 24.0 pttm -148.47 156.53 42.3 Favored Pre-proline 0 C--N 1.322 -0.628 0 N-CA-C 109.884 -0.413 . . . . 1.8100000000000001 109.884 -177.126 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.615 ' HA ' ' HA ' ' A' ' 69' ' ' TRP . 25.7 Cg_exo -63.93 148.17 91.77 Favored 'Trans proline' 0 N--CA 1.461 -0.392 0 C-N-CA 122.716 2.277 . . . . 0.84999999999999998 111.904 176.706 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.498 HD21 ' HB ' ' A' ' 70' ' ' THR . 82.0 mt -65.68 -27.39 68.31 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.595 -0.73 . . . . 1.7 110.659 179.363 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 152.0 -19.95 0.86 Allowed Glycine 0 N--CA 1.451 -0.361 0 N-CA-C 109.674 -1.371 . . . . 1.6899999999999999 109.674 -178.63 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 5.6 p30 -128.21 -157.87 0.84 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 114.414 -0.893 . . . . 2.96 109.314 174.865 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -77.07 45.48 0.44 Allowed 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 121.188 0.518 . . . . 2.5 112.158 -176.918 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.401 ' O ' ' HA ' ' A' ' 63' ' ' PRO . 19.5 m -141.51 165.54 27.22 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 107.391 -1.337 . . . . 1.3 107.391 172.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' TRP . . . . . 0.615 ' HA ' ' HA ' ' A' ' 63' ' ' PRO . 52.8 m0 -133.83 166.81 21.81 Favored 'General case' 0 C--N 1.32 -0.716 0 C-N-CA 120.487 -0.485 . . . . 0.46999999999999997 110.817 -166.38 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.498 ' HB ' HD21 ' A' ' 64' ' ' LEU . 8.9 t -146.49 143.98 29.32 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.419 -0.585 . . . . 0.82999999999999996 109.419 171.782 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 35.9 tp -93.08 100.95 13.27 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-O 121.662 0.744 . . . . 1.71 109.26 176.153 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -94.75 130.29 33.63 Favored Pre-proline 0 C--N 1.316 -0.863 0 CA-C-N 114.838 -1.073 . . . . 2.1299999999999999 111.267 -177.34 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_exo -69.98 113.37 3.39 Favored 'Trans proline' 0 N--CA 1.451 -0.995 0 C-N-CA 121.535 1.49 . . . . 1.3600000000000001 110.714 174.153 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.321 -0.663 0 CA-C-N 115.665 -0.698 . . . . 1.8899999999999999 109.192 179.572 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 19.6 pm0 . . . . . 0 N--CA 1.452 -0.362 0 CA-C-O 121.139 0.495 . . . . 4.0 110.582 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 12.4 p -149.19 156.08 7.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 115.589 -0.732 . . . . 1.6399999999999999 109.302 -179.358 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 -127.26 108.9 11.28 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.93 0.395 . . . . 2.29 109.978 -178.449 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 60.8 mt -131.16 151.18 35.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 N-CA-C 108.89 -0.781 . . . . 0.81999999999999995 108.89 -179.871 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.696 ' HB1' ' HD2' ' A' ' 7' ' ' PRO . . . -162.17 174.1 3.96 Favored Pre-proline 0 C--N 1.322 -0.625 0 CA-C-O 118.436 -0.792 . . . . 1.3799999999999999 108.956 -173.689 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.696 ' HD2' ' HB1' ' A' ' 6' ' ' ALA . 47.5 Cg_exo -38.48 135.53 0.71 Allowed 'Trans proline' 0 C--N 1.361 1.235 0 C-N-CA 123.227 2.618 . . . . 1.73 113.707 -176.264 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 153.13 168.59 17.23 Favored Glycine 0 N--CA 1.446 -0.686 0 N-CA-C 110.401 -1.08 . . . . 1.8400000000000001 110.401 -173.908 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.422 ' HA ' ' HA ' ' A' ' 36' ' ' GLN . 4.7 t -67.74 138.11 55.98 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.619 -0.511 . . . . 1.6100000000000001 109.619 -178.736 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 59.9 tp -58.12 -36.79 73.44 Favored 'General case' 0 CA--C 1.523 -0.083 0 CA-C-N 115.349 -0.841 . . . . 1.1899999999999999 111.649 -173.222 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -54.59 -50.58 67.68 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.186 -0.461 . . . . 2.1099999999999999 111.154 176.049 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . 0.662 ' O ' ' HG3' ' A' ' 16' ' ' GLN . 41.0 tttm -64.0 -35.43 80.69 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.473 0.178 . . . . 2.7200000000000002 110.591 177.003 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.42 -52.56 63.08 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.829 0.347 . . . . 0.46000000000000002 110.132 -178.484 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.629 ' HB3' HD11 ' A' ' 25' ' ' LEU . 77.5 mt -57.27 -38.52 74.02 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.779 -0.646 . . . . 0.68999999999999995 110.899 174.324 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 17.9 t-20 -61.03 -37.75 83.69 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.107 -0.497 . . . . 1.3100000000000001 111.06 179.336 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.662 ' HG3' ' O ' ' A' ' 12' ' ' LYS . 18.6 mt-30 -62.3 -40.05 95.01 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.758 -0.201 . . . . 2.23 110.587 178.199 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.44 ' O ' ' HB3' ' A' ' 20' ' ' HIS . 5.0 t80 -68.38 -43.77 76.61 Favored 'General case' 0 CA--C 1.52 -0.196 0 CA-C-O 121.636 0.731 . . . . 0.65000000000000002 109.169 177.433 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.684 ' HA ' ' CZ ' ' A' ' 23' ' ' PHE . . . -52.44 -46.22 66.34 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 114.707 -1.133 . . . . 0.37 111.317 176.521 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -64.52 -29.06 70.1 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.146 -0.479 . . . . 0.64000000000000001 111.392 179.013 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . 0.44 ' HB3' ' O ' ' A' ' 17' ' ' TYR . 84.9 t60 -61.1 -55.06 36.94 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.056 -0.52 . . . . 1.8500000000000001 111.51 -177.234 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.456 ' HB2' ' CD1' ' A' ' 23' ' ' PHE . 38.8 m -100.23 -9.21 22.66 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 112.134 0.42 . . . . 1.6699999999999999 112.134 -177.456 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 69.42 55.67 9.79 Favored Glycine 0 N--CA 1.452 -0.286 0 CA-C-N 115.808 -0.633 . . . . 0.62 113.405 178.914 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.684 ' CZ ' ' HA ' ' A' ' 18' ' ' ALA . 15.5 p90 -112.67 166.54 11.25 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.77 0.319 . . . . 0.56999999999999995 110.455 176.858 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 21.0 m -89.31 113.41 24.68 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.187 0.518 . . . . 0.68000000000000005 111.012 -177.403 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.629 HD11 ' HB3' ' A' ' 14' ' ' LEU . 1.9 tt -99.91 136.7 39.42 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.384 -0.825 . . . . 1.6699999999999999 109.588 179.002 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.67 ' HB2' ' HA ' ' A' ' 70' ' ' THR . 48.5 m -100.64 97.22 7.92 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 109.692 -0.484 . . . . 1.1499999999999999 109.692 175.809 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.487 ' HB ' HD22 ' A' ' 25' ' ' LEU . 12.6 p -145.36 150.33 15.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.353 -0.385 . . . . 0.90000000000000002 110.136 -177.505 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -130.42 122.82 28.48 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.402 -0.363 . . . . 2.3799999999999999 110.448 -179.921 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.17 67.7 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.375 0 O-C-N 123.855 0.722 . . . . 1.97 112.286 177.433 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 30.2 t -170.62 -34.48 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.518 -0.549 . . . . 2.2200000000000002 109.518 178.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 90.9 mt -69.13 -36.87 77.94 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.102 -0.499 . . . . 1.3799999999999999 110.338 178.119 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 8.9 p -93.7 36.85 1.08 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.952 -0.567 . . . . 1.4399999999999999 111.358 -179.822 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.49 105.92 2.38 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.914 0.388 . . . . 4.6299999999999999 110.381 -176.579 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 87.62 17.37 58.54 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.835 -0.697 . . . . 1.6200000000000001 112.062 -179.259 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.61 93.28 4.68 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.702 0.286 . . . . 2.75 110.249 179.735 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . 0.422 ' HA ' ' HA ' ' A' ' 9' ' ' SER . 49.0 mt-30 -102.69 158.09 16.49 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 110.249 -0.278 . . . . 2.2400000000000002 110.249 179.529 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 32.9 t -127.2 135.56 50.82 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 108.736 -0.838 . . . . 1.02 108.736 178.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.416 ' N ' HD22 ' A' ' 38' ' ' ASN . 0.9 OUTLIER -67.51 -12.87 61.36 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 113.231 0.826 . . . . 1.28 113.231 -175.499 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.407 ' HA3' ' HA ' ' A' ' 6' ' ' ALA . . . 125.13 174.83 14.06 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.028 -1.082 . . . . 0.41999999999999998 114.034 170.903 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 57.0 tp -161.25 120.2 2.5 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 108.238 -1.023 . . . . 0.69999999999999996 108.238 -176.239 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 11.7 p80 -144.28 99.39 3.37 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 119.808 -0.757 . . . . 2.96 111.519 -179.786 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -169.01 -177.84 40.05 Favored Glycine 0 N--CA 1.443 -0.868 0 CA-C-N 115.158 -0.928 . . . . 0.55000000000000004 111.131 177.833 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -88.87 77.02 7.84 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 108.897 -0.779 . . . . 2.1800000000000002 108.897 172.269 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 28.9 m-85 -98.26 129.59 44.98 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.766 -0.652 . . . . 1.4099999999999999 111.68 -173.138 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 32.4 t0 -70.55 162.56 28.62 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.308 -0.86 . . . . 2.23 109.047 173.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 46.4 t -47.92 -64.83 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 112.285 0.476 . . . . 0.56999999999999995 112.285 -172.54 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 40.9 mm-40 -56.81 -36.55 70.05 Favored 'General case' 0 N--CA 1.464 0.242 0 N-CA-C 111.773 0.286 . . . . 2.3900000000000001 111.773 -176.749 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 15.3 m -71.74 -33.67 68.89 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-O 120.97 0.414 . . . . 1.26 110.773 -174.684 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -67.75 -46.84 65.0 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.955 -0.64 . . . . 0.37 112.339 -175.192 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.572 HD11 ' CZ2' ' A' ' 69' ' ' TRP . 7.1 mp -68.9 -37.26 78.87 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 110.486 -0.19 . . . . 1.0900000000000001 110.486 -178.225 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -54.82 -45.86 74.49 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.433 -0.348 . . . . 2.5899999999999999 111.009 178.266 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 -65.66 -46.85 77.59 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.254 -0.43 . . . . 1.75 110.989 179.102 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 88.7 mt -57.14 -29.63 63.75 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 112.29 0.478 . . . . 0.72999999999999998 112.29 -178.826 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.487 ' HG ' ' O ' ' A' ' 50' ' ' LEU . 95.0 mt -77.84 -7.32 56.5 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 112.079 0.4 . . . . 2.1600000000000001 112.079 -176.839 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -66.72 93.87 0.27 Allowed 'General case' 0 C--O 1.233 0.207 0 CA-C-O 121.45 0.643 . . . . 2.2400000000000002 110.973 -178.703 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 136.73 -25.33 3.1 Favored Glycine 0 N--CA 1.444 -0.8 0 C-N-CA 120.835 -0.698 . . . . 1.7 112.162 -178.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 33.3 p -97.82 171.02 8.57 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 110.031 -0.359 . . . . 2.2799999999999998 110.031 177.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -111.21 -15.77 10.28 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.846 -0.693 . . . . 1.5800000000000001 112.103 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 2.1 pp -90.49 -178.16 5.25 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.788 -0.449 . . . . 1.4199999999999999 109.788 178.255 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 94.6 mt-30 -143.08 120.66 11.76 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 118.365 0.53 . . . . 2.6699999999999999 110.231 -167.493 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.475 HG21 HD11 ' A' ' 14' ' ' LEU . 21.6 t -97.38 128.25 48.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 N-CA-C 109.027 -0.731 . . . . 1.54 109.027 175.907 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 25.0 pttm -146.85 154.16 47.04 Favored Pre-proline 0 C--N 1.329 -0.312 0 C-N-CA 120.5 -0.48 . . . . 1.8100000000000001 111.299 -178.777 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.64 ' HA ' ' HA ' ' A' ' 69' ' ' TRP . 42.9 Cg_exo -58.57 133.7 56.14 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.984 2.456 . . . . 0.84999999999999998 111.864 173.467 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 54.4 tp -67.62 -29.15 68.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.473 -0.785 . . . . 1.7 111.141 -175.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 166.44 -56.26 0.24 Allowed Glycine 0 N--CA 1.45 -0.427 0 N-CA-C 110.972 -0.851 . . . . 1.6899999999999999 110.972 179.396 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 13.5 m120 -83.93 -164.48 0.93 Allowed 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 108.438 -0.949 . . . . 2.96 108.438 172.815 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 9.0 t30 -78.61 58.99 2.36 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.814 0.816 . . . . 2.5 109.904 177.291 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.467 ' O ' ' HA ' ' A' ' 63' ' ' PRO . 30.9 m -147.89 174.68 11.62 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 107.725 -1.213 . . . . 1.3 107.725 176.259 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' TRP . . . . . 0.64 ' HA ' ' HA ' ' A' ' 63' ' ' PRO . 53.7 m0 -137.8 166.5 23.84 Favored 'General case' 0 C--N 1.322 -0.603 0 C-N-CA 120.323 -0.551 . . . . 0.46999999999999997 110.601 -165.32 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.67 ' HA ' ' HB2' ' A' ' 26' ' ' SER . 12.3 t -146.81 150.2 34.82 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.108 -0.496 . . . . 0.82999999999999996 109.76 173.424 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 54.9 tp -92.95 104.82 17.02 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-O 121.813 0.816 . . . . 1.71 110.491 179.198 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.402 ' HA ' ' HD3' ' A' ' 73' ' ' PRO . 22.0 tt0 -91.3 118.89 68.74 Favored Pre-proline 0 C--N 1.316 -0.888 0 CA-C-N 114.185 -1.371 . . . . 2.1299999999999999 111.526 179.482 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 72' ' ' GLU . 1.2 Cg_endo -84.65 115.18 1.8 Allowed 'Trans proline' 0 N--CA 1.452 -0.942 0 C-N-CA 122.874 2.383 . . . . 1.3600000000000001 111.658 174.792 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.324 -0.504 0 CA-C-N 115.742 -0.663 . . . . 1.8899999999999999 109.308 177.011 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 . . . . . 0 N--CA 1.455 -0.192 0 CA-C-O 121.128 0.49 . . . . 4.0 110.742 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.457 HG12 HG12 ' A' ' 5' ' ' ILE . 62.8 t -127.42 136.3 60.93 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 115.433 -0.803 . . . . 1.6399999999999999 109.349 179.617 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 17.7 m120 -127.96 97.86 4.94 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.453 -0.573 . . . . 2.29 109.453 -174.625 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.624 HG13 HD21 ' A' ' 53' ' ' LEU . 43.0 mm -122.93 155.91 28.48 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 N-CA-C 109.33 -0.619 . . . . 0.81999999999999995 109.33 -178.515 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.648 ' HB1' ' HD2' ' A' ' 7' ' ' PRO . . . -162.43 163.41 18.34 Favored Pre-proline 0 C--N 1.325 -0.492 0 N-CA-C 109.27 -0.641 . . . . 1.3799999999999999 109.27 -176.781 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.648 ' HD2' ' HB1' ' A' ' 6' ' ' ALA . 9.4 Cg_endo -51.96 130.56 35.11 Favored 'Trans proline' 0 C--N 1.35 0.649 0 C-N-CA 122.831 2.354 . . . . 1.73 112.755 -175.33 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 163.15 42.81 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.408 0 CA-C-N 115.67 -0.695 . . . . 1.8400000000000001 112.441 -178.111 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.79 ' HA ' ' HA ' ' A' ' 36' ' ' GLN . 65.1 m 66.44 131.49 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 121.496 0.665 . . . . 1.6100000000000001 111.691 -178.706 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 64.1 tp -60.02 -35.4 74.99 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 115.924 -0.58 . . . . 1.1899999999999999 111.031 -178.493 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -50.6 -54.12 25.24 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 115.583 -0.735 . . . . 2.1099999999999999 111.589 177.372 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 85.3 tttt -66.78 -32.01 73.02 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.693 -0.23 . . . . 2.7200000000000002 110.755 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -63.29 -53.36 54.01 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.932 0.396 . . . . 0.46000000000000002 110.548 -176.206 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 88.6 mt -58.98 -39.51 81.99 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 115.988 -0.551 . . . . 0.68999999999999995 111.021 176.517 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 52.4 t30 -60.86 -39.7 90.13 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.209 -0.45 . . . . 1.3100000000000001 110.703 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 -58.85 -51.11 71.42 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.044 -0.525 . . . . 2.23 111.421 177.843 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.477 ' CD1' ' HH2' ' A' ' 69' ' ' TRP . 32.4 t80 -67.26 -38.43 85.1 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.038 -0.727 . . . . 0.65000000000000002 109.038 -175.739 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.835 ' HA ' ' CE2' ' A' ' 23' ' ' PHE . . . -55.7 -49.99 71.52 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 115.532 -0.758 . . . . 0.37 111.955 174.913 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.94 -23.64 67.42 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.211 -0.449 . . . . 0.64000000000000001 111.588 -178.319 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 75.0 t60 -61.71 -48.06 82.45 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.027 -0.533 . . . . 1.8500000000000001 111.498 -176.346 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.578 ' HB3' ' CD1' ' A' ' 23' ' ' PHE . 38.9 t -102.37 -4.5 25.44 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.882 0.372 . . . . 1.6699999999999999 111.114 -179.691 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 68.3 47.02 60.72 Favored Glycine 0 CA--C 1.518 0.23 0 CA-C-N 115.702 -0.681 . . . . 0.62 113.622 177.864 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.835 ' CE2' ' HA ' ' A' ' 18' ' ' ALA . 10.3 p90 -106.65 159.66 16.04 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 122.538 -0.39 . . . . 0.56999999999999995 110.294 176.9 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 22.4 m -88.28 119.5 28.75 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.943 -0.571 . . . . 0.68000000000000005 111.91 -173.443 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.629 HD21 ' CE3' ' A' ' 69' ' ' TRP . 0.8 OUTLIER -94.8 143.88 26.1 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.636 -0.711 . . . . 1.6699999999999999 111.278 178.351 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 36.2 t -115.53 92.15 3.83 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.114 -0.698 . . . . 1.1499999999999999 109.114 173.035 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 6.9 p -148.64 125.54 2.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 115.903 -0.59 . . . . 0.90000000000000002 110.0 -178.605 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -88.37 134.76 33.74 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 120.831 -0.347 . . . . 2.3799999999999999 110.634 -177.776 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.7 70.67 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.255 0 O-C-N 124.043 0.839 . . . . 1.97 112.095 176.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 79.4 p -168.64 -42.96 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.478 -0.564 . . . . 2.2200000000000002 109.478 178.662 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.414 ' O ' ' HD3' ' A' ' 35' ' ' LYS . 80.7 mt -66.97 -45.41 77.8 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.655 -0.702 . . . . 1.3799999999999999 110.029 177.142 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.3 p -91.4 -3.32 56.81 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.489 -0.778 . . . . 1.4399999999999999 111.592 -178.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 55.4 ttp180 -86.62 129.58 34.81 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.174 -0.466 . . . . 4.6299999999999999 110.586 -178.003 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 107.35 -20.44 32.65 Favored Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 120.703 -0.76 . . . . 1.6200000000000001 112.353 177.191 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.548 ' HD2' ' N ' ' A' ' 35' ' ' LYS . 0.0 OUTLIER -115.53 136.73 52.78 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-O 121.434 0.635 . . . . 2.75 111.664 -177.873 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . 0.79 ' HA ' ' HA ' ' A' ' 9' ' ' SER . 18.4 pt20 -103.34 156.15 17.95 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.343 -0.844 . . . . 2.2400000000000002 111.397 -177.49 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 31.2 t -117.92 119.61 35.35 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 106.28 -1.748 . . . . 1.02 106.28 171.317 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.558 ' O ' ' HD3' ' A' ' 7' ' ' PRO . 21.9 m-80 -72.27 -6.77 45.42 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 113.131 0.789 . . . . 1.28 113.131 -167.607 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . 0.427 ' HA2' HG22 ' A' ' 5' ' ' ILE . . . 127.7 175.62 14.16 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.052 -1.071 . . . . 0.41999999999999998 113.357 165.756 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.473 ' HB3' ' HB ' ' A' ' 5' ' ' ILE . 67.3 tp -160.13 129.24 5.04 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 109.139 -0.689 . . . . 0.69999999999999996 109.139 -177.962 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 44.5 m80 -138.15 96.7 3.24 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.171 0.51 . . . . 2.96 110.543 176.123 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -168.87 -169.42 32.25 Favored Glycine 0 N--CA 1.446 -0.693 0 CA-C-N 115.776 -0.647 . . . . 0.55000000000000004 111.899 176.083 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -98.12 111.47 23.78 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 108.783 -0.821 . . . . 2.1800000000000002 108.783 173.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.449 ' HB2' HG21 ' A' ' 3' ' ' VAL . 44.7 m-85 -133.54 134.29 43.2 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.289 0.566 . . . . 1.4099999999999999 112.362 -170.15 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 47.3 t0 -85.9 170.3 12.48 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 108.477 -0.935 . . . . 2.23 108.477 172.617 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 48.7 t -46.85 -70.04 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 N-CA-C 112.574 0.583 . . . . 0.56999999999999995 112.574 -172.364 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -57.89 -34.25 69.6 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 112.507 0.558 . . . . 2.3900000000000001 112.507 -177.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 7.2 m -72.14 -39.92 68.45 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-O 121.203 0.525 . . . . 1.26 110.845 -174.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.508 ' O ' ' HG ' ' A' ' 53' ' ' LEU . . . -74.31 -41.76 36.96 Favored Glycine 0 N--CA 1.446 -0.636 0 CA-C-N 115.599 -0.728 . . . . 0.37 111.448 -174.942 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.533 ' O ' ' HG ' ' A' ' 54' ' ' LEU . 90.4 mt -62.29 -38.38 89.14 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.763 0.316 . . . . 1.0900000000000001 110.831 -179.775 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 6.3 tp60 -57.12 -48.83 77.68 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 115.865 -0.607 . . . . 2.5899999999999999 111.246 179.862 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.446 ' HG2' HD13 ' A' ' 40' ' ' LEU . 50.4 tp60 -69.0 -38.59 79.35 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.625 -0.261 . . . . 1.75 110.957 -179.146 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.624 HD21 HG13 ' A' ' 5' ' ' ILE . 82.4 mt -56.84 -29.35 62.76 Favored 'General case' 0 N--CA 1.464 0.254 0 N-CA-C 112.014 0.375 . . . . 0.72999999999999998 112.014 179.369 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.533 ' HG ' ' O ' ' A' ' 50' ' ' LEU . 92.6 mt -78.35 -6.89 56.47 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.219 -0.446 . . . . 2.1600000000000001 111.893 -176.449 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -66.35 119.07 10.93 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.04 0.447 . . . . 2.2400000000000002 110.509 -177.161 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 111.98 -24.72 14.09 Favored Glycine 0 N--CA 1.446 -0.682 0 CA-C-N 115.757 -0.656 . . . . 1.7 111.635 -176.88 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 78.6 p -109.0 169.2 8.83 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.664 0.269 . . . . 2.2799999999999998 110.302 -179.858 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -114.14 49.52 0.84 Allowed Glycine 0 N--CA 1.443 -0.841 0 N-CA-C 111.161 -0.776 . . . . 1.5800000000000001 111.161 179.39 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.413 HD22 HD11 ' A' ' 71' ' ' LEU . 91.5 mt -124.34 174.96 7.39 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 120.694 0.283 . . . . 1.4199999999999999 110.398 -178.602 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . 0.409 ' CB ' ' HB3' ' A' ' 74' ' ' ALA . 8.5 tp-100 -148.86 118.48 7.0 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.264 -0.643 . . . . 2.6699999999999999 109.264 176.604 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 3.8 p -94.65 123.04 46.61 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 N-CA-C 109.393 -0.595 . . . . 1.54 109.393 177.777 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.482 ' HA ' ' HD3' ' A' ' 63' ' ' PRO . 20.2 ptmt -122.64 134.08 24.77 Favored Pre-proline 0 C--N 1.32 -0.702 0 CA-C-O 120.84 0.352 . . . . 1.8100000000000001 110.84 -172.73 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.482 ' HD3' ' HA ' ' A' ' 62' ' ' LYS . 37.9 Cg_exo -62.26 129.0 25.44 Favored 'Trans proline' 0 N--CA 1.462 -0.338 0 C-N-CA 122.92 2.413 . . . . 0.84999999999999998 111.64 176.36 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -68.32 -48.11 65.75 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.244 -0.889 . . . . 1.7 109.802 -177.41 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -175.37 -71.91 0.05 OUTLIER Glycine 0 N--CA 1.445 -0.756 0 C-N-CA 120.687 -0.768 . . . . 1.6899999999999999 112.074 177.778 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -89.63 -77.9 0.38 Allowed 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.891 0.377 . . . . 2.96 111.098 -176.78 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . 0.483 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 27.2 p-10 -138.31 39.72 2.27 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.402 0.62 . . . . 2.5 111.001 -175.528 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 35.2 t -138.65 166.51 24.17 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 108.124 -1.065 . . . . 1.3 108.124 177.287 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' TRP . . . . . 0.629 ' CE3' HD21 ' A' ' 25' ' ' LEU . 24.4 m0 -141.68 165.52 27.25 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 107.865 -1.161 . . . . 0.46999999999999997 107.865 -174.508 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 12.7 t -145.02 150.06 36.22 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 109.432 -0.581 . . . . 0.82999999999999996 109.432 172.383 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.413 HD11 HD22 ' A' ' 59' ' ' LEU . 1.0 OUTLIER -93.37 102.68 14.93 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.318 0.58 . . . . 1.71 110.335 -176.446 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -97.04 123.49 53.07 Favored Pre-proline 0 C--N 1.321 -0.663 0 CA-C-N 115.197 -0.911 . . . . 2.1299999999999999 110.294 173.757 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_exo -62.64 114.78 2.54 Favored 'Trans proline' 0 N--CA 1.461 -0.392 0 C-N-CA 122.403 2.069 . . . . 1.3600000000000001 111.72 178.307 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.409 ' HB3' ' CB ' ' A' ' 60' ' ' GLN . . . . . . . . 0 C--N 1.321 -0.646 0 N-CA-C 109.326 -0.62 . . . . 1.8899999999999999 109.326 179.108 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 . . . . . 0 CA--C 1.522 -0.107 0 CA-C-O 120.853 0.359 . . . . 4.0 110.469 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 31.5 m -139.99 152.68 22.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.95 -0.568 . . . . 1.6399999999999999 110.282 -178.479 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 19.1 p-10 -127.97 97.09 4.68 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.588 0.708 . . . . 2.29 109.374 176.095 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 66.1 mt -134.03 118.09 27.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.723 -0.671 . . . . 0.81999999999999995 110.004 -177.293 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -81.17 170.79 14.1 Favored Pre-proline 0 C--N 1.323 -0.574 0 CA-C-N 115.562 -0.744 . . . . 1.3799999999999999 109.431 -179.644 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -54.96 141.23 78.98 Favored 'Trans proline' 0 N--CA 1.458 -0.6 0 C-N-CA 121.374 1.382 . . . . 1.73 109.843 167.23 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.442 ' O ' ' HB2' ' A' ' 36' ' ' GLN . . . 173.68 -135.8 3.37 Favored Glycine 0 N--CA 1.446 -0.68 0 N-CA-C 110.575 -1.01 . . . . 1.8400000000000001 110.575 -169.312 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.867 ' HA ' ' HA ' ' A' ' 36' ' ' GLN . 23.7 m -125.25 155.9 39.38 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 117.427 0.614 . . . . 1.6100000000000001 110.407 178.097 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.615 HD22 ' HB2' ' A' ' 37' ' ' SER . 3.9 mm? -56.3 -39.3 72.5 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 118.074 0.397 . . . . 1.1899999999999999 111.093 179.231 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -47.08 -56.09 7.16 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 115.27 -0.877 . . . . 2.1099999999999999 111.822 178.561 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 3.3 tppp? -66.06 -31.14 71.84 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.796 -0.183 . . . . 2.7200000000000002 111.171 -178.752 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -66.26 -57.86 6.62 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.054 0.454 . . . . 0.46000000000000002 110.597 -177.278 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 95.4 mt -59.69 -39.17 83.63 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 115.871 -0.604 . . . . 0.68999999999999995 111.315 177.243 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -57.38 -41.46 80.25 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.27 0.557 . . . . 1.3100000000000001 110.038 177.031 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -63.46 -48.25 78.45 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.337 -0.847 . . . . 2.23 110.678 179.258 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -70.35 -37.82 74.7 Favored 'General case' 0 N--CA 1.456 -0.148 0 C-N-CA 120.894 -0.322 . . . . 0.65000000000000002 111.27 -172.183 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.594 ' HA ' ' CZ ' ' A' ' 23' ' ' PHE . . . -47.91 -44.74 30.07 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-O 120.777 0.323 . . . . 0.37 111.652 176.478 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.59 -21.24 66.25 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.736 -0.666 . . . . 0.64000000000000001 112.358 179.355 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 3.9 t-160 -58.96 -61.53 2.57 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 120.667 0.27 . . . . 1.8500000000000001 111.45 -175.647 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.636 ' HB3' ' HD1' ' A' ' 23' ' ' PHE . 8.2 t -100.78 -9.07 22.08 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.916 0.389 . . . . 1.6699999999999999 111.287 -177.764 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 73.33 56.54 5.57 Favored Glycine 0 C--N 1.331 0.284 0 C-N-CA 121.124 -0.56 . . . . 0.62 112.49 -179.714 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.636 ' HD1' ' HB3' ' A' ' 21' ' ' SER . 17.4 p90 -116.68 172.73 7.04 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.737 0.303 . . . . 0.56999999999999995 110.935 -177.617 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.603 ' O ' ' HB3' ' A' ' 68' ' ' SER . 27.3 m -94.49 111.0 22.74 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-O 121.345 0.593 . . . . 0.68000000000000005 111.088 -179.247 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 3.2 tt -93.72 117.77 30.53 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.216 -0.661 . . . . 1.6699999999999999 109.216 177.752 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 73.5 m -104.65 103.13 12.72 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.97 -0.559 . . . . 1.1499999999999999 111.341 -174.062 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.479 ' CG2' HD12 ' A' ' 71' ' ' LEU . 4.2 p -138.84 129.65 34.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 115.842 -0.617 . . . . 0.90000000000000002 110.668 178.254 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -72.57 121.76 20.23 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.727 -0.67 . . . . 2.3799999999999999 110.307 176.153 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.31 77.27 0.01 OUTLIER 'General case' 0 C--O 1.236 0.35 0 CA-C-N 115.778 -0.646 . . . . 1.97 111.984 177.693 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 30.6 t -175.47 -31.41 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.723 -0.671 . . . . 2.2200000000000002 109.513 178.317 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 80.1 mt -63.11 -53.01 60.24 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.639 -0.71 . . . . 1.3799999999999999 110.636 179.316 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 3.0 p -92.39 58.28 3.17 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.773 -0.649 . . . . 1.4399999999999999 110.831 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 16.6 ptp180 -71.26 105.72 3.57 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 115.742 -0.663 . . . . 4.6299999999999999 109.758 176.353 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 68.24 -93.25 0.28 Allowed Glycine 0 N--CA 1.45 -0.397 0 N-CA-C 110.633 -0.987 . . . . 1.6200000000000001 110.633 -170.363 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.587 ' HG3' HD23 ' A' ' 10' ' ' LEU . 40.7 tptt 50.82 94.3 0.02 OUTLIER 'General case' 0 C--O 1.236 0.355 0 C-N-CA 123.779 0.831 . . . . 2.75 111.974 171.288 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . 0.867 ' HA ' ' HA ' ' A' ' 9' ' ' SER . 2.8 pt20 -101.37 153.81 19.34 Favored 'General case' 0 N--CA 1.447 -0.58 0 O-C-N 121.994 -0.441 . . . . 2.2400000000000002 110.474 -174.804 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.615 ' HB2' HD22 ' A' ' 10' ' ' LEU . 32.8 t -128.08 138.66 52.63 Favored 'General case' 0 N--CA 1.446 -0.673 0 N-CA-C 108.469 -0.937 . . . . 1.02 108.469 -179.778 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.511 ' N ' HD22 ' A' ' 38' ' ' ASN . 0.9 OUTLIER -64.85 -8.96 17.39 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.997 -0.547 . . . . 1.28 112.143 -179.213 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 118.6 -177.39 16.43 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.868 -0.682 . . . . 0.41999999999999998 112.634 171.554 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.437 HD13 ' HG2' ' A' ' 52' ' ' GLN . 63.3 tp -159.62 109.52 1.88 Allowed 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 108.605 -0.887 . . . . 0.69999999999999996 108.605 -179.432 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 12.7 p80 -144.7 98.23 3.15 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 122.018 0.913 . . . . 2.96 111.332 -178.633 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -170.03 -169.82 33.68 Favored Glycine 0 N--CA 1.443 -0.888 0 CA-C-N 114.356 -1.293 . . . . 0.55000000000000004 111.043 176.689 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 32.1 m-20 -82.43 75.36 9.34 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.116 -0.698 . . . . 2.1800000000000002 109.116 173.36 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 79.8 m-85 -110.08 123.12 49.14 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.564 -0.744 . . . . 1.4099999999999999 110.798 -178.144 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -89.27 -163.1 0.94 Allowed 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 108.878 -0.786 . . . . 2.23 108.878 173.23 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.516 ' O ' ' HG ' ' A' ' 50' ' ' LEU . 37.5 t -53.09 -71.81 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 N-CA-C 112.751 0.648 . . . . 0.56999999999999995 112.751 -172.367 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -61.83 -42.44 99.03 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 112.944 0.72 . . . . 2.3900000000000001 112.944 -171.54 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 28.6 m -68.89 -29.99 68.39 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.158 0.504 . . . . 1.26 111.01 -173.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -80.07 -29.83 44.72 Favored Glycine 0 N--CA 1.445 -0.711 0 N-CA-C 110.9 -0.88 . . . . 0.37 110.9 -178.481 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.621 ' HB3' HG11 ' A' ' 61' ' ' VAL . 82.6 mt -74.73 -45.51 43.61 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 115.459 -0.371 . . . . 1.0900000000000001 110.385 -179.369 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 24.2 tp60 -55.63 -41.46 73.56 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.97 -0.559 . . . . 2.5899999999999999 111.27 178.413 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.935 HE21 ' HA ' ' A' ' 52' ' ' GLN . 0.0 OUTLIER -63.81 -48.36 77.16 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.613 -0.267 . . . . 1.75 111.028 -179.973 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 93.1 mt -58.71 -23.99 60.64 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 112.366 0.506 . . . . 0.72999999999999998 112.366 -179.603 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.608 HD11 HG12 ' A' ' 61' ' ' VAL . 68.8 mt -78.31 -19.65 53.13 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 112.23 0.456 . . . . 2.1600000000000001 112.23 -177.174 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -65.48 101.32 0.58 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.204 0.526 . . . . 2.2400000000000002 110.802 -176.475 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 124.1 -3.7 9.05 Favored Glycine 0 N--CA 1.449 -0.482 0 CA-C-N 115.604 -0.726 . . . . 1.7 111.844 -177.345 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 6.9 m -118.09 170.69 8.65 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.758 0.313 . . . . 2.2799999999999998 110.397 179.145 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -115.2 24.29 10.74 Favored Glycine 0 N--CA 1.442 -0.901 0 N-CA-C 110.44 -1.064 . . . . 1.5800000000000001 110.44 172.64 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 85.6 mt -101.57 175.23 5.64 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 120.822 0.344 . . . . 1.4199999999999999 110.108 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 72.1 mt-30 -133.84 118.32 17.85 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 109.334 -0.617 . . . . 2.6699999999999999 109.334 174.411 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.621 HG11 ' HB3' ' A' ' 50' ' ' LEU . 6.1 p -86.44 113.42 24.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 N-CA-C 108.781 -0.822 . . . . 1.54 108.781 174.35 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 40.0 ttpt -136.22 130.57 18.34 Favored Pre-proline 0 C--N 1.314 -0.94 0 CA-C-N 115.642 -0.708 . . . . 1.8100000000000001 110.213 -169.813 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.609 ' HA ' ' HA ' ' A' ' 69' ' ' TRP . 51.4 Cg_exo -55.0 130.64 41.87 Favored 'Trans proline' 0 N--CA 1.461 -0.402 0 C-N-CA 122.318 2.012 . . . . 0.84999999999999998 111.027 175.638 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.438 HD13 ' O ' ' A' ' 64' ' ' LEU . 2.8 tm? -62.64 -34.74 77.66 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.816 -0.629 . . . . 1.7 109.739 -176.545 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 177.07 -59.01 0.1 OUTLIER Glycine 0 N--CA 1.444 -0.824 0 N-CA-C 110.935 -0.866 . . . . 1.6899999999999999 110.935 177.164 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 21.0 m-80 -140.17 126.74 20.3 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.599 -0.3 . . . . 2.96 110.703 178.003 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 47.8 t30 75.25 -36.87 0.32 Allowed 'General case' 0 N--CA 1.475 0.781 0 O-C-N 124.096 0.872 . . . . 2.5 112.881 173.556 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.603 ' HB3' ' O ' ' A' ' 24' ' ' THR . 69.0 m -114.17 178.61 4.22 Favored 'General case' 0 C--N 1.321 -0.638 0 O-C-N 122.231 -0.293 . . . . 1.3 110.396 -168.072 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' TRP . . . . . 0.609 ' HA ' ' HA ' ' A' ' 63' ' ' PRO . 40.0 m0 -139.16 167.81 21.24 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 120.825 0.345 . . . . 0.46999999999999997 110.125 -169.224 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 14.3 t -149.95 150.56 32.02 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.348 -0.612 . . . . 0.82999999999999996 109.348 169.082 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.559 HD23 ' HA ' ' A' ' 61' ' ' VAL . 25.9 mt -92.79 102.89 15.28 Favored 'General case' 0 CA--C 1.517 -0.317 0 C-N-CA 120.285 -0.566 . . . . 1.71 110.056 174.644 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.416 ' HA ' ' HD3' ' A' ' 73' ' ' PRO . 42.7 tt0 -87.36 119.48 70.85 Favored Pre-proline 0 C--N 1.317 -0.807 0 CA-C-N 115.098 -0.956 . . . . 2.1299999999999999 110.528 177.493 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 72' ' ' GLU . 6.3 Cg_exo -75.25 114.07 3.92 Favored 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 122.341 2.027 . . . . 1.3600000000000001 111.187 177.109 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.32 -0.698 0 N-CA-C 108.681 -0.859 . . . . 1.8899999999999999 108.681 -179.771 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . 0.79 HE21 ' HA ' ' A' ' 2' ' ' GLN . 0.0 OUTLIER . . . . . 0 CA--C 1.513 -0.443 0 CA-C-O 121.523 0.678 . . . . 4.0 111.893 . . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 17.3 m -115.67 131.78 67.05 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 CA-C-N 114.64 -1.164 . . . . 1.6399999999999999 111.46 -175.211 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 50.5 m-80 -130.74 97.58 4.39 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 108.386 -0.968 . . . . 2.29 108.386 174.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 56.6 mt -121.35 132.45 70.62 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-N 115.989 -0.55 . . . . 0.81999999999999995 111.322 -170.907 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -75.01 157.73 85.12 Favored Pre-proline 0 C--N 1.326 -0.427 0 CA-C-N 115.68 -0.691 . . . . 1.3799999999999999 109.872 177.781 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.496 ' HA ' ' O ' ' A' ' 37' ' ' SER . 11.6 Cg_exo -72.12 54.91 2.3 Favored 'Trans proline' 0 CA--C 1.533 0.46 0 C-N-CA 123.003 2.468 . . . . 1.73 112.835 179.031 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -125.05 -161.54 11.08 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.771 -0.728 . . . . 1.8400000000000001 113.177 -178.083 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 18.7 m -47.01 125.88 8.19 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 123.566 0.746 . . . . 1.6100000000000001 112.322 -177.227 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 68.0 tp -60.94 -29.54 69.69 Favored 'General case' 0 CA--C 1.522 -0.102 0 CA-C-N 115.412 -0.813 . . . . 1.1899999999999999 110.756 -179.416 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.446 ' CA ' ' HB ' ' A' ' 32' ' ' THR . 22.9 t70 -51.43 -52.21 48.16 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.703 -0.68 . . . . 2.1099999999999999 111.232 176.643 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 21.9 tptm -69.88 -25.54 63.76 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.497 -0.32 . . . . 2.7200000000000002 110.616 -179.339 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.642 ' O ' ' HG3' ' A' ' 16' ' ' GLN . . . -65.12 -54.64 26.76 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.179 0.514 . . . . 0.46000000000000002 109.943 179.017 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.687 ' HB3' HD11 ' A' ' 25' ' ' LEU . 95.9 mt -59.9 -35.73 75.48 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.834 -0.621 . . . . 0.68999999999999995 110.397 174.155 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 24.1 t-20 -59.09 -47.22 86.07 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.554 -0.748 . . . . 1.3100000000000001 110.992 -179.463 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.642 ' HG3' ' O ' ' A' ' 13' ' ' ALA . 0.3 OUTLIER -65.43 -32.72 74.49 Favored 'General case' 0 C--O 1.232 0.176 0 C-N-CA 120.947 -0.301 . . . . 2.23 111.103 -177.587 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.496 ' N ' HE21 ' A' ' 16' ' ' GLN . 5.2 t80 -71.71 -42.82 66.91 Favored 'General case' 0 CA--C 1.527 0.071 0 N-CA-C 109.475 -0.565 . . . . 0.65000000000000002 109.475 178.128 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.731 ' HA ' ' CZ ' ' A' ' 23' ' ' PHE . . . -53.68 -46.28 70.59 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 115.993 -0.548 . . . . 0.37 111.614 177.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.29 -21.88 66.52 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.185 -0.461 . . . . 0.64000000000000001 111.708 -179.855 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 83.2 t60 -66.07 -52.5 48.3 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.717 -0.22 . . . . 1.8500000000000001 111.321 -178.537 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.606 ' HB3' ' HD1' ' A' ' 23' ' ' PHE . 31.9 t -100.04 -17.56 17.43 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.064 0.459 . . . . 1.6699999999999999 111.525 -175.399 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 75.77 48.28 10.5 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.945 -0.645 . . . . 0.62 112.912 -178.273 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.731 ' CZ ' ' HA ' ' A' ' 18' ' ' ALA . 25.3 p90 -107.83 166.14 10.92 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 110.082 -0.34 . . . . 0.56999999999999995 110.082 -179.943 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.505 ' O ' ' HB3' ' A' ' 68' ' ' SER . 40.3 m -91.32 109.12 20.39 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.274 0.559 . . . . 0.68000000000000005 111.234 -179.275 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.687 HD11 ' HB3' ' A' ' 14' ' ' LEU . 2.0 tt -92.33 122.83 35.17 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.153 -0.684 . . . . 1.6699999999999999 109.153 177.248 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 25.5 t -100.83 98.4 8.91 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 120.793 0.33 . . . . 1.1499999999999999 110.442 -175.288 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 8.2 p -149.14 141.89 18.0 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 CA-C-N 115.944 -0.571 . . . . 0.90000000000000002 110.878 179.598 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -90.97 138.2 31.78 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.327 -0.397 . . . . 2.3799999999999999 110.29 174.414 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.37 76.63 0.02 OUTLIER 'General case' 0 C--O 1.235 0.309 0 CA-C-N 116.025 -0.534 . . . . 1.97 111.939 176.757 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 22.3 p -166.84 -52.21 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.356 -0.383 . . . . 2.2200000000000002 110.342 -179.139 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.419 HD13 HD12 ' A' ' 71' ' ' LEU . 84.6 mt -66.51 -44.79 81.56 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.162 -0.472 . . . . 1.3799999999999999 110.649 179.188 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.446 ' HB ' ' CA ' ' A' ' 11' ' ' ASP . 4.0 p -91.83 -5.66 53.01 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.894 -0.594 . . . . 1.4399999999999999 111.198 179.744 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 28.0 ttp180 -82.49 129.38 34.9 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.609 -0.723 . . . . 4.6299999999999999 110.568 -177.417 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 80.47 -29.97 2.53 Favored Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 121.172 -0.537 . . . . 1.6200000000000001 112.2 178.202 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.505 ' HD3' ' C ' ' A' ' 35' ' ' LYS . 11.0 tmtt? -71.66 117.97 13.9 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 109.028 -0.73 . . . . 2.75 109.028 177.133 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -102.15 149.77 23.94 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.083 0.468 . . . . 2.2400000000000002 110.466 -178.071 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.496 ' O ' ' HA ' ' A' ' 7' ' ' PRO . 0.4 OUTLIER -123.31 134.74 54.03 Favored 'General case' 0 N--CA 1.431 -1.408 0 N-CA-C 107.731 -1.211 . . . . 1.02 107.731 176.117 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.424 ' HA ' ' HB3' ' A' ' 7' ' ' PRO . 0.9 OUTLIER -61.86 -2.0 0.77 Allowed 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 113.152 0.797 . . . . 1.28 113.152 -176.707 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 101.62 -171.55 22.09 Favored Glycine 0 CA--C 1.501 -0.807 0 C-N-CA 120.859 -0.686 . . . . 0.41999999999999998 111.976 171.16 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 48.9 tp -161.4 134.74 6.45 Favored 'General case' 0 N--CA 1.444 -0.752 0 N-CA-C 107.443 -1.317 . . . . 0.69999999999999996 107.443 -178.91 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 57.9 m80 -136.32 96.54 3.39 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.145 0.498 . . . . 2.96 110.658 178.554 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -170.49 176.13 44.15 Favored Glycine 0 N--CA 1.444 -0.81 0 CA-C-N 115.451 -0.795 . . . . 0.55000000000000004 112.077 177.183 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.557 ' HA ' ' CB ' ' A' ' 2' ' ' GLN . 5.3 p-10 -93.75 76.23 4.28 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.849 0.833 . . . . 2.1800000000000002 108.875 170.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' TYR . . . . . 0.465 ' O ' ' HG2' ' A' ' 2' ' ' GLN . 38.8 m-85 -94.85 149.51 21.17 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.462 -0.79 . . . . 1.4099999999999999 111.997 -173.214 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -85.49 179.12 7.2 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.467 -0.788 . . . . 2.23 109.347 173.693 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.489 ' O ' ' HG ' ' A' ' 50' ' ' LEU . 58.4 t -54.58 -71.99 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 N-CA-C 112.139 0.422 . . . . 0.56999999999999995 112.139 -176.53 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -58.54 -41.71 86.16 Favored 'General case' 0 C--O 1.233 0.229 0 N-CA-C 112.568 0.581 . . . . 2.3900000000000001 112.568 -175.431 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 1.3 p -71.38 -32.02 67.97 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.086 0.47 . . . . 1.26 111.004 -175.606 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.61 ' O ' ' HG ' ' A' ' 53' ' ' LEU . . . -73.84 -36.18 53.16 Favored Glycine 0 N--CA 1.442 -0.918 0 N-CA-C 111.089 -0.804 . . . . 0.37 111.089 179.673 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.501 HD23 HD12 ' A' ' 53' ' ' LEU . 91.2 mt -67.35 -40.62 85.87 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.617 -0.292 . . . . 1.0900000000000001 110.479 -179.833 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 -55.18 -45.44 75.77 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.043 -0.526 . . . . 2.5899999999999999 111.015 178.652 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 15.9 mm100 -68.52 -36.18 78.51 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.586 -0.279 . . . . 1.75 111.174 178.591 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.61 ' HG ' ' O ' ' A' ' 49' ' ' GLY . 80.1 mt -59.12 -21.03 58.66 Favored 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 112.033 0.382 . . . . 0.72999999999999998 112.033 178.259 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 7.3 mp -75.95 15.93 0.48 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.904 0.383 . . . . 2.1600000000000001 111.39 177.754 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -56.71 111.51 1.03 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.722 -0.672 . . . . 2.2400000000000002 111.138 176.486 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 65.27 23.64 70.08 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 121.067 -0.587 . . . . 1.7 112.543 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 50.9 m -99.86 148.63 24.24 Favored 'General case' 0 C--N 1.323 -0.579 0 O-C-N 122.545 -0.385 . . . . 2.2799999999999998 110.735 179.642 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -111.66 28.32 9.6 Favored Glycine 0 N--CA 1.441 -0.988 0 N-CA-C 109.679 -1.369 . . . . 1.5800000000000001 109.679 168.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.538 HD13 HD11 ' A' ' 71' ' ' LEU . 59.6 mt -121.82 179.8 4.37 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.122 -0.696 . . . . 1.4199999999999999 109.122 -179.62 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 27.4 tt0 -151.23 121.48 7.26 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.699 -0.482 . . . . 2.6699999999999999 109.699 178.245 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.441 HG11 HD22 ' A' ' 50' ' ' LEU . 7.3 p -93.51 137.11 23.38 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 N-CA-C 109.708 -0.479 . . . . 1.54 109.708 179.649 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.583 ' HG3' ' HG3' ' A' ' 72' ' ' GLU . 15.6 mtmm -130.19 135.51 27.57 Favored Pre-proline 0 C--N 1.327 -0.396 0 C-N-CA 121.065 -0.254 . . . . 1.8100000000000001 110.409 -179.218 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_exo -63.0 121.79 9.8 Favored 'Trans proline' 0 N--CA 1.458 -0.604 0 C-N-CA 122.407 2.071 . . . . 0.84999999999999998 110.341 169.568 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 44.8 tp -62.57 -40.46 96.93 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.414 -0.812 . . . . 1.7 111.102 -174.149 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 134.49 -22.16 3.74 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.855 -0.688 . . . . 1.6899999999999999 111.8 177.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 27.8 p-10 -106.95 41.65 1.43 Allowed 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.807 0.337 . . . . 2.96 110.582 -179.214 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 66.2 t30 56.33 36.06 26.88 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 121.684 0.754 . . . . 2.5 110.428 -177.024 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . 0.505 ' HB3' ' O ' ' A' ' 24' ' ' THR . 68.5 m -141.55 177.88 7.84 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 107.857 -1.164 . . . . 1.3 107.857 176.104 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' TRP . . . . . 0.463 ' CH2' HD21 ' A' ' 50' ' ' LEU . 54.5 m0 -136.27 167.14 21.86 Favored 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 120.521 -0.472 . . . . 0.46999999999999997 111.12 -167.154 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 3.8 t -145.46 142.42 29.26 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.402 -0.817 . . . . 0.82999999999999996 109.722 174.831 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.538 HD11 HD13 ' A' ' 59' ' ' LEU . 0.7 OUTLIER -92.85 104.01 16.3 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.36 -0.607 . . . . 1.71 109.36 179.773 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.583 ' HG3' ' HG3' ' A' ' 62' ' ' LYS . 4.5 mm-40 -88.28 120.63 70.55 Favored Pre-proline 0 C--N 1.319 -0.727 0 CA-C-N 115.009 -0.996 . . . . 2.1299999999999999 110.968 -178.389 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.473 ' HD3' ' HA ' ' A' ' 72' ' ' GLU . 4.9 Cg_endo -86.97 115.03 1.15 Allowed 'Trans proline' 0 N--CA 1.453 -0.873 0 C-N-CA 123.005 2.47 . . . . 1.3600000000000001 111.685 177.463 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.327 -0.382 0 CA-C-N 115.792 -0.64 . . . . 1.8899999999999999 109.736 -179.928 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.195 0 CA-C-O 121.32 0.581 . . . . 3.8100000000000001 110.862 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 11.7 pt20 -146.38 135.68 22.82 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.597 -0.728 . . . . 4.0 109.438 175.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.434 HG12 HG13 ' A' ' 5' ' ' ILE . 48.0 t -139.88 141.18 34.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.528 -0.305 . . . . 1.6399999999999999 110.919 -174.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -129.35 110.49 11.97 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.313 0.578 . . . . 2.29 109.67 177.415 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.434 HG13 HG12 ' A' ' 3' ' ' VAL . 58.2 mt -137.33 156.79 33.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 N-CA-C 109.413 -0.588 . . . . 0.81999999999999995 109.413 -178.129 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.616 ' HB1' ' HD2' ' A' ' 7' ' ' PRO . . . -161.69 163.45 19.54 Favored Pre-proline 0 C--N 1.324 -0.507 0 N-CA-C 109.796 -0.446 . . . . 1.3799999999999999 109.796 -174.578 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.616 ' HD2' ' HB1' ' A' ' 6' ' ' ALA . 6.1 Cg_exo -38.4 135.63 0.68 Allowed 'Trans proline' 0 C--N 1.352 0.735 0 C-N-CA 124.317 3.345 . . . . 1.73 114.151 -176.623 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.442 ' O ' ' HB2' ' A' ' 9' ' ' SER . . . -178.05 -75.71 0.06 OUTLIER Glycine 0 N--CA 1.443 -0.859 0 N-CA-C 110.31 -1.116 . . . . 1.8400000000000001 110.31 -179.637 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.442 ' HB2' ' O ' ' A' ' 8' ' ' GLY . 8.5 t 174.04 148.25 0.07 Allowed 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 107.277 -1.379 . . . . 1.6100000000000001 107.277 175.389 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.52 HD23 HG22 ' A' ' 32' ' ' THR . 56.1 tp -56.09 -42.59 76.98 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 119.348 0.976 . . . . 1.1899999999999999 111.304 -173.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 2.5 p-10 -50.75 -55.52 16.33 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 115.795 -0.638 . . . . 2.1099999999999999 112.006 177.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 55.7 mtmt -65.13 -27.51 68.78 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 111.719 0.266 . . . . 2.7200000000000002 111.719 179.69 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -65.23 -54.88 22.78 Favored 'General case' 0 C--O 1.233 0.237 0 CA-C-O 120.952 0.406 . . . . 0.46000000000000002 110.114 179.602 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 94.9 mt -59.36 -38.34 80.16 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 115.836 -0.62 . . . . 0.68999999999999995 111.129 176.614 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 50.8 t-20 -60.0 -47.05 87.41 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.659 -0.497 . . . . 1.3100000000000001 109.659 178.641 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.421 HE21 ' HB3' ' A' ' 16' ' ' GLN . 1.0 OUTLIER -61.74 -42.32 98.81 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.799 -0.637 . . . . 2.23 111.108 -179.982 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.469 ' HD1' ' HZ ' ' A' ' 23' ' ' PHE . 1.9 t80 -66.67 -39.55 88.22 Favored 'General case' 0 CA--C 1.53 0.187 0 N-CA-C 109.747 -0.464 . . . . 0.65000000000000002 109.747 -177.837 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.754 ' HA ' ' CE2' ' A' ' 23' ' ' PHE . . . -52.71 -42.82 65.19 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.186 -0.461 . . . . 0.37 111.872 177.772 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.37 -22.88 67.15 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.221 -0.445 . . . . 0.64000000000000001 111.851 -179.344 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . 0.447 ' HB3' ' O ' ' A' ' 17' ' ' TYR . 77.2 t60 -64.82 -62.9 1.28 Allowed 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.18 0.437 . . . . 1.8500000000000001 112.18 -178.534 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.657 ' HB2' ' CD1' ' A' ' 23' ' ' PHE . 9.6 m -100.46 -4.65 28.43 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 112.543 0.572 . . . . 1.6699999999999999 112.543 -172.676 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 67.27 47.49 63.65 Favored Glycine 0 CA--C 1.52 0.379 0 C-N-CA 121.099 -0.572 . . . . 0.62 113.419 177.642 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.754 ' CE2' ' HA ' ' A' ' 18' ' ' ALA . 3.7 p90 -104.61 171.4 7.35 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 110.152 -0.314 . . . . 0.56999999999999995 110.152 178.285 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 24.0 m -97.06 122.69 40.34 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.255 0.55 . . . . 0.68000000000000005 111.959 -175.237 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.632 HD21 ' CE3' ' A' ' 69' ' ' TRP . 1.5 mm? -96.27 143.35 27.43 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.56 -0.746 . . . . 1.6699999999999999 111.07 178.148 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 8.0 t -123.03 91.37 3.47 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 108.943 -0.762 . . . . 1.1499999999999999 108.943 172.43 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 6.0 p -148.76 138.26 15.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.929 -0.578 . . . . 0.90000000000000002 110.581 -175.054 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -102.27 131.87 48.58 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.293 -0.412 . . . . 2.3799999999999999 110.153 178.54 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.1 70.34 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.34 0 O-C-N 123.583 0.552 . . . . 1.97 112.215 178.338 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 50.0 p -163.98 -49.08 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.146 -0.479 . . . . 2.2200000000000002 109.939 -177.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.44 ' O ' HD11 ' A' ' 59' ' ' LEU . 98.0 mt -63.63 -39.07 93.43 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.213 -0.449 . . . . 1.3799999999999999 110.227 176.295 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.52 HG22 HD23 ' A' ' 10' ' ' LEU . 2.3 p -91.65 3.07 55.93 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.662 -0.699 . . . . 1.4399999999999999 111.446 179.6 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.4 HH11 ' HD2' ' A' ' 33' ' ' ARG . 6.0 tpp180 -75.42 106.41 6.95 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.064 -0.516 . . . . 4.6299999999999999 111.216 -174.189 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 119.27 -45.89 1.2 Allowed Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.346 -0.931 . . . . 1.6200000000000001 113.808 172.33 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.857 ' H ' ' HD2' ' A' ' 35' ' ' LYS . 0.0 OUTLIER -67.94 137.08 54.9 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.545 0.688 . . . . 2.75 111.741 -174.355 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 5.3 tp-100 -102.73 152.84 20.76 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 114.921 -1.036 . . . . 2.2400000000000002 110.073 -175.269 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 22.9 t -133.99 123.28 24.33 Favored 'General case' 0 N--CA 1.444 -0.743 0 N-CA-C 107.174 -1.417 . . . . 1.02 107.174 175.29 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 11.7 m120 -67.79 3.28 1.52 Allowed 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 112.907 0.706 . . . . 1.28 112.907 -173.591 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 107.35 -176.52 21.02 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.612 -0.804 . . . . 0.41999999999999998 112.958 170.395 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.414 HD13 ' HB3' ' A' ' 52' ' ' GLN . 39.6 tp -160.3 122.89 3.33 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 108.778 -0.823 . . . . 0.69999999999999996 108.778 -176.366 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 10.7 t-80 -144.48 98.59 3.22 Favored 'General case' 0 C--N 1.321 -0.664 0 C-N-CA 120.296 -0.561 . . . . 2.96 110.964 -179.202 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -168.91 -169.5 32.37 Favored Glycine 0 N--CA 1.446 -0.636 0 CA-C-N 115.264 -0.88 . . . . 0.55000000000000004 111.627 177.04 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -81.99 76.75 8.87 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.242 -0.651 . . . . 2.1800000000000002 109.242 175.305 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 78.8 m-85 -107.82 138.38 44.15 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.25 0.548 . . . . 1.4099999999999999 111.707 -175.626 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -101.93 -170.35 1.81 Allowed 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 108.904 -0.776 . . . . 2.23 108.904 173.208 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 56.0 t -51.97 -71.31 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 N-CA-C 112.739 0.644 . . . . 0.56999999999999995 112.739 -173.321 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -64.4 -40.82 96.54 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 112.548 0.573 . . . . 2.3900000000000001 112.548 -172.237 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 56.7 m -71.02 -25.9 62.88 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-O 120.919 0.39 . . . . 1.26 110.877 -174.518 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.483 ' O ' ' HG ' ' A' ' 53' ' ' LEU . . . -72.4 -37.71 58.61 Favored Glycine 0 N--CA 1.447 -0.621 0 C-N-CA 120.761 -0.733 . . . . 0.37 111.466 178.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.549 HD22 HG11 ' A' ' 61' ' ' VAL . 84.8 mt -67.53 -43.1 81.6 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.024 0.44 . . . . 1.0900000000000001 110.86 -178.808 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 36.2 tt0 -56.99 -42.19 79.78 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.625 -0.716 . . . . 2.5899999999999999 110.839 -179.39 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.414 ' HB3' HD13 ' A' ' 40' ' ' LEU . 25.6 mm-40 -70.0 -37.71 75.75 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 111.895 0.331 . . . . 1.75 111.895 176.205 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.483 ' HG ' ' O ' ' A' ' 49' ' ' GLY . 58.9 mt -58.47 -17.74 23.33 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 112.197 0.443 . . . . 0.72999999999999998 112.197 178.852 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 79.6 mt -69.8 -12.31 61.53 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.443 -0.344 . . . . 2.1600000000000001 111.007 177.517 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -67.4 109.55 3.22 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 121.041 0.448 . . . . 2.2400000000000002 110.038 178.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 105.66 -6.65 41.51 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.925 -0.655 . . . . 1.7 112.109 -179.221 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 49.1 m -121.75 169.35 10.82 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.833 0.349 . . . . 2.2799999999999998 110.845 -179.145 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.638 ' O ' ' HA ' ' A' ' 75' ' ' PRO . . . -121.21 15.62 9.34 Favored Glycine 0 N--CA 1.444 -0.813 0 N-CA-C 110.58 -1.008 . . . . 1.5800000000000001 110.58 172.317 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.527 HD13 HD21 ' A' ' 71' ' ' LEU . 90.8 mt -92.56 -179.4 5.17 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.697 -0.482 . . . . 1.4199999999999999 109.697 -178.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . 0.411 ' OE1' ' HB3' ' A' ' 74' ' ' ALA . 49.7 mt-30 -139.72 117.85 11.9 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 108.772 -0.825 . . . . 2.6699999999999999 108.772 177.837 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.549 HG11 HD22 ' A' ' 50' ' ' LEU . 18.4 t -86.99 113.6 24.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 N-CA-C 109.095 -0.706 . . . . 1.54 109.095 177.084 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -115.95 116.86 40.08 Favored Pre-proline 0 C--N 1.32 -0.702 0 CA-C-N 116.333 -0.394 . . . . 1.8100000000000001 110.027 -171.112 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.452 ' HA ' ' HA ' ' A' ' 69' ' ' TRP . 58.8 Cg_exo -52.7 121.8 9.82 Favored 'Trans proline' 0 N--CA 1.463 -0.284 0 C-N-CA 122.646 2.231 . . . . 0.84999999999999998 111.551 176.508 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.576 ' H ' ' HA ' ' A' ' 69' ' ' TRP . 3.3 tm? -68.53 -53.8 20.79 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.673 -0.694 . . . . 1.7 109.523 -177.696 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 176.78 149.33 7.62 Favored Glycine 0 N--CA 1.441 -0.986 0 N-CA-C 110.484 -1.046 . . . . 1.6899999999999999 110.484 178.16 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 91.2 m-20 65.47 -82.07 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.354 0 C-N-CA 122.606 0.362 . . . . 2.96 111.239 -179.612 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -147.16 13.18 1.1 Allowed 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.404 -0.591 . . . . 2.5 109.404 -178.713 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 42.9 m -103.56 174.32 5.92 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 108.691 -0.855 . . . . 1.3 108.691 -174.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . 0.632 ' CE3' HD21 ' A' ' 25' ' ' LEU . 34.1 m0 -139.64 161.92 36.36 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 118.136 0.426 . . . . 0.46999999999999997 109.874 -173.671 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 13.9 t -142.72 149.3 38.6 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 108.071 -1.085 . . . . 0.82999999999999996 108.071 169.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.527 HD21 HD13 ' A' ' 59' ' ' LEU . 37.9 tp -92.45 105.52 17.69 Favored 'General case' 0 C--N 1.32 -0.694 0 C-N-CA 120.048 -0.661 . . . . 1.71 110.186 -178.377 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -87.2 118.79 70.45 Favored Pre-proline 0 C--N 1.317 -0.808 0 CA-C-N 114.699 -1.137 . . . . 2.1299999999999999 110.024 -179.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -83.17 115.01 2.26 Favored 'Trans proline' 0 N--CA 1.45 -1.087 0 C-N-CA 122.341 2.027 . . . . 1.3600000000000001 112.409 -178.552 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.753 ' HA ' ' HG3' ' A' ' 77' ' ' PRO . . . -162.58 62.0 1.22 Allowed Pre-proline 0 C--N 1.32 -0.704 0 CA-C-N 115.474 -0.784 . . . . 1.8899999999999999 110.137 174.316 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.638 ' HA ' ' O ' ' A' ' 58' ' ' GLY . 5.0 Cg_exo -72.4 -75.72 0.01 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.532 0 C-N-CA 122.503 2.135 . . . . 2.73 111.347 -178.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.439 ' N ' ' HD3' ' A' ' 77' ' ' PRO . . . -143.41 56.34 4.51 Favored Pre-proline 0 C--N 1.32 -0.713 0 N-CA-C 108.265 -1.013 . . . . 4.21 108.265 168.1 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.753 ' HG3' ' HA ' ' A' ' 74' ' ' ALA . 60.4 Cg_endo -86.02 -7.86 8.05 Favored 'Trans proline' 0 N--CA 1.454 -0.824 0 C-N-CA 122.799 2.332 . . . . 4.2599999999999998 111.088 -170.21 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.694 ' HD2' ' HB3' ' A' ' 80' ' ' ASP . 48.4 pttt 177.16 132.7 0.06 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 113.871 -1.513 . . . . 6.21 108.24 171.121 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -89.02 47.77 1.54 Allowed 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 122.136 0.97 . . . . 8.1099999999999994 109.479 176.185 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.694 ' HB3' ' HD2' ' A' ' 78' ' ' LYS . 17.9 t70 . . . . . 0 C--O 1.25 1.083 0 CA-C-N 114.338 -1.301 . . . . 9.0500000000000007 109.58 -177.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.018 0 N-CA-C 110.177 -0.305 . . . . 3.8100000000000001 110.177 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.97 96.96 1.78 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.697 0.76 . . . . 4.0 110.674 178.085 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 27.7 m -94.83 129.76 44.57 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-N 115.497 -0.774 . . . . 1.6399999999999999 109.828 -177.474 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 40.1 m-80 -128.16 96.71 4.54 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.413 0.625 . . . . 2.29 109.329 -178.114 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.695 HD13 ' HB3' ' A' ' 40' ' ' LEU . 3.6 mp -105.0 112.39 38.43 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-N 115.279 -0.873 . . . . 0.81999999999999995 109.563 -178.069 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -85.49 155.94 59.4 Favored Pre-proline 0 C--N 1.32 -0.705 0 CA-C-N 115.855 -0.611 . . . . 1.3799999999999999 109.491 178.302 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.623 ' HA ' ' O ' ' A' ' 37' ' ' SER . 31.6 Cg_exo -58.88 136.07 71.08 Favored 'Trans proline' 0 C--O 1.234 0.323 0 C-N-CA 121.663 1.575 . . . . 1.73 109.858 169.779 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 149.2 49.9 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.011 -1.09 . . . . 1.8400000000000001 111.893 -170.475 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.646 ' HA ' ' HA ' ' A' ' 36' ' ' GLN . 25.9 t 66.36 145.85 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 123.282 0.633 . . . . 1.6100000000000001 112.1 -177.697 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.884 HD22 ' HB3' ' A' ' 37' ' ' SER . 3.0 mm? -57.52 -28.9 63.89 Favored 'General case' 0 N--CA 1.461 0.086 0 CA-C-N 115.784 -0.643 . . . . 1.1899999999999999 109.987 172.547 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.644 ' HB2' ' HB ' ' A' ' 32' ' ' THR . 18.7 t70 -44.11 -62.48 1.13 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 114.549 -1.205 . . . . 2.1099999999999999 111.796 178.563 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.45 ' HA ' ' HB3' ' A' ' 15' ' ' ASN . 36.5 ttpt -69.38 -19.93 63.83 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.423 -0.353 . . . . 2.7200000000000002 111.535 -177.743 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -65.7 -56.45 12.0 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-O 121.134 0.493 . . . . 0.46000000000000002 109.677 178.529 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 74.5 mt -57.86 -38.31 75.46 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.513 -0.767 . . . . 0.68999999999999995 110.943 174.437 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.45 ' HB3' ' HA ' ' A' ' 12' ' ' LYS . 21.4 t-20 -58.83 -42.02 88.25 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.124 -0.489 . . . . 1.3100000000000001 110.655 177.106 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.434 HE21 ' HB3' ' A' ' 16' ' ' GLN . 1.0 OUTLIER -60.63 -43.08 97.95 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.953 -0.567 . . . . 2.23 110.548 178.191 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.436 ' HD1' ' HZ ' ' A' ' 23' ' ' PHE . 0.3 OUTLIER -67.42 -51.14 55.31 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.767 0.317 . . . . 0.65000000000000002 110.63 -179.094 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.741 ' HA ' ' CE2' ' A' ' 23' ' ' PHE . . . -52.26 -53.4 44.29 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 115.799 -0.637 . . . . 0.37 112.352 -177.598 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.77 -21.07 66.24 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.255 -0.429 . . . . 0.64000000000000001 111.958 -177.245 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 32.0 t60 -65.26 -53.62 41.56 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 111.622 0.23 . . . . 1.8500000000000001 111.622 -177.689 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.571 ' HB3' ' CD1' ' A' ' 23' ' ' PHE . 48.1 t -99.81 -7.63 25.18 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.064 0.459 . . . . 1.6699999999999999 110.997 -178.109 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 76.3 44.27 17.96 Favored Glycine 0 N--CA 1.446 -0.687 0 CA-C-N 115.715 -0.675 . . . . 0.62 112.864 178.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.741 ' CE2' ' HA ' ' A' ' 18' ' ' ALA . 14.1 p90 -108.57 149.72 28.47 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.532 -0.544 . . . . 0.56999999999999995 109.532 176.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 28.1 m -90.31 123.61 34.21 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.083 -0.508 . . . . 0.68000000000000005 111.219 -174.392 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.597 HD11 ' HE3' ' A' ' 69' ' ' TRP . 0.9 OUTLIER -92.86 140.5 29.44 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.655 -0.702 . . . . 1.6699999999999999 111.458 -179.914 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.533 ' HB3' ' HA ' ' A' ' 70' ' ' THR . 29.6 t -100.66 92.18 4.99 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.041 -0.725 . . . . 1.1499999999999999 109.041 174.043 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.825 ' HB ' HD23 ' A' ' 71' ' ' LEU . 7.4 p -146.5 134.27 15.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.816 -0.629 . . . . 0.90000000000000002 110.429 -178.729 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 -89.43 128.82 35.99 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.058 -0.519 . . . . 2.3799999999999999 110.216 178.636 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.79 60.87 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.425 0 O-C-N 123.722 0.639 . . . . 1.97 111.667 173.36 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.757 ' HA ' ' HG3' ' A' ' 33' ' ' ARG . 68.7 m -165.28 -27.79 0.03 OUTLIER 'General case' 0 C--N 1.321 -0.642 0 C-N-CA 123.429 0.692 . . . . 2.2200000000000002 109.406 -176.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 97.1 mt -73.29 -23.13 60.25 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.414 0.626 . . . . 1.3799999999999999 109.585 173.513 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.644 ' HB ' ' HB2' ' A' ' 11' ' ' ASP . 17.5 p -98.45 13.0 33.27 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.167 -0.924 . . . . 1.4399999999999999 111.212 179.527 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.757 ' HG3' ' HA ' ' A' ' 30' ' ' SER . 29.4 mtt180 -67.16 126.17 28.35 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.114 -0.494 . . . . 4.6299999999999999 111.245 -179.429 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 67.58 17.27 68.68 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 121.038 -0.601 . . . . 1.6200000000000001 112.275 178.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 5.8 mptp? -88.44 148.96 23.94 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.05 0.452 . . . . 2.75 110.572 178.606 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . 0.646 ' HA ' ' HA ' ' A' ' 9' ' ' SER . 15.0 pt20 -144.02 137.87 27.97 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.51 -0.768 . . . . 2.2400000000000002 109.787 171.24 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.884 ' HB3' HD22 ' A' ' 10' ' ' LEU . 50.7 p -119.99 124.59 46.31 Favored 'General case' 0 N--CA 1.443 -0.784 0 N-CA-C 108.226 -1.027 . . . . 1.02 108.226 -177.066 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -57.26 -32.45 66.6 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 112.274 0.472 . . . . 1.28 112.274 -175.545 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 134.17 178.24 15.49 Favored Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 120.312 -0.947 . . . . 0.41999999999999998 112.481 175.316 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.695 ' HB3' HD13 ' A' ' 5' ' ' ILE . 55.1 tp -160.14 126.12 4.15 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 107.603 -1.258 . . . . 0.69999999999999996 107.603 -179.678 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 72.1 m80 -142.43 99.61 3.53 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.992 0.425 . . . . 2.96 111.439 -174.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -169.14 -170.13 33.35 Favored Glycine 0 N--CA 1.449 -0.459 0 N-CA-C 111.346 -0.702 . . . . 0.55000000000000004 111.346 175.488 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -101.35 76.61 1.71 Allowed 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 108.353 -0.98 . . . . 2.1800000000000002 108.353 171.543 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 26.6 m-85 -91.18 150.42 21.37 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.043 -0.98 . . . . 1.4099999999999999 111.421 -173.735 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 50.4 m-20 -110.24 176.03 5.21 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 107.941 -1.133 . . . . 2.23 107.941 169.218 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.413 HG23 ' H ' ' A' ' 46' ' ' VAL . 16.5 t -49.11 -62.49 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 N-CA-C 112.211 0.448 . . . . 0.56999999999999995 112.211 -169.331 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 25.9 mm-40 -44.31 -60.44 1.92 Allowed 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 113.182 0.808 . . . . 2.3900000000000001 113.182 179.667 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 10.2 m -69.04 -28.02 66.18 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.087 0.47 . . . . 1.26 110.904 -173.035 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.489 ' O ' ' HG ' ' A' ' 53' ' ' LEU . . . -74.4 -39.36 42.98 Favored Glycine 0 N--CA 1.444 -0.818 0 C-N-CA 120.765 -0.731 . . . . 0.37 111.853 -176.303 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.557 ' O ' ' HG ' ' A' ' 54' ' ' LEU . 84.0 mt -72.12 -41.38 67.29 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.563 0.221 . . . . 1.0900000000000001 110.505 -178.187 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 35.8 tt0 -52.89 -51.16 62.17 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 116.254 -0.43 . . . . 2.5899999999999999 111.7 179.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 25.8 mm-40 -64.42 -39.92 94.78 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.998 -0.281 . . . . 1.75 111.205 -179.13 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.489 ' HG ' ' O ' ' A' ' 49' ' ' GLY . 92.7 mt -59.32 -25.23 63.98 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.199 -0.455 . . . . 0.72999999999999998 112.123 177.626 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.557 ' HG ' ' O ' ' A' ' 50' ' ' LEU . 96.7 mt -76.3 -14.06 60.12 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 111.922 0.341 . . . . 2.1600000000000001 111.922 -176.394 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -82.88 103.9 12.7 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 120.989 0.423 . . . . 2.2400000000000002 111.116 -177.263 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 78.9 20.71 69.94 Favored Glycine 0 N--CA 1.45 -0.379 0 CA-C-N 115.698 -0.683 . . . . 1.7 113.485 174.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.455 ' HB2' ' HG ' ' A' ' 10' ' ' LEU . 16.3 p -88.8 -32.49 17.83 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.934 0.397 . . . . 2.2799999999999998 110.981 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.662 ' HA2' ' HA ' ' A' ' 75' ' ' PRO . . . 87.86 9.01 71.94 Favored Glycine 0 N--CA 1.444 -0.815 0 N-CA-C 111.3 -0.72 . . . . 1.5800000000000001 111.3 -176.687 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.585 ' HB3' HD12 ' A' ' 71' ' ' LEU . 85.7 mt -129.71 171.55 12.54 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 120.854 0.359 . . . . 1.4199999999999999 110.611 -176.275 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . 0.558 ' HB2' ' HB3' ' A' ' 74' ' ' ALA . 6.4 tt0 -136.16 118.84 16.04 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.177 -0.675 . . . . 2.6699999999999999 109.177 176.192 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.468 ' H ' HD21 ' A' ' 54' ' ' LEU . 52.6 t -87.26 118.46 33.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-O 120.905 0.383 . . . . 1.54 110.69 -178.288 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.427 ' HE3' ' HB3' ' A' ' 62' ' ' LYS . 22.4 mmmt -125.69 117.92 24.45 Favored Pre-proline 0 C--N 1.325 -0.47 0 CA-C-N 115.944 -0.571 . . . . 1.8100000000000001 110.172 177.663 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.511 ' HA ' ' HA ' ' A' ' 69' ' ' TRP . 41.7 Cg_exo -57.94 121.0 9.27 Favored 'Trans proline' 0 C--O 1.233 0.234 0 C-N-CA 122.351 2.034 . . . . 0.84999999999999998 110.762 174.763 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -75.61 -57.98 3.56 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.784 -0.643 . . . . 1.7 110.831 -171.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -127.04 -98.68 1.04 Allowed Glycine 0 N--CA 1.445 -0.73 0 C-N-CA 120.195 -1.002 . . . . 1.6899999999999999 112.395 -178.228 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -91.87 -74.07 0.52 Allowed 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.741 0.305 . . . . 2.96 110.929 -177.633 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 27.2 p-10 -122.19 34.87 5.03 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.186 0.517 . . . . 2.5 110.877 -178.143 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 47.0 t -126.66 169.21 13.37 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 108.713 -0.847 . . . . 1.3 108.713 179.315 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . 0.597 ' HE3' HD11 ' A' ' 25' ' ' LEU . 6.8 m0 -142.31 162.32 35.76 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 107.824 -1.176 . . . . 0.46999999999999997 107.824 -173.529 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.533 ' HA ' ' HB3' ' A' ' 26' ' ' SER . 12.4 t -140.32 146.52 38.6 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 109.517 -0.549 . . . . 0.82999999999999996 109.517 174.19 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.825 HD23 ' HB ' ' A' ' 27' ' ' VAL . 4.2 mm? -93.63 102.93 15.12 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.613 0.72 . . . . 1.71 110.751 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.434 ' HA ' ' HD3' ' A' ' 73' ' ' PRO . 24.9 mt-10 -86.65 126.28 64.4 Favored Pre-proline 0 C--N 1.319 -0.733 0 CA-C-N 114.744 -1.116 . . . . 2.1299999999999999 109.54 173.658 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' ' 72' ' ' GLU . 38.9 Cg_exo -60.81 114.46 2.16 Favored 'Trans proline' 0 N--CA 1.462 -0.378 0 C-N-CA 122.746 2.297 . . . . 1.3600000000000001 111.897 -176.494 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.558 ' HB3' ' HB2' ' A' ' 60' ' ' GLN . . . -159.3 82.87 2.43 Favored Pre-proline 0 C--N 1.32 -0.686 0 CA-C-N 115.007 -0.997 . . . . 1.8899999999999999 108.86 178.239 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.662 ' HA ' ' HA2' ' A' ' 58' ' ' GLY . 72.0 Cg_endo -76.53 55.55 4.79 Favored 'Trans proline' 0 C--O 1.235 0.357 0 C-N-CA 122.811 2.341 . . . . 2.73 113.172 -172.021 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.449 ' N ' ' HD3' ' A' ' 77' ' ' PRO . . . 54.1 59.39 11.95 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 115.84 -0.618 . . . . 4.21 110.149 -175.568 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.449 ' HD3' ' N ' ' A' ' 76' ' ' ALA . 59.4 Cg_endo -87.53 -179.51 2.68 Favored 'Trans proline' 0 N--CA 1.447 -1.215 0 C-N-CA 122.62 2.213 . . . . 4.2599999999999998 111.361 -175.32 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.42 ' HD2' ' HA ' ' A' ' 78' ' ' LYS . 17.4 tptm -162.55 70.79 0.29 Allowed 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.268 0.556 . . . . 6.21 110.22 -178.714 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -96.47 -5.08 40.37 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 108.617 -0.883 . . . . 8.1099999999999994 108.617 175.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 39.0 t70 . . . . . 0 C--O 1.249 1.047 0 CA-C-N 114.918 -1.037 . . . . 9.0500000000000007 110.134 179.218 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 0.858 0 N-CA-C 109.97 -0.381 . . . . 3.8100000000000001 109.97 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 1.023 ' H ' ' HA ' ' A' ' 43' ' ' ASP . 9.7 tt0 -82.75 -12.64 57.38 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.814 0.816 . . . . 4.0 110.198 -178.132 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 31.8 m -140.8 147.66 22.58 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 CA-C-N 114.766 -1.106 . . . . 1.6399999999999999 109.867 178.411 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 84.2 m-20 -129.2 102.56 6.51 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 109.465 -0.569 . . . . 2.29 109.465 179.768 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.433 HD12 ' HB3' ' A' ' 40' ' ' LEU . 56.6 mt -129.96 152.33 37.22 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 116.172 -0.467 . . . . 0.81999999999999995 109.851 -174.774 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.506 ' HB1' ' HD2' ' A' ' 7' ' ' PRO . . . -163.95 167.46 10.83 Favored Pre-proline 0 C--N 1.327 -0.39 0 N-CA-C 110.112 -0.329 . . . . 1.3799999999999999 110.112 -174.551 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.526 ' HA ' ' O ' ' A' ' 37' ' ' SER . 71.2 Cg_exo -49.31 136.86 31.48 Favored 'Trans proline' 0 C--N 1.351 0.673 0 C-N-CA 122.835 2.357 . . . . 1.73 113.43 -176.582 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 143.86 64.56 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.742 -0.742 . . . . 1.8400000000000001 112.681 177.146 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 50.0 m 66.36 116.14 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 121.372 0.606 . . . . 1.6100000000000001 112.017 179.159 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.402 HD21 HD23 ' A' ' 54' ' ' LEU . 60.0 tp -59.47 -42.04 91.14 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 115.996 -0.547 . . . . 1.1899999999999999 112.425 -178.543 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.628 ' HB3' ' HA ' ' A' ' 33' ' ' ARG . 8.4 p-10 -54.66 -37.86 66.23 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.75 -0.205 . . . . 2.1099999999999999 111.286 178.472 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -66.05 -31.16 71.88 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.949 0.404 . . . . 2.7200000000000002 110.7 178.308 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -67.11 -54.02 25.32 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.133 -0.485 . . . . 0.46000000000000002 110.337 -179.048 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.401 HD11 HD21 ' A' ' 54' ' ' LEU . 84.6 mt -59.26 -38.88 81.19 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 115.76 -0.654 . . . . 0.68999999999999995 110.838 175.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 7.9 t30 -59.75 -38.74 82.59 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.78 -0.645 . . . . 1.3100000000000001 110.353 178.273 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -62.81 -41.62 99.37 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.62 -0.718 . . . . 2.23 110.786 177.61 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.618 ' CD1' ' HH2' ' A' ' 69' ' ' TRP . 7.0 t80 -68.47 -41.39 80.22 Favored 'General case' 0 C--N 1.333 -0.112 0 N-CA-C 109.807 -0.442 . . . . 0.65000000000000002 109.807 -178.029 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.663 ' HA ' ' CE2' ' A' ' 23' ' ' PHE . . . -53.75 -46.87 71.03 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.05 -0.523 . . . . 0.37 111.691 177.06 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.68 -16.54 57.66 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.043 -0.526 . . . . 0.64000000000000001 112.15 -178.027 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 76.3 t60 -61.36 -47.55 85.33 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.669 -0.241 . . . . 1.8500000000000001 111.462 -179.288 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.463 ' HB3' ' CD1' ' A' ' 23' ' ' PHE . 32.5 t -118.77 -15.89 9.39 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 120.712 -0.395 . . . . 1.6699999999999999 112.008 -178.676 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 74.9 61.01 3.19 Favored Glycine 0 C--N 1.331 0.259 0 C-N-CA 120.867 -0.682 . . . . 0.62 112.732 -179.485 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.663 ' CE2' ' HA ' ' A' ' 18' ' ' ALA . 3.1 p90 -112.8 169.21 9.07 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.999 0.428 . . . . 0.56999999999999995 111.021 -179.103 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 14.8 m -89.66 101.38 14.07 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.457 0.646 . . . . 0.68000000000000005 111.276 -176.354 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.592 HD22 ' HB ' ' A' ' 27' ' ' VAL . 2.8 tt -93.58 126.78 38.92 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.551 -0.75 . . . . 1.6699999999999999 109.325 177.116 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.558 ' HB2' ' HA ' ' A' ' 70' ' ' THR . 8.5 m -98.99 91.15 4.89 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.162 -0.681 . . . . 1.1499999999999999 109.162 179.843 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.746 HG23 HD22 ' A' ' 71' ' ' LEU . 7.3 p -117.62 135.78 56.9 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 115.911 -0.586 . . . . 0.90000000000000002 111.533 -174.458 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 50.7 m-20 -78.19 112.81 15.54 Favored 'General case' 0 C--O 1.238 0.476 0 CA-C-N 115.882 -0.599 . . . . 2.3799999999999999 109.74 174.675 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -64.68 66.74 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.977 -0.556 . . . . 1.97 112.02 177.524 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 20.4 p -170.28 -44.09 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.255 -0.429 . . . . 2.2200000000000002 110.175 -179.074 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 91.0 mt -68.27 -52.58 32.29 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.951 -0.568 . . . . 1.3799999999999999 111.351 -179.286 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 13.0 p -101.82 -19.2 15.41 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 112.615 0.598 . . . . 1.4399999999999999 112.615 -176.265 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.628 ' HA ' ' HB3' ' A' ' 11' ' ' ASP . 16.1 tpp180 -59.9 119.16 7.2 Favored 'General case' 0 C--O 1.233 0.233 0 N-CA-C 110.115 -0.328 . . . . 4.6299999999999999 110.115 -178.463 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 93.66 -115.85 5.06 Favored Glycine 0 N--CA 1.439 -1.165 0 N-CA-C 111.056 -0.818 . . . . 1.6200000000000001 111.056 -177.041 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 9.3 mmmm 46.9 -165.84 0.02 OUTLIER 'General case' 0 N--CA 1.443 -0.775 0 CA-C-O 122.205 1.002 . . . . 2.75 111.654 -176.209 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 8.0 pt20 -150.16 132.71 15.75 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 114.887 -1.051 . . . . 2.2400000000000002 108.673 165.029 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.526 ' O ' ' HA ' ' A' ' 7' ' ' PRO . 33.9 t -118.45 139.22 51.75 Favored 'General case' 0 C--N 1.314 -0.944 0 N-CA-C 108.059 -1.089 . . . . 1.02 108.059 175.436 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 8.0 m120 -67.61 -14.46 62.96 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.091 -0.504 . . . . 1.28 111.065 -176.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.409 ' HA2' HG22 ' A' ' 5' ' ' ILE . . . 111.58 -169.53 13.25 Favored Glycine 0 N--CA 1.443 -0.882 0 C-N-CA 120.73 -0.747 . . . . 0.41999999999999998 112.331 173.527 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.433 ' HB3' HD12 ' A' ' 5' ' ' ILE . 42.1 tp -160.16 125.64 4.02 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 108.349 -0.982 . . . . 0.69999999999999996 108.349 179.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 39.4 t-80 -136.66 96.54 3.35 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 120.215 -0.594 . . . . 2.96 110.966 -178.544 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -168.79 -179.96 41.26 Favored Glycine 0 N--CA 1.448 -0.533 0 CA-C-N 115.398 -0.819 . . . . 0.55000000000000004 111.239 175.157 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 1.023 ' HA ' ' H ' ' A' ' 2' ' ' GLN . 21.9 m-20 -84.97 74.63 10.49 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 108.656 -0.868 . . . . 2.1800000000000002 108.656 173.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 22.5 m-85 -96.21 143.94 26.86 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.198 -0.91 . . . . 1.4099999999999999 111.061 -174.086 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -94.1 -172.39 2.81 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.543 -0.753 . . . . 2.23 110.057 179.386 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.434 HG13 ' HZ2' ' A' ' 69' ' ' TRP . 59.8 t -52.34 -71.57 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.042 -0.526 . . . . 0.56999999999999995 112.19 -178.095 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 21.1 mt-10 -63.88 -41.49 97.73 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.863 -0.608 . . . . 2.3900000000000001 112.061 -172.78 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 4.2 p -72.11 -32.04 66.6 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.098 -0.501 . . . . 1.26 111.306 -172.251 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -75.2 -39.24 37.42 Favored Glycine 0 N--CA 1.447 -0.617 0 N-CA-C 111.114 -0.794 . . . . 0.37 111.114 -176.39 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.521 ' CB ' HG11 ' A' ' 61' ' ' VAL . 62.9 mt -72.66 -41.5 65.36 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.773 0.321 . . . . 1.0900000000000001 110.58 -178.568 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 21.2 tt0 -54.8 -49.12 71.75 Favored 'General case' 0 C--O 1.222 -0.345 0 CA-C-N 115.808 -0.633 . . . . 2.5899999999999999 111.009 -176.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 16.4 mm100 -65.09 -40.19 94.26 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.455 -0.339 . . . . 1.75 111.485 -178.622 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 90.0 mt -57.77 -34.95 70.13 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 112.1 0.407 . . . . 0.72999999999999998 112.1 178.636 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.402 HD23 HD21 ' A' ' 10' ' ' LEU . 81.8 mt -102.42 -12.6 17.74 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.929 0.395 . . . . 2.1600000000000001 111.645 -174.432 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -64.68 130.2 42.68 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.05 -0.523 . . . . 2.2400000000000002 110.956 -177.833 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 100.41 -31.44 8.51 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.533 -0.842 . . . . 1.7 113.243 176.561 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 24.4 p -91.87 12.84 20.25 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 117.218 0.509 . . . . 2.2799999999999998 111.343 -177.001 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.546 ' HA2' ' HA ' ' A' ' 75' ' ' PRO . . . 74.37 25.14 71.31 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.683 -0.77 . . . . 1.5800000000000001 111.821 179.247 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 91.6 mt -123.42 156.01 36.32 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 109.939 -0.393 . . . . 1.4199999999999999 109.939 -178.687 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . 0.532 ' HB2' ' HB3' ' A' ' 74' ' ' ALA . 38.2 mm-40 -152.59 172.78 16.08 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.409 -0.589 . . . . 2.6699999999999999 109.409 176.496 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.521 HG11 ' CB ' ' A' ' 50' ' ' LEU . 10.8 p -139.89 148.96 22.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 CA-C-O 120.821 0.343 . . . . 1.54 110.709 -178.616 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.546 ' HG3' HG23 ' A' ' 70' ' ' THR . 1.6 ptpp? -139.83 128.59 13.44 Favored Pre-proline 0 C--N 1.321 -0.671 0 N-CA-C 109.519 -0.548 . . . . 1.8100000000000001 109.519 172.815 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -59.8 126.3 20.1 Favored 'Trans proline' 0 N--CA 1.462 -0.376 0 C-N-CA 122.309 2.006 . . . . 0.84999999999999998 110.425 173.332 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.404 HD22 ' HA ' ' A' ' 64' ' ' LEU . 2.5 tm? -59.78 -44.35 93.96 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.527 -0.761 . . . . 1.7 109.903 -175.537 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 152.24 -65.13 0.36 Allowed Glycine 0 N--CA 1.445 -0.729 0 C-N-CA 120.701 -0.761 . . . . 1.6899999999999999 111.722 176.028 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 12.8 t-20 -88.71 78.92 7.6 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.124 0.487 . . . . 2.96 110.043 -179.558 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 43.52 35.94 1.07 Allowed 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 124.482 1.113 . . . . 2.5 113.727 178.552 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 39.5 m -137.16 175.34 9.7 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 108.54 -0.911 . . . . 1.3 108.54 176.453 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . 0.618 ' HH2' ' CD1' ' A' ' 17' ' ' TYR . 54.9 m0 -137.52 167.1 22.33 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.952 0.406 . . . . 0.46999999999999997 110.923 -169.877 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.558 ' HA ' ' HB2' ' A' ' 26' ' ' SER . 3.7 t -145.91 147.38 31.69 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.58 -0.737 . . . . 0.82999999999999996 109.423 171.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.746 HD22 HG23 ' A' ' 27' ' ' VAL . 50.8 tp -91.62 105.71 17.94 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.144 0.497 . . . . 1.71 109.707 -178.03 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.482 ' HB2' ' HG2' ' A' ' 62' ' ' LYS . 12.7 tp10 -94.33 118.93 67.04 Favored Pre-proline 0 C--N 1.323 -0.577 0 CA-C-N 115.147 -0.933 . . . . 2.1299999999999999 110.766 -176.642 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_exo -70.02 113.5 3.44 Favored 'Trans proline' 0 N--CA 1.456 -0.701 0 C-N-CA 121.647 1.564 . . . . 1.3600000000000001 110.649 172.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.532 ' HB3' ' HB2' ' A' ' 60' ' ' GLN . . . -154.31 81.61 4.5 Favored Pre-proline 0 C--N 1.322 -0.623 0 CA-C-N 116.109 -0.496 . . . . 1.8899999999999999 109.891 -177.668 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.546 ' HA ' ' HA2' ' A' ' 58' ' ' GLY . 6.3 Cg_exo -77.51 -70.64 0.02 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 122.699 2.266 . . . . 2.73 112.304 -176.417 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.413 ' N ' ' HD3' ' A' ' 77' ' ' PRO . . . -141.99 59.39 9.32 Favored Pre-proline 0 C--N 1.324 -0.518 0 N-CA-C 108.545 -0.909 . . . . 4.21 108.545 173.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.48 ' HG3' ' HA ' ' A' ' 74' ' ' ALA . 83.4 Cg_endo -96.62 145.6 0.97 Allowed 'Trans proline' 0 N--CA 1.444 -1.417 0 C-N-CA 123.179 2.586 . . . . 4.2599999999999998 113.426 -167.149 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 68.2 mttm 69.05 116.98 0.04 OUTLIER 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 115.244 -0.889 . . . . 6.21 112.447 176.284 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -130.12 -60.91 1.0 Allowed 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.497 -0.774 . . . . 8.1099999999999994 109.298 174.201 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 34.4 t70 . . . . . 0 C--O 1.248 0.977 0 CA-C-O 118.558 -0.734 . . . . 9.0500000000000007 110.023 179.219 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 0.989 0 N-CA-C 110.424 -0.213 . . . . 3.8100000000000001 110.424 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.693 ' HA ' ' HA ' ' A' ' 43' ' ' ASP . 77.0 mt-30 65.93 149.03 0.04 OUTLIER 'General case' 0 C--O 1.231 0.125 0 CA-C-O 121.668 0.747 . . . . 4.0 112.005 -176.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 57.6 t -131.82 130.56 61.77 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 115.49 -0.777 . . . . 1.6399999999999999 109.221 178.417 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 4.2 p-10 -131.52 121.61 24.76 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 108.882 -0.784 . . . . 2.29 108.882 -178.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.492 HG13 HD21 ' A' ' 53' ' ' LEU . 36.4 mm -116.95 129.11 74.04 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 CA-C-N 115.925 -0.579 . . . . 0.81999999999999995 109.956 -178.256 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -73.56 156.52 88.62 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 116.069 -0.514 . . . . 1.3799999999999999 109.86 177.6 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.585 ' HA ' ' O ' ' A' ' 37' ' ' SER . 7.6 Cg_exo -74.45 39.86 0.58 Allowed 'Trans proline' 0 CA--C 1.532 0.394 0 C-N-CA 123.132 2.555 . . . . 1.73 112.888 179.449 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -115.35 -162.71 13.65 Favored Glycine 0 N--CA 1.447 -0.615 0 C-N-CA 120.786 -0.721 . . . . 1.8400000000000001 113.43 -176.792 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.541 ' HA ' ' HA ' ' A' ' 36' ' ' GLN . 15.7 m -55.77 132.21 48.72 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.222 0.534 . . . . 1.6100000000000001 111.197 -176.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 59.9 tp -58.88 -28.66 66.35 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.165 -0.925 . . . . 1.1899999999999999 111.055 -176.061 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -45.97 -48.05 16.55 Favored 'General case' 0 CA--C 1.52 -0.199 0 CA-C-O 121.059 0.457 . . . . 2.1099999999999999 110.576 175.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 65.3 mttm -67.58 -24.13 65.48 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.772 -0.649 . . . . 2.7200000000000002 111.811 -177.368 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -65.87 -64.03 0.95 Allowed 'General case' 0 C--O 1.233 0.233 0 N-CA-C 110.407 -0.22 . . . . 0.46000000000000002 110.407 -179.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.811 HD12 ' H ' ' A' ' 14' ' ' LEU . 4.4 mp -58.56 -35.72 72.8 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-N 116.431 -0.35 . . . . 0.68999999999999995 111.339 175.641 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -60.6 -46.69 89.32 Favored 'General case' 0 C--O 1.235 0.305 0 CA-C-O 121.07 0.462 . . . . 1.3100000000000001 109.94 178.232 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.422 HE21 ' HB3' ' A' ' 16' ' ' GLN . 1.0 OUTLIER -63.91 -43.21 96.66 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.509 -0.769 . . . . 2.23 110.435 178.028 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.476 ' O ' ' HB3' ' A' ' 20' ' ' HIS . 10.1 t80 -68.03 -40.46 82.92 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-O 120.76 0.314 . . . . 0.65000000000000002 110.182 -177.791 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.793 ' HA ' ' CE2' ' A' ' 23' ' ' PHE . . . -54.5 -44.2 72.47 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 116.329 -0.396 . . . . 0.37 111.532 176.14 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.24 -17.96 59.83 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.053 -0.522 . . . . 0.64000000000000001 111.988 -178.787 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . 0.476 ' HB3' ' O ' ' A' ' 17' ' ' TYR . 83.4 t60 -59.75 -54.88 41.18 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.532 -0.304 . . . . 1.8500000000000001 111.266 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.573 ' HB3' ' CD1' ' A' ' 23' ' ' PHE . 22.7 t -114.45 -12.35 12.35 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.482 -0.487 . . . . 1.6699999999999999 111.639 -177.438 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 75.92 49.63 8.56 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 121.062 -0.589 . . . . 0.62 112.754 179.229 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.793 ' CE2' ' HA ' ' A' ' 18' ' ' ALA . 1.8 p90 -103.76 158.11 16.61 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 110.222 -0.288 . . . . 0.56999999999999995 110.222 -179.541 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.568 ' O ' ' HB3' ' A' ' 68' ' ' SER . 32.6 m -93.13 101.31 13.61 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.238 0.542 . . . . 0.68000000000000005 111.878 -175.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.433 ' HB2' ' HB2' ' A' ' 69' ' ' TRP . 0.0 OUTLIER -99.43 150.27 22.34 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.385 -0.37 . . . . 1.6699999999999999 110.115 174.053 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.607 ' HB2' ' HA ' ' A' ' 70' ' ' THR . 43.3 m -106.54 104.07 13.67 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.376 -0.375 . . . . 1.1499999999999999 110.502 -177.389 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 14.9 p -123.57 143.82 35.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 N-CA-C 110.195 -0.298 . . . . 0.90000000000000002 110.195 178.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.419 ' OD2' ' HG ' ' A' ' 31' ' ' LEU . 21.6 t70 -97.32 108.71 21.5 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.433 -0.349 . . . . 2.3799999999999999 110.537 177.575 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.21 60.04 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 115.492 -0.777 . . . . 1.97 112.382 178.218 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 74.8 m -166.38 -36.6 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 123.188 0.595 . . . . 2.2200000000000002 109.526 179.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.419 ' HG ' ' OD2' ' A' ' 28' ' ' ASP . 89.0 mt -68.0 -28.5 67.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.383 0.611 . . . . 1.3799999999999999 110.087 176.034 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 5.0 p -97.69 18.38 15.74 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.528 -0.76 . . . . 1.4399999999999999 111.262 179.11 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 53.5 ttp180 -63.85 108.35 1.44 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.661 -0.245 . . . . 4.6299999999999999 110.415 -179.202 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 81.45 8.56 86.92 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.834 -0.698 . . . . 1.6200000000000001 112.268 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 41.8 tptt -86.65 108.14 18.5 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 109.622 -0.51 . . . . 2.75 109.622 -179.047 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . 0.541 ' HA ' ' HA ' ' A' ' 9' ' ' SER . 46.2 mt-30 -109.84 158.88 17.72 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 110.092 -0.336 . . . . 2.2400000000000002 110.092 -178.802 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.585 ' O ' ' HA ' ' A' ' 7' ' ' PRO . 7.2 t -128.63 127.55 42.45 Favored 'General case' 0 N--CA 1.445 -0.711 0 N-CA-C 107.863 -1.162 . . . . 1.02 107.863 175.158 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 8.7 m120 -64.25 -8.8 13.9 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 112.37 0.507 . . . . 1.28 112.37 -172.716 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 129.31 175.37 14.02 Favored Glycine 0 N--CA 1.444 -0.806 0 C-N-CA 120.152 -1.023 . . . . 0.41999999999999998 112.876 169.743 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 54.1 tp -160.06 124.93 3.9 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 107.624 -1.25 . . . . 0.69999999999999996 107.624 -179.376 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 52.9 m80 -136.42 97.95 3.71 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 120.26 -0.576 . . . . 2.96 111.438 -177.519 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -170.57 168.3 41.37 Favored Glycine 0 N--CA 1.447 -0.609 0 CA-C-N 115.199 -0.909 . . . . 0.55000000000000004 110.866 174.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.693 ' HA ' ' HA ' ' A' ' 2' ' ' GLN . 24.2 t70 -78.89 100.18 7.1 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 108.828 -0.805 . . . . 2.1800000000000002 108.828 170.069 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 43.8 m-85 -116.67 142.43 46.91 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.74 -0.664 . . . . 1.4099999999999999 111.496 -173.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -92.48 -175.3 3.95 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.438 -0.801 . . . . 2.23 108.861 175.34 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 14.1 t -52.0 -69.73 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 121.193 0.52 . . . . 0.56999999999999995 111.534 -174.592 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 5.0 tp10 -56.47 -49.1 75.62 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.263 -0.88 . . . . 2.3900000000000001 112.587 -173.531 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 4.6 t -71.73 -31.36 66.62 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.076 -0.511 . . . . 1.26 110.727 -171.358 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -75.91 -41.45 27.89 Favored Glycine 0 N--CA 1.445 -0.735 0 C-N-CA 120.608 -0.806 . . . . 0.37 111.833 -175.744 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.697 HD13 HG11 ' A' ' 61' ' ' VAL . 93.4 mt -74.03 -36.99 64.48 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.654 0.264 . . . . 1.0900000000000001 110.422 -178.323 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 1.8 tp-100 -54.76 -47.97 73.23 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.324 -0.398 . . . . 2.5899999999999999 111.648 179.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 -65.33 -38.53 90.41 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.612 -0.267 . . . . 1.75 111.363 -179.512 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.492 HD21 HG13 ' A' ' 5' ' ' ILE . 94.0 mt -59.23 -23.88 62.69 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 111.935 0.346 . . . . 0.72999999999999998 111.935 176.651 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.782 HD21 HG23 ' A' ' 61' ' ' VAL . 96.2 mt -80.7 -14.04 58.48 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 111.946 0.35 . . . . 2.1600000000000001 111.946 -176.631 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -62.66 115.34 4.21 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.158 0.504 . . . . 2.2400000000000002 110.806 -178.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 110.25 16.52 10.31 Favored Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 120.784 -0.722 . . . . 1.7 112.029 -178.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 89.5 p -146.29 177.4 9.04 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.873 -0.417 . . . . 2.2799999999999998 109.873 177.33 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.517 ' HA3' ' HB3' ' A' ' 75' ' ' PRO . . . -118.96 43.72 1.53 Allowed Glycine 0 N--CA 1.445 -0.741 0 N-CA-C 111.124 -0.791 . . . . 1.5800000000000001 111.124 176.708 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.516 HD13 HD21 ' A' ' 71' ' ' LEU . 55.1 mt -117.75 174.59 6.09 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.385 -0.407 . . . . 1.4199999999999999 110.164 -177.634 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 74.2 mt-30 -146.6 127.85 14.81 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.248 -0.649 . . . . 2.6699999999999999 109.248 177.206 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.782 HG23 HD21 ' A' ' 54' ' ' LEU . 48.2 t -88.49 119.72 36.21 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 109.014 -0.736 . . . . 1.54 109.014 174.556 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -132.42 122.97 18.31 Favored Pre-proline 0 N--CA 1.441 -0.912 0 CA-C-N 116.493 -0.322 . . . . 1.8100000000000001 110.134 -173.75 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.635 ' HA ' ' HA ' ' A' ' 69' ' ' TRP . 44.7 Cg_exo -57.79 144.48 93.4 Favored 'Trans proline' 0 C--O 1.234 0.286 0 C-N-CA 122.977 2.452 . . . . 0.84999999999999998 111.605 176.847 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -75.86 -47.55 25.03 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.616 -0.72 . . . . 1.7 109.843 -178.07 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 161.62 -46.8 0.37 Allowed Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.594 -0.812 . . . . 1.6899999999999999 111.968 179.005 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 11.0 t30 -110.76 86.62 2.35 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 110.148 -0.315 . . . . 2.96 110.148 -179.482 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 39.11 42.49 0.72 Allowed 'General case' 0 N--CA 1.48 1.032 0 C-N-CA 124.318 1.047 . . . . 2.5 113.313 178.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.568 ' HB3' ' O ' ' A' ' 24' ' ' THR . 50.1 m -142.06 174.84 10.23 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 108.745 -0.835 . . . . 1.3 108.745 176.173 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . 0.635 ' HA ' ' HA ' ' A' ' 63' ' ' PRO . 41.4 m0 -137.81 169.09 18.39 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.235 0.54 . . . . 0.46999999999999997 110.345 -173.079 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.607 ' HA ' ' HB2' ' A' ' 26' ' ' SER . 11.7 t -148.89 141.93 24.85 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-N 115.368 -0.833 . . . . 0.82999999999999996 109.064 168.076 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.516 HD21 HD13 ' A' ' 59' ' ' LEU . 60.8 tp -92.72 102.85 15.26 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.238 0.542 . . . . 1.71 109.76 178.823 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.429 ' HA ' ' HD3' ' A' ' 73' ' ' PRO . 33.0 tt0 -96.92 129.95 31.26 Favored Pre-proline 0 C--N 1.317 -0.817 0 CA-C-N 115.403 -0.817 . . . . 2.1299999999999999 110.839 179.331 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 72' ' ' GLU . 12.0 Cg_exo -71.3 115.2 4.18 Favored 'Trans proline' 0 N--CA 1.459 -0.509 0 C-N-CA 122.432 2.088 . . . . 1.3600000000000001 110.723 173.249 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -165.23 87.32 1.0 Allowed Pre-proline 0 C--N 1.323 -0.551 0 CA-C-N 115.83 -0.623 . . . . 1.8899999999999999 109.655 -177.329 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.517 ' HB3' ' HA3' ' A' ' 58' ' ' GLY . 88.5 Cg_endo -84.04 46.88 2.1 Favored 'Trans proline' 0 N--CA 1.456 -0.723 0 C-N-CA 122.324 2.016 . . . . 2.73 112.651 -174.745 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 54.76 60.66 9.95 Favored Pre-proline 0 N--CA 1.462 0.158 0 CA-C-N 116.112 -0.495 . . . . 4.21 109.905 -176.615 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -82.83 114.34 2.3 Favored 'Trans proline' 0 N--CA 1.449 -1.106 0 C-N-CA 122.595 2.196 . . . . 4.2599999999999998 112.267 -172.168 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.873 ' H ' ' HD2' ' A' ' 78' ' ' LYS . 1.7 mptt -81.89 -78.02 0.21 Allowed 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.488 -0.778 . . . . 6.21 109.128 -179.298 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.412 ' H ' ' HB2' ' A' ' 78' ' ' LYS . 26.4 tt0 -142.62 26.43 1.76 Allowed 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 107.675 -1.231 . . . . 8.1099999999999994 107.675 170.23 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 . . . . . 0 C--O 1.244 0.778 0 CA-C-N 113.896 -1.502 . . . . 9.0500000000000007 109.131 -177.498 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.033 0 N-CA-C 109.852 -0.425 . . . . 3.8100000000000001 109.852 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.835 ' H ' ' HA ' ' A' ' 43' ' ' ASP . 0.0 OUTLIER -73.06 -36.36 66.87 Favored 'General case' 0 CA--C 1.512 -0.488 0 CA-C-O 121.943 0.878 . . . . 4.0 109.806 -176.863 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.499 HG11 ' CD2' ' A' ' 17' ' ' TYR . 14.2 m -148.85 152.17 12.42 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.174 0 CA-C-N 113.689 -1.596 . . . . 1.6399999999999999 109.672 -178.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 69.9 m-20 -131.17 112.08 12.52 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.579 -0.526 . . . . 2.29 109.579 178.211 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.457 ' HB ' ' N ' ' A' ' 40' ' ' LEU . 48.5 mm -107.16 116.81 51.67 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 N-CA-C 109.821 -0.437 . . . . 0.81999999999999995 109.821 -178.771 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -82.8 157.86 66.09 Favored Pre-proline 0 C--N 1.323 -0.563 0 CA-C-N 115.923 -0.58 . . . . 1.3799999999999999 109.51 177.216 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.569 ' HA ' ' O ' ' A' ' 37' ' ' SER . 11.5 Cg_endo -58.71 145.49 95.67 Favored 'Trans proline' 0 N--CA 1.462 -0.376 0 C-N-CA 121.642 1.561 . . . . 1.73 109.879 168.504 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 148.71 -174.78 28.25 Favored Glycine 0 N--CA 1.449 -0.496 0 C-N-CA 120.437 -0.887 . . . . 1.8400000000000001 111.196 -169.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 47.1 t -63.37 128.82 37.57 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 117.029 0.414 . . . . 1.6100000000000001 110.657 -179.016 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.41 HD13 ' HB2' ' A' ' 37' ' ' SER . 61.9 tp -61.7 -31.41 71.55 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.022 -0.535 . . . . 1.1899999999999999 110.223 -179.59 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -49.39 -54.22 18.51 Favored 'General case' 0 CA--C 1.52 -0.178 0 CA-C-N 115.41 -0.814 . . . . 2.1099999999999999 110.345 173.218 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.427 ' HD3' ' HA ' ' A' ' 12' ' ' LYS . 0.1 OUTLIER -69.81 -27.69 65.09 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.755 -0.657 . . . . 2.7200000000000002 111.11 -178.863 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -66.51 -56.32 11.41 Favored 'General case' 0 C--O 1.235 0.3 0 CA-C-O 121.002 0.43 . . . . 0.46000000000000002 110.224 -179.745 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 94.0 mt -60.18 -40.5 90.2 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.894 -0.594 . . . . 0.68999999999999995 111.156 176.006 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 27.6 t-20 -62.14 -35.85 80.03 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.027 0.441 . . . . 1.3100000000000001 110.465 178.321 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.409 ' HB3' HE21 ' A' ' 16' ' ' GLN . 1.0 OUTLIER -62.92 -43.52 98.58 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 116.067 -0.515 . . . . 2.23 109.876 176.641 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.632 ' OH ' ' HA ' ' A' ' 46' ' ' VAL . 44.9 t80 -70.02 -35.53 74.4 Favored 'General case' 0 C--O 1.224 -0.251 0 N-CA-C 109.996 -0.372 . . . . 0.65000000000000002 109.996 -178.613 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.685 ' HA ' ' CE2' ' A' ' 23' ' ' PHE . . . -52.24 -39.85 60.87 Favored 'General case' 0 C--O 1.235 0.33 0 CA-C-O 120.695 0.283 . . . . 0.37 111.724 176.292 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.9 -15.58 55.67 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 112.478 0.548 . . . . 0.64000000000000001 112.478 178.796 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 17.8 t-80 -57.85 -57.44 12.75 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 122.312 0.245 . . . . 1.8500000000000001 111.316 -179.058 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.573 ' HB3' ' HD1' ' A' ' 23' ' ' PHE . 25.1 t -109.15 -12.47 14.81 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.069 0.462 . . . . 1.6699999999999999 111.237 -179.493 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 74.35 53.69 6.63 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.87 -0.681 . . . . 0.62 112.428 -179.302 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.685 ' CE2' ' HA ' ' A' ' 18' ' ' ALA . 3.2 p90 -104.41 172.67 6.67 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.715 0.293 . . . . 0.56999999999999995 110.497 -177.911 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 12.9 m -92.13 107.79 19.47 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.244 0.545 . . . . 0.68000000000000005 111.678 -177.512 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.469 ' HG ' ' HE3' ' A' ' 69' ' ' TRP . 1.0 OUTLIER -98.18 126.08 43.5 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.953 -0.567 . . . . 1.6699999999999999 110.178 177.549 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.472 ' HB2' HG22 ' A' ' 70' ' ' THR . 68.5 m -101.13 97.73 8.23 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.085 0.469 . . . . 1.1499999999999999 110.146 178.15 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 6.4 p -147.98 133.58 11.52 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 115.56 -0.745 . . . . 0.90000000000000002 110.171 179.272 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.525 ' HB2' ' CD1' ' A' ' 31' ' ' LEU . 50.2 m-20 -94.36 129.73 40.96 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 109.707 -0.479 . . . . 2.3799999999999999 109.707 176.283 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -58.04 -10.78 2.01 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.581 -0.736 . . . . 1.97 112.704 -178.686 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 6.0 p -71.7 -41.99 67.94 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.718 0.294 . . . . 2.2200000000000002 110.674 179.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.556 ' H ' HD12 ' A' ' 31' ' ' LEU . 5.7 mp -63.79 -42.18 97.8 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.021 0.439 . . . . 1.3799999999999999 111.329 179.013 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 2.5 p -91.67 13.36 18.28 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.026 -0.534 . . . . 1.4399999999999999 111.668 -177.004 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.446 HH11 ' HD3' ' A' ' 33' ' ' ARG . 30.5 ttt180 -68.6 112.42 5.37 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.28 -0.418 . . . . 4.6299999999999999 110.423 178.155 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 87.01 -0.79 86.41 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.783 -0.722 . . . . 1.6200000000000001 112.013 -178.331 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 24.6 tptp -86.01 114.6 23.02 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 110.507 -0.183 . . . . 2.75 110.507 -178.589 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -106.41 164.32 12.13 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 110.112 -0.329 . . . . 2.2400000000000002 110.112 176.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.569 ' O ' ' HA ' ' A' ' 7' ' ' PRO . 33.5 t -137.17 131.94 33.24 Favored 'General case' 0 N--CA 1.445 -0.719 0 N-CA-C 107.718 -1.216 . . . . 1.02 107.718 172.102 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.424 ' N ' HD22 ' A' ' 38' ' ' ASN . 0.9 OUTLIER -60.78 -21.61 63.24 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 112.761 0.652 . . . . 1.28 112.761 -176.367 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.432 ' HA2' HG22 ' A' ' 5' ' ' ILE . . . 128.37 -175.41 18.58 Favored Glycine 0 N--CA 1.446 -0.668 0 C-N-CA 120.033 -1.079 . . . . 0.41999999999999998 113.201 172.845 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.457 ' N ' ' HB ' ' A' ' 5' ' ' ILE . 43.3 tp -160.0 127.69 4.66 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 107.798 -1.186 . . . . 0.69999999999999996 107.798 -178.329 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 74.3 m80 -140.02 97.85 3.33 Favored 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 120.342 -0.543 . . . . 2.96 111.032 -178.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -169.4 175.75 43.58 Favored Glycine 0 N--CA 1.444 -0.808 0 C-N-CA 120.832 -0.699 . . . . 0.55000000000000004 112.341 175.634 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.835 ' HA ' ' H ' ' A' ' 2' ' ' GLN . 14.7 t70 -88.61 76.1 8.18 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 107.526 -1.287 . . . . 2.1800000000000002 107.526 170.616 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -96.98 149.29 22.07 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 114.844 -1.071 . . . . 1.4099999999999999 112.953 -167.737 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 19.8 t0 -90.71 166.94 12.86 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.102 -0.954 . . . . 2.23 109.649 174.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.632 ' HA ' ' OH ' ' A' ' 17' ' ' TYR . 42.9 t -47.5 -73.08 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 N-CA-C 113.616 0.969 . . . . 0.56999999999999995 113.616 -170.513 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -65.0 -29.5 70.42 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 112.467 0.543 . . . . 2.3900000000000001 112.467 -174.129 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 16.6 m -71.29 -33.1 69.43 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.216 0.531 . . . . 1.26 110.556 -177.189 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -76.51 -33.47 47.78 Favored Glycine 0 N--CA 1.446 -0.688 0 N-CA-C 111.275 -0.73 . . . . 0.37 111.275 -178.329 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.706 ' HB3' HG11 ' A' ' 61' ' ' VAL . 85.7 mt -67.9 -42.37 81.26 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.916 0.389 . . . . 1.0900000000000001 110.479 178.599 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -56.24 -38.81 71.6 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.846 -0.615 . . . . 2.5899999999999999 111.083 179.084 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 32.2 mm-40 -62.29 -56.31 19.72 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.918 0.39 . . . . 1.75 111.299 177.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 86.7 mt -57.5 -33.76 68.37 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.917 -0.583 . . . . 0.72999999999999998 112.092 -177.613 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 10.8 mp -98.98 13.88 31.12 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 112.362 0.505 . . . . 2.1600000000000001 112.362 -175.306 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -60.23 111.14 1.42 Allowed 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.916 0.389 . . . . 2.2400000000000002 111.175 177.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 66.02 39.18 94.69 Favored Glycine 0 C--N 1.332 0.311 0 CA-C-N 115.83 -0.623 . . . . 1.7 112.583 178.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 63.9 p -98.72 -17.13 18.69 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.812 0.339 . . . . 2.2799999999999998 111.733 -176.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.875 ' HA2' ' HB3' ' A' ' 75' ' ' PRO . . . 81.05 6.67 89.28 Favored Glycine 0 N--CA 1.448 -0.542 0 C-N-CA 120.57 -0.824 . . . . 1.5800000000000001 111.154 -172.811 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.494 HD13 HD21 ' A' ' 71' ' ' LEU . 96.1 mt -113.79 165.8 12.19 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.157 -0.521 . . . . 1.4199999999999999 110.335 -177.875 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 31.0 tt0 -145.35 117.93 8.59 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 108.823 -0.806 . . . . 2.6699999999999999 108.823 179.067 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.706 HG11 ' HB3' ' A' ' 50' ' ' LEU . 7.5 p -92.71 129.61 43.02 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 N-CA-C 110.116 -0.328 . . . . 1.54 110.116 -179.605 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.506 ' HZ1' ' HG3' ' A' ' 72' ' ' GLU . 21.1 mtmm -130.5 122.38 19.79 Favored Pre-proline 0 C--N 1.322 -0.601 0 CA-C-N 116.354 -0.385 . . . . 1.8100000000000001 110.736 179.361 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_exo -61.07 117.7 4.5 Favored 'Trans proline' 0 N--CA 1.456 -0.683 0 C-N-CA 122.141 1.894 . . . . 0.84999999999999998 109.895 169.456 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -62.2 -43.65 98.34 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.29 -0.868 . . . . 1.7 111.052 -170.323 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 152.95 -63.82 0.37 Allowed Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.476 -0.868 . . . . 1.6899999999999999 112.155 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 7.3 m-20 -82.92 57.2 3.75 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.654 0.264 . . . . 2.96 111.134 -178.475 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 6.3 t30 56.18 44.24 25.38 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 121.595 0.712 . . . . 2.5 110.78 178.004 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 14.7 m -142.34 177.61 8.15 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 108.848 -0.797 . . . . 1.3 108.848 177.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . 0.548 ' HH2' ' CD1' ' A' ' 17' ' ' TYR . 48.1 m0 -136.73 155.59 49.65 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 116.582 -0.281 . . . . 0.46999999999999997 110.488 -172.075 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.472 HG22 ' HB2' ' A' ' 26' ' ' SER . 1.6 p -139.47 132.43 29.4 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.143 -0.48 . . . . 0.82999999999999996 109.753 173.463 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.494 HD21 HD13 ' A' ' 59' ' ' LEU . 51.7 tp -93.19 104.31 16.51 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.501 0.667 . . . . 1.71 110.651 -178.766 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.506 ' HG3' ' HZ1' ' A' ' 62' ' ' LYS . 37.9 mm-40 -90.73 124.29 62.69 Favored Pre-proline 0 C--N 1.319 -0.748 0 CA-C-N 114.701 -1.136 . . . . 2.1299999999999999 110.75 177.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_exo -74.1 113.54 3.81 Favored 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 121.833 1.689 . . . . 1.3600000000000001 110.542 171.365 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . 175.78 103.76 0.09 OUTLIER Pre-proline 0 C--N 1.332 -0.172 0 CA-C-N 116.031 -0.531 . . . . 1.8899999999999999 110.581 -175.643 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.875 ' HB3' ' HA2' ' A' ' 58' ' ' GLY . 96.8 Cg_endo -80.19 43.76 1.59 Allowed 'Trans proline' 0 N--CA 1.461 -0.384 0 C-N-CA 122.558 2.172 . . . . 2.73 112.066 177.764 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 53.64 66.51 4.46 Favored Pre-proline 0 C--O 1.232 0.182 0 CA-C-N 115.65 -0.705 . . . . 4.21 110.409 -174.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -96.96 -178.97 0.38 Allowed 'Trans proline' 0 N--CA 1.449 -1.141 0 C-N-CA 123.717 2.945 . . . . 4.2599999999999998 111.558 -173.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.401 ' HA ' ' HD3' ' A' ' 78' ' ' LYS . 13.8 tppt? -95.51 62.57 2.41 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 120.567 -0.453 . . . . 6.21 110.717 179.9 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 7.1 mm-40 60.57 108.78 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 115.043 -0.981 . . . . 8.1099999999999994 112.244 176.456 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 . . . . . 0 C--O 1.245 0.841 0 CA-C-O 118.494 -0.765 . . . . 9.0500000000000007 110.572 179.063 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.024 0 N-CA-C 109.803 -0.443 . . . . 3.8100000000000001 109.803 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 46.8 mt-30 -72.0 130.54 41.2 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.154 0.502 . . . . 4.0 110.288 179.763 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 40.7 t -134.75 145.13 32.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 115.53 -0.759 . . . . 1.6399999999999999 109.6 -175.303 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 5.2 p30 -128.08 98.25 5.05 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-O 121.776 0.798 . . . . 2.29 109.337 179.322 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.42 ' HB ' ' HB3' ' A' ' 40' ' ' LEU . 50.0 mm -102.21 110.01 27.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 115.34 -0.845 . . . . 0.81999999999999995 109.558 -178.434 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -78.86 149.02 73.38 Favored Pre-proline 0 C--N 1.319 -0.73 0 CA-C-N 115.587 -0.733 . . . . 1.3799999999999999 109.692 -179.008 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -55.31 134.65 65.07 Favored 'Trans proline' 0 N--CA 1.461 -0.422 0 C-N-CA 121.961 1.774 . . . . 1.73 109.656 169.113 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 150.46 -177.23 28.66 Favored Glycine 0 N--CA 1.445 -0.767 0 N-CA-C 110.41 -1.076 . . . . 1.8400000000000001 110.41 -169.256 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.589 ' HA ' ' HA ' ' A' ' 36' ' ' GLN . 10.2 t -65.31 140.29 58.67 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 117.266 0.533 . . . . 1.6100000000000001 110.221 -178.615 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.503 HD12 ' HG3' ' A' ' 35' ' ' LYS . 12.6 mt -58.15 -27.27 63.64 Favored 'General case' 0 CA--C 1.52 -0.187 0 CA-C-N 116.332 -0.394 . . . . 1.1899999999999999 110.513 177.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -49.28 -55.27 13.27 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-N 115.417 -0.81 . . . . 2.1099999999999999 110.724 173.582 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 25.1 ttmm -66.07 -33.86 76.75 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.944 -0.571 . . . . 2.7200000000000002 110.806 -179.778 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -65.6 -59.83 3.55 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.239 -0.437 . . . . 0.46000000000000002 110.917 -176.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.402 ' HB3' ' CD1' ' A' ' 25' ' ' LEU . 93.7 mt -57.57 -38.47 74.86 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.149 -0.478 . . . . 0.68999999999999995 111.31 178.219 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 54.2 t30 -60.45 -35.51 76.02 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.119 -0.492 . . . . 1.3100000000000001 110.547 178.509 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 19.7 tm0? -61.19 -49.4 77.34 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.313 -0.403 . . . . 2.23 110.779 177.55 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -67.45 -42.64 82.74 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 109.309 -0.626 . . . . 0.65000000000000002 109.309 -177.209 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.654 ' HA ' ' CZ ' ' A' ' 23' ' ' PHE . . . -53.44 -51.08 63.8 Favored 'General case' 0 CA--C 1.521 -0.157 0 CA-C-N 115.552 -0.749 . . . . 0.37 111.724 176.812 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.94 -26.29 68.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.236 -0.438 . . . . 0.64000000000000001 111.507 -179.426 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 71.2 t60 -64.31 -50.34 68.21 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.265 -0.425 . . . . 1.8500000000000001 111.722 -177.652 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.626 ' HB3' ' HD1' ' A' ' 23' ' ' PHE . 47.0 t -99.26 -16.79 18.39 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-O 121.142 0.496 . . . . 1.6699999999999999 111.438 -177.6 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 74.27 48.67 14.02 Favored Glycine 0 N--CA 1.45 -0.427 0 CA-C-N 115.884 -0.598 . . . . 0.62 112.665 -178.709 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.654 ' CZ ' ' HA ' ' A' ' 18' ' ' ALA . 29.9 p90 -110.33 168.23 9.61 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.784 0.326 . . . . 0.56999999999999995 110.184 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 12.9 m -93.01 109.15 20.6 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.166 0.508 . . . . 0.68000000000000005 111.077 -178.429 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.402 ' CD1' ' HB3' ' A' ' 14' ' ' LEU . 2.0 tt -93.77 128.89 40.23 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.053 -0.721 . . . . 1.6699999999999999 109.053 177.763 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 34.5 t -103.1 99.81 9.7 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.108 0.48 . . . . 1.1499999999999999 110.211 -178.104 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.1 p -147.83 133.14 11.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 115.821 -0.627 . . . . 0.90000000000000002 110.498 179.05 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 -98.32 135.71 39.53 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.957 -0.565 . . . . 2.3799999999999999 110.218 177.297 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -56.4 -22.3 30.61 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 114.93 -1.032 . . . . 1.97 112.676 -174.639 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 14.3 m -69.01 -14.58 63.12 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.892 0.377 . . . . 2.2200000000000002 111.219 -176.55 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 90.7 mt -98.18 -22.78 16.0 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.11 0.481 . . . . 1.3799999999999999 110.584 -179.633 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 12.1 p -109.85 5.51 22.62 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.031 -0.531 . . . . 1.4399999999999999 112.211 -175.401 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 7.0 ptp180 -63.81 107.21 1.15 Allowed 'General case' 0 N--CA 1.453 -0.302 0 CA-C-O 121.199 0.524 . . . . 4.6299999999999999 111.128 -179.32 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 83.6 4.25 89.2 Favored Glycine 0 N--CA 1.446 -0.646 0 CA-C-N 115.789 -0.641 . . . . 1.6200000000000001 111.9 -179.542 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.503 ' HG3' HD12 ' A' ' 10' ' ' LEU . 20.9 tptm -83.78 104.42 13.87 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.766 -0.457 . . . . 2.75 109.766 -178.543 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . 0.589 ' HA ' ' HA ' ' A' ' 9' ' ' SER . 55.4 tt0 -103.77 155.09 18.86 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.64 -0.504 . . . . 2.2400000000000002 109.64 -177.33 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.408 ' HB2' ' HG ' ' A' ' 10' ' ' LEU . 10.2 t -124.81 134.57 52.71 Favored 'General case' 0 N--CA 1.445 -0.685 0 N-CA-C 107.863 -1.162 . . . . 1.02 107.863 171.532 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -64.85 -16.93 63.8 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.35 -0.386 . . . . 1.28 111.824 -179.751 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 123.27 175.45 14.52 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.647 -0.787 . . . . 0.41999999999999998 112.607 173.208 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.42 ' HB3' ' HB ' ' A' ' 5' ' ' ILE . 49.1 tp -160.1 128.2 4.74 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 108.919 -0.771 . . . . 0.69999999999999996 108.919 -178.688 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 54.7 m80 -138.69 97.86 3.44 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 120.388 -0.525 . . . . 2.96 111.119 179.611 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -169.73 178.15 42.84 Favored Glycine 0 N--CA 1.446 -0.635 0 CA-C-N 115.636 -0.711 . . . . 0.55000000000000004 111.812 175.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -82.69 87.1 6.75 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.479 0.657 . . . . 2.1800000000000002 109.383 170.581 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 56.6 m-85 -109.71 128.81 55.52 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.451 -0.795 . . . . 1.4099999999999999 110.478 -177.699 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 52.1 m-20 -82.97 177.03 8.81 Favored 'General case' 0 C--N 1.316 -0.867 0 N-CA-C 109.282 -0.636 . . . . 2.23 109.282 174.378 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.62 ' HB ' ' OE1' ' A' ' 47' ' ' GLU . 26.1 t -49.79 -70.31 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 N-CA-C 112.52 0.563 . . . . 0.56999999999999995 112.52 -170.777 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.62 ' OE1' ' HB ' ' A' ' 46' ' ' VAL . 1.7 mp0 -56.46 -45.82 80.69 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.53 0.567 . . . . 2.3900000000000001 112.53 -175.408 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 23.3 t -71.9 -35.1 69.62 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-O 121.036 0.446 . . . . 1.26 111.161 -171.524 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -76.19 -38.32 34.85 Favored Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 120.547 -0.835 . . . . 0.37 111.533 -175.672 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.567 ' HB3' HG13 ' A' ' 61' ' ' VAL . 96.5 mt -67.78 -39.12 84.11 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.971 0.415 . . . . 1.0900000000000001 110.719 179.88 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -58.58 -41.57 86.02 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.55 -0.75 . . . . 2.5899999999999999 111.044 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 5.9 tp-100 -66.94 -46.4 74.87 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.242 -0.436 . . . . 1.75 111.027 -179.779 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 91.8 mt -56.16 -32.24 64.12 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 113.129 0.788 . . . . 0.72999999999999998 113.129 -176.314 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 65.3 mt -92.19 9.0 35.49 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.904 0.705 . . . . 2.1600000000000001 112.904 -174.167 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 24.3 t70 -65.68 133.14 50.47 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 120.827 0.346 . . . . 2.2400000000000002 110.38 179.542 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 107.99 4.43 33.64 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.799 -0.715 . . . . 1.7 111.806 -176.107 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 22.2 p -149.91 -173.27 4.38 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 109.848 -0.427 . . . . 2.2799999999999998 109.848 177.732 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.666 ' HA2' ' HB3' ' A' ' 75' ' ' PRO . . . -118.76 30.24 5.99 Favored Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 120.82 -0.705 . . . . 1.5800000000000001 111.539 -176.277 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.463 ' HA ' ' HA ' ' A' ' 73' ' ' PRO . 42.8 mt -98.71 166.73 11.18 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 109.551 -0.537 . . . . 1.4199999999999999 109.551 179.666 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 35.1 tt0 -154.79 118.6 4.61 Favored 'General case' 0 N--CA 1.445 -0.697 0 N-CA-C 108.625 -0.88 . . . . 2.6699999999999999 108.625 178.126 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.567 HG13 ' HB3' ' A' ' 50' ' ' LEU . 3.2 p -94.61 127.12 46.84 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 N-CA-C 109.132 -0.692 . . . . 1.54 109.132 177.861 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.461 ' HA ' ' HD3' ' A' ' 63' ' ' PRO . 47.5 mtmt -128.58 142.72 45.79 Favored Pre-proline 0 C--N 1.318 -0.777 0 CA-C-N 115.909 -0.587 . . . . 1.8100000000000001 110.335 -170.809 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.461 ' HD3' ' HA ' ' A' ' 62' ' ' LYS . 12.4 Cg_exo -70.24 120.97 7.58 Favored 'Trans proline' 0 N--CA 1.457 -0.625 0 C-N-CA 122.596 2.197 . . . . 0.84999999999999998 111.022 175.739 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.446 HD21 ' HB ' ' A' ' 70' ' ' THR . 95.2 mt -58.39 -38.87 78.23 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.459 -0.792 . . . . 1.7 111.77 -174.607 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 161.8 -71.46 0.21 Allowed Glycine 0 N--CA 1.446 -0.697 0 C-N-CA 120.683 -0.77 . . . . 1.6899999999999999 111.367 177.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -59.98 -77.14 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.777 0.322 . . . . 2.96 111.054 179.456 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.406 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 62.8 t30 -167.1 56.08 0.08 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.544 0.688 . . . . 2.5 109.572 177.356 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.422 ' O ' ' HD1' ' A' ' 69' ' ' TRP . 24.2 m -146.45 173.99 11.79 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 108.379 -0.971 . . . . 1.3 108.379 176.27 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . 0.507 ' CZ2' HG13 ' A' ' 46' ' ' VAL . 52.4 m0 -140.0 164.78 29.11 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 109.716 -0.475 . . . . 0.46999999999999997 109.716 -168.793 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.446 ' HB ' HD21 ' A' ' 64' ' ' LEU . 6.6 t -149.01 145.43 27.3 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.711 -0.477 . . . . 0.82999999999999996 109.711 170.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 58.2 tp -95.49 103.09 14.95 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.148 0.499 . . . . 1.71 110.828 178.64 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.406 ' HA ' ' HD3' ' A' ' 73' ' ' PRO . 38.5 mt-10 -105.76 145.07 30.15 Favored Pre-proline 0 C--N 1.322 -0.611 0 CA-C-N 115.632 -0.713 . . . . 2.1299999999999999 111.115 174.788 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.463 ' HA ' ' HA ' ' A' ' 59' ' ' LEU . 7.2 Cg_exo -74.61 115.0 4.16 Favored 'Trans proline' 0 N--CA 1.46 -0.498 0 C-N-CA 122.333 2.022 . . . . 1.3600000000000001 110.722 170.348 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . 179.82 88.42 0.19 Allowed Pre-proline 0 C--N 1.33 -0.268 0 CA-C-N 115.878 -0.601 . . . . 1.8899999999999999 110.274 -175.591 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.666 ' HB3' ' HA2' ' A' ' 58' ' ' GLY . 98.6 Cg_endo -79.41 42.35 1.28 Allowed 'Trans proline' 0 N--CA 1.462 -0.369 0 C-N-CA 122.526 2.151 . . . . 2.73 112.002 -177.604 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 56.07 64.99 4.63 Favored Pre-proline 0 C--O 1.231 0.121 0 CA-C-N 115.629 -0.714 . . . . 4.21 109.377 -171.316 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -84.61 139.7 7.87 Favored 'Trans proline' 0 N--CA 1.455 -0.772 0 C-N-CA 122.849 2.366 . . . . 4.2599999999999998 112.933 -170.438 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 99.7 mttt 65.87 -168.78 0.2 Allowed 'General case' 0 C--O 1.235 0.342 0 CA-C-N 115.584 -0.735 . . . . 6.21 110.53 179.525 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -140.8 100.59 3.88 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 120.893 0.378 . . . . 8.1099999999999994 110.598 -178.307 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 . . . . . 0 C--O 1.245 0.866 0 CA-C-O 118.315 -0.85 . . . . 9.0500000000000007 109.637 174.462 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.057 0 N-CA-C 110.087 -0.338 . . . . 3.8100000000000001 110.087 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -168.47 165.93 12.38 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.391 0.615 . . . . 4.0 110.642 171.43 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 23.2 m -132.35 143.62 39.37 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 CA-C-N 115.076 -0.965 . . . . 1.6399999999999999 109.555 177.464 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 5.2 p30 -128.43 96.82 4.53 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 108.741 -0.837 . . . . 2.29 108.741 179.079 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.51 ' HB ' ' H ' ' A' ' 40' ' ' LEU . 25.5 mt -132.82 159.72 43.02 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 CA-C-N 115.298 -0.865 . . . . 0.81999999999999995 109.073 -173.845 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.696 ' HB1' ' HD2' ' A' ' 7' ' ' PRO . . . -164.67 172.15 4.93 Favored Pre-proline 0 C--N 1.319 -0.752 0 N-CA-C 108.419 -0.956 . . . . 1.3799999999999999 108.419 -174.545 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.696 ' HD2' ' HB1' ' A' ' 6' ' ' ALA . 19.8 Cg_exo -30.49 126.75 0.07 OUTLIER 'Trans proline' 0 C--N 1.358 1.055 0 C-N-CA 124.001 3.134 . . . . 1.73 113.782 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 162.99 157.0 8.83 Favored Glycine 0 N--CA 1.445 -0.746 0 N-CA-C 110.33 -1.108 . . . . 1.8400000000000001 110.33 -176.456 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.582 ' HA ' ' HA ' ' A' ' 36' ' ' GLN . 9.3 t -58.59 133.1 55.56 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 117.285 0.542 . . . . 1.6100000000000001 110.038 179.857 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.731 HD21 ' HG ' ' A' ' 54' ' ' LEU . 62.2 tp -57.62 -30.49 65.39 Favored 'General case' 0 N--CA 1.462 0.131 0 CA-C-N 115.537 -0.756 . . . . 1.1899999999999999 111.422 -173.26 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.553 ' CA ' ' HB ' ' A' ' 32' ' ' THR . 31.3 t70 -50.18 -56.77 9.67 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.627 -0.715 . . . . 2.1099999999999999 111.367 176.808 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 37.3 ttmt -66.92 -26.99 67.13 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.549 -0.296 . . . . 2.7200000000000002 110.96 -179.337 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.497 ' O ' ' HB3' ' A' ' 16' ' ' GLN . . . -65.84 -55.78 15.31 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.867 0.365 . . . . 0.46000000000000002 110.467 179.335 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.593 HD12 HG21 ' A' ' 32' ' ' THR . 82.6 mt -59.18 -35.76 74.13 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.175 -0.466 . . . . 0.68999999999999995 111.425 176.523 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -61.05 -39.61 90.48 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.933 -0.395 . . . . 1.3100000000000001 109.933 176.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.497 ' HB3' ' O ' ' A' ' 13' ' ' ALA . 41.0 tp60 -58.74 -45.26 90.08 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.672 -0.694 . . . . 2.23 111.379 175.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.609 ' O ' ' HB2' ' A' ' 20' ' ' HIS . 8.5 t80 -66.49 -45.24 80.27 Favored 'General case' 0 CA--C 1.514 -0.422 0 CA-C-O 121.044 0.45 . . . . 0.65000000000000002 110.127 -179.157 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.717 ' HA ' ' CE2' ' A' ' 23' ' ' PHE . . . -50.46 -33.84 22.6 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.165 -0.925 . . . . 0.37 111.966 179.327 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.3 -10.09 14.7 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 116.089 -0.505 . . . . 0.64000000000000001 112.241 178.262 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . 0.609 ' HB2' ' O ' ' A' ' 17' ' ' TYR . 0.0 OUTLIER -55.8 -61.44 2.36 Favored 'General case' 0 CA--C 1.518 -0.286 0 CA-C-O 120.899 0.38 . . . . 1.8500000000000001 111.524 178.235 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.569 ' HB3' ' HD1' ' A' ' 23' ' ' PHE . 46.0 t -113.65 -15.56 12.48 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.02 0.438 . . . . 1.6699999999999999 111.411 -177.678 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 77.8 55.71 4.07 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.628 -0.796 . . . . 0.62 111.307 -174.428 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.717 ' CE2' ' HA ' ' A' ' 18' ' ' ALA . 2.7 p90 -101.87 164.55 11.66 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 120.696 0.284 . . . . 0.56999999999999995 110.459 -177.62 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.566 ' O ' ' HB3' ' A' ' 68' ' ' SER . 5.6 m -88.8 107.02 18.75 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.489 0.661 . . . . 0.68000000000000005 111.25 -174.496 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.51 HD22 ' HB ' ' A' ' 27' ' ' VAL . 1.2 tt -93.22 132.62 37.22 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.569 -0.742 . . . . 1.6699999999999999 109.311 178.399 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.669 ' HB2' ' HA ' ' A' ' 70' ' ' THR . 50.1 m -94.95 92.29 6.81 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.533 -0.543 . . . . 1.1499999999999999 109.533 176.508 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.51 ' HB ' HD22 ' A' ' 25' ' ' LEU . 11.6 p -144.76 148.22 18.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.607 -0.724 . . . . 0.90000000000000002 110.529 -174.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -111.91 139.08 47.7 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.196 -0.456 . . . . 2.3799999999999999 109.94 178.713 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -64.05 64.8 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.29 0 O-C-N 123.76 0.662 . . . . 1.97 111.829 176.511 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 26.1 p -170.91 -42.65 0.02 OUTLIER 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 109.507 -0.553 . . . . 2.2200000000000002 109.507 -178.394 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 72.9 mt -64.71 -40.87 96.09 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.217 -0.902 . . . . 1.3799999999999999 110.687 178.666 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.593 HG21 HD12 ' A' ' 14' ' ' LEU . 0.9 OUTLIER -103.83 -12.54 16.86 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.757 -0.656 . . . . 1.4399999999999999 112.473 -178.515 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 57.4 ttp180 -88.38 134.88 33.71 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.856 0.36 . . . . 4.6299999999999999 110.658 -176.047 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 104.37 -51.43 0.8 Allowed Glycine 0 N--CA 1.448 -0.534 0 N-CA-C 111.512 -0.635 . . . . 1.6200000000000001 111.512 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.974 ' H ' ' HD2' ' A' ' 35' ' ' LYS . 0.0 OUTLIER -76.9 132.09 38.92 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.437 -0.579 . . . . 2.75 109.437 175.586 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . 0.582 ' HA ' ' HA ' ' A' ' 9' ' ' SER . 71.3 mt-30 -104.38 161.83 13.74 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.193 -0.458 . . . . 2.2400000000000002 110.84 -175.23 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 13.1 t -131.89 136.51 47.47 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 107.838 -1.171 . . . . 1.02 107.838 173.227 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -70.75 -0.75 9.55 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 112.377 0.51 . . . . 1.28 112.377 -176.647 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 99.97 -171.44 23.64 Favored Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.632 -0.794 . . . . 0.41999999999999998 113.222 170.757 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.51 ' H ' ' HB ' ' A' ' 5' ' ' ILE . 64.1 tp -160.44 145.6 14.7 Favored 'General case' 0 C--O 1.235 0.325 0 N-CA-C 107.85 -1.167 . . . . 0.69999999999999996 107.85 -178.812 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 10.0 t-160 -145.11 98.09 3.11 Favored 'General case' 0 C--N 1.326 -0.449 0 C-N-CA 120.366 -0.534 . . . . 2.96 110.847 177.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -169.31 -175.4 38.51 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.849 -0.691 . . . . 0.55000000000000004 112.392 175.485 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 28.6 t0 -89.99 88.13 7.18 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 108.422 -0.955 . . . . 2.1800000000000002 108.422 173.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 31.7 m-85 -116.08 142.42 46.83 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.491 0.662 . . . . 1.4099999999999999 112.362 -170.251 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -90.77 -179.78 5.6 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 114.694 -1.139 . . . . 2.23 109.612 174.782 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.467 HG13 ' CZ2' ' A' ' 69' ' ' TRP . 78.7 t -53.03 -71.99 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 N-CA-C 112.679 0.622 . . . . 0.56999999999999995 112.679 -176.562 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 15.0 pt-20 -62.18 -41.36 98.26 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.751 0.648 . . . . 2.3900000000000001 112.751 -169.184 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 23.3 t -74.4 -34.29 63.25 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.17 0.509 . . . . 1.26 110.672 -174.487 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -74.49 -41.42 36.52 Favored Glycine 0 N--CA 1.446 -0.662 0 C-N-CA 120.803 -0.713 . . . . 0.37 111.659 -176.126 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.447 HD13 ' CG1' ' A' ' 61' ' ' VAL . 68.3 mt -67.3 -34.52 77.55 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.711 0.291 . . . . 1.0900000000000001 110.638 -179.491 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 7.3 tp60 -57.27 -48.86 77.81 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.101 -0.499 . . . . 2.5899999999999999 110.679 178.571 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.951 HE21 ' HA ' ' A' ' 52' ' ' GLN . 0.0 OUTLIER -67.67 -42.48 82.08 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.415 -0.357 . . . . 1.75 111.065 -178.599 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 78.8 mt -57.0 -40.6 76.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.053 -0.521 . . . . 0.72999999999999998 112.16 -179.335 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.731 ' HG ' HD21 ' A' ' 10' ' ' LEU . 10.1 mp -97.74 2.54 49.7 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 112.306 0.484 . . . . 2.1600000000000001 112.306 -173.772 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -62.07 111.85 2.11 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.047 0.451 . . . . 2.2400000000000002 110.481 179.424 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 97.88 -7.2 62.74 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 121.06 -0.59 . . . . 1.7 112.505 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.5 m -87.75 -12.91 43.81 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.818 0.342 . . . . 2.2799999999999998 111.043 -176.314 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.428 ' HA2' ' HA ' ' A' ' 75' ' ' PRO . . . 76.16 20.21 77.64 Favored Glycine 0 N--CA 1.447 -0.609 0 C-N-CA 120.678 -0.772 . . . . 1.5800000000000001 111.942 -179.363 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.428 ' CB ' HD23 ' A' ' 54' ' ' LEU . 96.3 mt -124.02 166.26 16.05 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 110.183 -0.302 . . . . 1.4199999999999999 110.183 -179.473 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 17.2 tp60 -147.89 118.59 7.53 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.486 -0.561 . . . . 2.6699999999999999 109.486 178.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.571 HG23 ' CD2' ' A' ' 54' ' ' LEU . 59.9 t -91.64 127.29 44.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 N-CA-C 109.473 -0.566 . . . . 1.54 109.473 176.409 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 41.4 tttm -117.12 128.01 26.32 Favored Pre-proline 0 C--N 1.318 -0.797 0 CA-C-N 116.051 -0.522 . . . . 1.8100000000000001 109.761 -179.016 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -60.17 120.68 8.59 Favored 'Trans proline' 0 N--CA 1.461 -0.431 0 C-N-CA 121.867 1.712 . . . . 0.84999999999999998 110.008 171.648 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -68.06 -50.51 54.73 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.973 -0.558 . . . . 1.7 110.211 -173.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 151.79 -52.92 0.48 Allowed Glycine 0 N--CA 1.445 -0.732 0 C-N-CA 120.605 -0.807 . . . . 1.6899999999999999 112.001 178.402 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 78.8 m-20 -87.94 57.95 4.58 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.747 0.308 . . . . 2.96 110.949 -176.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 67.0 t30 50.73 37.37 16.54 Favored 'General case' 0 N--CA 1.473 0.675 0 CA-C-N 115.659 -0.701 . . . . 2.5 110.89 -177.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.566 ' HB3' ' O ' ' A' ' 24' ' ' THR . 49.7 m -141.21 178.63 7.27 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 108.128 -1.064 . . . . 1.3 108.128 178.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . 0.479 ' HH2' ' CD1' ' A' ' 17' ' ' TYR . 54.2 m0 -135.49 167.41 21.13 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.046 0.45 . . . . 0.46999999999999997 110.669 -169.22 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.669 ' HA ' ' HB2' ' A' ' 26' ' ' SER . 6.9 t -141.3 139.79 33.71 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.205 -0.907 . . . . 0.82999999999999996 108.97 173.625 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.469 HD22 HG23 ' A' ' 27' ' ' VAL . 48.9 tp -92.37 104.29 16.64 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.642 0.734 . . . . 1.71 109.69 178.506 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 28.0 mm-40 -88.71 119.61 70.03 Favored Pre-proline 0 C--N 1.313 -0.994 0 CA-C-N 114.509 -1.223 . . . . 2.1299999999999999 110.843 -179.605 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_exo -66.77 113.6 2.82 Favored 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 121.698 1.598 . . . . 1.3600000000000001 110.037 172.142 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -161.19 78.24 2.3 Favored Pre-proline 0 C--N 1.321 -0.659 0 CA-C-N 115.692 -0.685 . . . . 1.8899999999999999 109.374 -176.619 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.428 ' HA ' ' HA2' ' A' ' 58' ' ' GLY . 57.8 Cg_endo -79.32 -72.17 0.01 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.874 0 C-N-CA 122.297 1.998 . . . . 2.73 112.384 -174.434 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.479 ' HA ' ' HG2' ' A' ' 79' ' ' GLU . . . -136.89 66.52 55.38 Favored Pre-proline 0 C--N 1.317 -0.832 0 N-CA-C 107.886 -1.153 . . . . 4.21 107.886 171.649 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -93.83 -15.95 0.74 Allowed 'Trans proline' 0 N--CA 1.451 -1.018 0 C-N-CA 123.031 2.487 . . . . 4.2599999999999998 113.512 -168.728 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 62.0 mttm -143.47 26.53 1.6 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.156 0.503 . . . . 6.21 110.148 175.691 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.479 ' HG2' ' HA ' ' A' ' 76' ' ' ALA . 11.4 mm-40 -96.96 -40.87 8.67 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.814 -0.63 . . . . 8.1099999999999994 109.815 -175.838 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 13.1 t70 . . . . . 0 C--O 1.245 0.82 0 CA-C-N 115.38 -0.827 . . . . 9.0500000000000007 109.221 -179.637 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.516 ' O ' ' HA ' ' A' ' 43' ' ' ASP . . . . . . . . 0 N--CA 1.478 0.959 0 CA-C-O 121.027 0.441 . . . . 3.8100000000000001 109.964 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -69.29 105.12 2.43 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-O 121.728 0.775 . . . . 4.0 111.434 -178.327 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 60.5 t -91.81 121.56 42.43 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 N-CA-C 107.966 -1.124 . . . . 1.6399999999999999 107.966 172.25 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -130.1 128.87 42.74 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 109.532 -0.544 . . . . 2.29 109.532 -174.204 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 75.2 mt -133.88 132.26 56.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 CA-C-N 116.391 -0.368 . . . . 0.81999999999999995 110.608 -177.581 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -70.82 153.46 94.8 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 115.538 -0.756 . . . . 1.3799999999999999 110.775 179.687 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.648 ' HA ' ' O ' ' A' ' 37' ' ' SER . 5.5 Cg_exo -75.23 34.16 0.4 Allowed 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 123.299 2.666 . . . . 1.73 113.492 -179.027 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.406 ' HA2' ' HB3' ' A' ' 36' ' ' GLN . . . -159.14 140.22 6.72 Favored Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 120.403 -0.903 . . . . 1.8400000000000001 113.322 -178.073 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.516 ' H ' ' HG2' ' A' ' 36' ' ' GLN . 0.1 OUTLIER 64.01 92.15 0.07 Allowed 'General case' 0 C--O 1.233 0.203 0 C-N-CA 123.455 0.702 . . . . 1.6100000000000001 111.993 175.019 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.663 HD11 ' HB3' ' A' ' 53' ' ' LEU . 52.2 tp -64.01 -36.91 85.53 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.172 0.511 . . . . 1.1899999999999999 110.533 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 14.1 p-10 -55.34 -43.41 74.95 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.525 -0.761 . . . . 2.1099999999999999 111.392 177.288 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 27.8 ttpp -71.27 -28.47 64.17 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.168 0.508 . . . . 2.7200000000000002 110.006 178.431 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -67.5 -52.47 38.73 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.475 -0.784 . . . . 0.46000000000000002 110.736 179.722 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 91.3 mt -57.39 -40.59 78.53 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 115.812 -0.631 . . . . 0.68999999999999995 111.596 178.366 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 10.9 t30 -59.75 -37.11 78.08 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.14 -0.482 . . . . 1.3100000000000001 110.334 179.53 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.424 HE21 ' HB3' ' A' ' 16' ' ' GLN . 0.9 OUTLIER -63.41 -43.73 96.66 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.581 -0.736 . . . . 2.23 110.67 177.422 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.507 ' OH ' ' HA ' ' A' ' 46' ' ' VAL . 7.2 t80 -67.55 -45.61 75.17 Favored 'General case' 0 C--O 1.232 0.157 0 N-CA-C 109.846 -0.427 . . . . 0.65000000000000002 109.846 -177.344 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.628 ' HA ' ' CZ ' ' A' ' 23' ' ' PHE . . . -53.98 -52.77 59.67 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 115.54 -0.754 . . . . 0.37 112.12 179.393 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.32 -30.59 71.7 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.911 0.386 . . . . 0.64000000000000001 110.868 -178.337 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 75.1 t60 -65.85 -55.26 18.0 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.946 -0.57 . . . . 1.8500000000000001 111.407 -178.183 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.568 ' HB3' ' CD1' ' A' ' 23' ' ' PHE . 34.9 t -90.82 0.67 57.39 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-O 120.786 0.327 . . . . 1.6699999999999999 111.607 -173.465 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 64.68 36.53 93.25 Favored Glycine 0 CA--C 1.517 0.191 0 CA-C-N 116.19 -0.459 . . . . 0.62 113.785 175.074 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.628 ' CZ ' ' HA ' ' A' ' 18' ' ' ALA . 53.1 p90 -109.42 161.07 15.66 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.667 -0.494 . . . . 0.56999999999999995 109.667 177.484 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 39.2 m -89.8 107.04 18.86 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.074 0.464 . . . . 0.68000000000000005 110.077 178.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 6.9 tt -91.92 125.28 36.56 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.814 -0.63 . . . . 1.6699999999999999 109.368 -179.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.597 ' O ' ' HA ' ' A' ' 70' ' ' THR . 14.6 t -111.54 97.56 6.83 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.352 0.596 . . . . 1.1499999999999999 110.015 -178.62 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 6.6 p -91.72 130.64 40.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 109.279 -0.637 . . . . 0.90000000000000002 109.279 177.274 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -69.83 105.92 2.95 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.403 -0.362 . . . . 2.3799999999999999 110.642 -177.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 55.87 -90.86 0.03 OUTLIER 'General case' 0 C--O 1.232 0.176 0 O-C-N 124.152 0.908 . . . . 1.97 111.235 -176.458 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 2.3 t -171.32 56.22 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 108.933 -0.766 . . . . 2.2200000000000002 108.933 176.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 90.3 mt -67.07 -17.16 64.76 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.55 -0.75 . . . . 1.3799999999999999 111.136 -178.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 17.1 p -92.89 -1.74 56.47 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.05 -0.523 . . . . 1.4399999999999999 111.214 -179.476 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 40.7 ttm180 -68.8 122.97 19.69 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.27 -0.423 . . . . 4.6299999999999999 110.43 -179.753 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 99.05 -15.94 59.96 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.726 -0.75 . . . . 1.6200000000000001 111.806 -178.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.874 ' HE3' ' HB3' ' A' ' 57' ' ' SER . 41.0 tttm -89.33 132.57 34.88 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-O 120.597 0.237 . . . . 2.75 110.362 177.404 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . 0.516 ' HG2' ' H ' ' A' ' 9' ' ' SER . 25.0 mt-30 -102.43 168.87 9.03 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 109.276 -0.638 . . . . 2.2400000000000002 109.276 173.648 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.648 ' O ' ' HA ' ' A' ' 7' ' ' PRO . 22.9 t -139.33 124.02 18.48 Favored 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 106.823 -1.547 . . . . 1.02 106.823 173.273 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.428 ' N ' HD22 ' A' ' 38' ' ' ASN . 0.9 OUTLIER -55.19 -17.31 4.14 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 112.829 0.677 . . . . 1.28 112.829 -173.396 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 131.49 -178.93 17.48 Favored Glycine 0 N--CA 1.441 -1.012 0 C-N-CA 120.351 -0.928 . . . . 0.41999999999999998 112.662 171.104 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 43.8 tp -160.35 122.72 3.28 Favored 'General case' 0 N--CA 1.445 -0.711 0 N-CA-C 107.275 -1.38 . . . . 0.69999999999999996 107.275 -178.319 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 33.1 m-70 -142.5 97.82 3.19 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.176 0.513 . . . . 2.96 111.211 -178.056 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -171.75 178.19 44.15 Favored Glycine 0 N--CA 1.445 -0.701 0 CA-C-N 115.535 -0.757 . . . . 0.55000000000000004 111.586 174.326 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.516 ' HA ' ' O ' ' A' ' 1' ' ' ALA . 6.5 m-20 -80.41 76.7 7.22 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 107.954 -1.128 . . . . 2.1800000000000002 107.954 166.623 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -92.67 139.09 30.92 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 113.061 0.763 . . . . 1.4099999999999999 113.061 -167.357 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 29.8 t70 -75.22 158.44 32.95 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 114.468 -1.242 . . . . 2.23 109.808 172.412 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.605 HG13 ' HZ2' ' A' ' 69' ' ' TRP . 85.0 t -49.32 -68.13 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 O-C-N 123.674 0.609 . . . . 0.56999999999999995 112.056 -177.038 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -61.87 -31.56 71.85 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.141 -0.481 . . . . 2.3900000000000001 112.148 -176.371 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 22.9 t -69.71 -35.03 74.69 Favored 'General case' 0 C--O 1.238 0.492 0 CA-C-O 121.308 0.575 . . . . 1.26 110.262 -176.669 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.517 ' O ' ' HG ' ' A' ' 53' ' ' LEU . . . -74.15 -30.8 60.39 Favored Glycine 0 N--CA 1.446 -0.668 0 N-CA-C 111.036 -0.826 . . . . 0.37 111.036 -177.479 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.621 ' HB3' HG11 ' A' ' 61' ' ' VAL . 98.3 mt -70.71 -41.52 71.83 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.537 -0.331 . . . . 1.0900000000000001 110.798 179.121 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -51.96 -46.52 64.81 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.07 -0.513 . . . . 2.5899999999999999 111.232 178.507 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 13.2 mm100 -64.06 -45.81 87.12 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.741 0.305 . . . . 1.75 110.973 -179.711 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.663 ' HB3' HD11 ' A' ' 10' ' ' LEU . 79.9 mt -60.02 -32.24 70.7 Favored 'General case' 0 C--O 1.237 0.438 0 CA-C-N 116.115 -0.493 . . . . 0.72999999999999998 111.874 179.068 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.449 ' O ' HD13 ' A' ' 54' ' ' LEU . 0.8 OUTLIER -70.06 -34.98 73.89 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.071 -0.513 . . . . 2.1600000000000001 110.569 -177.926 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -55.9 110.14 0.69 Allowed 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.205 -0.452 . . . . 2.2400000000000002 110.752 -176.564 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 119.64 -2.7 13.65 Favored Glycine 0 N--CA 1.444 -0.8 0 C-N-CA 120.771 -0.728 . . . . 1.7 112.294 -179.235 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.874 ' HB3' ' HE3' ' A' ' 35' ' ' LYS . 68.9 p -121.35 169.46 10.58 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.923 0.392 . . . . 2.2799999999999998 110.865 176.651 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -109.46 35.45 4.89 Favored Glycine 0 N--CA 1.445 -0.761 0 N-CA-C 110.112 -1.195 . . . . 1.5800000000000001 110.112 175.16 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 27.4 mt -108.49 -179.35 3.85 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 114.805 -0.697 . . . . 1.4199999999999999 109.138 -178.642 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 57.4 tp60 -142.57 119.47 11.26 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 108.483 -0.932 . . . . 2.6699999999999999 108.483 173.654 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.621 HG11 ' HB3' ' A' ' 50' ' ' LEU . 3.7 p -85.1 117.8 30.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-O 121.446 0.641 . . . . 1.54 109.386 179.147 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 49.2 mtpt -123.47 124.94 26.19 Favored Pre-proline 0 C--N 1.32 -0.693 0 CA-C-N 115.828 -0.624 . . . . 1.8100000000000001 110.139 -173.543 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_exo -60.4 118.49 5.37 Favored 'Trans proline' 0 N--CA 1.456 -0.71 0 C-N-CA 121.861 1.707 . . . . 0.84999999999999998 109.886 171.795 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -57.13 -38.37 73.38 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.395 -0.821 . . . . 1.7 111.361 -171.137 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 160.55 -50.57 0.36 Allowed Glycine 0 N--CA 1.447 -0.594 0 C-N-CA 119.812 -1.185 . . . . 1.6899999999999999 112.949 176.554 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 3.4 p30 -116.66 71.85 0.8 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.174 0.512 . . . . 2.96 111.305 -176.644 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 58.6 t30 55.87 43.03 28.21 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 115.292 -0.867 . . . . 2.5 110.749 179.598 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.428 ' O ' ' HD1' ' A' ' 69' ' ' TRP . 42.4 t -139.61 173.04 11.95 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 107.369 -1.345 . . . . 1.3 107.369 177.215 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . 0.62 ' CZ3' HD21 ' A' ' 50' ' ' LEU . 30.1 m0 -141.62 160.87 39.28 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.445 -0.576 . . . . 0.46999999999999997 109.445 -171.783 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.597 ' HA ' ' O ' ' A' ' 26' ' ' SER . 8.9 t -148.67 146.14 28.03 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.618 -0.512 . . . . 0.82999999999999996 109.618 169.791 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -93.7 99.93 12.25 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.373 0.606 . . . . 1.71 109.471 176.122 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.447 ' HA ' ' HD3' ' A' ' 73' ' ' PRO . 33.2 tt0 -96.59 126.86 41.76 Favored Pre-proline 0 C--N 1.319 -0.749 0 CA-C-N 115.187 -0.915 . . . . 2.1299999999999999 110.636 177.611 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.447 ' HD3' ' HA ' ' A' ' 72' ' ' GLU . 7.1 Cg_exo -72.34 114.11 3.9 Favored 'Trans proline' 0 N--CA 1.456 -0.707 0 C-N-CA 122.02 1.813 . . . . 1.3600000000000001 111.103 177.227 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -166.06 80.76 1.09 Allowed Pre-proline 0 C--N 1.322 -0.589 0 CA-C-N 115.721 -0.672 . . . . 1.8899999999999999 109.87 -177.213 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -84.41 36.87 0.59 Allowed 'Trans proline' 0 N--CA 1.459 -0.5 0 C-N-CA 122.706 2.27 . . . . 2.73 112.497 -177.328 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 57.84 59.66 6.63 Favored Pre-proline 0 N--CA 1.463 0.186 0 CA-C-N 116.074 -0.512 . . . . 4.21 110.4 -174.553 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -85.2 10.5 3.71 Favored 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 122.762 2.308 . . . . 4.2599999999999998 112.356 -173.513 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 23.0 tptm -70.79 -40.43 72.57 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.812 -0.631 . . . . 6.21 110.182 179.144 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -127.62 174.72 8.84 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.822 -0.626 . . . . 8.1099999999999994 110.38 -177.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 26.2 t70 . . . . . 0 C--O 1.248 0.982 0 CA-C-O 118.572 -0.727 . . . . 9.0500000000000007 109.549 176.732 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.962 0 CA-C-O 120.777 0.322 . . . . 3.8100000000000001 110.805 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 4.8 pp0? -69.59 150.4 47.12 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.972 0.415 . . . . 4.0 110.708 -176.085 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 9.4 p -142.38 147.36 21.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 115.757 -0.656 . . . . 1.6399999999999999 109.939 -176.054 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 47.2 m-80 -128.9 100.26 5.61 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.882 0.372 . . . . 2.29 110.001 -177.338 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.459 ' HB ' ' H ' ' A' ' 40' ' ' LEU . 48.4 mm -108.69 127.45 65.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 116.121 -0.491 . . . . 0.81999999999999995 110.856 -177.611 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.491 ' HA ' ' HD3' ' A' ' 7' ' ' PRO . . . -67.78 139.52 93.61 Favored Pre-proline 0 C--N 1.331 -0.22 0 CA-C-N 116.21 -0.45 . . . . 1.3799999999999999 110.725 178.607 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.491 ' HD3' ' HA ' ' A' ' 6' ' ' ALA . 14.6 Cg_exo -72.17 36.87 0.34 Allowed 'Trans proline' 0 CA--C 1.534 0.522 0 C-N-CA 123.818 3.012 . . . . 1.73 114.628 -176.219 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -175.22 45.93 0.13 Allowed Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 119.467 -1.349 . . . . 1.8400000000000001 114.55 176.446 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.441 ' HA ' ' O ' ' A' ' 35' ' ' LYS . 32.1 t -177.78 101.75 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 117.342 0.571 . . . . 1.6100000000000001 111.279 173.391 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.418 ' CD1' ' HB3' ' A' ' 53' ' ' LEU . 53.7 tp -64.36 -37.29 86.99 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-O 121.328 0.585 . . . . 1.1899999999999999 109.459 169.122 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -48.79 -60.95 2.31 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 114.849 -1.069 . . . . 2.1099999999999999 111.366 177.281 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -68.22 -22.48 64.79 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.702 0.287 . . . . 2.7200000000000002 111.068 179.45 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.407 ' HB1' HD12 ' A' ' 5' ' ' ILE . . . -63.73 -54.72 30.95 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.902 0.382 . . . . 0.46000000000000002 110.475 179.778 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 93.3 mt -58.63 -39.06 79.45 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.618 -0.719 . . . . 0.68999999999999995 110.696 176.514 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 55.8 t30 -61.68 -45.52 93.67 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.903 -0.59 . . . . 1.3100000000000001 110.276 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.427 HE21 ' HB3' ' A' ' 16' ' ' GLN . 0.9 OUTLIER -61.7 -45.61 93.26 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.934 -0.575 . . . . 2.23 110.892 177.489 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.442 ' HD1' ' HZ ' ' A' ' 23' ' ' PHE . 1.3 t80 -65.18 -43.15 92.6 Favored 'General case' 0 C--O 1.234 0.272 0 N-CA-C 109.719 -0.475 . . . . 0.65000000000000002 109.719 -177.396 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.816 ' HA ' ' CE2' ' A' ' 23' ' ' PHE . . . -55.3 -49.34 72.38 Favored 'General case' 0 CA--C 1.519 -0.226 0 CA-C-N 115.564 -0.743 . . . . 0.37 111.551 178.211 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.64 -28.08 68.2 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.398 -0.365 . . . . 0.64000000000000001 111.249 -178.72 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 42.3 t60 -58.69 -50.23 74.64 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.919 -0.582 . . . . 1.8500000000000001 111.906 -176.581 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.487 ' HB3' ' CD1' ' A' ' 23' ' ' PHE . 8.2 t -109.79 1.61 19.45 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-O 121.207 0.527 . . . . 1.6699999999999999 111.452 -178.514 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 62.11 47.54 89.19 Favored Glycine 0 CA--C 1.522 0.509 0 CA-C-N 115.638 -0.71 . . . . 0.62 114.366 175.848 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.816 ' CE2' ' HA ' ' A' ' 18' ' ' ALA . 3.6 p90 -104.96 166.59 10.27 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 117.238 0.519 . . . . 0.56999999999999995 110.563 177.222 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 24.2 m -90.93 119.39 31.09 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.417 0.627 . . . . 0.68000000000000005 112.183 -175.478 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.649 HD11 ' HE3' ' A' ' 69' ' ' TRP . 1.5 mm? -92.93 122.5 35.37 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.36 -0.836 . . . . 1.6699999999999999 111.231 175.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 63.4 m -97.99 94.91 7.13 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.291 0.567 . . . . 1.1499999999999999 109.603 175.645 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 11.2 p -139.07 140.51 38.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-N 115.611 -0.722 . . . . 0.90000000000000002 110.846 -174.743 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.982 ' HB3' HD11 ' A' ' 31' ' ' LEU . 7.8 t70 -68.43 149.46 49.29 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.81 -0.632 . . . . 2.3799999999999999 109.771 174.863 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -53.3 -16.39 1.29 Allowed 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 114.952 1.464 . . . . 1.97 114.952 -170.553 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 7.4 p -165.57 69.99 0.14 Allowed 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 114.003 1.112 . . . . 2.2200000000000002 114.003 -176.386 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.982 HD11 ' HB3' ' A' ' 28' ' ' ASP . 2.7 mp -96.99 -34.2 11.28 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.585 0.707 . . . . 1.3799999999999999 109.132 164.181 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 5.6 p -95.46 21.19 8.45 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 114.959 -1.019 . . . . 1.4399999999999999 111.507 -178.189 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 32.8 ttt180 -66.28 105.63 1.48 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.033 0.444 . . . . 4.6299999999999999 110.385 -176.623 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 77.24 22.91 69.68 Favored Glycine 0 N--CA 1.447 -0.598 0 CA-C-N 115.804 -0.634 . . . . 1.6200000000000001 112.572 -179.069 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.441 ' O ' ' HA ' ' A' ' 9' ' ' SER . 8.8 tptp -76.33 156.41 33.36 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.678 -0.49 . . . . 2.75 109.678 178.456 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -139.36 140.61 37.53 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.075 0.464 . . . . 2.2400000000000002 110.892 -177.669 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 9.4 t -140.04 133.21 29.66 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 107.427 -1.324 . . . . 1.02 107.427 175.103 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.421 ' C ' ' HA ' ' A' ' 7' ' ' PRO . 0.9 OUTLIER -60.47 -7.47 2.12 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 112.85 0.685 . . . . 1.28 112.85 -176.383 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 114.8 179.79 18.6 Favored Glycine 0 CA--C 1.503 -0.675 0 C-N-CA 120.509 -0.853 . . . . 0.41999999999999998 112.652 167.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.459 ' H ' ' HB ' ' A' ' 5' ' ' ILE . 19.4 tp -160.96 123.05 3.07 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 107.681 -1.229 . . . . 0.69999999999999996 107.681 -176.077 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 20.8 t-160 -144.57 97.49 3.04 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.356 0.598 . . . . 2.96 110.853 -178.125 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -169.67 -173.09 36.89 Favored Glycine 0 N--CA 1.445 -0.718 0 CA-C-N 115.228 -0.896 . . . . 0.55000000000000004 110.919 177.262 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -88.89 82.26 6.77 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 109.559 -0.534 . . . . 2.1800000000000002 109.559 171.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 73.6 m-85 -97.55 136.28 38.18 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.047 -0.524 . . . . 1.4099999999999999 111.403 -175.6 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -86.6 173.6 9.44 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 108.801 -0.814 . . . . 2.23 108.801 176.119 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 52.9 t -52.56 -57.71 3.76 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 N-CA-C 111.928 0.344 . . . . 0.56999999999999995 111.928 -173.111 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 51.5 mm-40 -62.86 -49.49 74.68 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-O 121.076 0.465 . . . . 2.3900000000000001 111.809 -175.333 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 11.7 p -72.72 -24.18 60.95 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.892 -0.595 . . . . 1.26 111.286 -172.798 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.45 ' O ' ' HG ' ' A' ' 53' ' ' LEU . . . -75.87 -40.33 31.11 Favored Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 120.766 -0.73 . . . . 0.37 111.337 -178.263 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.51 ' HB3' HG13 ' A' ' 61' ' ' VAL . 95.4 mt -68.33 -45.09 73.86 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.811 0.338 . . . . 1.0900000000000001 110.647 -178.757 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 42.6 tt0 -57.69 -42.94 84.69 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.818 -0.628 . . . . 2.5899999999999999 110.865 -179.034 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 15.2 mm100 -66.44 -43.06 86.64 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.485 -0.325 . . . . 1.75 111.061 -179.37 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.45 ' HG ' ' O ' ' A' ' 49' ' ' GLY . 86.4 mt -57.64 -21.99 43.04 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 116.126 -0.488 . . . . 0.72999999999999998 112.099 178.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.588 HD21 HG12 ' A' ' 61' ' ' VAL . 97.7 mt -70.23 -8.97 54.28 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 111.932 0.345 . . . . 2.1600000000000001 111.932 -179.234 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -67.89 107.75 2.76 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.097 0.475 . . . . 2.2400000000000002 110.164 178.756 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 116.94 2.17 18.85 Favored Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 120.827 -0.702 . . . . 1.7 112.055 -177.121 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 50.3 m -137.24 167.77 20.93 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.113 0.482 . . . . 2.2799999999999998 111.307 179.642 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -116.97 15.29 13.69 Favored Glycine 0 N--CA 1.442 -0.927 0 N-CA-C 110.3 -1.12 . . . . 1.5800000000000001 110.3 172.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.444 HD13 HD11 ' A' ' 71' ' ' LEU . 76.8 mt -92.29 179.48 5.54 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 109.339 -0.615 . . . . 1.4199999999999999 109.339 179.577 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 30.9 tp60 -140.2 117.6 11.41 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.864 -0.421 . . . . 2.6699999999999999 109.864 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.588 HG12 HD21 ' A' ' 54' ' ' LEU . 7.3 p -98.97 129.44 49.34 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 N-CA-C 109.623 -0.51 . . . . 1.54 109.623 175.79 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.842 ' HD3' ' HG3' ' A' ' 72' ' ' GLU . 20.4 ptmt -144.66 144.19 23.9 Favored Pre-proline 0 C--N 1.32 -0.712 0 CA-C-N 116.236 -0.438 . . . . 1.8100000000000001 110.569 -176.865 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.601 ' HA ' ' HA ' ' A' ' 69' ' ' TRP . 21.1 Cg_exo -67.1 140.6 54.62 Favored 'Trans proline' 0 N--CA 1.462 -0.33 0 C-N-CA 122.82 2.347 . . . . 0.84999999999999998 111.807 175.872 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.523 HD21 ' HB ' ' A' ' 70' ' ' THR . 59.7 mt -65.71 -44.65 85.46 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.668 -0.696 . . . . 1.7 111.108 -179.379 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 178.52 -60.8 0.09 OUTLIER Glycine 0 N--CA 1.445 -0.762 0 C-N-CA 120.274 -0.965 . . . . 1.6899999999999999 112.307 178.027 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . 0.406 HD22 ' HA ' ' A' ' 66' ' ' ASN . 3.7 m120 -91.84 -79.8 0.37 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.738 0.304 . . . . 2.96 111.477 -177.362 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -142.2 42.35 1.65 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.36 0.6 . . . . 2.5 110.916 -174.323 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 9.8 m -143.53 172.91 12.14 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 108.28 -1.007 . . . . 1.3 108.28 175.798 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . 0.649 ' HE3' HD11 ' A' ' 25' ' ' LEU . 55.0 m0 -136.68 167.86 20.6 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.55 -0.537 . . . . 0.46999999999999997 109.55 -172.716 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.523 ' HB ' HD21 ' A' ' 64' ' ' LEU . 9.5 t -142.36 142.5 32.46 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.641 -0.503 . . . . 0.82999999999999996 109.641 174.125 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.74 HD12 HD22 ' A' ' 31' ' ' LEU . 0.4 OUTLIER -93.7 101.04 13.17 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 108.985 -0.746 . . . . 1.71 108.985 176.44 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.842 ' HG3' ' HD3' ' A' ' 62' ' ' LYS . 10.5 mm-40 -87.78 119.54 70.6 Favored Pre-proline 0 C--N 1.318 -0.799 0 CA-C-N 114.72 -1.127 . . . . 2.1299999999999999 111.264 178.499 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_endo -88.01 113.58 0.83 Allowed 'Trans proline' 0 N--CA 1.447 -1.209 0 C-N-CA 122.154 1.903 . . . . 1.3600000000000001 111.104 173.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.63 ' HA ' ' HG3' ' A' ' 77' ' ' PRO . . . -169.14 73.2 0.73 Allowed Pre-proline 0 C--N 1.323 -0.582 0 CA-C-N 115.585 -0.734 . . . . 1.8899999999999999 109.791 -178.835 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -75.83 -75.51 0.01 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.696 0 C-N-CA 122.458 2.105 . . . . 2.73 111.461 -177.199 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -142.08 60.89 11.44 Favored Pre-proline 0 C--N 1.32 -0.714 0 N-CA-C 107.81 -1.181 . . . . 4.21 107.81 170.166 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.63 ' HG3' ' HA ' ' A' ' 74' ' ' ALA . 86.1 Cg_endo -89.35 4.12 5.25 Favored 'Trans proline' 0 N--CA 1.453 -0.88 0 C-N-CA 123.097 2.531 . . . . 4.2599999999999998 113.19 -165.333 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 22.5 ttmm -141.0 85.6 1.99 Allowed 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 108.862 -0.792 . . . . 6.21 108.862 171.146 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -69.28 144.92 53.46 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 114.502 -1.227 . . . . 8.1099999999999994 111.052 -174.556 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 30.9 t70 . . . . . 0 C--O 1.249 1.035 0 CA-C-O 118.108 -0.949 . . . . 9.0500000000000007 110.985 -177.384 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 0.987 0 CA-C-O 121.246 0.546 . . . . 3.8100000000000001 109.784 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 77.6 mt-30 -99.83 163.1 12.61 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.786 0.803 . . . . 4.0 112.262 -175.091 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.743 ' HB ' ' HE1' ' A' ' 44' ' ' TYR . 41.5 t -145.91 152.7 13.86 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 N-CA-C 106.857 -1.535 . . . . 1.6399999999999999 106.857 176.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 8.9 m120 -124.31 101.21 7.06 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.333 0.587 . . . . 2.29 109.766 -177.167 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 62.2 mt -116.63 147.51 19.97 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 115.371 -0.831 . . . . 0.81999999999999995 109.291 -178.297 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.701 ' HB1' ' HD2' ' A' ' 7' ' ' PRO . . . -162.56 167.19 12.58 Favored Pre-proline 0 C--N 1.319 -0.745 0 N-CA-C 108.588 -0.893 . . . . 1.3799999999999999 108.588 -172.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.701 ' HD2' ' HB1' ' A' ' 6' ' ' ALA . 11.2 Cg_exo -32.85 131.58 0.1 Allowed 'Trans proline' 0 C--N 1.357 0.998 0 C-N-CA 124.183 3.255 . . . . 1.73 113.748 -175.326 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 156.0 171.57 22.53 Favored Glycine 0 N--CA 1.441 -1.0 0 N-CA-C 110.154 -1.178 . . . . 1.8400000000000001 110.154 -174.25 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -67.59 137.76 55.93 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 108.95 -0.759 . . . . 1.6100000000000001 108.95 178.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.433 HD12 ' HB3' ' A' ' 13' ' ' ALA . 49.8 tp -59.07 -27.13 65.24 Favored 'General case' 0 C--O 1.232 0.178 0 C-N-CA 122.675 0.39 . . . . 1.1899999999999999 110.204 -178.161 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -49.53 -49.58 45.48 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.185 -0.916 . . . . 2.1099999999999999 109.873 172.663 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 57.9 tttm -68.08 -32.14 72.25 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.561 -0.745 . . . . 2.7200000000000002 110.882 -178.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.433 ' HB3' HD12 ' A' ' 10' ' ' LEU . . . -65.07 -52.48 55.41 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.878 0.371 . . . . 0.46000000000000002 110.043 -179.902 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.452 HD23 HD13 ' A' ' 53' ' ' LEU . 91.5 mt -56.71 -40.6 75.95 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.707 -0.679 . . . . 0.68999999999999995 110.485 173.676 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 9.3 t30 -62.23 -41.06 98.06 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.837 -0.62 . . . . 1.3100000000000001 110.612 179.83 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 24.2 tp60 -59.45 -46.45 88.73 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.194 -0.457 . . . . 2.23 111.475 179.034 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.464 ' HD1' ' HZ ' ' A' ' 23' ' ' PHE . 1.6 t80 -67.74 -44.02 78.55 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 109.061 -0.718 . . . . 0.65000000000000002 109.061 179.568 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.779 ' HA ' ' CE2' ' A' ' 23' ' ' PHE . . . -54.23 -53.7 49.95 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 114.894 -1.048 . . . . 0.37 111.823 179.225 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -65.98 -27.26 68.01 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.794 0.331 . . . . 0.64000000000000001 111.225 -178.34 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . 0.402 ' HB3' ' O ' ' A' ' 17' ' ' TYR . 69.1 t60 -61.52 -49.46 76.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.034 -0.53 . . . . 1.8500000000000001 111.399 -178.617 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.6 ' HB3' ' CD1' ' A' ' 23' ' ' PHE . 1.9 t -109.49 2.85 20.75 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-O 121.136 0.493 . . . . 1.6699999999999999 111.485 -176.882 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 60.23 46.84 93.53 Favored Glycine 0 C--N 1.333 0.397 0 CA-C-N 115.56 -0.746 . . . . 0.62 114.366 174.221 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.925 ' HB3' ' HB3' ' A' ' 67' ' ' ASN . 5.8 p90 -106.47 167.06 10.1 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 117.273 0.536 . . . . 0.56999999999999995 112.017 -179.824 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 6.7 m -94.14 112.88 24.74 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.206 -0.906 . . . . 0.68000000000000005 112.055 -176.369 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.614 HD21 ' CE3' ' A' ' 69' ' ' TRP . 0.6 OUTLIER -88.43 123.68 33.21 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.213 -0.903 . . . . 1.6699999999999999 111.341 176.828 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 20.7 t -103.05 91.14 3.99 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.152 -0.684 . . . . 1.1499999999999999 109.152 176.44 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.7 p -146.78 135.96 16.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.017 -0.538 . . . . 0.90000000000000002 110.922 -178.819 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.561 ' HB3' ' HG ' ' A' ' 31' ' ' LEU . 33.0 t70 -69.49 118.94 13.0 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-N 115.819 -0.628 . . . . 2.3799999999999999 110.339 178.713 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.04 65.17 0.01 OUTLIER 'General case' 0 N--CA 1.466 0.354 0 O-C-N 123.825 0.703 . . . . 1.97 112.172 177.391 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.437 ' HB3' ' OD2' ' A' ' 28' ' ' ASP . 34.3 t -172.68 -28.75 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.717 -0.674 . . . . 2.2200000000000002 109.333 -179.111 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.561 ' HG ' ' HB3' ' A' ' 28' ' ' ASP . 98.1 mt -60.87 -51.26 70.05 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.757 -0.656 . . . . 1.3799999999999999 111.133 178.699 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 6.9 t -101.99 11.31 38.69 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.194 -0.457 . . . . 1.4399999999999999 111.394 -178.362 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 41.2 ttp180 -72.37 128.85 36.9 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.605 -0.271 . . . . 4.6299999999999999 110.407 -177.643 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 88.15 -2.29 85.23 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.864 -0.684 . . . . 1.6200000000000001 111.934 -179.606 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 32.5 tttp -88.95 139.2 30.69 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 109.644 -0.502 . . . . 2.75 109.644 179.627 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 65.4 mt-30 -128.98 150.68 50.29 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 110.044 -0.354 . . . . 2.2400000000000002 110.044 -177.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 20.7 t -126.51 131.2 51.66 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 108.642 -0.873 . . . . 1.02 108.642 178.561 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.613 ' O ' ' HD3' ' A' ' 7' ' ' PRO . 9.2 m120 -73.04 -6.67 47.1 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 112.837 0.68 . . . . 1.28 112.837 -176.223 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 138.48 165.37 10.27 Favored Glycine 0 C--O 1.235 0.178 0 C-N-CA 119.903 -1.142 . . . . 0.41999999999999998 114.049 168.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.736 ' HG ' ' OH ' ' A' ' 44' ' ' TYR . 57.1 tp -161.47 125.34 3.31 Favored 'General case' 0 CA--C 1.537 0.473 0 N-CA-C 108.701 -0.852 . . . . 0.69999999999999996 108.701 -178.606 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 15.4 p80 -145.45 109.0 4.67 Favored 'General case' 0 N--CA 1.472 0.63 0 N-CA-C 112.254 0.465 . . . . 2.96 112.254 -179.049 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -168.92 -178.68 40.55 Favored Glycine 0 C--N 1.334 0.451 0 C-N-CA 120.511 -0.852 . . . . 0.55000000000000004 112.932 170.625 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -86.39 110.64 19.84 Favored 'General case' 0 CA--C 1.517 -0.32 0 N-CA-C 107.801 -1.185 . . . . 2.1800000000000002 107.801 167.255 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.743 ' HE1' ' HB ' ' A' ' 3' ' ' VAL . 51.0 m-85 -101.94 148.21 25.61 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.817 0.818 . . . . 1.4099999999999999 113.015 -167.49 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 31.5 m-20 -92.92 144.21 25.49 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 106.137 -1.801 . . . . 2.23 106.137 156.275 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.471 ' O ' ' HG ' ' A' ' 50' ' ' LEU . 97.0 t -45.69 -63.14 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.528 0 N-CA-C 112.738 0.644 . . . . 0.56999999999999995 112.738 -169.035 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.5 pm0 -62.83 -32.11 73.25 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.883 0.373 . . . . 2.3900000000000001 111.855 -176.131 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 62.5 m -71.08 -34.69 71.39 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.251 0.548 . . . . 1.26 111.075 -175.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -78.86 -27.22 57.05 Favored Glycine 0 N--CA 1.448 -0.525 0 N-CA-C 110.773 -0.931 . . . . 0.37 110.773 -176.539 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.748 ' HB3' HG11 ' A' ' 61' ' ' VAL . 87.6 mt -74.63 -36.18 62.9 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.282 -0.459 . . . . 1.0900000000000001 110.461 179.702 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -59.1 -39.46 82.28 Favored 'General case' 0 N--CA 1.455 -0.186 0 CA-C-N 116.032 -0.531 . . . . 2.5899999999999999 110.397 176.441 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 79.2 mm-40 -64.17 -38.92 92.79 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.859 0.362 . . . . 1.75 111.284 177.736 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.452 HD13 HD23 ' A' ' 14' ' ' LEU . 96.1 mt -60.0 -34.02 72.76 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 120.841 0.353 . . . . 0.72999999999999998 111.395 177.303 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.446 HD22 ' HB2' ' A' ' 59' ' ' LEU . 96.1 mt -84.29 2.03 42.07 Favored 'General case' 0 C--O 1.236 0.347 0 CA-C-N 116.082 -0.508 . . . . 2.1600000000000001 111.807 -176.646 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -62.23 114.86 3.7 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.037 -0.529 . . . . 2.2400000000000002 111.146 -176.418 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 106.31 7.35 35.11 Favored Glycine 0 N--CA 1.45 -0.39 0 CA-C-N 116.005 -0.543 . . . . 1.7 112.533 179.341 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 20.3 p -143.24 -174.2 4.14 Favored 'General case' 0 C--N 1.324 -0.531 0 O-C-N 122.775 -0.25 . . . . 2.2799999999999998 110.573 -178.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -132.05 44.91 1.16 Allowed Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 120.402 -0.904 . . . . 1.5800000000000001 112.844 -175.508 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.584 ' HA ' ' H ' ' A' ' 74' ' ' ALA . 3.9 mp -100.65 177.28 5.05 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.824 -0.436 . . . . 1.4199999999999999 109.824 171.773 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 26.8 tp60 -149.84 117.81 6.31 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 108.893 -0.78 . . . . 2.6699999999999999 108.893 179.098 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.748 HG11 ' HB3' ' A' ' 50' ' ' LEU . 7.4 p -86.54 133.79 28.99 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 N-CA-C 109.655 -0.498 . . . . 1.54 109.655 178.36 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.425 ' HA ' ' HD3' ' A' ' 63' ' ' PRO . 55.1 mtpt -124.6 110.41 28.09 Favored Pre-proline 0 C--N 1.32 -0.688 0 N-CA-C 109.809 -0.441 . . . . 1.8100000000000001 109.809 -178.141 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.555 ' HA ' ' HA ' ' A' ' 69' ' ' TRP . 2.8 Cg_exo -76.65 144.77 25.37 Favored 'Trans proline' 0 N--CA 1.462 -0.344 0 C-N-CA 123.161 2.574 . . . . 0.84999999999999998 112.868 -177.697 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -91.09 23.48 3.23 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.834 0.826 . . . . 1.7 109.474 175.15 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 84.38 -68.1 3.58 Favored Glycine 0 N--CA 1.447 -0.603 0 CA-C-N 114.493 -1.23 . . . . 1.6899999999999999 113.053 175.172 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 58.9 t30 -85.47 74.95 10.25 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.705 0.288 . . . . 2.96 111.184 -175.106 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.925 ' HB3' ' HB3' ' A' ' 23' ' ' PHE . 7.8 m-20 72.35 -26.43 0.18 Allowed 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 113.253 0.834 . . . . 2.5 113.253 170.26 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 15.2 m -85.81 146.45 26.76 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 110.274 -0.269 . . . . 1.3 110.274 -175.578 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . 0.614 ' CE3' HD21 ' A' ' 25' ' ' LEU . 6.6 m0 -140.03 168.73 19.15 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.0 -0.741 . . . . 0.46999999999999997 109.0 -175.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 14.9 t -143.85 136.08 26.73 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.13 -0.692 . . . . 0.82999999999999996 109.13 169.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 54.6 tp -95.11 102.85 14.68 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.079 0.466 . . . . 1.71 110.732 -177.381 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -95.14 128.5 38.59 Favored Pre-proline 0 C--N 1.319 -0.725 0 CA-C-N 115.402 -0.817 . . . . 2.1299999999999999 110.687 174.597 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -73.99 115.49 4.34 Favored 'Trans proline' 0 N--CA 1.46 -0.482 0 C-N-CA 121.976 1.784 . . . . 1.3600000000000001 110.893 174.428 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.584 ' H ' ' HA ' ' A' ' 59' ' ' LEU . . . 176.48 123.11 0.16 Allowed Pre-proline 0 CA--C 1.521 -0.147 0 CA-C-N 116.094 -0.503 . . . . 1.8899999999999999 110.29 -176.291 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 74' ' ' ALA . 5.1 Cg_endo -84.64 37.43 0.62 Allowed 'Trans proline' 0 N--CA 1.456 -0.681 0 C-N-CA 122.704 2.269 . . . . 2.73 111.502 177.35 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.685 ' HB1' ' HB2' ' A' ' 79' ' ' GLU . . . 55.87 55.58 9.56 Favored Pre-proline 0 CA--C 1.53 0.193 0 CA-C-N 115.435 -0.802 . . . . 4.21 110.309 -174.777 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_endo -78.56 -9.93 15.95 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.506 2.137 . . . . 4.2599999999999998 113.023 -169.724 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -118.09 -6.8 10.89 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.876 -0.602 . . . . 6.21 110.044 175.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.685 ' HB2' ' HB1' ' A' ' 76' ' ' ALA . 32.5 mm-40 -97.91 -37.96 9.6 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.735 -0.666 . . . . 8.1099999999999994 109.728 -178.204 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 24.6 m-20 . . . . . 0 C--O 1.248 0.99 0 CA-C-O 118.185 -0.912 . . . . 9.0500000000000007 110.815 -179.369 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.142 0 N-CA-C 110.177 -0.305 . . . . 3.8100000000000001 110.177 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 31.8 tt0 -58.47 119.79 7.63 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.536 0.684 . . . . 4.0 111.545 -177.462 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.455 HG12 HG12 ' A' ' 5' ' ' ILE . 58.2 t -104.34 128.54 57.75 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 CA-C-N 114.861 -1.063 . . . . 1.6399999999999999 108.457 174.545 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 43.8 t30 -126.9 98.87 5.5 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.14 0.495 . . . . 2.29 109.677 -175.405 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.615 HG22 ' HA2' ' A' ' 39' ' ' GLY . 27.1 mm -123.57 156.17 30.08 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 CA-C-N 115.306 -0.861 . . . . 0.81999999999999995 108.777 -177.295 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.649 ' HB1' ' HD2' ' A' ' 7' ' ' PRO . . . -160.04 163.56 22.04 Favored Pre-proline 0 C--N 1.321 -0.657 0 N-CA-C 109.503 -0.554 . . . . 1.3799999999999999 109.503 -177.35 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.649 ' HD2' ' HB1' ' A' ' 6' ' ' ALA . 6.6 Cg_exo -33.3 130.39 0.13 Allowed 'Trans proline' 0 C--N 1.357 1.002 0 C-N-CA 124.398 3.399 . . . . 1.73 113.314 -174.933 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 152.1 169.54 17.67 Favored Glycine 0 N--CA 1.44 -1.078 0 N-CA-C 110.96 -0.856 . . . . 1.8400000000000001 110.96 -174.471 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.664 ' HB3' ' OD2' ' A' ' 11' ' ' ASP . 53.9 m -61.48 141.56 57.61 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 120.815 0.34 . . . . 1.6100000000000001 111.471 179.693 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.75 HD22 ' HB2' ' A' ' 57' ' ' SER . 43.8 tp -59.65 -35.77 75.08 Favored 'General case' 0 CA--C 1.52 -0.175 0 CA-C-O 121.104 0.478 . . . . 1.1899999999999999 110.458 178.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.706 ' HB3' ' HB ' ' A' ' 32' ' ' THR . 2.0 p-10 -56.93 -31.77 65.29 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.305 -0.861 . . . . 2.1099999999999999 111.256 175.735 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 29.0 ttpt -70.52 -41.06 73.08 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.227 0.537 . . . . 2.7200000000000002 109.881 174.418 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -64.97 -55.38 19.41 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 115.424 -0.807 . . . . 0.46000000000000002 110.972 -174.195 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.439 ' HB3' HD11 ' A' ' 25' ' ' LEU . 89.2 mt -58.06 -41.12 82.68 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.809 -0.632 . . . . 0.68999999999999995 111.174 177.743 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 52.9 t30 -62.92 -40.29 97.18 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.223 -0.444 . . . . 1.3100000000000001 110.288 179.102 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -62.57 -42.68 99.7 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.204 -0.453 . . . . 2.23 110.218 176.698 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.469 ' O ' ' HB3' ' A' ' 20' ' ' HIS . 4.9 t80 -65.58 -39.86 92.07 Favored 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 109.229 -0.656 . . . . 0.65000000000000002 109.229 179.77 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.732 ' HA ' ' CZ ' ' A' ' 23' ' ' PHE . . . -55.56 -39.65 70.9 Favored 'General case' 0 CA--C 1.52 -0.184 0 CA-C-N 115.669 -0.696 . . . . 0.37 111.327 175.426 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.49 -30.09 71.27 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.202 -0.454 . . . . 0.64000000000000001 111.212 179.272 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . 0.469 ' HB3' ' O ' ' A' ' 17' ' ' TYR . 62.8 t60 -60.55 -58.43 8.52 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 116.264 -0.425 . . . . 1.8500000000000001 111.701 -177.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.538 ' HB3' ' HD1' ' A' ' 23' ' ' PHE . 11.4 t -98.38 -10.58 23.54 Favored 'General case' 0 CA--C 1.533 0.322 0 CA-C-O 121.13 0.49 . . . . 1.6699999999999999 111.739 -174.615 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 69.01 53.09 20.51 Favored Glycine 0 C--N 1.33 0.205 0 CA-C-N 115.833 -0.621 . . . . 0.62 113.232 179.62 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.732 ' CZ ' ' HA ' ' A' ' 18' ' ' ALA . 26.1 p90 -109.03 167.45 10.08 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.808 0.337 . . . . 0.56999999999999995 110.535 179.264 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 25.3 m -92.9 109.73 21.18 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.439 0.638 . . . . 0.68000000000000005 110.982 178.859 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.439 HD11 ' HB3' ' A' ' 14' ' ' LEU . 4.4 tt -91.64 128.09 37.34 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.433 -0.803 . . . . 1.6699999999999999 109.299 179.7 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 25.4 t -99.09 100.2 11.31 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.07 0.462 . . . . 1.1499999999999999 109.955 -179.319 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.429 HG23 ' HG ' ' A' ' 71' ' ' LEU . 7.3 p -129.34 130.86 67.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 115.987 -0.551 . . . . 0.90000000000000002 110.552 -178.871 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.498 ' OD2' ' HB2' ' A' ' 30' ' ' SER . 23.7 t70 -75.46 123.83 26.11 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.663 -0.699 . . . . 2.3799999999999999 110.816 178.791 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.62 49.75 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 113.338 0.866 . . . . 1.97 113.338 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.498 ' HB2' ' OD2' ' A' ' 28' ' ' ASP . 69.5 m -161.53 -28.12 0.05 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.847 0.356 . . . . 2.2200000000000002 110.19 -179.696 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 75.9 mt -72.64 -43.79 62.76 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.51 0.672 . . . . 1.3799999999999999 110.443 176.59 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.706 ' HB ' ' HB3' ' A' ' 11' ' ' ASP . 9.5 p -96.38 52.55 1.25 Allowed 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.726 -0.67 . . . . 1.4399999999999999 112.279 -175.579 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 4.7 ptp180 -99.96 106.77 18.6 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-O 121.142 0.496 . . . . 4.6299999999999999 111.042 175.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 70.77 46.61 45.01 Favored Glycine 0 N--CA 1.449 -0.474 0 CA-C-N 115.656 -0.702 . . . . 1.6200000000000001 113.569 174.334 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.649 ' O ' ' HA ' ' A' ' 9' ' ' SER . 13.3 mptt -85.27 173.75 10.12 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 110.039 -0.356 . . . . 2.75 110.039 176.037 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 50.3 tt0 -149.84 134.85 17.92 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 120.778 0.323 . . . . 2.2400000000000002 110.871 173.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 42.7 t -132.82 130.61 40.05 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 107.368 -1.345 . . . . 1.02 107.368 171.408 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.422 ' O ' ' HD3' ' A' ' 7' ' ' PRO . 0.1 OUTLIER -69.48 -7.75 40.77 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 113.122 0.786 . . . . 1.28 113.122 -173.89 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.615 ' HA2' HG22 ' A' ' 5' ' ' ILE . . . 117.4 -177.05 16.46 Favored Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 120.134 -1.032 . . . . 0.41999999999999998 113.345 171.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.479 ' N ' ' HB ' ' A' ' 5' ' ' ILE . 60.4 tp -159.96 141.92 13.04 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 108.574 -0.899 . . . . 0.69999999999999996 108.574 -178.414 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 50.8 t-80 -144.27 97.09 2.99 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.919 0.39 . . . . 2.96 110.658 179.72 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -170.46 177.88 43.41 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.973 -0.632 . . . . 0.55000000000000004 111.837 175.071 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -92.7 99.99 12.58 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 108.44 -0.948 . . . . 2.1800000000000002 108.44 171.316 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.44 ' HB2' ' CG2' ' A' ' 3' ' ' VAL . 25.6 m-85 -116.39 156.54 26.57 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 121.455 0.645 . . . . 1.4099999999999999 112.227 -170.817 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -92.73 169.72 10.27 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 114.69 -1.141 . . . . 2.23 108.276 172.374 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.548 ' O ' ' HG ' ' A' ' 50' ' ' LEU . 78.1 t -48.01 -64.78 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 O-C-N 123.05 0.219 . . . . 0.56999999999999995 111.438 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -61.53 -44.32 97.27 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 112.824 0.675 . . . . 2.3900000000000001 112.824 -175.785 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 3.8 p -73.44 -31.06 63.6 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.037 0.446 . . . . 1.26 111.244 -173.418 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -72.48 -36.96 58.74 Favored Glycine 0 N--CA 1.446 -0.666 0 N-CA-C 111.233 -0.747 . . . . 0.37 111.233 179.56 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.548 ' HG ' ' O ' ' A' ' 46' ' ' VAL . 88.1 mt -71.61 -37.34 70.94 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.495 -0.352 . . . . 1.0900000000000001 110.464 178.706 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -53.68 -47.42 70.44 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.866 -0.606 . . . . 2.5899999999999999 110.576 179.307 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 14.1 mm100 -64.72 -42.27 95.36 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-O 120.807 0.337 . . . . 1.75 110.778 179.349 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.411 HD21 HG13 ' A' ' 5' ' ' ILE . 90.8 mt -59.75 -30.34 68.78 Favored 'General case' 0 CA--C 1.534 0.345 0 CA-C-N 116.261 -0.427 . . . . 0.72999999999999998 111.878 178.498 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.633 HD11 HG12 ' A' ' 61' ' ' VAL . 5.9 mp -72.73 -21.11 61.08 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.313 -0.403 . . . . 2.1600000000000001 111.449 -179.457 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -71.94 86.98 1.01 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.139 0.495 . . . . 2.2400000000000002 111.159 -177.234 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 113.1 -9.64 24.93 Favored Glycine 0 CA--C 1.52 0.365 0 CA-C-N 115.904 -0.589 . . . . 1.7 113.457 175.189 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.75 ' HB2' HD22 ' A' ' 10' ' ' LEU . 11.7 p -82.26 -24.72 34.61 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.961 0.381 . . . . 2.2799999999999998 111.91 -175.577 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 88.57 5.1 75.53 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.918 -0.658 . . . . 1.5800000000000001 112.664 176.748 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.571 HD12 HD23 ' A' ' 10' ' ' LEU . 95.8 mt -126.34 179.4 5.3 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.611 0.243 . . . . 1.4199999999999999 110.86 -178.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 9.1 tt0 -147.39 118.97 7.96 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 109.163 -0.68 . . . . 2.6699999999999999 109.163 179.597 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.633 HG12 HD11 ' A' ' 54' ' ' LEU . 7.7 p -98.43 128.02 50.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.721 0 CA-C-O 121.215 0.531 . . . . 1.54 109.978 179.202 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.76 ' HE2' ' HB2' ' A' ' 72' ' ' GLU . 48.1 mtmt -109.36 130.12 23.13 Favored Pre-proline 0 C--N 1.322 -0.592 0 CA-C-N 116.146 -0.479 . . . . 1.8100000000000001 110.719 -176.468 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -67.62 113.43 2.94 Favored 'Trans proline' 0 N--CA 1.457 -0.629 0 C-N-CA 122.102 1.868 . . . . 0.84999999999999998 109.536 168.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 37.3 tp -60.04 -41.8 93.05 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.655 -0.702 . . . . 1.7 111.5 -171.102 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 165.67 -54.61 0.26 Allowed Glycine 0 N--CA 1.448 -0.556 0 N-CA-C 110.207 -1.157 . . . . 1.6899999999999999 110.207 179.381 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 27.5 p-10 -86.32 -158.66 0.42 Allowed 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 108.935 -0.765 . . . . 2.96 108.935 171.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 20.1 p-10 -81.7 49.37 1.33 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.515 0.674 . . . . 2.5 110.796 176.108 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.443 ' O ' ' HD1' ' A' ' 69' ' ' TRP . 40.3 m -139.12 169.24 18.13 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 108.409 -0.96 . . . . 1.3 108.409 174.745 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . 0.443 ' HD1' ' O ' ' A' ' 68' ' ' SER . 45.0 m0 -140.12 171.35 14.31 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 110.035 -0.358 . . . . 0.46999999999999997 110.035 -167.483 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.489 HG23 ' HE3' ' A' ' 62' ' ' LYS . 6.8 t -146.04 147.22 31.39 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.167 -0.47 . . . . 0.82999999999999996 109.989 173.129 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.429 ' HG ' HG23 ' A' ' 27' ' ' VAL . 0.9 OUTLIER -92.77 108.76 20.23 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.123 0.487 . . . . 1.71 110.992 -174.279 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.76 ' HB2' ' HE2' ' A' ' 62' ' ' LYS . 4.3 tp10 -93.21 122.23 63.72 Favored Pre-proline 0 C--N 1.322 -0.608 0 CA-C-N 115.345 -0.843 . . . . 2.1299999999999999 110.539 175.091 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -84.43 113.47 1.71 Allowed 'Trans proline' 0 N--CA 1.453 -0.891 0 C-N-CA 121.863 1.709 . . . . 1.3600000000000001 111.56 174.194 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . 178.7 106.48 0.15 Allowed Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 115.849 -0.614 . . . . 1.8899999999999999 109.776 -178.363 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -83.31 -82.78 0.0 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.686 0 C-N-CA 122.636 2.224 . . . . 2.73 112.667 -179.353 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -151.14 62.2 4.92 Favored Pre-proline 0 C--N 1.32 -0.707 0 N-CA-C 108.156 -1.053 . . . . 4.21 108.156 174.409 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_endo -91.52 14.55 1.85 Allowed 'Trans proline' 0 N--CA 1.453 -0.874 0 C-N-CA 123.086 2.524 . . . . 4.2599999999999998 113.162 -165.461 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 60.9 tttm -113.71 157.19 22.52 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.546 -0.538 . . . . 6.21 109.546 178.696 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 64.56 30.84 12.66 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 121.108 0.48 . . . . 8.1099999999999994 111.236 -176.713 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 28.4 t70 . . . . . 0 C--O 1.247 0.928 0 CA-C-O 118.467 -0.777 . . . . 9.0500000000000007 109.708 176.736 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.942 0 N-CA-C 110.215 -0.291 . . . . 3.8100000000000001 110.215 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.716 ' HB2' ' H ' ' A' ' 44' ' ' TYR . 7.9 mm100 -115.38 -8.81 12.22 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-O 120.864 0.364 . . . . 4.0 111.952 178.552 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 21.5 m -145.61 143.3 21.82 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-N 115.927 -0.579 . . . . 1.6399999999999999 111.114 -178.638 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 4.5 p-10 -128.55 96.88 4.53 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 107.967 -1.123 . . . . 2.29 107.967 171.748 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.411 HD12 ' HB3' ' A' ' 40' ' ' LEU . 21.3 mt -130.86 157.41 43.15 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.761 0 CA-C-N 115.655 -0.702 . . . . 0.81999999999999995 109.883 -170.055 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.741 ' HB1' ' HD2' ' A' ' 7' ' ' PRO . . . -162.36 178.63 1.5 Allowed Pre-proline 0 C--N 1.321 -0.67 0 N-CA-C 108.224 -1.028 . . . . 1.3799999999999999 108.224 -174.569 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.741 ' HD2' ' HB1' ' A' ' 6' ' ' ALA . 51.2 Cg_exo -39.33 129.38 1.6 Allowed 'Trans proline' 0 C--N 1.359 1.122 0 C-N-CA 122.685 2.257 . . . . 1.73 113.023 -178.383 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 163.41 161.85 13.34 Favored Glycine 0 N--CA 1.443 -0.872 0 N-CA-C 110.727 -0.949 . . . . 1.8400000000000001 110.727 -174.664 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.409 ' HA ' ' O ' ' A' ' 35' ' ' LYS . 37.2 p -61.61 137.69 58.26 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.951 0.376 . . . . 1.6100000000000001 110.616 -178.127 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.462 HD21 ' HG ' ' A' ' 54' ' ' LEU . 64.0 tp -60.06 -32.43 70.93 Favored 'General case' 0 CA--C 1.52 -0.204 0 CA-C-O 121.102 0.477 . . . . 1.1899999999999999 109.739 178.648 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.593 ' HB2' ' HB ' ' A' ' 32' ' ' THR . 11.4 t70 -50.32 -54.0 24.68 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.143 -0.935 . . . . 2.1099999999999999 110.449 172.665 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 59.0 tttp -67.09 -32.38 73.49 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 116.213 -0.449 . . . . 2.7200000000000002 110.949 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -64.26 -54.49 32.59 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.292 -0.413 . . . . 0.46000000000000002 110.447 -177.861 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 85.5 mt -57.96 -41.92 83.9 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 115.854 -0.612 . . . . 0.68999999999999995 111.071 176.165 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 12.9 t30 -62.65 -35.21 78.88 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.972 -0.558 . . . . 1.3100000000000001 110.738 179.806 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.453 HE21 ' HB3' ' A' ' 16' ' ' GLN . 0.8 OUTLIER -61.17 -46.74 89.27 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 116.392 -0.367 . . . . 2.23 110.875 175.865 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.645 ' HD1' ' HH2' ' A' ' 69' ' ' TRP . 34.2 t80 -67.64 -32.05 72.48 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 120.986 -0.286 . . . . 0.65000000000000002 110.421 -176.9 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.83 ' HA ' ' CZ ' ' A' ' 23' ' ' PHE . . . -50.94 -34.89 30.57 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 112.114 0.412 . . . . 0.37 112.114 175.625 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.55 -15.71 52.3 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.305 -0.407 . . . . 0.64000000000000001 111.93 179.579 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 30.8 t-80 -59.67 -67.85 0.34 Allowed 'General case' 0 C--N 1.333 -0.127 0 CA-C-N 116.628 -0.26 . . . . 1.8500000000000001 111.42 179.866 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.695 ' HB3' ' HD1' ' A' ' 23' ' ' PHE . 23.0 t -101.12 -6.65 24.05 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.797 0.332 . . . . 1.6699999999999999 111.505 -174.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 70.32 46.74 47.69 Favored Glycine 0 C--N 1.334 0.418 0 C-N-CA 120.771 -0.728 . . . . 0.62 112.524 178.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.83 ' CZ ' ' HA ' ' A' ' 18' ' ' ALA . 11.6 p90 -100.68 170.21 8.51 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.697 0.284 . . . . 0.56999999999999995 110.477 -175.856 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.47 ' O ' ' HB3' ' A' ' 68' ' ' SER . 24.0 m -91.67 111.19 22.6 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.129 0.49 . . . . 0.68000000000000005 110.872 -178.38 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 5.2 tt -93.32 125.82 38.13 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 115.915 -0.584 . . . . 1.6699999999999999 109.565 -179.736 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.629 ' HB2' ' HA ' ' A' ' 70' ' ' THR . 15.2 m -99.1 93.01 5.75 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.158 -0.474 . . . . 1.1499999999999999 109.908 -179.021 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 9.7 p -113.64 141.57 29.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 115.994 -0.548 . . . . 0.90000000000000002 109.758 -178.503 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.421 ' HB3' ' HG ' ' A' ' 31' ' ' LEU . 23.1 t70 -98.0 125.62 43.02 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 110.176 -0.305 . . . . 2.3799999999999999 110.176 179.604 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -65.16 57.97 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.525 0 O-C-N 123.802 0.689 . . . . 1.97 112.622 179.066 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 25.9 t -173.04 -28.61 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.221 -0.445 . . . . 2.2200000000000002 110.042 -179.732 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.421 ' HG ' ' HB3' ' A' ' 28' ' ' ASP . 86.3 mt -77.28 -33.69 55.74 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.328 -0.396 . . . . 1.3799999999999999 111.361 -178.136 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.593 ' HB ' ' HB2' ' A' ' 11' ' ' ASP . 6.0 p -92.4 13.27 20.02 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.26 0.552 . . . . 1.4399999999999999 111.25 179.455 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 39.5 ttm180 -73.16 114.22 11.1 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.635 -0.711 . . . . 4.6299999999999999 110.266 179.646 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 84.08 21.18 57.77 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.74 -0.743 . . . . 1.6200000000000001 111.875 179.688 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.409 ' O ' ' HA ' ' A' ' 9' ' ' SER . 12.7 mptt -107.53 124.04 49.32 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.117 0.484 . . . . 2.75 111.23 -179.001 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 6.8 tt0 -131.69 141.06 49.47 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.353 -0.839 . . . . 2.2400000000000002 109.135 177.734 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 7.3 t -121.8 121.06 36.36 Favored 'General case' 0 N--CA 1.443 -0.823 0 N-CA-C 107.003 -1.48 . . . . 1.02 107.003 174.768 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 8.9 m-80 -70.65 -0.54 8.94 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 113.296 0.85 . . . . 1.28 113.296 -169.662 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 134.97 168.32 11.62 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 119.894 -1.145 . . . . 0.41999999999999998 114.213 166.838 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.433 HD13 ' HG2' ' A' ' 52' ' ' GLN . 60.9 tp -160.59 131.71 5.62 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 107.883 -1.155 . . . . 0.69999999999999996 107.883 179.825 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 39.1 t60 -144.5 97.84 3.1 Favored 'General case' 0 C--N 1.321 -0.635 0 C-N-CA 120.055 -0.658 . . . . 2.96 110.971 179.721 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -169.63 175.78 43.71 Favored Glycine 0 N--CA 1.445 -0.749 0 CA-C-N 115.117 -0.947 . . . . 0.55000000000000004 111.322 176.625 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.528 ' HA ' ' N ' ' A' ' 2' ' ' GLN . 12.2 t70 -83.65 94.41 8.1 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 108.216 -1.031 . . . . 2.1800000000000002 108.216 171.564 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.716 ' H ' ' HB2' ' A' ' 2' ' ' GLN . 45.8 m-85 -115.1 126.57 54.82 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-O 121.111 0.481 . . . . 1.4099999999999999 111.927 -174.718 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -67.97 170.21 8.65 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.254 -0.884 . . . . 2.23 109.915 174.085 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.628 HG13 ' HZ2' ' A' ' 69' ' ' TRP . 86.0 t -48.45 -65.55 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 O-C-N 123.549 0.531 . . . . 0.56999999999999995 111.758 -175.387 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -59.02 -43.46 91.57 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 112.629 0.603 . . . . 2.3900000000000001 112.629 -177.719 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 22.9 t -71.37 -33.21 69.35 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.097 0.475 . . . . 1.26 110.967 -172.513 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -73.73 -39.47 48.12 Favored Glycine 0 N--CA 1.445 -0.713 0 C-N-CA 120.735 -0.745 . . . . 0.37 111.496 -176.335 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.654 ' HB3' HG11 ' A' ' 61' ' ' VAL . 85.9 mt -67.95 -40.4 83.24 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.755 0.312 . . . . 1.0900000000000001 110.857 -179.738 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . 0.424 HE21 ' HB3' ' A' ' 51' ' ' GLN . 0.9 OUTLIER -54.28 -50.13 67.98 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.929 -0.578 . . . . 2.5899999999999999 111.03 179.22 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.433 ' HG2' HD13 ' A' ' 40' ' ' LEU . 25.4 tp60 -68.07 -40.61 82.67 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.395 -0.366 . . . . 1.75 111.226 -177.173 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 51.0 mt -56.6 -42.17 78.26 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 112.217 0.451 . . . . 0.72999999999999998 112.217 -179.303 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.462 ' HG ' HD21 ' A' ' 10' ' ' LEU . 11.0 mp -85.14 -5.02 59.35 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 112.374 0.509 . . . . 2.1600000000000001 112.374 -174.614 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -66.62 105.65 1.59 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.29 0.566 . . . . 2.2400000000000002 109.769 178.752 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 133.6 -15.0 4.7 Favored Glycine 0 N--CA 1.447 -0.615 0 N-CA-C 110.66 -0.976 . . . . 1.7 110.66 -172.038 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 79.4 p -119.49 175.96 5.59 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.271 -0.64 . . . . 2.2799999999999998 109.271 175.709 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -113.74 17.64 20.33 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.21 -0.995 . . . . 1.5800000000000001 112.266 -177.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 98.6 mt -92.24 175.45 6.85 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 110.254 -0.276 . . . . 1.4199999999999999 110.254 -179.137 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 27.2 mp0 -139.0 118.98 13.31 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.156 -0.683 . . . . 2.6699999999999999 109.156 -179.464 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.654 HG11 ' HB3' ' A' ' 50' ' ' LEU . 7.5 p -98.54 127.11 51.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.7 0 N-CA-C 109.674 -0.491 . . . . 1.54 109.674 176.915 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.467 ' HA ' ' HD3' ' A' ' 63' ' ' PRO . 0.0 OUTLIER -140.55 137.06 17.09 Favored Pre-proline 0 C--N 1.323 -0.584 0 CA-C-N 116.234 -0.439 . . . . 1.8100000000000001 110.962 -176.559 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.529 ' HA ' ' HA ' ' A' ' 69' ' ' TRP . 28.4 Cg_exo -62.74 128.79 24.23 Favored 'Trans proline' 0 N--CA 1.462 -0.371 0 C-N-CA 122.915 2.41 . . . . 0.84999999999999998 110.982 177.131 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -66.64 -43.76 83.77 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.702 -0.681 . . . . 1.7 109.732 -177.379 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 165.16 -60.42 0.24 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.564 -0.827 . . . . 1.6899999999999999 112.276 176.336 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 50.5 t30 -86.12 68.85 10.41 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.997 0.427 . . . . 2.96 111.211 -175.597 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 66.4 t30 58.93 12.16 2.22 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-N 115.742 -0.663 . . . . 2.5 111.84 175.73 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.47 ' HB3' ' O ' ' A' ' 24' ' ' THR . 50.7 m -122.5 177.83 5.24 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 108.811 -0.811 . . . . 1.3 108.811 -173.844 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . 0.645 ' HH2' ' HD1' ' A' ' 17' ' ' TYR . 49.9 m0 -137.44 166.18 24.46 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.886 -0.413 . . . . 0.46999999999999997 109.886 -167.357 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.629 ' HA ' ' HB2' ' A' ' 26' ' ' SER . 15.1 t -148.05 147.57 29.72 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 108.814 -0.81 . . . . 0.82999999999999996 108.814 169.921 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 31.8 tp -92.23 103.84 16.27 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.442 0.639 . . . . 1.71 109.928 -179.192 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -88.11 119.49 70.38 Favored Pre-proline 0 C--N 1.319 -0.753 0 CA-C-N 114.918 -1.037 . . . . 2.1299999999999999 111.19 -179.715 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -90.32 115.14 0.53 Allowed 'Trans proline' 0 N--CA 1.449 -1.143 0 C-N-CA 122.393 2.062 . . . . 1.3600000000000001 112.33 177.404 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -163.83 73.57 1.77 Allowed Pre-proline 0 C--N 1.323 -0.556 0 CA-C-N 115.725 -0.67 . . . . 1.8899999999999999 109.487 176.31 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.492 ' C ' ' HD3' ' A' ' 77' ' ' PRO . 80.7 Cg_endo -85.92 -136.15 0.02 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.796 0 C-N-CA 122.407 2.072 . . . . 2.73 111.942 -172.514 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.416 ' H ' ' HB2' ' A' ' 75' ' ' PRO . . . -113.56 70.71 1.61 Allowed Pre-proline 0 C--N 1.324 -0.523 0 N-CA-C 109.058 -0.719 . . . . 4.21 109.058 172.402 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.492 ' HD3' ' C ' ' A' ' 75' ' ' PRO . 43.3 Cg_endo -91.21 60.53 1.16 Allowed 'Trans proline' 0 N--CA 1.453 -0.891 0 C-N-CA 123.012 2.475 . . . . 4.2599999999999998 112.018 -169.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 67.5 mttm -124.1 13.82 9.07 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.267 -0.424 . . . . 6.21 111.512 -175.373 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -155.45 60.69 0.62 Allowed 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.636 -0.426 . . . . 8.1099999999999994 111.503 -176.515 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 31.2 t70 . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.535 -0.745 . . . . 9.0500000000000007 110.109 175.906 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.893 0 N-CA-C 109.95 -0.389 . . . . 3.8100000000000001 109.95 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 32.9 mm-40 -74.0 110.76 8.54 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.86 0.362 . . . . 4.0 111.012 -178.859 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 31.4 m -103.39 136.36 36.55 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-N 115.964 -0.562 . . . . 1.6399999999999999 109.787 174.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -127.01 96.55 4.65 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 108.589 -0.893 . . . . 2.29 108.589 -179.81 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.504 HD12 ' HB3' ' A' ' 40' ' ' LEU . 50.5 mt -126.11 149.24 30.85 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.761 0 CA-C-N 115.763 -0.653 . . . . 0.81999999999999995 110.153 -173.821 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.564 ' HB1' ' HD2' ' A' ' 7' ' ' PRO . . . -162.96 168.12 10.83 Favored Pre-proline 0 C--N 1.323 -0.544 0 N-CA-C 108.844 -0.798 . . . . 1.3799999999999999 108.844 -176.381 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.564 ' HD2' ' HB1' ' A' ' 6' ' ' ALA . 89.8 Cg_exo -44.56 133.48 9.89 Favored 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 122.806 2.337 . . . . 1.73 112.998 -178.103 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.401 ' O ' ' HG2' ' A' ' 12' ' ' LYS . . . 154.91 41.56 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.635 -0.793 . . . . 1.8400000000000001 112.062 178.299 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.624 ' HA ' ' HA ' ' A' ' 36' ' ' GLN . 20.2 m 66.98 138.92 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.281 0 CA-C-O 121.326 0.584 . . . . 1.6100000000000001 110.699 -172.376 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.596 HD11 ' HB3' ' A' ' 53' ' ' LEU . 49.5 tp -58.37 -24.2 59.22 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.138 0.494 . . . . 1.1899999999999999 110.27 177.284 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -48.06 -51.59 23.72 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.073 -0.967 . . . . 2.1099999999999999 111.892 175.031 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.451 ' HE3' ' HB2' ' A' ' 12' ' ' LYS . 0.0 OUTLIER -66.91 -25.47 66.39 Favored 'General case' 0 C--N 1.335 -0.063 0 C-N-CA 121.064 -0.255 . . . . 2.7200000000000002 111.375 -176.397 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -65.42 -59.29 4.17 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.049 0.452 . . . . 0.46000000000000002 110.073 178.796 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 86.9 mt -58.46 -37.38 75.36 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.675 -0.693 . . . . 0.68999999999999995 110.905 176.428 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 47.4 t30 -60.94 -40.76 94.52 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.257 -0.429 . . . . 1.3100000000000001 110.257 178.399 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -61.1 -47.87 84.28 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 116.028 -0.533 . . . . 2.23 110.541 178.548 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.53 ' O ' ' HB3' ' A' ' 20' ' ' HIS . 3.1 t80 -69.58 -43.93 71.86 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-O 120.871 0.367 . . . . 0.65000000000000002 110.251 -177.653 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.604 ' HA ' ' CZ ' ' A' ' 23' ' ' PHE . . . -53.92 -53.48 52.11 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 115.912 -0.585 . . . . 0.37 112.275 -179.72 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.53 -22.55 66.4 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.804 0.335 . . . . 0.64000000000000001 111.517 -178.817 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . 0.53 ' HB3' ' O ' ' A' ' 17' ' ' TYR . 77.9 t60 -65.73 -52.12 53.77 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.993 -0.549 . . . . 1.8500000000000001 111.5 -179.866 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.43 ' HB2' ' CD1' ' A' ' 23' ' ' PHE . 19.7 m -108.13 -3.6 18.45 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 112.619 0.599 . . . . 1.6699999999999999 112.619 -174.355 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 69.2 47.73 50.88 Favored Glycine 0 C--O 1.227 -0.295 0 CA-C-N 116.142 -0.481 . . . . 0.62 113.884 174.262 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.604 ' CZ ' ' HA ' ' A' ' 18' ' ' ALA . 13.3 p90 -110.78 162.93 14.29 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.84 0.32 . . . . 0.56999999999999995 110.209 178.398 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.63 ' O ' ' HB3' ' A' ' 68' ' ' SER . 28.0 m -98.11 122.17 40.93 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.363 0.601 . . . . 0.68000000000000005 112.173 -174.725 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.481 HD21 ' CE3' ' A' ' 69' ' ' TRP . 1.1 mm? -88.49 115.11 25.77 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.677 -0.692 . . . . 1.6699999999999999 110.322 175.491 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 32.9 t -98.08 93.92 6.55 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.795 -0.638 . . . . 1.1499999999999999 109.799 -179.653 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.752 HG21 HD12 ' A' ' 71' ' ' LEU . 7.2 p -148.16 141.71 18.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.768 -0.651 . . . . 0.90000000000000002 110.655 -178.849 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -88.88 132.12 34.81 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.933 -0.576 . . . . 2.3799999999999999 110.009 175.578 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.33 78.57 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.308 0 O-C-N 123.8 0.687 . . . . 1.97 111.863 179.658 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 74.1 m -165.83 -38.19 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 123.142 0.577 . . . . 2.2200000000000002 109.556 -179.736 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 88.0 mt -75.24 -33.17 61.28 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.093 -0.503 . . . . 1.3799999999999999 110.693 178.791 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 7.5 p -92.32 -10.93 36.54 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.329 -0.396 . . . . 1.4399999999999999 110.948 177.526 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 53.1 ttp180 -64.69 107.12 1.33 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.815 -0.63 . . . . 4.6299999999999999 110.143 179.87 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 102.51 17.66 18.83 Favored Glycine 0 N--CA 1.444 -0.806 0 C-N-CA 121.002 -0.618 . . . . 1.6200000000000001 111.797 -177.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 12.9 mptt -107.5 122.26 46.3 Favored 'General case' 0 CA--C 1.514 -0.418 0 CA-C-O 121.106 0.479 . . . . 2.75 111.711 178.85 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . 0.624 ' HA ' ' HA ' ' A' ' 9' ' ' SER . 18.4 pt20 -138.24 133.66 33.43 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.564 -0.744 . . . . 2.2400000000000002 109.168 173.593 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.424 ' O ' ' HA ' ' A' ' 7' ' ' PRO . 19.2 t -115.66 140.3 49.32 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 109.569 -0.53 . . . . 1.02 109.569 -176.567 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.402 ' N ' HD22 ' A' ' 38' ' ' ASN . 0.9 OUTLIER -71.0 2.9 3.81 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 112.162 0.431 . . . . 1.28 112.162 177.258 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.46 ' HA3' ' HA ' ' A' ' 6' ' ' ALA . . . 114.85 -178.03 17.72 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.775 -0.726 . . . . 0.41999999999999998 113.445 166.331 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.504 ' HB3' HD12 ' A' ' 5' ' ' ILE . 56.1 tp -160.82 131.07 5.15 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 107.797 -1.186 . . . . 0.69999999999999996 107.797 179.632 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 17.4 t-160 -143.4 99.89 3.51 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 120.07 -0.652 . . . . 2.96 111.71 -177.63 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -169.03 -169.68 32.7 Favored Glycine 0 N--CA 1.448 -0.545 0 CA-C-N 115.403 -0.817 . . . . 0.55000000000000004 111.459 176.156 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -103.55 90.64 3.74 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 108.832 -0.803 . . . . 2.1800000000000002 108.832 172.112 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 64.1 m-85 -110.47 151.86 27.02 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.61 -0.723 . . . . 1.4099999999999999 110.584 -175.79 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -99.47 -171.94 2.16 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 108.302 -0.999 . . . . 2.23 108.302 174.218 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.423 ' O ' ' HG ' ' A' ' 50' ' ' LEU . 39.2 t -51.7 -71.0 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 N-CA-C 112.976 0.732 . . . . 0.56999999999999995 112.976 -172.636 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.31 -47.45 82.22 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 113.266 0.839 . . . . 2.3900000000000001 113.266 -169.102 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 7.5 t -73.97 -26.86 60.7 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.032 0.444 . . . . 1.26 110.75 -170.692 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -75.13 -38.94 38.56 Favored Glycine 0 N--CA 1.447 -0.626 0 N-CA-C 111.042 -0.823 . . . . 0.37 111.042 -178.874 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.775 HD13 HG11 ' A' ' 61' ' ' VAL . 80.7 mt -70.11 -41.53 73.87 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 115.441 -0.379 . . . . 1.0900000000000001 110.261 179.068 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 55.3 tp60 -55.96 -38.06 69.87 Favored 'General case' 0 CA--C 1.53 0.18 0 CA-C-N 116.102 -0.499 . . . . 2.5899999999999999 111.524 -179.244 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 24.6 mm-40 -63.5 -45.64 89.75 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.857 0.361 . . . . 1.75 110.616 177.771 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.596 ' HB3' HD11 ' A' ' 10' ' ' LEU . 90.3 mt -60.94 -22.87 64.83 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.838 -0.619 . . . . 0.72999999999999998 111.859 176.787 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.782 HD21 HG23 ' A' ' 61' ' ' VAL . 87.4 mt -85.28 -24.05 27.91 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 112.14 0.422 . . . . 2.1600000000000001 112.14 -175.494 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -70.07 93.63 0.82 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.179 0.514 . . . . 2.2400000000000002 110.905 -175.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 114.77 -10.45 21.2 Favored Glycine 0 N--CA 1.446 -0.69 0 CA-C-N 115.799 -0.637 . . . . 1.7 112.532 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.429 ' OG ' ' HA ' ' A' ' 54' ' ' LEU . 27.1 p -98.92 -12.12 21.0 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.883 0.373 . . . . 2.2799999999999998 111.448 -178.547 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.581 ' HA2' ' HB3' ' A' ' 75' ' ' PRO . . . 71.3 28.39 70.0 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 121.0 -0.619 . . . . 1.5800000000000001 112.892 175.72 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 94.8 mt -119.12 167.98 11.29 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.74 0.305 . . . . 1.4199999999999999 110.857 -178.555 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . 0.419 ' HA ' HD13 ' A' ' 54' ' ' LEU . 62.8 tt0 -143.97 118.97 10.0 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 109.082 -0.71 . . . . 2.6699999999999999 109.082 177.47 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.782 HG23 HD21 ' A' ' 54' ' ' LEU . 36.8 t -94.81 130.2 43.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 N-CA-C 110.044 -0.354 . . . . 1.54 110.044 -178.25 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.414 ' HA ' ' HD3' ' A' ' 63' ' ' PRO . 17.9 ptmt -131.67 127.61 21.47 Favored Pre-proline 0 C--N 1.317 -0.815 0 N-CA-C 109.624 -0.51 . . . . 1.8100000000000001 109.624 179.015 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 62' ' ' LYS . 32.2 Cg_exo -60.15 132.92 46.85 Favored 'Trans proline' 0 N--CA 1.463 -0.279 0 C-N-CA 122.577 2.185 . . . . 0.84999999999999998 111.191 177.612 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 42.7 tp -69.27 -40.31 77.87 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.713 -0.676 . . . . 1.7 110.925 -174.592 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 158.65 -44.48 0.47 Allowed Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.758 -0.735 . . . . 1.6899999999999999 112.092 175.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 9.2 m120 -77.15 -89.39 0.04 OUTLIER 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.394 0.616 . . . . 2.96 110.644 -179.481 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 30.4 p-10 -146.69 24.85 1.2 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.626 -0.715 . . . . 2.5 109.095 177.057 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.63 ' HB3' ' O ' ' A' ' 24' ' ' THR . 50.4 m -128.74 178.82 6.07 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 108.178 -1.045 . . . . 1.3 108.178 -171.784 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . 0.481 ' CE3' HD21 ' A' ' 25' ' ' LEU . 1.9 m0 -140.15 169.73 17.16 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 119.836 -0.746 . . . . 0.46999999999999997 110.055 -170.864 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 9.6 t -140.97 144.03 34.85 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 108.722 -0.844 . . . . 0.82999999999999996 108.722 171.654 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.752 HD12 HG21 ' A' ' 27' ' ' VAL . 52.0 mt -93.85 105.62 17.63 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.415 0.626 . . . . 1.71 111.484 -173.839 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 18.4 tt0 -89.44 129.48 47.14 Favored Pre-proline 0 C--N 1.318 -0.789 0 CA-C-N 115.051 -0.977 . . . . 2.1299999999999999 110.347 174.108 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -79.12 114.68 3.39 Favored 'Trans proline' 0 N--CA 1.453 -0.875 0 C-N-CA 121.92 1.747 . . . . 1.3600000000000001 111.325 177.75 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -172.93 94.99 0.36 Allowed Pre-proline 0 C--N 1.322 -0.598 0 CA-C-N 115.654 -0.703 . . . . 1.8899999999999999 110.446 -179.121 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.581 ' HB3' ' HA2' ' A' ' 58' ' ' GLY . 97.1 Cg_endo -80.73 35.41 0.58 Allowed 'Trans proline' 0 N--CA 1.462 -0.369 0 C-N-CA 122.717 2.278 . . . . 2.73 111.809 178.755 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 58.46 64.41 3.59 Favored Pre-proline 0 C--N 1.332 -0.196 0 CA-C-N 115.786 -0.643 . . . . 4.21 109.411 -170.842 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -84.04 62.15 6.79 Favored 'Trans proline' 0 N--CA 1.455 -0.764 0 C-N-CA 122.939 2.426 . . . . 4.2599999999999998 112.112 -173.492 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.61 59.12 1.46 Allowed 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.012 -0.995 . . . . 6.21 110.068 -178.933 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 4.1 mp0 -58.54 110.02 0.9 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.59 -0.732 . . . . 8.1099999999999994 110.823 -177.806 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 33.1 t70 . . . . . 0 C--O 1.248 1.003 0 CA-C-O 118.244 -0.884 . . . . 9.0500000000000007 110.051 -178.15 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.957 0 CA-C-O 121.02 0.438 . . . . 3.8100000000000001 111.047 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 5.1 pm0 -143.12 139.28 30.34 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 109.353 -0.61 . . . . 4.0 109.353 176.352 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 33.7 m -137.39 152.74 27.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 120.73 0.3 . . . . 1.6399999999999999 110.922 -175.645 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 31.7 m-80 -127.82 96.31 4.47 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 108.641 -0.874 . . . . 2.29 108.641 174.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.421 HG21 HD21 ' A' ' 53' ' ' LEU . 28.8 mm -119.69 149.71 22.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 N-CA-C 109.406 -0.591 . . . . 0.81999999999999995 109.406 -176.423 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -163.4 162.15 17.54 Favored Pre-proline 0 C--N 1.323 -0.578 0 N-CA-C 109.488 -0.56 . . . . 1.3799999999999999 109.488 -177.205 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.452 ' HA ' ' O ' ' A' ' 37' ' ' SER . 53.3 Cg_exo -52.23 130.54 35.92 Favored 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 122.95 2.433 . . . . 1.73 113.006 -175.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 158.69 48.03 0.01 OUTLIER Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 120.744 -0.741 . . . . 1.8400000000000001 112.255 -178.345 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 19.8 m 67.81 126.81 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 123.155 0.582 . . . . 1.6100000000000001 111.285 -177.167 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.623 HD11 ' HB3' ' A' ' 53' ' ' LEU . 67.1 tp -60.78 -36.01 77.89 Favored 'General case' 0 CA--C 1.521 -0.147 0 CA-C-N 116.109 -0.496 . . . . 1.1899999999999999 110.482 179.589 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -49.23 -55.02 13.94 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.471 -0.786 . . . . 2.1099999999999999 111.018 173.534 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 64.5 tttm -67.95 -27.67 66.8 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.944 0.402 . . . . 2.7200000000000002 111.086 -178.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -66.08 -56.77 9.83 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.289 -0.414 . . . . 0.46000000000000002 110.112 178.541 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 96.2 mt -59.42 -38.39 80.5 Favored 'General case' 0 C--O 1.232 0.162 0 CA-C-N 115.959 -0.564 . . . . 0.68999999999999995 110.981 175.773 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 25.2 t-20 -60.95 -38.58 86.39 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.937 -0.574 . . . . 1.3100000000000001 110.397 179.254 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 6.3 tt0 -62.86 -40.03 96.23 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.994 -0.548 . . . . 2.23 110.648 176.848 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.493 ' HD1' ' HZ ' ' A' ' 23' ' ' PHE . 3.7 t80 -67.86 -41.68 82.5 Favored 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 108.477 -0.935 . . . . 0.65000000000000002 108.477 179.813 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.718 ' HA ' ' CE2' ' A' ' 23' ' ' PHE . . . -55.2 -48.06 74.4 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.292 -0.867 . . . . 0.37 111.76 175.699 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.84 -25.1 67.31 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.242 -0.435 . . . . 0.64000000000000001 111.544 -179.364 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 74.0 t60 -64.43 -49.01 73.18 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.282 -0.417 . . . . 1.8500000000000001 111.602 -177.118 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.406 ' HB2' ' CD1' ' A' ' 23' ' ' PHE . 15.8 m -108.68 -11.24 15.1 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.584 -0.447 . . . . 1.6699999999999999 112.116 -175.896 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 75.78 58.06 3.92 Favored Glycine 0 CA--C 1.519 0.322 0 CA-C-N 115.932 -0.576 . . . . 0.62 113.564 177.066 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.718 ' CE2' ' HA ' ' A' ' 18' ' ' ALA . 10.6 p90 -117.97 169.85 9.31 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.968 0.384 . . . . 0.56999999999999995 111.028 178.524 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 13.3 m -92.18 118.18 30.59 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-O 121.201 0.524 . . . . 0.68000000000000005 112.226 -172.193 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.616 HD21 ' CE3' ' A' ' 69' ' ' TRP . 1.5 mm? -99.32 138.98 35.65 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.71 -0.677 . . . . 1.6699999999999999 110.742 175.056 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 44.4 m -125.41 100.74 6.63 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.075 0.464 . . . . 1.1499999999999999 110.197 177.144 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 5.9 p -145.67 135.32 17.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.737 -0.665 . . . . 0.90000000000000002 110.785 -177.865 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -98.98 129.01 45.25 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.076 -0.511 . . . . 2.3799999999999999 109.724 177.81 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -54.36 -23.79 16.91 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 113.877 1.065 . . . . 1.97 113.877 -172.098 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 85.4 p -66.42 -27.49 67.88 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.12 0.486 . . . . 2.2200000000000002 110.718 -175.278 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 96.7 mt -75.99 -47.13 26.13 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.551 -0.75 . . . . 1.3799999999999999 111.13 -177.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 3.5 t -99.31 40.78 1.19 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.621 0.724 . . . . 1.4399999999999999 110.706 -177.217 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.479 ' O ' ' HG3' ' A' ' 33' ' ' ARG . 8.6 ptp180 -63.25 105.89 0.8 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.656 -0.702 . . . . 4.6299999999999999 111.039 179.546 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 63.01 19.44 61.31 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 121.088 -0.577 . . . . 1.6200000000000001 112.377 179.656 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.637 ' HE3' ' HA ' ' A' ' 57' ' ' SER . 8.6 tptp -74.32 112.71 10.75 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.601 -0.518 . . . . 2.75 109.601 -177.149 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 14.0 pt20 -103.87 156.65 17.66 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.731 0.301 . . . . 2.2400000000000002 110.479 -177.122 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.452 ' O ' ' HA ' ' A' ' 7' ' ' PRO . 46.7 t -128.62 130.27 47.05 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 107.222 -1.399 . . . . 1.02 107.222 172.657 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 8.0 m120 -63.96 -15.23 58.76 Favored 'General case' 0 C--N 1.322 -0.606 0 O-C-N 123.441 0.463 . . . . 1.28 112.086 -173.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 123.36 172.31 13.78 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.901 -0.666 . . . . 0.41999999999999998 112.159 172.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.411 ' HB3' ' HB ' ' A' ' 5' ' ' ILE . 31.4 tp -161.31 121.39 2.65 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.023 -0.732 . . . . 0.69999999999999996 109.023 -177.338 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 19.2 t-80 -143.85 99.28 3.38 Favored 'General case' 0 C--N 1.321 -0.664 0 C-N-CA 120.205 -0.598 . . . . 2.96 110.892 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -168.27 -169.54 31.86 Favored Glycine 0 N--CA 1.446 -0.656 0 CA-C-N 115.451 -0.795 . . . . 0.55000000000000004 111.917 178.252 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -78.35 85.98 4.45 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 109.518 -0.549 . . . . 2.1800000000000002 109.518 174.789 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 67.5 m-85 -119.53 122.57 41.93 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.289 0.566 . . . . 1.4099999999999999 111.628 -176.205 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -84.25 -174.49 5.31 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.278 -0.873 . . . . 2.23 108.798 173.758 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 47.3 t -51.88 -67.93 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-O 120.671 0.272 . . . . 0.56999999999999995 111.499 -177.319 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -55.11 -41.76 72.07 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 112.815 0.672 . . . . 2.3900000000000001 112.815 -176.105 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 22.1 m -71.69 -31.04 66.34 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 120.966 0.412 . . . . 1.26 111.34 -174.831 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.415 ' O ' ' HG ' ' A' ' 53' ' ' LEU . . . -71.82 -49.21 24.19 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.85 -0.691 . . . . 0.37 112.071 -175.705 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.441 ' O ' ' HG ' ' A' ' 54' ' ' LEU . 8.5 mp -65.57 -38.73 90.4 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 121.959 0.104 . . . . 1.0900000000000001 111.208 -178.248 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 58.1 tt0 -53.27 -52.99 57.25 Favored 'General case' 0 C--N 1.331 -0.218 0 O-C-N 123.222 0.326 . . . . 2.5899999999999999 111.752 179.743 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 12.5 mm100 -64.31 -41.9 96.62 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.882 0.373 . . . . 1.75 111.035 -177.808 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.623 ' HB3' HD11 ' A' ' 10' ' ' LEU . 88.0 mt -59.71 -21.48 60.71 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 115.905 -0.589 . . . . 0.72999999999999998 112.417 -179.796 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.643 HD21 HG12 ' A' ' 61' ' ' VAL . 65.0 mt -75.36 -14.52 60.48 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.032 0.382 . . . . 2.1600000000000001 112.032 -177.415 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -72.3 131.61 42.91 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.995 0.426 . . . . 2.2400000000000002 110.09 -177.345 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 101.72 -17.45 54.81 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.889 -0.672 . . . . 1.7 111.526 -175.838 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.637 ' HA ' ' HE3' ' A' ' 35' ' ' LYS . 4.3 m -102.55 160.07 14.89 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-O 120.733 0.302 . . . . 2.2799999999999998 110.203 178.501 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -107.27 35.75 4.83 Favored Glycine 0 N--CA 1.441 -0.984 0 N-CA-C 109.705 -1.358 . . . . 1.5800000000000001 109.705 171.018 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.637 ' HB3' HD21 ' A' ' 71' ' ' LEU . 50.7 mt -126.57 174.31 8.78 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.265 -0.642 . . . . 1.4199999999999999 109.265 -177.866 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 24.3 mt-30 -146.94 118.97 8.19 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.348 -0.612 . . . . 2.6699999999999999 109.348 179.733 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.643 HG12 HD21 ' A' ' 54' ' ' LEU . 7.6 p -86.65 130.36 36.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 N-CA-C 109.667 -0.494 . . . . 1.54 109.667 179.153 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 26.8 ttpp -131.53 131.73 23.05 Favored Pre-proline 0 N--CA 1.442 -0.834 0 N-CA-C 109.816 -0.438 . . . . 1.8100000000000001 109.816 -174.622 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -54.09 125.71 19.67 Favored 'Trans proline' 0 N--CA 1.463 -0.313 0 C-N-CA 122.418 2.079 . . . . 0.84999999999999998 111.088 177.433 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.556 ' HG ' ' HB ' ' A' ' 70' ' ' THR . 0.7 OUTLIER -74.03 -63.66 1.17 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.46 -0.791 . . . . 1.7 110.254 -173.856 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -155.48 -107.07 0.27 Allowed Glycine 0 N--CA 1.445 -0.74 0 C-N-CA 120.755 -0.736 . . . . 1.6899999999999999 111.961 177.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -80.81 94.55 6.45 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.571 0.225 . . . . 2.96 110.687 179.787 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.591 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 2.8 t-20 58.08 39.6 26.06 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.404 0.621 . . . . 2.5 110.44 174.759 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.44 ' O ' ' HD1' ' A' ' 69' ' ' TRP . 15.2 p -135.82 169.13 18.06 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 109.457 -0.572 . . . . 1.3 109.457 179.235 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . 0.616 ' CE3' HD21 ' A' ' 25' ' ' LEU . 26.8 m0 -140.87 154.69 46.28 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 108.975 -0.75 . . . . 0.46999999999999997 108.975 -175.354 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.556 ' HB ' ' HG ' ' A' ' 64' ' ' LEU . 8.6 t -137.73 138.13 39.01 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 108.802 -0.814 . . . . 0.82999999999999996 108.802 175.002 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.637 HD21 ' HB3' ' A' ' 59' ' ' LEU . 6.5 tt -93.12 102.57 14.89 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.51 0.671 . . . . 1.71 109.799 -178.451 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.424 ' HA ' ' HD3' ' A' ' 73' ' ' PRO . 25.8 mm-40 -89.3 132.73 36.6 Favored Pre-proline 0 C--N 1.319 -0.738 0 CA-C-N 114.678 -1.146 . . . . 2.1299999999999999 111.248 178.649 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 72' ' ' GLU . 7.7 Cg_exo -73.15 115.15 4.25 Favored 'Trans proline' 0 N--CA 1.461 -0.392 0 C-N-CA 122.677 2.251 . . . . 1.3600000000000001 111.574 176.361 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -167.88 92.02 0.66 Allowed Pre-proline 0 C--N 1.324 -0.532 0 CA-C-N 116.039 -0.528 . . . . 1.8899999999999999 109.758 -178.102 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -79.28 -78.68 0.0 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.569 0 C-N-CA 122.543 2.162 . . . . 2.73 112.133 -178.42 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -142.55 62.83 13.5 Favored Pre-proline 0 C--N 1.321 -0.652 0 N-CA-C 108.147 -1.057 . . . . 4.21 108.147 171.241 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -94.78 30.15 0.23 Allowed 'Trans proline' 0 N--CA 1.451 -1.022 0 C-N-CA 123.408 2.739 . . . . 4.2599999999999998 112.669 -168.43 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.566 ' HG2' ' HB3' ' A' ' 80' ' ' ASP . 27.6 ttpp -158.61 107.75 1.97 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.978 -0.556 . . . . 6.21 109.97 178.473 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 28.2 mm-40 -77.45 63.5 2.62 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.327 0.584 . . . . 8.1099999999999994 109.907 176.69 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.566 ' HB3' ' HG2' ' A' ' 78' ' ' LYS . 17.3 t70 . . . . . 0 C--O 1.246 0.904 0 CA-C-O 118.072 -0.966 . . . . 9.0500000000000007 109.346 -176.559 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.442 ' O ' ' HA ' ' A' ' 43' ' ' ASP . . . . . . . . 0 N--CA 1.481 1.106 0 N-CA-C 110.152 -0.314 . . . . 3.8100000000000001 110.152 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 19.6 pt20 -86.88 134.9 33.49 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.327 0.584 . . . . 4.0 110.841 -178.631 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.63 ' O ' ' HA ' ' A' ' 41' ' ' HIS . 36.2 t -101.59 131.7 48.92 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.938 0 CA-C-N 115.301 -0.863 . . . . 1.6399999999999999 108.859 174.492 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -129.48 109.49 11.09 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.229 0.537 . . . . 2.29 109.995 179.465 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.644 HD13 ' HB1' ' A' ' 13' ' ' ALA . 68.6 mt -131.02 127.06 60.58 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-N 115.932 -0.576 . . . . 0.81999999999999995 110.537 -177.199 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -76.18 159.7 79.69 Favored Pre-proline 0 N--CA 1.45 -0.459 0 CA-C-N 115.916 -0.584 . . . . 1.3799999999999999 109.657 177.446 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.587 ' HA ' ' O ' ' A' ' 37' ' ' SER . 44.7 Cg_endo -69.6 49.91 0.72 Allowed 'Trans proline' 0 CA--C 1.534 0.495 0 C-N-CA 122.915 2.41 . . . . 1.73 113.123 177.632 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -116.75 -150.06 9.25 Favored Glycine 0 C--O 1.226 -0.347 0 C-N-CA 121.241 -0.504 . . . . 1.8400000000000001 112.574 -178.703 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.583 ' HA ' ' O ' ' A' ' 35' ' ' LYS . 22.8 p -62.54 125.47 24.05 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.162 0.506 . . . . 1.6100000000000001 111.867 -176.294 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.804 ' HB3' ' HB3' ' A' ' 35' ' ' LYS . 70.3 tp -65.49 -32.4 73.98 Favored 'General case' 0 N--CA 1.456 -0.172 0 CA-C-N 115.64 -0.709 . . . . 1.1899999999999999 109.696 178.758 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.579 ' OD2' ' HB ' ' A' ' 32' ' ' THR . 10.6 m-20 -50.5 -53.89 26.52 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.19 -0.914 . . . . 2.1099999999999999 110.401 175.21 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -68.84 -26.66 65.27 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.772 -0.649 . . . . 2.7200000000000002 110.638 177.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.644 ' HB1' HD13 ' A' ' 5' ' ' ILE . . . -67.36 -53.07 32.73 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.988 -0.551 . . . . 0.46000000000000002 110.816 -178.85 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 87.2 mt -56.96 -43.73 81.88 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.116 -0.493 . . . . 0.68999999999999995 110.873 177.026 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 52.9 t30 -62.4 -32.55 73.39 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.831 -0.622 . . . . 1.3100000000000001 110.371 -179.64 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -62.16 -45.35 93.79 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.283 -0.417 . . . . 2.23 110.445 177.096 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 13.5 t80 -71.38 -41.36 69.78 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 109.65 -0.5 . . . . 0.65000000000000002 109.65 -178.78 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.709 ' HA ' ' CE2' ' A' ' 23' ' ' PHE . . . -53.37 -53.41 51.47 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 115.501 -0.772 . . . . 0.37 112.141 178.194 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -64.54 -26.2 68.31 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.311 -0.404 . . . . 0.64000000000000001 111.461 -178.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 70.5 t60 -64.8 -45.19 87.28 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.293 -0.412 . . . . 1.8500000000000001 111.298 -176.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.479 ' HB2' ' CE1' ' A' ' 23' ' ' PHE . 24.5 m -101.04 -7.02 23.63 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.269 0.557 . . . . 1.6699999999999999 111.594 -178.735 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 67.66 47.11 63.63 Favored Glycine 0 N--CA 1.449 -0.494 0 CA-C-N 115.309 -0.86 . . . . 0.62 114.023 176.791 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.709 ' CE2' ' HA ' ' A' ' 18' ' ' ALA . 5.9 p90 -109.21 160.73 15.87 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 117.389 0.595 . . . . 0.56999999999999995 110.624 175.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.447 ' O ' ' HB3' ' A' ' 68' ' ' SER . 25.0 m -88.14 119.82 28.9 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.431 0.634 . . . . 0.68000000000000005 112.529 -171.532 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.577 HD21 ' CE3' ' A' ' 69' ' ' TRP . 1.6 mm? -95.73 121.34 37.34 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.609 -0.723 . . . . 1.6699999999999999 111.174 176.617 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 18.9 m -104.35 93.32 4.75 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 109.67 -0.492 . . . . 1.1499999999999999 109.67 175.633 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.479 ' HB ' HD23 ' A' ' 71' ' ' LEU . 5.4 p -139.78 135.0 38.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.911 -0.586 . . . . 0.90000000000000002 111.456 -174.289 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -92.52 117.54 30.05 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.819 -0.628 . . . . 2.3799999999999999 110.085 175.221 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.48 76.67 0.01 OUTLIER 'General case' 0 C--O 1.232 0.165 0 CA-C-N 115.86 -0.609 . . . . 1.97 112.089 178.398 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 13.8 m -159.38 -50.31 0.06 Allowed 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 108.294 -1.002 . . . . 2.2200000000000002 108.294 179.542 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 87.5 mt -62.93 -44.0 97.27 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 108.771 -0.825 . . . . 1.3799999999999999 108.771 172.477 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.579 ' HB ' ' OD2' ' A' ' 11' ' ' ASP . 26.3 p -93.7 59.08 2.79 Favored 'General case' 0 N--CA 1.447 -0.618 0 CA-C-N 114.942 -1.026 . . . . 1.4399999999999999 110.273 175.518 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 9.7 tpt180 -102.4 112.04 24.59 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.881 -0.599 . . . . 4.6299999999999999 110.173 174.512 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 69.65 34.74 73.2 Favored Glycine 0 N--CA 1.446 -0.637 0 C-N-CA 120.712 -0.756 . . . . 1.6200000000000001 112.596 176.37 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.804 ' HB3' ' HB3' ' A' ' 10' ' ' LEU . 13.2 mptt -81.13 140.56 34.96 Favored 'General case' 0 CA--C 1.511 -0.529 0 N-CA-C 109.478 -0.564 . . . . 2.75 109.478 176.666 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . 0.4 ' HA ' ' HA ' ' A' ' 9' ' ' SER . 49.1 mt-30 -138.17 134.18 34.22 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 109.944 -0.391 . . . . 2.2400000000000002 109.944 -179.764 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.587 ' O ' ' HA ' ' A' ' 7' ' ' PRO . 7.8 t -124.34 134.13 53.25 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.278 -0.638 . . . . 1.02 109.278 -178.584 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.442 ' N ' HD22 ' A' ' 38' ' ' ASN . 0.9 OUTLIER -60.08 -14.88 18.94 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 112.716 0.636 . . . . 1.28 112.716 -178.332 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 132.05 178.66 15.63 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.248 -0.977 . . . . 0.41999999999999998 113.008 170.829 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.502 HD23 HG11 ' A' ' 3' ' ' VAL . 48.4 tp -160.44 122.01 3.1 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 108.135 -1.061 . . . . 0.69999999999999996 108.135 -179.135 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . 0.63 ' HA ' ' O ' ' A' ' 3' ' ' VAL . 39.7 t-80 -145.37 99.84 3.36 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.213 -0.595 . . . . 2.96 111.972 179.215 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -169.37 178.14 42.63 Favored Glycine 0 N--CA 1.443 -0.892 0 N-CA-C 110.969 -0.852 . . . . 0.55000000000000004 110.969 174.483 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.442 ' HA ' ' O ' ' A' ' 1' ' ' ALA . 11.9 t70 -82.39 113.06 19.9 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 108.12 -1.067 . . . . 2.1800000000000002 108.12 169.031 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 50.5 m-85 -128.89 131.13 47.58 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.074 0.464 . . . . 1.4099999999999999 111.888 -173.501 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -66.15 160.37 24.24 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.256 -0.884 . . . . 2.23 109.219 169.288 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 47.2 t -49.03 -61.22 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 O-C-N 123.507 0.504 . . . . 0.56999999999999995 111.502 -174.609 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.683 ' HA ' HD23 ' A' ' 50' ' ' LEU . 46.5 mt-10 -64.24 -40.18 95.48 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.256 -0.429 . . . . 2.3900000000000001 111.695 -178.398 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 28.1 t -71.07 -30.4 66.53 Favored 'General case' 0 C--O 1.237 0.401 0 CA-C-O 120.892 0.377 . . . . 1.26 111.428 -170.81 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -81.18 -32.11 32.68 Favored Glycine 0 N--CA 1.447 -0.615 0 C-N-CA 120.531 -0.842 . . . . 0.37 111.526 -177.136 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.683 HD23 ' HA ' ' A' ' 47' ' ' GLU . 0.3 OUTLIER -80.59 -41.14 24.5 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 109.539 -0.541 . . . . 1.0900000000000001 109.539 -178.198 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . 0.576 ' N ' ' HG ' ' A' ' 50' ' ' LEU . 54.3 tt0 -53.95 -39.23 65.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.735 -0.666 . . . . 2.5899999999999999 111.768 174.451 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 8.5 tp-100 -63.07 -46.64 86.48 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.377 -0.374 . . . . 1.75 110.133 178.885 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.475 ' HB3' HD11 ' A' ' 10' ' ' LEU . 95.8 mt -58.39 -21.71 51.34 Favored 'General case' 0 CA--C 1.532 0.264 0 CA-C-N 115.803 -0.635 . . . . 0.72999999999999998 112.344 178.375 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.41 ' HG ' ' O ' ' A' ' 50' ' ' LEU . 87.2 mt -73.88 -24.71 59.76 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-O 120.685 0.278 . . . . 2.1600000000000001 111.611 -178.036 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -73.5 113.55 10.73 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.115 0.483 . . . . 2.2400000000000002 110.77 -176.693 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 127.67 -12.96 6.54 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.807 -0.711 . . . . 1.7 111.846 -179.05 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 70.6 p -118.12 175.1 5.84 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 110.005 -0.368 . . . . 2.2799999999999998 110.005 179.041 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -113.13 33.25 5.67 Favored Glycine 0 N--CA 1.448 -0.541 0 N-CA-C 111.271 -0.732 . . . . 1.5800000000000001 111.271 179.251 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 85.1 mt -119.99 179.31 4.3 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 108.872 -0.788 . . . . 1.4199999999999999 108.872 178.829 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -149.87 119.11 6.8 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.091 0.472 . . . . 2.6699999999999999 109.925 178.478 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 59.9 t -92.92 126.58 45.35 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 N-CA-C 109.08 -0.711 . . . . 1.54 109.08 176.547 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.487 ' HE2' ' HB2' ' A' ' 72' ' ' GLU . 50.9 mtmt -126.17 134.35 25.87 Favored Pre-proline 0 C--N 1.319 -0.751 0 N-CA-C 109.509 -0.552 . . . . 1.8100000000000001 109.509 -177.812 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.475 ' HA ' ' O ' ' A' ' 68' ' ' SER . 47.8 Cg_exo -56.32 117.86 4.58 Favored 'Trans proline' 0 N--CA 1.459 -0.557 0 C-N-CA 122.232 1.955 . . . . 0.84999999999999998 110.825 173.679 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 55.6 tp -58.07 -42.41 85.48 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 114.917 -1.038 . . . . 1.7 112.079 -171.13 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -179.64 -86.64 0.07 OUTLIER Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 120.553 -0.832 . . . . 1.6899999999999999 112.287 179.744 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 50.3 t30 -61.18 -76.03 0.06 Allowed 'General case' 0 C--N 1.33 -0.265 0 O-C-N 123.52 0.188 . . . . 2.96 111.138 -179.344 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 66.5 t30 -155.93 53.14 0.57 Allowed 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 121.662 0.744 . . . . 2.5 109.626 178.738 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.475 ' O ' ' HA ' ' A' ' 63' ' ' PRO . 10.8 m -138.11 178.79 6.86 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 107.883 -1.154 . . . . 1.3 107.883 -179.328 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . 0.577 ' CE3' HD21 ' A' ' 25' ' ' LEU . 51.5 m0 -136.52 157.1 47.57 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.114 -0.698 . . . . 0.46999999999999997 109.114 -176.364 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 13.8 t -142.6 147.81 36.45 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.752 0.311 . . . . 0.82999999999999996 110.236 176.072 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.479 HD23 ' HB ' ' A' ' 27' ' ' VAL . 3.9 mm? -93.41 102.95 15.2 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.167 0.508 . . . . 1.71 111.253 179.457 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.487 ' HB2' ' HE2' ' A' ' 62' ' ' LYS . 17.8 mt-10 -106.25 131.42 21.74 Favored Pre-proline 0 C--N 1.32 -0.715 0 CA-C-N 115.328 -0.851 . . . . 2.1299999999999999 111.182 172.538 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.455 ' HD3' ' HA ' ' A' ' 72' ' ' GLU . 24.0 Cg_exo -64.01 114.78 2.77 Favored 'Trans proline' 0 N--CA 1.456 -0.708 0 C-N-CA 122.249 1.966 . . . . 1.3600000000000001 111.274 176.193 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -141.91 63.51 16.25 Favored Pre-proline 0 C--N 1.318 -0.77 0 CA-C-N 115.41 -0.814 . . . . 1.8899999999999999 108.865 175.105 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -84.92 63.96 6.32 Favored 'Trans proline' 0 N--CA 1.452 -0.957 0 C-N-CA 122.656 2.238 . . . . 2.73 112.316 -170.596 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 52.63 64.47 7.3 Favored Pre-proline 0 C--O 1.234 0.253 0 N-CA-C 109.35 -0.611 . . . . 4.21 109.35 -174.233 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -83.72 87.1 1.26 Allowed 'Trans proline' 0 N--CA 1.448 -1.202 0 C-N-CA 122.9 2.4 . . . . 4.2599999999999998 112.551 -167.804 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.758 ' HA ' ' HE2' ' A' ' 78' ' ' LYS . 0.2 OUTLIER -81.7 57.0 3.21 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.457 -0.792 . . . . 6.21 109.047 176.966 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -68.53 -21.08 64.59 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.231 -0.895 . . . . 8.1099999999999994 110.813 -175.795 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 15.1 t70 . . . . . 0 C--O 1.249 1.073 0 CA-C-O 118.163 -0.922 . . . . 9.0500000000000007 109.24 172.258 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.077 0 N-CA-C 111.355 0.131 . . . . 3.8100000000000001 111.355 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.663 ' HA ' ' HA ' ' A' ' 43' ' ' ASP . 8.0 tp-100 67.91 120.54 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.346 0 CA-C-O 122.01 0.91 . . . . 4.0 111.69 -178.454 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 60.3 t -101.43 131.44 49.22 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 CA-C-N 114.437 -1.256 . . . . 1.6399999999999999 108.724 178.586 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 50.6 m-80 -123.41 99.54 6.38 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.069 0.462 . . . . 2.29 110.114 -173.592 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.477 ' HB ' ' H ' ' A' ' 40' ' ' LEU . 30.2 mt -130.49 160.29 41.77 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 N-CA-C 108.766 -0.828 . . . . 0.81999999999999995 108.766 179.48 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.7 ' HB1' ' HD2' ' A' ' 7' ' ' PRO . . . -164.6 172.87 4.31 Favored Pre-proline 0 C--N 1.323 -0.555 0 CA-C-O 118.815 -0.612 . . . . 1.3799999999999999 109.448 -176.958 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.7 ' HD2' ' HB1' ' A' ' 6' ' ' ALA . 33.7 Cg_exo -36.97 130.49 0.49 Allowed 'Trans proline' 0 C--N 1.357 1.006 0 C-N-CA 123.297 2.665 . . . . 1.73 113.685 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 155.57 -177.16 32.87 Favored Glycine 0 N--CA 1.444 -0.767 0 N-CA-C 110.982 -0.847 . . . . 1.8400000000000001 110.982 -177.886 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.588 ' HA ' ' O ' ' A' ' 35' ' ' LYS . 19.6 m -68.32 133.68 49.12 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 110.068 -0.345 . . . . 1.6100000000000001 110.068 178.926 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 59.9 tp -58.8 -32.32 69.24 Favored 'General case' 0 C--O 1.23 0.071 0 CA-C-O 120.989 0.423 . . . . 1.1899999999999999 110.727 179.58 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -49.64 -46.65 49.76 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.436 -0.802 . . . . 2.1099999999999999 110.559 172.871 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 5.1 tmtm? -64.37 -35.03 79.55 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.658 -0.701 . . . . 2.7200000000000002 110.066 -178.246 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -65.26 -59.41 4.1 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.155 -0.475 . . . . 0.46000000000000002 110.961 -176.746 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 94.0 mt -59.61 -39.07 83.03 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.097 -0.501 . . . . 0.68999999999999995 111.232 178.142 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 47.2 t30 -60.99 -38.39 85.84 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.966 0.412 . . . . 1.3100000000000001 110.052 178.311 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.445 HE21 ' HB3' ' A' ' 16' ' ' GLN . 0.9 OUTLIER -61.6 -44.05 97.73 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.974 -0.557 . . . . 2.23 110.663 177.054 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.417 ' CD1' ' HH2' ' A' ' 69' ' ' TRP . 3.9 t80 -68.53 -43.51 76.58 Favored 'General case' 0 N--CA 1.457 -0.106 0 N-CA-C 109.24 -0.652 . . . . 0.65000000000000002 109.24 -179.503 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.692 ' HA ' ' CZ ' ' A' ' 23' ' ' PHE . . . -54.55 -49.16 70.96 Favored 'General case' 0 C--N 1.333 -0.109 0 CA-C-N 115.619 -0.719 . . . . 0.37 111.546 176.923 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -64.92 -24.98 67.69 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.403 -0.362 . . . . 0.64000000000000001 111.515 -179.488 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 56.1 t60 -60.99 -50.95 71.29 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.342 -0.39 . . . . 1.8500000000000001 111.305 -177.567 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.564 ' HB2' ' CD1' ' A' ' 23' ' ' PHE . 15.7 m -108.11 -1.5 20.33 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.993 0.425 . . . . 1.6699999999999999 111.783 -177.245 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 62.24 46.62 93.56 Favored Glycine 0 C--N 1.332 0.339 0 CA-C-N 115.595 -0.729 . . . . 0.62 113.699 174.497 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.692 ' CZ ' ' HA ' ' A' ' 18' ' ' ALA . 14.4 p90 -105.12 172.79 6.6 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.842 0.321 . . . . 0.56999999999999995 110.568 -179.419 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 47.6 m -91.71 106.19 18.29 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.34 0.59 . . . . 0.68000000000000005 111.41 -179.514 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 3.6 tt -92.98 123.03 35.94 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.017 -0.735 . . . . 1.6699999999999999 109.017 175.633 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.407 ' O ' ' HA ' ' A' ' 70' ' ' THR . 33.4 t -101.04 101.11 11.81 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.172 0.51 . . . . 1.1499999999999999 110.064 -176.552 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.2 p -141.22 135.14 31.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.729 -0.669 . . . . 0.90000000000000002 110.444 -179.898 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -81.83 123.3 28.68 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.857 -0.611 . . . . 2.3799999999999999 110.406 177.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.14 82.77 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.805 -0.634 . . . . 1.97 111.954 178.893 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.526 ' HA ' ' NE ' ' A' ' 33' ' ' ARG . 55.5 p -172.44 -45.4 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.289 -0.414 . . . . 2.2200000000000002 110.053 -179.706 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 93.5 mt -62.09 -44.61 96.3 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.584 -0.734 . . . . 1.3799999999999999 112.227 -174.386 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.461 ' O ' ' HB2' ' A' ' 35' ' ' LYS . 30.0 p -97.86 2.55 49.4 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 112.206 0.447 . . . . 1.4399999999999999 112.206 -176.265 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . 0.526 ' NE ' ' HA ' ' A' ' 30' ' ' SER . 64.6 mtm180 -58.55 121.66 11.5 Favored 'General case' 0 N--CA 1.454 -0.265 0 CA-C-O 120.581 0.229 . . . . 4.6299999999999999 111.442 -178.408 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 81.3 11.71 83.06 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 121.056 -0.593 . . . . 1.6200000000000001 112.781 175.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.588 ' O ' ' HA ' ' A' ' 9' ' ' SER . 12.8 mptt -85.08 151.01 24.46 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.872 0.368 . . . . 2.75 110.817 -179.763 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 32.1 mm-40 -131.46 138.3 48.97 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 108.437 -0.949 . . . . 2.2400000000000002 108.437 178.667 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.501 ' O ' ' HA ' ' A' ' 7' ' ' PRO . 34.6 t -131.6 141.66 49.71 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 109.186 -0.672 . . . . 1.02 109.186 179.236 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -77.1 -2.36 33.82 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.431 -0.349 . . . . 1.28 111.65 178.062 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.472 ' HA2' HG22 ' A' ' 5' ' ' ILE . . . 98.02 -169.63 24.29 Favored Glycine 0 N--CA 1.445 -0.754 0 C-N-CA 120.421 -0.895 . . . . 0.41999999999999998 113.619 170.714 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.477 ' H ' ' HB ' ' A' ' 5' ' ' ILE . 54.8 tp -160.23 140.41 11.54 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 107.537 -1.283 . . . . 0.69999999999999996 107.537 -179.28 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 17.4 t60 -144.52 99.54 3.38 Favored 'General case' 0 C--N 1.323 -0.555 0 C-N-CA 120.195 -0.602 . . . . 2.96 111.241 -178.185 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -169.48 170.69 42.81 Favored Glycine 0 N--CA 1.448 -0.518 0 N-CA-C 110.547 -1.021 . . . . 0.55000000000000004 110.547 175.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.663 ' HA ' ' HA ' ' A' ' 2' ' ' GLN . 44.2 t0 -86.0 91.77 8.49 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 108.607 -0.886 . . . . 2.1800000000000002 108.607 175.84 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 25.6 m-85 -107.4 138.01 44.38 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.555 -0.748 . . . . 1.4099999999999999 112.173 -170.131 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -75.33 165.56 24.97 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 108.449 -0.945 . . . . 2.23 108.449 169.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.484 HG13 ' HZ2' ' A' ' 69' ' ' TRP . 61.2 t -50.44 -70.31 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 112.356 0.502 . . . . 0.56999999999999995 112.356 -174.383 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -61.33 -42.19 98.26 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 112.285 0.476 . . . . 2.3900000000000001 112.285 -172.465 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 34.9 t -70.18 -26.21 63.8 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.878 0.37 . . . . 1.26 110.524 -175.221 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.447 ' O ' ' HG ' ' A' ' 53' ' ' LEU . . . -77.24 -36.08 35.96 Favored Glycine 0 N--CA 1.444 -0.826 0 N-CA-C 110.956 -0.858 . . . . 0.37 110.956 -179.664 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.677 ' HB3' HG13 ' A' ' 61' ' ' VAL . 92.8 mt -72.69 -43.62 62.83 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.76 0.314 . . . . 1.0900000000000001 110.628 -179.38 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 57.0 tp60 -52.96 -50.06 64.86 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.837 -0.62 . . . . 2.5899999999999999 111.575 178.902 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.458 ' HA ' ' OE1' ' A' ' 52' ' ' GLN . 12.8 mm-40 -65.86 -37.13 85.36 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.524 -0.307 . . . . 1.75 111.458 -178.039 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.447 ' HG ' ' O ' ' A' ' 49' ' ' GLY . 66.1 mt -57.88 -39.86 78.85 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 112.176 0.436 . . . . 0.72999999999999998 112.176 179.327 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.473 HD12 HG12 ' A' ' 61' ' ' VAL . 45.2 mt -105.39 16.84 24.93 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.257 0.466 . . . . 2.1600000000000001 112.257 -174.856 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -68.15 94.58 0.52 Allowed 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 120.993 0.425 . . . . 2.2400000000000002 111.188 -179.895 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 109.57 -7.01 31.8 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.919 -0.658 . . . . 1.7 113.565 176.621 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 60.4 p -83.72 -1.54 54.33 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 117.357 0.579 . . . . 2.2799999999999998 111.705 -175.755 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 76.57 17.67 79.71 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.764 -0.732 . . . . 1.5800000000000001 112.118 -179.739 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 96.7 mt -124.96 168.57 13.13 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.516 -0.342 . . . . 1.4199999999999999 110.091 -179.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 33.7 tt0 -150.69 118.64 6.24 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.18 -0.674 . . . . 2.6699999999999999 109.18 175.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.677 HG13 ' HB3' ' A' ' 50' ' ' LEU . 7.2 p -109.73 129.67 64.2 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 N-CA-C 109.998 -0.371 . . . . 1.54 109.998 179.425 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 24.0 pttm -148.47 156.53 42.3 Favored Pre-proline 0 C--N 1.322 -0.628 0 N-CA-C 109.884 -0.413 . . . . 1.8100000000000001 109.884 -177.126 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.615 ' HA ' ' HA ' ' A' ' 69' ' ' TRP . 25.7 Cg_exo -63.93 148.17 91.77 Favored 'Trans proline' 0 N--CA 1.461 -0.392 0 C-N-CA 122.716 2.277 . . . . 0.84999999999999998 111.904 176.706 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.498 HD21 ' HB ' ' A' ' 70' ' ' THR . 82.0 mt -65.68 -27.39 68.31 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.595 -0.73 . . . . 1.7 110.659 179.363 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 152.0 -19.95 0.86 Allowed Glycine 0 N--CA 1.451 -0.361 0 N-CA-C 109.674 -1.371 . . . . 1.6899999999999999 109.674 -178.63 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 5.6 p30 -128.21 -157.87 0.84 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 114.414 -0.893 . . . . 2.96 109.314 174.865 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -77.07 45.48 0.44 Allowed 'General case' 0 N--CA 1.468 0.438 0 CA-C-O 121.188 0.518 . . . . 2.5 112.158 -176.918 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.401 ' O ' ' HA ' ' A' ' 63' ' ' PRO . 19.5 m -141.51 165.54 27.22 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 107.391 -1.337 . . . . 1.3 107.391 172.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . 0.615 ' HA ' ' HA ' ' A' ' 63' ' ' PRO . 52.8 m0 -133.83 166.81 21.81 Favored 'General case' 0 C--N 1.32 -0.716 0 C-N-CA 120.487 -0.485 . . . . 0.46999999999999997 110.817 -166.38 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.498 ' HB ' HD21 ' A' ' 64' ' ' LEU . 8.9 t -146.49 143.98 29.32 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.419 -0.585 . . . . 0.82999999999999996 109.419 171.782 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 35.9 tp -93.08 100.95 13.27 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-O 121.662 0.744 . . . . 1.71 109.26 176.153 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -94.75 130.29 33.63 Favored Pre-proline 0 C--N 1.316 -0.863 0 CA-C-N 114.838 -1.073 . . . . 2.1299999999999999 111.267 -177.34 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_exo -69.98 113.37 3.39 Favored 'Trans proline' 0 N--CA 1.451 -0.995 0 C-N-CA 121.535 1.49 . . . . 1.3600000000000001 110.714 174.153 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -152.07 75.64 7.37 Favored Pre-proline 0 C--N 1.321 -0.663 0 CA-C-N 115.665 -0.698 . . . . 1.8899999999999999 109.192 179.572 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -87.34 35.64 0.44 Allowed 'Trans proline' 0 N--CA 1.454 -0.835 0 C-N-CA 122.62 2.213 . . . . 2.73 112.5 -173.767 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 55.78 56.9 10.16 Favored Pre-proline 0 C--O 1.232 0.14 0 O-C-N 123.803 0.689 . . . . 4.21 109.634 -172.795 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -71.26 102.02 1.2 Allowed 'Trans proline' 0 N--CA 1.458 -0.563 0 C-N-CA 122.495 2.13 . . . . 4.2599999999999998 112.253 -168.732 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 57.02 31.42 19.89 Favored 'General case' 0 C--O 1.232 0.169 0 CA-C-N 115.35 -0.841 . . . . 6.21 109.875 -176.1 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -91.15 63.47 5.05 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.768 0.794 . . . . 8.1099999999999994 110.558 -174.31 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 38.1 t70 . . . . . 0 C--O 1.252 1.222 0 CA-C-N 115.214 -0.903 . . . . 9.0500000000000007 109.353 175.096 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.961 0 CA-C-O 121.0 0.429 . . . . 3.8100000000000001 110.781 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 19.6 pm0 -81.43 151.2 28.0 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.139 0.495 . . . . 4.0 110.582 -178.326 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 12.4 p -149.19 156.08 7.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 115.589 -0.732 . . . . 1.6399999999999999 109.302 -179.358 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 25.6 t-20 -127.26 108.9 11.28 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.93 0.395 . . . . 2.29 109.978 -178.449 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 60.8 mt -131.16 151.18 35.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 N-CA-C 108.89 -0.781 . . . . 0.81999999999999995 108.89 -179.871 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.696 ' HB1' ' HD2' ' A' ' 7' ' ' PRO . . . -162.17 174.1 3.96 Favored Pre-proline 0 C--N 1.322 -0.625 0 CA-C-O 118.436 -0.792 . . . . 1.3799999999999999 108.956 -173.689 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.696 ' HD2' ' HB1' ' A' ' 6' ' ' ALA . 47.5 Cg_exo -38.48 135.53 0.71 Allowed 'Trans proline' 0 C--N 1.361 1.235 0 C-N-CA 123.227 2.618 . . . . 1.73 113.707 -176.264 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 153.13 168.59 17.23 Favored Glycine 0 N--CA 1.446 -0.686 0 N-CA-C 110.401 -1.08 . . . . 1.8400000000000001 110.401 -173.908 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.422 ' HA ' ' HA ' ' A' ' 36' ' ' GLN . 4.7 t -67.74 138.11 55.98 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.619 -0.511 . . . . 1.6100000000000001 109.619 -178.736 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 59.9 tp -58.12 -36.79 73.44 Favored 'General case' 0 CA--C 1.523 -0.083 0 CA-C-N 115.349 -0.841 . . . . 1.1899999999999999 111.649 -173.222 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.4 p30 -54.59 -50.58 67.68 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.186 -0.461 . . . . 2.1099999999999999 111.154 176.049 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . 0.662 ' O ' ' HG3' ' A' ' 16' ' ' GLN . 41.0 tttm -64.0 -35.43 80.69 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.473 0.178 . . . . 2.7200000000000002 110.591 177.003 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.42 -52.56 63.08 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.829 0.347 . . . . 0.46000000000000002 110.132 -178.484 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.629 ' HB3' HD11 ' A' ' 25' ' ' LEU . 77.5 mt -57.27 -38.52 74.02 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.779 -0.646 . . . . 0.68999999999999995 110.899 174.324 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 17.9 t-20 -61.03 -37.75 83.69 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.107 -0.497 . . . . 1.3100000000000001 111.06 179.336 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.662 ' HG3' ' O ' ' A' ' 12' ' ' LYS . 18.6 mt-30 -62.3 -40.05 95.01 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.758 -0.201 . . . . 2.23 110.587 178.199 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.44 ' O ' ' HB3' ' A' ' 20' ' ' HIS . 5.0 t80 -68.38 -43.77 76.61 Favored 'General case' 0 CA--C 1.52 -0.196 0 CA-C-O 121.636 0.731 . . . . 0.65000000000000002 109.169 177.433 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.684 ' HA ' ' CZ ' ' A' ' 23' ' ' PHE . . . -52.44 -46.22 66.34 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 114.707 -1.133 . . . . 0.37 111.317 176.521 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -64.52 -29.06 70.1 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.146 -0.479 . . . . 0.64000000000000001 111.392 179.013 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . 0.44 ' HB3' ' O ' ' A' ' 17' ' ' TYR . 84.9 t60 -61.1 -55.06 36.94 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.056 -0.52 . . . . 1.8500000000000001 111.51 -177.234 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.456 ' HB2' ' CD1' ' A' ' 23' ' ' PHE . 38.8 m -100.23 -9.21 22.66 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 112.134 0.42 . . . . 1.6699999999999999 112.134 -177.456 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 69.42 55.67 9.79 Favored Glycine 0 N--CA 1.452 -0.286 0 CA-C-N 115.808 -0.633 . . . . 0.62 113.405 178.914 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.684 ' CZ ' ' HA ' ' A' ' 18' ' ' ALA . 15.5 p90 -112.67 166.54 11.25 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.77 0.319 . . . . 0.56999999999999995 110.455 176.858 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 21.0 m -89.31 113.41 24.68 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.187 0.518 . . . . 0.68000000000000005 111.012 -177.403 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.629 HD11 ' HB3' ' A' ' 14' ' ' LEU . 1.9 tt -99.91 136.7 39.42 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.384 -0.825 . . . . 1.6699999999999999 109.588 179.002 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.67 ' HB2' ' HA ' ' A' ' 70' ' ' THR . 48.5 m -100.64 97.22 7.92 Favored 'General case' 0 C--N 1.32 -0.715 0 N-CA-C 109.692 -0.484 . . . . 1.1499999999999999 109.692 175.809 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.487 ' HB ' HD22 ' A' ' 25' ' ' LEU . 12.6 p -145.36 150.33 15.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.353 -0.385 . . . . 0.90000000000000002 110.136 -177.505 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -130.42 122.82 28.48 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.402 -0.363 . . . . 2.3799999999999999 110.448 -179.921 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -63.17 67.7 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.375 0 O-C-N 123.855 0.722 . . . . 1.97 112.286 177.433 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 30.2 t -170.62 -34.48 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 109.518 -0.549 . . . . 2.2200000000000002 109.518 178.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 90.9 mt -69.13 -36.87 77.94 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.102 -0.499 . . . . 1.3799999999999999 110.338 178.119 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 8.9 p -93.7 36.85 1.08 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.952 -0.567 . . . . 1.4399999999999999 111.358 -179.822 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.49 105.92 2.38 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.914 0.388 . . . . 4.6299999999999999 110.381 -176.579 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 87.62 17.37 58.54 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.835 -0.697 . . . . 1.6200000000000001 112.062 -179.259 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.61 93.28 4.68 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.702 0.286 . . . . 2.75 110.249 179.735 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . 0.422 ' HA ' ' HA ' ' A' ' 9' ' ' SER . 49.0 mt-30 -102.69 158.09 16.49 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 110.249 -0.278 . . . . 2.2400000000000002 110.249 179.529 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 32.9 t -127.2 135.56 50.82 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 108.736 -0.838 . . . . 1.02 108.736 178.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.416 ' N ' HD22 ' A' ' 38' ' ' ASN . 0.9 OUTLIER -67.51 -12.87 61.36 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 113.231 0.826 . . . . 1.28 113.231 -175.499 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.407 ' HA3' ' HA ' ' A' ' 6' ' ' ALA . . . 125.13 174.83 14.06 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.028 -1.082 . . . . 0.41999999999999998 114.034 170.903 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 57.0 tp -161.25 120.2 2.5 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 108.238 -1.023 . . . . 0.69999999999999996 108.238 -176.239 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 11.7 p80 -144.28 99.39 3.37 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 119.808 -0.757 . . . . 2.96 111.519 -179.786 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -169.01 -177.84 40.05 Favored Glycine 0 N--CA 1.443 -0.868 0 CA-C-N 115.158 -0.928 . . . . 0.55000000000000004 111.131 177.833 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -88.87 77.02 7.84 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 108.897 -0.779 . . . . 2.1800000000000002 108.897 172.269 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 28.9 m-85 -98.26 129.59 44.98 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.766 -0.652 . . . . 1.4099999999999999 111.68 -173.138 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 32.4 t0 -70.55 162.56 28.62 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.308 -0.86 . . . . 2.23 109.047 173.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 46.4 t -47.92 -64.83 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 112.285 0.476 . . . . 0.56999999999999995 112.285 -172.54 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 40.9 mm-40 -56.81 -36.55 70.05 Favored 'General case' 0 N--CA 1.464 0.242 0 N-CA-C 111.773 0.286 . . . . 2.3900000000000001 111.773 -176.749 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 15.3 m -71.74 -33.67 68.89 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-O 120.97 0.414 . . . . 1.26 110.773 -174.684 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -67.75 -46.84 65.0 Favored Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.955 -0.64 . . . . 0.37 112.339 -175.192 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.572 HD11 ' CZ2' ' A' ' 69' ' ' TRP . 7.1 mp -68.9 -37.26 78.87 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 110.486 -0.19 . . . . 1.0900000000000001 110.486 -178.225 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 63.7 tt0 -54.82 -45.86 74.49 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.433 -0.348 . . . . 2.5899999999999999 111.009 178.266 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 -65.66 -46.85 77.59 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.254 -0.43 . . . . 1.75 110.989 179.102 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 88.7 mt -57.14 -29.63 63.75 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 112.29 0.478 . . . . 0.72999999999999998 112.29 -178.826 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.487 ' HG ' ' O ' ' A' ' 50' ' ' LEU . 95.0 mt -77.84 -7.32 56.5 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 112.079 0.4 . . . . 2.1600000000000001 112.079 -176.839 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -66.72 93.87 0.27 Allowed 'General case' 0 C--O 1.233 0.207 0 CA-C-O 121.45 0.643 . . . . 2.2400000000000002 110.973 -178.703 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 136.73 -25.33 3.1 Favored Glycine 0 N--CA 1.444 -0.8 0 C-N-CA 120.835 -0.698 . . . . 1.7 112.162 -178.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 33.3 p -97.82 171.02 8.57 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 110.031 -0.359 . . . . 2.2799999999999998 110.031 177.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -111.21 -15.77 10.28 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 120.846 -0.693 . . . . 1.5800000000000001 112.103 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 2.1 pp -90.49 -178.16 5.25 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.788 -0.449 . . . . 1.4199999999999999 109.788 178.255 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 94.6 mt-30 -143.08 120.66 11.76 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 118.365 0.53 . . . . 2.6699999999999999 110.231 -167.493 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.475 HG21 HD11 ' A' ' 14' ' ' LEU . 21.6 t -97.38 128.25 48.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 N-CA-C 109.027 -0.731 . . . . 1.54 109.027 175.907 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 25.0 pttm -146.85 154.16 47.04 Favored Pre-proline 0 C--N 1.329 -0.312 0 C-N-CA 120.5 -0.48 . . . . 1.8100000000000001 111.299 -178.777 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.64 ' HA ' ' HA ' ' A' ' 69' ' ' TRP . 42.9 Cg_exo -58.57 133.7 56.14 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.984 2.456 . . . . 0.84999999999999998 111.864 173.467 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 54.4 tp -67.62 -29.15 68.41 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.473 -0.785 . . . . 1.7 111.141 -175.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 166.44 -56.26 0.24 Allowed Glycine 0 N--CA 1.45 -0.427 0 N-CA-C 110.972 -0.851 . . . . 1.6899999999999999 110.972 179.396 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 13.5 m120 -83.93 -164.48 0.93 Allowed 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 108.438 -0.949 . . . . 2.96 108.438 172.815 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 9.0 t30 -78.61 58.99 2.36 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.814 0.816 . . . . 2.5 109.904 177.291 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.467 ' O ' ' HA ' ' A' ' 63' ' ' PRO . 30.9 m -147.89 174.68 11.62 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 107.725 -1.213 . . . . 1.3 107.725 176.259 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . 0.64 ' HA ' ' HA ' ' A' ' 63' ' ' PRO . 53.7 m0 -137.8 166.5 23.84 Favored 'General case' 0 C--N 1.322 -0.603 0 C-N-CA 120.323 -0.551 . . . . 0.46999999999999997 110.601 -165.32 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.67 ' HA ' ' HB2' ' A' ' 26' ' ' SER . 12.3 t -146.81 150.2 34.82 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.108 -0.496 . . . . 0.82999999999999996 109.76 173.424 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 54.9 tp -92.95 104.82 17.02 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-O 121.813 0.816 . . . . 1.71 110.491 179.198 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.402 ' HA ' ' HD3' ' A' ' 73' ' ' PRO . 22.0 tt0 -91.3 118.89 68.74 Favored Pre-proline 0 C--N 1.316 -0.888 0 CA-C-N 114.185 -1.371 . . . . 2.1299999999999999 111.526 179.482 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 72' ' ' GLU . 1.2 Cg_endo -84.65 115.18 1.8 Allowed 'Trans proline' 0 N--CA 1.452 -0.942 0 C-N-CA 122.874 2.383 . . . . 1.3600000000000001 111.658 174.792 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -164.05 76.35 1.64 Allowed Pre-proline 0 C--N 1.324 -0.504 0 CA-C-N 115.742 -0.663 . . . . 1.8899999999999999 109.308 177.011 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.511 ' O ' ' HD3' ' A' ' 77' ' ' PRO . 45.0 Cg_endo -87.1 -90.36 0.0 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.803 0 C-N-CA 123.014 2.476 . . . . 2.73 113.612 -169.441 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -116.6 68.64 4.1 Favored Pre-proline 0 C--N 1.326 -0.42 0 N-CA-C 108.902 -0.777 . . . . 4.21 108.902 174.797 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.511 ' HD3' ' O ' ' A' ' 75' ' ' PRO . 36.5 Cg_endo -92.76 50.72 0.46 Allowed 'Trans proline' 0 N--CA 1.443 -1.481 0 C-N-CA 123.411 2.741 . . . . 4.2599999999999998 111.383 -169.883 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 27.8 tptp -72.0 -50.48 28.27 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.157 -0.929 . . . . 6.21 110.356 177.835 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -110.58 101.57 10.23 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.814 -0.63 . . . . 8.1099999999999994 111.213 -176.804 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 34.8 t70 . . . . . 0 C--O 1.251 1.142 0 CA-C-N 115.106 -0.952 . . . . 9.0500000000000007 109.558 176.394 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.965 0 N-CA-C 110.093 -0.336 . . . . 3.8100000000000001 110.093 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 -75.0 148.26 40.05 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.128 0.49 . . . . 4.0 110.742 -178.762 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.457 HG12 HG12 ' A' ' 5' ' ' ILE . 62.8 t -127.42 136.3 60.93 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 115.433 -0.803 . . . . 1.6399999999999999 109.349 179.617 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 17.7 m120 -127.96 97.86 4.94 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.453 -0.573 . . . . 2.29 109.453 -174.625 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.624 HG13 HD21 ' A' ' 53' ' ' LEU . 43.0 mm -122.93 155.91 28.48 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 N-CA-C 109.33 -0.619 . . . . 0.81999999999999995 109.33 -178.515 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.648 ' HB1' ' HD2' ' A' ' 7' ' ' PRO . . . -162.43 163.41 18.34 Favored Pre-proline 0 C--N 1.325 -0.492 0 N-CA-C 109.27 -0.641 . . . . 1.3799999999999999 109.27 -176.781 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.648 ' HD2' ' HB1' ' A' ' 6' ' ' ALA . 9.4 Cg_endo -51.96 130.56 35.11 Favored 'Trans proline' 0 C--N 1.35 0.649 0 C-N-CA 122.831 2.354 . . . . 1.73 112.755 -175.33 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 163.15 42.81 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.408 0 CA-C-N 115.67 -0.695 . . . . 1.8400000000000001 112.441 -178.111 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.79 ' HA ' ' HA ' ' A' ' 36' ' ' GLN . 65.1 m 66.44 131.49 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 121.496 0.665 . . . . 1.6100000000000001 111.691 -178.706 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 64.1 tp -60.02 -35.4 74.99 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 115.924 -0.58 . . . . 1.1899999999999999 111.031 -178.493 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -50.6 -54.12 25.24 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 115.583 -0.735 . . . . 2.1099999999999999 111.589 177.372 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 85.3 tttt -66.78 -32.01 73.02 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.693 -0.23 . . . . 2.7200000000000002 110.755 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -63.29 -53.36 54.01 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.932 0.396 . . . . 0.46000000000000002 110.548 -176.206 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 88.6 mt -58.98 -39.51 81.99 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 115.988 -0.551 . . . . 0.68999999999999995 111.021 176.517 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 52.4 t30 -60.86 -39.7 90.13 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-N 116.209 -0.45 . . . . 1.3100000000000001 110.703 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 -58.85 -51.11 71.42 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.044 -0.525 . . . . 2.23 111.421 177.843 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.477 ' CD1' ' HH2' ' A' ' 69' ' ' TRP . 32.4 t80 -67.26 -38.43 85.1 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.038 -0.727 . . . . 0.65000000000000002 109.038 -175.739 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.835 ' HA ' ' CE2' ' A' ' 23' ' ' PHE . . . -55.7 -49.99 71.52 Favored 'General case' 0 C--O 1.235 0.322 0 CA-C-N 115.532 -0.758 . . . . 0.37 111.955 174.913 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.94 -23.64 67.42 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.211 -0.449 . . . . 0.64000000000000001 111.588 -178.319 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 75.0 t60 -61.71 -48.06 82.45 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.027 -0.533 . . . . 1.8500000000000001 111.498 -176.346 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.578 ' HB3' ' CD1' ' A' ' 23' ' ' PHE . 38.9 t -102.37 -4.5 25.44 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.882 0.372 . . . . 1.6699999999999999 111.114 -179.691 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 68.3 47.02 60.72 Favored Glycine 0 CA--C 1.518 0.23 0 CA-C-N 115.702 -0.681 . . . . 0.62 113.622 177.864 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.835 ' CE2' ' HA ' ' A' ' 18' ' ' ALA . 10.3 p90 -106.65 159.66 16.04 Favored 'General case' 0 C--N 1.325 -0.476 0 O-C-N 122.538 -0.39 . . . . 0.56999999999999995 110.294 176.9 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 22.4 m -88.28 119.5 28.75 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.943 -0.571 . . . . 0.68000000000000005 111.91 -173.443 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.629 HD21 ' CE3' ' A' ' 69' ' ' TRP . 0.8 OUTLIER -94.8 143.88 26.1 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.636 -0.711 . . . . 1.6699999999999999 111.278 178.351 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 36.2 t -115.53 92.15 3.83 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.114 -0.698 . . . . 1.1499999999999999 109.114 173.035 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 6.9 p -148.64 125.54 2.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 115.903 -0.59 . . . . 0.90000000000000002 110.0 -178.605 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -88.37 134.76 33.74 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 120.831 -0.347 . . . . 2.3799999999999999 110.634 -177.776 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -61.7 70.67 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.255 0 O-C-N 124.043 0.839 . . . . 1.97 112.095 176.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 79.4 p -168.64 -42.96 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.478 -0.564 . . . . 2.2200000000000002 109.478 178.662 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.414 ' O ' ' HD3' ' A' ' 35' ' ' LYS . 80.7 mt -66.97 -45.41 77.8 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.655 -0.702 . . . . 1.3799999999999999 110.029 177.142 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.3 p -91.4 -3.32 56.81 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.489 -0.778 . . . . 1.4399999999999999 111.592 -178.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 55.4 ttp180 -86.62 129.58 34.81 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.174 -0.466 . . . . 4.6299999999999999 110.586 -178.003 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 107.35 -20.44 32.65 Favored Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 120.703 -0.76 . . . . 1.6200000000000001 112.353 177.191 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.548 ' HD2' ' N ' ' A' ' 35' ' ' LYS . 0.0 OUTLIER -115.53 136.73 52.78 Favored 'General case' 0 N--CA 1.447 -0.616 0 CA-C-O 121.434 0.635 . . . . 2.75 111.664 -177.873 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . 0.79 ' HA ' ' HA ' ' A' ' 9' ' ' SER . 18.4 pt20 -103.34 156.15 17.95 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.343 -0.844 . . . . 2.2400000000000002 111.397 -177.49 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 31.2 t -117.92 119.61 35.35 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 106.28 -1.748 . . . . 1.02 106.28 171.317 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.558 ' O ' ' HD3' ' A' ' 7' ' ' PRO . 21.9 m-80 -72.27 -6.77 45.42 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 113.131 0.789 . . . . 1.28 113.131 -167.607 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . 0.427 ' HA2' HG22 ' A' ' 5' ' ' ILE . . . 127.7 175.62 14.16 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.052 -1.071 . . . . 0.41999999999999998 113.357 165.756 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.473 ' HB3' ' HB ' ' A' ' 5' ' ' ILE . 67.3 tp -160.13 129.24 5.04 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 109.139 -0.689 . . . . 0.69999999999999996 109.139 -177.962 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 44.5 m80 -138.15 96.7 3.24 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.171 0.51 . . . . 2.96 110.543 176.123 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -168.87 -169.42 32.25 Favored Glycine 0 N--CA 1.446 -0.693 0 CA-C-N 115.776 -0.647 . . . . 0.55000000000000004 111.899 176.083 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -98.12 111.47 23.78 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 108.783 -0.821 . . . . 2.1800000000000002 108.783 173.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.449 ' HB2' HG21 ' A' ' 3' ' ' VAL . 44.7 m-85 -133.54 134.29 43.2 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.289 0.566 . . . . 1.4099999999999999 112.362 -170.15 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 47.3 t0 -85.9 170.3 12.48 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 108.477 -0.935 . . . . 2.23 108.477 172.617 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 48.7 t -46.85 -70.04 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 N-CA-C 112.574 0.583 . . . . 0.56999999999999995 112.574 -172.364 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -57.89 -34.25 69.6 Favored 'General case' 0 C--O 1.234 0.278 0 N-CA-C 112.507 0.558 . . . . 2.3900000000000001 112.507 -177.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 7.2 m -72.14 -39.92 68.45 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-O 121.203 0.525 . . . . 1.26 110.845 -174.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.508 ' O ' ' HG ' ' A' ' 53' ' ' LEU . . . -74.31 -41.76 36.96 Favored Glycine 0 N--CA 1.446 -0.636 0 CA-C-N 115.599 -0.728 . . . . 0.37 111.448 -174.942 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.533 ' O ' ' HG ' ' A' ' 54' ' ' LEU . 90.4 mt -62.29 -38.38 89.14 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.763 0.316 . . . . 1.0900000000000001 110.831 -179.775 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 6.3 tp60 -57.12 -48.83 77.68 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 115.865 -0.607 . . . . 2.5899999999999999 111.246 179.862 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.446 ' HG2' HD13 ' A' ' 40' ' ' LEU . 50.4 tp60 -69.0 -38.59 79.35 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.625 -0.261 . . . . 1.75 110.957 -179.146 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.624 HD21 HG13 ' A' ' 5' ' ' ILE . 82.4 mt -56.84 -29.35 62.76 Favored 'General case' 0 N--CA 1.464 0.254 0 N-CA-C 112.014 0.375 . . . . 0.72999999999999998 112.014 179.369 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.533 ' HG ' ' O ' ' A' ' 50' ' ' LEU . 92.6 mt -78.35 -6.89 56.47 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.219 -0.446 . . . . 2.1600000000000001 111.893 -176.449 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -66.35 119.07 10.93 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.04 0.447 . . . . 2.2400000000000002 110.509 -177.161 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 111.98 -24.72 14.09 Favored Glycine 0 N--CA 1.446 -0.682 0 CA-C-N 115.757 -0.656 . . . . 1.7 111.635 -176.88 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 78.6 p -109.0 169.2 8.83 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.664 0.269 . . . . 2.2799999999999998 110.302 -179.858 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -114.14 49.52 0.84 Allowed Glycine 0 N--CA 1.443 -0.841 0 N-CA-C 111.161 -0.776 . . . . 1.5800000000000001 111.161 179.39 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.413 HD22 HD11 ' A' ' 71' ' ' LEU . 91.5 mt -124.34 174.96 7.39 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 120.694 0.283 . . . . 1.4199999999999999 110.398 -178.602 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . 0.409 ' CB ' ' HB3' ' A' ' 74' ' ' ALA . 8.5 tp-100 -148.86 118.48 7.0 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.264 -0.643 . . . . 2.6699999999999999 109.264 176.604 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 3.8 p -94.65 123.04 46.61 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.772 0 N-CA-C 109.393 -0.595 . . . . 1.54 109.393 177.777 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.482 ' HA ' ' HD3' ' A' ' 63' ' ' PRO . 20.2 ptmt -122.64 134.08 24.77 Favored Pre-proline 0 C--N 1.32 -0.702 0 CA-C-O 120.84 0.352 . . . . 1.8100000000000001 110.84 -172.73 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.482 ' HD3' ' HA ' ' A' ' 62' ' ' LYS . 37.9 Cg_exo -62.26 129.0 25.44 Favored 'Trans proline' 0 N--CA 1.462 -0.338 0 C-N-CA 122.92 2.413 . . . . 0.84999999999999998 111.64 176.36 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -68.32 -48.11 65.75 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.244 -0.889 . . . . 1.7 109.802 -177.41 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -175.37 -71.91 0.05 OUTLIER Glycine 0 N--CA 1.445 -0.756 0 C-N-CA 120.687 -0.768 . . . . 1.6899999999999999 112.074 177.778 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 15.6 m120 -89.63 -77.9 0.38 Allowed 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.891 0.377 . . . . 2.96 111.098 -176.78 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . 0.483 ' O ' ' HB2' ' A' ' 23' ' ' PHE . 27.2 p-10 -138.31 39.72 2.27 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.402 0.62 . . . . 2.5 111.001 -175.528 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 35.2 t -138.65 166.51 24.17 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 108.124 -1.065 . . . . 1.3 108.124 177.287 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . 0.629 ' CE3' HD21 ' A' ' 25' ' ' LEU . 24.4 m0 -141.68 165.52 27.25 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 107.865 -1.161 . . . . 0.46999999999999997 107.865 -174.508 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 12.7 t -145.02 150.06 36.22 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 109.432 -0.581 . . . . 0.82999999999999996 109.432 172.383 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.413 HD11 HD22 ' A' ' 59' ' ' LEU . 1.0 OUTLIER -93.37 102.68 14.93 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.318 0.58 . . . . 1.71 110.335 -176.446 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -97.04 123.49 53.07 Favored Pre-proline 0 C--N 1.321 -0.663 0 CA-C-N 115.197 -0.911 . . . . 2.1299999999999999 110.294 173.757 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_exo -62.64 114.78 2.54 Favored 'Trans proline' 0 N--CA 1.461 -0.392 0 C-N-CA 122.403 2.069 . . . . 1.3600000000000001 111.72 178.307 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.409 ' HB3' ' CB ' ' A' ' 60' ' ' GLN . . . -151.19 89.38 4.26 Favored Pre-proline 0 C--N 1.321 -0.646 0 N-CA-C 109.326 -0.62 . . . . 1.8899999999999999 109.326 179.108 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -88.14 -80.43 0.0 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.255 0 C-N-CA 122.963 2.442 . . . . 2.73 112.77 -173.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -127.45 68.75 74.11 Favored Pre-proline 0 C--N 1.323 -0.553 0 N-CA-C 107.966 -1.124 . . . . 4.21 107.966 173.368 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_endo -90.14 66.78 1.89 Allowed 'Trans proline' 0 N--CA 1.447 -1.214 0 C-N-CA 123.467 2.778 . . . . 4.2599999999999998 111.44 -168.068 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 44.3 mtmt -123.49 -173.16 2.67 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 114.602 -1.181 . . . . 6.21 109.953 -176.844 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -98.67 52.43 1.0 Allowed 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.933 0.873 . . . . 8.1099999999999994 109.064 175.728 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 20.1 t70 . . . . . 0 C--O 1.248 1.01 0 CA-C-N 114.889 -1.051 . . . . 9.0500000000000007 110.09 -174.61 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 0.788 0 CA-C-O 120.541 0.21 . . . . 3.8100000000000001 110.619 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -155.69 149.92 25.72 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.853 0.359 . . . . 4.0 110.469 177.777 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 31.5 m -139.99 152.68 22.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 115.95 -0.568 . . . . 1.6399999999999999 110.282 -178.479 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 19.1 p-10 -127.97 97.09 4.68 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.588 0.708 . . . . 2.29 109.374 176.095 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 66.1 mt -134.03 118.09 27.6 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 115.723 -0.671 . . . . 0.81999999999999995 110.004 -177.293 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -81.17 170.79 14.1 Favored Pre-proline 0 C--N 1.323 -0.574 0 CA-C-N 115.562 -0.744 . . . . 1.3799999999999999 109.431 -179.644 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -54.96 141.23 78.98 Favored 'Trans proline' 0 N--CA 1.458 -0.6 0 C-N-CA 121.374 1.382 . . . . 1.73 109.843 167.23 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.442 ' O ' ' HB2' ' A' ' 36' ' ' GLN . . . 173.68 -135.8 3.37 Favored Glycine 0 N--CA 1.446 -0.68 0 N-CA-C 110.575 -1.01 . . . . 1.8400000000000001 110.575 -169.312 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.867 ' HA ' ' HA ' ' A' ' 36' ' ' GLN . 23.7 m -125.25 155.9 39.38 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 117.427 0.614 . . . . 1.6100000000000001 110.407 178.097 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.615 HD22 ' HB2' ' A' ' 37' ' ' SER . 3.9 mm? -56.3 -39.3 72.5 Favored 'General case' 0 C--O 1.234 0.247 0 CA-C-N 118.074 0.397 . . . . 1.1899999999999999 111.093 179.231 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -47.08 -56.09 7.16 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-N 115.27 -0.877 . . . . 2.1099999999999999 111.822 178.561 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 3.3 tppp? -66.06 -31.14 71.84 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.796 -0.183 . . . . 2.7200000000000002 111.171 -178.752 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -66.26 -57.86 6.62 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.054 0.454 . . . . 0.46000000000000002 110.597 -177.278 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 95.4 mt -59.69 -39.17 83.63 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 115.871 -0.604 . . . . 0.68999999999999995 111.315 177.243 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 25.7 t-20 -57.38 -41.46 80.25 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.27 0.557 . . . . 1.3100000000000001 110.038 177.031 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -63.46 -48.25 78.45 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.337 -0.847 . . . . 2.23 110.678 179.258 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -70.35 -37.82 74.7 Favored 'General case' 0 N--CA 1.456 -0.148 0 C-N-CA 120.894 -0.322 . . . . 0.65000000000000002 111.27 -172.183 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.594 ' HA ' ' CZ ' ' A' ' 23' ' ' PHE . . . -47.91 -44.74 30.07 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-O 120.777 0.323 . . . . 0.37 111.652 176.478 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.59 -21.24 66.25 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.736 -0.666 . . . . 0.64000000000000001 112.358 179.355 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 3.9 t-160 -58.96 -61.53 2.57 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 120.667 0.27 . . . . 1.8500000000000001 111.45 -175.647 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.636 ' HB3' ' HD1' ' A' ' 23' ' ' PHE . 8.2 t -100.78 -9.07 22.08 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.916 0.389 . . . . 1.6699999999999999 111.287 -177.764 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 73.33 56.54 5.57 Favored Glycine 0 C--N 1.331 0.284 0 C-N-CA 121.124 -0.56 . . . . 0.62 112.49 -179.714 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.636 ' HD1' ' HB3' ' A' ' 21' ' ' SER . 17.4 p90 -116.68 172.73 7.04 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.737 0.303 . . . . 0.56999999999999995 110.935 -177.617 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.603 ' O ' ' HB3' ' A' ' 68' ' ' SER . 27.3 m -94.49 111.0 22.74 Favored 'General case' 0 N--CA 1.448 -0.53 0 CA-C-O 121.345 0.593 . . . . 0.68000000000000005 111.088 -179.247 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 3.2 tt -93.72 117.77 30.53 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.216 -0.661 . . . . 1.6699999999999999 109.216 177.752 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 73.5 m -104.65 103.13 12.72 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.97 -0.559 . . . . 1.1499999999999999 111.341 -174.062 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.479 ' CG2' HD12 ' A' ' 71' ' ' LEU . 4.2 p -138.84 129.65 34.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 115.842 -0.617 . . . . 0.90000000000000002 110.668 178.254 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -72.57 121.76 20.23 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.727 -0.67 . . . . 2.3799999999999999 110.307 176.153 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -60.31 77.27 0.01 OUTLIER 'General case' 0 C--O 1.236 0.35 0 CA-C-N 115.778 -0.646 . . . . 1.97 111.984 177.693 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 30.6 t -175.47 -31.41 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.723 -0.671 . . . . 2.2200000000000002 109.513 178.317 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 80.1 mt -63.11 -53.01 60.24 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 115.639 -0.71 . . . . 1.3799999999999999 110.636 179.316 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 3.0 p -92.39 58.28 3.17 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.773 -0.649 . . . . 1.4399999999999999 110.831 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 16.6 ptp180 -71.26 105.72 3.57 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 115.742 -0.663 . . . . 4.6299999999999999 109.758 176.353 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 68.24 -93.25 0.28 Allowed Glycine 0 N--CA 1.45 -0.397 0 N-CA-C 110.633 -0.987 . . . . 1.6200000000000001 110.633 -170.363 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.587 ' HG3' HD23 ' A' ' 10' ' ' LEU . 40.7 tptt 50.82 94.3 0.02 OUTLIER 'General case' 0 C--O 1.236 0.355 0 C-N-CA 123.779 0.831 . . . . 2.75 111.974 171.288 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . 0.867 ' HA ' ' HA ' ' A' ' 9' ' ' SER . 2.8 pt20 -101.37 153.81 19.34 Favored 'General case' 0 N--CA 1.447 -0.58 0 O-C-N 121.994 -0.441 . . . . 2.2400000000000002 110.474 -174.804 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.615 ' HB2' HD22 ' A' ' 10' ' ' LEU . 32.8 t -128.08 138.66 52.63 Favored 'General case' 0 N--CA 1.446 -0.673 0 N-CA-C 108.469 -0.937 . . . . 1.02 108.469 -179.778 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.511 ' N ' HD22 ' A' ' 38' ' ' ASN . 0.9 OUTLIER -64.85 -8.96 17.39 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.997 -0.547 . . . . 1.28 112.143 -179.213 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 118.6 -177.39 16.43 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 120.868 -0.682 . . . . 0.41999999999999998 112.634 171.554 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.437 HD13 ' HG2' ' A' ' 52' ' ' GLN . 63.3 tp -159.62 109.52 1.88 Allowed 'General case' 0 N--CA 1.449 -0.486 0 N-CA-C 108.605 -0.887 . . . . 0.69999999999999996 108.605 -179.432 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 12.7 p80 -144.7 98.23 3.15 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 122.018 0.913 . . . . 2.96 111.332 -178.633 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -170.03 -169.82 33.68 Favored Glycine 0 N--CA 1.443 -0.888 0 CA-C-N 114.356 -1.293 . . . . 0.55000000000000004 111.043 176.689 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 32.1 m-20 -82.43 75.36 9.34 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.116 -0.698 . . . . 2.1800000000000002 109.116 173.36 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . . . . . . . . . 79.8 m-85 -110.08 123.12 49.14 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.564 -0.744 . . . . 1.4099999999999999 110.798 -178.144 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -89.27 -163.1 0.94 Allowed 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 108.878 -0.786 . . . . 2.23 108.878 173.23 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.516 ' O ' ' HG ' ' A' ' 50' ' ' LEU . 37.5 t -53.09 -71.81 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 N-CA-C 112.751 0.648 . . . . 0.56999999999999995 112.751 -172.367 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -61.83 -42.44 99.03 Favored 'General case' 0 C--O 1.234 0.262 0 N-CA-C 112.944 0.72 . . . . 2.3900000000000001 112.944 -171.54 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 28.6 m -68.89 -29.99 68.39 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.158 0.504 . . . . 1.26 111.01 -173.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . -80.07 -29.83 44.72 Favored Glycine 0 N--CA 1.445 -0.711 0 N-CA-C 110.9 -0.88 . . . . 0.37 110.9 -178.481 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.621 ' HB3' HG11 ' A' ' 61' ' ' VAL . 82.6 mt -74.73 -45.51 43.61 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 115.459 -0.371 . . . . 1.0900000000000001 110.385 -179.369 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 24.2 tp60 -55.63 -41.46 73.56 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.97 -0.559 . . . . 2.5899999999999999 111.27 178.413 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.935 HE21 ' HA ' ' A' ' 52' ' ' GLN . 0.0 OUTLIER -63.81 -48.36 77.16 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.613 -0.267 . . . . 1.75 111.028 -179.973 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 93.1 mt -58.71 -23.99 60.64 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 112.366 0.506 . . . . 0.72999999999999998 112.366 -179.603 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.608 HD11 HG12 ' A' ' 61' ' ' VAL . 68.8 mt -78.31 -19.65 53.13 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 112.23 0.456 . . . . 2.1600000000000001 112.23 -177.174 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -65.48 101.32 0.58 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.204 0.526 . . . . 2.2400000000000002 110.802 -176.475 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 124.1 -3.7 9.05 Favored Glycine 0 N--CA 1.449 -0.482 0 CA-C-N 115.604 -0.726 . . . . 1.7 111.844 -177.345 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 6.9 m -118.09 170.69 8.65 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.758 0.313 . . . . 2.2799999999999998 110.397 179.145 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -115.2 24.29 10.74 Favored Glycine 0 N--CA 1.442 -0.901 0 N-CA-C 110.44 -1.064 . . . . 1.5800000000000001 110.44 172.64 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 85.6 mt -101.57 175.23 5.64 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 120.822 0.344 . . . . 1.4199999999999999 110.108 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 72.1 mt-30 -133.84 118.32 17.85 Favored 'General case' 0 C--N 1.318 -0.768 0 N-CA-C 109.334 -0.617 . . . . 2.6699999999999999 109.334 174.411 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.621 HG11 ' HB3' ' A' ' 50' ' ' LEU . 6.1 p -86.44 113.42 24.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 N-CA-C 108.781 -0.822 . . . . 1.54 108.781 174.35 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 40.0 ttpt -136.22 130.57 18.34 Favored Pre-proline 0 C--N 1.314 -0.94 0 CA-C-N 115.642 -0.708 . . . . 1.8100000000000001 110.213 -169.813 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.609 ' HA ' ' HA ' ' A' ' 69' ' ' TRP . 51.4 Cg_exo -55.0 130.64 41.87 Favored 'Trans proline' 0 N--CA 1.461 -0.402 0 C-N-CA 122.318 2.012 . . . . 0.84999999999999998 111.027 175.638 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.438 HD13 ' O ' ' A' ' 64' ' ' LEU . 2.8 tm? -62.64 -34.74 77.66 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.816 -0.629 . . . . 1.7 109.739 -176.545 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 177.07 -59.01 0.1 OUTLIER Glycine 0 N--CA 1.444 -0.824 0 N-CA-C 110.935 -0.866 . . . . 1.6899999999999999 110.935 177.164 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 21.0 m-80 -140.17 126.74 20.3 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.599 -0.3 . . . . 2.96 110.703 178.003 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 47.8 t30 75.25 -36.87 0.32 Allowed 'General case' 0 N--CA 1.475 0.781 0 O-C-N 124.096 0.872 . . . . 2.5 112.881 173.556 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.603 ' HB3' ' O ' ' A' ' 24' ' ' THR . 69.0 m -114.17 178.61 4.22 Favored 'General case' 0 C--N 1.321 -0.638 0 O-C-N 122.231 -0.293 . . . . 1.3 110.396 -168.072 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . 0.609 ' HA ' ' HA ' ' A' ' 63' ' ' PRO . 40.0 m0 -139.16 167.81 21.24 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 120.825 0.345 . . . . 0.46999999999999997 110.125 -169.224 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 14.3 t -149.95 150.56 32.02 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.348 -0.612 . . . . 0.82999999999999996 109.348 169.082 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.559 HD23 ' HA ' ' A' ' 61' ' ' VAL . 25.9 mt -92.79 102.89 15.28 Favored 'General case' 0 CA--C 1.517 -0.317 0 C-N-CA 120.285 -0.566 . . . . 1.71 110.056 174.644 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.416 ' HA ' ' HD3' ' A' ' 73' ' ' PRO . 42.7 tt0 -87.36 119.48 70.85 Favored Pre-proline 0 C--N 1.317 -0.807 0 CA-C-N 115.098 -0.956 . . . . 2.1299999999999999 110.528 177.493 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 72' ' ' GLU . 6.3 Cg_exo -75.25 114.07 3.92 Favored 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 122.341 2.027 . . . . 1.3600000000000001 111.187 177.109 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -163.15 76.82 1.83 Allowed Pre-proline 0 C--N 1.32 -0.698 0 N-CA-C 108.681 -0.859 . . . . 1.8899999999999999 108.681 -179.771 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -81.33 54.76 5.32 Favored 'Trans proline' 0 N--CA 1.459 -0.549 0 C-N-CA 122.714 2.276 . . . . 2.73 112.855 -170.608 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 52.59 68.15 3.32 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.277 0.561 . . . . 4.21 109.976 -174.802 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -91.59 146.29 3.29 Favored 'Trans proline' 0 N--CA 1.446 -1.274 0 C-N-CA 124.076 3.184 . . . . 4.2599999999999998 111.138 -173.118 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.431 ' NZ ' ' HB2' ' A' ' 78' ' ' LYS . 3.4 mtmp? -126.84 -54.58 1.41 Allowed 'General case' 0 C--N 1.32 -0.695 0 C-N-CA 120.672 -0.411 . . . . 6.21 111.969 -167.916 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -156.85 26.64 0.32 Allowed 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 122.251 1.024 . . . . 8.1099999999999994 108.37 174.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 . . . . . 0 C--O 1.245 0.832 0 CA-C-N 113.619 -1.628 . . . . 9.0500000000000007 109.492 -172.862 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.061 0 N-CA-C 110.01 -0.367 . . . . 3.8100000000000001 110.01 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.79 HE21 ' HA ' ' A' ' 2' ' ' GLN . 0.0 OUTLIER -68.98 -57.51 5.37 Favored 'General case' 0 CA--C 1.513 -0.443 0 CA-C-O 121.523 0.678 . . . . 4.0 111.893 -172.475 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 17.3 m -115.67 131.78 67.05 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 CA-C-N 114.64 -1.164 . . . . 1.6399999999999999 111.46 -175.211 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' ASN . . . . . . . . . . . . . 50.5 m-80 -130.74 97.58 4.39 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 108.386 -0.968 . . . . 2.29 108.386 174.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 56.6 mt -121.35 132.45 70.62 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-N 115.989 -0.55 . . . . 0.81999999999999995 111.322 -170.907 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -75.01 157.73 85.12 Favored Pre-proline 0 C--N 1.326 -0.427 0 CA-C-N 115.68 -0.691 . . . . 1.3799999999999999 109.872 177.781 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.496 ' HA ' ' O ' ' A' ' 37' ' ' SER . 11.6 Cg_exo -72.12 54.91 2.3 Favored 'Trans proline' 0 CA--C 1.533 0.46 0 C-N-CA 123.003 2.468 . . . . 1.73 112.835 179.031 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -125.05 -161.54 11.08 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.771 -0.728 . . . . 1.8400000000000001 113.177 -178.083 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 18.7 m -47.01 125.88 8.19 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 123.566 0.746 . . . . 1.6100000000000001 112.322 -177.227 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 68.0 tp -60.94 -29.54 69.69 Favored 'General case' 0 CA--C 1.522 -0.102 0 CA-C-N 115.412 -0.813 . . . . 1.1899999999999999 110.756 -179.416 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.446 ' CA ' ' HB ' ' A' ' 32' ' ' THR . 22.9 t70 -51.43 -52.21 48.16 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.703 -0.68 . . . . 2.1099999999999999 111.232 176.643 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' LYS . . . . . . . . . . . . . 21.9 tptm -69.88 -25.54 63.76 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.497 -0.32 . . . . 2.7200000000000002 110.616 -179.339 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.642 ' O ' ' HG3' ' A' ' 16' ' ' GLN . . . -65.12 -54.64 26.76 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.179 0.514 . . . . 0.46000000000000002 109.943 179.017 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.687 ' HB3' HD11 ' A' ' 25' ' ' LEU . 95.9 mt -59.9 -35.73 75.48 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.834 -0.621 . . . . 0.68999999999999995 110.397 174.155 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 24.1 t-20 -59.09 -47.22 86.07 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.554 -0.748 . . . . 1.3100000000000001 110.992 -179.463 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.642 ' HG3' ' O ' ' A' ' 13' ' ' ALA . 0.3 OUTLIER -65.43 -32.72 74.49 Favored 'General case' 0 C--O 1.232 0.176 0 C-N-CA 120.947 -0.301 . . . . 2.23 111.103 -177.587 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.496 ' N ' HE21 ' A' ' 16' ' ' GLN . 5.2 t80 -71.71 -42.82 66.91 Favored 'General case' 0 CA--C 1.527 0.071 0 N-CA-C 109.475 -0.565 . . . . 0.65000000000000002 109.475 178.128 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.731 ' HA ' ' CZ ' ' A' ' 23' ' ' PHE . . . -53.68 -46.28 70.59 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-N 115.993 -0.548 . . . . 0.37 111.614 177.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.29 -21.88 66.52 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.185 -0.461 . . . . 0.64000000000000001 111.708 -179.855 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 83.2 t60 -66.07 -52.5 48.3 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.717 -0.22 . . . . 1.8500000000000001 111.321 -178.537 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.606 ' HB3' ' HD1' ' A' ' 23' ' ' PHE . 31.9 t -100.04 -17.56 17.43 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.064 0.459 . . . . 1.6699999999999999 111.525 -175.399 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 75.77 48.28 10.5 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.945 -0.645 . . . . 0.62 112.912 -178.273 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.731 ' CZ ' ' HA ' ' A' ' 18' ' ' ALA . 25.3 p90 -107.83 166.14 10.92 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 110.082 -0.34 . . . . 0.56999999999999995 110.082 -179.943 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.505 ' O ' ' HB3' ' A' ' 68' ' ' SER . 40.3 m -91.32 109.12 20.39 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.274 0.559 . . . . 0.68000000000000005 111.234 -179.275 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.687 HD11 ' HB3' ' A' ' 14' ' ' LEU . 2.0 tt -92.33 122.83 35.17 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.153 -0.684 . . . . 1.6699999999999999 109.153 177.248 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 25.5 t -100.83 98.4 8.91 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 120.793 0.33 . . . . 1.1499999999999999 110.442 -175.288 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 8.2 p -149.14 141.89 18.0 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 CA-C-N 115.944 -0.571 . . . . 0.90000000000000002 110.878 179.598 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -90.97 138.2 31.78 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.327 -0.397 . . . . 2.3799999999999999 110.29 174.414 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -62.37 76.63 0.02 OUTLIER 'General case' 0 C--O 1.235 0.309 0 CA-C-N 116.025 -0.534 . . . . 1.97 111.939 176.757 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 22.3 p -166.84 -52.21 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.356 -0.383 . . . . 2.2200000000000002 110.342 -179.139 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.419 HD13 HD12 ' A' ' 71' ' ' LEU . 84.6 mt -66.51 -44.79 81.56 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.162 -0.472 . . . . 1.3799999999999999 110.649 179.188 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.446 ' HB ' ' CA ' ' A' ' 11' ' ' ASP . 4.0 p -91.83 -5.66 53.01 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.894 -0.594 . . . . 1.4399999999999999 111.198 179.744 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' ARG . . . . . . . . . . . . . 28.0 ttp180 -82.49 129.38 34.9 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.609 -0.723 . . . . 4.6299999999999999 110.568 -177.417 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . 80.47 -29.97 2.53 Favored Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 121.172 -0.537 . . . . 1.6200000000000001 112.2 178.202 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.505 ' HD3' ' C ' ' A' ' 35' ' ' LYS . 11.0 tmtt? -71.66 117.97 13.9 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 109.028 -0.73 . . . . 2.75 109.028 177.133 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -102.15 149.77 23.94 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.083 0.468 . . . . 2.2400000000000002 110.466 -178.071 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.496 ' O ' ' HA ' ' A' ' 7' ' ' PRO . 0.4 OUTLIER -123.31 134.74 54.03 Favored 'General case' 0 N--CA 1.431 -1.408 0 N-CA-C 107.731 -1.211 . . . . 1.02 107.731 176.117 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.424 ' HA ' ' HB3' ' A' ' 7' ' ' PRO . 0.9 OUTLIER -61.86 -2.0 0.77 Allowed 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 113.152 0.797 . . . . 1.28 113.152 -176.707 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 101.62 -171.55 22.09 Favored Glycine 0 CA--C 1.501 -0.807 0 C-N-CA 120.859 -0.686 . . . . 0.41999999999999998 111.976 171.16 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 48.9 tp -161.4 134.74 6.45 Favored 'General case' 0 N--CA 1.444 -0.752 0 N-CA-C 107.443 -1.317 . . . . 0.69999999999999996 107.443 -178.91 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 57.9 m80 -136.32 96.54 3.39 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 121.145 0.498 . . . . 2.96 110.658 178.554 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -170.49 176.13 44.15 Favored Glycine 0 N--CA 1.444 -0.81 0 CA-C-N 115.451 -0.795 . . . . 0.55000000000000004 112.077 177.183 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.708 ' HA ' ' H ' ' A' ' 2' ' ' GLN . 5.3 p-10 -93.75 76.23 4.28 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.849 0.833 . . . . 2.1800000000000002 108.875 170.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' TYR . . . . . 0.465 ' O ' ' HG2' ' A' ' 2' ' ' GLN . 38.8 m-85 -94.85 149.51 21.17 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.462 -0.79 . . . . 1.4099999999999999 111.997 -173.214 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -85.49 179.12 7.2 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.467 -0.788 . . . . 2.23 109.347 173.693 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.489 ' O ' ' HG ' ' A' ' 50' ' ' LEU . 58.4 t -54.58 -71.99 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 N-CA-C 112.139 0.422 . . . . 0.56999999999999995 112.139 -176.53 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -58.54 -41.71 86.16 Favored 'General case' 0 C--O 1.233 0.229 0 N-CA-C 112.568 0.581 . . . . 2.3900000000000001 112.568 -175.431 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' SER . . . . . . . . . . . . . 1.3 p -71.38 -32.02 67.97 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.086 0.47 . . . . 1.26 111.004 -175.606 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.61 ' O ' ' HG ' ' A' ' 53' ' ' LEU . . . -73.84 -36.18 53.16 Favored Glycine 0 N--CA 1.442 -0.918 0 N-CA-C 111.089 -0.804 . . . . 0.37 111.089 179.673 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.501 HD23 HD12 ' A' ' 53' ' ' LEU . 91.2 mt -67.35 -40.62 85.87 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.617 -0.292 . . . . 1.0900000000000001 110.479 -179.833 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 -55.18 -45.44 75.77 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.043 -0.526 . . . . 2.5899999999999999 111.015 178.652 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 15.9 mm100 -68.52 -36.18 78.51 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.586 -0.279 . . . . 1.75 111.174 178.591 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.61 ' HG ' ' O ' ' A' ' 49' ' ' GLY . 80.1 mt -59.12 -21.03 58.66 Favored 'General case' 0 N--CA 1.464 0.27 0 N-CA-C 112.033 0.382 . . . . 0.72999999999999998 112.033 178.259 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 7.3 mp -75.95 15.93 0.48 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.904 0.383 . . . . 2.1600000000000001 111.39 177.754 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -56.71 111.51 1.03 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.722 -0.672 . . . . 2.2400000000000002 111.138 176.486 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 65.27 23.64 70.08 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 121.067 -0.587 . . . . 1.7 112.543 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 50.9 m -99.86 148.63 24.24 Favored 'General case' 0 C--N 1.323 -0.579 0 O-C-N 122.545 -0.385 . . . . 2.2799999999999998 110.735 179.642 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -111.66 28.32 9.6 Favored Glycine 0 N--CA 1.441 -0.988 0 N-CA-C 109.679 -1.369 . . . . 1.5800000000000001 109.679 168.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.538 HD13 HD11 ' A' ' 71' ' ' LEU . 59.6 mt -121.82 179.8 4.37 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.122 -0.696 . . . . 1.4199999999999999 109.122 -179.62 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' GLN . . . . . . . . . . . . . 27.4 tt0 -151.23 121.48 7.26 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.699 -0.482 . . . . 2.6699999999999999 109.699 178.245 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.441 HG11 HD22 ' A' ' 50' ' ' LEU . 7.3 p -93.51 137.11 23.38 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 N-CA-C 109.708 -0.479 . . . . 1.54 109.708 179.649 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.583 ' HG3' ' HG3' ' A' ' 72' ' ' GLU . 15.6 mtmm -130.19 135.51 27.57 Favored Pre-proline 0 C--N 1.327 -0.396 0 C-N-CA 121.065 -0.254 . . . . 1.8100000000000001 110.409 -179.218 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_exo -63.0 121.79 9.8 Favored 'Trans proline' 0 N--CA 1.458 -0.604 0 C-N-CA 122.407 2.071 . . . . 0.84999999999999998 110.341 169.568 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 44.8 tp -62.57 -40.46 96.93 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.414 -0.812 . . . . 1.7 111.102 -174.149 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . 134.49 -22.16 3.74 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.855 -0.688 . . . . 1.6899999999999999 111.8 177.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' ASN . . . . . . . . . . . . . 27.8 p-10 -106.95 41.65 1.43 Allowed 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.807 0.337 . . . . 2.96 110.582 -179.214 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 66.2 t30 56.33 36.06 26.88 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 121.684 0.754 . . . . 2.5 110.428 -177.024 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . 0.505 ' HB3' ' O ' ' A' ' 24' ' ' THR . 68.5 m -141.55 177.88 7.84 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 107.857 -1.164 . . . . 1.3 107.857 176.104 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' TRP . . . . . 0.463 ' CH2' HD21 ' A' ' 50' ' ' LEU . 54.5 m0 -136.27 167.14 21.86 Favored 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 120.521 -0.472 . . . . 0.46999999999999997 111.12 -167.154 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 3.8 t -145.46 142.42 29.26 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.402 -0.817 . . . . 0.82999999999999996 109.722 174.831 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.538 HD11 HD13 ' A' ' 59' ' ' LEU . 0.7 OUTLIER -92.85 104.01 16.3 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 109.36 -0.607 . . . . 1.71 109.36 179.773 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.583 ' HG3' ' HG3' ' A' ' 62' ' ' LYS . 4.5 mm-40 -88.28 120.63 70.55 Favored Pre-proline 0 C--N 1.319 -0.727 0 CA-C-N 115.009 -0.996 . . . . 2.1299999999999999 110.968 -178.389 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.473 ' HD3' ' HA ' ' A' ' 72' ' ' GLU . 4.9 Cg_endo -86.97 115.03 1.15 Allowed 'Trans proline' 0 N--CA 1.453 -0.873 0 C-N-CA 123.005 2.47 . . . . 1.3600000000000001 111.685 177.463 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -172.82 85.93 0.41 Allowed Pre-proline 0 C--N 1.327 -0.382 0 CA-C-N 115.792 -0.64 . . . . 1.8899999999999999 109.736 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.488 ' HB2' ' H ' ' A' ' 76' ' ' ALA . 2.2 Cg_endo -80.37 -91.17 0.0 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.823 0 C-N-CA 122.398 2.065 . . . . 2.73 112.59 -175.088 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.488 ' H ' ' HB2' ' A' ' 75' ' ' PRO . . . -134.27 61.76 52.05 Favored Pre-proline 0 C--N 1.322 -0.593 0 N-CA-C 108.69 -0.856 . . . . 4.21 108.69 170.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -87.61 39.25 0.55 Allowed 'Trans proline' 0 N--CA 1.451 -0.988 0 C-N-CA 123.02 2.48 . . . . 4.2599999999999998 112.182 -168.444 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 48.3 tptt -92.52 -51.01 5.33 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 115.735 -0.666 . . . . 6.21 110.037 178.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -89.34 -63.02 1.35 Allowed 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.94 -0.393 . . . . 8.1099999999999994 109.94 178.836 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 38.1 t70 . . . . . 0 C--O 1.247 0.955 0 CA-C-O 118.327 -0.844 . . . . 9.0500000000000007 110.202 177.005 . . . . . . . . 0 0 . 1 stop_ save_